data_2kw2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kw2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 8' ' ' VAL . 23.7 m . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 120.373 0.13 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -68.67 -35.48 77.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -43.24 80.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.266 0.627 . . . . 0.0 110.638 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -72.55 -44.89 61.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.957 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 4' ' ' THR . 95.2 t -60.01 -42.09 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.334 0.654 . . . . 0.0 111.369 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.76 99.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.803 0.841 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -63.37 -42.66 98.86 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.873 0.869 . . . . 0.0 112.023 174.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.578 HG23 HG13 ' A' ' 47' ' ' ILE . 24.5 mm -56.79 -58.65 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.683 0.793 . . . . 0.0 109.527 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.37 -34.08 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.239 1.015 . . . . 0.0 110.944 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -59.16 -53.54 57.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.358 0.663 . . . . 0.0 111.608 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.57 -25.4 38.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.453 0.701 . . . . 0.0 112.01 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.4 m -75.94 -62.41 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.312 0.645 . . . . 0.0 110.149 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.57 ' SG ' HD12 ' A' ' 43' ' ' ILE . 2.7 m -85.81 -2.92 58.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.943 0.897 . . . . 0.0 112.368 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 65.11 16.22 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.912 1.285 . . . . 0.0 112.468 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 73.4 mt -79.33 120.7 81.37 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_endo -62.04 145.11 96.74 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.269 1.979 . . . . 0.0 112.291 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -54.74 -34.48 62.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.195 0.998 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -59.67 -38.25 80.95 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.877 0.736 . . . . 0.0 111.658 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 21' ' ' GLU . 76.2 p -86.84 -6.05 58.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.305 0.642 . . . . 0.0 111.687 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.01 133.87 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.992 0.917 . . . . 0.0 109.489 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -144.48 153.1 54.93 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.588 1.155 . . . . 0.0 110.006 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.54 -43.16 56.99 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.408 2.739 . . . . 0.0 114.448 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.83 -3.59 58.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.799 0.44 . . . . 0.0 111.638 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.4 t -68.55 137.36 54.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 49.6 t-80 -98.19 131.34 44.63 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.156 0.982 . . . . 0.0 108.76 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -49.9 -58.95 4.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.48 0.712 . . . . 0.0 111.97 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.36 -55.31 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.585 0.354 . . . . 0.0 111.132 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.1 t70 -63.08 -55.29 26.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.695 0.798 . . . . 0.0 111.768 -172.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.76 -65.74 0.98 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.905 0.482 . . . . 0.0 110.685 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 HD12 ' A' ' 77' ' ' LEU . 88.5 mt -64.44 -28.49 69.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.531 0.732 . . . . 0.0 111.962 -173.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.64 40.2 27.58 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-O 121.31 0.394 . . . . 0.0 112.373 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.39 127.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.466 1.106 . . . . 0.0 109.31 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.04 159.24 17.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.847 0.859 . . . . 0.0 109.604 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 48.1 m -49.51 -38.55 30.82 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.1 0.96 . . . . 0.0 112.781 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 mt -71.06 -35.22 71.84 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.445 0.698 . . . . 0.0 110.999 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.11 -37.59 64.08 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.275 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -71.45 -22.04 61.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.208 0.603 . . . . 0.0 110.776 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.7 mt -57.1 -47.24 81.52 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.29 -35.35 79.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.579 1.151 . . . . 0.0 111.732 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.57 HD12 ' SG ' ' A' ' 16' ' ' CYS . 74.5 mt -64.92 -53.1 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.017 0.527 . . . . 0.0 110.144 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -67.34 -29.03 68.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.037 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.11 -38.37 56.96 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.988 0.805 . . . . 0.0 110.84 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.32 -36.65 74.4 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.578 HG13 HG23 ' A' ' 11' ' ' ILE . 85.3 mt -66.52 -42.49 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.206 1.003 . . . . 0.0 110.586 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.23 -43.96 71.29 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.366 1.066 . . . . 0.0 110.474 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.71 -37.07 23.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.236 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.91 23.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.212 0.605 . . . . 0.0 111.401 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -78.68 -18.03 55.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.021 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.34 50.5 38.18 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.0 pt -133.13 160.39 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.538 1.135 . . . . 0.0 109.156 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -94.68 96.92 9.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD22 ' HB1' ' A' ' 44' ' ' ALA . 6.7 tt -83.29 111.29 29.9 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.58 81.9 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.843 1.695 . . . . 0.0 110.802 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.74 -28.11 66.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.788 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.68 -33.32 64.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.792 0.837 . . . . 0.0 111.472 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.6 tttp -80.11 -49.68 11.38 Favored 'General case' 0 C--O 1.211 -0.961 0 C-N-CA 122.999 0.519 . . . . 0.0 109.917 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -60.27 -48.81 80.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.644 0.778 . . . . 0.0 111.705 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.5 m -52.2 -46.23 65.52 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.728 1.211 . . . . 0.0 111.705 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -64.24 -37.52 87.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.926 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.8 mm-40 -59.88 -42.69 94.3 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.072 0.549 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.02 -49.97 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.523 0.729 . . . . 0.0 110.887 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -61.51 -31.42 71.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.032 0.933 . . . . 0.0 112.94 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.46 0.88 55.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.546 0.738 . . . . 0.0 111.127 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.61 78.19 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.61 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -88.06 -12.93 42.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.543 0.737 . . . . 0.0 111.089 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.55 36.36 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.104 0.962 . . . . 0.0 109.825 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -108.37 159.57 16.55 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.162 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 p -58.23 -33.51 69.41 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.487 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 76' ' ' VAL . 44.2 tt0 -49.75 -48.49 50.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.946 0.899 . . . . 0.0 112.002 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.88 -30.9 71.17 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.98 5.0 10.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 86.8 m-85 -133.67 -32.51 1.13 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.93 0.786 . . . . 0.0 111.876 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 89.8 t -59.91 127.27 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.561 HD12 HD11 ' A' ' 33' ' ' LEU . 27.5 mt -59.7 -38.36 81.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -163.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.52 -36.75 76.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.814 0.446 . . . . 0.0 112.059 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.51 -46.15 64.21 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.619 0.768 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.23 -49.63 63.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.64 1.576 . . . . 0.0 110.127 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.48 64.97 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.43 61.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.688 0.395 . . . . 0.0 110.332 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.477 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 21.4 mmm180 -67.28 -31.34 71.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.429 0.691 . . . . 0.0 111.895 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 47' ' ' ILE . 79.8 mt -77.58 -42.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.21 0.604 . . . . 0.0 110.026 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.471 ' HA ' HG21 ' A' ' 88' ' ' VAL . 31.0 t70 -54.97 -34.64 63.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.685 0.794 . . . . 0.0 111.588 170.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.98 -49.46 77.36 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.464 0.706 . . . . 0.0 110.73 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 54.0 mt -68.35 -37.74 80.78 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.67 0.788 . . . . 0.0 112.468 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 85' ' ' ASP . 19.3 m -74.91 -27.87 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.038 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.11 67.9 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.286 171.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 123.691 0.796 . . . . 0.0 112.883 176.584 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -74.65 -37.19 62.8 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.294 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -52.21 -49.28 64.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 123.835 0.709 . . . . 0.0 110.732 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -65.66 -47.09 76.68 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.235 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.64 -36.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.326 0.651 . . . . 0.0 111.973 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.36 96.09 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.159 0.983 . . . . 0.0 110.342 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -57.38 -47.14 82.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.254 1.021 . . . . 0.0 112.034 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.432 HG22 HG13 ' A' ' 47' ' ' ILE . 95.3 mt -66.57 -49.86 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.739 . . . . 0.0 111.65 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.435 HG12 HD12 ' A' ' 43' ' ' ILE . 62.8 mt -63.87 -35.5 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.643 0.777 . . . . 0.0 111.259 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.38 35.14 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.506 0.722 . . . . 0.0 111.551 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.23 -29.05 53.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.154 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.4 m -72.36 -62.11 1.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.84 0.456 . . . . 0.0 110.612 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.7 m -83.41 -1.09 52.66 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -170.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.94 61.74 2.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.959 0.904 . . . . 0.0 110.028 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -127.57 138.38 32.71 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.887 1.275 . . . . 0.0 108.409 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.14 123.04 11.69 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.872 2.382 . . . . 0.0 111.72 167.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -41.23 89.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.639 1.576 . . . . 0.0 110.764 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.85 -29.43 65.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.794 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -80.25 -25.38 39.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.443 0.297 . . . . 0.0 111.104 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -56.35 110.99 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.456 0.702 . . . . 0.0 111.034 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -94.62 147.13 32.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.605 0.762 . . . . 0.0 109.743 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 37.1 Cg_endo -65.07 -28.87 56.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.404 2.069 . . . . 0.0 111.955 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.41 -11.08 59.92 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.226 0.61 . . . . 0.0 111.709 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.1 p -74.31 140.35 44.83 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.813 0.339 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.2 t-80 -90.81 130.47 36.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.43 -61.29 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.051 0.94 . . . . 0.0 112.596 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -74.89 -44.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 122.65 0.38 . . . . 0.0 111.318 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 25.8 t70 -71.16 -65.48 0.74 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.758 0.423 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.89 -62.98 1.31 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.039 0.536 . . . . 0.0 110.651 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.733 HD11 HD13 ' A' ' 77' ' ' LEU . 76.3 mt -73.42 -11.06 60.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.438 0.695 . . . . 0.0 112.532 -172.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.26 72.34 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.45 130.24 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.716 0.806 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -71.08 149.28 46.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -67.12 -17.3 64.8 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.071 0.396 . . . . 0.0 110.489 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.28 -31.56 24.86 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.119 0.968 . . . . 0.0 110.226 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.43 -30.17 53.3 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.408 0.623 . . . . 0.0 109.783 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -67.23 -21.51 65.74 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.561 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 57' ' ' LEU . 84.2 mt -59.69 -40.3 87.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.016 0.526 . . . . 0.0 110.498 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.61 -35.93 75.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.547 0.739 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.5 mt -61.95 -48.33 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 55' ' ' LEU . . . -65.19 -31.82 73.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.448 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.55 -41.65 72.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.436 0.694 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.0 -27.55 60.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.52 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 HD13 HD12 ' A' ' 84' ' ' ILE . 94.1 mt -70.73 -42.7 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.833 0.853 . . . . 0.0 109.794 172.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.32 -40.28 74.13 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.624 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -76.43 -48.86 18.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 111.81 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.07 70.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.599 0.76 . . . . 0.0 112.124 -170.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.445 ' HB2' HG12 ' A' ' 53' ' ' ILE . 96.3 m-85 -83.45 -22.43 32.62 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.179 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.57 33.79 57.82 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 112.161 -0.376 . . . . 0.0 112.161 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.445 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.6 pt -114.94 158.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.227 1.011 . . . . 0.0 109.802 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.2 98.58 11.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 44' ' ' ALA . 8.5 tt -88.52 105.68 10.38 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.43 80.97 2.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.79 1.66 . . . . 0.0 111.225 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 41' ' ' LEU . 53.6 tp -75.87 -29.56 58.56 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.31 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 -29.76 66.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.521 0.728 . . . . 0.0 110.742 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 61.8 tttp -84.27 -48.49 9.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.621 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -61.59 -39.33 90.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.407 0.683 . . . . 0.0 111.575 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -61.83 -43.92 97.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.89 0.876 . . . . 0.0 110.881 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -65.85 -30.33 70.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.099 0.96 . . . . 0.0 111.462 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 15.2 mm-40 -62.08 -46.71 87.88 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.108 0.563 . . . . 0.0 109.892 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.6 -44.89 99.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.578 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.52 1.128 . . . . 0.0 112.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.14 -18.73 26.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.107 0.963 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.03 65.47 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.792 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -67.95 -32.86 73.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.996 0.518 . . . . 0.0 109.831 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.35 164.46 27.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.573 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -105.61 154.52 20.31 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -61.96 -32.32 72.75 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.849 0.859 . . . . 0.0 110.431 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.35 -41.41 89.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.89 -32.58 70.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 112.575 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -105.92 -58.54 1.9 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.605 0.362 . . . . 0.0 111.437 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -67.37 -19.73 65.46 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 85.2 t -66.47 129.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 119.681 1.128 . . . . 0.0 108.408 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.733 HD13 HD11 ' A' ' 33' ' ' LEU . 12.3 mt -66.34 -34.81 78.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -161.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG2' HG11 ' A' ' 76' ' ' VAL . 21.9 pttp -65.34 -36.7 84.81 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.935 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 64.1 m-20 -73.59 -44.7 56.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.419 0.688 . . . . 0.0 109.825 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.86 -48.23 67.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.642 1.177 . . . . 0.0 110.723 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.3 67.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.943 0.897 . . . . 0.0 111.391 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.39 64.29 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -63.4 -39.51 94.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.941 0.896 . . . . 0.0 111.506 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.45 HD12 HD13 ' A' ' 47' ' ' ILE . 96.6 mt -70.47 -43.02 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.109 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.32 -37.8 65.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.243 0.617 . . . . 0.0 111.382 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.15 -44.35 80.01 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.74 -42.33 95.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.604 0.762 . . . . 0.0 112.428 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 m -72.71 -29.34 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 122.999 0.52 . . . . 0.0 110.788 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.4 86.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.401 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 8' ' ' VAL . 9.0 m . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HE1' ' HB3' ' A' ' 77' ' ' LEU . 59.7 t80 -63.11 -55.95 20.99 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.399 0.437 . . . . 0.0 111.132 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.06 -36.69 70.82 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 124.188 0.93 . . . . 0.0 110.99 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -63.15 -53.13 58.19 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.679 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 4' ' ' THR . 51.8 t -61.24 -36.38 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.054 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.07 79.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 110.975 -173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.45 ' HB ' ' NH2' ' A' ' 20' ' ' ARG . 11.9 t -69.18 -29.75 67.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.658 0.383 . . . . 0.0 110.68 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.46 -50.74 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.191 0.596 . . . . 0.0 109.895 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.4 mt -60.06 -36.43 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.406 0.682 . . . . 0.0 110.395 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.74 42.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.323 1.049 . . . . 0.0 112.202 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.78 -32.43 65.59 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.7 m -77.58 -60.06 2.52 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.262 0.625 . . . . 0.0 110.787 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -91.94 5.57 49.55 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 111.576 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.99 24.74 13.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.693 1.197 . . . . 0.0 113.202 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.5 114.63 56.2 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.305 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -48.51 146.88 9.91 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.327 2.685 . . . . 0.0 113.47 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.45 ' NH2' ' HB ' ' A' ' 10' ' ' THR . 3.9 mmt85 -60.31 -33.83 72.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 0.0 111.521 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.47 -35.78 80.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.082 0.953 . . . . 0.0 111.838 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -86.54 -4.75 59.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.315 0.646 . . . . 0.0 111.825 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -96.15 126.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.763 0.825 . . . . 0.0 108.841 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' HD13 ' A' ' 77' ' ' LEU . 81.8 p -140.84 148.85 54.24 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.096 0.958 . . . . 0.0 109.013 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.35 -36.41 68.59 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.81 2.34 . . . . 0.0 113.256 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -74.92 -25.04 58.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.743 0.817 . . . . 0.0 112.373 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.1 p -76.68 144.59 39.31 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.645 0.26 . . . . 0.0 111.21 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 46.7 t-80 -92.24 131.43 37.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.768 1.227 . . . . 0.0 108.963 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.05 -56.81 9.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 112.2 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -71.3 -52.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 120.409 0.147 . . . . 0.0 110.88 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 31.4 t70 -70.41 -54.62 11.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.786 0.434 . . . . 0.0 112.127 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.48 -60.55 1.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.388 0.275 . . . . 0.0 110.946 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 HD11 ' A' ' 77' ' ' LEU . 76.5 mt -68.37 -30.8 69.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.868 0.467 . . . . 0.0 111.336 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.75 0.9 68.55 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.957 -0.357 . . . . 0.0 113.189 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.09 104.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.829 0.852 . . . . 0.0 110.145 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -77.87 167.12 22.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -58.58 -17.02 18.42 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.347 0.659 . . . . 0.0 112.191 174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.04 -41.47 18.62 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.13 0.972 . . . . 0.0 110.563 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.66 -40.46 92.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.511 0.672 . . . . 0.0 109.661 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -67.66 -18.73 65.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.883 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.582 HD21 HD21 ' A' ' 57' ' ' LEU . 94.5 mt -54.43 -45.81 73.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.432 0.56 . . . . 0.0 110.852 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.83 -37.59 70.28 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.75 -41.36 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.227 0.611 . . . . 0.0 110.653 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.34 -35.27 80.47 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.12 0.887 . . . . 0.0 110.356 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.23 -42.29 88.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.904 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.85 74.38 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.484 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.6 -39.44 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.944 . . . . 0.0 110.628 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.92 -47.75 64.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.981 0.912 . . . . 0.0 111.138 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.63 -52.7 19.54 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.924 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.78 -57.02 14.87 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.186 0.929 . . . . 0.0 111.979 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.555 ' HB2' HG12 ' A' ' 53' ' ' ILE . 76.2 m-85 -83.26 -15.12 51.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.443 0.697 . . . . 0.0 111.532 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.68 31.34 67.75 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 51' ' ' PHE . 42.9 pt -113.55 -170.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.576 1.15 . . . . 0.0 109.77 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.9 114.92 17.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 163.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.25 105.07 4.55 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.24 85.51 1.76 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 121.766 1.644 . . . . 0.0 110.351 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.582 HD21 HD21 ' A' ' 41' ' ' LEU . 42.5 tp -69.4 -24.35 63.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.985 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.93 -38.57 67.84 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.889 0.876 . . . . 0.0 111.019 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.5 tttp -74.01 -50.82 18.09 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.501 1.12 . . . . 0.0 110.577 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.402 ' HB2' HD13 ' A' ' 57' ' ' LEU . 30.8 m0 -62.82 -47.19 84.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.801 0.84 . . . . 0.0 112.113 -171.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.1 m -54.57 -44.41 72.94 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.84 0.856 . . . . 0.0 111.351 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -68.38 -32.68 72.93 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.158 0.983 . . . . 0.0 111.654 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 53.7 mm-40 -57.56 -46.14 84.31 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.582 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.44 -49.84 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.355 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.43 -36.54 84.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.085 0.954 . . . . 0.0 112.675 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.02 -5.91 40.01 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.483 1.113 . . . . 0.0 111.308 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.06 61.22 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.81 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.12 -24.94 30.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.071 0.549 . . . . 0.0 111.017 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 63' ' ' GLU . . . -160.12 168.74 24.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.923 0.489 . . . . 0.0 110.664 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.5 p -105.52 163.56 12.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.826 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.9 p -67.39 -32.38 73.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.693 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 76' ' ' VAL . 42.1 tt0 -63.69 -38.81 92.5 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.232 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 29.4 tt0 -62.41 -29.68 70.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.732 0.413 . . . . 0.0 111.999 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -107.46 -71.31 0.76 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.839 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.5 m-85 -62.15 -20.83 64.52 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -165.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -62.13 126.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.298 1.408 . . . . 0.0 107.874 170.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.757 HD11 HD13 ' A' ' 33' ' ' LEU . 56.8 mt -59.01 -34.94 72.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -163.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.1 pttp -65.31 -40.72 94.13 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 173.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' GLN . 3.3 m-20 -69.22 -46.84 66.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.125 0.57 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -50.3 -48.62 55.05 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.835 1.654 . . . . 0.0 111.274 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.93 73.27 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.704 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.34 57.24 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.055 0.847 . . . . 0.0 111.409 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 26.7 mmm180 -64.28 -41.69 96.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.65 0.78 . . . . 0.0 111.276 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -70.35 -39.28 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.208 0.603 . . . . 0.0 110.385 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.07 -38.28 65.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.336 0.654 . . . . 0.0 111.653 169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -68.55 -44.74 73.84 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.607 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 95.8 mt -64.4 -41.9 96.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.108 0.963 . . . . 0.0 112.688 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.69 -32.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.148 0.579 . . . . 0.0 110.489 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.02 62.47 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 124.448 1.099 . . . . 0.0 112.656 178.37 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 8' ' ' VAL . 4.9 m . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 120.468 0.175 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.06 -52.3 63.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.896 0.479 . . . . 0.0 111.282 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -61.89 -32.38 72.75 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.863 0.727 . . . . 0.0 110.573 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.404 ' O ' HG12 ' A' ' 11' ' ' ILE . 25.8 mmt180 -66.05 -53.08 42.84 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.838 0.855 . . . . 0.0 111.409 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 81' ' ' ALA . 69.9 t -62.91 -38.09 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.361 0.601 . . . . 0.0 110.748 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 23' ' ' ILE . . . -67.97 -39.75 83.27 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.271 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 7.6 t -73.73 -27.65 61.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.243 0.217 . . . . 0.0 110.865 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 7' ' ' ARG . 34.6 mm -61.02 -55.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 18' ' ' ILE . 60.3 mt -66.51 -29.9 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.645 0.778 . . . . 0.0 111.034 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.33 -51.3 70.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.995 0.918 . . . . 0.0 111.247 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.8 mm-40 -78.98 -28.33 43.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.66 0.384 . . . . 0.0 111.676 -177.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -75.53 -61.68 1.83 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.897 0.479 . . . . 0.0 110.838 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 43' ' ' ILE . 58.6 m -95.54 7.4 46.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.402 0.681 . . . . 0.0 112.307 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.29 67.94 0.92 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.343 1.057 . . . . 0.0 111.126 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 12' ' ' ILE . 23.6 mt -121.77 122.06 27.96 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 139.73 84.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.516 2.144 . . . . 0.0 112.21 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -58.65 -35.4 72.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 0.0 111.511 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.42 -37.53 86.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.043 0.937 . . . . 0.0 111.883 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 p -84.48 -13.65 51.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.191 0.596 . . . . 0.0 111.419 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 9' ' ' ALA . 88.9 mt -81.46 113.46 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.341 0.656 . . . . 0.0 109.295 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 p -117.78 158.3 45.95 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 109.486 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 58.3 Cg_exo -55.36 -33.16 84.44 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.868 2.379 . . . . 0.0 113.506 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.17 -0.58 56.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.597 0.759 . . . . 0.0 112.441 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 26.6 m -72.59 129.2 37.74 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.3 t-80 -98.5 133.06 43.39 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -53.3 -60.14 3.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.092 0.557 . . . . 0.0 111.98 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -75.11 -42.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.451 0.301 . . . . 0.0 111.755 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.05 -56.94 3.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.371 0.668 . . . . 0.0 111.844 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -82.54 -61.52 1.86 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.266 0.626 . . . . 0.0 110.638 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 77' ' ' LEU . 79.6 mt -69.94 -19.28 63.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.054 0.942 . . . . 0.0 111.332 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.73 90.11 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 43' ' ' ILE . 85.0 mt -68.63 98.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.648 1.179 . . . . 0.0 110.346 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.23 165.78 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.094 0.957 . . . . 0.0 111.506 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.0 p -48.43 -28.2 3.12 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.013 1.325 . . . . 0.0 113.57 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.35 -40.84 16.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.504 0.721 . . . . 0.0 110.442 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.32 -30.76 69.82 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.3 0.572 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -74.38 -20.2 60.15 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD22 HD22 ' A' ' 57' ' ' LEU . 73.2 mt -56.82 -41.11 77.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.157 0.435 . . . . 0.0 111.115 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.18 -35.94 69.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.809 0.844 . . . . 0.0 110.538 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.64 HD11 ' SG ' ' A' ' 16' ' ' CYS . 37.7 mt -64.07 -48.98 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.13 0.572 . . . . 0.0 110.107 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.34 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.302 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -67.33 -43.37 81.75 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.187 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.49 76.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 111.579 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.4 mt -69.57 -37.66 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 110.692 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -56.78 -47.51 80.0 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.0 0.52 . . . . 0.0 111.056 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -71.21 -48.18 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.573 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.58 -52.64 36.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.929 0.891 . . . . 0.0 111.53 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -86.65 -11.95 49.87 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 111.933 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.94 38.57 84.95 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.286 0.366 . . . . 0.0 112.55 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 pt -126.72 -173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.11 0.964 . . . . 0.0 110.72 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -126.94 96.4 4.61 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -76.07 108.37 5.99 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.11 84.56 1.53 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.792 1.661 . . . . 0.0 110.616 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD22 HD22 ' A' ' 41' ' ' LEU . 54.0 tp -66.48 -32.21 73.43 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.773 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.96 -33.9 75.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.206 1.002 . . . . 0.0 111.108 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 56.8 tttp -72.92 -58.8 3.06 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.897 0.879 . . . . 0.0 109.771 172.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -57.18 -44.3 83.44 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.259 1.024 . . . . 0.0 111.966 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 m -63.74 -36.51 84.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.62 -30.76 61.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.5 mm-40 -60.3 -39.4 86.82 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.302 0.641 . . . . 0.0 109.317 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.1 -44.44 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.779 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.594 0.757 . . . . 0.0 112.358 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.49 -18.87 21.81 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.103 0.961 . . . . 0.0 111.189 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.15 59.23 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 113.375 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.56 -23.76 61.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.296 0.639 . . . . 0.0 110.943 169.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.36 26.4 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.692 0.797 . . . . 0.0 110.257 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 73' ' ' GLN . 8.0 t -107.15 156.48 18.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.496 0.718 . . . . 0.0 110.334 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.9 p -63.14 -33.78 76.21 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.087 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.18 -33.72 75.06 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.534 0.734 . . . . 0.0 111.986 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.442 ' H ' HG22 ' A' ' 70' ' ' THR . 8.3 tt0 -65.36 -28.36 69.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.589 . . . . 0.0 111.675 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -106.84 -76.99 0.6 Allowed 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.581 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.5 m-85 -59.18 -19.06 41.94 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -162.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 98.8 t -65.11 124.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.48 HD11 HD13 ' A' ' 33' ' ' LEU . 72.3 mt -58.86 -36.71 75.06 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 60.9 pttt -61.29 -42.35 98.5 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.43 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -72.4 -44.94 61.79 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -55.29 -44.96 76.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.684 1.594 . . . . 0.0 110.676 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 8' ' ' VAL . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.528 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.36 61.56 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.711 0.632 . . . . 0.0 111.548 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.2 mmm180 -71.32 -35.79 71.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.663 0.785 . . . . 0.0 111.354 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.81 -39.61 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.348 0.659 . . . . 0.0 109.712 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 88' ' ' VAL . 25.2 t70 -57.25 -38.97 74.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.726 0.81 . . . . 0.0 111.397 170.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -60.83 -45.96 92.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.01 0.924 . . . . 0.0 110.009 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 91.6 mt -66.58 -42.75 86.51 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.016 0.926 . . . . 0.0 113.275 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 85' ' ' ASP . 24.1 m -70.51 -31.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.058 0.456 . . . . 0.0 110.474 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.28 -51.81 27.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.718 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 124.974 1.309 . . . . 0.0 113.559 -176.544 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.5 m . . . . . 0 CA--C 1.553 1.076 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -66.57 -49.62 65.82 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.81 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.13 -41.35 68.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.13 0.894 . . . . 0.0 111.356 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.82 -46.45 62.76 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.802 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -60.92 -36.46 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 122.994 0.518 . . . . 0.0 110.911 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.89 85.15 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.559 1.144 . . . . 0.0 110.089 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.6 m -56.02 -47.07 78.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.235 1.014 . . . . 0.0 111.671 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 47' ' ' ILE . 33.3 mm -59.2 -51.59 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.84 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.436 HG23 ' SG ' ' A' ' 16' ' ' CYS . 71.1 mt -63.95 -34.77 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.82 0.848 . . . . 0.0 111.289 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -60.25 -52.28 65.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.884 0.474 . . . . 0.0 111.866 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -72.51 -37.69 68.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.581 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.6 m -74.42 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.335 0.654 . . . . 0.0 110.785 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 43' ' ' ILE . 3.3 m -82.09 -1.16 47.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.04 0.936 . . . . 0.0 113.341 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 64.28 22.67 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.373 1.082 . . . . 0.0 111.048 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 HG22 HD21 ' A' ' 33' ' ' LEU . 82.3 mt -96.0 126.4 44.75 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.524 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 40.9 Cg_endo -65.16 145.61 84.84 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.627 2.218 . . . . 0.0 112.177 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -60.11 -27.64 67.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.663 1.185 . . . . 0.0 112.653 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.8 -26.79 68.49 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.783 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.464 HG22 ' HG3' ' A' ' 21' ' ' GLU . 80.1 p -108.87 15.41 23.52 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.377 0.671 . . . . 0.0 111.236 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.72 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -121.46 151.31 56.33 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.908 0.883 . . . . 0.0 109.712 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.22 -36.23 66.41 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.037 2.491 . . . . 0.0 113.374 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.66 -17.68 59.89 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.494 0.718 . . . . 0.0 112.067 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 t -68.68 142.54 55.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.506 0.723 . . . . 0.0 111.202 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 42.3 t-80 -105.75 133.45 50.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.659 1.184 . . . . 0.0 108.715 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 75' ' ' PHE . . . -50.96 -56.72 11.04 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.349 0.66 . . . . 0.0 112.524 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.5 -51.13 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.462 0.305 . . . . 0.0 110.76 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.4 t70 -69.94 -42.78 72.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.608 0.763 . . . . 0.0 112.465 -170.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.48 -64.38 1.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.719 0.408 . . . . 0.0 110.044 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 77' ' ' LEU . 95.5 mt -71.41 -25.07 62.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.771 0.828 . . . . 0.0 112.799 -171.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 45.96 31.31 Favored Glycine 0 N--CA 1.472 1.066 0 CA-C-O 120.969 0.205 . . . . 0.0 112.772 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.404 HD12 HD11 ' A' ' 43' ' ' ILE . 68.1 mt -98.23 127.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 108.51 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -89.75 166.79 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.972 0.509 . . . . 0.0 109.839 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.8 m -59.38 -27.25 65.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.155 0.582 . . . . 0.0 111.968 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.89 -49.0 64.47 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.554 0.741 . . . . 0.0 111.028 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.63 -29.61 62.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.485 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -72.76 -23.22 60.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.477 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD21 HD21 ' A' ' 57' ' ' LEU . 60.6 mt -60.34 -41.43 93.57 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.585 0.354 . . . . 0.0 110.239 170.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.45 -34.57 70.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.779 0.831 . . . . 0.0 111.156 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.653 HD11 ' SG ' ' A' ' 16' ' ' CYS . 63.7 mt -62.9 -51.54 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.6 76.27 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.823 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.94 -47.2 78.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.495 1.118 . . . . 0.0 110.161 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.65 72.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.077 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 11' ' ' ILE . 86.2 mt -71.18 -38.55 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.845 0.858 . . . . 0.0 111.157 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -51.3 -48.14 62.39 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.32 0.581 . . . . 0.0 110.882 173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.49 -49.32 16.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.509 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.11 69.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.688 0.795 . . . . 0.0 111.906 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -84.52 -17.25 39.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.579 0.752 . . . . 0.0 111.688 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.57 48.61 35.12 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.03 177.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.332 1.053 . . . . 0.0 110.815 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -106.76 109.57 21.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 162.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.454 HD11 HG22 ' A' ' 47' ' ' ILE . 7.5 tt -84.66 104.47 4.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 165.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.48 81.8 2.39 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.513 1.476 . . . . 0.0 111.082 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 HD21 ' A' ' 41' ' ' LEU . 57.8 tp -69.7 -31.34 69.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.861 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.04 -33.54 73.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.04 0.936 . . . . 0.0 111.068 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.5 ttpp -82.58 -41.29 19.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.182 0.593 . . . . 0.0 110.365 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -69.98 -41.78 73.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.639 0.776 . . . . 0.0 111.939 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.3 m -60.72 -36.22 78.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.045 0.938 . . . . 0.0 110.483 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -69.52 -38.3 77.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.052 0.941 . . . . 0.0 110.49 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HG3' ' HH ' ' A' ' 74' ' ' TYR . 80.2 mm-40 -56.15 -45.63 79.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.515 0.726 . . . . 0.0 110.287 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 62.8 t -67.82 -44.53 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.748 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.03 -28.94 70.44 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.845 0.858 . . . . 0.0 112.697 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -87.55 -9.82 53.35 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.147 0.579 . . . . 0.0 111.895 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.85 72.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 120.374 -0.126 . . . . 0.0 113.258 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -83.84 -22.67 31.64 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.755 0.822 . . . . 0.0 110.258 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -143.88 160.66 40.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.827 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -98.99 160.61 14.14 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.731 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.7 p -60.05 -29.84 68.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 171.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HA ' HG22 ' A' ' 76' ' ' VAL . 41.3 tt0 -56.39 -46.87 79.93 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.589 0.756 . . . . 0.0 111.316 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -57.11 -31.61 65.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.472 0.709 . . . . 0.0 112.104 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 52.2 m-85 -106.67 -74.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.459 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 29' ' ' ALA . 85.5 m-85 -56.06 -25.36 44.77 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -165.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.2 t -62.6 126.14 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 119.91 1.232 . . . . 0.0 108.47 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.559 HD11 HD12 ' A' ' 33' ' ' LEU . 18.7 mt -62.56 -36.5 82.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 112.641 -161.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG2' HG12 ' A' ' 76' ' ' VAL . 65.8 pttt -64.09 -39.33 93.82 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.247 0.342 . . . . 0.0 111.119 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.9 m-20 -75.81 -42.79 48.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.507 0.723 . . . . 0.0 110.277 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.1 tp -53.09 -49.41 66.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.833 1.253 . . . . 0.0 110.325 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.2 -33.04 73.79 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.014 0.821 . . . . 0.0 111.252 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.64 63.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.94 0.496 . . . . 0.0 110.539 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.3 mmm180 -64.04 -31.84 73.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.718 0.807 . . . . 0.0 111.76 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 -41.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.811 0.845 . . . . 0.0 110.534 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.464 ' HA ' HG23 ' A' ' 88' ' ' VAL . 22.1 t70 -56.44 -36.55 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.577 0.751 . . . . 0.0 111.591 172.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.26 -47.25 86.08 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.975 0.91 . . . . 0.0 110.671 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 59.6 mt -64.5 -46.96 80.69 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.002 0.921 . . . . 0.0 112.434 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 85' ' ' ASP . 13.9 m -67.89 -29.0 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.048 0.451 . . . . 0.0 110.657 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.81 -42.37 67.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.898 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 C-N-CA 124.166 0.986 . . . . 0.0 113.536 -179.211 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 8' ' ' VAL . 17.6 m . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -69.59 -44.56 70.5 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.145 0.278 . . . . 0.0 110.656 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.68 -35.89 82.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.286 0.634 . . . . 0.0 110.682 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.414 ' NH2' ' HB2' ' A' ' 50' ' ' ALA . 21.1 mmm180 -59.6 -57.69 11.85 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.713 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.42 -35.88 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.937 0.895 . . . . 0.0 111.193 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.6 90.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.252 1.021 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 14.9 m -60.86 -43.61 98.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 111.281 172.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.49 -50.23 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.322 0.649 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 43' ' ' ILE . 72.6 mt -62.18 -39.62 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.342 1.057 . . . . 0.0 111.223 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.03 87.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.089 0.555 . . . . 0.0 111.129 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.9 mm-40 -72.06 -38.95 69.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -69.71 -62.57 1.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.361 0.601 . . . . 0.0 110.745 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 43' ' ' ILE . 20.0 m -84.98 -10.14 57.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.845 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.15 24.21 12.56 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.747 0.819 . . . . 0.0 112.175 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.454 HD11 HD11 ' A' ' 35' ' ' ILE . 50.8 mt -77.46 128.41 80.22 Favored Pre-proline 0 C--O 1.246 0.88 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.86 128.82 27.98 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.683 2.256 . . . . 0.0 112.322 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 tpt85 -56.37 -32.31 64.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.486 1.114 . . . . 0.0 110.429 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.97 -38.48 91.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.208 1.003 . . . . 0.0 112.365 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -82.71 -9.83 59.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.764 0.425 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.63 113.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.457 0.703 . . . . 0.0 109.437 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 p -123.67 154.88 66.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.763 0.825 . . . . 0.0 109.187 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 -39.95 79.93 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.631 2.22 . . . . 0.0 112.61 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.03 -9.92 59.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.892 0.477 . . . . 0.0 112.236 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p -73.27 134.27 44.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.6 t-80 -90.5 131.59 36.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.97 0.908 . . . . 0.0 108.624 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 75' ' ' PHE . . . -52.17 -55.53 20.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 0.0 112.214 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.1 -47.41 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.367 0.267 . . . . 0.0 111.442 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -72.6 -66.6 0.64 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.813 0.445 . . . . 0.0 112.064 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -75.72 -60.74 2.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.145 0.578 . . . . 0.0 111.429 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 77' ' ' LEU . 81.3 mt -69.27 -29.12 66.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.112 0.565 . . . . 0.0 111.921 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.28 85.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 43' ' ' ILE . 36.9 mt -73.85 98.94 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.437 0.695 . . . . 0.0 109.962 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.92 165.06 25.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.019 0.928 . . . . 0.0 109.974 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 57.0 p -51.56 -18.34 1.1 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.713 1.605 . . . . 0.0 114.585 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 mt -84.72 -44.28 13.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.545 0.611 . . . . 0.0 110.292 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.24 -34.01 65.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.986 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.11 -21.56 66.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.238 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 HD23 ' A' ' 57' ' ' LEU . 94.1 mt -57.78 -38.39 75.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.243 0.617 . . . . 0.0 111.43 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.21 -30.65 48.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.558 HD12 ' SG ' ' A' ' 16' ' ' CYS . 41.8 mt -62.56 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.75 74.55 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -65.46 -43.26 90.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.021 0.928 . . . . 0.0 110.327 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.27 78.9 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.132 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.17 -37.72 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.887 0.875 . . . . 0.0 111.328 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -56.35 -42.06 77.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -82.88 -40.89 19.64 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.781 0.833 . . . . 0.0 111.272 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HB2' ' NH2' ' A' ' 7' ' ' ARG . . . -68.92 -51.95 34.45 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.52 1.128 . . . . 0.0 111.349 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -87.91 -24.9 23.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.403 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.71 52.27 10.04 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.15 -176.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.28 1.032 . . . . 0.0 110.452 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -118.71 109.99 16.75 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.15 98.85 20.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 95.0 Cg_endo -85.4 85.12 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.383 2.055 . . . . 0.0 111.43 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD23 HD23 ' A' ' 41' ' ' LEU . 42.2 tp -69.52 -32.51 71.4 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.58 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.6 -31.8 70.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.579 0.351 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 35.7 ttpt -80.84 -40.69 24.47 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.789 0.836 . . . . 0.0 109.913 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -59.11 -45.72 90.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.816 0.847 . . . . 0.0 110.51 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.2 m -72.34 -28.88 63.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.786 1.234 . . . . 0.0 111.452 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.66 -34.59 67.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.499 0.72 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.04 -32.79 74.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.68 0.792 . . . . 0.0 110.143 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.93 -43.19 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.075 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -58.27 -45.04 88.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.692 0.797 . . . . 0.0 112.189 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -85.92 -11.79 52.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.857 0.863 . . . . 0.0 111.79 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.59 69.93 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.229 0.331 . . . . 0.0 113.562 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -70.36 -27.11 64.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.99 0.916 . . . . 0.0 110.436 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.02 170.49 21.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.978 0.911 . . . . 0.0 110.335 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.414 HG21 ' H ' ' A' ' 73' ' ' GLN . 8.4 t -107.37 158.67 16.98 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.439 0.696 . . . . 0.0 111.443 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.5 p -62.42 -36.62 82.93 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.08 0.952 . . . . 0.0 110.743 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -53.15 -41.67 65.37 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.89 0.876 . . . . 0.0 111.204 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.414 ' H ' HG21 ' A' ' 70' ' ' THR . 8.4 tt0 -63.68 -32.22 73.63 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.392 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.17 -8.45 12.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -169.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ALA . 85.1 m-85 -128.49 -29.24 2.44 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.513 -169.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 88.8 t -61.54 125.58 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 33' ' ' LEU . 26.9 mt -61.42 -34.14 74.88 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -161.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.82 -37.54 70.33 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.577 0.351 . . . . 0.0 111.362 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -68.2 -49.19 62.48 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.636 0.775 . . . . 0.0 109.873 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -51.86 -47.07 64.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.938 1.695 . . . . 0.0 111.481 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.72 67.06 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.11 -39.19 55.76 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.625 0.578 . . . . 0.0 110.665 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.416 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mmm180 -59.27 -48.22 82.45 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.566 0.746 . . . . 0.0 110.581 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.7 mt -67.72 -42.7 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.694 1.197 . . . . 0.0 110.269 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HA ' HG23 ' A' ' 88' ' ' VAL . 30.9 t70 -56.69 -36.29 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.631 0.582 . . . . 0.0 111.914 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.99 -44.07 85.92 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.723 0.639 . . . . 0.0 110.461 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 82.0 mt -64.49 -40.9 96.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.724 0.81 . . . . 0.0 112.278 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 85' ' ' ASP . 16.3 m -76.3 -28.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.855 0.462 . . . . 0.0 111.378 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.99 58.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.349 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.662 1.185 . . . . 0.0 112.682 176.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 8' ' ' VAL . 31.0 m . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -58.67 -54.66 44.52 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.689 0.618 . . . . 0.0 111.536 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.61 -28.47 69.15 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.039 0.837 . . . . 0.0 110.195 -173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -69.8 -46.04 66.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.701 0.8 . . . . 0.0 111.659 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 4' ' ' THR . 84.8 t -64.19 -35.76 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.324 0.65 . . . . 0.0 110.525 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.06 99.43 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 110.284 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.8 m -56.34 -49.78 73.39 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.186 171.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 HG13 ' A' ' 47' ' ' ILE . 44.9 mm -59.58 -49.61 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 123.775 0.672 . . . . 0.0 110.731 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.18 -36.83 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.334 0.654 . . . . 0.0 111.126 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.94 83.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.518 0.727 . . . . 0.0 111.924 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.25 -51.73 14.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 0.0 112.359 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -66.6 -57.84 6.4 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.39 1.076 . . . . 0.0 111.189 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 35' ' ' ILE . 49.5 t -82.93 -9.93 59.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.662 0.785 . . . . 0.0 111.878 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.35 76.96 0.31 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.518 1.127 . . . . 0.0 110.4 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mt -127.59 135.35 27.32 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.081 0.952 . . . . 0.0 109.222 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.57 119.49 4.73 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.33 2.686 . . . . 0.0 111.346 168.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -65.14 -25.18 67.64 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.051 0.941 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -65.81 -33.73 76.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 111.886 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -86.83 -17.94 32.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.143 0.577 . . . . 0.0 111.177 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.31 110.23 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -119.74 158.46 49.59 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.889 0.876 . . . . 0.0 109.535 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 -33.1 97.35 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.399 2.066 . . . . 0.0 112.401 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.4 -11.04 44.33 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 73.5 p -70.53 127.5 32.92 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.9 t-80 -91.75 133.06 35.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.227 1.011 . . . . 0.0 108.875 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.74 -59.76 3.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.634 0.774 . . . . 0.0 112.697 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -72.71 -57.56 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 120.838 0.351 . . . . 0.0 110.381 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 16.8 t70 -58.96 -49.63 77.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.246 . . . . 0.0 112.852 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.82 -58.87 1.82 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.685 0.394 . . . . 0.0 111.529 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 77' ' ' LEU . 92.7 mt -74.19 -11.84 60.41 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.338 0.655 . . . . 0.0 112.012 -171.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.01 88.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.815 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.535 HG12 ' SG ' ' A' ' 16' ' ' CYS . 59.0 mt -74.01 102.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 109.987 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.92 156.24 38.87 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -57.05 -16.96 8.36 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.696 0.798 . . . . 0.0 112.875 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.92 -36.98 18.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.338 0.655 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.35 -30.4 68.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.504 0.669 . . . . 0.0 109.855 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.27 63.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.424 1.09 . . . . 0.0 111.996 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 HD21 HD23 ' A' ' 57' ' ' LEU . 93.6 mt -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.566 0.747 . . . . 0.0 110.412 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.21 -38.5 81.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.402 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.27 -42.32 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.663 0.602 . . . . 0.0 110.035 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' A' ' 55' ' ' LEU . . . -62.79 -36.89 84.62 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -75.06 -37.9 61.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.139 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.74 71.73 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.66 0.384 . . . . 0.0 110.975 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.553 HG13 HG21 ' A' ' 11' ' ' ILE . 96.6 mt -72.55 -39.61 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.853 0.861 . . . . 0.0 110.087 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.05 -44.86 71.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.469 1.108 . . . . 0.0 110.262 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.26 -44.88 28.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.21 1.004 . . . . 0.0 111.371 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.34 -53.83 46.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.424 0.69 . . . . 0.0 111.91 -172.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.62 -12.67 58.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.136 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.07 39.56 84.04 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.427 0.455 . . . . 0.0 111.971 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 pt -119.91 173.98 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 0.0 110.087 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 5.0 ttmp? -106.86 102.62 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 44' ' ' ALA . 7.3 tt -88.56 109.47 29.59 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -88.82 83.04 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.772 1.648 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 41' ' ' LEU . 46.4 tp -72.47 -25.35 61.4 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.293 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.52 -36.41 66.69 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.789 0.835 . . . . 0.0 110.94 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -79.12 -47.58 15.84 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.025 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -61.01 -51.22 70.17 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.905 0.882 . . . . 0.0 111.384 -173.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -55.13 -44.76 75.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.734 1.214 . . . . 0.0 111.76 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.28 -40.19 96.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.351 0.66 . . . . 0.0 110.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.04 -38.69 92.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.595 0.758 . . . . 0.0 110.852 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.56 -47.16 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.378 0.671 . . . . 0.0 110.601 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.31 -16.3 62.45 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.73 0.812 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -93.51 -8.3 41.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.27 0.628 . . . . 0.0 110.274 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.89 79.73 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 114.281 0.472 . . . . 0.0 114.281 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.41 -55.3 4.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.133 0.573 . . . . 0.0 109.922 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.54 163.66 12.48 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -99.39 157.46 16.4 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.597 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.0 p -61.59 -34.19 75.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.77 0.828 . . . . 0.0 110.4 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.5 tt0 -49.86 -46.14 51.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 111.633 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.19 -28.81 69.93 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.7 0.8 . . . . 0.0 113.073 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -121.16 0.08 10.06 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.81 -31.39 1.53 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.628 0.649 . . . . 0.0 111.403 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 72' ' ' GLU . 86.5 t -65.01 125.24 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.582 HD11 HD12 ' A' ' 33' ' ' LEU . 16.2 mt -61.45 -33.35 73.58 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -162.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.4 pttp -65.76 -41.9 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.259 0.349 . . . . 0.0 111.674 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.75 -46.22 38.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 0.0 109.942 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.37 -49.71 63.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.337 1.455 . . . . 0.0 110.771 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.42 64.89 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.546 0.739 . . . . 0.0 111.311 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.51 66.57 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 123.724 0.64 . . . . 0.0 110.259 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -59.91 -43.14 95.04 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.593 0.757 . . . . 0.0 110.761 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.57 -40.21 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.599 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 88' ' ' VAL . 28.0 t70 -57.21 -31.36 65.39 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.559 0.744 . . . . 0.0 111.889 171.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.91 -42.94 72.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.196 0.31 . . . . 0.0 110.182 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.1 -40.43 90.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.479 0.712 . . . . 0.0 111.735 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 85' ' ' ASP . 15.9 m -73.72 -29.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.954 0.501 . . . . 0.0 110.906 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.44 86.23 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.342 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -179.397 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG21 ' A' ' 8' ' ' VAL . 47.9 m . . . . . 0 CA--C 1.55 0.964 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -62.52 -43.38 98.94 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.95 0.5 . . . . 0.0 111.447 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.17 -40.6 98.0 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 11' ' ' ILE . 26.8 mmt180 -61.53 -54.49 42.53 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.001 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 4' ' ' THR . 84.1 t -62.13 -35.52 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.191 0.997 . . . . 0.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.93 83.5 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.019 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 96.4 m -59.88 -46.5 89.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.806 0.843 . . . . 0.0 111.64 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 7' ' ' ARG . 38.9 mm -61.33 -50.16 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.805 0.442 . . . . 0.0 110.783 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.2 mt -67.67 -30.25 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 122.968 0.507 . . . . 0.0 110.828 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.08 95.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 10' ' ' THR . 16.6 mm-40 -73.87 -45.71 49.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.838 0.455 . . . . 0.0 111.586 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -66.78 -59.59 3.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.836 0.854 . . . . 0.0 111.447 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -92.43 4.63 53.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.31 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.19 67.98 0.91 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.76 1.224 . . . . 0.0 111.515 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.72 120.48 21.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_exo -61.64 148.4 93.11 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.531 2.154 . . . . 0.0 112.84 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -63.16 -28.26 69.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.659 0.784 . . . . 0.0 111.419 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -65.08 -30.35 71.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -93.82 -11.54 31.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 0.0 111.269 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.28 122.58 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.965 0.906 . . . . 0.0 109.838 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.9 p -133.63 161.59 62.81 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 124.332 1.053 . . . . 0.0 108.924 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 -30.52 88.35 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.845 2.363 . . . . 0.0 113.225 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -89.8 -5.36 56.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.885 0.874 . . . . 0.0 112.275 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.3 m -62.33 99.95 0.16 Allowed 'General case' 0 C--N 1.353 0.755 0 C-N-CA 122.964 0.506 . . . . 0.0 110.987 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 58.7 t-80 -73.22 125.38 27.62 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 168.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.04 -53.42 20.27 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.88 0.738 . . . . 0.0 112.35 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.08 -45.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 117.878 0.308 . . . . 0.0 110.985 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.8 t70 -70.44 -74.34 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.216 0.322 . . . . 0.0 111.126 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.49 -53.64 10.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.685 0.394 . . . . 0.0 111.671 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.53 -18.23 59.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.99 79.42 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.728 HD11 HD12 ' A' ' 43' ' ' ILE . 82.6 mt -86.05 116.54 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.151 1.38 . . . . 0.0 110.61 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.18 165.16 21.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.918 0.887 . . . . 0.0 109.512 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -56.99 -17.29 9.2 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.739 1.216 . . . . 0.0 113.142 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.92 -45.71 16.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.726 0.81 . . . . 0.0 110.114 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.57 -26.1 60.68 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.596 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.94 -20.75 63.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.27 1.028 . . . . 0.0 111.063 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD21 HD22 ' A' ' 57' ' ' LEU . 92.1 mt -57.93 -43.32 86.21 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.962 0.505 . . . . 0.0 110.481 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.66 -36.22 83.04 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.399 1.08 . . . . 0.0 111.336 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 35' ' ' ILE . 47.3 mt -62.32 -49.92 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -34.28 77.61 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 124.53 1.144 . . . . 0.0 110.201 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -64.13 -49.68 71.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.27 1.028 . . . . 0.0 110.967 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.4 80.16 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.32 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.483 HD12 HD11 ' A' ' 84' ' ' ILE . 64.7 mt -69.54 -40.92 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.358 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -60.93 -41.8 96.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.949 0.5 . . . . 0.0 111.343 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.37 -42.27 62.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.443 0.697 . . . . 0.0 111.394 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.55 -58.84 3.99 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.695 0.798 . . . . 0.0 111.031 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.47 -19.9 35.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.697 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.81 56.43 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.435 0.459 . . . . 0.0 111.964 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 pt -120.91 -174.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.082 0.953 . . . . 0.0 111.193 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.21 105.59 11.11 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.16 0.984 . . . . 0.0 108.61 169.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 80' ' ' LEU . 7.3 tt -88.37 102.65 4.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 166.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.64 81.46 2.23 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 110.871 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 41' ' ' LEU . 39.8 tp -71.6 -33.95 69.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.852 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.67 -37.81 76.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.766 0.826 . . . . 0.0 111.043 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.756 0.822 . . . . 0.0 110.523 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -64.29 -40.37 95.8 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.528 0.731 . . . . 0.0 110.97 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.1 m -55.06 -46.01 75.34 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.121 0.969 . . . . 0.0 111.407 171.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.48 -33.11 74.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.98 0.512 . . . . 0.0 111.248 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.89 -46.73 84.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.764 0.426 . . . . 0.0 110.443 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 48.6 t -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.599 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.61 -35.2 75.55 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.973 0.909 . . . . 0.0 113.127 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.28 -8.97 49.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.316 0.646 . . . . 0.0 111.394 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.28 67.95 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 122.358 -0.214 . . . . 0.0 113.623 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.3 mmpt? -73.03 -33.14 65.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.426 0.691 . . . . 0.0 110.216 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -142.25 163.03 33.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.939 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -107.61 158.99 16.79 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.193 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.412 HG22 HG13 ' A' ' 64' ' ' VAL . 28.7 p -58.13 -30.43 66.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.425 0.69 . . . . 0.0 111.494 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 9.1 tm-20 -53.48 -45.05 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.705 0.802 . . . . 0.0 111.146 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.441 ' HA ' HD21 ' A' ' 79' ' ' ASN . 9.2 tt0 -65.15 -23.48 67.13 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 4.16 6.55 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -123.78 -27.22 4.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.583 0.629 . . . . 0.0 111.57 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.9 t -64.34 132.68 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 27' ' ' SER . 31.1 mt -59.58 -43.91 93.49 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -169.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.39 -34.39 77.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 123.24 0.337 . . . . 0.0 111.446 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 73' ' ' GLN . 5.1 m-20 -70.86 -51.61 25.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.05 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 55' ' ' LEU . 48.2 tp -54.47 -44.25 72.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.13 . . . . 0.0 110.886 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.72 81.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.265 1.026 . . . . 0.0 111.669 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.73 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.646 0.591 . . . . 0.0 110.373 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mmm180 -59.88 -42.87 94.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.787 0.835 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.483 HD11 HD12 ' A' ' 47' ' ' ILE . 96.7 mt -68.74 -36.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.584 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HA ' HG23 ' A' ' 88' ' ' VAL . 23.3 t70 -58.17 -34.38 70.25 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.985 0.514 . . . . 0.0 111.58 170.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -43.13 85.11 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 58.3 mt -67.19 -40.4 86.53 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.805 0.842 . . . . 0.0 112.124 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 85' ' ' ASP . 31.6 m -75.44 -29.47 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.201 0.6 . . . . 0.0 111.171 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.71 89.66 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.042 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.825 0 C-N-CA 124.376 1.07 . . . . 0.0 112.468 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 8' ' ' VAL . 26.3 m . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -67.61 -44.61 77.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.394 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.21 -46.94 65.83 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.985 0.803 . . . . 0.0 111.21 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.63 -43.8 65.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.868 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.88 -41.11 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.814 0.446 . . . . 0.0 110.958 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.13 92.88 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.29 1.036 . . . . 0.0 110.508 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.4 m -56.25 -49.01 75.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 0.0 110.841 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.19 -46.31 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.114 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.473 HG12 HD13 ' A' ' 43' ' ' ILE . 75.6 mt -62.35 -42.5 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.919 0.888 . . . . 0.0 110.86 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.78 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 0.0 111.918 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.62 -43.32 69.51 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.614 0.766 . . . . 0.0 111.519 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.1 m -65.44 -63.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.376 0.67 . . . . 0.0 111.849 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.66 -1.47 56.84 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.612 0.765 . . . . 0.0 111.577 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.34 77.8 0.28 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.723 1.209 . . . . 0.0 110.89 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 33' ' ' LEU . 54.5 mt -136.06 132.2 19.13 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.299 1.04 . . . . 0.0 108.8 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HG2' ' HG1' ' A' ' 22' ' ' THR . 38.1 Cg_endo -66.5 135.52 39.57 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.591 2.194 . . . . 0.0 111.488 173.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.41 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 25.7 mtm180 -71.93 -22.63 61.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.578 0.351 . . . . 0.0 111.866 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.32 -15.06 62.14 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.159 0.584 . . . . 0.0 111.667 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.407 ' HG1' ' HG2' ' A' ' 19' ' ' PRO . 38.3 p -105.57 -18.83 13.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.001 0.521 . . . . 0.0 110.568 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 87.3 mt -77.77 106.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.449 ' O ' HD13 ' A' ' 77' ' ' LEU . 73.8 p -111.84 154.54 44.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.858 0.863 . . . . 0.0 109.478 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 39.2 Cg_endo -64.08 -22.81 67.57 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.279 1.986 . . . . 0.0 111.534 174.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.41 -17.56 51.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.844 0.858 . . . . 0.0 111.415 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.6 t -73.95 150.8 40.57 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.929 0.892 . . . . 0.0 110.724 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.6 t-80 -107.84 134.46 50.76 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.848 1.259 . . . . 0.0 109.151 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -49.41 -55.03 14.43 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.882 0.873 . . . . 0.0 112.657 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -76.94 -53.88 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 122.165 0.186 . . . . 0.0 110.944 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 29.3 m-20 -65.58 -52.77 49.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -89.38 -59.77 2.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.745 0.418 . . . . 0.0 111.078 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 77' ' ' LEU . 87.3 mt -68.25 -21.44 64.82 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 22.02 65.52 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 123.388 0.43 . . . . 0.0 113.44 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.7 mt -80.9 130.01 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 123.957 0.903 . . . . 0.0 110.013 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -89.34 160.35 16.91 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 50.3 m -59.25 -19.05 42.6 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.308 0.643 . . . . 0.0 112.562 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -76.89 -42.19 40.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.678 0.791 . . . . 0.0 110.872 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.57 -32.71 64.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.215 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 -22.17 65.17 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.67 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.526 HD22 HD23 ' A' ' 57' ' ' LEU . 95.7 mt -59.5 -42.97 93.39 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.73 -36.03 70.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.406 1.083 . . . . 0.0 110.698 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.473 HD13 HG12 ' A' ' 12' ' ' ILE . 61.3 mt -65.26 -48.32 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.024 0.53 . . . . 0.0 109.879 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.13 83.09 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.955 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -67.87 -40.06 83.64 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.248 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.35 75.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.809 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.78 -38.84 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.95 0.9 . . . . 0.0 110.839 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.35 -43.61 83.59 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.383 0.673 . . . . 0.0 111.096 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 8.5 mtpm? -81.54 -26.04 35.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.058 0.943 . . . . 0.0 112.302 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.71 -58.11 3.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.798 0.839 . . . . 0.0 110.651 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -81.9 -27.56 33.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.051 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.13 46.4 7.64 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.68 -175.34 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.511 1.124 . . . . 0.0 110.257 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -120.29 107.56 13.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 163.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -77.94 107.11 4.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 165.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.92 81.34 2.43 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.63 1.553 . . . . 0.0 110.965 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.526 HD23 HD22 ' A' ' 41' ' ' LEU . 24.4 tp -70.23 -24.23 63.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.308 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.78 -38.3 72.3 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.997 0.919 . . . . 0.0 111.284 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.9 tttp -74.56 -53.57 9.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.067 0.547 . . . . 0.0 109.732 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -60.49 -46.95 88.23 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.055 0.847 . . . . 0.0 111.618 -168.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.3 m -54.28 -48.55 71.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.987 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.65 -33.88 75.93 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.675 0.79 . . . . 0.0 110.811 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.662 ' HG3' ' HH ' ' A' ' 74' ' ' TYR . 36.7 mm-40 -61.97 -40.57 96.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.856 0.862 . . . . 0.0 110.686 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.78 -45.9 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 122.717 0.407 . . . . 0.0 110.136 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -51.4 -44.08 62.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.96 1.304 . . . . 0.0 112.409 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.03 0.72 41.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.51 19.37 76.24 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 113.596 0.199 . . . . 0.0 113.596 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -75.85 -17.12 59.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.153 0.981 . . . . 0.0 111.922 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -167.24 166.03 15.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.664 1.186 . . . . 0.0 109.07 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.2 t -105.36 162.01 13.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.38 0.672 . . . . 0.0 110.821 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.5 p -65.06 -30.89 71.89 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.816 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.36 -45.54 84.28 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.766 0.427 . . . . 0.0 110.263 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 70' ' ' THR . 25.5 tt0 -60.92 -30.6 70.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 112.042 -171.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.662 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 54.2 m-85 -105.49 -65.01 1.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.563 0.345 . . . . 0.0 111.234 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -65.34 -21.58 66.72 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.3 t -62.03 127.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 119.872 1.215 . . . . 0.0 108.057 168.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 33' ' ' LEU . 39.3 mt -65.09 -32.94 74.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -160.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.8 pttp -62.96 -37.21 86.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 172.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 62.6 m-20 -77.15 -44.89 28.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.746 0.818 . . . . 0.0 109.631 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.92 -50.48 61.05 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 110.268 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.35 -30.83 70.75 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.14 -42.09 69.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.666 0.386 . . . . 0.0 110.881 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 16.4 mmm180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.197 0.999 . . . . 0.0 110.433 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.59 -40.04 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.62 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 88' ' ' VAL . 27.1 t70 -60.39 -33.86 73.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.968 0.507 . . . . 0.0 111.612 172.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -38.38 79.96 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.544 0.528 . . . . 0.0 110.154 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 90.2 mt -66.99 -40.17 87.33 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.631 0.772 . . . . 0.0 112.398 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.9 m -72.54 -33.76 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 120.856 0.36 . . . . 0.0 110.389 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.49 80.35 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.051 1.341 . . . . 0.0 113.051 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -60.88 -53.72 53.86 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.451 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.67 -39.64 81.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.289 0.993 . . . . 0.0 111.847 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -69.83 -47.29 63.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 111.465 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.46 -35.5 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.146 0.578 . . . . 0.0 110.417 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.78 86.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 0.0 110.244 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -54.88 -49.23 71.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.907 1.283 . . . . 0.0 111.392 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.424 HG22 HG13 ' A' ' 47' ' ' ILE . 34.9 mm -57.2 -52.41 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.775 0.83 . . . . 0.0 110.478 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.468 HG12 HD13 ' A' ' 43' ' ' ILE . 72.7 mt -64.93 -38.14 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.737 0.815 . . . . 0.0 111.157 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.34 77.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.052 0.941 . . . . 0.0 112.109 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -71.44 -52.91 15.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.357 0.663 . . . . 0.0 111.65 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -66.35 -45.38 80.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.341 0.656 . . . . 0.0 111.71 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 43' ' ' ILE . 41.7 m -96.36 5.46 50.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.81 26.68 15.72 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.176 0.99 . . . . 0.0 112.428 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.61 124.87 53.7 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.502 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -61.95 135.78 57.43 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.511 2.14 . . . . 0.0 112.412 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HD2' HD12 ' A' ' 23' ' ' ILE . 26.2 mmm-85 -59.91 -29.83 68.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.474 1.109 . . . . 0.0 112.165 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.22 -30.57 71.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.325 0.65 . . . . 0.0 111.647 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -96.05 -7.6 35.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.976 0.511 . . . . 0.0 111.533 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.472 HD12 ' HD2' ' A' ' 20' ' ' ARG . 53.2 mt -80.89 123.19 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.247 0.619 . . . . 0.0 109.708 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -124.31 157.4 64.74 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.948 0.899 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.63 -37.38 88.42 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.81 2.34 . . . . 0.0 113.429 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.08 -7.26 58.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.136 0.574 . . . . 0.0 111.645 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -64.19 121.83 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.25 0.62 . . . . 0.0 110.906 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 65.3 t-80 -86.27 127.22 34.73 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -52.38 -54.75 27.78 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.87 -54.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.015 0.197 . . . . 0.0 110.743 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.0 t70 -69.02 -66.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.35 -173.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.78 -55.63 5.63 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.343 -168.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.569 HD12 HD11 ' A' ' 77' ' ' LEU . 90.1 mt -75.48 -14.48 60.43 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.161 0.584 . . . . 0.0 112.274 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.36 8.1 87.65 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 122.993 0.183 . . . . 0.0 113.403 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.582 HD13 HD12 ' A' ' 43' ' ' ILE . 93.8 mt -85.01 99.52 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.873 1.269 . . . . 0.0 110.707 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.71 163.27 16.85 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.954 0.901 . . . . 0.0 110.09 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 t -57.02 -15.97 6.14 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.242 1.017 . . . . 0.0 113.0 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.87 -45.37 13.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 110.298 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.83 -31.34 70.25 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.101 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -67.41 -20.84 65.58 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.397 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.1 mt -57.85 -38.6 75.96 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.108 0.563 . . . . 0.0 111.273 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.22 -41.17 77.4 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.775 0.83 . . . . 0.0 110.854 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.582 HD12 HD13 ' A' ' 35' ' ' ILE . 73.3 mt -61.7 -49.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.268 175.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 55' ' ' LEU . . . -61.31 -40.23 93.41 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.411 -175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -73.59 -34.22 64.98 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.56 64.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.678 0.391 . . . . 0.0 110.934 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG13 HG22 ' A' ' 11' ' ' ILE . 91.1 mt -78.23 -38.18 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.504 1.121 . . . . 0.0 110.53 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.64 -40.81 66.15 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.066 0.946 . . . . 0.0 110.278 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -81.48 -50.0 9.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.907 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.56 67.39 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.37 0.668 . . . . 0.0 111.671 -171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.51 -22.62 28.09 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.515 0.726 . . . . 0.0 110.548 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.58 10.96 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.28 -177.23 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.038 0.935 . . . . 0.0 110.659 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.96 113.27 26.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 167.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 44' ' ' ALA . 5.9 tt -103.79 96.62 9.38 Favored Pre-proline 0 C--O 1.243 0.746 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -83.03 84.05 1.82 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.98 1.787 . . . . 0.0 111.334 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.0 -28.45 69.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.33 -37.76 70.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.369 1.068 . . . . 0.0 111.049 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.2 tttp -80.51 -49.12 11.79 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 124.33 1.052 . . . . 0.0 110.321 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -59.02 -43.83 91.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.012 0.925 . . . . 0.0 111.008 -174.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -65.39 -40.53 93.59 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.676 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -63.71 -33.73 76.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.575 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 43.7 mm-40 -59.27 -38.27 79.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.306 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.508 HG13 HG21 ' A' ' 71' ' ' THR . 40.1 t -72.03 -45.38 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.161 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.52 -29.43 67.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.764 1.226 . . . . 0.0 112.639 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -99.3 -14.28 19.29 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.627 0.771 . . . . 0.0 111.051 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.31 63.85 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 116.607 -0.269 . . . . 0.0 113.308 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.28 -30.09 65.86 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 0.0 111.35 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 172.17 18.61 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.574 0.75 . . . . 0.0 111.098 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -108.6 154.07 22.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.866 0.866 . . . . 0.0 110.413 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.508 HG21 HG13 ' A' ' 64' ' ' VAL . 34.0 p -61.78 -28.58 69.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.381 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -56.14 -44.93 79.68 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.532 0.733 . . . . 0.0 111.663 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' HD21 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -66.77 -21.73 66.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 122.776 0.431 . . . . 0.0 111.252 -174.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -104.36 -76.68 0.59 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.89 0.476 . . . . 0.0 110.952 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 88.4 m-85 -60.28 -24.14 64.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -165.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 91.9 t -63.14 127.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 119.195 0.907 . . . . 0.0 108.751 172.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.569 HD11 HD12 ' A' ' 33' ' ' LEU . 26.3 mt -61.82 -36.94 82.61 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -162.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -68.12 -35.83 78.76 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 73' ' ' GLN . 3.5 m-20 -72.3 -45.21 60.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.892 0.877 . . . . 0.0 110.52 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -53.93 -46.43 71.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.122 1.769 . . . . 0.0 111.349 170.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.66 71.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.156 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.05 61.68 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.689 0.618 . . . . 0.0 110.963 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -59.52 -47.88 83.8 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.971 0.909 . . . . 0.0 111.75 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.6 -38.35 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.769 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.05 -37.56 64.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.602 0.761 . . . . 0.0 111.643 169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.44 -38.05 68.4 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.229 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.17 -40.58 94.48 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.526 0.73 . . . . 0.0 111.841 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 m -78.82 -20.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.58 73.96 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 124.392 1.077 . . . . 0.0 113.107 178.522 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' VAL . 24.0 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -64.11 -46.38 84.42 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.259 0.223 . . . . 0.0 111.356 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.99 -42.31 80.02 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.076 0.86 . . . . 0.0 111.093 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -63.56 -52.12 62.44 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.165 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.7 -38.81 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.373 0.669 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.47 -44.92 85.66 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.026 0.931 . . . . 0.0 110.126 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.0 m -56.62 -43.6 80.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.365 1.066 . . . . 0.0 112.041 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 47' ' ' ILE . 32.7 mm -59.3 -55.25 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.609 0.763 . . . . 0.0 110.394 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.72 -35.14 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.196 0.935 . . . . 0.0 111.429 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -52.69 64.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.168 0.987 . . . . 0.0 111.728 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.2 -25.81 33.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 43' ' ' ILE . 19.0 p -73.96 -63.03 1.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.188 0.449 . . . . 0.0 110.801 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' HD13 ' A' ' 43' ' ' ILE . 57.7 m -92.42 7.98 40.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.278 -171.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.1 30.87 20.76 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.454 1.102 . . . . 0.0 112.241 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 33' ' ' LEU . 62.9 mt -86.55 129.69 52.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 118.59 4.58 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.133 2.555 . . . . 0.0 112.375 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.2 tpt85 -57.83 -37.44 73.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.724 1.61 . . . . 0.0 111.727 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.472 ' HG3' HG22 ' A' ' 22' ' ' THR . 9.1 pt-20 -63.1 -38.77 92.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.379 0.672 . . . . 0.0 111.539 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.24 -15.49 40.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.158 0.583 . . . . 0.0 112.236 -174.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.88 110.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.926 0.491 . . . . 0.0 110.142 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.1 p -112.69 154.23 44.82 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.428 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 59.6 Cg_exo -55.15 -36.66 93.62 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.108 2.539 . . . . 0.0 112.371 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.51 -28.01 62.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.413 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.5 p -70.37 137.03 50.19 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.889 0.476 . . . . 0.0 111.209 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 60.8 t-80 -89.7 130.17 36.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.667 1.187 . . . . 0.0 108.774 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -49.09 -59.95 3.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.741 0.816 . . . . 0.0 112.648 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.78 -48.86 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.1 t70 -69.89 -61.28 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.664 -173.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.72 -54.62 5.46 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.789 0.436 . . . . 0.0 110.9 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.709 HD13 HD12 ' A' ' 77' ' ' LEU . 80.4 mt -82.36 -14.09 55.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.151 0.581 . . . . 0.0 112.042 -170.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.21 14.05 82.23 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 122.804 0.24 . . . . 0.0 113.511 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.69 115.25 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.83 0.852 . . . . 0.0 110.264 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -76.83 165.55 24.55 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.5 m -66.29 -18.04 65.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.464 0.575 . . . . 0.0 111.63 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.22 -38.27 19.14 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.833 0.853 . . . . 0.0 109.852 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.26 -26.82 64.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.545 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.48 -21.43 52.87 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.913 0.885 . . . . 0.0 110.612 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 57' ' ' LEU . 85.7 mt -55.44 -36.7 66.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.166 0.439 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -69.51 -39.45 77.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.544 1.138 . . . . 0.0 110.668 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.604 HD13 ' SG ' ' A' ' 16' ' ' CYS . 58.8 mt -64.82 -51.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.625 0.77 . . . . 0.0 110.224 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 55' ' ' LEU . . . -63.01 -37.49 87.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.316 1.047 . . . . 0.0 110.624 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.1 -41.47 90.55 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.068 0.855 . . . . 0.0 110.332 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.27 76.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 111.336 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.409 HG13 HG23 ' A' ' 11' ' ' ILE . 84.2 mt -67.79 -39.26 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.336 1.054 . . . . 0.0 110.748 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -56.58 -44.54 81.14 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.019 0.528 . . . . 0.0 110.698 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 7.5 mtpm? -77.87 -29.97 50.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.011 0.924 . . . . 0.0 111.789 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.01 -58.45 3.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.663 0.785 . . . . 0.0 110.879 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.421 ' HB2' HG12 ' A' ' 53' ' ' ILE . 52.0 m-85 -84.37 -20.36 32.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.732 0.813 . . . . 0.0 111.15 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.0 18.97 66.18 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.407 0.442 . . . . 0.0 112.42 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 51' ' ' PHE . 29.5 pt -105.51 -176.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.423 1.089 . . . . 0.0 110.971 -172.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -116.47 111.55 20.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.304 0.641 . . . . 0.0 109.529 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 44' ' ' ALA . 8.2 tt -102.14 103.07 27.79 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.23 84.94 1.06 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.002 1.801 . . . . 0.0 111.671 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 41' ' ' LEU . 59.9 tp -62.71 -34.78 77.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.812 0.845 . . . . 0.0 110.101 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.91 -36.53 77.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.3 1.04 . . . . 0.0 111.193 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -77.67 -44.4 28.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.625 0.77 . . . . 0.0 110.004 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -58.36 -47.48 83.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.997 . . . . 0.0 110.959 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.4 m -63.74 -34.92 78.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.987 0.915 . . . . 0.0 111.021 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.264 1.025 . . . . 0.0 111.287 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.52 -33.53 76.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.416 0.686 . . . . 0.0 110.388 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 84.8 t -67.35 -44.09 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.436 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.26 -32.93 73.7 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.044 0.938 . . . . 0.0 112.458 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -90.71 -12.22 37.32 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.448 1.099 . . . . 0.0 111.371 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.15 16.88 55.05 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 116.931 -0.122 . . . . 0.0 113.37 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.04 -23.4 21.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -147.9 158.53 44.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.123 0.569 . . . . 0.0 110.672 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -95.62 159.95 14.74 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.134 0.574 . . . . 0.0 109.778 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.0 p -62.47 -31.27 71.97 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.954 0.502 . . . . 0.0 109.649 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.5 ' HA ' HG23 ' A' ' 76' ' ' VAL . 31.5 tt0 -54.98 -50.48 68.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.961 0.904 . . . . 0.0 111.112 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -55.95 -30.03 61.07 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.285 1.034 . . . . 0.0 112.404 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' LEU . 42.1 m-85 -104.31 -77.43 0.58 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.717 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.484 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 97.6 m-85 -56.42 -27.99 58.16 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -166.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.7 t -65.3 124.37 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.106 1.321 . . . . 0.0 108.413 170.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.709 HD12 HD13 ' A' ' 33' ' ' LEU . 25.5 mt -63.62 -32.47 73.95 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -159.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HG2' HG13 ' A' ' 76' ' ' VAL . 21.0 pttp -67.61 -37.37 82.43 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.756 0.312 . . . . 0.0 111.263 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.1 m-20 -75.97 -42.9 47.03 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 123.509 0.723 . . . . 0.0 109.832 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 50.3 tp -52.2 -48.39 65.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.332 1.453 . . . . 0.0 110.843 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.78 71.86 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.893 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.78 -39.88 50.07 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.992 0.808 . . . . 0.0 111.61 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 23.3 mmm180 -61.37 -45.3 94.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.83 0.852 . . . . 0.0 111.057 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -70.87 -38.54 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.095 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.517 ' HA ' HG23 ' A' ' 88' ' ' VAL . 38.3 t70 -56.44 -34.68 67.06 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.962 0.905 . . . . 0.0 112.35 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 8.1 tp10 -63.3 -47.4 82.43 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.837 0.711 . . . . 0.0 110.356 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 51.7 mt -65.73 -40.9 92.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.03 0.932 . . . . 0.0 111.548 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 85' ' ' ASP . 13.8 m -78.08 -26.23 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 122.841 0.456 . . . . 0.0 111.49 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.8 72.98 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.79 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 O-C-N 123.741 0.651 . . . . 0.0 112.505 176.305 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -71.07 -41.41 70.74 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.304 0.641 . . . . 0.0 110.691 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.65 -51.84 26.22 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.177 0.991 . . . . 0.0 112.072 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -73.01 -43.53 62.02 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.425 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.76 -40.01 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.163 0.585 . . . . 0.0 110.847 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.79 77.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.995 . . . . 0.0 110.042 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -58.28 -41.43 84.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.05 0.94 . . . . 0.0 111.91 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 47' ' ' ILE . 21.7 mm -58.74 -53.32 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.537 0.735 . . . . 0.0 110.658 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.16 -33.12 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.036 0.934 . . . . 0.0 111.195 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -53.78 50.26 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 111.537 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -68.93 -37.58 78.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.145 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -72.48 -63.79 1.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.894 0.478 . . . . 0.0 110.64 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.702 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.5 m -91.43 12.27 21.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 61.39 21.6 12.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.978 0.911 . . . . 0.0 112.079 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.5 mt -87.6 121.78 70.84 Favored Pre-proline 0 N--CA 1.479 0.996 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.173 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.06 133.55 55.72 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.158 1.906 . . . . 0.0 112.422 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -55.23 -33.02 62.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.442 1.097 . . . . 0.0 110.968 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.49 -35.02 79.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.156 . . . . 0.0 112.208 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -85.71 -19.21 31.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.885 0.474 . . . . 0.0 111.357 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -71.5 112.15 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.056 0.542 . . . . 0.0 110.431 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.1 p -115.9 146.47 37.03 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.187 0.995 . . . . 0.0 109.464 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -33.41 73.69 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.808 2.338 . . . . 0.0 112.911 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.43 -6.65 58.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.913 0.885 . . . . 0.0 111.835 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.4 t -74.87 146.84 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.306 1.042 . . . . 0.0 110.648 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 63.8 t-80 -103.01 134.26 46.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.718 1.207 . . . . 0.0 108.489 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -52.15 -58.64 5.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.555 0.742 . . . . 0.0 112.192 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -72.75 -57.3 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.5 t70 -64.58 -47.22 79.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.202 1.001 . . . . 0.0 112.841 -170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -96.54 -58.17 2.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.559 0.344 . . . . 0.0 111.298 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.58 HD12 HD11 ' A' ' 77' ' ' LEU . 90.4 mt -72.01 -27.58 62.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.994 0.518 . . . . 0.0 111.814 -175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 15.82 62.37 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-O 120.084 -0.287 . . . . 0.0 113.322 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.04 123.76 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.449 0.7 . . . . 0.0 109.454 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.97 148.05 36.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -58.42 -16.38 14.62 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.678 0.791 . . . . 0.0 111.707 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.12 -51.99 18.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.343 1.057 . . . . 0.0 110.199 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -71.06 -27.18 63.46 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.347 0.659 . . . . 0.0 111.101 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.37 -22.23 66.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 HD22 HD22 ' A' ' 57' ' ' LEU . 90.0 mt -58.6 -38.58 78.28 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.216 0.606 . . . . 0.0 111.131 174.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.07 -28.54 48.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.231 0.612 . . . . 0.0 111.246 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.702 HD11 ' SG ' ' A' ' 16' ' ' CYS . 57.1 mt -62.82 -49.01 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 55' ' ' LEU . . . -65.57 -32.62 74.3 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.129 -177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.38 -43.2 77.85 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.918 0.762 . . . . 0.0 110.525 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.14 73.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.657 0.783 . . . . 0.0 111.723 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 11' ' ' ILE . 89.6 mt -67.45 -40.29 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.778 0.831 . . . . 0.0 110.617 176.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -54.26 -46.6 72.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.289 0.636 . . . . 0.0 110.399 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.503 ' HB3' ' HZ1' ' A' ' 49' ' ' LYS . 6.9 mtpm? -69.71 -50.99 38.35 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.096 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 11' ' ' ILE . . . -64.47 -55.83 18.19 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.13 0.972 . . . . 0.0 112.379 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -80.22 -20.44 44.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.753 0.821 . . . . 0.0 111.863 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.33 41.04 39.04 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.48 175.73 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.089 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -114.9 92.72 4.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 167.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 44' ' ' ALA . 8.3 tt -74.53 114.29 32.5 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -89.03 83.97 0.6 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.193 1.929 . . . . 0.0 111.311 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.546 HD22 HD22 ' A' ' 41' ' ' LEU . 37.4 tp -73.19 -28.31 62.13 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.45 -33.42 73.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.409 0.684 . . . . 0.0 110.746 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -73.38 -50.66 20.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.319 1.048 . . . . 0.0 110.261 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -63.1 -45.91 89.85 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.654 0.782 . . . . 0.0 111.837 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 m -61.72 -38.06 86.51 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.924 0.889 . . . . 0.0 110.954 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -63.92 -43.56 95.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.99 0.916 . . . . 0.0 110.686 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.81 -32.6 74.37 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.582 0.753 . . . . 0.0 110.798 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 55.6 t -68.33 -51.78 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.347 0.659 . . . . 0.0 111.215 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.07 -22.01 64.95 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.518 0.727 . . . . 0.0 112.414 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.43 -12.89 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.842 1.257 . . . . 0.0 110.747 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 21.06 58.54 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.114 -0.494 . . . . 0.0 114.242 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -90.35 -54.48 3.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -105.09 156.6 17.92 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.522 1.129 . . . . 0.0 110.64 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -100.07 159.15 15.32 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.52 0.728 . . . . 0.0 109.92 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.5 p -68.23 -29.57 68.42 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.21 -44.39 88.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.991 0.517 . . . . 0.0 111.034 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -58.3 -30.93 67.03 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.705 0.802 . . . . 0.0 112.109 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -104.19 -77.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.476 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 59.9 m-85 -55.91 -24.1 35.52 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -163.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 87.0 t -61.11 124.28 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 119.732 1.151 . . . . 0.0 108.25 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD11 HD12 ' A' ' 33' ' ' LEU . 18.7 mt -60.51 -37.72 82.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.763 0.825 . . . . 0.0 112.935 -161.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -70.1 -36.35 74.8 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.501 0.501 . . . . 0.0 112.097 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -70.86 -44.45 66.36 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.895 0.878 . . . . 0.0 110.193 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 tp -53.06 -47.42 68.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.54 1.536 . . . . 0.0 110.672 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.04 66.71 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.666 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.5 49.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.762 0.425 . . . . 0.0 110.619 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -59.49 -43.58 93.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.215 1.006 . . . . 0.0 111.479 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 47' ' ' ILE . 96.7 mt -72.91 -39.19 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.289 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.401 ' HA ' HG21 ' A' ' 88' ' ' VAL . 19.5 t70 -54.09 -37.86 64.72 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.277 0.631 . . . . 0.0 111.518 170.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 -41.42 81.13 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.88 -42.97 94.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.462 0.705 . . . . 0.0 112.313 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' ' 85' ' ' ASP . 16.8 m -74.0 -26.6 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 122.791 0.436 . . . . 0.0 110.564 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.6 -36.46 65.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.619 0.368 . . . . 0.0 110.541 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.458 0 C-N-CA 124.655 1.182 . . . . 0.0 113.322 177.875 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 8' ' ' VAL . 38.9 m . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 111.115 0.043 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.33 -41.68 93.7 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.376 0.422 . . . . 0.0 111.35 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.51 -42.6 92.59 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.559 0.695 . . . . 0.0 111.059 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 11' ' ' ILE . 23.7 mmt180 -71.29 -44.8 64.5 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.325 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 4' ' ' THR . 77.3 t -57.73 -41.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.312 0.577 . . . . 0.0 110.522 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.66 97.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.225 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -75.35 -30.35 60.22 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.76 0.254 . . . . 0.0 111.411 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.512 HG21 HG13 ' A' ' 47' ' ' ILE . 28.7 mm -61.61 -52.93 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.77 -32.07 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.921 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.46 69.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.597 0.759 . . . . 0.0 111.411 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.13 -53.82 7.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.253 0.621 . . . . 0.0 112.611 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -63.65 -51.52 64.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.795 0.838 . . . . 0.0 111.306 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.413 ' HG ' HG12 ' A' ' 35' ' ' ILE . 43.3 t -90.29 2.19 55.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.507 0.723 . . . . 0.0 111.798 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.88 21.73 13.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.232 1.013 . . . . 0.0 112.697 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.9 132.63 67.26 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 122.983 0.513 . . . . 0.0 110.636 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.0 122.22 11.3 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.0 2.467 . . . . 0.0 112.452 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -61.82 -30.22 70.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.0 1.32 . . . . 0.0 111.342 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' A' ' 22' ' ' THR . 12.5 pt-20 -63.34 -28.81 70.26 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.338 1.055 . . . . 0.0 112.355 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.416 HG21 ' HG3' ' A' ' 21' ' ' GLU . 34.9 p -100.35 -2.24 34.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.703 0.801 . . . . 0.0 111.381 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.92 113.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 0.0 109.825 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -119.6 160.41 42.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.18 -25.58 77.13 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.71 -13.02 58.37 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 111.53 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.427 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 70.4 m -65.06 112.22 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.481 0.713 . . . . 0.0 111.597 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 60.8 t-80 -76.88 127.27 32.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.8 -50.39 56.31 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.3 mt -76.95 -55.06 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 122.555 0.342 . . . . 0.0 111.244 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.0 t70 -71.15 -43.49 67.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.45 0.7 . . . . 0.0 112.607 -170.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -96.78 -55.68 2.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.235 0.614 . . . . 0.0 111.331 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 77' ' ' LEU . 85.0 mt -76.05 -24.24 55.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.271 0.629 . . . . 0.0 111.596 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.88 6.0 80.23 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.821 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.413 HG12 ' HG ' ' A' ' 16' ' ' CYS . 90.3 mt -64.73 130.18 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.358 1.063 . . . . 0.0 110.815 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.59 162.76 13.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.94 . . . . 0.0 108.869 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.8 p -46.65 -34.18 4.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.265 1.426 . . . . 0.0 113.519 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.56 -36.46 52.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.698 0.799 . . . . 0.0 110.866 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.14 -40.51 74.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.989 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.57 -21.03 64.55 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.332 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.9 mt -55.56 -48.95 73.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.278 0.631 . . . . 0.0 110.95 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.23 -31.7 70.44 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.448 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.68 -45.91 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.121 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.15 79.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.874 0.734 . . . . 0.0 110.941 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.924 . . . . 0.0 110.835 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -30.7 71.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.482 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 11' ' ' ILE . 93.3 mt -70.65 -42.04 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.492 0.717 . . . . 0.0 110.838 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -55.21 -40.72 71.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.721 0.808 . . . . 0.0 111.536 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.65 -51.23 10.17 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.351 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.01 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.404 0.682 . . . . 0.0 111.924 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -83.95 -17.21 41.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.057 0.543 . . . . 0.0 111.07 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.56 47.49 62.02 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.36 -175.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.685 0.794 . . . . 0.0 112.094 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -122.39 94.88 4.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.05 1.34 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 47' ' ' ILE . 9.1 tt -84.54 111.86 37.72 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -87.1 81.54 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.079 1.852 . . . . 0.0 111.855 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.15 -30.41 66.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.939 0.496 . . . . 0.0 110.446 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.05 -38.82 65.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.121 0.968 . . . . 0.0 111.315 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.7 ttpt -80.98 -46.38 15.17 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.205 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -55.85 -51.1 68.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.855 0.862 . . . . 0.0 110.975 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.6 m -56.87 -47.11 81.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.402 1.081 . . . . 0.0 111.904 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -63.22 -45.25 92.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.863 0.865 . . . . 0.0 111.621 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 23.1 mm-40 -70.72 -37.19 73.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.027 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.4 t -67.29 -42.93 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.14 -20.96 64.94 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.542 0.737 . . . . 0.0 112.222 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.96 -7.52 42.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.454 0.702 . . . . 0.0 110.756 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.32 87.48 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.565 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 30.3 mmtp -68.91 -25.31 64.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.972 0.909 . . . . 0.0 110.934 175.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 166.19 30.26 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.734 0.813 . . . . 0.0 110.3 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.458 HG21 ' H ' ' A' ' 73' ' ' GLN . 6.1 t -105.1 151.72 23.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.784 0.834 . . . . 0.0 109.863 174.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.9 p -58.42 -34.63 70.99 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.497 0.719 . . . . 0.0 110.404 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.7 tt0 -55.68 -42.03 74.54 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.582 1.153 . . . . 0.0 111.785 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.458 ' H ' HG21 ' A' ' 70' ' ' THR . 29.5 tt0 -62.11 -29.79 70.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.874 0.869 . . . . 0.0 111.755 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -104.05 -78.41 0.56 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.014 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.3 m-85 -51.06 -29.31 12.51 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -165.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 66.1 t -62.33 125.83 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.819 1.191 . . . . 0.0 108.409 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 33' ' ' LEU . 23.1 mt -59.65 -35.13 73.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -163.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -63.24 -39.82 95.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 120.838 0.351 . . . . 0.0 111.431 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -79.73 -40.59 28.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.223 1.009 . . . . 0.0 110.466 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.67 -47.55 73.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.419 1.488 . . . . 0.0 110.288 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.51 72.73 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.81 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.36 -43.92 66.01 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.439 0.462 . . . . 0.0 111.086 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 22.9 mmm180 -62.6 -42.75 99.76 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.754 0.822 . . . . 0.0 111.357 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.25 -37.92 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.512 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.487 ' HA ' HG22 ' A' ' 88' ' ' VAL . 29.9 t70 -58.55 -36.52 74.02 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.203 0.601 . . . . 0.0 111.246 170.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.01 -44.73 83.91 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -61.98 -45.56 93.08 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.868 0.867 . . . . 0.0 112.371 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 85' ' ' ASP . 22.3 m -71.59 -34.36 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 122.851 0.461 . . . . 0.0 110.948 -177.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.7 60.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.679 0.392 . . . . 0.0 110.689 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 C-N-CA 123.529 0.731 . . . . 0.0 112.932 -179.607 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 8' ' ' VAL . 9.1 m . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.68 -46.31 82.94 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.335 0.397 . . . . 0.0 110.884 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.35 -42.52 82.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 123.894 0.746 . . . . 0.0 111.299 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.415 ' O ' HG12 ' A' ' 11' ' ' ILE . 31.2 mmm-85 -70.12 -47.18 62.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.264 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 4' ' ' THR . 95.6 t -58.4 -39.21 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.305 0.574 . . . . 0.0 110.698 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.999 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 t -69.64 -25.44 63.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.587 0.355 . . . . 0.0 111.524 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.595 HG23 HG13 ' A' ' 47' ' ' ILE . 34.2 mm -61.99 -58.0 9.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.2 -30.13 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.89 0.744 . . . . 0.0 110.95 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.17 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.431 1.092 . . . . 0.0 111.622 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 -29.54 56.06 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.135 0.574 . . . . 0.0 112.17 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.5 m -79.79 -60.23 2.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.803 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 43' ' ' ILE . 42.9 m -90.44 -3.95 57.33 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 60.7 69.88 0.65 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.875 0.87 . . . . 0.0 110.129 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -133.51 116.32 13.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 23.8 Cg_endo -58.74 145.66 95.21 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.868 2.379 . . . . 0.0 112.313 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HD2' HD13 ' A' ' 23' ' ' ILE . 55.6 mmm-85 -62.67 -25.32 68.09 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.343 1.057 . . . . 0.0 112.249 -175.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 17.1 pt-20 -61.12 -41.27 96.4 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.444 HG22 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.82 -12.71 47.16 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 111.48 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 20' ' ' ARG . 76.0 mt -83.6 104.68 12.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.2 p -120.45 153.39 56.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.284 1.034 . . . . 0.0 109.335 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.0 -30.15 82.73 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.64 2.226 . . . . 0.0 112.752 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.42 -15.78 58.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.3 t -66.46 134.86 53.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.942 0.497 . . . . 0.0 110.165 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 20.5 t-80 -103.27 134.7 46.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.279 . . . . 0.0 108.054 174.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.47 -58.47 6.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.169 0.588 . . . . 0.0 112.358 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.89 -49.02 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.0 t70 -72.67 -37.38 67.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.646 0.778 . . . . 0.0 112.663 -170.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -107.64 -56.89 2.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.976 0.51 . . . . 0.0 110.814 -172.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 77' ' ' LEU . 91.5 mt -72.58 -20.39 61.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.771 0.829 . . . . 0.0 111.91 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.54 8.78 87.49 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.213 0.32 . . . . 0.0 113.054 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.62 HD11 HD12 ' A' ' 43' ' ' ILE . 79.5 mt -72.79 106.56 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.222 1.009 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.2 159.29 7.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.645 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -62.15 -15.56 46.79 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.354 0.662 . . . . 0.0 111.009 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.97 -44.98 21.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.486 1.114 . . . . 0.0 110.376 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.4 -26.82 62.01 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.29 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -73.0 -20.72 60.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.434 1.094 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.488 HD22 HD21 ' A' ' 57' ' ' LEU . 96.0 mt -55.99 -42.42 76.33 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.175 0.59 . . . . 0.0 110.4 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.08 -33.64 68.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.936 1.294 . . . . 0.0 110.793 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 35' ' ' ILE . 58.0 mt -65.09 -48.2 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.204 0.602 . . . . 0.0 109.624 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' HD22 ' A' ' 55' ' ' LEU . . . -61.89 -34.85 76.79 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.003 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.05 -49.51 64.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.427 1.08 . . . . 0.0 111.081 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.76 72.84 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.079 0.552 . . . . 0.0 111.849 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.595 HG13 HG23 ' A' ' 11' ' ' ILE . 80.0 mt -67.78 -44.19 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 124.156 0.983 . . . . 0.0 110.135 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.34 -45.01 65.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.144 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -70.49 -50.7 35.26 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.04 -55.08 38.43 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.15 0.98 . . . . 0.0 112.301 -170.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.47 ' HB2' HG12 ' A' ' 53' ' ' ILE . 90.4 m-85 -82.05 -22.54 36.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.048 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.89 29.27 57.51 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 51' ' ' PHE . 31.9 pt -113.38 162.34 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.204 1.002 . . . . 0.0 109.632 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -95.1 103.45 15.3 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 44' ' ' ALA . 9.6 tt -83.87 115.93 62.23 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.26 81.8 0.69 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.227 1.951 . . . . 0.0 112.224 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.488 HD21 HD22 ' A' ' 41' ' ' LEU . 48.9 tp -73.29 -32.39 64.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.29 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.17 -34.83 72.57 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.293 0.637 . . . . 0.0 111.186 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.94 -46.64 51.33 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.85 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -62.8 -46.83 86.14 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.704 0.802 . . . . 0.0 111.303 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.7 m -56.41 -45.56 80.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.819 1.248 . . . . 0.0 111.269 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -64.03 -38.49 91.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.889 0.876 . . . . 0.0 110.975 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.4 -33.74 76.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.668 0.787 . . . . 0.0 110.751 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.95 -43.9 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.847 0.459 . . . . 0.0 110.433 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -56.2 -39.25 72.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.623 0.769 . . . . 0.0 112.65 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -84.24 -3.72 58.38 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.21 19.35 79.82 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 117.973 0.351 . . . . 0.0 113.178 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -82.18 -58.96 2.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.361 0.665 . . . . 0.0 109.668 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.63 161.72 15.11 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.054 0.941 . . . . 0.0 110.211 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.2 p -105.74 165.34 11.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.893 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.8 p -65.08 -29.95 70.86 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.203 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.79 -44.84 93.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.662 0.785 . . . . 0.0 111.642 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.68 -33.01 69.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.301 0.64 . . . . 0.0 112.291 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.0 -64.76 1.18 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 31.8 m-85 -61.78 -21.79 64.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -167.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.5 t -62.13 129.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.614 1.097 . . . . 0.0 108.424 170.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.482 HD11 HD13 ' A' ' 33' ' ' LEU . 32.0 mt -60.8 -38.41 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -165.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' HG11 ' A' ' 76' ' ' VAL . 23.0 pttp -64.52 -38.22 90.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.1 m-20 -69.71 -48.92 57.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.57 0.748 . . . . 0.0 110.172 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.7 tp -52.08 -48.51 64.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.774 1.63 . . . . 0.0 110.825 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.1 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.72 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.38 64.75 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.458 0.474 . . . . 0.0 111.306 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 30.1 mmm180 -60.99 -40.6 94.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.698 0.799 . . . . 0.0 111.492 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.454 HD13 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -74.61 -42.52 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.417 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -51.95 -38.28 55.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.076 0.95 . . . . 0.0 111.294 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -66.08 -44.86 83.21 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.951 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.21 -38.83 82.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.725 0.81 . . . . 0.0 112.08 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.01 -31.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.82 92.06 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.027 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.807 0 O-C-N 124.325 1.015 . . . . 0.0 112.906 178.635 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 8' ' ' VAL . 53.5 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 119.844 -0.122 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -60.83 -42.64 98.15 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.805 0.69 . . . . 0.0 111.517 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.63 -40.73 84.18 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.867 0.73 . . . . 0.0 111.271 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.48 ' O ' HG12 ' A' ' 11' ' ' ILE . 19.6 mmt180 -75.81 -39.18 57.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.128 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 4' ' ' THR . 94.5 t -60.4 -39.38 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.565 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.05 88.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.519 1.127 . . . . 0.0 111.054 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -69.35 -31.76 70.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.223 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -59.09 -53.64 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.1 mt -61.03 -38.21 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.972 0.909 . . . . 0.0 111.092 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.81 68.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.74 0.816 . . . . 0.0 111.345 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.29 -40.53 64.49 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.774 0.83 . . . . 0.0 112.568 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.412 ' OG1' HG12 ' A' ' 43' ' ' ILE . 18.1 p -76.86 -58.41 3.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.06 0.544 . . . . 0.0 111.416 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 35' ' ' ILE . 48.4 t -84.79 -0.97 55.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.829 0.852 . . . . 0.0 112.426 -172.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.55 45.19 16.65 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.22 1.008 . . . . 0.0 112.069 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.34 130.76 23.49 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.843 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.9 128.33 28.32 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.543 2.162 . . . . 0.0 111.464 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 tpt85 -56.72 -36.72 70.04 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.014 0.926 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -32.64 74.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.652 1.181 . . . . 0.0 112.614 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -82.74 -10.05 59.07 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 122.556 0.342 . . . . 0.0 111.717 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.61 110.39 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.268 0.627 . . . . 0.0 110.035 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.7 p -117.39 148.77 43.42 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.359 1.064 . . . . 0.0 109.54 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -51.29 -41.4 58.86 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.976 2.451 . . . . 0.0 113.833 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.01 -16.64 59.24 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.984 -172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.428 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 33.5 t -63.43 132.16 50.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.567 0.747 . . . . 0.0 110.672 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 59.2 t-80 -89.87 128.48 36.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.57 -64.15 0.88 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.696 0.799 . . . . 0.0 112.475 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.06 -35.79 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.2 t70 -82.32 -67.99 0.74 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.521 0.328 . . . . 0.0 111.114 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.39 -51.37 17.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.305 0.642 . . . . 0.0 110.776 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 77' ' ' LEU . 87.6 mt -81.84 -18.34 44.28 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.423 0.689 . . . . 0.0 111.546 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.48 36.86 78.07 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.191 0.307 . . . . 0.0 113.809 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.489 HG12 ' SG ' ' A' ' 16' ' ' CYS . 54.7 mt -85.16 133.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.935 0.894 . . . . 0.0 109.691 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.25 154.21 31.2 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -66.22 -17.94 65.05 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.641 0.376 . . . . 0.0 110.374 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.06 -42.65 18.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 109.901 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.08 -32.97 73.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.92 -21.32 65.99 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.007 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD23 HD23 ' A' ' 57' ' ' LEU . 90.3 mt -59.47 -35.91 74.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.085 0.554 . . . . 0.0 111.816 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.01 -35.55 56.95 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.333 0.653 . . . . 0.0 110.221 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.412 HG12 ' OG1' ' A' ' 15' ' ' THR . 55.1 mt -60.29 -50.61 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HA ' HD13 ' A' ' 47' ' ' ILE . . . -66.87 -32.76 74.23 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.831 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -69.43 -40.12 77.43 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.15 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.78 70.13 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.559 HG13 HG23 ' A' ' 11' ' ' ILE . 87.7 mt -66.96 -40.64 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.076 0.95 . . . . 0.0 110.743 173.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.28 -45.39 87.99 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.231 0.612 . . . . 0.0 110.941 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -80.82 -27.36 36.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.546 0.738 . . . . 0.0 112.63 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.41 -53.7 5.52 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.166 0.587 . . . . 0.0 110.495 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -87.62 -23.83 24.15 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.962 0.905 . . . . 0.0 111.201 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.34 39.72 30.36 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.06 -177.99 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 0.0 110.26 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -124.71 109.12 12.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.69 106.46 18.76 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.09 82.89 2.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 121.778 1.652 . . . . 0.0 111.693 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 HD23 ' A' ' 41' ' ' LEU . 57.2 tp -69.11 -34.92 75.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.904 -174.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.75 -36.97 70.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.285 1.034 . . . . 0.0 110.976 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 ttpp -87.77 -34.74 18.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.908 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -62.52 -43.86 97.79 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.505 0.722 . . . . 0.0 110.969 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.9 m -63.98 -33.5 75.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.931 0.892 . . . . 0.0 110.604 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -72.48 -29.83 64.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.358 0.663 . . . . 0.0 111.585 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 30.8 mm-40 -58.46 -39.93 81.26 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.55 0.69 . . . . 0.0 109.475 171.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 44.0 t -69.03 -47.34 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.46 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -57.51 -44.05 84.71 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.034 0.934 . . . . 0.0 112.612 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -86.1 -13.67 46.55 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.003 0.921 . . . . 0.0 111.321 -175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.88 61.53 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 113.804 0.282 . . . . 0.0 113.804 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.81 -34.84 79.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.45 0.7 . . . . 0.0 110.336 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -158.57 171.23 20.5 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.877 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.9 p -100.83 157.74 16.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.809 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.63 -32.09 68.71 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.448 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 76' ' ' VAL . 45.1 tt0 -55.87 -41.56 74.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.095 1.358 . . . . 0.0 111.682 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.58 -21.7 64.5 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.898 0.879 . . . . 0.0 112.584 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -121.46 -6.38 9.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -126.9 -26.9 3.1 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.595 -0.716 . . . . 0.0 112.805 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 58.0 t -61.26 126.44 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 167.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.691 HD12 HD11 ' A' ' 33' ' ' LEU . 36.9 mt -59.07 -35.43 73.35 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.089 0.868 . . . . 0.0 112.642 -161.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -69.85 -36.4 75.52 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.411 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 80.8 m-20 -71.43 -48.31 50.36 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.116 0.966 . . . . 0.0 110.235 177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.9 tp -50.44 -50.74 51.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 110.987 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.12 61.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.826 0.851 . . . . 0.0 111.696 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.29 56.43 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.563 0.539 . . . . 0.0 110.384 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 24.1 mmm180 -70.65 -32.2 69.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.298 0.639 . . . . 0.0 111.486 175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.34 -39.55 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HA ' HG23 ' A' ' 88' ' ' VAL . 34.7 t70 -58.2 -37.94 75.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.689 . . . . 0.0 111.567 170.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 7.5 tp10 -59.08 -47.79 83.95 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.189 0.995 . . . . 0.0 110.196 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.8 mt -67.6 -41.11 84.58 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.034 0.934 . . . . 0.0 113.112 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 85' ' ' ASP . 17.3 m -75.73 -28.4 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.997 -0.439 . . . . 0.0 111.032 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.67 56.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 C-N-CA 123.274 0.63 . . . . 0.0 112.462 170.968 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 85' ' ' ASP . 7.8 m . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -68.32 -46.31 70.58 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.65 -42.15 70.96 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.39 0.676 . . . . 0.0 111.057 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -60.88 -58.03 10.14 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.473 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.23 -37.67 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.297 1.039 . . . . 0.0 111.528 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.08 79.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.647 1.179 . . . . 0.0 110.657 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -62.01 -40.95 97.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.452 0.701 . . . . 0.0 111.395 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.98 -50.81 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.298 0.639 . . . . 0.0 110.579 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.56 -34.69 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 111.006 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.51 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.962 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -75.46 -50.89 14.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 43' ' ' ILE . 10.1 m -62.79 -46.94 85.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.436 0.694 . . . . 0.0 111.199 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.31 7.64 43.59 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.879 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 59.99 21.15 10.23 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.881 1.273 . . . . 0.0 113.011 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -77.15 138.25 64.79 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.331 0.652 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.76 121.02 9.27 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.102 1.868 . . . . 0.0 111.291 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.37 -29.46 67.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.163 0.585 . . . . 0.0 110.634 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.96 -33.67 69.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.064 0.945 . . . . 0.0 112.312 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -88.84 -18.61 27.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.408 0.683 . . . . 0.0 111.575 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.4 mt -72.94 111.14 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.625 0.77 . . . . 0.0 111.334 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -111.03 161.41 25.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.265 1.026 . . . . 0.0 108.989 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.17 -24.31 59.08 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.18 -23.73 61.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.75 1.22 . . . . 0.0 110.944 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.452 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.5 m -61.88 119.39 8.71 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 123.737 0.648 . . . . 0.0 111.161 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.4 t-80 -86.05 127.9 34.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -48.81 -54.02 16.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.133 0.573 . . . . 0.0 111.799 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -77.3 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.497 0.189 . . . . 0.0 110.776 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.65 -47.27 73.06 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.324 0.65 . . . . 0.0 112.693 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.7 -51.69 5.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.615 . . . . 0.0 111.852 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.657 HD11 HD11 ' A' ' 77' ' ' LEU . 87.9 mt -79.31 -42.66 25.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.92 0.488 . . . . 0.0 110.266 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.16 -7.49 25.1 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.313 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.4 112.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.337 1.055 . . . . 0.0 111.1 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.38 160.32 29.68 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 p -58.93 -15.43 12.85 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.678 0.791 . . . . 0.0 112.859 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.2 mt -86.18 -38.67 17.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.972 0.909 . . . . 0.0 110.806 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.79 -32.7 67.9 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.97 -19.16 64.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 57' ' ' LEU . 90.4 mt -60.19 -42.11 94.36 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.847 0.459 . . . . 0.0 110.246 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.25 -42.3 93.45 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.858 1.263 . . . . 0.0 110.584 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.482 ' HA ' HG23 ' A' ' 15' ' ' THR . 55.8 mt -67.64 -41.62 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.391 0.676 . . . . 0.0 111.004 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.0 73.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.994 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -65.45 -43.57 89.98 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.6 1.188 . . . . 0.0 110.962 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.92 74.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.782 0.433 . . . . 0.0 111.355 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.84 -40.01 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.343 0.657 . . . . 0.0 110.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -53.42 -50.86 64.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.218 0.607 . . . . 0.0 110.677 174.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -73.25 -48.47 34.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.695 -172.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.78 -44.38 73.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.347 0.659 . . . . 0.0 111.571 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.92 -11.31 39.49 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.946 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.38 71.04 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.235 0.335 . . . . 0.0 112.837 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.24 175.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.061 0.944 . . . . 0.0 111.019 -175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -116.59 92.71 3.95 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tt -78.18 114.09 39.32 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.99 85.86 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.185 1.924 . . . . 0.0 112.401 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 41' ' ' LEU . 51.7 tp -72.5 -30.4 64.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.6 -30.79 68.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.005 0.522 . . . . 0.0 111.404 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -70.39 -55.48 8.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 0.0 108.659 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -61.1 -48.46 81.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.665 1.186 . . . . 0.0 112.879 -168.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -60.0 -44.3 94.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.664 0.786 . . . . 0.0 111.682 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -70.36 -30.86 67.89 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.287 0.635 . . . . 0.0 110.684 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.3 -40.36 97.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.458 0.703 . . . . 0.0 110.723 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 71' ' ' THR . 60.3 t -66.96 -42.82 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.215 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.16 -31.07 65.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.691 0.796 . . . . 0.0 112.7 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -102.24 -14.64 16.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.938 0.495 . . . . 0.0 111.45 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.16 24.1 64.53 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.706 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.57 -31.26 72.37 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.291 0.546 . . . . 0.0 109.607 168.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.18 166.56 31.19 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.616 1.166 . . . . 0.0 109.773 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.6 p -99.29 158.69 15.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.7 0.8 . . . . 0.0 110.972 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.545 HG22 HG12 ' A' ' 64' ' ' VAL . 38.5 p -64.49 -32.34 73.94 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 76' ' ' VAL . 36.8 tt0 -55.63 -46.34 77.44 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.569 0.747 . . . . 0.0 111.033 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.44 -34.84 69.38 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.812 0.845 . . . . 0.0 112.58 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -104.43 -75.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.536 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 85.9 m-85 -58.18 -26.16 62.42 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 125.275 1.43 . . . . 0.0 114.844 -165.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -61.48 124.72 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 120.001 1.273 . . . . 0.0 108.257 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.657 HD11 HD11 ' A' ' 33' ' ' LEU . 34.7 mt -61.96 -33.59 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -162.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.4 pttp -69.41 -36.48 76.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -72.69 -44.24 62.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.61 0.764 . . . . 0.0 109.878 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.81 -43.97 69.8 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.171 1.788 . . . . 0.0 111.367 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.815 0.697 . . . . 0.0 110.759 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.02 -44.4 65.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -62.68 -44.06 97.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.542 0.737 . . . . 0.0 111.484 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -69.52 -43.07 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.574 0.749 . . . . 0.0 110.154 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.515 ' HB2' HG21 ' A' ' 4' ' ' THR . 22.1 t70 -53.74 -39.87 65.68 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.983 0.513 . . . . 0.0 111.652 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.66 -48.37 81.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.415 0.626 . . . . 0.0 110.639 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.68 -39.03 80.78 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.396 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.444 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.7 m -76.53 -33.89 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 122.661 0.384 . . . . 0.0 110.802 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.15 -21.86 65.8 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 O-C-N 123.68 0.612 . . . . 0.0 112.398 173.872 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 8' ' ' VAL . 71.3 m . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.81 -0.07 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.67 -45.99 90.41 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.835 0.709 . . . . 0.0 110.941 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.18 -36.35 79.6 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.493 0.717 . . . . 0.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 7' ' ' ARG . 5.4 mmt-85 -68.32 -47.98 66.11 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.694 0.621 . . . . 0.0 111.422 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 4' ' ' THR . 97.6 t -59.62 -37.13 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.708 0.766 . . . . 0.0 110.269 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.27 73.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.005 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -72.14 -23.01 61.23 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 122.425 0.29 . . . . 0.0 111.553 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.487 HG23 HG13 ' A' ' 47' ' ' ILE . 28.0 mm -59.59 -58.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 167.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.85 -30.04 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.925 0.765 . . . . 0.0 111.044 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.37 -53.61 54.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.502 1.121 . . . . 0.0 111.64 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.2 -34.53 59.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.595 0.358 . . . . 0.0 111.703 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.2 m -71.75 -60.48 2.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.775 0.83 . . . . 0.0 111.292 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 43' ' ' ILE . 61.1 m -96.06 4.13 52.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.611 0.764 . . . . 0.0 112.321 -173.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.31 33.47 22.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.27 1.028 . . . . 0.0 112.599 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.08 123.95 59.53 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.16 137.5 63.12 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.937 2.425 . . . . 0.0 112.681 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.5 0.72 . . . . 0.0 111.127 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.04 -28.47 68.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.975 0.91 . . . . 0.0 111.817 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -88.84 -20.34 24.77 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.781 0.432 . . . . 0.0 110.718 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.86 123.32 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.511 0.724 . . . . 0.0 109.227 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -136.35 157.54 75.23 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.347 1.059 . . . . 0.0 109.602 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -59.84 -32.5 95.46 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.228 1.952 . . . . 0.0 112.263 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.49 -28.47 61.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.415 0.686 . . . . 0.0 112.123 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 30.9 p -72.76 118.51 15.78 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.922 0.391 . . . . 0.0 111.496 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 62.0 t-80 -68.67 129.36 39.69 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 109.267 167.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.2 -58.04 5.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.251 0.621 . . . . 0.0 112.46 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 26.9 mt -72.9 -44.76 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.304 0.241 . . . . 0.0 111.447 -174.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 22.1 t70 -75.48 -64.04 1.15 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.29 0.236 . . . . 0.0 111.164 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.72 -48.75 15.93 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 77' ' ' LEU . 82.1 mt -79.84 -27.66 40.17 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.254 0.222 . . . . 0.0 111.281 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.12 47.88 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.426 -0.352 . . . . 0.0 113.413 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 43' ' ' ILE . 66.3 mt -80.69 133.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.93 0.892 . . . . 0.0 109.748 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.63 153.89 19.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -61.58 -15.94 43.47 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 mt -84.21 -32.8 24.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.625 0.726 . . . . 0.0 109.661 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.85 -27.87 40.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.143 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -73.7 -21.25 60.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.319 1.048 . . . . 0.0 110.282 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.579 HD22 HD22 ' A' ' 57' ' ' LEU . 88.9 mt -56.04 -42.5 76.64 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.073 0.549 . . . . 0.0 110.143 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.77 -38.13 89.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.894 0.878 . . . . 0.0 110.986 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.549 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.0 mt -62.26 -51.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.119 0.568 . . . . 0.0 110.371 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HB2' HD22 ' A' ' 55' ' ' LEU . . . -62.35 -40.07 95.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.74 -176.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -67.73 -39.21 84.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.818 0.847 . . . . 0.0 111.311 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.38 -31.39 69.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.682 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 11' ' ' ILE . 81.2 mt -69.82 -40.92 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.95 0.9 . . . . 0.0 110.822 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -54.32 -42.34 70.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.491 0.716 . . . . 0.0 111.126 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -76.78 -48.48 18.5 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.458 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.12 63.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.489 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.456 ' HB2' HG12 ' A' ' 53' ' ' ILE . 78.4 m-85 -85.44 -24.91 27.25 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.63 34.17 44.97 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.48 0.487 . . . . 0.0 112.114 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 51' ' ' PHE . 32.2 pt -121.88 173.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 109.649 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.14 110.56 22.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 44' ' ' ALA . 7.6 tt -96.36 104.17 16.58 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.92 84.27 1.61 Allowed 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.04 1.827 . . . . 0.0 111.521 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.579 HD22 HD22 ' A' ' 41' ' ' LEU . 61.2 tp -69.17 -30.6 68.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.64 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.919 0.888 . . . . 0.0 111.059 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 54.7 tttp -77.69 -46.62 21.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.938 0.895 . . . . 0.0 110.361 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -66.88 -38.66 86.72 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.088 0.555 . . . . 0.0 111.539 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 m -66.51 -35.64 80.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.704 0.802 . . . . 0.0 110.522 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.93 -34.8 77.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.135 0.974 . . . . 0.0 110.653 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HG3' ' HH ' ' A' ' 74' ' ' TYR . 61.4 mm-40 -58.13 -41.89 84.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.47 -47.26 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.706 0.802 . . . . 0.0 110.4 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.92 -27.99 68.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.865 1.266 . . . . 0.0 112.806 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.78 -8.62 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.796 0.839 . . . . 0.0 112.252 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.78 81.3 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 122.812 0.07 . . . . 0.0 113.139 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -71.55 -21.94 61.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.581 1.152 . . . . 0.0 110.347 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.34 168.89 25.25 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.431 1.093 . . . . 0.0 109.457 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -101.3 158.76 15.8 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.735 0.814 . . . . 0.0 109.64 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -61.99 -31.59 71.97 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.085 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.44 -36.76 84.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.972 0.909 . . . . 0.0 111.843 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 28.3 tt0 -63.36 -29.05 70.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.176 0.59 . . . . 0.0 111.928 -173.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.546 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 70.2 m-85 -107.69 -64.13 1.24 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.391 0.277 . . . . 0.0 111.436 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.28 -20.79 63.28 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -167.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t -65.63 131.99 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 119.862 1.21 . . . . 0.0 108.894 171.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 33' ' ' LEU . 25.2 mt -59.96 -36.41 77.05 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -165.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.6 pttt -58.7 -43.1 89.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.454 0.471 . . . . 0.0 111.056 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.0 m-20 -76.47 -46.2 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.298 1.039 . . . . 0.0 110.308 -174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.38 -52.38 37.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.109 1.363 . . . . 0.0 110.539 171.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.48 -25.79 65.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.13 -42.73 59.56 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.795 0.685 . . . . 0.0 111.097 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 22.1 mmm180 -64.93 -42.93 94.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 53' ' ' ILE . 93.9 mt -64.93 -43.26 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.922 . . . . 0.0 110.549 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.478 ' HA ' HG21 ' A' ' 88' ' ' VAL . 23.4 t70 -56.1 -36.83 68.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.455 0.702 . . . . 0.0 111.899 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.51 -39.07 77.8 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 123.719 0.637 . . . . 0.0 110.407 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.74 -38.53 86.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.43 0.692 . . . . 0.0 111.996 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 85' ' ' ASP . 13.7 m -80.55 -25.73 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 122.184 -0.323 . . . . 0.0 110.839 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.17 -38.12 78.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.145 0.578 . . . . 0.0 109.825 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 124.083 0.953 . . . . 0.0 112.704 177.534 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' VAL . 16.8 m . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -68.25 -32.11 72.07 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -59.31 -48.09 82.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.66 0.384 . . . . 0.0 111.071 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -69.33 -46.23 67.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.865 0.728 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -57.97 -42.67 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.76 0.824 . . . . 0.0 111.314 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.98 91.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.608 0.763 . . . . 0.0 110.647 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -56.41 -44.12 80.04 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.956 0.903 . . . . 0.0 111.597 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.482 HG22 HG13 ' A' ' 47' ' ' ILE . 29.3 mm -58.17 -57.87 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.88 0.872 . . . . 0.0 110.049 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 43' ' ' ILE . 73.0 mt -61.65 -33.17 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.37 1.068 . . . . 0.0 111.593 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.24 59.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.933 0.893 . . . . 0.0 111.437 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.17 -24.66 30.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 43' ' ' ILE . 37.4 p -74.95 -62.05 1.68 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.745 0.418 . . . . 0.0 110.353 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 43' ' ' ILE . 26.2 m -94.48 12.57 26.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.206 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t70 67.34 16.91 10.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.775 1.23 . . . . 0.0 111.991 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.8 mt -77.34 127.36 83.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 122.892 0.477 . . . . 0.0 110.284 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.71 127.03 23.01 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.744 2.296 . . . . 0.0 112.365 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -59.57 -31.54 69.53 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.248 1.019 . . . . 0.0 110.804 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG22 ' A' ' 22' ' ' THR . 10.8 pt-20 -59.91 -27.92 67.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.811 1.244 . . . . 0.0 112.374 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 21' ' ' GLU . 45.0 p -105.15 -6.82 19.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.539 0.735 . . . . 0.0 111.947 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.1 mt -71.04 116.19 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.164 0.507 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 138.25 31.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.085 1.354 . . . . 0.0 108.435 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 36.8 Cg_endo -60.93 -27.22 84.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.998 2.465 . . . . 0.0 112.942 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.29 -20.84 61.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.179 0.992 . . . . 0.0 112.351 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 146.62 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.724 0.41 . . . . 0.0 110.362 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 30.1 t-80 -107.85 136.38 47.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 124.159 0.984 . . . . 0.0 108.819 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.34 -63.49 1.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.28 1.432 . . . . 0.0 113.545 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.89 -28.21 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.797 0.439 . . . . 0.0 110.836 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.7 t70 -63.8 -65.97 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.07 0.948 . . . . 0.0 112.018 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.69 -48.02 3.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.048 0.539 . . . . 0.0 110.527 -170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.33 -23.53 66.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.087 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.05 26.67 71.55 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.046 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.5 mt -65.52 120.57 12.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.57 164.43 25.89 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t -77.08 -22.04 53.43 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 122.053 -0.404 . . . . 0.0 110.003 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.7 -32.03 22.15 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.684 0.794 . . . . 0.0 109.537 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -73.05 -29.63 63.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.243 1.017 . . . . 0.0 110.534 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.88 -22.5 59.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.695 . . . . 0.0 110.059 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.577 HD23 HD21 ' A' ' 57' ' ' LEU . 93.4 mt -57.71 -35.78 71.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.745 0.418 . . . . 0.0 110.815 174.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.74 -36.77 76.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.653 0.781 . . . . 0.0 110.858 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.609 HD12 ' SG ' ' A' ' 16' ' ' CYS . 52.3 mt -62.08 -53.03 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.585 0.754 . . . . 0.0 109.538 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.24 85.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.329 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.84 -40.13 69.27 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.622 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.877 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.482 HG13 HG22 ' A' ' 11' ' ' ILE . 82.1 mt -72.11 -38.67 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.607 1.163 . . . . 0.0 111.388 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -53.32 -46.16 69.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.86 0.864 . . . . 0.0 110.925 174.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -77.53 -47.57 19.18 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.347 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.41 -50.33 65.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.662 0.785 . . . . 0.0 111.803 -170.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.4 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.8 m-85 -83.92 -28.36 27.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.632 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 45.88 8.82 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 51' ' ' PHE . 37.6 pt -127.14 -175.35 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.049 0.94 . . . . 0.0 111.051 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -124.04 99.71 6.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.28 1.032 . . . . 0.0 108.488 174.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 104.26 8.06 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.68 81.65 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.47 1.447 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.577 HD21 HD23 ' A' ' 41' ' ' LEU . 54.3 tp -69.75 -32.76 71.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.767 0.427 . . . . 0.0 110.099 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.18 -36.35 70.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.44 1.096 . . . . 0.0 110.903 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 39.4 ttpt -78.11 -44.16 26.91 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.677 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -62.89 -39.38 94.31 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 0.0 111.436 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 m -56.56 -46.31 80.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.508 1.123 . . . . 0.0 111.073 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -66.38 -34.91 79.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.076 0.95 . . . . 0.0 111.101 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.9 mm-40 -59.44 -42.72 92.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.117 0.567 . . . . 0.0 110.442 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 HG21 ' A' ' 71' ' ' THR . 59.0 t -68.28 -49.61 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.662 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -61.9 -28.9 69.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.93 0.892 . . . . 0.0 112.947 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -95.06 -7.8 38.52 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.851 0.861 . . . . 0.0 110.849 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.87 80.87 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.558 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.61 -10.92 57.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.7 0.8 . . . . 0.0 112.121 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -161.72 168.63 22.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.253 0.621 . . . . 0.0 110.837 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.5 p -104.36 157.45 17.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.919 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 64' ' ' VAL . 32.2 p -67.98 -28.63 67.61 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.634 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.62 -39.56 88.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.164 0.586 . . . . 0.0 110.65 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.37 -34.72 66.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.868 0.867 . . . . 0.0 112.133 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -107.47 -71.81 0.74 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.373 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 57.2 m-85 -60.66 -18.23 52.41 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -165.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 84.8 t -65.6 128.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.811 1.187 . . . . 0.0 108.189 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.82 -39.2 77.07 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.2 pttp -68.55 -38.17 80.56 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.428 0.455 . . . . 0.0 112.089 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.0 m-20 -70.36 -46.61 63.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.47 0.708 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.06 -49.14 64.08 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.285 1.434 . . . . 0.0 110.863 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.48 69.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.347 0.659 . . . . 0.0 110.832 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.07 -39.61 55.02 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.723 0.409 . . . . 0.0 110.739 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.5 mmm180 -59.35 -43.39 92.8 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.352 0.596 . . . . 0.0 110.899 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -71.7 -38.35 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.294 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.4 -38.64 66.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.744 0.818 . . . . 0.0 111.882 170.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.48 -40.66 76.92 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.545 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.43 -42.82 95.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.142 0.977 . . . . 0.0 112.957 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.9 m -75.73 -26.6 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.604 0.362 . . . . 0.0 110.27 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.8 73.08 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.953 171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 123.706 0.803 . . . . 0.0 112.981 176.169 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' HG21 ' A' ' 8' ' ' VAL . 79.8 m . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 119.943 -0.075 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.35 -58.68 5.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.81 -29.77 68.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 123.867 0.729 . . . . 0.0 111.588 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -64.98 -51.53 61.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 110.75 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 4' ' ' THR . 54.3 t -61.83 -36.17 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.144 0.578 . . . . 0.0 111.028 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.31 93.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.849 . . . . 0.0 109.958 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.2 m -54.92 -46.91 74.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.738 1.215 . . . . 0.0 111.409 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.564 HG22 HG13 ' A' ' 47' ' ' ILE . 41.9 mm -58.4 -58.32 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.76 -37.14 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.434 1.094 . . . . 0.0 111.387 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.14 78.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.927 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.58 -27.44 21.37 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 p -80.4 -59.94 2.51 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.502 0.592 . . . . 0.0 110.74 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.645 ' SG ' HG12 ' A' ' 35' ' ' ILE . 44.8 t -80.06 -8.39 59.36 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.234 1.014 . . . . 0.0 111.887 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 61.68 71.92 0.53 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.822 0.849 . . . . 0.0 110.158 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.3 mt -127.78 128.48 23.87 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.241 1.016 . . . . 0.0 108.842 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.58 134.9 60.01 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.992 2.461 . . . . 0.0 112.553 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HD2' HD13 ' A' ' 23' ' ' ILE . 9.4 mmm180 -59.25 -29.2 67.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.873 0.869 . . . . 0.0 111.554 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 22' ' ' THR . 14.2 pt-20 -63.26 -33.71 76.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 21' ' ' GLU . 46.0 p -101.7 21.42 14.48 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.152 0.981 . . . . 0.0 111.447 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 HD13 ' HD2' ' A' ' 20' ' ' ARG . 63.5 mt -106.45 128.21 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -138.41 155.66 73.79 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.073 0.949 . . . . 0.0 109.557 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.5 -35.01 96.34 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.328 2.019 . . . . 0.0 112.878 170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.15 -21.69 53.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.732 0.813 . . . . 0.0 112.092 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.3 p -69.98 128.89 37.91 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 53.5 t-80 -88.41 129.89 35.31 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.68 -59.12 4.64 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.016 0.526 . . . . 0.0 111.994 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 45.1 mt -71.33 -60.55 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 120.657 0.265 . . . . 0.0 110.803 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.74 -49.15 77.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.268 1.027 . . . . 0.0 112.901 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.86 -58.56 2.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.83 0.452 . . . . 0.0 111.498 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.13 -19.6 58.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.401 0.68 . . . . 0.0 111.767 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.12 76.01 Favored Glycine 0 N--CA 1.478 1.463 0 O-C-N 122.986 0.178 . . . . 0.0 113.518 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.645 HG12 ' SG ' ' A' ' 16' ' ' CYS . 47.6 mt -73.32 117.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.106 0.962 . . . . 0.0 110.22 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.6 163.19 27.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 m -63.64 -16.51 61.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.911 0.484 . . . . 0.0 111.726 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -85.15 -43.88 13.45 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.718 0.807 . . . . 0.0 109.509 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.89 -31.4 72.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.116 0.966 . . . . 0.0 110.793 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 57' ' ' LEU . 8.8 t80 -72.2 -20.93 61.49 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.01 0.924 . . . . 0.0 110.685 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.504 HD22 HD22 ' A' ' 57' ' ' LEU . 78.4 mt -57.62 -31.2 65.99 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.784 0.434 . . . . 0.0 111.849 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -69.75 -43.24 72.67 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.233 1.013 . . . . 0.0 109.262 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -60.06 -51.59 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.118 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.74 89.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.842 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.1 -38.33 87.97 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.423 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 11' ' ' ILE . . . -73.73 -29.23 62.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.178 0.591 . . . . 0.0 111.652 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.564 HG13 HG22 ' A' ' 11' ' ' ILE . 87.3 mt -70.72 -39.38 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.654 0.782 . . . . 0.0 110.587 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.34 -34.77 61.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.97 0.908 . . . . 0.0 111.829 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.38 -51.79 7.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.42 0.688 . . . . 0.0 111.251 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.337 1.055 . . . . 0.0 111.673 -171.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 53' ' ' ILE . 72.9 m-85 -88.58 -14.41 37.65 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.022 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.47 11.32 82.62 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.089 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.4 pt -96.13 -171.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.878 0.871 . . . . 0.0 110.58 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.63 114.83 25.42 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.05 98.35 7.4 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.442 ' HG2' ' HD3' ' A' ' 59' ' ' LYS . 86.9 Cg_endo -81.09 86.41 1.63 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.287 1.991 . . . . 0.0 110.442 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.504 HD22 HD22 ' A' ' 41' ' ' LEU . 65.9 tp -67.08 -40.41 86.99 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.774 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.63 -31.07 72.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.109 0.964 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HD3' ' HG2' ' A' ' 56' ' ' PRO . 47.7 tttp -65.5 -48.29 73.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.004 1.322 . . . . 0.0 110.187 171.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . 0.408 ' O ' HG21 ' A' ' 64' ' ' VAL . 45.2 m0 -63.36 -43.63 97.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.854 0.861 . . . . 0.0 110.787 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.0 m -59.36 -46.0 89.86 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.459 1.504 . . . . 0.0 111.243 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -65.14 -44.9 87.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.532 0.733 . . . . 0.0 111.001 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.96 -26.69 59.77 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.881 0.473 . . . . 0.0 112.222 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 HG13 HG21 ' A' ' 71' ' ' THR . 90.3 t -72.72 -42.28 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.68 -17.45 62.84 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.623 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.01 -6.88 34.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 10.55 84.96 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.071 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.18 -16.98 55.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.842 0.857 . . . . 0.0 110.981 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.26 166.89 30.37 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.888 0.875 . . . . 0.0 109.999 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.416 HG21 ' H ' ' A' ' 73' ' ' GLN . 9.7 t -111.57 155.65 22.98 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.47 0.708 . . . . 0.0 110.326 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 64' ' ' VAL . 30.2 p -63.09 -32.52 73.91 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.558 0.743 . . . . 0.0 110.988 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG3' HG21 ' A' ' 76' ' ' VAL . 36.1 tt0 -58.29 -44.36 88.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.561 0.344 . . . . 0.0 111.459 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.416 ' H ' HG21 ' A' ' 70' ' ' THR . 30.3 tt0 -56.32 -32.59 64.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.768 0.827 . . . . 0.0 111.61 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -102.12 -82.09 0.48 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.9 m-85 -55.89 -24.6 38.3 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -161.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.2 t -65.54 124.79 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 119.783 1.174 . . . . 0.0 108.303 170.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.85 -32.97 73.35 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -160.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.482 ' HG2' HG11 ' A' ' 76' ' ' VAL . 62.9 pttt -65.5 -41.28 93.39 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.976 0.51 . . . . 0.0 111.243 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.29 -41.07 49.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.95 -47.07 68.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.831 1.652 . . . . 0.0 110.931 169.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.35 70.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.447 0.699 . . . . 0.0 111.467 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.39 -41.5 47.69 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.413 0.685 . . . . 0.0 110.871 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 23.2 mmm180 -57.58 -50.28 73.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.028 0.931 . . . . 0.0 111.101 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.08 -38.83 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.031 0.932 . . . . 0.0 110.443 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.9 t70 -58.14 -35.52 71.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.81 0.444 . . . . 0.0 111.569 171.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.47 -39.79 70.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.491 0.316 . . . . 0.0 110.735 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 61.4 mt -61.93 -43.77 98.16 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.428 0.691 . . . . 0.0 111.733 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 85' ' ' ASP . 12.2 m -71.68 -27.68 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 122.761 0.424 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.1 65.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.101 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 123.696 0.799 . . . . 0.0 112.934 174.739 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG21 ' A' ' 8' ' ' VAL . 6.9 m . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.49 -47.28 70.48 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.728 0.411 . . . . 0.0 110.299 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -54.78 -44.4 73.68 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.406 0.683 . . . . 0.0 111.461 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -60.49 -55.63 31.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.088 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 81' ' ' ALA . 58.3 t -60.39 -37.14 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.51 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.37 87.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.105 0.962 . . . . 0.0 110.518 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -57.53 -42.81 83.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.141 0.976 . . . . 0.0 111.778 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.505 HG23 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -58.79 -50.94 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -33.99 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.149 0.58 . . . . 0.0 110.648 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -51.26 62.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.382 1.073 . . . . 0.0 112.317 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.44 -46.51 22.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.708 0.403 . . . . 0.0 111.959 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.1 m -72.46 -51.96 17.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.12 0.568 . . . . 0.0 111.616 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.77 -9.28 56.22 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.382 0.673 . . . . 0.0 111.777 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 59.02 72.07 0.55 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.381 1.072 . . . . 0.0 110.597 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.13 129.65 21.79 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.14 139.33 85.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.796 2.33 . . . . 0.0 112.358 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -61.06 -28.98 69.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.335 0.654 . . . . 0.0 112.129 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.34 -37.07 84.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.544 0.738 . . . . 0.0 111.236 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -81.48 -23.03 37.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.953 0.501 . . . . 0.0 111.012 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 77' ' ' LEU . 75.8 mt -76.63 116.4 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -132.32 144.72 54.23 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.504 1.122 . . . . 0.0 109.204 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.9 -32.18 92.33 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.814 2.343 . . . . 0.0 112.792 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.13 -20.67 60.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.642 0.777 . . . . 0.0 112.011 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.9 t -73.58 147.76 43.57 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.989 0.915 . . . . 0.0 110.709 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 56.1 t-80 -104.37 133.71 48.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.553 1.141 . . . . 0.0 108.955 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -64.43 0.84 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.717 0.807 . . . . 0.0 112.705 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 46.2 mt -69.81 -39.6 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.835 0.454 . . . . 0.0 111.603 -173.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.8 t70 -80.52 -67.62 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.499 -174.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.79 -57.7 3.89 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.683 0.393 . . . . 0.0 111.067 -171.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.595 HD12 HD11 ' A' ' 77' ' ' LEU . 84.9 mt -71.67 -26.94 62.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.209 0.604 . . . . 0.0 111.108 -176.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.79 21.9 60.72 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.863 0.727 . . . . 0.0 113.552 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.6 mt -70.2 129.21 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.811 0.844 . . . . 0.0 110.026 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.1 158.69 30.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 33.1 m -65.55 -17.4 64.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.53 0.332 . . . . 0.0 110.84 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 mt -75.88 -47.57 24.91 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.52 1.128 . . . . 0.0 109.299 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -29.2 65.49 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.721 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -73.06 -22.26 60.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.616 0.766 . . . . 0.0 110.451 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.512 HD21 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -60.15 -39.61 86.96 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.681 0.392 . . . . 0.0 109.985 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.0 -44.11 97.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.883 0.873 . . . . 0.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.57 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.493 0.717 . . . . 0.0 109.948 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.07 73.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.21 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -65.2 -43.8 90.42 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.05 0.94 . . . . 0.0 110.179 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.03 -32.05 70.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.245 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 11' ' ' ILE . 84.9 mt -65.22 -42.64 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.855 0.862 . . . . 0.0 110.478 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -53.89 -48.71 69.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.399 0.68 . . . . 0.0 111.463 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -80.04 -37.49 33.92 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.445 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.22 31.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.367 0.667 . . . . 0.0 111.287 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.16 -28.05 32.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.22 39.4 8.47 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 pt -126.5 -172.48 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.197 0.999 . . . . 0.0 110.85 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -131.0 100.94 5.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tt -72.82 113.62 23.13 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.91 80.5 2.14 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.976 1.784 . . . . 0.0 110.966 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.512 HD23 HD21 ' A' ' 41' ' ' LEU . 46.3 tp -70.08 -35.62 74.34 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.146 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.0 -39.43 81.82 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.481 1.113 . . . . 0.0 111.127 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.8 ttpt -74.65 -40.89 61.18 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.033 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -64.02 -42.47 97.09 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.929 0.768 . . . . 0.0 111.233 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.6 m -59.51 -39.56 84.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.937 0.895 . . . . 0.0 111.141 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -68.97 -34.94 76.13 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.961 0.904 . . . . 0.0 110.888 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 23.0 mm-40 -61.89 -39.95 93.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.356 0.662 . . . . 0.0 110.595 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 58.1 t -65.44 -44.55 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.993 0.517 . . . . 0.0 109.972 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -57.93 -44.29 86.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.327 1.051 . . . . 0.0 112.173 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.31 -18.72 35.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.017 0.927 . . . . 0.0 111.654 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.04 21.94 53.92 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 122.674 0.178 . . . . 0.0 113.0 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -79.03 -24.03 43.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.515 0.726 . . . . 0.0 110.552 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.87 166.41 33.0 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.818 0.847 . . . . 0.0 110.047 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.2 t -107.74 166.85 10.38 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.193 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m -67.72 -30.91 70.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.76 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.58 -35.17 78.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.764 0.825 . . . . 0.0 111.399 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.11 -31.99 72.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 112.392 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -109.27 -58.55 2.02 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.91 -10.9 60.53 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -165.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t -63.99 133.39 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.595 HD11 HD12 ' A' ' 33' ' ' LEU . 36.1 mt -60.03 -41.12 91.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.539 0.735 . . . . 0.0 112.641 -166.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.8 -35.21 78.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 123.147 0.279 . . . . 0.0 111.721 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -68.22 -47.99 66.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.184 0.593 . . . . 0.0 109.662 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -52.19 -46.79 65.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.619 1.568 . . . . 0.0 110.385 172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.453 ' HA ' HG23 ' A' ' 8' ' ' VAL . . . -63.78 -34.55 78.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.892 0.877 . . . . 0.0 111.994 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 -37.54 61.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.1 0.56 . . . . 0.0 110.861 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -64.03 -39.04 93.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.087 0.955 . . . . 0.0 111.401 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 47' ' ' ILE . 96.7 mt -72.83 -37.03 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.547 0.739 . . . . 0.0 109.861 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.91 -42.91 65.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.787 0.835 . . . . 0.0 111.419 167.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -62.76 -46.83 86.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.433 0.693 . . . . 0.0 111.087 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.55 -45.47 92.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.326 1.05 . . . . 0.0 112.578 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.2 -27.37 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 122.913 0.485 . . . . 0.0 109.985 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.64 76.08 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.34 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.68 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.9 m -69.14 102.79 1.74 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.012 0.525 . . . . 0.0 109.979 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.9 t -94.05 174.61 7.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.875 0.87 . . . . 0.0 110.353 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 8' ' ' VAL . 23.7 m -53.97 -37.4 63.91 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.872 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -68.67 -35.48 77.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -43.24 80.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.266 0.627 . . . . 0.0 110.638 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -72.55 -44.89 61.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.957 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 4' ' ' THR . 95.2 t -60.01 -42.09 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.334 0.654 . . . . 0.0 111.369 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.76 99.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.803 0.841 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -63.37 -42.66 98.86 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.873 0.869 . . . . 0.0 112.023 174.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.578 HG23 HG13 ' A' ' 47' ' ' ILE . 24.5 mm -56.79 -58.65 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.683 0.793 . . . . 0.0 109.527 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.37 -34.08 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.239 1.015 . . . . 0.0 110.944 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -59.16 -53.54 57.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.358 0.663 . . . . 0.0 111.608 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.57 -25.4 38.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.453 0.701 . . . . 0.0 112.01 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.4 m -75.94 -62.41 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.312 0.645 . . . . 0.0 110.149 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.57 ' SG ' HD12 ' A' ' 43' ' ' ILE . 2.7 m -85.81 -2.92 58.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.943 0.897 . . . . 0.0 112.368 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 65.11 16.22 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.912 1.285 . . . . 0.0 112.468 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 73.4 mt -79.33 120.7 81.37 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_endo -62.04 145.11 96.74 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.269 1.979 . . . . 0.0 112.291 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -54.74 -34.48 62.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.195 0.998 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -59.67 -38.25 80.95 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.877 0.736 . . . . 0.0 111.658 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.468 HG22 ' HG3' ' A' ' 21' ' ' GLU . 76.2 p -86.84 -6.05 58.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.305 0.642 . . . . 0.0 111.687 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.01 133.87 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.992 0.917 . . . . 0.0 109.489 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -144.48 153.1 54.93 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.588 1.155 . . . . 0.0 110.006 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.54 -43.16 56.99 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.408 2.739 . . . . 0.0 114.448 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.83 -3.59 58.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.799 0.44 . . . . 0.0 111.638 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.4 t -68.55 137.36 54.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 49.6 t-80 -98.19 131.34 44.63 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.156 0.982 . . . . 0.0 108.76 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.41 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -49.9 -58.95 4.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.48 0.712 . . . . 0.0 111.97 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.36 -55.31 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.585 0.354 . . . . 0.0 111.132 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.1 t70 -63.08 -55.29 26.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.695 0.798 . . . . 0.0 111.768 -172.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.76 -65.74 0.98 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.905 0.482 . . . . 0.0 110.685 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 HD12 ' A' ' 77' ' ' LEU . 88.5 mt -64.44 -28.49 69.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.531 0.732 . . . . 0.0 111.962 -173.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.64 40.2 27.58 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-O 121.31 0.394 . . . . 0.0 112.373 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.39 127.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.466 1.106 . . . . 0.0 109.31 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.04 159.24 17.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.847 0.859 . . . . 0.0 109.604 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.488 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 48.1 m -49.51 -38.55 30.82 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.1 0.96 . . . . 0.0 112.781 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 mt -71.06 -35.22 71.84 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.445 0.698 . . . . 0.0 110.999 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.11 -37.59 64.08 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.275 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -71.45 -22.04 61.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.208 0.603 . . . . 0.0 110.776 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.7 mt -57.1 -47.24 81.52 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.29 -35.35 79.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.579 1.151 . . . . 0.0 111.732 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.57 HD12 ' SG ' ' A' ' 16' ' ' CYS . 74.5 mt -64.92 -53.1 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.017 0.527 . . . . 0.0 110.144 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -67.34 -29.03 68.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.037 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.11 -38.37 56.96 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.988 0.805 . . . . 0.0 110.84 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.32 -36.65 74.4 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.578 HG13 HG23 ' A' ' 11' ' ' ILE . 85.3 mt -66.52 -42.49 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.206 1.003 . . . . 0.0 110.586 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.23 -43.96 71.29 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.366 1.066 . . . . 0.0 110.474 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.71 -37.07 23.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.236 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.91 23.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.212 0.605 . . . . 0.0 111.401 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -78.68 -18.03 55.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.021 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.34 50.5 38.18 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.0 pt -133.13 160.39 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.538 1.135 . . . . 0.0 109.156 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -94.68 96.92 9.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD22 ' HB1' ' A' ' 44' ' ' ALA . 6.7 tt -83.29 111.29 29.9 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.58 81.9 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.843 1.695 . . . . 0.0 110.802 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.74 -28.11 66.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.788 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.68 -33.32 64.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.792 0.837 . . . . 0.0 111.472 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.6 tttp -80.11 -49.68 11.38 Favored 'General case' 0 C--O 1.211 -0.961 0 C-N-CA 122.999 0.519 . . . . 0.0 109.917 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -60.27 -48.81 80.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.644 0.778 . . . . 0.0 111.705 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.5 m -52.2 -46.23 65.52 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.728 1.211 . . . . 0.0 111.705 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -64.24 -37.52 87.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.926 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.8 mm-40 -59.88 -42.69 94.3 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.072 0.549 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.02 -49.97 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.523 0.729 . . . . 0.0 110.887 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -61.51 -31.42 71.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.032 0.933 . . . . 0.0 112.94 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.46 0.88 55.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.546 0.738 . . . . 0.0 111.127 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.61 78.19 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.61 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -88.06 -12.93 42.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.543 0.737 . . . . 0.0 111.089 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.55 36.36 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.104 0.962 . . . . 0.0 109.825 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -108.37 159.57 16.55 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.162 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 p -58.23 -33.51 69.41 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.487 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' HG21 ' A' ' 76' ' ' VAL . 44.2 tt0 -49.75 -48.49 50.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.946 0.899 . . . . 0.0 112.002 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.88 -30.9 71.17 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.98 5.0 10.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.41 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 86.8 m-85 -133.67 -32.51 1.13 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.93 0.786 . . . . 0.0 111.876 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 89.8 t -59.91 127.27 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.561 HD12 HD11 ' A' ' 33' ' ' LEU . 27.5 mt -59.7 -38.36 81.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -163.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.52 -36.75 76.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.814 0.446 . . . . 0.0 112.059 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.51 -46.15 64.21 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.619 0.768 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.23 -49.63 63.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.64 1.576 . . . . 0.0 110.127 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.48 64.97 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.43 61.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.688 0.395 . . . . 0.0 110.332 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.477 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 21.4 mmm180 -67.28 -31.34 71.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.429 0.691 . . . . 0.0 111.895 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.409 HD11 HD12 ' A' ' 47' ' ' ILE . 79.8 mt -77.58 -42.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.21 0.604 . . . . 0.0 110.026 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.471 ' HA ' HG21 ' A' ' 88' ' ' VAL . 31.0 t70 -54.97 -34.64 63.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.685 0.794 . . . . 0.0 111.588 170.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -60.98 -49.46 77.36 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.464 0.706 . . . . 0.0 110.73 173.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 54.0 mt -68.35 -37.74 80.78 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.67 0.788 . . . . 0.0 112.468 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG21 ' HA ' ' A' ' 85' ' ' ASP . 19.3 m -74.91 -27.87 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.038 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.11 67.9 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.286 171.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.83 84.0 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.691 0.796 . . . . 0.0 112.883 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -71.36 -33.69 69.79 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.255 -0.278 . . . . 0.0 110.59 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -20.17 71.88 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 170.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.08 65.6 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.762 0.425 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.77 -13.41 14.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.773 1.229 . . . . 0.0 112.95 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.53 137.51 57.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.988 0.915 . . . . 0.0 109.906 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.74 71.29 2.57 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.733 0.813 . . . . 0.0 110.838 -172.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.0 p80 50.33 19.21 0.5 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.574 1.949 . . . . 0.0 115.269 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -100.41 91.15 4.57 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -73.07 81.72 1.25 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 110.28 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -168.95 139.16 2.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.58 1.152 . . . . 0.0 108.55 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 69.0 t60 . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.772 177.202 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 m -73.09 108.35 5.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 111.001 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.421 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 40.8 t -89.77 144.17 26.19 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 164.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 m -65.85 -25.19 67.08 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -74.65 -37.19 62.8 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.294 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.421 ' HB2' ' HB3' ' A' ' 3' ' ' SER . 29.2 t70 -52.21 -49.28 64.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 123.835 0.709 . . . . 0.0 110.732 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -65.66 -47.09 76.68 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.235 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.64 -36.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.326 0.651 . . . . 0.0 111.973 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.36 96.09 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.159 0.983 . . . . 0.0 110.342 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -57.38 -47.14 82.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.254 1.021 . . . . 0.0 112.034 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.432 HG22 HG13 ' A' ' 47' ' ' ILE . 95.3 mt -66.57 -49.86 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.739 . . . . 0.0 111.65 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.435 HG12 HD12 ' A' ' 43' ' ' ILE . 62.8 mt -63.87 -35.5 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.643 0.777 . . . . 0.0 111.259 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.38 35.14 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.506 0.722 . . . . 0.0 111.551 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.23 -29.05 53.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.154 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.4 m -72.36 -62.11 1.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.84 0.456 . . . . 0.0 110.612 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.7 m -83.41 -1.09 52.66 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -170.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.94 61.74 2.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.959 0.904 . . . . 0.0 110.028 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -127.57 138.38 32.71 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.887 1.275 . . . . 0.0 108.409 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.14 123.04 11.69 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.872 2.382 . . . . 0.0 111.72 167.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -41.23 89.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.639 1.576 . . . . 0.0 110.764 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.85 -29.43 65.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.794 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -80.25 -25.38 39.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.443 0.297 . . . . 0.0 111.104 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -56.35 110.99 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.456 0.702 . . . . 0.0 111.034 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -94.62 147.13 32.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.605 0.762 . . . . 0.0 109.743 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 37.1 Cg_endo -65.07 -28.87 56.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.404 2.069 . . . . 0.0 111.955 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.41 -11.08 59.92 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.226 0.61 . . . . 0.0 111.709 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.1 p -74.31 140.35 44.83 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.813 0.339 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.2 t-80 -90.81 130.47 36.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.43 -61.29 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.051 0.94 . . . . 0.0 112.596 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -74.89 -44.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 122.65 0.38 . . . . 0.0 111.318 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.516 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 25.8 t70 -71.16 -65.48 0.74 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.758 0.423 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.89 -62.98 1.31 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.039 0.536 . . . . 0.0 110.651 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.733 HD11 HD13 ' A' ' 77' ' ' LEU . 76.3 mt -73.42 -11.06 60.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.438 0.695 . . . . 0.0 112.532 -172.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.26 72.34 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.45 130.24 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.716 0.806 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -71.08 149.28 46.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -67.12 -17.3 64.8 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.071 0.396 . . . . 0.0 110.489 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.28 -31.56 24.86 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.119 0.968 . . . . 0.0 110.226 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.43 -30.17 53.3 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.408 0.623 . . . . 0.0 109.783 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -67.23 -21.51 65.74 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.561 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.458 HD22 HD23 ' A' ' 57' ' ' LEU . 84.2 mt -59.69 -40.3 87.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.016 0.526 . . . . 0.0 110.498 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.61 -35.93 75.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.547 0.739 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.5 mt -61.95 -48.33 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.499 ' HB3' HD22 ' A' ' 55' ' ' LEU . . . -65.19 -31.82 73.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.448 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.55 -41.65 72.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.436 0.694 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.0 -27.55 60.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.52 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 HD13 HD12 ' A' ' 84' ' ' ILE . 94.1 mt -70.73 -42.7 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.833 0.853 . . . . 0.0 109.794 172.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.32 -40.28 74.13 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.624 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -76.43 -48.86 18.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 111.81 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.07 70.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.599 0.76 . . . . 0.0 112.124 -170.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.445 ' HB2' HG12 ' A' ' 53' ' ' ILE . 96.3 m-85 -83.45 -22.43 32.62 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.179 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.57 33.79 57.82 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 112.161 -0.376 . . . . 0.0 112.161 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.445 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.6 pt -114.94 158.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.227 1.011 . . . . 0.0 109.802 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.2 98.58 11.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 44' ' ' ALA . 8.5 tt -88.52 105.68 10.38 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.43 80.97 2.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.79 1.66 . . . . 0.0 111.225 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 HD23 HD22 ' A' ' 41' ' ' LEU . 53.6 tp -75.87 -29.56 58.56 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.31 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 -29.76 66.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.521 0.728 . . . . 0.0 110.742 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 61.8 tttp -84.27 -48.49 9.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.621 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -61.59 -39.33 90.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.407 0.683 . . . . 0.0 111.575 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -61.83 -43.92 97.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.89 0.876 . . . . 0.0 110.881 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -65.85 -30.33 70.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.099 0.96 . . . . 0.0 111.462 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 15.2 mm-40 -62.08 -46.71 87.88 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.108 0.563 . . . . 0.0 109.892 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.6 -44.89 99.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.578 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.52 1.128 . . . . 0.0 112.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.14 -18.73 26.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.107 0.963 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.03 65.47 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.792 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -67.95 -32.86 73.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.996 0.518 . . . . 0.0 109.831 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.35 164.46 27.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.573 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -105.61 154.52 20.31 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -61.96 -32.32 72.75 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.849 0.859 . . . . 0.0 110.431 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.35 -41.41 89.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -59.89 -32.58 70.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 112.575 -171.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -105.92 -58.54 1.9 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.605 0.362 . . . . 0.0 111.437 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -67.37 -19.73 65.46 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 85.2 t -66.47 129.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 119.681 1.128 . . . . 0.0 108.408 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.733 HD13 HD11 ' A' ' 33' ' ' LEU . 12.3 mt -66.34 -34.81 78.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -161.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG2' HG11 ' A' ' 76' ' ' VAL . 21.9 pttp -65.34 -36.7 84.81 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.935 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.419 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 64.1 m-20 -73.59 -44.7 56.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.419 0.688 . . . . 0.0 109.825 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.86 -48.23 67.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.642 1.177 . . . . 0.0 110.723 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.3 67.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.943 0.897 . . . . 0.0 111.391 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.39 64.29 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -63.4 -39.51 94.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.941 0.896 . . . . 0.0 111.506 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.45 HD12 HD13 ' A' ' 47' ' ' ILE . 96.6 mt -70.47 -43.02 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.109 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.32 -37.8 65.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.243 0.617 . . . . 0.0 111.382 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.15 -44.35 80.01 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.74 -42.33 95.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.604 0.762 . . . . 0.0 112.428 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 m -72.71 -29.34 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 122.999 0.52 . . . . 0.0 110.788 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.4 86.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.401 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.4 80.78 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.5 -31.77 63.89 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.515 0.598 . . . . 0.0 110.37 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.5 -20.28 78.27 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.778 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.26 70.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.271 0.629 . . . . 0.0 111.262 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.1 mt -51.11 -33.93 28.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.508 1.123 . . . . 0.0 111.55 172.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -99.54 99.1 9.93 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.114 0.965 . . . . 0.0 108.802 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -64.1 -26.3 68.48 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.685 0.794 . . . . 0.0 111.013 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -159.52 123.75 3.87 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 170.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -64.7 124.05 20.93 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -63.91 158.99 20.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.162 0.985 . . . . 0.0 111.773 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 68.82 28.08 5.52 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.568 1.147 . . . . 0.0 111.377 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 124.913 1.285 . . . . 0.0 108.573 173.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 110.959 -0.015 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.8 m -69.77 101.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.927 0.491 . . . . 0.0 109.676 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 t -109.99 -172.19 1.99 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.017 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' O ' HG22 ' A' ' 8' ' ' VAL . 9.0 m -54.96 -26.87 39.48 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.426 0.69 . . . . 0.0 111.731 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' HE1' ' HB3' ' A' ' 77' ' ' LEU . 59.7 t80 -63.11 -55.95 20.99 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.399 0.437 . . . . 0.0 111.132 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.06 -36.69 70.82 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 124.188 0.93 . . . . 0.0 110.99 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -63.15 -53.13 58.19 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.679 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG22 ' O ' ' A' ' 4' ' ' THR . 51.8 t -61.24 -36.38 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.054 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.07 79.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 110.975 -173.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.45 ' HB ' ' NH2' ' A' ' 20' ' ' ARG . 11.9 t -69.18 -29.75 67.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.658 0.383 . . . . 0.0 110.68 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 45.4 mm -64.46 -50.74 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.191 0.596 . . . . 0.0 109.895 172.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.4 mt -60.06 -36.43 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.406 0.682 . . . . 0.0 110.395 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.74 42.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.323 1.049 . . . . 0.0 112.202 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.78 -32.43 65.59 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.7 m -77.58 -60.06 2.52 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.262 0.625 . . . . 0.0 110.787 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -91.94 5.57 49.55 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 111.576 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.99 24.74 13.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.693 1.197 . . . . 0.0 113.202 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.5 114.63 56.2 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.305 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -48.51 146.88 9.91 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.327 2.685 . . . . 0.0 113.47 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.45 ' NH2' ' HB ' ' A' ' 10' ' ' THR . 3.9 mmt85 -60.31 -33.83 72.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 0.0 111.521 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.47 -35.78 80.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.082 0.953 . . . . 0.0 111.838 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -86.54 -4.75 59.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.315 0.646 . . . . 0.0 111.825 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -96.15 126.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.763 0.825 . . . . 0.0 108.841 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' HD13 ' A' ' 77' ' ' LEU . 81.8 p -140.84 148.85 54.24 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.096 0.958 . . . . 0.0 109.013 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.35 -36.41 68.59 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.81 2.34 . . . . 0.0 113.256 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -74.92 -25.04 58.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.743 0.817 . . . . 0.0 112.373 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.1 p -76.68 144.59 39.31 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.645 0.26 . . . . 0.0 111.21 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 46.7 t-80 -92.24 131.43 37.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.768 1.227 . . . . 0.0 108.963 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.05 -56.81 9.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 112.2 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -71.3 -52.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 120.409 0.147 . . . . 0.0 110.88 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 31.4 t70 -70.41 -54.62 11.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.786 0.434 . . . . 0.0 112.127 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.48 -60.55 1.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.388 0.275 . . . . 0.0 110.946 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.757 HD13 HD11 ' A' ' 77' ' ' LEU . 76.5 mt -68.37 -30.8 69.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.868 0.467 . . . . 0.0 111.336 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.75 0.9 68.55 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.957 -0.357 . . . . 0.0 113.189 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.09 104.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.829 0.852 . . . . 0.0 110.145 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -77.87 167.12 22.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -58.58 -17.02 18.42 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.347 0.659 . . . . 0.0 112.191 174.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.04 -41.47 18.62 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.13 0.972 . . . . 0.0 110.563 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.66 -40.46 92.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.511 0.672 . . . . 0.0 109.661 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -67.66 -18.73 65.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.883 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.582 HD21 HD21 ' A' ' 57' ' ' LEU . 94.5 mt -54.43 -45.81 73.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.432 0.56 . . . . 0.0 110.852 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.83 -37.59 70.28 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.75 -41.36 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.227 0.611 . . . . 0.0 110.653 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.34 -35.27 80.47 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.12 0.887 . . . . 0.0 110.356 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.23 -42.29 88.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.904 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.85 74.38 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.484 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.6 -39.44 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.944 . . . . 0.0 110.628 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.92 -47.75 64.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.981 0.912 . . . . 0.0 111.138 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.63 -52.7 19.54 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.924 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.78 -57.02 14.87 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.186 0.929 . . . . 0.0 111.979 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.555 ' HB2' HG12 ' A' ' 53' ' ' ILE . 76.2 m-85 -83.26 -15.12 51.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.443 0.697 . . . . 0.0 111.532 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.68 31.34 67.75 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 51' ' ' PHE . 42.9 pt -113.55 -170.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.576 1.15 . . . . 0.0 109.77 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.9 114.92 17.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 163.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.25 105.07 4.55 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.24 85.51 1.76 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 121.766 1.644 . . . . 0.0 110.351 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.582 HD21 HD21 ' A' ' 41' ' ' LEU . 42.5 tp -69.4 -24.35 63.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.985 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.93 -38.57 67.84 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.889 0.876 . . . . 0.0 111.019 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.5 tttp -74.01 -50.82 18.09 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.501 1.12 . . . . 0.0 110.577 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.402 ' HB2' HD13 ' A' ' 57' ' ' LEU . 30.8 m0 -62.82 -47.19 84.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.801 0.84 . . . . 0.0 112.113 -171.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.1 m -54.57 -44.41 72.94 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.84 0.856 . . . . 0.0 111.351 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -68.38 -32.68 72.93 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.158 0.983 . . . . 0.0 111.654 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.551 ' HB3' ' HB1' ' A' ' 69' ' ' ALA . 53.7 mm-40 -57.56 -46.14 84.31 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.582 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.44 -49.84 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.355 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.43 -36.54 84.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.085 0.954 . . . . 0.0 112.675 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.02 -5.91 40.01 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.483 1.113 . . . . 0.0 111.308 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.06 61.22 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.81 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.516 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.12 -24.94 30.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.071 0.549 . . . . 0.0 111.017 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.551 ' HB1' ' HB3' ' A' ' 63' ' ' GLU . . . -160.12 168.74 24.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.923 0.489 . . . . 0.0 110.664 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.5 p -105.52 163.56 12.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.826 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.9 p -67.39 -32.38 73.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.693 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.443 ' HA ' HG21 ' A' ' 76' ' ' VAL . 42.1 tt0 -63.69 -38.81 92.5 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.232 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.424 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 29.4 tt0 -62.41 -29.68 70.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.732 0.413 . . . . 0.0 111.999 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -107.46 -71.31 0.76 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.839 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.5 m-85 -62.15 -20.83 64.52 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -165.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -62.13 126.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.298 1.408 . . . . 0.0 107.874 170.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.757 HD11 HD13 ' A' ' 33' ' ' LEU . 56.8 mt -59.01 -34.94 72.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -163.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.1 pttp -65.31 -40.72 94.13 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 173.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.424 ' HB3' ' O ' ' A' ' 73' ' ' GLN . 3.3 m-20 -69.22 -46.84 66.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.125 0.57 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -50.3 -48.62 55.05 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.835 1.654 . . . . 0.0 111.274 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.93 73.27 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.704 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.34 57.24 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.055 0.847 . . . . 0.0 111.409 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 26.7 mmm180 -64.28 -41.69 96.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.65 0.78 . . . . 0.0 111.276 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -70.35 -39.28 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.208 0.603 . . . . 0.0 110.385 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.07 -38.28 65.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.336 0.654 . . . . 0.0 111.653 169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -68.55 -44.74 73.84 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.607 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 95.8 mt -64.4 -41.9 96.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.108 0.963 . . . . 0.0 112.688 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.69 -32.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.148 0.579 . . . . 0.0 110.489 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.02 62.47 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.448 1.099 . . . . 0.0 112.656 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.486 ' HD3' HG22 ' A' ' 53' ' ' ILE . 11.8 pttp -63.71 -39.28 93.91 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.536 ' HA2' ' HB3' ' A' ' 95' ' ' GLU . . . -77.83 -12.93 83.96 Favored Glycine 0 C--N 1.356 1.694 0 O-C-N 123.889 0.743 . . . . 0.0 114.147 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.82 -30.89 62.96 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 -37.46 10.36 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 0.0 110.182 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.536 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 33.5 tt0 -72.75 83.23 1.17 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.213 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -81.57 160.85 23.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.851 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -62.81 101.97 0.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.426 0.69 . . . . 0.0 110.951 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -130.57 153.95 48.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.143 1.377 . . . . 0.0 108.822 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -62.69 104.07 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.096 0.558 . . . . 0.0 110.787 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -126.15 20.59 7.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.181 0.992 . . . . 0.0 110.367 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.6 t60 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 109.558 -170.842 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.8 m -68.33 112.19 5.06 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -74.67 164.64 26.35 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 122.883 0.473 . . . . 0.0 111.678 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.443 ' O ' HG21 ' A' ' 8' ' ' VAL . 4.9 m -57.64 -29.45 64.59 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.001 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.06 -52.3 63.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.896 0.479 . . . . 0.0 111.282 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -61.89 -32.38 72.75 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.863 0.727 . . . . 0.0 110.573 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.404 ' O ' HG12 ' A' ' 11' ' ' ILE . 25.8 mmt180 -66.05 -53.08 42.84 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.838 0.855 . . . . 0.0 111.409 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 81' ' ' ALA . 69.9 t -62.91 -38.09 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.361 0.601 . . . . 0.0 110.748 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 23' ' ' ILE . . . -67.97 -39.75 83.27 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.271 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.409 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 7.6 t -73.73 -27.65 61.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.243 0.217 . . . . 0.0 110.865 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 7' ' ' ARG . 34.6 mm -61.02 -55.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 18' ' ' ILE . 60.3 mt -66.51 -29.9 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.645 0.778 . . . . 0.0 111.034 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.33 -51.3 70.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.995 0.918 . . . . 0.0 111.247 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.8 mm-40 -78.98 -28.33 43.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.66 0.384 . . . . 0.0 111.676 -177.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -75.53 -61.68 1.83 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.897 0.479 . . . . 0.0 110.838 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.64 ' SG ' HD11 ' A' ' 43' ' ' ILE . 58.6 m -95.54 7.4 46.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.402 0.681 . . . . 0.0 112.307 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.29 67.94 0.92 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.343 1.057 . . . . 0.0 111.126 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 12' ' ' ILE . 23.6 mt -121.77 122.06 27.96 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 139.73 84.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.516 2.144 . . . . 0.0 112.21 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -58.65 -35.4 72.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 0.0 111.511 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.42 -37.53 86.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.043 0.937 . . . . 0.0 111.883 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 p -84.48 -13.65 51.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.191 0.596 . . . . 0.0 111.419 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 9' ' ' ALA . 88.9 mt -81.46 113.46 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.341 0.656 . . . . 0.0 109.295 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 p -117.78 158.3 45.95 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 109.486 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.526 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 58.3 Cg_exo -55.36 -33.16 84.44 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.868 2.379 . . . . 0.0 113.506 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.17 -0.58 56.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.597 0.759 . . . . 0.0 112.441 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.446 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 26.6 m -72.59 129.2 37.74 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.3 t-80 -98.5 133.06 43.39 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -53.3 -60.14 3.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.092 0.557 . . . . 0.0 111.98 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -75.11 -42.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.451 0.301 . . . . 0.0 111.755 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.05 -56.94 3.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.371 0.668 . . . . 0.0 111.844 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -82.54 -61.52 1.86 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.266 0.626 . . . . 0.0 110.638 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.48 HD13 HD11 ' A' ' 77' ' ' LEU . 79.6 mt -69.94 -19.28 63.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.054 0.942 . . . . 0.0 111.332 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.73 90.11 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 HD11 HD11 ' A' ' 43' ' ' ILE . 85.0 mt -68.63 98.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.648 1.179 . . . . 0.0 110.346 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.23 165.78 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.094 0.957 . . . . 0.0 111.506 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.0 p -48.43 -28.2 3.12 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.013 1.325 . . . . 0.0 113.57 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.35 -40.84 16.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.504 0.721 . . . . 0.0 110.442 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.32 -30.76 69.82 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.3 0.572 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -74.38 -20.2 60.15 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD22 HD22 ' A' ' 57' ' ' LEU . 73.2 mt -56.82 -41.11 77.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.157 0.435 . . . . 0.0 111.115 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.18 -35.94 69.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.809 0.844 . . . . 0.0 110.538 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.64 HD11 ' SG ' ' A' ' 16' ' ' CYS . 37.7 mt -64.07 -48.98 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.13 0.572 . . . . 0.0 110.107 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.34 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.302 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -67.33 -43.37 81.75 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.187 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.49 76.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 111.579 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.4 mt -69.57 -37.66 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 110.692 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -56.78 -47.51 80.0 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.0 0.52 . . . . 0.0 111.056 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -71.21 -48.18 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.573 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.58 -52.64 36.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.929 0.891 . . . . 0.0 111.53 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -86.65 -11.95 49.87 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 111.933 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.94 38.57 84.95 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.286 0.366 . . . . 0.0 112.55 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.51 HG22 ' HD3' ' A' ' 91' ' ' LYS . 36.5 pt -126.72 -173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.11 0.964 . . . . 0.0 110.72 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -126.94 96.4 4.61 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -76.07 108.37 5.99 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.11 84.56 1.53 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.792 1.661 . . . . 0.0 110.616 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD22 HD22 ' A' ' 41' ' ' LEU . 54.0 tp -66.48 -32.21 73.43 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.773 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.96 -33.9 75.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.206 1.002 . . . . 0.0 111.108 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 56.8 tttp -72.92 -58.8 3.06 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.897 0.879 . . . . 0.0 109.771 172.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -57.18 -44.3 83.44 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.259 1.024 . . . . 0.0 111.966 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 m -63.74 -36.51 84.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.62 -30.76 61.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.414 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.5 mm-40 -60.3 -39.4 86.82 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.302 0.641 . . . . 0.0 109.317 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.1 -44.44 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.779 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.594 0.757 . . . . 0.0 112.358 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.49 -18.87 21.81 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.103 0.961 . . . . 0.0 111.189 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.15 59.23 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 113.375 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.443 ' HE3' ' HA ' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.56 -23.76 61.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.296 0.639 . . . . 0.0 110.943 169.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.36 26.4 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.692 0.797 . . . . 0.0 110.257 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.442 HG22 ' H ' ' A' ' 73' ' ' GLN . 8.0 t -107.15 156.48 18.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.496 0.718 . . . . 0.0 110.334 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.9 p -63.14 -33.78 76.21 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.087 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.18 -33.72 75.06 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.534 0.734 . . . . 0.0 111.986 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.442 ' H ' HG22 ' A' ' 70' ' ' THR . 8.3 tt0 -65.36 -28.36 69.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.589 . . . . 0.0 111.675 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -106.84 -76.99 0.6 Allowed 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.581 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.462 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.5 m-85 -59.18 -19.06 41.94 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -162.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.537 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 98.8 t -65.11 124.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.48 HD11 HD13 ' A' ' 33' ' ' LEU . 72.3 mt -58.86 -36.71 75.06 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 60.9 pttt -61.29 -42.35 98.5 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.43 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -72.4 -44.94 61.79 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -55.29 -44.96 76.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.684 1.594 . . . . 0.0 110.676 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.488 ' HA ' HG23 ' A' ' 8' ' ' VAL . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.528 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.36 61.56 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.711 0.632 . . . . 0.0 111.548 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.2 mmm180 -71.32 -35.79 71.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.663 0.785 . . . . 0.0 111.354 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.3 mt -71.81 -39.61 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.348 0.659 . . . . 0.0 109.712 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 88' ' ' VAL . 25.2 t70 -57.25 -38.97 74.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.726 0.81 . . . . 0.0 111.397 170.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -60.83 -45.96 92.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.01 0.924 . . . . 0.0 110.009 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 91.6 mt -66.58 -42.75 86.51 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.016 0.926 . . . . 0.0 113.275 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 85' ' ' ASP . 24.1 m -70.51 -31.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.058 0.456 . . . . 0.0 110.474 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.28 -51.81 27.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.718 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.59 71.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.974 1.309 . . . . 0.0 113.559 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.51 ' HD3' HG22 ' A' ' 53' ' ' ILE . 21.9 pttp -57.77 -31.02 66.1 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.31 0.644 . . . . 0.0 112.042 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.9 44.72 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.114 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.71 -34.72 78.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.763 1.225 . . . . 0.0 111.767 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 91' ' ' LYS . 96.7 mt -51.42 -47.87 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.004 0.922 . . . . 0.0 109.653 170.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.86 -25.58 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.509 1.523 . . . . 0.0 112.458 167.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -64.28 110.57 2.27 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.623 0.769 . . . . 0.0 110.149 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -77.08 152.43 35.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.192 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -74.59 81.6 2.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.879 0.872 . . . . 0.0 110.492 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -130.55 19.54 5.2 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.017 1.327 . . . . 0.0 109.938 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -149.63 111.61 4.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.25 1.087 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.123 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.5 m -122.76 125.58 45.77 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -66.74 144.58 56.25 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.193 0.597 . . . . 0.0 111.193 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.5 m -59.14 -25.24 63.71 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.575 -176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -66.57 -49.62 65.82 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.81 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.13 -41.35 68.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.13 0.894 . . . . 0.0 111.356 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.82 -46.45 62.76 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.802 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -60.92 -36.46 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 122.994 0.518 . . . . 0.0 110.911 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.89 85.15 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.559 1.144 . . . . 0.0 110.089 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.6 m -56.02 -47.07 78.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.235 1.014 . . . . 0.0 111.671 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.465 HG21 HG13 ' A' ' 47' ' ' ILE . 33.3 mm -59.2 -51.59 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.84 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.436 HG23 ' SG ' ' A' ' 16' ' ' CYS . 71.1 mt -63.95 -34.77 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.82 0.848 . . . . 0.0 111.289 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -60.25 -52.28 65.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.884 0.474 . . . . 0.0 111.866 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -72.51 -37.69 68.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.581 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.6 m -74.42 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.335 0.654 . . . . 0.0 110.785 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.653 ' SG ' HD11 ' A' ' 43' ' ' ILE . 3.3 m -82.09 -1.16 47.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.04 0.936 . . . . 0.0 113.341 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 64.28 22.67 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.373 1.082 . . . . 0.0 111.048 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 HG22 HD21 ' A' ' 33' ' ' LEU . 82.3 mt -96.0 126.4 44.75 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.524 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 40.9 Cg_endo -65.16 145.61 84.84 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.627 2.218 . . . . 0.0 112.177 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -60.11 -27.64 67.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.663 1.185 . . . . 0.0 112.653 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.544 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.8 -26.79 68.49 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.783 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.464 HG22 ' HG3' ' A' ' 21' ' ' GLU . 80.1 p -108.87 15.41 23.52 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.377 0.671 . . . . 0.0 111.236 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.72 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -121.46 151.31 56.33 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.908 0.883 . . . . 0.0 109.712 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.22 -36.23 66.41 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.037 2.491 . . . . 0.0 113.374 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.66 -17.68 59.89 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.494 0.718 . . . . 0.0 112.067 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 t -68.68 142.54 55.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.506 0.723 . . . . 0.0 111.202 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.613 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 42.3 t-80 -105.75 133.45 50.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.659 1.184 . . . . 0.0 108.715 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB2' ' HB3' ' A' ' 75' ' ' PHE . . . -50.96 -56.72 11.04 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.349 0.66 . . . . 0.0 112.524 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.5 -51.13 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.462 0.305 . . . . 0.0 110.76 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.4 t70 -69.94 -42.78 72.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.608 0.763 . . . . 0.0 112.465 -170.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.48 -64.38 1.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.719 0.408 . . . . 0.0 110.044 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.559 HD12 HD11 ' A' ' 77' ' ' LEU . 95.5 mt -71.41 -25.07 62.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.771 0.828 . . . . 0.0 112.799 -171.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 45.96 31.31 Favored Glycine 0 N--CA 1.472 1.066 0 CA-C-O 120.969 0.205 . . . . 0.0 112.772 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.404 HD12 HD11 ' A' ' 43' ' ' ILE . 68.1 mt -98.23 127.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 108.51 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -89.75 166.79 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.972 0.509 . . . . 0.0 109.839 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.8 m -59.38 -27.25 65.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.155 0.582 . . . . 0.0 111.968 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.89 -49.0 64.47 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.554 0.741 . . . . 0.0 111.028 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.63 -29.61 62.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.485 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -72.76 -23.22 60.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.477 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD21 HD21 ' A' ' 57' ' ' LEU . 60.6 mt -60.34 -41.43 93.57 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.585 0.354 . . . . 0.0 110.239 170.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.45 -34.57 70.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.779 0.831 . . . . 0.0 111.156 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.653 HD11 ' SG ' ' A' ' 16' ' ' CYS . 63.7 mt -62.9 -51.54 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.6 76.27 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.823 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.94 -47.2 78.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.495 1.118 . . . . 0.0 110.161 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.65 72.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.077 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 11' ' ' ILE . 86.2 mt -71.18 -38.55 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.845 0.858 . . . . 0.0 111.157 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -51.3 -48.14 62.39 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.32 0.581 . . . . 0.0 110.882 173.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.49 -49.32 16.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.509 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.11 69.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.688 0.795 . . . . 0.0 111.906 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -84.52 -17.25 39.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.579 0.752 . . . . 0.0 111.688 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.57 48.61 35.12 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.03 177.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.332 1.053 . . . . 0.0 110.815 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -106.76 109.57 21.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 162.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.454 HD11 HG22 ' A' ' 47' ' ' ILE . 7.5 tt -84.66 104.47 4.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 165.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.48 81.8 2.39 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.513 1.476 . . . . 0.0 111.082 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.503 HD21 HD21 ' A' ' 41' ' ' LEU . 57.8 tp -69.7 -31.34 69.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.861 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.04 -33.54 73.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.04 0.936 . . . . 0.0 111.068 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.5 ttpp -82.58 -41.29 19.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.182 0.593 . . . . 0.0 110.365 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -69.98 -41.78 73.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.639 0.776 . . . . 0.0 111.939 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.3 m -60.72 -36.22 78.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.045 0.938 . . . . 0.0 110.483 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -69.52 -38.3 77.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.052 0.941 . . . . 0.0 110.49 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' HG3' ' HH ' ' A' ' 74' ' ' TYR . 80.2 mm-40 -56.15 -45.63 79.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.515 0.726 . . . . 0.0 110.287 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 62.8 t -67.82 -44.53 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.748 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.03 -28.94 70.44 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.845 0.858 . . . . 0.0 112.697 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -87.55 -9.82 53.35 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.147 0.579 . . . . 0.0 111.895 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.85 72.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 120.374 -0.126 . . . . 0.0 113.258 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -83.84 -22.67 31.64 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.755 0.822 . . . . 0.0 110.258 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -143.88 160.66 40.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.827 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -98.99 160.61 14.14 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.731 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.7 p -60.05 -29.84 68.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 171.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.522 ' HA ' HG22 ' A' ' 76' ' ' VAL . 41.3 tt0 -56.39 -46.87 79.93 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.589 0.756 . . . . 0.0 111.316 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -57.11 -31.61 65.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.472 0.709 . . . . 0.0 112.104 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.523 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 52.2 m-85 -106.67 -74.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.459 178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 29' ' ' ALA . 85.5 m-85 -56.06 -25.36 44.77 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -165.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.613 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.2 t -62.6 126.14 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 119.91 1.232 . . . . 0.0 108.47 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.559 HD11 HD12 ' A' ' 33' ' ' LEU . 18.7 mt -62.56 -36.5 82.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 112.641 -161.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG2' HG12 ' A' ' 76' ' ' VAL . 65.8 pttt -64.09 -39.33 93.82 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.247 0.342 . . . . 0.0 111.119 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.423 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.9 m-20 -75.81 -42.79 48.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.507 0.723 . . . . 0.0 110.277 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.1 tp -53.09 -49.41 66.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.833 1.253 . . . . 0.0 110.325 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.2 -33.04 73.79 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.014 0.821 . . . . 0.0 111.252 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.64 63.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.94 0.496 . . . . 0.0 110.539 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.3 mmm180 -64.04 -31.84 73.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.718 0.807 . . . . 0.0 111.76 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 -41.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.811 0.845 . . . . 0.0 110.534 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.464 ' HA ' HG23 ' A' ' 88' ' ' VAL . 22.1 t70 -56.44 -36.55 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.577 0.751 . . . . 0.0 111.591 172.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.26 -47.25 86.08 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.975 0.91 . . . . 0.0 110.671 172.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 59.6 mt -64.5 -46.96 80.69 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.002 0.921 . . . . 0.0 112.434 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.464 HG23 ' HA ' ' A' ' 85' ' ' ASP . 13.9 m -67.89 -29.0 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.048 0.451 . . . . 0.0 110.657 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.81 -42.37 67.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.898 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.44 68.14 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.166 0.986 . . . . 0.0 113.536 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -67.5 -35.91 80.05 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 123.185 0.303 . . . . 0.0 111.128 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.7 -11.5 77.57 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.68 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.58 -36.2 17.67 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.477 0.711 . . . . 0.0 110.895 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 79.5 mt -53.04 -61.29 2.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.96 0.904 . . . . 0.0 109.906 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.97 114.41 13.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 166.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -63.98 92.63 0.08 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.844 0.715 . . . . 0.0 112.38 -163.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -103.72 25.69 9.48 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -93.82 149.42 21.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.99 87.56 0.56 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 111.829 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -100.16 -30.48 11.9 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.921 0.889 . . . . 0.0 109.831 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 . . . . . 0 CA--C 1.56 1.328 0 C-N-CA 124.439 1.096 . . . . 0.0 108.665 176.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.4 m -65.36 103.79 0.86 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.195 0.998 . . . . 0.0 111.394 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -98.16 -171.85 2.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.467 0.707 . . . . 0.0 109.732 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.466 ' O ' HG22 ' A' ' 8' ' ' VAL . 17.6 m -59.81 -34.09 72.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.584 0.354 . . . . 0.0 111.383 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -69.59 -44.56 70.5 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.145 0.278 . . . . 0.0 110.656 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.68 -35.89 82.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.286 0.634 . . . . 0.0 110.682 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.414 ' NH2' ' HB2' ' A' ' 50' ' ' ALA . 21.1 mmm180 -59.6 -57.69 11.85 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.713 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.42 -35.88 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.937 0.895 . . . . 0.0 111.193 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.6 90.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.252 1.021 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.403 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 14.9 m -60.86 -43.61 98.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 111.281 172.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.49 -50.23 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.322 0.649 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.492 HG12 HD13 ' A' ' 43' ' ' ILE . 72.6 mt -62.18 -39.62 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.342 1.057 . . . . 0.0 111.223 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.03 87.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.089 0.555 . . . . 0.0 111.129 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.9 mm-40 -72.06 -38.95 69.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -69.71 -62.57 1.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.361 0.601 . . . . 0.0 110.745 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.558 ' SG ' HD12 ' A' ' 43' ' ' ILE . 20.0 m -84.98 -10.14 57.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.845 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.15 24.21 12.56 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.747 0.819 . . . . 0.0 112.175 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.454 HD11 HD11 ' A' ' 35' ' ' ILE . 50.8 mt -77.46 128.41 80.22 Favored Pre-proline 0 C--O 1.246 0.88 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.86 128.82 27.98 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.683 2.256 . . . . 0.0 112.322 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 tpt85 -56.37 -32.31 64.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.486 1.114 . . . . 0.0 110.429 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.97 -38.48 91.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.208 1.003 . . . . 0.0 112.365 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -82.71 -9.83 59.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.764 0.425 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.63 113.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.457 0.703 . . . . 0.0 109.437 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 p -123.67 154.88 66.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.763 0.825 . . . . 0.0 109.187 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 -39.95 79.93 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.631 2.22 . . . . 0.0 112.61 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.03 -9.92 59.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.892 0.477 . . . . 0.0 112.236 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p -73.27 134.27 44.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.6 t-80 -90.5 131.59 36.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.97 0.908 . . . . 0.0 108.624 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB2' ' HB3' ' A' ' 75' ' ' PHE . . . -52.17 -55.53 20.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 0.0 112.214 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.1 -47.41 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.367 0.267 . . . . 0.0 111.442 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -72.6 -66.6 0.64 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.813 0.445 . . . . 0.0 112.064 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -75.72 -60.74 2.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.145 0.578 . . . . 0.0 111.429 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 77' ' ' LEU . 81.3 mt -69.27 -29.12 66.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.112 0.565 . . . . 0.0 111.921 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.28 85.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 43' ' ' ILE . 36.9 mt -73.85 98.94 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.437 0.695 . . . . 0.0 109.962 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.92 165.06 25.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.019 0.928 . . . . 0.0 109.974 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 57.0 p -51.56 -18.34 1.1 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.713 1.605 . . . . 0.0 114.585 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 mt -84.72 -44.28 13.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.545 0.611 . . . . 0.0 110.292 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.24 -34.01 65.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.986 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.11 -21.56 66.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.238 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 HD23 ' A' ' 57' ' ' LEU . 94.1 mt -57.78 -38.39 75.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.243 0.617 . . . . 0.0 111.43 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.21 -30.65 48.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.558 HD12 ' SG ' ' A' ' 16' ' ' CYS . 41.8 mt -62.56 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.75 74.55 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -65.46 -43.26 90.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.021 0.928 . . . . 0.0 110.327 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.27 78.9 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.132 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 87.2 mt -65.17 -37.72 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.887 0.875 . . . . 0.0 111.328 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -56.35 -42.06 77.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -82.88 -40.89 19.64 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.781 0.833 . . . . 0.0 111.272 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.414 ' HB2' ' NH2' ' A' ' 7' ' ' ARG . . . -68.92 -51.95 34.45 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.52 1.128 . . . . 0.0 111.349 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -87.91 -24.9 23.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.403 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.71 52.27 10.04 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.403 HG23 ' HD3' ' A' ' 91' ' ' LYS . 34.3 pt -135.15 -176.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.28 1.032 . . . . 0.0 110.452 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -118.71 109.99 16.75 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.15 98.85 20.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 95.0 Cg_endo -85.4 85.12 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.383 2.055 . . . . 0.0 111.43 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD23 HD23 ' A' ' 41' ' ' LEU . 42.2 tp -69.52 -32.51 71.4 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.58 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.6 -31.8 70.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.579 0.351 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 35.7 ttpt -80.84 -40.69 24.47 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.789 0.836 . . . . 0.0 109.913 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -59.11 -45.72 90.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.816 0.847 . . . . 0.0 110.51 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.2 m -72.34 -28.88 63.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.786 1.234 . . . . 0.0 111.452 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.66 -34.59 67.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.499 0.72 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.04 -32.79 74.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.68 0.792 . . . . 0.0 110.143 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.6 t -70.93 -43.19 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.075 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -58.27 -45.04 88.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.692 0.797 . . . . 0.0 112.189 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -85.92 -11.79 52.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.857 0.863 . . . . 0.0 111.79 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.59 69.93 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.229 0.331 . . . . 0.0 113.562 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -70.36 -27.11 64.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.99 0.916 . . . . 0.0 110.436 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.02 170.49 21.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.978 0.911 . . . . 0.0 110.335 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.414 HG21 ' H ' ' A' ' 73' ' ' GLN . 8.4 t -107.37 158.67 16.98 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.439 0.696 . . . . 0.0 111.443 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.5 p -62.42 -36.62 82.93 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.08 0.952 . . . . 0.0 110.743 174.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -53.15 -41.67 65.37 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.89 0.876 . . . . 0.0 111.204 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.414 ' H ' HG21 ' A' ' 70' ' ' THR . 8.4 tt0 -63.68 -32.22 73.63 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.392 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.17 -8.45 12.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -169.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' HB3' ' HB2' ' A' ' 29' ' ' ALA . 85.1 m-85 -128.49 -29.24 2.44 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.513 -169.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 88.8 t -61.54 125.58 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD11 HD11 ' A' ' 33' ' ' LEU . 26.9 mt -61.42 -34.14 74.88 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -161.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.82 -37.54 70.33 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.577 0.351 . . . . 0.0 111.362 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -68.2 -49.19 62.48 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.636 0.775 . . . . 0.0 109.873 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -51.86 -47.07 64.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.938 1.695 . . . . 0.0 111.481 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.72 67.06 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.11 -39.19 55.76 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.625 0.578 . . . . 0.0 110.665 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.416 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mmm180 -59.27 -48.22 82.45 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.566 0.746 . . . . 0.0 110.581 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 98.7 mt -67.72 -42.7 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.694 1.197 . . . . 0.0 110.269 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HA ' HG23 ' A' ' 88' ' ' VAL . 30.9 t70 -56.69 -36.29 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.631 0.582 . . . . 0.0 111.914 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.99 -44.07 85.92 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.723 0.639 . . . . 0.0 110.461 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 82.0 mt -64.49 -40.9 96.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.724 0.81 . . . . 0.0 112.278 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.463 HG23 ' HA ' ' A' ' 85' ' ' ASP . 16.3 m -76.3 -28.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.855 0.462 . . . . 0.0 111.378 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.99 58.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.349 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.94 -47.41 80.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.662 1.185 . . . . 0.0 112.682 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.403 ' HD3' HG23 ' A' ' 53' ' ' ILE . 22.6 pttp -67.6 -32.89 73.94 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.27 0.228 . . . . 0.0 110.467 177.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.41 -23.73 76.35 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.72 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.47 -34.76 27.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.061 0.944 . . . . 0.0 109.884 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.35 -14.62 41.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.045 0.938 . . . . 0.0 112.453 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -58.44 -39.4 79.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.531 0.682 . . . . 0.0 109.627 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -96.23 54.43 1.42 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.209 1.004 . . . . 0.0 109.538 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -75.17 107.53 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.312 0.645 . . . . 0.0 109.391 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -98.88 141.79 31.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.678 0.791 . . . . 0.0 109.625 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -84.66 71.94 10.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.886 0.474 . . . . 0.0 110.395 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.1 -37.77 84.52 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 t -94.82 158.32 15.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.169 0.587 . . . . 0.0 110.686 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -67.17 164.4 18.2 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.056 0.942 . . . . 0.0 112.384 -175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.43 ' O ' HG22 ' A' ' 8' ' ' VAL . 31.0 m -57.17 -34.75 68.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.663 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -58.67 -54.66 44.52 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.689 0.618 . . . . 0.0 111.536 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.61 -28.47 69.15 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.039 0.837 . . . . 0.0 110.195 -173.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -69.8 -46.04 66.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.701 0.8 . . . . 0.0 111.659 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 4' ' ' THR . 84.8 t -64.19 -35.76 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.324 0.65 . . . . 0.0 110.525 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.06 99.43 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 110.284 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.8 m -56.34 -49.78 73.39 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.186 171.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 HG13 ' A' ' 47' ' ' ILE . 44.9 mm -59.58 -49.61 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 123.775 0.672 . . . . 0.0 110.731 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.18 -36.83 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.334 0.654 . . . . 0.0 111.126 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.94 83.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.518 0.727 . . . . 0.0 111.924 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.25 -51.73 14.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 0.0 112.359 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -66.6 -57.84 6.4 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.39 1.076 . . . . 0.0 111.189 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' SG ' HG12 ' A' ' 35' ' ' ILE . 49.5 t -82.93 -9.93 59.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.662 0.785 . . . . 0.0 111.878 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.35 76.96 0.31 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.518 1.127 . . . . 0.0 110.4 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mt -127.59 135.35 27.32 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.081 0.952 . . . . 0.0 109.222 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.57 119.49 4.73 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.33 2.686 . . . . 0.0 111.346 168.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -65.14 -25.18 67.64 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.051 0.941 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -65.81 -33.73 76.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 111.886 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -86.83 -17.94 32.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.143 0.577 . . . . 0.0 111.177 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.31 110.23 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -119.74 158.46 49.59 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.889 0.876 . . . . 0.0 109.535 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 -33.1 97.35 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.399 2.066 . . . . 0.0 112.401 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.4 -11.04 44.33 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.414 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 73.5 p -70.53 127.5 32.92 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.9 t-80 -91.75 133.06 35.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.227 1.011 . . . . 0.0 108.875 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.74 -59.76 3.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.634 0.774 . . . . 0.0 112.697 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -72.71 -57.56 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 120.838 0.351 . . . . 0.0 110.381 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.509 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 16.8 t70 -58.96 -49.63 77.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.246 . . . . 0.0 112.852 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.82 -58.87 1.82 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.685 0.394 . . . . 0.0 111.529 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.582 HD12 HD11 ' A' ' 77' ' ' LEU . 92.7 mt -74.19 -11.84 60.41 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.338 0.655 . . . . 0.0 112.012 -171.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.01 88.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.815 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.535 HG12 ' SG ' ' A' ' 16' ' ' CYS . 59.0 mt -74.01 102.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 109.987 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.92 156.24 38.87 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -57.05 -16.96 8.36 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.696 0.798 . . . . 0.0 112.875 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.92 -36.98 18.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.338 0.655 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.35 -30.4 68.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.504 0.669 . . . . 0.0 109.855 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.27 63.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.424 1.09 . . . . 0.0 111.996 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 HD21 HD23 ' A' ' 57' ' ' LEU . 93.6 mt -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.566 0.747 . . . . 0.0 110.412 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.21 -38.5 81.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.402 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.27 -42.32 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.663 0.602 . . . . 0.0 110.035 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.537 ' HB2' HD23 ' A' ' 55' ' ' LEU . . . -62.79 -36.89 84.62 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -75.06 -37.9 61.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.139 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.74 71.73 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.66 0.384 . . . . 0.0 110.975 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.553 HG13 HG21 ' A' ' 11' ' ' ILE . 96.6 mt -72.55 -39.61 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.853 0.861 . . . . 0.0 110.087 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.05 -44.86 71.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.469 1.108 . . . . 0.0 110.262 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.26 -44.88 28.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.21 1.004 . . . . 0.0 111.371 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.34 -53.83 46.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.424 0.69 . . . . 0.0 111.91 -172.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.62 -12.67 58.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.136 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.07 39.56 84.04 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.427 0.455 . . . . 0.0 111.971 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 pt -119.91 173.98 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 0.0 110.087 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.559 ' HB2' ' HZ3' ' A' ' 54' ' ' LYS . 5.0 ttmp? -106.86 102.62 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 44' ' ' ALA . 7.3 tt -88.56 109.47 29.59 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -88.82 83.04 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.772 1.648 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.519 HD23 HD21 ' A' ' 41' ' ' LEU . 46.4 tp -72.47 -25.35 61.4 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.293 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.52 -36.41 66.69 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.789 0.835 . . . . 0.0 110.94 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -79.12 -47.58 15.84 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.025 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -61.01 -51.22 70.17 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.905 0.882 . . . . 0.0 111.384 -173.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -55.13 -44.76 75.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.734 1.214 . . . . 0.0 111.76 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.28 -40.19 96.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.351 0.66 . . . . 0.0 110.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.04 -38.69 92.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.595 0.758 . . . . 0.0 110.852 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.56 -47.16 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.378 0.671 . . . . 0.0 110.601 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.31 -16.3 62.45 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.73 0.812 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -93.51 -8.3 41.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.27 0.628 . . . . 0.0 110.274 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.89 79.73 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 114.281 0.472 . . . . 0.0 114.281 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.41 -55.3 4.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.133 0.573 . . . . 0.0 109.922 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.54 163.66 12.48 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -99.39 157.46 16.4 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.597 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.0 p -61.59 -34.19 75.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.77 0.828 . . . . 0.0 110.4 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.5 tt0 -49.86 -46.14 51.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 111.633 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.19 -28.81 69.93 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.7 0.8 . . . . 0.0 113.073 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -121.16 0.08 10.06 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -131.81 -31.39 1.53 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.628 0.649 . . . . 0.0 111.403 -173.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.482 HG23 ' HA ' ' A' ' 72' ' ' GLU . 86.5 t -65.01 125.24 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.582 HD11 HD12 ' A' ' 33' ' ' LEU . 16.2 mt -61.45 -33.35 73.58 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -162.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.4 pttp -65.76 -41.9 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.259 0.349 . . . . 0.0 111.674 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.75 -46.22 38.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 0.0 109.942 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.37 -49.71 63.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.337 1.455 . . . . 0.0 110.771 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.42 64.89 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.546 0.739 . . . . 0.0 111.311 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.51 66.57 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 123.724 0.64 . . . . 0.0 110.259 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -59.91 -43.14 95.04 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.593 0.757 . . . . 0.0 110.761 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.57 -40.21 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.599 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.472 ' HA ' HG22 ' A' ' 88' ' ' VAL . 28.0 t70 -57.21 -31.36 65.39 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.559 0.744 . . . . 0.0 111.889 171.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.91 -42.94 72.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.196 0.31 . . . . 0.0 110.182 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.1 -40.43 90.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.479 0.712 . . . . 0.0 111.735 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG22 ' HA ' ' A' ' 85' ' ' ASP . 15.9 m -73.72 -29.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.954 0.501 . . . . 0.0 110.906 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.44 86.23 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.342 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.93 -47.62 74.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.405 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 22.0 pttp -67.2 -35.69 80.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.276 0.23 . . . . 0.0 111.136 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.28 -14.5 82.28 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 116.584 -0.28 . . . . 0.0 113.796 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.55 -35.26 30.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.995 0.918 . . . . 0.0 109.783 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.85 -23.26 67.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.97 0.908 . . . . 0.0 111.282 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.6 128.82 34.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -61.37 -28.13 69.01 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 117.964 0.347 . . . . 0.0 111.004 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -133.14 134.67 44.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.846 0.858 . . . . 0.0 108.976 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -70.46 159.16 34.74 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.706 0.802 . . . . 0.0 111.029 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -57.44 121.22 9.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.738 0.815 . . . . 0.0 111.717 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -73.42 119.67 17.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.479 0.711 . . . . 0.0 109.828 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.275 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.4 m -86.72 129.12 35.0 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.753 0.821 . . . . 0.0 109.619 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -57.33 135.06 56.48 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.08 0.862 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.428 ' O ' HG21 ' A' ' 8' ' ' VAL . 47.9 m -60.38 -26.31 66.54 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.262 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -62.52 -43.38 98.94 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.95 0.5 . . . . 0.0 111.447 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.17 -40.6 98.0 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 11' ' ' ILE . 26.8 mmt180 -61.53 -54.49 42.53 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.001 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 4' ' ' THR . 84.1 t -62.13 -35.52 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.191 0.997 . . . . 0.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.93 83.5 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.019 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 96.4 m -59.88 -46.5 89.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.806 0.843 . . . . 0.0 111.64 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 7' ' ' ARG . 38.9 mm -61.33 -50.16 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.805 0.442 . . . . 0.0 110.783 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.2 mt -67.67 -30.25 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 122.968 0.507 . . . . 0.0 110.828 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.08 95.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 10' ' ' THR . 16.6 mm-40 -73.87 -45.71 49.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.838 0.455 . . . . 0.0 111.586 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -66.78 -59.59 3.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.836 0.854 . . . . 0.0 111.447 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 64.3 m -92.43 4.63 53.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.31 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.19 67.98 0.91 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.76 1.224 . . . . 0.0 111.515 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.72 120.48 21.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.423 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_exo -61.64 148.4 93.11 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.531 2.154 . . . . 0.0 112.84 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -63.16 -28.26 69.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.659 0.784 . . . . 0.0 111.419 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -65.08 -30.35 71.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -93.82 -11.54 31.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 0.0 111.269 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.28 122.58 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.965 0.906 . . . . 0.0 109.838 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.9 p -133.63 161.59 62.81 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 124.332 1.053 . . . . 0.0 108.924 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 -30.52 88.35 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.845 2.363 . . . . 0.0 113.225 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -89.8 -5.36 56.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.885 0.874 . . . . 0.0 112.275 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.425 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.3 m -62.33 99.95 0.16 Allowed 'General case' 0 C--N 1.353 0.755 0 C-N-CA 122.964 0.506 . . . . 0.0 110.987 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 58.7 t-80 -73.22 125.38 27.62 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 168.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.04 -53.42 20.27 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.88 0.738 . . . . 0.0 112.35 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.08 -45.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 117.878 0.308 . . . . 0.0 110.985 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.561 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.8 t70 -70.44 -74.34 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.216 0.322 . . . . 0.0 111.126 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.49 -53.64 10.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.685 0.394 . . . . 0.0 111.671 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.53 -18.23 59.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.99 79.42 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.728 HD11 HD12 ' A' ' 43' ' ' ILE . 82.6 mt -86.05 116.54 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.151 1.38 . . . . 0.0 110.61 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.18 165.16 21.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.918 0.887 . . . . 0.0 109.512 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -56.99 -17.29 9.2 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.739 1.216 . . . . 0.0 113.142 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.92 -45.71 16.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.726 0.81 . . . . 0.0 110.114 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.57 -26.1 60.68 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.596 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.94 -20.75 63.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.27 1.028 . . . . 0.0 111.063 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD21 HD22 ' A' ' 57' ' ' LEU . 92.1 mt -57.93 -43.32 86.21 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.962 0.505 . . . . 0.0 110.481 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.66 -36.22 83.04 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.399 1.08 . . . . 0.0 111.336 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.728 HD12 HD11 ' A' ' 35' ' ' ILE . 47.3 mt -62.32 -49.92 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -34.28 77.61 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 124.53 1.144 . . . . 0.0 110.201 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -64.13 -49.68 71.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.27 1.028 . . . . 0.0 110.967 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.4 80.16 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.32 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.483 HD12 HD11 ' A' ' 84' ' ' ILE . 64.7 mt -69.54 -40.92 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.358 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -60.93 -41.8 96.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.949 0.5 . . . . 0.0 111.343 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.37 -42.27 62.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.443 0.697 . . . . 0.0 111.394 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.55 -58.84 3.99 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.695 0.798 . . . . 0.0 111.031 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.47 -19.9 35.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.697 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.81 56.43 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.435 0.459 . . . . 0.0 111.964 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 pt -120.91 -174.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.082 0.953 . . . . 0.0 111.193 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.21 105.59 11.11 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.16 0.984 . . . . 0.0 108.61 169.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD11 HD13 ' A' ' 80' ' ' LEU . 7.3 tt -88.37 102.65 4.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 166.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.64 81.46 2.23 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 110.871 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD22 HD21 ' A' ' 41' ' ' LEU . 39.8 tp -71.6 -33.95 69.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.852 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.67 -37.81 76.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.766 0.826 . . . . 0.0 111.043 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.756 0.822 . . . . 0.0 110.523 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -64.29 -40.37 95.8 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.528 0.731 . . . . 0.0 110.97 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.1 m -55.06 -46.01 75.34 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.121 0.969 . . . . 0.0 111.407 171.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.48 -33.11 74.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.98 0.512 . . . . 0.0 111.248 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.89 -46.73 84.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.764 0.426 . . . . 0.0 110.443 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 48.6 t -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.599 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.61 -35.2 75.55 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.973 0.909 . . . . 0.0 113.127 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.28 -8.97 49.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.316 0.646 . . . . 0.0 111.394 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.28 67.95 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 122.358 -0.214 . . . . 0.0 113.623 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.409 ' HE2' ' HA ' ' A' ' 68' ' ' LYS . 10.3 mmpt? -73.03 -33.14 65.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.426 0.691 . . . . 0.0 110.216 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -142.25 163.03 33.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.939 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -107.61 158.99 16.79 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.193 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.412 HG22 HG13 ' A' ' 64' ' ' VAL . 28.7 p -58.13 -30.43 66.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.425 0.69 . . . . 0.0 111.494 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 9.1 tm-20 -53.48 -45.05 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.705 0.802 . . . . 0.0 111.146 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.441 ' HA ' HD21 ' A' ' 79' ' ' ASN . 9.2 tt0 -65.15 -23.48 67.13 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 4.16 6.55 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -123.78 -27.22 4.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.583 0.629 . . . . 0.0 111.57 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.9 t -64.34 132.68 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 27' ' ' SER . 31.1 mt -59.58 -43.91 93.49 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -169.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.39 -34.39 77.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 123.24 0.337 . . . . 0.0 111.446 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.441 HD21 ' HA ' ' A' ' 73' ' ' GLN . 5.1 m-20 -70.86 -51.61 25.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.05 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD13 HD11 ' A' ' 55' ' ' LEU . 48.2 tp -54.47 -44.25 72.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.13 . . . . 0.0 110.886 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.72 81.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.265 1.026 . . . . 0.0 111.669 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.73 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.646 0.591 . . . . 0.0 110.373 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mmm180 -59.88 -42.87 94.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.787 0.835 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.483 HD11 HD12 ' A' ' 47' ' ' ILE . 96.7 mt -68.74 -36.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.584 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HA ' HG23 ' A' ' 88' ' ' VAL . 23.3 t70 -58.17 -34.38 70.25 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.985 0.514 . . . . 0.0 111.58 170.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -43.13 85.11 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 58.3 mt -67.19 -40.4 86.53 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.805 0.842 . . . . 0.0 112.124 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG23 ' HA ' ' A' ' 85' ' ' ASP . 31.6 m -75.44 -29.47 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.201 0.6 . . . . 0.0 111.171 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.71 89.66 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.042 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.471 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -55.29 -46.82 76.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.376 1.07 . . . . 0.0 112.468 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.576 ' HZ1' ' HB3' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -63.32 -38.11 89.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 118.203 0.456 . . . . 0.0 110.829 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.5 -25.13 72.64 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.863 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.92 -38.53 20.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.117 0.967 . . . . 0.0 110.524 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 77.7 mt -61.63 -36.98 82.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.562 0.745 . . . . 0.0 109.963 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.03 116.74 12.79 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -146.17 107.94 4.32 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.942 0.897 . . . . 0.0 108.815 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -73.6 156.23 38.27 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -61.86 -41.61 98.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.032 0.533 . . . . 0.0 110.539 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -85.61 121.24 28.01 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.646 0.778 . . . . 0.0 109.759 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.7 101.96 5.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 123.929 0.892 . . . . 0.0 108.761 179.122 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.459 HG22 ' HE ' ' A' ' 7' ' ' ARG . 42.0 m -68.17 112.15 4.94 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.312 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.541 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 59.5 p -143.1 172.28 12.92 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.994 1.318 . . . . 0.0 108.513 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.409 ' O ' HG21 ' A' ' 8' ' ' VAL . 26.3 m -63.55 -36.08 82.6 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 122.985 0.178 . . . . 0.0 110.605 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -67.61 -44.61 77.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.394 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.541 ' HB3' ' H ' ' A' ' 3' ' ' SER . 10.5 t70 -52.21 -46.94 65.83 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.985 0.803 . . . . 0.0 111.21 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HE ' HG22 ' A' ' 2' ' ' THR . 20.7 mmt85 -71.63 -43.8 65.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.868 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.88 -41.11 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.814 0.446 . . . . 0.0 110.958 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.13 92.88 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.29 1.036 . . . . 0.0 110.508 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.4 m -56.25 -49.01 75.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 0.0 110.841 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.19 -46.31 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.114 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.473 HG12 HD13 ' A' ' 43' ' ' ILE . 75.6 mt -62.35 -42.5 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.919 0.888 . . . . 0.0 110.86 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.78 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 0.0 111.918 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.62 -43.32 69.51 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.614 0.766 . . . . 0.0 111.519 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.1 m -65.44 -63.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.376 0.67 . . . . 0.0 111.849 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.66 -1.47 56.84 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.612 0.765 . . . . 0.0 111.577 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.34 77.8 0.28 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.723 1.209 . . . . 0.0 110.89 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.442 HG23 HD21 ' A' ' 33' ' ' LEU . 54.5 mt -136.06 132.2 19.13 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.299 1.04 . . . . 0.0 108.8 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HG2' ' HG1' ' A' ' 22' ' ' THR . 38.1 Cg_endo -66.5 135.52 39.57 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.591 2.194 . . . . 0.0 111.488 173.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.41 ' HA ' ' HB ' ' A' ' 23' ' ' ILE . 25.7 mtm180 -71.93 -22.63 61.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.578 0.351 . . . . 0.0 111.866 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.32 -15.06 62.14 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.159 0.584 . . . . 0.0 111.667 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.407 ' HG1' ' HG2' ' A' ' 19' ' ' PRO . 38.3 p -105.57 -18.83 13.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.001 0.521 . . . . 0.0 110.568 172.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.41 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 87.3 mt -77.77 106.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.449 ' O ' HD13 ' A' ' 77' ' ' LEU . 73.8 p -111.84 154.54 44.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.858 0.863 . . . . 0.0 109.478 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 39.2 Cg_endo -64.08 -22.81 67.57 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.279 1.986 . . . . 0.0 111.534 174.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.41 -17.56 51.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.844 0.858 . . . . 0.0 111.415 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.6 t -73.95 150.8 40.57 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.929 0.892 . . . . 0.0 110.724 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.6 t-80 -107.84 134.46 50.76 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.848 1.259 . . . . 0.0 109.151 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' HA ' HD13 ' A' ' 33' ' ' LEU . . . -49.41 -55.03 14.43 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.882 0.873 . . . . 0.0 112.657 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -76.94 -53.88 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 122.165 0.186 . . . . 0.0 110.944 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 29.3 m-20 -65.58 -52.77 49.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -89.38 -59.77 2.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.745 0.418 . . . . 0.0 111.078 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 77' ' ' LEU . 87.3 mt -68.25 -21.44 64.82 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 22.02 65.52 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 123.388 0.43 . . . . 0.0 113.44 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.7 mt -80.9 130.01 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 123.957 0.903 . . . . 0.0 110.013 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -89.34 160.35 16.91 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.409 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 50.3 m -59.25 -19.05 42.6 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.308 0.643 . . . . 0.0 112.562 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -76.89 -42.19 40.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.678 0.791 . . . . 0.0 110.872 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.57 -32.71 64.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.215 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 -22.17 65.17 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.67 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.526 HD22 HD23 ' A' ' 57' ' ' LEU . 95.7 mt -59.5 -42.97 93.39 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.73 -36.03 70.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.406 1.083 . . . . 0.0 110.698 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.473 HD13 HG12 ' A' ' 12' ' ' ILE . 61.3 mt -65.26 -48.32 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.024 0.53 . . . . 0.0 109.879 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.13 83.09 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.955 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -67.87 -40.06 83.64 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.248 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.35 75.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.809 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.78 -38.84 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.95 0.9 . . . . 0.0 110.839 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.35 -43.61 83.59 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.383 0.673 . . . . 0.0 111.096 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 8.5 mtpm? -81.54 -26.04 35.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.058 0.943 . . . . 0.0 112.302 -175.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.71 -58.11 3.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.798 0.839 . . . . 0.0 110.651 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.428 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 95.5 m-85 -81.9 -27.56 33.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.051 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.13 46.4 7.64 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 HG22 ' HD3' ' A' ' 91' ' ' LYS . 43.3 pt -128.68 -175.34 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.511 1.124 . . . . 0.0 110.257 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -120.29 107.56 13.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 163.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -77.94 107.11 4.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 165.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.92 81.34 2.43 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.63 1.553 . . . . 0.0 110.965 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.526 HD23 HD22 ' A' ' 41' ' ' LEU . 24.4 tp -70.23 -24.23 63.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.308 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.78 -38.3 72.3 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.997 0.919 . . . . 0.0 111.284 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.9 tttp -74.56 -53.57 9.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.067 0.547 . . . . 0.0 109.732 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -60.49 -46.95 88.23 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.055 0.847 . . . . 0.0 111.618 -168.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.3 m -54.28 -48.55 71.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.987 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.65 -33.88 75.93 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.675 0.79 . . . . 0.0 110.811 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.662 ' HG3' ' HH ' ' A' ' 74' ' ' TYR . 36.7 mm-40 -61.97 -40.57 96.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.856 0.862 . . . . 0.0 110.686 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.78 -45.9 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 122.717 0.407 . . . . 0.0 110.136 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -51.4 -44.08 62.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.96 1.304 . . . . 0.0 112.409 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.03 0.72 41.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.51 19.37 76.24 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 113.596 0.199 . . . . 0.0 113.596 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -75.85 -17.12 59.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.153 0.981 . . . . 0.0 111.922 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.513 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -167.24 166.03 15.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.664 1.186 . . . . 0.0 109.07 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.44 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.2 t -105.36 162.01 13.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.38 0.672 . . . . 0.0 110.821 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.5 p -65.06 -30.89 71.89 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.816 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.36 -45.54 84.28 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.766 0.427 . . . . 0.0 110.263 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.44 ' H ' HG23 ' A' ' 70' ' ' THR . 25.5 tt0 -60.92 -30.6 70.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 112.042 -171.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.662 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 54.2 m-85 -105.49 -65.01 1.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.563 0.345 . . . . 0.0 111.234 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -65.34 -21.58 66.72 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.3 t -62.03 127.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 119.872 1.215 . . . . 0.0 108.057 168.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 33' ' ' LEU . 39.3 mt -65.09 -32.94 74.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -160.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.8 pttp -62.96 -37.21 86.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 172.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 62.6 m-20 -77.15 -44.89 28.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.746 0.818 . . . . 0.0 109.631 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.92 -50.48 61.05 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 110.268 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.35 -30.83 70.75 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.14 -42.09 69.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.666 0.386 . . . . 0.0 110.881 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 16.4 mmm180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.197 0.999 . . . . 0.0 110.433 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.59 -40.04 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.62 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 88' ' ' VAL . 27.1 t70 -60.39 -33.86 73.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.968 0.507 . . . . 0.0 111.612 172.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -38.38 79.96 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.544 0.528 . . . . 0.0 110.154 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 90.2 mt -66.99 -40.17 87.33 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.631 0.772 . . . . 0.0 112.398 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.9 m -72.54 -33.76 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 120.856 0.36 . . . . 0.0 110.389 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.49 80.35 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.1 86.82 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.051 1.341 . . . . 0.0 113.051 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HD3' HG22 ' A' ' 53' ' ' ILE . 23.0 pttp -64.91 -34.91 79.52 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.331 0.395 . . . . 0.0 111.028 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.66 -40.92 58.09 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.009 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.96 72.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.869 1.267 . . . . 0.0 111.809 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.437 HD12 ' HA ' ' A' ' 91' ' ' LYS . 82.0 mt -58.51 -47.12 85.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.443 0.697 . . . . 0.0 110.594 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.52 145.62 41.17 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.928 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -82.97 84.65 7.37 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -89.3 50.77 1.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.665 1.186 . . . . 0.0 111.144 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -75.96 87.56 2.91 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -94.35 -64.95 1.02 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.87 165.55 33.27 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.42 1.088 . . . . 0.0 109.032 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 t -77.99 131.11 37.25 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 38.5 t -70.33 153.33 43.15 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.536 0.735 . . . . 0.0 111.011 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.4 m -57.65 -27.81 63.17 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.362 173.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -60.88 -53.72 53.86 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.451 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.67 -39.64 81.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.289 0.993 . . . . 0.0 111.847 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' SER . 68.4 mtt180 -69.83 -47.29 63.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 111.465 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 99.6 t -64.46 -35.5 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.146 0.578 . . . . 0.0 110.417 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.78 86.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 0.0 110.244 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -54.88 -49.23 71.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.907 1.283 . . . . 0.0 111.392 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 HG22 HG13 ' A' ' 47' ' ' ILE . 34.9 mm -57.2 -52.41 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.775 0.83 . . . . 0.0 110.478 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.468 HG12 HD13 ' A' ' 43' ' ' ILE . 72.7 mt -64.93 -38.14 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.737 0.815 . . . . 0.0 111.157 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.34 77.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.052 0.941 . . . . 0.0 112.109 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -71.44 -52.91 15.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.357 0.663 . . . . 0.0 111.65 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -66.35 -45.38 80.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.341 0.656 . . . . 0.0 111.71 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 43' ' ' ILE . 41.7 m -96.36 5.46 50.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.81 26.68 15.72 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.176 0.99 . . . . 0.0 112.428 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.61 124.87 53.7 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.502 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -61.95 135.78 57.43 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.511 2.14 . . . . 0.0 112.412 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' HD2' HD12 ' A' ' 23' ' ' ILE . 26.2 mmm-85 -59.91 -29.83 68.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.474 1.109 . . . . 0.0 112.165 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.469 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.22 -30.57 71.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.325 0.65 . . . . 0.0 111.647 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -96.05 -7.6 35.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.976 0.511 . . . . 0.0 111.533 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.472 HD12 ' HD2' ' A' ' 20' ' ' ARG . 53.2 mt -80.89 123.19 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.247 0.619 . . . . 0.0 109.708 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -124.31 157.4 64.74 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.948 0.899 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.63 -37.38 88.42 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.81 2.34 . . . . 0.0 113.429 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.08 -7.26 58.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.136 0.574 . . . . 0.0 111.645 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -64.19 121.83 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.25 0.62 . . . . 0.0 110.906 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 65.3 t-80 -86.27 127.22 34.73 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -52.38 -54.75 27.78 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.87 -54.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.015 0.197 . . . . 0.0 110.743 -177.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.0 t70 -69.02 -66.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.35 -173.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.78 -55.63 5.63 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.343 -168.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.569 HD12 HD11 ' A' ' 77' ' ' LEU . 90.1 mt -75.48 -14.48 60.43 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.161 0.584 . . . . 0.0 112.274 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.36 8.1 87.65 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 122.993 0.183 . . . . 0.0 113.403 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.582 HD13 HD12 ' A' ' 43' ' ' ILE . 93.8 mt -85.01 99.52 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.873 1.269 . . . . 0.0 110.707 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.71 163.27 16.85 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.954 0.901 . . . . 0.0 110.09 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 t -57.02 -15.97 6.14 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.242 1.017 . . . . 0.0 113.0 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.87 -45.37 13.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 110.298 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.83 -31.34 70.25 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.101 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -67.41 -20.84 65.58 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.397 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.1 mt -57.85 -38.6 75.96 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.108 0.563 . . . . 0.0 111.273 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.22 -41.17 77.4 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.775 0.83 . . . . 0.0 110.854 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.582 HD12 HD13 ' A' ' 35' ' ' ILE . 73.3 mt -61.7 -49.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.268 175.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.454 ' HB2' HD21 ' A' ' 55' ' ' LEU . . . -61.31 -40.23 93.41 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.411 -175.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -73.59 -34.22 64.98 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.56 64.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.678 0.391 . . . . 0.0 110.934 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG13 HG22 ' A' ' 11' ' ' ILE . 91.1 mt -78.23 -38.18 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.504 1.121 . . . . 0.0 110.53 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.64 -40.81 66.15 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.066 0.946 . . . . 0.0 110.278 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -81.48 -50.0 9.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.907 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.56 67.39 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.37 0.668 . . . . 0.0 111.671 -171.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.51 -22.62 28.09 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.515 0.726 . . . . 0.0 110.548 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.58 10.96 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.28 -177.23 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.038 0.935 . . . . 0.0 110.659 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.96 113.27 26.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 167.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 44' ' ' ALA . 5.9 tt -103.79 96.62 9.38 Favored Pre-proline 0 C--O 1.243 0.746 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -83.03 84.05 1.82 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.98 1.787 . . . . 0.0 111.334 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.0 -28.45 69.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.33 -37.76 70.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.369 1.068 . . . . 0.0 111.049 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.2 tttp -80.51 -49.12 11.79 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 124.33 1.052 . . . . 0.0 110.321 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -59.02 -43.83 91.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.012 0.925 . . . . 0.0 111.008 -174.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -65.39 -40.53 93.59 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.676 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -63.71 -33.73 76.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.575 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 43.7 mm-40 -59.27 -38.27 79.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.306 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.508 HG13 HG21 ' A' ' 71' ' ' THR . 40.1 t -72.03 -45.38 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.161 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.52 -29.43 67.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.764 1.226 . . . . 0.0 112.639 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -99.3 -14.28 19.29 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.627 0.771 . . . . 0.0 111.051 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.31 63.85 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 116.607 -0.269 . . . . 0.0 113.308 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.28 -30.09 65.86 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 0.0 111.35 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 172.17 18.61 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.574 0.75 . . . . 0.0 111.098 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -108.6 154.07 22.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.866 0.866 . . . . 0.0 110.413 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.508 HG21 HG13 ' A' ' 64' ' ' VAL . 34.0 p -61.78 -28.58 69.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.381 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -56.14 -44.93 79.68 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.532 0.733 . . . . 0.0 111.663 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.419 ' HA ' HD21 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -66.77 -21.73 66.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 122.776 0.431 . . . . 0.0 111.252 -174.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -104.36 -76.68 0.59 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.89 0.476 . . . . 0.0 110.952 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 88.4 m-85 -60.28 -24.14 64.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -165.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 91.9 t -63.14 127.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 119.195 0.907 . . . . 0.0 108.751 172.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.569 HD11 HD12 ' A' ' 33' ' ' LEU . 26.3 mt -61.82 -36.94 82.61 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -162.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -68.12 -35.83 78.76 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 73' ' ' GLN . 3.5 m-20 -72.3 -45.21 60.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.892 0.877 . . . . 0.0 110.52 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -53.93 -46.43 71.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.122 1.769 . . . . 0.0 111.349 170.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.66 71.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.156 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.05 61.68 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.689 0.618 . . . . 0.0 110.963 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -59.52 -47.88 83.8 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.971 0.909 . . . . 0.0 111.75 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.6 -38.35 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.769 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.05 -37.56 64.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.602 0.761 . . . . 0.0 111.643 169.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.44 -38.05 68.4 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.229 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.17 -40.58 94.48 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.526 0.73 . . . . 0.0 111.841 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 m -78.82 -20.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.58 73.96 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.41 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -52.2 -47.49 65.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.392 1.077 . . . . 0.0 113.107 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -65.58 -38.52 89.76 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.504 0.503 . . . . 0.0 111.094 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.18 -26.43 71.55 Favored Glycine 0 C--N 1.356 1.64 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.751 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.06 35.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.077 0.951 . . . . 0.0 110.136 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 96.0 mt -58.9 -33.76 70.9 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.072 0.949 . . . . 0.0 111.462 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.58 117.28 7.82 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.884 0.74 . . . . 0.0 109.869 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -140.28 115.91 10.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.657 0.783 . . . . 0.0 109.989 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -82.02 69.31 8.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.787 0.803 . . . . 0.0 109.358 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -147.24 130.17 16.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.173 . . . . 0.0 109.047 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -63.3 -37.83 88.78 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.118 0.967 . . . . 0.0 112.272 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -160.28 111.51 1.91 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.056 0.542 . . . . 0.0 109.565 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 CA--C 1.561 1.389 0 C-N-CA 123.358 0.663 . . . . 0.0 110.563 175.9 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.804 0.335 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.8 m -73.75 134.33 43.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.845 0.858 . . . . 0.0 110.73 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 m -118.2 171.92 7.78 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.363 0.665 . . . . 0.0 109.936 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.467 ' O ' HG22 ' A' ' 8' ' ' VAL . 24.0 m -56.28 -32.75 64.84 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.397 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -64.11 -46.38 84.42 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.259 0.223 . . . . 0.0 111.356 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.99 -42.31 80.02 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.076 0.86 . . . . 0.0 111.093 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -63.56 -52.12 62.44 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.165 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.7 -38.81 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.373 0.669 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.47 -44.92 85.66 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.026 0.931 . . . . 0.0 110.126 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.0 m -56.62 -43.6 80.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.365 1.066 . . . . 0.0 112.041 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 47' ' ' ILE . 32.7 mm -59.3 -55.25 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.609 0.763 . . . . 0.0 110.394 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.72 -35.14 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.196 0.935 . . . . 0.0 111.429 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -52.69 64.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.168 0.987 . . . . 0.0 111.728 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.2 -25.81 33.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.434 HG22 ' HA ' ' A' ' 43' ' ' ILE . 19.0 p -73.96 -63.03 1.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.188 0.449 . . . . 0.0 110.801 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.604 ' SG ' HD13 ' A' ' 43' ' ' ILE . 57.7 m -92.42 7.98 40.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.278 -171.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.1 30.87 20.76 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.454 1.102 . . . . 0.0 112.241 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.413 HD11 ' HB3' ' A' ' 33' ' ' LEU . 62.9 mt -86.55 129.69 52.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 118.59 4.58 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.133 2.555 . . . . 0.0 112.375 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.2 tpt85 -57.83 -37.44 73.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.724 1.61 . . . . 0.0 111.727 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.472 ' HG3' HG22 ' A' ' 22' ' ' THR . 9.1 pt-20 -63.1 -38.77 92.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.379 0.672 . . . . 0.0 111.539 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.472 HG22 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.24 -15.49 40.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.158 0.583 . . . . 0.0 112.236 -174.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.88 110.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.926 0.491 . . . . 0.0 110.142 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.1 p -112.69 154.23 44.82 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.428 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 59.6 Cg_exo -55.15 -36.66 93.62 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.108 2.539 . . . . 0.0 112.371 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.51 -28.01 62.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.413 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.5 p -70.37 137.03 50.19 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.889 0.476 . . . . 0.0 111.209 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 60.8 t-80 -89.7 130.17 36.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.667 1.187 . . . . 0.0 108.774 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -49.09 -59.95 3.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.741 0.816 . . . . 0.0 112.648 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.78 -48.86 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.52 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.1 t70 -69.89 -61.28 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.664 -173.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.72 -54.62 5.46 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.789 0.436 . . . . 0.0 110.9 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.709 HD13 HD12 ' A' ' 77' ' ' LEU . 80.4 mt -82.36 -14.09 55.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.151 0.581 . . . . 0.0 112.042 -170.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.21 14.05 82.23 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 122.804 0.24 . . . . 0.0 113.511 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.69 115.25 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.83 0.852 . . . . 0.0 110.264 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -76.83 165.55 24.55 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.5 m -66.29 -18.04 65.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.464 0.575 . . . . 0.0 111.63 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.22 -38.27 19.14 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.833 0.853 . . . . 0.0 109.852 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.26 -26.82 64.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.545 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.48 -21.43 52.87 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.913 0.885 . . . . 0.0 110.612 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 57' ' ' LEU . 85.7 mt -55.44 -36.7 66.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.166 0.439 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -69.51 -39.45 77.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.544 1.138 . . . . 0.0 110.668 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.604 HD13 ' SG ' ' A' ' 16' ' ' CYS . 58.8 mt -64.82 -51.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.625 0.77 . . . . 0.0 110.224 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.421 ' HB2' HD23 ' A' ' 55' ' ' LEU . . . -63.01 -37.49 87.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.316 1.047 . . . . 0.0 110.624 -176.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.1 -41.47 90.55 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.068 0.855 . . . . 0.0 110.332 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.27 76.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 111.336 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.409 HG13 HG23 ' A' ' 11' ' ' ILE . 84.2 mt -67.79 -39.26 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.336 1.054 . . . . 0.0 110.748 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -56.58 -44.54 81.14 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.019 0.528 . . . . 0.0 110.698 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB3' ' HZ3' ' A' ' 49' ' ' LYS . 7.5 mtpm? -77.87 -29.97 50.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.011 0.924 . . . . 0.0 111.789 -175.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.01 -58.45 3.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.663 0.785 . . . . 0.0 110.879 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.421 ' HB2' HG12 ' A' ' 53' ' ' ILE . 52.0 m-85 -84.37 -20.36 32.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.732 0.813 . . . . 0.0 111.15 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.0 18.97 66.18 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.407 0.442 . . . . 0.0 112.42 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.421 HG12 ' HB2' ' A' ' 51' ' ' PHE . 29.5 pt -105.51 -176.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.423 1.089 . . . . 0.0 110.971 -172.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -116.47 111.55 20.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.304 0.641 . . . . 0.0 109.529 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.421 HD23 ' HB2' ' A' ' 44' ' ' ALA . 8.2 tt -102.14 103.07 27.79 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -86.23 84.94 1.06 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.002 1.801 . . . . 0.0 111.671 174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.514 HD22 HD22 ' A' ' 41' ' ' LEU . 59.9 tp -62.71 -34.78 77.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.812 0.845 . . . . 0.0 110.101 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.91 -36.53 77.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.3 1.04 . . . . 0.0 111.193 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -77.67 -44.4 28.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.625 0.77 . . . . 0.0 110.004 178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 44.2 m0 -58.36 -47.48 83.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.997 . . . . 0.0 110.959 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.4 m -63.74 -34.92 78.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.987 0.915 . . . . 0.0 111.021 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.264 1.025 . . . . 0.0 111.287 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.52 -33.53 76.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.416 0.686 . . . . 0.0 110.388 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 84.8 t -67.35 -44.09 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.436 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.26 -32.93 73.7 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.044 0.938 . . . . 0.0 112.458 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -90.71 -12.22 37.32 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.448 1.099 . . . . 0.0 111.371 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.15 16.88 55.05 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 116.931 -0.122 . . . . 0.0 113.37 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.04 -23.4 21.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -147.9 158.53 44.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.123 0.569 . . . . 0.0 110.672 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -95.62 159.95 14.74 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.134 0.574 . . . . 0.0 109.778 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.0 p -62.47 -31.27 71.97 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.954 0.502 . . . . 0.0 109.649 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.5 ' HA ' HG23 ' A' ' 76' ' ' VAL . 31.5 tt0 -54.98 -50.48 68.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.961 0.904 . . . . 0.0 111.112 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -55.95 -30.03 61.07 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.285 1.034 . . . . 0.0 112.404 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.4 ' O ' ' HB2' ' A' ' 80' ' ' LEU . 42.1 m-85 -104.31 -77.43 0.58 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.717 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.484 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 97.6 m-85 -56.42 -27.99 58.16 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -166.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.7 t -65.3 124.37 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.106 1.321 . . . . 0.0 108.413 170.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.709 HD12 HD13 ' A' ' 33' ' ' LEU . 25.5 mt -63.62 -32.47 73.95 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -159.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HG2' HG13 ' A' ' 76' ' ' VAL . 21.0 pttp -67.61 -37.37 82.43 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.756 0.312 . . . . 0.0 111.263 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.1 m-20 -75.97 -42.9 47.03 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 123.509 0.723 . . . . 0.0 109.832 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 50.3 tp -52.2 -48.39 65.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.332 1.453 . . . . 0.0 110.843 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.78 71.86 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.893 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.78 -39.88 50.07 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.992 0.808 . . . . 0.0 111.61 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 23.3 mmm180 -61.37 -45.3 94.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.83 0.852 . . . . 0.0 111.057 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -70.87 -38.54 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.095 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.517 ' HA ' HG23 ' A' ' 88' ' ' VAL . 38.3 t70 -56.44 -34.68 67.06 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.962 0.905 . . . . 0.0 112.35 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 8.1 tp10 -63.3 -47.4 82.43 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.837 0.711 . . . . 0.0 110.356 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 51.7 mt -65.73 -40.9 92.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.03 0.932 . . . . 0.0 111.548 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 85' ' ' ASP . 13.8 m -78.08 -26.23 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 122.841 0.456 . . . . 0.0 111.49 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.8 72.98 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.79 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.82 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.741 0.651 . . . . 0.0 112.505 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.35 -35.48 77.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.766 0.257 . . . . 0.0 110.665 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.65 -21.6 79.51 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 114.854 0.702 . . . . 0.0 114.854 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.97 -52.15 5.43 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.253 0.549 . . . . 0.0 111.08 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.22 -2.25 44.1 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.7 0.8 . . . . 0.0 112.982 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.42 -40.68 77.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.912 0.485 . . . . 0.0 111.102 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -148.85 71.04 1.13 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.068 1.347 . . . . 0.0 107.89 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -79.38 69.94 5.72 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 122.269 1.033 . . . . 0.0 110.671 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -143.15 161.37 38.39 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.686 -172.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -65.84 97.04 0.32 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -68.54 163.17 24.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 111.144 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.746 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.987 0.423 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 t -111.61 133.45 53.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.09 0.556 . . . . 0.0 109.896 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 m -92.18 164.99 13.36 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 163.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -67.49 -19.15 65.29 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 122.155 -0.34 . . . . 0.0 110.326 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -71.07 -41.41 70.74 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.304 0.641 . . . . 0.0 110.691 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.65 -51.84 26.22 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.177 0.991 . . . . 0.0 112.072 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -73.01 -43.53 62.02 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.425 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.76 -40.01 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.163 0.585 . . . . 0.0 110.847 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.79 77.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.995 . . . . 0.0 110.042 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -58.28 -41.43 84.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.05 0.94 . . . . 0.0 111.91 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.505 HG22 HG13 ' A' ' 47' ' ' ILE . 21.7 mm -58.74 -53.32 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.537 0.735 . . . . 0.0 110.658 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.16 -33.12 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.036 0.934 . . . . 0.0 111.195 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -53.78 50.26 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 111.537 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -68.93 -37.58 78.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.145 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -72.48 -63.79 1.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.894 0.478 . . . . 0.0 110.64 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.702 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.5 m -91.43 12.27 21.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 61.39 21.6 12.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.978 0.911 . . . . 0.0 112.079 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.5 mt -87.6 121.78 70.84 Favored Pre-proline 0 N--CA 1.479 0.996 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.173 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.06 133.55 55.72 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.158 1.906 . . . . 0.0 112.422 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -55.23 -33.02 62.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.442 1.097 . . . . 0.0 110.968 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.49 -35.02 79.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.156 . . . . 0.0 112.208 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -85.71 -19.21 31.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.885 0.474 . . . . 0.0 111.357 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -71.5 112.15 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.056 0.542 . . . . 0.0 110.431 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.1 p -115.9 146.47 37.03 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.187 0.995 . . . . 0.0 109.464 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -33.41 73.69 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.808 2.338 . . . . 0.0 112.911 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.43 -6.65 58.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.913 0.885 . . . . 0.0 111.835 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.4 t -74.87 146.84 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.306 1.042 . . . . 0.0 110.648 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 63.8 t-80 -103.01 134.26 46.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.718 1.207 . . . . 0.0 108.489 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -52.15 -58.64 5.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.555 0.742 . . . . 0.0 112.192 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -72.75 -57.3 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.5 t70 -64.58 -47.22 79.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.202 1.001 . . . . 0.0 112.841 -170.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -96.54 -58.17 2.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.559 0.344 . . . . 0.0 111.298 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.58 HD12 HD11 ' A' ' 77' ' ' LEU . 90.4 mt -72.01 -27.58 62.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.994 0.518 . . . . 0.0 111.814 -175.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 15.82 62.37 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-O 120.084 -0.287 . . . . 0.0 113.322 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.04 123.76 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.449 0.7 . . . . 0.0 109.454 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.97 148.05 36.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -58.42 -16.38 14.62 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.678 0.791 . . . . 0.0 111.707 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.12 -51.99 18.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.343 1.057 . . . . 0.0 110.199 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -71.06 -27.18 63.46 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.347 0.659 . . . . 0.0 111.101 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.37 -22.23 66.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 HD22 HD22 ' A' ' 57' ' ' LEU . 90.0 mt -58.6 -38.58 78.28 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.216 0.606 . . . . 0.0 111.131 174.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.07 -28.54 48.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.231 0.612 . . . . 0.0 111.246 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.702 HD11 ' SG ' ' A' ' 16' ' ' CYS . 57.1 mt -62.82 -49.01 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 55' ' ' LEU . . . -65.57 -32.62 74.3 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.129 -177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.38 -43.2 77.85 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.918 0.762 . . . . 0.0 110.525 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.14 73.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.657 0.783 . . . . 0.0 111.723 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG13 HG22 ' A' ' 11' ' ' ILE . 89.6 mt -67.45 -40.29 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.778 0.831 . . . . 0.0 110.617 176.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -54.26 -46.6 72.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.289 0.636 . . . . 0.0 110.399 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.503 ' HB3' ' HZ1' ' A' ' 49' ' ' LYS . 6.9 mtpm? -69.71 -50.99 38.35 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.096 -176.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB2' HD13 ' A' ' 11' ' ' ILE . . . -64.47 -55.83 18.19 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.13 0.972 . . . . 0.0 112.379 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -80.22 -20.44 44.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.753 0.821 . . . . 0.0 111.863 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.33 41.04 39.04 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.48 175.73 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.089 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -114.9 92.72 4.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 167.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 44' ' ' ALA . 8.3 tt -74.53 114.29 32.5 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -89.03 83.97 0.6 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.193 1.929 . . . . 0.0 111.311 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.546 HD22 HD22 ' A' ' 41' ' ' LEU . 37.4 tp -73.19 -28.31 62.13 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.45 -33.42 73.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.409 0.684 . . . . 0.0 110.746 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -73.38 -50.66 20.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.319 1.048 . . . . 0.0 110.261 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -63.1 -45.91 89.85 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.654 0.782 . . . . 0.0 111.837 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 m -61.72 -38.06 86.51 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.924 0.889 . . . . 0.0 110.954 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -63.92 -43.56 95.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.99 0.916 . . . . 0.0 110.686 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.81 -32.6 74.37 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.582 0.753 . . . . 0.0 110.798 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 55.6 t -68.33 -51.78 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.347 0.659 . . . . 0.0 111.215 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.07 -22.01 64.95 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.518 0.727 . . . . 0.0 112.414 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.43 -12.89 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.842 1.257 . . . . 0.0 110.747 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 21.06 58.54 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.114 -0.494 . . . . 0.0 114.242 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -90.35 -54.48 3.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -105.09 156.6 17.92 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.522 1.129 . . . . 0.0 110.64 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -100.07 159.15 15.32 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.52 0.728 . . . . 0.0 109.92 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.5 p -68.23 -29.57 68.42 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.21 -44.39 88.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.991 0.517 . . . . 0.0 111.034 173.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -58.3 -30.93 67.03 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.705 0.802 . . . . 0.0 112.109 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -104.19 -77.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.476 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 59.9 m-85 -55.91 -24.1 35.52 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -163.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.583 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 87.0 t -61.11 124.28 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 119.732 1.151 . . . . 0.0 108.25 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD11 HD12 ' A' ' 33' ' ' LEU . 18.7 mt -60.51 -37.72 82.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.763 0.825 . . . . 0.0 112.935 -161.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -70.1 -36.35 74.8 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.501 0.501 . . . . 0.0 112.097 175.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -70.86 -44.45 66.36 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.895 0.878 . . . . 0.0 110.193 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 tp -53.06 -47.42 68.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.54 1.536 . . . . 0.0 110.672 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.04 66.71 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.666 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.5 49.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.762 0.425 . . . . 0.0 110.619 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -59.49 -43.58 93.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.215 1.006 . . . . 0.0 111.479 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.434 HD11 HD11 ' A' ' 47' ' ' ILE . 96.7 mt -72.91 -39.19 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.289 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.401 ' HA ' HG21 ' A' ' 88' ' ' VAL . 19.5 t70 -54.09 -37.86 64.72 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.277 0.631 . . . . 0.0 111.518 170.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 -41.42 81.13 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.88 -42.97 94.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.462 0.705 . . . . 0.0 112.313 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.401 HG21 ' HA ' ' A' ' 85' ' ' ASP . 16.8 m -74.0 -26.6 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 122.791 0.436 . . . . 0.0 110.564 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.6 -36.46 65.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.619 0.368 . . . . 0.0 110.541 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.87 68.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.655 1.182 . . . . 0.0 113.322 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -63.34 -36.38 83.51 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.078 0.236 . . . . 0.0 110.522 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.94 -23.0 78.46 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.515 0.509 . . . . 0.0 113.534 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.8 41.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.205 1.002 . . . . 0.0 110.224 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -66.1 -37.64 86.28 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.982 170.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.44 -7.41 54.0 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.772 0.829 . . . . 0.0 112.317 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -82.82 56.36 3.38 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.247 1.019 . . . . 0.0 108.679 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.3 m170 67.16 -72.13 0.09 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.865 1.666 . . . . 0.0 112.775 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 77.02 47.86 0.06 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.756 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -79.32 136.62 37.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.489 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -79.78 151.28 30.43 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.141 0.576 . . . . 0.0 111.075 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.28 1.032 . . . . 0.0 108.692 176.063 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.636 0.255 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.457 HG23 ' HE ' ' A' ' 7' ' ' ARG . 54.4 m -81.68 122.24 27.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 170.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 p -103.62 139.15 39.3 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.416 ' O ' HG21 ' A' ' 8' ' ' VAL . 38.9 m -58.87 -33.22 70.24 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.115 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.33 -41.68 93.7 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.376 0.422 . . . . 0.0 111.35 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.51 -42.6 92.59 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.559 0.695 . . . . 0.0 111.059 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.475 ' O ' HG12 ' A' ' 11' ' ' ILE . 23.7 mmt180 -71.29 -44.8 64.5 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.325 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 4' ' ' THR . 77.3 t -57.73 -41.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.312 0.577 . . . . 0.0 110.522 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.66 97.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.225 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -75.35 -30.35 60.22 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.76 0.254 . . . . 0.0 111.411 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.512 HG21 HG13 ' A' ' 47' ' ' ILE . 28.7 mm -61.61 -52.93 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.77 -32.07 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.921 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.46 69.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.597 0.759 . . . . 0.0 111.411 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.13 -53.82 7.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.253 0.621 . . . . 0.0 112.611 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -63.65 -51.52 64.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.795 0.838 . . . . 0.0 111.306 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.413 ' HG ' HG12 ' A' ' 35' ' ' ILE . 43.3 t -90.29 2.19 55.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.507 0.723 . . . . 0.0 111.798 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.88 21.73 13.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.232 1.013 . . . . 0.0 112.697 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.9 132.63 67.26 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 122.983 0.513 . . . . 0.0 110.636 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.0 122.22 11.3 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.0 2.467 . . . . 0.0 112.452 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -61.82 -30.22 70.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.0 1.32 . . . . 0.0 111.342 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' A' ' 22' ' ' THR . 12.5 pt-20 -63.34 -28.81 70.26 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.338 1.055 . . . . 0.0 112.355 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.416 HG21 ' HG3' ' A' ' 21' ' ' GLU . 34.9 p -100.35 -2.24 34.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.703 0.801 . . . . 0.0 111.381 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.92 113.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 0.0 109.825 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -119.6 160.41 42.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.18 -25.58 77.13 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.71 -13.02 58.37 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 111.53 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.427 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 70.4 m -65.06 112.22 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.481 0.713 . . . . 0.0 111.597 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 60.8 t-80 -76.88 127.27 32.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.8 -50.39 56.31 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.3 mt -76.95 -55.06 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 122.555 0.342 . . . . 0.0 111.244 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.457 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.0 t70 -71.15 -43.49 67.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.45 0.7 . . . . 0.0 112.607 -170.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -96.78 -55.68 2.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.235 0.614 . . . . 0.0 111.331 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 77' ' ' LEU . 85.0 mt -76.05 -24.24 55.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.271 0.629 . . . . 0.0 111.596 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.88 6.0 80.23 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.821 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.413 HG12 ' HG ' ' A' ' 16' ' ' CYS . 90.3 mt -64.73 130.18 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.358 1.063 . . . . 0.0 110.815 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.59 162.76 13.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.94 . . . . 0.0 108.869 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.8 p -46.65 -34.18 4.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.265 1.426 . . . . 0.0 113.519 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.56 -36.46 52.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.698 0.799 . . . . 0.0 110.866 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.14 -40.51 74.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.989 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.57 -21.03 64.55 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.332 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.9 mt -55.56 -48.95 73.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.278 0.631 . . . . 0.0 110.95 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.23 -31.7 70.44 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.448 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.68 -45.91 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.121 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.15 79.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.874 0.734 . . . . 0.0 110.941 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.924 . . . . 0.0 110.835 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -30.7 71.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.482 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.512 HG13 HG21 ' A' ' 11' ' ' ILE . 93.3 mt -70.65 -42.04 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.492 0.717 . . . . 0.0 110.838 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -55.21 -40.72 71.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.721 0.808 . . . . 0.0 111.536 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.65 -51.23 10.17 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.351 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.01 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.404 0.682 . . . . 0.0 111.924 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -83.95 -17.21 41.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.057 0.543 . . . . 0.0 111.07 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.56 47.49 62.02 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.478 HG23 ' HD3' ' A' ' 91' ' ' LYS . 47.6 pt -130.36 -175.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.685 0.794 . . . . 0.0 112.094 -172.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -122.39 94.88 4.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.05 1.34 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 47' ' ' ILE . 9.1 tt -84.54 111.86 37.72 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -87.1 81.54 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.079 1.852 . . . . 0.0 111.855 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.15 -30.41 66.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.939 0.496 . . . . 0.0 110.446 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.05 -38.82 65.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.121 0.968 . . . . 0.0 111.315 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.7 ttpt -80.98 -46.38 15.17 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.205 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -55.85 -51.1 68.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.855 0.862 . . . . 0.0 110.975 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.6 m -56.87 -47.11 81.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.402 1.081 . . . . 0.0 111.904 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -63.22 -45.25 92.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.863 0.865 . . . . 0.0 111.621 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 23.1 mm-40 -70.72 -37.19 73.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.027 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.4 t -67.29 -42.93 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.14 -20.96 64.94 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.542 0.737 . . . . 0.0 112.222 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.96 -7.52 42.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.454 0.702 . . . . 0.0 110.756 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.32 87.48 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.565 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 30.3 mmtp -68.91 -25.31 64.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.972 0.909 . . . . 0.0 110.934 175.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 166.19 30.26 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.734 0.813 . . . . 0.0 110.3 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.458 HG21 ' H ' ' A' ' 73' ' ' GLN . 6.1 t -105.1 151.72 23.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.784 0.834 . . . . 0.0 109.863 174.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.9 p -58.42 -34.63 70.99 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.497 0.719 . . . . 0.0 110.404 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.7 tt0 -55.68 -42.03 74.54 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.582 1.153 . . . . 0.0 111.785 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.458 ' H ' HG21 ' A' ' 70' ' ' THR . 29.5 tt0 -62.11 -29.79 70.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.874 0.869 . . . . 0.0 111.755 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -104.05 -78.41 0.56 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.014 177.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.3 m-85 -51.06 -29.31 12.51 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -165.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 66.1 t -62.33 125.83 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.819 1.191 . . . . 0.0 108.409 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 33' ' ' LEU . 23.1 mt -59.65 -35.13 73.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -163.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.458 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -63.24 -39.82 95.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 120.838 0.351 . . . . 0.0 111.431 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -79.73 -40.59 28.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.223 1.009 . . . . 0.0 110.466 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.67 -47.55 73.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.419 1.488 . . . . 0.0 110.288 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.51 72.73 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.81 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.36 -43.92 66.01 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.439 0.462 . . . . 0.0 111.086 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 22.9 mmm180 -62.6 -42.75 99.76 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.754 0.822 . . . . 0.0 111.357 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.25 -37.92 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.512 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.487 ' HA ' HG22 ' A' ' 88' ' ' VAL . 29.9 t70 -58.55 -36.52 74.02 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.203 0.601 . . . . 0.0 111.246 170.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.01 -44.73 83.91 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -61.98 -45.56 93.08 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.868 0.867 . . . . 0.0 112.371 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.487 HG22 ' HA ' ' A' ' 85' ' ' ASP . 22.3 m -71.59 -34.36 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 122.851 0.461 . . . . 0.0 110.948 -177.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.7 60.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.679 0.392 . . . . 0.0 110.689 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.22 82.06 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.529 0.731 . . . . 0.0 112.932 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' HD3' HG23 ' A' ' 53' ' ' ILE . 52.3 pttt -65.58 -34.73 78.92 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.19 -37.91 54.81 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.714 0.634 . . . . 0.0 112.497 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.5 -31.14 61.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.753 1.221 . . . . 0.0 111.804 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.87 -48.53 7.17 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.388 0.675 . . . . 0.0 111.49 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -33.6 73.4 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.619 0.767 . . . . 0.0 112.642 -168.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -83.7 68.22 9.79 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.234 0.614 . . . . 0.0 110.497 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.1 p80 35.43 65.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.76 2.024 . . . . 0.0 114.371 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -125.66 109.37 12.53 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.07 75.89 10.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 110.712 -166.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 63.36 24.0 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.934 1.294 . . . . 0.0 112.491 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 25.1 p80 . . . . . 0 N--CA 1.496 1.846 0 C-N-CA 126.157 1.783 . . . . 0.0 113.352 -175.04 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.4 m -91.69 120.06 32.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.526 0.73 . . . . 0.0 111.144 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.2 p -98.06 143.36 28.69 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 8' ' ' VAL . 9.1 m -61.6 -27.12 68.42 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.39 0.431 . . . . 0.0 110.417 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.68 -46.31 82.94 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.335 0.397 . . . . 0.0 110.884 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.35 -42.52 82.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 123.894 0.746 . . . . 0.0 111.299 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.415 ' O ' HG12 ' A' ' 11' ' ' ILE . 31.2 mmm-85 -70.12 -47.18 62.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.264 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 4' ' ' THR . 95.6 t -58.4 -39.21 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.305 0.574 . . . . 0.0 110.698 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.999 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 t -69.64 -25.44 63.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.587 0.355 . . . . 0.0 111.524 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.595 HG23 HG13 ' A' ' 47' ' ' ILE . 34.2 mm -61.99 -58.0 9.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.2 -30.13 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.89 0.744 . . . . 0.0 110.95 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.17 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.431 1.092 . . . . 0.0 111.622 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 -29.54 56.06 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.135 0.574 . . . . 0.0 112.17 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.5 m -79.79 -60.23 2.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.803 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' SG ' HD12 ' A' ' 43' ' ' ILE . 42.9 m -90.44 -3.95 57.33 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 60.7 69.88 0.65 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.875 0.87 . . . . 0.0 110.129 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -133.51 116.32 13.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.552 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 23.8 Cg_endo -58.74 145.66 95.21 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.868 2.379 . . . . 0.0 112.313 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.481 ' HD2' HD13 ' A' ' 23' ' ' ILE . 55.6 mmm-85 -62.67 -25.32 68.09 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.343 1.057 . . . . 0.0 112.249 -175.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 17.1 pt-20 -61.12 -41.27 96.4 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.444 HG22 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.82 -12.71 47.16 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 111.48 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.481 HD13 ' HD2' ' A' ' 20' ' ' ARG . 76.0 mt -83.6 104.68 12.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.2 p -120.45 153.39 56.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.284 1.034 . . . . 0.0 109.335 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.0 -30.15 82.73 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.64 2.226 . . . . 0.0 112.752 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.42 -15.78 58.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.3 t -66.46 134.86 53.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.942 0.497 . . . . 0.0 110.165 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 20.5 t-80 -103.27 134.7 46.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.279 . . . . 0.0 108.054 174.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.47 -58.47 6.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.169 0.588 . . . . 0.0 112.358 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.89 -49.02 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.0 t70 -72.67 -37.38 67.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.646 0.778 . . . . 0.0 112.663 -170.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -107.64 -56.89 2.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.976 0.51 . . . . 0.0 110.814 -172.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.482 HD13 HD11 ' A' ' 77' ' ' LEU . 91.5 mt -72.58 -20.39 61.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.771 0.829 . . . . 0.0 111.91 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.54 8.78 87.49 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.213 0.32 . . . . 0.0 113.054 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.62 HD11 HD12 ' A' ' 43' ' ' ILE . 79.5 mt -72.79 106.56 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.222 1.009 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.2 159.29 7.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.645 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -62.15 -15.56 46.79 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.354 0.662 . . . . 0.0 111.009 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.97 -44.98 21.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.486 1.114 . . . . 0.0 110.376 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.4 -26.82 62.01 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.29 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -73.0 -20.72 60.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.434 1.094 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.488 HD22 HD21 ' A' ' 57' ' ' LEU . 96.0 mt -55.99 -42.42 76.33 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.175 0.59 . . . . 0.0 110.4 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.08 -33.64 68.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.936 1.294 . . . . 0.0 110.793 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.62 HD12 HD11 ' A' ' 35' ' ' ILE . 58.0 mt -65.09 -48.2 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.204 0.602 . . . . 0.0 109.624 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.406 ' HB2' HD22 ' A' ' 55' ' ' LEU . . . -61.89 -34.85 76.79 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.003 -179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.05 -49.51 64.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.427 1.08 . . . . 0.0 111.081 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.76 72.84 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.079 0.552 . . . . 0.0 111.849 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.595 HG13 HG23 ' A' ' 11' ' ' ILE . 80.0 mt -67.78 -44.19 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 124.156 0.983 . . . . 0.0 110.135 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.34 -45.01 65.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.144 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -70.49 -50.7 35.26 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.04 -55.08 38.43 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.15 0.98 . . . . 0.0 112.301 -170.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.47 ' HB2' HG12 ' A' ' 53' ' ' ILE . 90.4 m-85 -82.05 -22.54 36.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.048 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.89 29.27 57.51 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 51' ' ' PHE . 31.9 pt -113.38 162.34 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.204 1.002 . . . . 0.0 109.632 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -95.1 103.45 15.3 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD22 ' HB2' ' A' ' 44' ' ' ALA . 9.6 tt -83.87 115.93 62.23 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.26 81.8 0.69 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.227 1.951 . . . . 0.0 112.224 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.488 HD21 HD22 ' A' ' 41' ' ' LEU . 48.9 tp -73.29 -32.39 64.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.29 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.17 -34.83 72.57 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.293 0.637 . . . . 0.0 111.186 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.94 -46.64 51.33 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.85 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -62.8 -46.83 86.14 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.704 0.802 . . . . 0.0 111.303 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.7 m -56.41 -45.56 80.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.819 1.248 . . . . 0.0 111.269 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -64.03 -38.49 91.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.889 0.876 . . . . 0.0 110.975 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.4 -33.74 76.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.668 0.787 . . . . 0.0 110.751 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.95 -43.9 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.847 0.459 . . . . 0.0 110.433 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -56.2 -39.25 72.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.623 0.769 . . . . 0.0 112.65 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -84.24 -3.72 58.38 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.21 19.35 79.82 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 117.973 0.351 . . . . 0.0 113.178 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -82.18 -58.96 2.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.361 0.665 . . . . 0.0 109.668 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.63 161.72 15.11 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.054 0.941 . . . . 0.0 110.211 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.2 p -105.74 165.34 11.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.893 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.8 p -65.08 -29.95 70.86 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.203 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.79 -44.84 93.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.662 0.785 . . . . 0.0 111.642 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.68 -33.01 69.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.301 0.64 . . . . 0.0 112.291 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.0 -64.76 1.18 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.516 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 31.8 m-85 -61.78 -21.79 64.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -167.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.608 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.5 t -62.13 129.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.614 1.097 . . . . 0.0 108.424 170.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.482 HD11 HD13 ' A' ' 33' ' ' LEU . 32.0 mt -60.8 -38.41 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -165.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG2' HG11 ' A' ' 76' ' ' VAL . 23.0 pttp -64.52 -38.22 90.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.1 m-20 -69.71 -48.92 57.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.57 0.748 . . . . 0.0 110.172 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.7 tp -52.08 -48.51 64.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.774 1.63 . . . . 0.0 110.825 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.1 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.72 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.38 64.75 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.458 0.474 . . . . 0.0 111.306 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 30.1 mmm180 -60.99 -40.6 94.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.698 0.799 . . . . 0.0 111.492 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.454 HD13 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -74.61 -42.52 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.417 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -51.95 -38.28 55.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.076 0.95 . . . . 0.0 111.294 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -66.08 -44.86 83.21 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.951 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.21 -38.83 82.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.725 0.81 . . . . 0.0 112.08 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.01 -31.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.82 92.06 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.027 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.7 -51.18 68.17 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.325 1.015 . . . . 0.0 112.906 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -71.12 -33.51 70.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.153 0.181 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.42 -27.3 72.87 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.424 -0.353 . . . . 0.0 113.597 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -33.81 63.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.02 -35.29 69.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.449 0.7 . . . . 0.0 110.415 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -68.08 89.42 0.3 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.82 0.848 . . . . 0.0 110.256 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t60 55.66 85.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.758 1.223 . . . . 0.0 110.044 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -75.92 74.56 2.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.316 0.647 . . . . 0.0 110.723 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 175.43 55.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.156 2.182 . . . . 0.0 106.86 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -86.3 89.99 8.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.803 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -74.07 -34.91 64.18 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.387 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.603 -0.713 . . . . 0.0 109.505 -175.764 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 mmt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.572 HG23 ' HE ' ' A' ' 7' ' ' ARG . 91.0 m -90.91 132.4 35.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.069 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 m -65.62 137.31 57.26 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 122.825 0.45 . . . . 0.0 110.267 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 8' ' ' VAL . 53.5 m -55.58 -36.39 66.83 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.95 0.781 . . . . 0.0 111.044 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -60.83 -42.64 98.15 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.805 0.69 . . . . 0.0 111.517 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.63 -40.73 84.18 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.867 0.73 . . . . 0.0 111.271 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.572 ' HE ' HG23 ' A' ' 2' ' ' THR . 19.6 mmt180 -75.81 -39.18 57.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.128 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 4' ' ' THR . 94.5 t -60.4 -39.38 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.565 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.05 88.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.519 1.127 . . . . 0.0 111.054 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -69.35 -31.76 70.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.223 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.559 HG23 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -59.09 -53.64 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.1 mt -61.03 -38.21 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.972 0.909 . . . . 0.0 111.092 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.81 68.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.74 0.816 . . . . 0.0 111.345 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.29 -40.53 64.49 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.774 0.83 . . . . 0.0 112.568 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.412 ' OG1' HG12 ' A' ' 43' ' ' ILE . 18.1 p -76.86 -58.41 3.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.06 0.544 . . . . 0.0 111.416 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.489 ' SG ' HG12 ' A' ' 35' ' ' ILE . 48.4 t -84.79 -0.97 55.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.829 0.852 . . . . 0.0 112.426 -172.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.55 45.19 16.65 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.22 1.008 . . . . 0.0 112.069 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.34 130.76 23.49 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.843 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.9 128.33 28.32 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.543 2.162 . . . . 0.0 111.464 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 tpt85 -56.72 -36.72 70.04 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.014 0.926 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -32.64 74.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.652 1.181 . . . . 0.0 112.614 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -82.74 -10.05 59.07 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 122.556 0.342 . . . . 0.0 111.717 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.61 110.39 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.268 0.627 . . . . 0.0 110.035 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.7 p -117.39 148.77 43.42 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.359 1.064 . . . . 0.0 109.54 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -51.29 -41.4 58.86 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.976 2.451 . . . . 0.0 113.833 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.01 -16.64 59.24 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.984 -172.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.428 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 33.5 t -63.43 132.16 50.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.567 0.747 . . . . 0.0 110.672 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 59.2 t-80 -89.87 128.48 36.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.57 -64.15 0.88 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.696 0.799 . . . . 0.0 112.475 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.06 -35.79 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.2 t70 -82.32 -67.99 0.74 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.521 0.328 . . . . 0.0 111.114 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.39 -51.37 17.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.305 0.642 . . . . 0.0 110.776 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.691 HD11 HD12 ' A' ' 77' ' ' LEU . 87.6 mt -81.84 -18.34 44.28 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.423 0.689 . . . . 0.0 111.546 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.48 36.86 78.07 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.191 0.307 . . . . 0.0 113.809 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.489 HG12 ' SG ' ' A' ' 16' ' ' CYS . 54.7 mt -85.16 133.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.935 0.894 . . . . 0.0 109.691 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.25 154.21 31.2 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -66.22 -17.94 65.05 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.641 0.376 . . . . 0.0 110.374 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.06 -42.65 18.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 109.901 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.08 -32.97 73.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.92 -21.32 65.99 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.007 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD23 HD23 ' A' ' 57' ' ' LEU . 90.3 mt -59.47 -35.91 74.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.085 0.554 . . . . 0.0 111.816 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.01 -35.55 56.95 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.333 0.653 . . . . 0.0 110.221 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.412 HG12 ' OG1' ' A' ' 15' ' ' THR . 55.1 mt -60.29 -50.61 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.405 ' HA ' HD13 ' A' ' 47' ' ' ILE . . . -66.87 -32.76 74.23 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.831 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -69.43 -40.12 77.43 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.15 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.78 70.13 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.559 HG13 HG23 ' A' ' 11' ' ' ILE . 87.7 mt -66.96 -40.64 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.076 0.95 . . . . 0.0 110.743 173.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.28 -45.39 87.99 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.231 0.612 . . . . 0.0 110.941 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -80.82 -27.36 36.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.546 0.738 . . . . 0.0 112.63 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.41 -53.7 5.52 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.166 0.587 . . . . 0.0 110.495 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.459 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 90.6 m-85 -87.62 -23.83 24.15 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.962 0.905 . . . . 0.0 111.201 -173.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.34 39.72 30.36 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.06 -177.99 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 0.0 110.26 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -124.71 109.12 12.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.69 106.46 18.76 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.09 82.89 2.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 121.778 1.652 . . . . 0.0 111.693 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD23 HD23 ' A' ' 41' ' ' LEU . 57.2 tp -69.11 -34.92 75.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.904 -174.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.75 -36.97 70.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.285 1.034 . . . . 0.0 110.976 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 ttpp -87.77 -34.74 18.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.908 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -62.52 -43.86 97.79 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.505 0.722 . . . . 0.0 110.969 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.9 m -63.98 -33.5 75.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.931 0.892 . . . . 0.0 110.604 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -72.48 -29.83 64.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.358 0.663 . . . . 0.0 111.585 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 30.8 mm-40 -58.46 -39.93 81.26 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.55 0.69 . . . . 0.0 109.475 171.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 44.0 t -69.03 -47.34 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.46 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -57.51 -44.05 84.71 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.034 0.934 . . . . 0.0 112.612 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -86.1 -13.67 46.55 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.003 0.921 . . . . 0.0 111.321 -175.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.88 61.53 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 113.804 0.282 . . . . 0.0 113.804 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.81 -34.84 79.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.45 0.7 . . . . 0.0 110.336 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -158.57 171.23 20.5 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.877 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.9 p -100.83 157.74 16.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.809 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.63 -32.09 68.71 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.448 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.433 ' HG3' HG23 ' A' ' 76' ' ' VAL . 45.1 tt0 -55.87 -41.56 74.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.095 1.358 . . . . 0.0 111.682 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.58 -21.7 64.5 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.898 0.879 . . . . 0.0 112.584 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -121.46 -6.38 9.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -126.9 -26.9 3.1 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.595 -0.716 . . . . 0.0 112.805 -172.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 58.0 t -61.26 126.44 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 167.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.691 HD12 HD11 ' A' ' 33' ' ' LEU . 36.9 mt -59.07 -35.43 73.35 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.089 0.868 . . . . 0.0 112.642 -161.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.434 ' HG3' HG13 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -69.85 -36.4 75.52 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.411 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 80.8 m-20 -71.43 -48.31 50.36 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.116 0.966 . . . . 0.0 110.235 177.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.9 tp -50.44 -50.74 51.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 110.987 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.12 61.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.826 0.851 . . . . 0.0 111.696 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.29 56.43 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.563 0.539 . . . . 0.0 110.384 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.408 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 24.1 mmm180 -70.65 -32.2 69.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.298 0.639 . . . . 0.0 111.486 175.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.34 -39.55 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HA ' HG23 ' A' ' 88' ' ' VAL . 34.7 t70 -58.2 -37.94 75.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.689 . . . . 0.0 111.567 170.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.403 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 7.5 tp10 -59.08 -47.79 83.95 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.189 0.995 . . . . 0.0 110.196 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.8 mt -67.6 -41.11 84.58 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.034 0.934 . . . . 0.0 113.112 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.523 HG23 ' HA ' ' A' ' 85' ' ' ASP . 17.3 m -75.73 -28.4 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.997 -0.439 . . . . 0.0 111.032 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.67 56.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -48.07 80.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.274 0.63 . . . . 0.0 112.462 170.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 19.9 pttp -70.93 -36.58 72.69 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.22 -22.36 67.09 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 123.485 0.564 . . . . 0.0 113.766 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.39 73.06 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.795 -0.702 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.2 mt -82.77 -34.46 27.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.375 1.07 . . . . 0.0 110.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 47.5 mt-10 -73.01 102.17 3.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.254 1.022 . . . . 0.0 109.878 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -84.69 91.3 7.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -51.73 10.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 110.884 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 60.11 53.77 4.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.54 1.136 . . . . 0.0 109.832 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -80.31 136.02 36.33 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -59.93 131.98 52.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.545 0.738 . . . . 0.0 110.659 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.838 0.855 . . . . 0.0 109.165 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -142.87 131.06 21.96 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.528 0.731 . . . . 0.0 109.881 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -64.86 137.3 57.68 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.723 0.809 . . . . 0.0 110.545 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.515 HG21 ' HB2' ' A' ' 85' ' ' ASP . 7.8 m -60.35 -26.83 66.89 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.419 0.449 . . . . 0.0 111.493 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -68.32 -46.31 70.58 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.65 -42.15 70.96 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.39 0.676 . . . . 0.0 111.057 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.9 mmp_? -60.88 -58.03 10.14 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.473 177.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.23 -37.67 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.297 1.039 . . . . 0.0 111.528 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.01 -43.08 79.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.647 1.179 . . . . 0.0 110.657 -175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -62.01 -40.95 97.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.452 0.701 . . . . 0.0 111.395 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 42.0 mm -61.98 -50.81 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.298 0.639 . . . . 0.0 110.579 179.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.56 -34.69 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 111.006 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.51 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.962 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -75.46 -50.89 14.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 43' ' ' ILE . 10.1 m -62.79 -46.94 85.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.436 0.694 . . . . 0.0 111.199 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.31 7.64 43.59 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.879 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 59.99 21.15 10.23 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.881 1.273 . . . . 0.0 113.011 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -77.15 138.25 64.79 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.331 0.652 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.76 121.02 9.27 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.102 1.868 . . . . 0.0 111.291 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.37 -29.46 67.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.163 0.585 . . . . 0.0 110.634 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.96 -33.67 69.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.064 0.945 . . . . 0.0 112.312 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -88.84 -18.61 27.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.408 0.683 . . . . 0.0 111.575 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 41.4 mt -72.94 111.14 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.625 0.77 . . . . 0.0 111.334 -177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -111.03 161.41 25.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.265 1.026 . . . . 0.0 108.989 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.17 -24.31 59.08 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.18 -23.73 61.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.75 1.22 . . . . 0.0 110.944 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.452 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.5 m -61.88 119.39 8.71 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 123.737 0.648 . . . . 0.0 111.161 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.644 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.4 t-80 -86.05 127.9 34.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 75' ' ' PHE . . . -48.81 -54.02 16.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.133 0.573 . . . . 0.0 111.799 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -77.3 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.497 0.189 . . . . 0.0 110.776 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.65 -47.27 73.06 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.324 0.65 . . . . 0.0 112.693 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.7 -51.69 5.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.615 . . . . 0.0 111.852 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.657 HD11 HD11 ' A' ' 77' ' ' LEU . 87.9 mt -79.31 -42.66 25.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.92 0.488 . . . . 0.0 110.266 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.16 -7.49 25.1 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.313 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.4 112.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.337 1.055 . . . . 0.0 111.1 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.38 160.32 29.68 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 p -58.93 -15.43 12.85 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.678 0.791 . . . . 0.0 112.859 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.2 mt -86.18 -38.67 17.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.972 0.909 . . . . 0.0 110.806 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.79 -32.7 67.9 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.97 -19.16 64.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 57' ' ' LEU . 90.4 mt -60.19 -42.11 94.36 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.847 0.459 . . . . 0.0 110.246 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.25 -42.3 93.45 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.858 1.263 . . . . 0.0 110.584 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.482 ' HA ' HG23 ' A' ' 15' ' ' THR . 55.8 mt -67.64 -41.62 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.391 0.676 . . . . 0.0 111.004 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.0 73.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.994 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -65.45 -43.57 89.98 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.6 1.188 . . . . 0.0 110.962 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.92 74.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.782 0.433 . . . . 0.0 111.355 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.84 -40.01 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.343 0.657 . . . . 0.0 110.17 177.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -53.42 -50.86 64.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.218 0.607 . . . . 0.0 110.677 174.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -73.25 -48.47 34.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.695 -172.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.78 -44.38 73.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.347 0.659 . . . . 0.0 111.571 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.92 -11.31 39.49 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.946 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.38 71.04 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.235 0.335 . . . . 0.0 112.837 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.24 175.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.061 0.944 . . . . 0.0 111.019 -175.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -116.59 92.71 3.95 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tt -78.18 114.09 39.32 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.99 85.86 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.185 1.924 . . . . 0.0 112.401 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 41' ' ' LEU . 51.7 tp -72.5 -30.4 64.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.6 -30.79 68.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.005 0.522 . . . . 0.0 111.404 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -70.39 -55.48 8.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 0.0 108.659 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -61.1 -48.46 81.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.665 1.186 . . . . 0.0 112.879 -168.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -60.0 -44.3 94.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.664 0.786 . . . . 0.0 111.682 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -70.36 -30.86 67.89 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.287 0.635 . . . . 0.0 110.684 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.3 -40.36 97.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.458 0.703 . . . . 0.0 110.723 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.545 HG12 HG22 ' A' ' 71' ' ' THR . 60.3 t -66.96 -42.82 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.215 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.16 -31.07 65.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.691 0.796 . . . . 0.0 112.7 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -102.24 -14.64 16.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.938 0.495 . . . . 0.0 111.45 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.16 24.1 64.53 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.706 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.57 -31.26 72.37 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.291 0.546 . . . . 0.0 109.607 168.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.18 166.56 31.19 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.616 1.166 . . . . 0.0 109.773 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.6 p -99.29 158.69 15.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.7 0.8 . . . . 0.0 110.972 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.545 HG22 HG12 ' A' ' 64' ' ' VAL . 38.5 p -64.49 -32.34 73.94 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.491 ' HA ' HG23 ' A' ' 76' ' ' VAL . 36.8 tt0 -55.63 -46.34 77.44 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.569 0.747 . . . . 0.0 111.033 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.44 -34.84 69.38 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.812 0.845 . . . . 0.0 112.58 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -104.43 -75.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.536 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 85.9 m-85 -58.18 -26.16 62.42 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 125.275 1.43 . . . . 0.0 114.844 -165.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.644 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -61.48 124.72 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 120.001 1.273 . . . . 0.0 108.257 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.657 HD11 HD11 ' A' ' 33' ' ' LEU . 34.7 mt -61.96 -33.59 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -162.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' HG13 ' A' ' 76' ' ' VAL . 22.4 pttp -69.41 -36.48 76.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -72.69 -44.24 62.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.61 0.764 . . . . 0.0 109.878 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.81 -43.97 69.8 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.171 1.788 . . . . 0.0 111.367 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.815 0.697 . . . . 0.0 110.759 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.02 -44.4 65.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -62.68 -44.06 97.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.542 0.737 . . . . 0.0 111.484 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.0 mt -69.52 -43.07 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.574 0.749 . . . . 0.0 110.154 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.515 ' HB2' HG21 ' A' ' 4' ' ' THR . 22.1 t70 -53.74 -39.87 65.68 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.983 0.513 . . . . 0.0 111.652 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.66 -48.37 81.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.415 0.626 . . . . 0.0 110.639 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.68 -39.03 80.78 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.396 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.498 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 16.7 m -76.53 -33.89 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 122.661 0.384 . . . . 0.0 110.802 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.15 -21.86 65.8 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -53.33 -55.15 27.09 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.68 0.612 . . . . 0.0 112.398 173.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -61.36 -37.68 84.25 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.876 0.37 . . . . 0.0 110.425 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.7 69.52 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.551 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -35.88 63.88 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.311 0.644 . . . . 0.0 109.804 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.8 mt -73.06 -35.05 66.6 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.373 172.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 71.05 -60.16 0.52 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.045 1.738 . . . . 0.0 110.506 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -59.75 117.23 4.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.357 1.063 . . . . 0.0 109.919 164.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -64.03 146.02 54.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.428 0.691 . . . . 0.0 110.456 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -103.2 32.8 3.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.528 0.731 . . . . 0.0 111.877 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -78.34 74.82 4.88 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.839 0.828 . . . . 0.0 110.143 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -162.5 17.92 0.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.859 1.663 . . . . 0.0 108.17 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.854 1.262 . . . . 0.0 108.641 -176.722 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 t -82.01 121.79 26.99 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -92.38 -179.43 5.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.51 0.724 . . . . 0.0 111.282 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.445 ' O ' HG22 ' A' ' 8' ' ' VAL . 71.3 m -58.49 -40.5 82.95 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.701 0.8 . . . . 0.0 110.81 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.67 -45.99 90.41 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.835 0.709 . . . . 0.0 110.941 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.18 -36.35 79.6 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.493 0.717 . . . . 0.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' HG2' HH11 ' A' ' 7' ' ' ARG . 5.4 mmt-85 -68.32 -47.98 66.11 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.694 0.621 . . . . 0.0 111.422 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 4' ' ' THR . 97.6 t -59.62 -37.13 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.708 0.766 . . . . 0.0 110.269 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.27 73.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.005 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -72.14 -23.01 61.23 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 122.425 0.29 . . . . 0.0 111.553 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.487 HG23 HG13 ' A' ' 47' ' ' ILE . 28.0 mm -59.59 -58.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 167.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.85 -30.04 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.925 0.765 . . . . 0.0 111.044 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.37 -53.61 54.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.502 1.121 . . . . 0.0 111.64 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.2 -34.53 59.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.595 0.358 . . . . 0.0 111.703 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.2 m -71.75 -60.48 2.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.775 0.83 . . . . 0.0 111.292 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.549 ' SG ' HD11 ' A' ' 43' ' ' ILE . 61.1 m -96.06 4.13 52.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.611 0.764 . . . . 0.0 112.321 -173.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.31 33.47 22.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.27 1.028 . . . . 0.0 112.599 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.08 123.95 59.53 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.16 137.5 63.12 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.937 2.425 . . . . 0.0 112.681 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.5 0.72 . . . . 0.0 111.127 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.04 -28.47 68.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.975 0.91 . . . . 0.0 111.817 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -88.84 -20.34 24.77 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.781 0.432 . . . . 0.0 110.718 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.86 123.32 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.511 0.724 . . . . 0.0 109.227 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -136.35 157.54 75.23 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.347 1.059 . . . . 0.0 109.602 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -59.84 -32.5 95.46 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.228 1.952 . . . . 0.0 112.263 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.49 -28.47 61.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.415 0.686 . . . . 0.0 112.123 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.463 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 30.9 p -72.76 118.51 15.78 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.922 0.391 . . . . 0.0 111.496 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.675 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 62.0 t-80 -68.67 129.36 39.69 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 109.267 167.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.2 -58.04 5.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.251 0.621 . . . . 0.0 112.46 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 26.9 mt -72.9 -44.76 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.304 0.241 . . . . 0.0 111.447 -174.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.553 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 22.1 t70 -75.48 -64.04 1.15 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.29 0.236 . . . . 0.0 111.164 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.72 -48.75 15.93 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 77' ' ' LEU . 82.1 mt -79.84 -27.66 40.17 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.254 0.222 . . . . 0.0 111.281 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.12 47.88 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.426 -0.352 . . . . 0.0 113.413 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.476 HD12 HD11 ' A' ' 43' ' ' ILE . 66.3 mt -80.69 133.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.93 0.892 . . . . 0.0 109.748 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.63 153.89 19.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -61.58 -15.94 43.47 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 mt -84.21 -32.8 24.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.625 0.726 . . . . 0.0 109.661 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.85 -27.87 40.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.143 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -73.7 -21.25 60.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.319 1.048 . . . . 0.0 110.282 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.579 HD22 HD22 ' A' ' 57' ' ' LEU . 88.9 mt -56.04 -42.5 76.64 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.073 0.549 . . . . 0.0 110.143 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.77 -38.13 89.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.894 0.878 . . . . 0.0 110.986 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.549 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.0 mt -62.26 -51.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.119 0.568 . . . . 0.0 110.371 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' HB2' HD22 ' A' ' 55' ' ' LEU . . . -62.35 -40.07 95.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.74 -176.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -67.73 -39.21 84.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.818 0.847 . . . . 0.0 111.311 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.38 -31.39 69.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.682 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.487 HG13 HG23 ' A' ' 11' ' ' ILE . 81.2 mt -69.82 -40.92 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.95 0.9 . . . . 0.0 110.822 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -54.32 -42.34 70.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.491 0.716 . . . . 0.0 111.126 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -76.78 -48.48 18.5 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.458 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.12 63.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.489 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.456 ' HB2' HG12 ' A' ' 53' ' ' ILE . 78.4 m-85 -85.44 -24.91 27.25 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.63 34.17 44.97 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.48 0.487 . . . . 0.0 112.114 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.456 HG12 ' HB2' ' A' ' 51' ' ' PHE . 32.2 pt -121.88 173.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 109.649 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.14 110.56 22.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.412 HD22 ' HB2' ' A' ' 44' ' ' ALA . 7.6 tt -96.36 104.17 16.58 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.92 84.27 1.61 Allowed 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.04 1.827 . . . . 0.0 111.521 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.579 HD22 HD22 ' A' ' 41' ' ' LEU . 61.2 tp -69.17 -30.6 68.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.64 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.919 0.888 . . . . 0.0 111.059 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 54.7 tttp -77.69 -46.62 21.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.938 0.895 . . . . 0.0 110.361 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -66.88 -38.66 86.72 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.088 0.555 . . . . 0.0 111.539 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 m -66.51 -35.64 80.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.704 0.802 . . . . 0.0 110.522 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.93 -34.8 77.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.135 0.974 . . . . 0.0 110.653 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.546 ' HG3' ' HH ' ' A' ' 74' ' ' TYR . 61.4 mm-40 -58.13 -41.89 84.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.47 -47.26 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.706 0.802 . . . . 0.0 110.4 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.92 -27.99 68.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.865 1.266 . . . . 0.0 112.806 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.78 -8.62 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.796 0.839 . . . . 0.0 112.252 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.78 81.3 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 122.812 0.07 . . . . 0.0 113.139 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -71.55 -21.94 61.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.581 1.152 . . . . 0.0 110.347 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.34 168.89 25.25 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.431 1.093 . . . . 0.0 109.457 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.0 t -101.3 158.76 15.8 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.735 0.814 . . . . 0.0 109.64 175.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -61.99 -31.59 71.97 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.085 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.44 -36.76 84.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.972 0.909 . . . . 0.0 111.843 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.409 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 28.3 tt0 -63.36 -29.05 70.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.176 0.59 . . . . 0.0 111.928 -173.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.546 ' HH ' ' HG3' ' A' ' 63' ' ' GLU . 70.2 m-85 -107.69 -64.13 1.24 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.391 0.277 . . . . 0.0 111.436 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.28 -20.79 63.28 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -167.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.675 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t -65.63 131.99 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 119.862 1.21 . . . . 0.0 108.894 171.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.759 HD11 HD11 ' A' ' 33' ' ' LEU . 25.2 mt -59.96 -36.41 77.05 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -165.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.447 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.6 pttt -58.7 -43.1 89.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.454 0.471 . . . . 0.0 111.056 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.458 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.0 m-20 -76.47 -46.2 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.298 1.039 . . . . 0.0 110.308 -174.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.38 -52.38 37.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.109 1.363 . . . . 0.0 110.539 171.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.48 -25.79 65.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.13 -42.73 59.56 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.795 0.685 . . . . 0.0 111.097 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 22.1 mmm180 -64.93 -42.93 94.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.433 HG22 HD12 ' A' ' 53' ' ' ILE . 93.9 mt -64.93 -43.26 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.922 . . . . 0.0 110.549 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.478 ' HA ' HG21 ' A' ' 88' ' ' VAL . 23.4 t70 -56.1 -36.83 68.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.455 0.702 . . . . 0.0 111.899 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.51 -39.07 77.8 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 123.719 0.637 . . . . 0.0 110.407 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.74 -38.53 86.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.43 0.692 . . . . 0.0 111.996 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 85' ' ' ASP . 13.7 m -80.55 -25.73 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 122.184 -0.323 . . . . 0.0 110.839 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.17 -38.12 78.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.145 0.578 . . . . 0.0 109.825 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.72 -49.34 65.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.083 0.953 . . . . 0.0 112.704 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.02 -33.69 65.89 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.787 0.435 . . . . 0.0 111.108 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.73 -27.0 73.08 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.743 -0.208 . . . . 0.0 113.508 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.17 -25.08 60.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 0.0 110.597 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.5 -18.71 42.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.846 0.858 . . . . 0.0 112.457 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.04 111.72 6.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -73.17 146.58 45.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.855 0.862 . . . . 0.0 111.618 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.2 t60 73.18 2.14 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.393 1.477 . . . . 0.0 112.873 168.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 43.65 110.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 126.742 2.017 . . . . 0.0 113.295 -171.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -79.57 71.96 6.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.682 0.753 . . . . 0.0 109.811 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -149.63 94.04 2.13 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.7 m80 . . . . . 0 C--O 1.247 0.94 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.71 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 m -67.0 119.08 11.37 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -61.55 132.83 54.64 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 8' ' ' VAL . 16.8 m -51.07 -35.37 34.45 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 124.458 1.099 . . . . 0.0 111.55 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -68.25 -32.11 72.07 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -59.31 -48.09 82.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.66 0.384 . . . . 0.0 111.071 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -69.33 -46.23 67.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.865 0.728 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -57.97 -42.67 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.76 0.824 . . . . 0.0 111.314 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.98 91.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.608 0.763 . . . . 0.0 110.647 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -56.41 -44.12 80.04 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.956 0.903 . . . . 0.0 111.597 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.482 HG22 HG13 ' A' ' 47' ' ' ILE . 29.3 mm -58.17 -57.87 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.88 0.872 . . . . 0.0 110.049 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.4 HG12 HD13 ' A' ' 43' ' ' ILE . 73.0 mt -61.65 -33.17 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.37 1.068 . . . . 0.0 111.593 -175.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.24 59.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.933 0.893 . . . . 0.0 111.437 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.17 -24.66 30.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.491 HG21 ' HA ' ' A' ' 43' ' ' ILE . 37.4 p -74.95 -62.05 1.68 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.745 0.418 . . . . 0.0 110.353 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' SG ' HD12 ' A' ' 43' ' ' ILE . 26.2 m -94.48 12.57 26.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.206 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t70 67.34 16.91 10.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.775 1.23 . . . . 0.0 111.991 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.8 mt -77.34 127.36 83.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 122.892 0.477 . . . . 0.0 110.284 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.71 127.03 23.01 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.744 2.296 . . . . 0.0 112.365 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -59.57 -31.54 69.53 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.248 1.019 . . . . 0.0 110.804 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG22 ' A' ' 22' ' ' THR . 10.8 pt-20 -59.91 -27.92 67.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.811 1.244 . . . . 0.0 112.374 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.49 HG22 ' HG3' ' A' ' 21' ' ' GLU . 45.0 p -105.15 -6.82 19.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.539 0.735 . . . . 0.0 111.947 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.1 mt -71.04 116.19 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.164 0.507 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 138.25 31.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.085 1.354 . . . . 0.0 108.435 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.555 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 36.8 Cg_endo -60.93 -27.22 84.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.998 2.465 . . . . 0.0 112.942 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.29 -20.84 61.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.179 0.992 . . . . 0.0 112.351 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 146.62 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.724 0.41 . . . . 0.0 110.362 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 30.1 t-80 -107.85 136.38 47.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 124.159 0.984 . . . . 0.0 108.819 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.34 -63.49 1.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.28 1.432 . . . . 0.0 113.545 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.89 -28.21 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.797 0.439 . . . . 0.0 110.836 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.484 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.7 t70 -63.8 -65.97 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.07 0.948 . . . . 0.0 112.018 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.69 -48.02 3.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.048 0.539 . . . . 0.0 110.527 -170.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.33 -23.53 66.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.087 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.05 26.67 71.55 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.046 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.5 mt -65.52 120.57 12.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.57 164.43 25.89 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t -77.08 -22.04 53.43 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 122.053 -0.404 . . . . 0.0 110.003 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.7 -32.03 22.15 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.684 0.794 . . . . 0.0 109.537 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -73.05 -29.63 63.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.243 1.017 . . . . 0.0 110.534 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.88 -22.5 59.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.695 . . . . 0.0 110.059 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.577 HD23 HD21 ' A' ' 57' ' ' LEU . 93.4 mt -57.71 -35.78 71.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.745 0.418 . . . . 0.0 110.815 174.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.74 -36.77 76.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.653 0.781 . . . . 0.0 110.858 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.609 HD12 ' SG ' ' A' ' 16' ' ' CYS . 52.3 mt -62.08 -53.03 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.585 0.754 . . . . 0.0 109.538 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.24 85.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.329 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.84 -40.13 69.27 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.622 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.877 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.482 HG13 HG22 ' A' ' 11' ' ' ILE . 82.1 mt -72.11 -38.67 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.607 1.163 . . . . 0.0 111.388 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -53.32 -46.16 69.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.86 0.864 . . . . 0.0 110.925 174.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -77.53 -47.57 19.18 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.347 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.41 -50.33 65.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.662 0.785 . . . . 0.0 111.803 -170.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.454 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 59.8 m-85 -83.92 -28.36 27.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.632 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 45.88 8.82 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.4 HG12 ' HB2' ' A' ' 51' ' ' PHE . 37.6 pt -127.14 -175.35 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.049 0.94 . . . . 0.0 111.051 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -124.04 99.71 6.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.28 1.032 . . . . 0.0 108.488 174.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 104.26 8.06 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.68 81.65 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.47 1.447 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.577 HD21 HD23 ' A' ' 41' ' ' LEU . 54.3 tp -69.75 -32.76 71.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.767 0.427 . . . . 0.0 110.099 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.18 -36.35 70.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.44 1.096 . . . . 0.0 110.903 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 39.4 ttpt -78.11 -44.16 26.91 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.677 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -62.89 -39.38 94.31 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 0.0 111.436 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 m -56.56 -46.31 80.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.508 1.123 . . . . 0.0 111.073 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -66.38 -34.91 79.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.076 0.95 . . . . 0.0 111.101 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.9 mm-40 -59.44 -42.72 92.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.117 0.567 . . . . 0.0 110.442 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.458 HG12 HG21 ' A' ' 71' ' ' THR . 59.0 t -68.28 -49.61 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.662 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -61.9 -28.9 69.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.93 0.892 . . . . 0.0 112.947 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -95.06 -7.8 38.52 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.851 0.861 . . . . 0.0 110.849 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.87 80.87 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.558 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.61 -10.92 57.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.7 0.8 . . . . 0.0 112.121 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -161.72 168.63 22.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.253 0.621 . . . . 0.0 110.837 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.5 p -104.36 157.45 17.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.919 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.458 HG21 HG12 ' A' ' 64' ' ' VAL . 32.2 p -67.98 -28.63 67.61 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.634 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.62 -39.56 88.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.164 0.586 . . . . 0.0 110.65 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.37 -34.72 66.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.868 0.867 . . . . 0.0 112.133 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -107.47 -71.81 0.74 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.373 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.414 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 57.2 m-85 -60.66 -18.23 52.41 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -165.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 84.8 t -65.6 128.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.811 1.187 . . . . 0.0 108.189 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.82 -39.2 77.07 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.2 pttp -68.55 -38.17 80.56 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.428 0.455 . . . . 0.0 112.089 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.0 m-20 -70.36 -46.61 63.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.47 0.708 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.06 -49.14 64.08 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.285 1.434 . . . . 0.0 110.863 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.48 69.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.347 0.659 . . . . 0.0 110.832 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.07 -39.61 55.02 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.723 0.409 . . . . 0.0 110.739 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.5 mmm180 -59.35 -43.39 92.8 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.352 0.596 . . . . 0.0 110.899 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.4 mt -71.7 -38.35 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.294 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.4 -38.64 66.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.744 0.818 . . . . 0.0 111.882 170.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.48 -40.66 76.92 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.545 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.43 -42.82 95.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.142 0.977 . . . . 0.0 112.957 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.9 m -75.73 -26.6 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.604 0.362 . . . . 0.0 110.27 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.8 73.08 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.953 171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.82 81.92 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.706 0.803 . . . . 0.0 112.981 176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 22.8 pttp -73.83 -33.39 64.12 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.798 0.333 . . . . 0.0 110.6 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.85 -26.75 72.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.56 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.11 -24.32 63.18 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.902 0.481 . . . . 0.0 111.631 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.5 mt -50.54 -49.47 55.9 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.892 0.877 . . . . 0.0 110.02 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.22 105.38 11.44 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -62.46 128.9 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 111.038 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -64.28 105.94 1.01 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.247 1.419 . . . . 0.0 111.166 -172.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -128.53 156.43 43.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.653 1.181 . . . . 0.0 109.431 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -73.21 115.94 13.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.306 0.642 . . . . 0.0 109.483 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -85.83 135.08 33.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.727 0.811 . . . . 0.0 109.56 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.246 0.913 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -176.12 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m -103.98 151.3 23.35 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.952 0.501 . . . . 0.0 109.723 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -139.91 160.44 39.91 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.232 1.413 . . . . 0.0 109.237 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.493 ' O ' HG21 ' A' ' 8' ' ' VAL . 79.8 m -58.38 -28.29 65.02 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.964 173.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.35 -58.68 5.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.81 -29.77 68.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 123.867 0.729 . . . . 0.0 111.588 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -64.98 -51.53 61.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 110.75 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 4' ' ' THR . 54.3 t -61.83 -36.17 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.144 0.578 . . . . 0.0 111.028 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.31 93.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.849 . . . . 0.0 109.958 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.2 m -54.92 -46.91 74.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.738 1.215 . . . . 0.0 111.409 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.564 HG22 HG13 ' A' ' 47' ' ' ILE . 41.9 mm -58.4 -58.32 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.76 -37.14 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.434 1.094 . . . . 0.0 111.387 -175.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.14 78.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.927 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.58 -27.44 21.37 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 21.7 p -80.4 -59.94 2.51 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.502 0.592 . . . . 0.0 110.74 179.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.645 ' SG ' HG12 ' A' ' 35' ' ' ILE . 44.8 t -80.06 -8.39 59.36 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.234 1.014 . . . . 0.0 111.887 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 61.68 71.92 0.53 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.822 0.849 . . . . 0.0 110.158 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.3 mt -127.78 128.48 23.87 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.241 1.016 . . . . 0.0 108.842 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.58 134.9 60.01 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.992 2.461 . . . . 0.0 112.553 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HD2' HD13 ' A' ' 23' ' ' ILE . 9.4 mmm180 -59.25 -29.2 67.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.873 0.869 . . . . 0.0 111.554 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.542 ' HG3' HG21 ' A' ' 22' ' ' THR . 14.2 pt-20 -63.26 -33.71 76.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.542 HG21 ' HG3' ' A' ' 21' ' ' GLU . 46.0 p -101.7 21.42 14.48 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.152 0.981 . . . . 0.0 111.447 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 HD13 ' HD2' ' A' ' 20' ' ' ARG . 63.5 mt -106.45 128.21 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -138.41 155.66 73.79 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.073 0.949 . . . . 0.0 109.557 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.5 -35.01 96.34 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.328 2.019 . . . . 0.0 112.878 170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.15 -21.69 53.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.732 0.813 . . . . 0.0 112.092 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.3 p -69.98 128.89 37.91 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 53.5 t-80 -88.41 129.89 35.31 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.68 -59.12 4.64 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.016 0.526 . . . . 0.0 111.994 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 45.1 mt -71.33 -60.55 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 120.657 0.265 . . . . 0.0 110.803 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.74 -49.15 77.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.268 1.027 . . . . 0.0 112.901 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.86 -58.56 2.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.83 0.452 . . . . 0.0 111.498 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.13 -19.6 58.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.401 0.68 . . . . 0.0 111.767 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.12 76.01 Favored Glycine 0 N--CA 1.478 1.463 0 O-C-N 122.986 0.178 . . . . 0.0 113.518 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.645 HG12 ' SG ' ' A' ' 16' ' ' CYS . 47.6 mt -73.32 117.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.106 0.962 . . . . 0.0 110.22 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.6 163.19 27.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 m -63.64 -16.51 61.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.911 0.484 . . . . 0.0 111.726 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -85.15 -43.88 13.45 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.718 0.807 . . . . 0.0 109.509 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.89 -31.4 72.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.116 0.966 . . . . 0.0 110.793 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.405 ' HB3' HD21 ' A' ' 57' ' ' LEU . 8.8 t80 -72.2 -20.93 61.49 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.01 0.924 . . . . 0.0 110.685 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.504 HD22 HD22 ' A' ' 57' ' ' LEU . 78.4 mt -57.62 -31.2 65.99 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.784 0.434 . . . . 0.0 111.849 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -69.75 -43.24 72.67 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.233 1.013 . . . . 0.0 109.262 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 64.4 mt -60.06 -51.59 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.118 178.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.74 89.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.842 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.1 -38.33 87.97 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.423 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB2' HG23 ' A' ' 11' ' ' ILE . . . -73.73 -29.23 62.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.178 0.591 . . . . 0.0 111.652 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.564 HG13 HG22 ' A' ' 11' ' ' ILE . 87.3 mt -70.72 -39.38 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.654 0.782 . . . . 0.0 110.587 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.34 -34.77 61.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.97 0.908 . . . . 0.0 111.829 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.38 -51.79 7.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.42 0.688 . . . . 0.0 111.251 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.337 1.055 . . . . 0.0 111.673 -171.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.517 ' HB2' HG12 ' A' ' 53' ' ' ILE . 72.9 m-85 -88.58 -14.41 37.65 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.022 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.47 11.32 82.62 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.089 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.517 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.4 pt -96.13 -171.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.878 0.871 . . . . 0.0 110.58 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.63 114.83 25.42 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.05 98.35 7.4 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.442 ' HG2' ' HD3' ' A' ' 59' ' ' LYS . 86.9 Cg_endo -81.09 86.41 1.63 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.287 1.991 . . . . 0.0 110.442 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.504 HD22 HD22 ' A' ' 41' ' ' LEU . 65.9 tp -67.08 -40.41 86.99 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.774 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.63 -31.07 72.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.109 0.964 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' HD3' ' HG2' ' A' ' 56' ' ' PRO . 47.7 tttp -65.5 -48.29 73.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.004 1.322 . . . . 0.0 110.187 171.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . 0.408 ' O ' HG21 ' A' ' 64' ' ' VAL . 45.2 m0 -63.36 -43.63 97.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.854 0.861 . . . . 0.0 110.787 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.0 m -59.36 -46.0 89.86 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.459 1.504 . . . . 0.0 111.243 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -65.14 -44.9 87.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.532 0.733 . . . . 0.0 111.001 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.96 -26.69 59.77 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.881 0.473 . . . . 0.0 112.222 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 HG13 HG21 ' A' ' 71' ' ' THR . 90.3 t -72.72 -42.28 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.68 -17.45 62.84 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.623 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.01 -6.88 34.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 10.55 84.96 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.071 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.18 -16.98 55.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.842 0.857 . . . . 0.0 110.981 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.26 166.89 30.37 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.888 0.875 . . . . 0.0 109.999 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.416 HG21 ' H ' ' A' ' 73' ' ' GLN . 9.7 t -111.57 155.65 22.98 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.47 0.708 . . . . 0.0 110.326 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.456 HG21 HG13 ' A' ' 64' ' ' VAL . 30.2 p -63.09 -32.52 73.91 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.558 0.743 . . . . 0.0 110.988 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.469 ' HG3' HG21 ' A' ' 76' ' ' VAL . 36.1 tt0 -58.29 -44.36 88.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.561 0.344 . . . . 0.0 111.459 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.416 ' H ' HG21 ' A' ' 70' ' ' THR . 30.3 tt0 -56.32 -32.59 64.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.768 0.827 . . . . 0.0 111.61 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -102.12 -82.09 0.48 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.9 m-85 -55.89 -24.6 38.3 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -161.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.2 t -65.54 124.79 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 119.783 1.174 . . . . 0.0 108.303 170.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.85 -32.97 73.35 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -160.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.482 ' HG2' HG11 ' A' ' 76' ' ' VAL . 62.9 pttt -65.5 -41.28 93.39 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.976 0.51 . . . . 0.0 111.243 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.29 -41.07 49.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.95 -47.07 68.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.831 1.652 . . . . 0.0 110.931 169.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.35 70.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.447 0.699 . . . . 0.0 111.467 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.39 -41.5 47.69 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.413 0.685 . . . . 0.0 110.871 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 23.2 mmm180 -57.58 -50.28 73.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.028 0.931 . . . . 0.0 111.101 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.08 -38.83 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.031 0.932 . . . . 0.0 110.443 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.9 t70 -58.14 -35.52 71.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.81 0.444 . . . . 0.0 111.569 171.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.47 -39.79 70.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.491 0.316 . . . . 0.0 110.735 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 61.4 mt -61.93 -43.77 98.16 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.428 0.691 . . . . 0.0 111.733 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.415 HG22 ' HA ' ' A' ' 85' ' ' ASP . 12.2 m -71.68 -27.68 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 122.761 0.424 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.1 65.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.101 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.92 95.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.696 0.799 . . . . 0.0 112.934 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -71.12 -36.24 72.05 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.41 64.64 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.824 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.27 76.54 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.7 -29.39 64.51 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.945 0.898 . . . . 0.0 110.393 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.98 101.6 1.15 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 164.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -60.11 130.45 46.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -172.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -64.46 121.26 13.97 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.746 0.654 . . . . 0.0 110.168 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -123.75 32.96 5.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.61 1.164 . . . . 0.0 110.405 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 29.8 p80 42.22 73.51 0.13 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.385 1.874 . . . . 0.0 113.563 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -99.72 77.75 2.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.505 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.498 1.119 . . . . 0.0 108.695 -176.794 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m -75.61 125.3 28.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.774 0.43 . . . . 0.0 110.578 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -72.74 144.99 47.42 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.597 0.759 . . . . 0.0 110.519 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG21 ' A' ' 8' ' ' VAL . 6.9 m -64.62 -18.6 65.07 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.621 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.49 -47.28 70.48 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.728 0.411 . . . . 0.0 110.299 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -54.78 -44.4 73.68 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.406 0.683 . . . . 0.0 111.461 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -60.49 -55.63 31.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.088 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.453 HG23 ' HA ' ' A' ' 81' ' ' ALA . 58.3 t -60.39 -37.14 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.51 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.37 87.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.105 0.962 . . . . 0.0 110.518 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -57.53 -42.81 83.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.141 0.976 . . . . 0.0 111.778 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.505 HG23 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -58.79 -50.94 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -33.99 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.149 0.58 . . . . 0.0 110.648 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -51.26 62.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.382 1.073 . . . . 0.0 112.317 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.44 -46.51 22.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.708 0.403 . . . . 0.0 111.959 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.1 m -72.46 -51.96 17.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.12 0.568 . . . . 0.0 111.616 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.77 -9.28 56.22 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.382 0.673 . . . . 0.0 111.777 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 59.02 72.07 0.55 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.381 1.072 . . . . 0.0 110.597 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.13 129.65 21.79 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.14 139.33 85.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.796 2.33 . . . . 0.0 112.358 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -61.06 -28.98 69.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.335 0.654 . . . . 0.0 112.129 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.34 -37.07 84.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.544 0.738 . . . . 0.0 111.236 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -81.48 -23.03 37.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.953 0.501 . . . . 0.0 111.012 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 77' ' ' LEU . 75.8 mt -76.63 116.4 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -132.32 144.72 54.23 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.504 1.122 . . . . 0.0 109.204 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.9 -32.18 92.33 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.814 2.343 . . . . 0.0 112.792 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.13 -20.67 60.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.642 0.777 . . . . 0.0 112.011 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.9 t -73.58 147.76 43.57 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.989 0.915 . . . . 0.0 110.709 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 56.1 t-80 -104.37 133.71 48.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.553 1.141 . . . . 0.0 108.955 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -64.43 0.84 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.717 0.807 . . . . 0.0 112.705 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 46.2 mt -69.81 -39.6 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.835 0.454 . . . . 0.0 111.603 -173.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.8 t70 -80.52 -67.62 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.499 -174.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.79 -57.7 3.89 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.683 0.393 . . . . 0.0 111.067 -171.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.595 HD12 HD11 ' A' ' 77' ' ' LEU . 84.9 mt -71.67 -26.94 62.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.209 0.604 . . . . 0.0 111.108 -176.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.79 21.9 60.72 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.863 0.727 . . . . 0.0 113.552 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.6 mt -70.2 129.21 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.811 0.844 . . . . 0.0 110.026 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.1 158.69 30.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.401 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 33.1 m -65.55 -17.4 64.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.53 0.332 . . . . 0.0 110.84 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 mt -75.88 -47.57 24.91 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.52 1.128 . . . . 0.0 109.299 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -29.2 65.49 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.721 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -73.06 -22.26 60.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.616 0.766 . . . . 0.0 110.451 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.512 HD21 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -60.15 -39.61 86.96 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.681 0.392 . . . . 0.0 109.985 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.0 -44.11 97.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.883 0.873 . . . . 0.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.57 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.493 0.717 . . . . 0.0 109.948 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.07 73.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.21 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -65.2 -43.8 90.42 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.05 0.94 . . . . 0.0 110.179 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.03 -32.05 70.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.245 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 11' ' ' ILE . 84.9 mt -65.22 -42.64 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.855 0.862 . . . . 0.0 110.478 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -53.89 -48.71 69.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.399 0.68 . . . . 0.0 111.463 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -80.04 -37.49 33.92 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.445 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.22 31.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.367 0.667 . . . . 0.0 111.287 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PHE . . . . . 0.439 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 92.6 m-85 -82.16 -28.05 32.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.22 39.4 8.47 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 pt -126.5 -172.48 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.197 0.999 . . . . 0.0 110.85 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -131.0 100.94 5.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tt -72.82 113.62 23.13 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.91 80.5 2.14 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.976 1.784 . . . . 0.0 110.966 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.512 HD23 HD21 ' A' ' 41' ' ' LEU . 46.3 tp -70.08 -35.62 74.34 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.146 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.0 -39.43 81.82 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.481 1.113 . . . . 0.0 111.127 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.8 ttpt -74.65 -40.89 61.18 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.033 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -64.02 -42.47 97.09 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.929 0.768 . . . . 0.0 111.233 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.6 m -59.51 -39.56 84.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.937 0.895 . . . . 0.0 111.141 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -68.97 -34.94 76.13 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.961 0.904 . . . . 0.0 110.888 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 23.0 mm-40 -61.89 -39.95 93.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.356 0.662 . . . . 0.0 110.595 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 58.1 t -65.44 -44.55 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.993 0.517 . . . . 0.0 109.972 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -57.93 -44.29 86.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.327 1.051 . . . . 0.0 112.173 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.31 -18.72 35.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.017 0.927 . . . . 0.0 111.654 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.04 21.94 53.92 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 122.674 0.178 . . . . 0.0 113.0 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -79.03 -24.03 43.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.515 0.726 . . . . 0.0 110.552 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.87 166.41 33.0 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.818 0.847 . . . . 0.0 110.047 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.2 t -107.74 166.85 10.38 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.193 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m -67.72 -30.91 70.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.76 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.58 -35.17 78.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.764 0.825 . . . . 0.0 111.399 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.11 -31.99 72.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 112.392 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -109.27 -58.55 2.02 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.91 -10.9 60.53 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -165.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t -63.99 133.39 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.595 HD11 HD12 ' A' ' 33' ' ' LEU . 36.1 mt -60.03 -41.12 91.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.539 0.735 . . . . 0.0 112.641 -166.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.8 -35.21 78.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 123.147 0.279 . . . . 0.0 111.721 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -68.22 -47.99 66.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.184 0.593 . . . . 0.0 109.662 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -52.19 -46.79 65.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.619 1.568 . . . . 0.0 110.385 172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.453 ' HA ' HG23 ' A' ' 8' ' ' VAL . . . -63.78 -34.55 78.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.892 0.877 . . . . 0.0 111.994 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 -37.54 61.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.1 0.56 . . . . 0.0 110.861 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -64.03 -39.04 93.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.087 0.955 . . . . 0.0 111.401 173.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.485 HD11 HD12 ' A' ' 47' ' ' ILE . 96.7 mt -72.83 -37.03 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.547 0.739 . . . . 0.0 109.861 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.91 -42.91 65.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.787 0.835 . . . . 0.0 111.419 167.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -62.76 -46.83 86.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.433 0.693 . . . . 0.0 111.087 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.55 -45.47 92.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.326 1.05 . . . . 0.0 112.578 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.2 -27.37 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 122.913 0.485 . . . . 0.0 109.985 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.64 76.08 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.34 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.15 93.04 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 22.4 pttp -76.64 -33.36 58.35 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 122.291 -0.256 . . . . 0.0 110.501 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.06 -20.88 71.3 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.087 169.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . -75.78 -30.51 59.13 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.164 0.586 . . . . 0.0 110.505 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.04 -21.23 44.39 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.161 0.984 . . . . 0.0 111.397 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -88.9 60.34 5.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.102 0.961 . . . . 0.0 108.871 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 55.2 t-80 -91.97 56.19 2.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.272 1.029 . . . . 0.0 109.911 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 58.84 -143.34 0.62 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.627 0.771 . . . . 0.0 109.502 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -79.72 167.97 19.94 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 118.08 0.4 . . . . 0.0 109.928 166.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -59.85 133.51 56.16 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.176 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.57 143.8 37.5 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 CA--C 1.553 1.058 0 C-N-CA 123.976 0.911 . . . . 0.0 110.707 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.7 m . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 120.373 0.13 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -68.67 -35.48 77.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -43.24 80.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.266 0.627 . . . . 0.0 110.638 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -72.55 -44.89 61.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.957 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 4' ' ' THR . 95.2 t -60.01 -42.09 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.334 0.654 . . . . 0.0 111.369 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.76 99.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.803 0.841 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -63.37 -42.66 98.86 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.873 0.869 . . . . 0.0 112.023 174.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.589 HG21 HG13 ' A' ' 47' ' ' ILE . 24.5 mm -56.79 -58.65 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.683 0.793 . . . . 0.0 109.527 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.37 -34.08 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.239 1.015 . . . . 0.0 110.944 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -59.16 -53.54 57.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.358 0.663 . . . . 0.0 111.608 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.57 -25.4 38.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.453 0.701 . . . . 0.0 112.01 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.4 m -75.94 -62.41 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.312 0.645 . . . . 0.0 110.149 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 43' ' ' ILE . 2.7 m -85.81 -2.92 58.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.943 0.897 . . . . 0.0 112.368 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 65.11 16.22 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.912 1.285 . . . . 0.0 112.468 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 73.4 mt -79.33 120.7 81.37 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.543 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_endo -62.04 145.11 96.74 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.269 1.979 . . . . 0.0 112.291 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -54.74 -34.48 62.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.195 0.998 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -59.67 -38.25 80.95 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.877 0.736 . . . . 0.0 111.658 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' GLU . 76.2 p -86.84 -6.05 58.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.305 0.642 . . . . 0.0 111.687 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.01 133.87 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.992 0.917 . . . . 0.0 109.489 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -144.48 153.1 54.93 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.588 1.155 . . . . 0.0 110.006 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.54 -43.16 56.99 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.408 2.739 . . . . 0.0 114.448 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.83 -3.59 58.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.799 0.44 . . . . 0.0 111.638 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.4 t -68.55 137.36 54.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 49.6 t-80 -98.19 131.34 44.63 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.156 0.982 . . . . 0.0 108.76 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.9 -58.95 4.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.48 0.712 . . . . 0.0 111.97 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.36 -55.31 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.585 0.354 . . . . 0.0 111.132 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.1 t70 -63.08 -55.29 26.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.695 0.798 . . . . 0.0 111.768 -172.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.76 -65.74 0.98 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.905 0.482 . . . . 0.0 110.685 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 77' ' ' LEU . 88.5 mt -64.44 -28.49 69.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.531 0.732 . . . . 0.0 111.962 -173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.64 40.2 27.58 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-O 121.31 0.394 . . . . 0.0 112.373 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.39 127.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.466 1.106 . . . . 0.0 109.31 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.04 159.24 17.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.847 0.859 . . . . 0.0 109.604 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.499 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 48.1 m -49.51 -38.55 30.82 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.1 0.96 . . . . 0.0 112.781 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 mt -71.06 -35.22 71.84 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.445 0.698 . . . . 0.0 110.999 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.11 -37.59 64.08 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.275 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -71.45 -22.04 61.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.208 0.603 . . . . 0.0 110.776 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.7 mt -57.1 -47.24 81.52 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.29 -35.35 79.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.579 1.151 . . . . 0.0 111.732 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.598 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.5 mt -64.92 -53.1 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.017 0.527 . . . . 0.0 110.144 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -67.34 -29.03 68.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.037 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.11 -38.37 56.96 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.988 0.805 . . . . 0.0 110.84 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.32 -36.65 74.4 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.589 HG13 HG21 ' A' ' 11' ' ' ILE . 85.3 mt -66.52 -42.49 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.206 1.003 . . . . 0.0 110.586 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.23 -43.96 71.29 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.366 1.066 . . . . 0.0 110.474 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.71 -37.07 23.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.236 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.91 23.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.212 0.605 . . . . 0.0 111.401 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -78.68 -18.03 55.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.021 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.34 50.5 38.18 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.0 pt -133.13 160.39 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.538 1.135 . . . . 0.0 109.156 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -94.68 96.92 9.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD22 ' HB1' ' A' ' 44' ' ' ALA . 6.7 tt -83.29 111.29 29.9 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.58 81.9 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.843 1.695 . . . . 0.0 110.802 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.74 -28.11 66.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.788 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.68 -33.32 64.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.792 0.837 . . . . 0.0 111.472 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.6 tttp -80.11 -49.68 11.38 Favored 'General case' 0 C--O 1.211 -0.961 0 C-N-CA 122.999 0.519 . . . . 0.0 109.917 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -60.27 -48.81 80.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.644 0.778 . . . . 0.0 111.705 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.5 m -52.2 -46.23 65.52 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.728 1.211 . . . . 0.0 111.705 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -64.24 -37.52 87.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.926 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.8 mm-40 -59.88 -42.69 94.3 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.072 0.549 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.02 -49.97 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.523 0.729 . . . . 0.0 110.887 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -61.51 -31.42 71.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.032 0.933 . . . . 0.0 112.94 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.46 0.88 55.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.546 0.738 . . . . 0.0 111.127 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.61 78.19 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.61 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -88.06 -12.93 42.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.543 0.737 . . . . 0.0 111.089 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.55 36.36 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.104 0.962 . . . . 0.0 109.825 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -108.37 159.57 16.55 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.162 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 p -58.23 -33.51 69.41 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.487 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' A' ' 76' ' ' VAL . 44.2 tt0 -49.75 -48.49 50.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.946 0.899 . . . . 0.0 112.002 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.88 -30.9 71.17 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.98 5.0 10.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.8 m-85 -133.67 -32.51 1.13 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.93 0.786 . . . . 0.0 111.876 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 89.8 t -59.91 127.27 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 33' ' ' LEU . 27.5 mt -59.7 -38.36 81.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -163.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.52 -36.75 76.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.814 0.446 . . . . 0.0 112.059 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.51 -46.15 64.21 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.619 0.768 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.23 -49.63 63.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.64 1.576 . . . . 0.0 110.127 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.48 64.97 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.43 61.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.688 0.395 . . . . 0.0 110.332 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.479 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 21.4 mmm180 -67.28 -31.34 71.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.429 0.691 . . . . 0.0 111.895 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 47' ' ' ILE . 79.8 mt -77.58 -42.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.21 0.604 . . . . 0.0 110.026 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 88' ' ' VAL . 31.0 t70 -54.97 -34.64 63.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.685 0.794 . . . . 0.0 111.588 170.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 9.3 tp10 -60.98 -49.46 77.36 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.464 0.706 . . . . 0.0 110.73 173.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 54.0 mt -68.35 -37.74 80.78 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.67 0.788 . . . . 0.0 112.468 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 85' ' ' ASP . 19.3 m -74.91 -27.87 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.038 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.11 67.9 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.286 171.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 123.691 0.796 . . . . 0.0 112.883 176.584 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -74.65 -37.19 62.8 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.294 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -52.21 -49.28 64.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 123.835 0.709 . . . . 0.0 110.732 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -65.66 -47.09 76.68 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.235 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.64 -36.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.326 0.651 . . . . 0.0 111.973 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.36 96.09 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.159 0.983 . . . . 0.0 110.342 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -57.38 -47.14 82.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.254 1.021 . . . . 0.0 112.034 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.453 HG21 HG13 ' A' ' 47' ' ' ILE . 95.3 mt -66.57 -49.86 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.739 . . . . 0.0 111.65 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.434 HG12 HD13 ' A' ' 43' ' ' ILE . 62.8 mt -63.87 -35.5 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.643 0.777 . . . . 0.0 111.259 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.38 35.14 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.506 0.722 . . . . 0.0 111.551 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.23 -29.05 53.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.154 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.4 m -72.36 -62.11 1.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.84 0.456 . . . . 0.0 110.612 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.7 m -83.41 -1.09 52.66 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -170.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.94 61.74 2.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.959 0.904 . . . . 0.0 110.028 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -127.57 138.38 32.71 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.887 1.275 . . . . 0.0 108.409 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.14 123.04 11.69 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.872 2.382 . . . . 0.0 111.72 167.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -41.23 89.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.639 1.576 . . . . 0.0 110.764 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.85 -29.43 65.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.794 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -80.25 -25.38 39.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.443 0.297 . . . . 0.0 111.104 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -56.35 110.99 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.456 0.702 . . . . 0.0 111.034 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -94.62 147.13 32.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.605 0.762 . . . . 0.0 109.743 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 37.1 Cg_endo -65.07 -28.87 56.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.404 2.069 . . . . 0.0 111.955 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.41 -11.08 59.92 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.226 0.61 . . . . 0.0 111.709 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.1 p -74.31 140.35 44.83 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.813 0.339 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.2 t-80 -90.81 130.47 36.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.43 -61.29 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.051 0.94 . . . . 0.0 112.596 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -74.89 -44.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 122.65 0.38 . . . . 0.0 111.318 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 25.8 t70 -71.16 -65.48 0.74 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.758 0.423 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.89 -62.98 1.31 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.039 0.536 . . . . 0.0 110.651 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 77' ' ' LEU . 76.3 mt -73.42 -11.06 60.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.438 0.695 . . . . 0.0 112.532 -172.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.26 72.34 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.45 130.24 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.716 0.806 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -71.08 149.28 46.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -67.12 -17.3 64.8 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.071 0.396 . . . . 0.0 110.489 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.28 -31.56 24.86 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.119 0.968 . . . . 0.0 110.226 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.43 -30.17 53.3 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.408 0.623 . . . . 0.0 109.783 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -67.23 -21.51 65.74 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.561 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 57' ' ' LEU . 84.2 mt -59.69 -40.3 87.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.016 0.526 . . . . 0.0 110.498 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.61 -35.93 75.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.547 0.739 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.63 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.5 mt -61.95 -48.33 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.19 -31.82 73.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.448 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.55 -41.65 72.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.436 0.694 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.0 -27.55 60.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.52 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.453 HG13 HG21 ' A' ' 11' ' ' ILE . 94.1 mt -70.73 -42.7 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.833 0.853 . . . . 0.0 109.794 172.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.32 -40.28 74.13 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.624 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -76.43 -48.86 18.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 111.81 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.07 70.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.599 0.76 . . . . 0.0 112.124 -170.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' HG12 ' A' ' 53' ' ' ILE . 96.3 m-85 -83.45 -22.43 32.62 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.179 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.57 33.79 57.82 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 112.161 -0.376 . . . . 0.0 112.161 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.6 pt -114.94 158.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.227 1.011 . . . . 0.0 109.802 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.2 98.58 11.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.5 tt -88.52 105.68 10.38 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.43 80.97 2.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.79 1.66 . . . . 0.0 111.225 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 41' ' ' LEU . 53.6 tp -75.87 -29.56 58.56 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.31 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 -29.76 66.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.521 0.728 . . . . 0.0 110.742 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 61.8 tttp -84.27 -48.49 9.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.621 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -61.59 -39.33 90.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.407 0.683 . . . . 0.0 111.575 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -61.83 -43.92 97.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.89 0.876 . . . . 0.0 110.881 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -65.85 -30.33 70.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.099 0.96 . . . . 0.0 111.462 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 15.2 mm-40 -62.08 -46.71 87.88 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.108 0.563 . . . . 0.0 109.892 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.6 -44.89 99.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.578 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.52 1.128 . . . . 0.0 112.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.14 -18.73 26.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.107 0.963 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.03 65.47 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.792 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -67.95 -32.86 73.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.996 0.518 . . . . 0.0 109.831 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.35 164.46 27.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.573 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 73' ' ' GLN . 12.4 t -105.61 154.52 20.31 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -61.96 -32.32 72.75 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.849 0.859 . . . . 0.0 110.431 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.35 -41.41 89.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.434 ' H ' HG23 ' A' ' 70' ' ' THR . 55.0 tt0 -59.89 -32.58 70.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 112.575 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -105.92 -58.54 1.9 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.605 0.362 . . . . 0.0 111.437 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -67.37 -19.73 65.46 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 85.2 t -66.47 129.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 119.681 1.128 . . . . 0.0 108.408 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 33' ' ' LEU . 12.3 mt -66.34 -34.81 78.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -161.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -65.34 -36.7 84.81 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.935 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 64.1 m-20 -73.59 -44.7 56.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.419 0.688 . . . . 0.0 109.825 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.86 -48.23 67.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.642 1.177 . . . . 0.0 110.723 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.3 67.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.943 0.897 . . . . 0.0 111.391 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.39 64.29 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -63.4 -39.51 94.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.941 0.896 . . . . 0.0 111.506 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.445 HD11 HD13 ' A' ' 47' ' ' ILE . 96.6 mt -70.47 -43.02 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.109 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.32 -37.8 65.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.243 0.617 . . . . 0.0 111.382 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.15 -44.35 80.01 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.74 -42.33 95.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.604 0.762 . . . . 0.0 112.428 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 m -72.71 -29.34 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 122.999 0.52 . . . . 0.0 110.788 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.4 86.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.401 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.0 m . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 77' ' ' LEU . 59.7 t80 -63.11 -55.95 20.99 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.399 0.437 . . . . 0.0 111.132 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.06 -36.69 70.82 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 124.188 0.93 . . . . 0.0 110.99 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 11' ' ' ILE . 14.0 mmm180 -63.15 -53.13 58.19 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.679 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 4' ' ' THR . 51.8 t -61.24 -36.38 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.054 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.07 79.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 110.975 -173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' NH2' ' A' ' 20' ' ' ARG . 11.9 t -69.18 -29.75 67.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.658 0.383 . . . . 0.0 110.68 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 7' ' ' ARG . 45.4 mm -64.46 -50.74 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.191 0.596 . . . . 0.0 109.895 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.4 mt -60.06 -36.43 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.406 0.682 . . . . 0.0 110.395 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.74 42.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.323 1.049 . . . . 0.0 112.202 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.78 -32.43 65.59 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.7 m -77.58 -60.06 2.52 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.262 0.625 . . . . 0.0 110.787 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -91.94 5.57 49.55 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 111.576 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.99 24.74 13.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.693 1.197 . . . . 0.0 113.202 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.5 114.63 56.2 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.305 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -48.51 146.88 9.91 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.327 2.685 . . . . 0.0 113.47 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' NH2' ' HB ' ' A' ' 10' ' ' THR . 3.9 mmt85 -60.31 -33.83 72.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 0.0 111.521 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.47 -35.78 80.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.082 0.953 . . . . 0.0 111.838 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -86.54 -4.75 59.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.315 0.646 . . . . 0.0 111.825 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -96.15 126.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.763 0.825 . . . . 0.0 108.841 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' HD12 ' A' ' 77' ' ' LEU . 81.8 p -140.84 148.85 54.24 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.096 0.958 . . . . 0.0 109.013 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.35 -36.41 68.59 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.81 2.34 . . . . 0.0 113.256 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -74.92 -25.04 58.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.743 0.817 . . . . 0.0 112.373 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.1 p -76.68 144.59 39.31 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.645 0.26 . . . . 0.0 111.21 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 46.7 t-80 -92.24 131.43 37.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.768 1.227 . . . . 0.0 108.963 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.05 -56.81 9.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 112.2 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -71.3 -52.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 120.409 0.147 . . . . 0.0 110.88 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 31.4 t70 -70.41 -54.62 11.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.786 0.434 . . . . 0.0 112.127 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.48 -60.55 1.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.388 0.275 . . . . 0.0 110.946 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 77' ' ' LEU . 76.5 mt -68.37 -30.8 69.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.868 0.467 . . . . 0.0 111.336 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.75 0.9 68.55 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.957 -0.357 . . . . 0.0 113.189 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.09 104.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.829 0.852 . . . . 0.0 110.145 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -77.87 167.12 22.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -58.58 -17.02 18.42 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.347 0.659 . . . . 0.0 112.191 174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.04 -41.47 18.62 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.13 0.972 . . . . 0.0 110.563 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.66 -40.46 92.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.511 0.672 . . . . 0.0 109.661 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -67.66 -18.73 65.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.883 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 57' ' ' LEU . 94.5 mt -54.43 -45.81 73.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.432 0.56 . . . . 0.0 110.852 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.83 -37.59 70.28 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.75 -41.36 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.227 0.611 . . . . 0.0 110.653 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.34 -35.27 80.47 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.12 0.887 . . . . 0.0 110.356 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.23 -42.29 88.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.904 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.85 74.38 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.484 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.6 -39.44 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.944 . . . . 0.0 110.628 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.92 -47.75 64.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.981 0.912 . . . . 0.0 111.138 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.63 -52.7 19.54 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.924 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.78 -57.02 14.87 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.186 0.929 . . . . 0.0 111.979 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HB2' HG12 ' A' ' 53' ' ' ILE . 76.2 m-85 -83.26 -15.12 51.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.443 0.697 . . . . 0.0 111.532 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.68 31.34 67.75 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 51' ' ' PHE . 42.9 pt -113.55 -170.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.576 1.15 . . . . 0.0 109.77 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.9 114.92 17.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 163.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.25 105.07 4.55 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.24 85.51 1.76 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 121.766 1.644 . . . . 0.0 110.351 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 41' ' ' LEU . 42.5 tp -69.4 -24.35 63.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.985 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.93 -38.57 67.84 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.889 0.876 . . . . 0.0 111.019 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.5 tttp -74.01 -50.82 18.09 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.501 1.12 . . . . 0.0 110.577 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HB2' HD12 ' A' ' 57' ' ' LEU . 30.8 m0 -62.82 -47.19 84.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.801 0.84 . . . . 0.0 112.113 -171.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.1 m -54.57 -44.41 72.94 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.84 0.856 . . . . 0.0 111.351 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -68.38 -32.68 72.93 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.158 0.983 . . . . 0.0 111.654 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 53.7 mm-40 -57.56 -46.14 84.31 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.582 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.44 -49.84 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.355 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.43 -36.54 84.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.085 0.954 . . . . 0.0 112.675 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.02 -5.91 40.01 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.483 1.113 . . . . 0.0 111.308 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.06 61.22 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.81 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.12 -24.94 30.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.071 0.549 . . . . 0.0 111.017 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -160.12 168.74 24.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.923 0.489 . . . . 0.0 110.664 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.5 p -105.52 163.56 12.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.826 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.9 p -67.39 -32.38 73.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.693 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.1 tt0 -63.69 -38.81 92.5 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.232 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 29.4 tt0 -62.41 -29.68 70.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.732 0.413 . . . . 0.0 111.999 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -107.46 -71.31 0.76 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.839 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.5 m-85 -62.15 -20.83 64.52 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -165.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -62.13 126.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.298 1.408 . . . . 0.0 107.874 170.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.01 -34.94 72.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -163.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.1 pttp -65.31 -40.72 94.13 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 173.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 73' ' ' GLN . 3.3 m-20 -69.22 -46.84 66.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.125 0.57 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -50.3 -48.62 55.05 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.835 1.654 . . . . 0.0 111.274 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.93 73.27 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.704 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.34 57.24 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.055 0.847 . . . . 0.0 111.409 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.7 mmm180 -64.28 -41.69 96.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.65 0.78 . . . . 0.0 111.276 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -70.35 -39.28 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.208 0.603 . . . . 0.0 110.385 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.07 -38.28 65.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.336 0.654 . . . . 0.0 111.653 169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -68.55 -44.74 73.84 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.607 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 95.8 mt -64.4 -41.9 96.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.108 0.963 . . . . 0.0 112.688 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.69 -32.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.148 0.579 . . . . 0.0 110.489 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.02 62.47 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 124.448 1.099 . . . . 0.0 112.656 178.37 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.9 m . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 120.468 0.175 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.06 -52.3 63.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.896 0.479 . . . . 0.0 111.282 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -61.89 -32.38 72.75 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.863 0.727 . . . . 0.0 110.573 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 11' ' ' ILE . 25.8 mmt180 -66.05 -53.08 42.84 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.838 0.855 . . . . 0.0 111.409 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 81' ' ' ALA . 69.9 t -62.91 -38.09 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.361 0.601 . . . . 0.0 110.748 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.513 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -67.97 -39.75 83.27 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.271 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 7.6 t -73.73 -27.65 61.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.243 0.217 . . . . 0.0 110.865 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 7' ' ' ARG . 34.6 mm -61.02 -55.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 18' ' ' ILE . 60.3 mt -66.51 -29.9 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.645 0.778 . . . . 0.0 111.034 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.33 -51.3 70.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.995 0.918 . . . . 0.0 111.247 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.8 mm-40 -78.98 -28.33 43.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.66 0.384 . . . . 0.0 111.676 -177.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -75.53 -61.68 1.83 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.897 0.479 . . . . 0.0 110.838 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 43' ' ' ILE . 58.6 m -95.54 7.4 46.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.402 0.681 . . . . 0.0 112.307 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.29 67.94 0.92 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.343 1.057 . . . . 0.0 111.126 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 12' ' ' ILE . 23.6 mt -121.77 122.06 27.96 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 139.73 84.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.516 2.144 . . . . 0.0 112.21 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -58.65 -35.4 72.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 0.0 111.511 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.42 -37.53 86.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.043 0.937 . . . . 0.0 111.883 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 p -84.48 -13.65 51.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.191 0.596 . . . . 0.0 111.419 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB1' ' A' ' 9' ' ' ALA . 88.9 mt -81.46 113.46 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.341 0.656 . . . . 0.0 109.295 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 p -117.78 158.3 45.95 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 109.486 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 58.3 Cg_exo -55.36 -33.16 84.44 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.868 2.379 . . . . 0.0 113.506 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.17 -0.58 56.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.597 0.759 . . . . 0.0 112.441 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 26.6 m -72.59 129.2 37.74 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.3 t-80 -98.5 133.06 43.39 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -53.3 -60.14 3.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.092 0.557 . . . . 0.0 111.98 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -75.11 -42.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.451 0.301 . . . . 0.0 111.755 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.05 -56.94 3.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.371 0.668 . . . . 0.0 111.844 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -82.54 -61.52 1.86 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.266 0.626 . . . . 0.0 110.638 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 77' ' ' LEU . 79.6 mt -69.94 -19.28 63.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.054 0.942 . . . . 0.0 111.332 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.73 90.11 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 43' ' ' ILE . 85.0 mt -68.63 98.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.648 1.179 . . . . 0.0 110.346 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.23 165.78 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.094 0.957 . . . . 0.0 111.506 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.0 p -48.43 -28.2 3.12 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.013 1.325 . . . . 0.0 113.57 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.35 -40.84 16.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.504 0.721 . . . . 0.0 110.442 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.32 -30.76 69.82 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.3 0.572 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -74.38 -20.2 60.15 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 57' ' ' LEU . 73.2 mt -56.82 -41.11 77.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.157 0.435 . . . . 0.0 111.115 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.18 -35.94 69.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.809 0.844 . . . . 0.0 110.538 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.659 HD11 ' SG ' ' A' ' 16' ' ' CYS . 37.7 mt -64.07 -48.98 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.13 0.572 . . . . 0.0 110.107 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.34 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.302 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -67.33 -43.37 81.75 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.187 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.49 76.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 111.579 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 84' ' ' ILE . 91.4 mt -69.57 -37.66 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 110.692 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -56.78 -47.51 80.0 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.0 0.52 . . . . 0.0 111.056 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -71.21 -48.18 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.573 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.58 -52.64 36.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.929 0.891 . . . . 0.0 111.53 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -86.65 -11.95 49.87 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 111.933 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.94 38.57 84.95 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.286 0.366 . . . . 0.0 112.55 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 pt -126.72 -173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.11 0.964 . . . . 0.0 110.72 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -126.94 96.4 4.61 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -76.07 108.37 5.99 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.11 84.56 1.53 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.792 1.661 . . . . 0.0 110.616 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 41' ' ' LEU . 54.0 tp -66.48 -32.21 73.43 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.773 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.96 -33.9 75.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.206 1.002 . . . . 0.0 111.108 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 56.8 tttp -72.92 -58.8 3.06 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.897 0.879 . . . . 0.0 109.771 172.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -57.18 -44.3 83.44 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.259 1.024 . . . . 0.0 111.966 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 m -63.74 -36.51 84.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -74.62 -30.76 61.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.5 mm-40 -60.3 -39.4 86.82 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.302 0.641 . . . . 0.0 109.317 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.1 -44.44 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.779 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.594 0.757 . . . . 0.0 112.358 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.49 -18.87 21.81 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.103 0.961 . . . . 0.0 111.189 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.15 59.23 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 113.375 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.56 -23.76 61.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.296 0.639 . . . . 0.0 110.943 169.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.36 26.4 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.692 0.797 . . . . 0.0 110.257 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.0 t -107.15 156.48 18.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.496 0.718 . . . . 0.0 110.334 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.9 p -63.14 -33.78 76.21 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.087 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.18 -33.72 75.06 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.534 0.734 . . . . 0.0 111.986 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 70' ' ' THR . 58.2 tt0 -65.36 -28.36 69.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.589 . . . . 0.0 111.675 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -106.84 -76.99 0.6 Allowed 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.581 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.5 m-85 -59.18 -19.06 41.94 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -162.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 98.8 t -65.11 124.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 33' ' ' LEU . 72.3 mt -58.86 -36.71 75.06 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 60.9 pttt -61.29 -42.35 98.5 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -72.4 -44.94 61.79 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -55.29 -44.96 76.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.684 1.594 . . . . 0.0 110.676 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.528 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.36 61.56 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.711 0.632 . . . . 0.0 111.548 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.2 mmm180 -71.32 -35.79 71.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.663 0.785 . . . . 0.0 111.354 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.403 HD11 HD13 ' A' ' 47' ' ' ILE . 96.3 mt -71.81 -39.61 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.348 0.659 . . . . 0.0 109.712 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 25.2 t70 -57.25 -38.97 74.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.726 0.81 . . . . 0.0 111.397 170.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -60.83 -45.96 92.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.01 0.924 . . . . 0.0 110.009 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 91.6 mt -66.58 -42.75 86.51 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.016 0.926 . . . . 0.0 113.275 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 24.1 m -70.51 -31.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.058 0.456 . . . . 0.0 110.474 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.28 -51.81 27.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.718 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 124.974 1.309 . . . . 0.0 113.559 -176.544 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.5 m . . . . . 0 CA--C 1.553 1.076 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -66.57 -49.62 65.82 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.81 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.13 -41.35 68.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.13 0.894 . . . . 0.0 111.356 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.82 -46.45 62.76 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.802 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -60.92 -36.46 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 122.994 0.518 . . . . 0.0 110.911 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.89 85.15 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.559 1.144 . . . . 0.0 110.089 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.6 m -56.02 -47.07 78.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.235 1.014 . . . . 0.0 111.671 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 47' ' ' ILE . 33.3 mm -59.2 -51.59 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.84 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' A' ' 16' ' ' CYS . 71.1 mt -63.95 -34.77 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.82 0.848 . . . . 0.0 111.289 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -60.25 -52.28 65.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.884 0.474 . . . . 0.0 111.866 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -72.51 -37.69 68.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.581 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.6 m -74.42 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.335 0.654 . . . . 0.0 110.785 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.679 ' SG ' HD11 ' A' ' 43' ' ' ILE . 3.3 m -82.09 -1.16 47.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.04 0.936 . . . . 0.0 113.341 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 64.28 22.67 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.373 1.082 . . . . 0.0 111.048 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 82.3 mt -96.0 126.4 44.75 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.524 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 40.9 Cg_endo -65.16 145.61 84.84 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.627 2.218 . . . . 0.0 112.177 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -60.11 -27.64 67.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.663 1.185 . . . . 0.0 112.653 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.8 -26.79 68.49 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.783 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.477 HG23 ' HG3' ' A' ' 21' ' ' GLU . 80.1 p -108.87 15.41 23.52 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.377 0.671 . . . . 0.0 111.236 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.72 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -121.46 151.31 56.33 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.908 0.883 . . . . 0.0 109.712 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.22 -36.23 66.41 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.037 2.491 . . . . 0.0 113.374 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.66 -17.68 59.89 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.494 0.718 . . . . 0.0 112.067 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 t -68.68 142.54 55.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.506 0.723 . . . . 0.0 111.202 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 42.3 t-80 -105.75 133.45 50.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.659 1.184 . . . . 0.0 108.715 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.96 -56.72 11.04 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.349 0.66 . . . . 0.0 112.524 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.5 -51.13 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.462 0.305 . . . . 0.0 110.76 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.4 t70 -69.94 -42.78 72.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.608 0.763 . . . . 0.0 112.465 -170.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.48 -64.38 1.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.719 0.408 . . . . 0.0 110.044 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 95.5 mt -71.41 -25.07 62.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.771 0.828 . . . . 0.0 112.799 -171.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 45.96 31.31 Favored Glycine 0 N--CA 1.472 1.066 0 CA-C-O 120.969 0.205 . . . . 0.0 112.772 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 43' ' ' ILE . 68.1 mt -98.23 127.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 108.51 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -89.75 166.79 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.972 0.509 . . . . 0.0 109.839 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.8 m -59.38 -27.25 65.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.155 0.582 . . . . 0.0 111.968 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.89 -49.0 64.47 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.554 0.741 . . . . 0.0 111.028 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.63 -29.61 62.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.485 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -72.76 -23.22 60.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.477 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 57' ' ' LEU . 60.6 mt -60.34 -41.43 93.57 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.585 0.354 . . . . 0.0 110.239 170.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.45 -34.57 70.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.779 0.831 . . . . 0.0 111.156 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.679 HD11 ' SG ' ' A' ' 16' ' ' CYS . 63.7 mt -62.9 -51.54 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.6 76.27 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.823 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.94 -47.2 78.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.495 1.118 . . . . 0.0 110.161 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.65 72.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.077 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 11' ' ' ILE . 86.2 mt -71.18 -38.55 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.845 0.858 . . . . 0.0 111.157 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -51.3 -48.14 62.39 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.32 0.581 . . . . 0.0 110.882 173.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.49 -49.32 16.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.509 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.11 69.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.688 0.795 . . . . 0.0 111.906 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -84.52 -17.25 39.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.579 0.752 . . . . 0.0 111.688 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.57 48.61 35.12 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.03 177.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.332 1.053 . . . . 0.0 110.815 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -106.76 109.57 21.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 162.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -84.66 104.47 4.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 165.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.48 81.8 2.39 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.513 1.476 . . . . 0.0 111.082 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 41' ' ' LEU . 57.8 tp -69.7 -31.34 69.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.861 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.04 -33.54 73.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.04 0.936 . . . . 0.0 111.068 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.5 ttpp -82.58 -41.29 19.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.182 0.593 . . . . 0.0 110.365 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -69.98 -41.78 73.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.639 0.776 . . . . 0.0 111.939 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.3 m -60.72 -36.22 78.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.045 0.938 . . . . 0.0 110.483 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -69.52 -38.3 77.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.052 0.941 . . . . 0.0 110.49 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 80.2 mm-40 -56.15 -45.63 79.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.515 0.726 . . . . 0.0 110.287 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 62.8 t -67.82 -44.53 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.748 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.03 -28.94 70.44 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.845 0.858 . . . . 0.0 112.697 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -87.55 -9.82 53.35 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.147 0.579 . . . . 0.0 111.895 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.85 72.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 120.374 -0.126 . . . . 0.0 113.258 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -83.84 -22.67 31.64 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.755 0.822 . . . . 0.0 110.258 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -143.88 160.66 40.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.827 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -98.99 160.61 14.14 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.731 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.7 p -60.05 -29.84 68.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 171.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.545 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.3 tt0 -56.39 -46.87 79.93 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.589 0.756 . . . . 0.0 111.316 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -57.11 -31.61 65.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.472 0.709 . . . . 0.0 112.104 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.67 -74.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.459 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.5 m-85 -56.06 -25.36 44.77 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -165.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.2 t -62.6 126.14 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 119.91 1.232 . . . . 0.0 108.47 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -62.56 -36.5 82.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 112.641 -161.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' HG12 ' A' ' 76' ' ' VAL . 65.8 pttt -64.09 -39.33 93.82 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.247 0.342 . . . . 0.0 111.119 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.9 m-20 -75.81 -42.79 48.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.507 0.723 . . . . 0.0 110.277 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.1 tp -53.09 -49.41 66.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.833 1.253 . . . . 0.0 110.325 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.2 -33.04 73.79 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.014 0.821 . . . . 0.0 111.252 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.64 63.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.94 0.496 . . . . 0.0 110.539 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.3 mmm180 -64.04 -31.84 73.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.718 0.807 . . . . 0.0 111.76 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 -41.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.811 0.845 . . . . 0.0 110.534 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 22.1 t70 -56.44 -36.55 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.577 0.751 . . . . 0.0 111.591 172.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 10.6 tp10 -59.26 -47.25 86.08 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.975 0.91 . . . . 0.0 110.671 172.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 59.6 mt -64.5 -46.96 80.69 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.002 0.921 . . . . 0.0 112.434 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.9 m -67.89 -29.0 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.048 0.451 . . . . 0.0 110.657 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.81 -42.37 67.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.898 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 C-N-CA 124.166 0.986 . . . . 0.0 113.536 -179.211 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.6 m . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -69.59 -44.56 70.5 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.145 0.278 . . . . 0.0 110.656 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.68 -35.89 82.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.286 0.634 . . . . 0.0 110.682 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 21.1 mmm180 -59.6 -57.69 11.85 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.713 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.42 -35.88 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.937 0.895 . . . . 0.0 111.193 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.6 90.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.252 1.021 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 14.9 m -60.86 -43.61 98.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 111.281 172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.49 -50.23 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.322 0.649 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 43' ' ' ILE . 72.6 mt -62.18 -39.62 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.342 1.057 . . . . 0.0 111.223 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.03 87.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.089 0.555 . . . . 0.0 111.129 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.9 mm-40 -72.06 -38.95 69.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -69.71 -62.57 1.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.361 0.601 . . . . 0.0 110.745 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 43' ' ' ILE . 20.0 m -84.98 -10.14 57.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.845 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.15 24.21 12.56 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.747 0.819 . . . . 0.0 112.175 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.471 HD12 HD11 ' A' ' 35' ' ' ILE . 50.8 mt -77.46 128.41 80.22 Favored Pre-proline 0 C--O 1.246 0.88 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.86 128.82 27.98 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.683 2.256 . . . . 0.0 112.322 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 tpt85 -56.37 -32.31 64.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.486 1.114 . . . . 0.0 110.429 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.97 -38.48 91.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.208 1.003 . . . . 0.0 112.365 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -82.71 -9.83 59.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.764 0.425 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.63 113.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.457 0.703 . . . . 0.0 109.437 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 p -123.67 154.88 66.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.763 0.825 . . . . 0.0 109.187 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 -39.95 79.93 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.631 2.22 . . . . 0.0 112.61 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.03 -9.92 59.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.892 0.477 . . . . 0.0 112.236 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p -73.27 134.27 44.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.6 t-80 -90.5 131.59 36.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.97 0.908 . . . . 0.0 108.624 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.17 -55.53 20.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 0.0 112.214 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.1 -47.41 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.367 0.267 . . . . 0.0 111.442 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -72.6 -66.6 0.64 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.813 0.445 . . . . 0.0 112.064 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -75.72 -60.74 2.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.145 0.578 . . . . 0.0 111.429 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 77' ' ' LEU . 81.3 mt -69.27 -29.12 66.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.112 0.565 . . . . 0.0 111.921 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.28 85.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 43' ' ' ILE . 36.9 mt -73.85 98.94 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.437 0.695 . . . . 0.0 109.962 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.92 165.06 25.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.019 0.928 . . . . 0.0 109.974 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 57.0 p -51.56 -18.34 1.1 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.713 1.605 . . . . 0.0 114.585 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 mt -84.72 -44.28 13.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.545 0.611 . . . . 0.0 110.292 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.24 -34.01 65.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.986 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.11 -21.56 66.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.238 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 57' ' ' LEU . 94.1 mt -57.78 -38.39 75.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.243 0.617 . . . . 0.0 111.43 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.21 -30.65 48.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.589 HD11 ' SG ' ' A' ' 16' ' ' CYS . 41.8 mt -62.56 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.75 74.55 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -65.46 -43.26 90.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.021 0.928 . . . . 0.0 110.327 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.27 78.9 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.132 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.401 HD13 HD11 ' A' ' 84' ' ' ILE . 87.2 mt -65.17 -37.72 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.887 0.875 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -56.35 -42.06 77.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -82.88 -40.89 19.64 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.781 0.833 . . . . 0.0 111.272 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -68.92 -51.95 34.45 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.52 1.128 . . . . 0.0 111.349 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -87.91 -24.9 23.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.403 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.71 52.27 10.04 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.15 -176.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.28 1.032 . . . . 0.0 110.452 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -118.71 109.99 16.75 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.15 98.85 20.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 95.0 Cg_endo -85.4 85.12 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.383 2.055 . . . . 0.0 111.43 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 41' ' ' LEU . 42.2 tp -69.52 -32.51 71.4 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.58 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.6 -31.8 70.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.579 0.351 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 35.7 ttpt -80.84 -40.69 24.47 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.789 0.836 . . . . 0.0 109.913 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -59.11 -45.72 90.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.816 0.847 . . . . 0.0 110.51 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.2 m -72.34 -28.88 63.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.786 1.234 . . . . 0.0 111.452 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.66 -34.59 67.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.499 0.72 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.04 -32.79 74.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.68 0.792 . . . . 0.0 110.143 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 71' ' ' THR . 57.6 t -70.93 -43.19 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.075 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -58.27 -45.04 88.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.692 0.797 . . . . 0.0 112.189 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -85.92 -11.79 52.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.857 0.863 . . . . 0.0 111.79 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.59 69.93 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.229 0.331 . . . . 0.0 113.562 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -70.36 -27.11 64.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.99 0.916 . . . . 0.0 110.436 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.02 170.49 21.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.978 0.911 . . . . 0.0 110.335 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.4 t -107.37 158.67 16.98 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.439 0.696 . . . . 0.0 111.443 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 HG11 ' A' ' 64' ' ' VAL . 40.5 p -62.42 -36.62 82.93 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.08 0.952 . . . . 0.0 110.743 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -53.15 -41.67 65.37 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.89 0.876 . . . . 0.0 111.204 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.471 ' H ' HG23 ' A' ' 70' ' ' THR . 50.1 tt0 -63.68 -32.22 73.63 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.392 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.17 -8.45 12.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -169.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.1 m-85 -128.49 -29.24 2.44 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.513 -169.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 88.8 t -61.54 125.58 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 33' ' ' LEU . 26.9 mt -61.42 -34.14 74.88 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -161.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.82 -37.54 70.33 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.577 0.351 . . . . 0.0 111.362 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -68.2 -49.19 62.48 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.636 0.775 . . . . 0.0 109.873 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -51.86 -47.07 64.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.938 1.695 . . . . 0.0 111.481 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.72 67.06 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.11 -39.19 55.76 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.625 0.578 . . . . 0.0 110.665 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mmm180 -59.27 -48.22 82.45 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.566 0.746 . . . . 0.0 110.581 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 47' ' ' ILE . 98.7 mt -67.72 -42.7 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.694 1.197 . . . . 0.0 110.269 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 88' ' ' VAL . 30.9 t70 -56.69 -36.29 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.631 0.582 . . . . 0.0 111.914 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.99 -44.07 85.92 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.723 0.639 . . . . 0.0 110.461 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 82.0 mt -64.49 -40.9 96.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.724 0.81 . . . . 0.0 112.278 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.3 m -76.3 -28.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.855 0.462 . . . . 0.0 111.378 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.99 58.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.349 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.662 1.185 . . . . 0.0 112.682 176.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 8' ' ' VAL . 31.0 m . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -58.67 -54.66 44.52 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.689 0.618 . . . . 0.0 111.536 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.61 -28.47 69.15 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.039 0.837 . . . . 0.0 110.195 -173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -69.8 -46.04 66.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.701 0.8 . . . . 0.0 111.659 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 84.8 t -64.19 -35.76 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.324 0.65 . . . . 0.0 110.525 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.06 99.43 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 110.284 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.8 m -56.34 -49.78 73.39 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.186 171.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.594 HG21 HG13 ' A' ' 47' ' ' ILE . 44.9 mm -59.58 -49.61 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 123.775 0.672 . . . . 0.0 110.731 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.18 -36.83 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.334 0.654 . . . . 0.0 111.126 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.94 83.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.518 0.727 . . . . 0.0 111.924 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.25 -51.73 14.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 0.0 112.359 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -66.6 -57.84 6.4 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.39 1.076 . . . . 0.0 111.189 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 35' ' ' ILE . 49.5 t -82.93 -9.93 59.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.662 0.785 . . . . 0.0 111.878 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.35 76.96 0.31 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.518 1.127 . . . . 0.0 110.4 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mt -127.59 135.35 27.32 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.081 0.952 . . . . 0.0 109.222 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.57 119.49 4.73 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.33 2.686 . . . . 0.0 111.346 168.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -65.14 -25.18 67.64 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.051 0.941 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -65.81 -33.73 76.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 111.886 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -86.83 -17.94 32.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.143 0.577 . . . . 0.0 111.177 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.31 110.23 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -119.74 158.46 49.59 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.889 0.876 . . . . 0.0 109.535 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 -33.1 97.35 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.399 2.066 . . . . 0.0 112.401 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.4 -11.04 44.33 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 73.5 p -70.53 127.5 32.92 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.9 t-80 -91.75 133.06 35.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.227 1.011 . . . . 0.0 108.875 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.74 -59.76 3.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.634 0.774 . . . . 0.0 112.697 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -72.71 -57.56 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 120.838 0.351 . . . . 0.0 110.381 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 16.8 t70 -58.96 -49.63 77.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.246 . . . . 0.0 112.852 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.82 -58.87 1.82 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.685 0.394 . . . . 0.0 111.529 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 92.7 mt -74.19 -11.84 60.41 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.338 0.655 . . . . 0.0 112.012 -171.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.01 88.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.815 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.541 HG12 ' SG ' ' A' ' 16' ' ' CYS . 59.0 mt -74.01 102.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 109.987 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.92 156.24 38.87 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -57.05 -16.96 8.36 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.696 0.798 . . . . 0.0 112.875 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.92 -36.98 18.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.338 0.655 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.35 -30.4 68.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.504 0.669 . . . . 0.0 109.855 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.27 63.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.424 1.09 . . . . 0.0 111.996 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 57' ' ' LEU . 93.6 mt -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.566 0.747 . . . . 0.0 110.412 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.21 -38.5 81.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.402 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.27 -42.32 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.663 0.602 . . . . 0.0 110.035 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -62.79 -36.89 84.62 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -75.06 -37.9 61.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.139 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.74 71.73 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.66 0.384 . . . . 0.0 110.975 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.594 HG13 HG21 ' A' ' 11' ' ' ILE . 96.6 mt -72.55 -39.61 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.853 0.861 . . . . 0.0 110.087 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.05 -44.86 71.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.469 1.108 . . . . 0.0 110.262 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.26 -44.88 28.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.21 1.004 . . . . 0.0 111.371 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.34 -53.83 46.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.424 0.69 . . . . 0.0 111.91 -172.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.62 -12.67 58.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.136 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.07 39.56 84.04 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.427 0.455 . . . . 0.0 111.971 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 pt -119.91 173.98 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 0.0 110.087 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -106.86 102.62 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD22 ' HB1' ' A' ' 44' ' ' ALA . 7.3 tt -88.56 109.47 29.59 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -88.82 83.04 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.772 1.648 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 41' ' ' LEU . 46.4 tp -72.47 -25.35 61.4 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.293 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.52 -36.41 66.69 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.789 0.835 . . . . 0.0 110.94 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -79.12 -47.58 15.84 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.025 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.402 ' HB2' HD12 ' A' ' 57' ' ' LEU . 41.7 m0 -61.01 -51.22 70.17 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.905 0.882 . . . . 0.0 111.384 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -55.13 -44.76 75.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.734 1.214 . . . . 0.0 111.76 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.28 -40.19 96.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.351 0.66 . . . . 0.0 110.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.04 -38.69 92.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.595 0.758 . . . . 0.0 110.852 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.56 -47.16 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.378 0.671 . . . . 0.0 110.601 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.31 -16.3 62.45 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.73 0.812 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -93.51 -8.3 41.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.27 0.628 . . . . 0.0 110.274 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.89 79.73 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 114.281 0.472 . . . . 0.0 114.281 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.41 -55.3 4.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.133 0.573 . . . . 0.0 109.922 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.54 163.66 12.48 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -99.39 157.46 16.4 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.597 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.0 p -61.59 -34.19 75.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.77 0.828 . . . . 0.0 110.4 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.521 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.5 tt0 -49.86 -46.14 51.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 111.633 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.19 -28.81 69.93 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.7 0.8 . . . . 0.0 113.073 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -121.16 0.08 10.06 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 92.0 m-85 -131.81 -31.39 1.53 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.628 0.649 . . . . 0.0 111.403 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 72' ' ' GLU . 86.5 t -65.01 125.24 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 16.2 mt -61.45 -33.35 73.58 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -162.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -65.76 -41.9 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.259 0.349 . . . . 0.0 111.674 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.75 -46.22 38.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 0.0 109.942 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.37 -49.71 63.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.337 1.455 . . . . 0.0 110.771 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.42 64.89 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.546 0.739 . . . . 0.0 111.311 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.51 66.57 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 123.724 0.64 . . . . 0.0 110.259 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -59.91 -43.14 95.04 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.593 0.757 . . . . 0.0 110.761 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.57 -40.21 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.599 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 28.0 t70 -57.21 -31.36 65.39 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.559 0.744 . . . . 0.0 111.889 171.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.91 -42.94 72.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.196 0.31 . . . . 0.0 110.182 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.1 -40.43 90.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.479 0.712 . . . . 0.0 111.735 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 15.9 m -73.72 -29.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.954 0.501 . . . . 0.0 110.906 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.44 86.23 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.342 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -179.397 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 47.9 m . . . . . 0 CA--C 1.55 0.964 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -62.52 -43.38 98.94 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.95 0.5 . . . . 0.0 111.447 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.17 -40.6 98.0 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 11' ' ' ILE . 26.8 mmt180 -61.53 -54.49 42.53 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.001 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 84.1 t -62.13 -35.52 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.191 0.997 . . . . 0.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.93 83.5 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.019 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 96.4 m -59.88 -46.5 89.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.806 0.843 . . . . 0.0 111.64 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 7' ' ' ARG . 38.9 mm -61.33 -50.16 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.805 0.442 . . . . 0.0 110.783 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 HD22 ' A' ' 77' ' ' LEU . 56.2 mt -67.67 -30.25 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 122.968 0.507 . . . . 0.0 110.828 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.08 95.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 10' ' ' THR . 16.6 mm-40 -73.87 -45.71 49.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.838 0.455 . . . . 0.0 111.586 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -66.78 -59.59 3.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.836 0.854 . . . . 0.0 111.447 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 43' ' ' ILE . 64.3 m -92.43 4.63 53.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.31 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.19 67.98 0.91 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.76 1.224 . . . . 0.0 111.515 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.72 120.48 21.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_exo -61.64 148.4 93.11 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.531 2.154 . . . . 0.0 112.84 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -63.16 -28.26 69.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.659 0.784 . . . . 0.0 111.419 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -65.08 -30.35 71.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -93.82 -11.54 31.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 0.0 111.269 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.28 122.58 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.965 0.906 . . . . 0.0 109.838 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.9 p -133.63 161.59 62.81 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 124.332 1.053 . . . . 0.0 108.924 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 -30.52 88.35 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.845 2.363 . . . . 0.0 113.225 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -89.8 -5.36 56.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.885 0.874 . . . . 0.0 112.275 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.3 m -62.33 99.95 0.16 Allowed 'General case' 0 C--N 1.353 0.755 0 C-N-CA 122.964 0.506 . . . . 0.0 110.987 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 58.7 t-80 -73.22 125.38 27.62 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 168.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.04 -53.42 20.27 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.88 0.738 . . . . 0.0 112.35 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.08 -45.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 117.878 0.308 . . . . 0.0 110.985 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.8 t70 -70.44 -74.34 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.216 0.322 . . . . 0.0 111.126 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.49 -53.64 10.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.685 0.394 . . . . 0.0 111.671 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.53 -18.23 59.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.99 79.42 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HD11 ' A' ' 43' ' ' ILE . 82.6 mt -86.05 116.54 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.151 1.38 . . . . 0.0 110.61 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.18 165.16 21.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.918 0.887 . . . . 0.0 109.512 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -56.99 -17.29 9.2 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.739 1.216 . . . . 0.0 113.142 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.92 -45.71 16.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.726 0.81 . . . . 0.0 110.114 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.57 -26.1 60.68 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.596 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.94 -20.75 63.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.27 1.028 . . . . 0.0 111.063 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 57' ' ' LEU . 92.1 mt -57.93 -43.32 86.21 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.962 0.505 . . . . 0.0 110.481 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.66 -36.22 83.04 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.399 1.08 . . . . 0.0 111.336 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.763 HD11 HD13 ' A' ' 35' ' ' ILE . 47.3 mt -62.32 -49.92 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -34.28 77.61 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 124.53 1.144 . . . . 0.0 110.201 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -64.13 -49.68 71.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.27 1.028 . . . . 0.0 110.967 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.4 80.16 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.32 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 84' ' ' ILE . 64.7 mt -69.54 -40.92 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.358 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -60.93 -41.8 96.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.949 0.5 . . . . 0.0 111.343 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.37 -42.27 62.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.443 0.697 . . . . 0.0 111.394 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.55 -58.84 3.99 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.695 0.798 . . . . 0.0 111.031 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.47 -19.9 35.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.697 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.81 56.43 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.435 0.459 . . . . 0.0 111.964 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 pt -120.91 -174.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.082 0.953 . . . . 0.0 111.193 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.21 105.59 11.11 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.16 0.984 . . . . 0.0 108.61 169.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 80' ' ' LEU . 7.3 tt -88.37 102.65 4.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 166.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.64 81.46 2.23 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 110.871 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 41' ' ' LEU . 39.8 tp -71.6 -33.95 69.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.852 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.67 -37.81 76.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.766 0.826 . . . . 0.0 111.043 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.756 0.822 . . . . 0.0 110.523 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -64.29 -40.37 95.8 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.528 0.731 . . . . 0.0 110.97 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.1 m -55.06 -46.01 75.34 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.121 0.969 . . . . 0.0 111.407 171.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.48 -33.11 74.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.98 0.512 . . . . 0.0 111.248 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.89 -46.73 84.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.764 0.426 . . . . 0.0 110.443 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 48.6 t -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.599 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.61 -35.2 75.55 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.973 0.909 . . . . 0.0 113.127 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.28 -8.97 49.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.316 0.646 . . . . 0.0 111.394 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.28 67.95 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 122.358 -0.214 . . . . 0.0 113.623 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.3 mmpt? -73.03 -33.14 65.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.426 0.691 . . . . 0.0 110.216 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -142.25 163.03 33.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.939 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -107.61 158.99 16.79 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.193 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 HG11 ' A' ' 64' ' ' VAL . 28.7 p -58.13 -30.43 66.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.425 0.69 . . . . 0.0 111.494 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 9.1 tm-20 -53.48 -45.05 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.705 0.802 . . . . 0.0 111.146 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' HA ' HD22 ' A' ' 79' ' ' ASN . 58.1 tt0 -65.15 -23.48 67.13 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 4.16 6.55 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -123.78 -27.22 4.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.583 0.629 . . . . 0.0 111.57 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.9 t -64.34 132.68 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 27' ' ' SER . 31.1 mt -59.58 -43.91 93.49 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -169.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.39 -34.39 77.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 123.24 0.337 . . . . 0.0 111.446 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.549 HD22 ' HA ' ' A' ' 73' ' ' GLN . 5.1 m-20 -70.86 -51.61 25.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.05 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 55' ' ' LEU . 48.2 tp -54.47 -44.25 72.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.13 . . . . 0.0 110.886 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.72 81.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.265 1.026 . . . . 0.0 111.669 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.73 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.646 0.591 . . . . 0.0 110.373 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mmm180 -59.88 -42.87 94.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.787 0.835 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.527 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -68.74 -36.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.584 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.3 t70 -58.17 -34.38 70.25 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.985 0.514 . . . . 0.0 111.58 170.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -43.13 85.11 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 58.3 mt -67.19 -40.4 86.53 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.805 0.842 . . . . 0.0 112.124 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 85' ' ' ASP . 31.6 m -75.44 -29.47 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.201 0.6 . . . . 0.0 111.171 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.71 89.66 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.042 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.825 0 C-N-CA 124.376 1.07 . . . . 0.0 112.468 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.3 m . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -67.61 -44.61 77.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.394 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.21 -46.94 65.83 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.985 0.803 . . . . 0.0 111.21 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.63 -43.8 65.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.868 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.88 -41.11 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.814 0.446 . . . . 0.0 110.958 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.13 92.88 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.29 1.036 . . . . 0.0 110.508 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.4 m -56.25 -49.01 75.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 0.0 110.841 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.19 -46.31 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.114 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 43' ' ' ILE . 75.6 mt -62.35 -42.5 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.919 0.888 . . . . 0.0 110.86 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.78 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 0.0 111.918 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.62 -43.32 69.51 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.614 0.766 . . . . 0.0 111.519 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.1 m -65.44 -63.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.376 0.67 . . . . 0.0 111.849 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.66 -1.47 56.84 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.612 0.765 . . . . 0.0 111.577 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.34 77.8 0.28 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.723 1.209 . . . . 0.0 110.89 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 54.5 mt -136.06 132.2 19.13 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.299 1.04 . . . . 0.0 108.8 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.5 135.52 39.57 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.591 2.194 . . . . 0.0 111.488 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' THR . 25.7 mtm180 -71.93 -22.63 61.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.578 0.351 . . . . 0.0 111.866 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.32 -15.06 62.14 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.159 0.584 . . . . 0.0 111.667 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -105.57 -18.83 13.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.001 0.521 . . . . 0.0 110.568 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 87.3 mt -77.77 106.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . 73.8 p -111.84 154.54 44.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.858 0.863 . . . . 0.0 109.478 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 39.2 Cg_endo -64.08 -22.81 67.57 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.279 1.986 . . . . 0.0 111.534 174.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.41 -17.56 51.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.844 0.858 . . . . 0.0 111.415 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.6 t -73.95 150.8 40.57 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.929 0.892 . . . . 0.0 110.724 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.6 t-80 -107.84 134.46 50.76 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.848 1.259 . . . . 0.0 109.151 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.41 -55.03 14.43 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.882 0.873 . . . . 0.0 112.657 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -76.94 -53.88 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 122.165 0.186 . . . . 0.0 110.944 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 29.3 m-20 -65.58 -52.77 49.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -89.38 -59.77 2.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.745 0.418 . . . . 0.0 111.078 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 77' ' ' LEU . 87.3 mt -68.25 -21.44 64.82 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 22.02 65.52 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 123.388 0.43 . . . . 0.0 113.44 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.7 mt -80.9 130.01 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 123.957 0.903 . . . . 0.0 110.013 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -89.34 160.35 16.91 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 50.3 m -59.25 -19.05 42.6 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.308 0.643 . . . . 0.0 112.562 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -76.89 -42.19 40.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.678 0.791 . . . . 0.0 110.872 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.57 -32.71 64.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.215 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 -22.17 65.17 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.67 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 57' ' ' LEU . 95.7 mt -59.5 -42.97 93.39 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.73 -36.03 70.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.406 1.083 . . . . 0.0 110.698 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.491 HD13 HG12 ' A' ' 12' ' ' ILE . 61.3 mt -65.26 -48.32 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.024 0.53 . . . . 0.0 109.879 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.13 83.09 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.955 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -67.87 -40.06 83.64 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.248 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.35 75.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.809 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.78 -38.84 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.95 0.9 . . . . 0.0 110.839 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.35 -43.61 83.59 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.383 0.673 . . . . 0.0 111.096 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -81.54 -26.04 35.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.058 0.943 . . . . 0.0 112.302 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.71 -58.11 3.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.798 0.839 . . . . 0.0 110.651 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -81.9 -27.56 33.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.051 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.13 46.4 7.64 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.68 -175.34 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.511 1.124 . . . . 0.0 110.257 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -120.29 107.56 13.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 163.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -77.94 107.11 4.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 165.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.92 81.34 2.43 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.63 1.553 . . . . 0.0 110.965 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 41' ' ' LEU . 24.4 tp -70.23 -24.23 63.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.308 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.78 -38.3 72.3 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.997 0.919 . . . . 0.0 111.284 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.9 tttp -74.56 -53.57 9.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.067 0.547 . . . . 0.0 109.732 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -60.49 -46.95 88.23 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.055 0.847 . . . . 0.0 111.618 -168.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.3 m -54.28 -48.55 71.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.987 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.65 -33.88 75.93 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.675 0.79 . . . . 0.0 110.811 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 36.7 mm-40 -61.97 -40.57 96.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.856 0.862 . . . . 0.0 110.686 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.78 -45.9 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 122.717 0.407 . . . . 0.0 110.136 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -51.4 -44.08 62.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.96 1.304 . . . . 0.0 112.409 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.03 0.72 41.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.51 19.37 76.24 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 113.596 0.199 . . . . 0.0 113.596 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -75.85 -17.12 59.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.153 0.981 . . . . 0.0 111.922 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -167.24 166.03 15.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.664 1.186 . . . . 0.0 109.07 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.2 t -105.36 162.01 13.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.38 0.672 . . . . 0.0 110.821 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.5 p -65.06 -30.89 71.89 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.816 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.36 -45.54 84.28 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.766 0.427 . . . . 0.0 110.263 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 70' ' ' THR . 25.5 tt0 -60.92 -30.6 70.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 112.042 -171.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.49 -65.01 1.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.563 0.345 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -65.34 -21.58 66.72 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.3 t -62.03 127.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 119.872 1.215 . . . . 0.0 108.057 168.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 33' ' ' LEU . 39.3 mt -65.09 -32.94 74.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -160.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.8 pttp -62.96 -37.21 86.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 172.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 62.6 m-20 -77.15 -44.89 28.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.746 0.818 . . . . 0.0 109.631 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.92 -50.48 61.05 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 110.268 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.35 -30.83 70.75 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.14 -42.09 69.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.666 0.386 . . . . 0.0 110.881 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 16.4 mmm180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.197 0.999 . . . . 0.0 110.433 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.59 -40.04 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.62 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.489 ' HA ' HG22 ' A' ' 88' ' ' VAL . 27.1 t70 -60.39 -33.86 73.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.968 0.507 . . . . 0.0 111.612 172.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -38.38 79.96 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.544 0.528 . . . . 0.0 110.154 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 90.2 mt -66.99 -40.17 87.33 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.631 0.772 . . . . 0.0 112.398 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.9 m -72.54 -33.76 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 120.856 0.36 . . . . 0.0 110.389 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.49 80.35 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.051 1.341 . . . . 0.0 113.051 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.4 m . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -60.88 -53.72 53.86 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.451 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.67 -39.64 81.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.289 0.993 . . . . 0.0 111.847 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -69.83 -47.29 63.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 111.465 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 4' ' ' THR . 99.6 t -64.46 -35.5 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.146 0.578 . . . . 0.0 110.417 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.78 86.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 0.0 110.244 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -54.88 -49.23 71.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.907 1.283 . . . . 0.0 111.392 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 47' ' ' ILE . 34.9 mm -57.2 -52.41 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.775 0.83 . . . . 0.0 110.478 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG12 HD13 ' A' ' 43' ' ' ILE . 72.7 mt -64.93 -38.14 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.737 0.815 . . . . 0.0 111.157 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.34 77.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.052 0.941 . . . . 0.0 112.109 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -71.44 -52.91 15.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.357 0.663 . . . . 0.0 111.65 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -66.35 -45.38 80.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.341 0.656 . . . . 0.0 111.71 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 43' ' ' ILE . 41.7 m -96.36 5.46 50.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.81 26.68 15.72 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.176 0.99 . . . . 0.0 112.428 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.61 124.87 53.7 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.502 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -61.95 135.78 57.43 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.511 2.14 . . . . 0.0 112.412 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HD2' HD12 ' A' ' 23' ' ' ILE . 26.2 mmm-85 -59.91 -29.83 68.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.474 1.109 . . . . 0.0 112.165 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.22 -30.57 71.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.325 0.65 . . . . 0.0 111.647 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -96.05 -7.6 35.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.976 0.511 . . . . 0.0 111.533 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 20' ' ' ARG . 53.2 mt -80.89 123.19 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.247 0.619 . . . . 0.0 109.708 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -124.31 157.4 64.74 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.948 0.899 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.63 -37.38 88.42 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.81 2.34 . . . . 0.0 113.429 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.08 -7.26 58.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.136 0.574 . . . . 0.0 111.645 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -64.19 121.83 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.25 0.62 . . . . 0.0 110.906 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 65.3 t-80 -86.27 127.22 34.73 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.38 -54.75 27.78 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 59.7 mt -66.87 -54.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.015 0.197 . . . . 0.0 110.743 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.0 t70 -69.02 -66.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.35 -173.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.78 -55.63 5.63 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.343 -168.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 77' ' ' LEU . 90.1 mt -75.48 -14.48 60.43 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.161 0.584 . . . . 0.0 112.274 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.36 8.1 87.65 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 122.993 0.183 . . . . 0.0 113.403 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 43' ' ' ILE . 93.8 mt -85.01 99.52 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.873 1.269 . . . . 0.0 110.707 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.71 163.27 16.85 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.954 0.901 . . . . 0.0 110.09 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 t -57.02 -15.97 6.14 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.242 1.017 . . . . 0.0 113.0 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.87 -45.37 13.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 110.298 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.83 -31.34 70.25 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.101 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -67.41 -20.84 65.58 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.397 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.1 mt -57.85 -38.6 75.96 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.108 0.563 . . . . 0.0 111.273 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.22 -41.17 77.4 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.775 0.83 . . . . 0.0 110.854 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 35' ' ' ILE . 73.3 mt -61.7 -49.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.268 175.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -61.31 -40.23 93.41 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.411 -175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -73.59 -34.22 64.98 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.56 64.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.678 0.391 . . . . 0.0 110.934 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 11' ' ' ILE . 91.1 mt -78.23 -38.18 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.504 1.121 . . . . 0.0 110.53 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.64 -40.81 66.15 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.066 0.946 . . . . 0.0 110.278 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -81.48 -50.0 9.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.907 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.56 67.39 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.37 0.668 . . . . 0.0 111.671 -171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.51 -22.62 28.09 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.515 0.726 . . . . 0.0 110.548 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.58 10.96 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.28 -177.23 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.038 0.935 . . . . 0.0 110.659 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 56' ' ' PRO . 87.3 tttt -108.96 113.27 26.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 167.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.438 HD22 ' HB1' ' A' ' 44' ' ' ALA . 5.9 tt -103.79 96.62 9.38 Favored Pre-proline 0 C--O 1.243 0.746 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HB3' ' HE2' ' A' ' 54' ' ' LYS . 97.3 Cg_endo -83.03 84.05 1.82 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.98 1.787 . . . . 0.0 111.334 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.0 -28.45 69.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.33 -37.76 70.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.369 1.068 . . . . 0.0 111.049 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.2 tttp -80.51 -49.12 11.79 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 124.33 1.052 . . . . 0.0 110.321 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -59.02 -43.83 91.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.012 0.925 . . . . 0.0 111.008 -174.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -65.39 -40.53 93.59 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.676 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.71 -33.73 76.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.575 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 43.7 mm-40 -59.27 -38.27 79.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.306 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG11 HG23 ' A' ' 71' ' ' THR . 40.1 t -72.03 -45.38 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.161 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -59.52 -29.43 67.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.764 1.226 . . . . 0.0 112.639 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -99.3 -14.28 19.29 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.627 0.771 . . . . 0.0 111.051 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.31 63.85 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 116.607 -0.269 . . . . 0.0 113.308 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.28 -30.09 65.86 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 0.0 111.35 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 172.17 18.61 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.574 0.75 . . . . 0.0 111.098 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -108.6 154.07 22.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.866 0.866 . . . . 0.0 110.413 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG11 ' A' ' 64' ' ' VAL . 34.0 p -61.78 -28.58 69.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.381 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.2 tt0 -56.14 -44.93 79.68 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.532 0.733 . . . . 0.0 111.663 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.471 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -66.77 -21.73 66.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 122.776 0.431 . . . . 0.0 111.252 -174.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -104.36 -76.68 0.59 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.89 0.476 . . . . 0.0 110.952 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.4 m-85 -60.28 -24.14 64.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -165.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 91.9 t -63.14 127.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 119.195 0.907 . . . . 0.0 108.751 172.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 33' ' ' LEU . 26.3 mt -61.82 -36.94 82.61 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -162.077 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -68.12 -35.83 78.76 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.471 HD22 ' HA ' ' A' ' 73' ' ' GLN . 3.5 m-20 -72.3 -45.21 60.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.892 0.877 . . . . 0.0 110.52 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -53.93 -46.43 71.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.122 1.769 . . . . 0.0 111.349 170.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.66 71.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.156 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.05 61.68 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.689 0.618 . . . . 0.0 110.963 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -59.52 -47.88 83.8 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.971 0.909 . . . . 0.0 111.75 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.6 -38.35 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.769 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.05 -37.56 64.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.602 0.761 . . . . 0.0 111.643 169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.44 -38.05 68.4 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.229 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.17 -40.58 94.48 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.526 0.73 . . . . 0.0 111.841 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 m -78.82 -20.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.58 73.96 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 124.392 1.077 . . . . 0.0 113.107 178.522 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.0 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -64.11 -46.38 84.42 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.259 0.223 . . . . 0.0 111.356 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.99 -42.31 80.02 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.076 0.86 . . . . 0.0 111.093 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -63.56 -52.12 62.44 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.165 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.7 -38.81 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.373 0.669 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.47 -44.92 85.66 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.026 0.931 . . . . 0.0 110.126 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.0 m -56.62 -43.6 80.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.365 1.066 . . . . 0.0 112.041 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.425 HG21 HG13 ' A' ' 47' ' ' ILE . 32.7 mm -59.3 -55.25 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.609 0.763 . . . . 0.0 110.394 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.72 -35.14 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.196 0.935 . . . . 0.0 111.429 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -52.69 64.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.168 0.987 . . . . 0.0 111.728 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.2 -25.81 33.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 43' ' ' ILE . 19.0 p -73.96 -63.03 1.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.188 0.449 . . . . 0.0 110.801 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 43' ' ' ILE . 57.7 m -92.42 7.98 40.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.278 -171.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.1 30.87 20.76 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.454 1.102 . . . . 0.0 112.241 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 33' ' ' LEU . 62.9 mt -86.55 129.69 52.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 118.59 4.58 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.133 2.555 . . . . 0.0 112.375 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.2 tpt85 -57.83 -37.44 73.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.724 1.61 . . . . 0.0 111.727 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 9.1 pt-20 -63.1 -38.77 92.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.379 0.672 . . . . 0.0 111.539 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.24 -15.49 40.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.158 0.583 . . . . 0.0 112.236 -174.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.88 110.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.926 0.491 . . . . 0.0 110.142 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.1 p -112.69 154.23 44.82 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 59.6 Cg_exo -55.15 -36.66 93.62 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.108 2.539 . . . . 0.0 112.371 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.51 -28.01 62.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.413 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.5 p -70.37 137.03 50.19 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.889 0.476 . . . . 0.0 111.209 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 60.8 t-80 -89.7 130.17 36.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.667 1.187 . . . . 0.0 108.774 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.09 -59.95 3.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.741 0.816 . . . . 0.0 112.648 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.78 -48.86 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.1 t70 -69.89 -61.28 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.664 -173.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.72 -54.62 5.46 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.789 0.436 . . . . 0.0 110.9 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 77' ' ' LEU . 80.4 mt -82.36 -14.09 55.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.151 0.581 . . . . 0.0 112.042 -170.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.21 14.05 82.23 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 122.804 0.24 . . . . 0.0 113.511 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.69 115.25 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.83 0.852 . . . . 0.0 110.264 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -76.83 165.55 24.55 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.5 m -66.29 -18.04 65.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.464 0.575 . . . . 0.0 111.63 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.22 -38.27 19.14 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.833 0.853 . . . . 0.0 109.852 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.26 -26.82 64.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.545 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.48 -21.43 52.87 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.913 0.885 . . . . 0.0 110.612 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 57' ' ' LEU . 85.7 mt -55.44 -36.7 66.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.166 0.439 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -69.51 -39.45 77.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.544 1.138 . . . . 0.0 110.668 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 16' ' ' CYS . 58.8 mt -64.82 -51.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.625 0.77 . . . . 0.0 110.224 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.49 87.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.316 1.047 . . . . 0.0 110.624 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.1 -41.47 90.55 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.068 0.855 . . . . 0.0 110.332 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.27 76.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 111.336 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG13 HG21 ' A' ' 11' ' ' ILE . 84.2 mt -67.79 -39.26 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.336 1.054 . . . . 0.0 110.748 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -56.58 -44.54 81.14 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.019 0.528 . . . . 0.0 110.698 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.87 -29.97 50.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.011 0.924 . . . . 0.0 111.789 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.01 -58.45 3.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.663 0.785 . . . . 0.0 110.879 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HB2' HG12 ' A' ' 53' ' ' ILE . 52.0 m-85 -84.37 -20.36 32.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.732 0.813 . . . . 0.0 111.15 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.0 18.97 66.18 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.407 0.442 . . . . 0.0 112.42 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 51' ' ' PHE . 29.5 pt -105.51 -176.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.423 1.089 . . . . 0.0 110.971 -172.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -116.47 111.55 20.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.304 0.641 . . . . 0.0 109.529 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -102.14 103.07 27.79 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 68.6 Cg_endo -86.23 84.94 1.06 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.002 1.801 . . . . 0.0 111.671 174.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 41' ' ' LEU . 59.9 tp -62.71 -34.78 77.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.812 0.845 . . . . 0.0 110.101 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.91 -36.53 77.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.3 1.04 . . . . 0.0 111.193 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 33.9 ttpt -77.67 -44.4 28.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.625 0.77 . . . . 0.0 110.004 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.409 ' O ' HG23 ' A' ' 64' ' ' VAL . 44.2 m0 -58.36 -47.48 83.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.997 . . . . 0.0 110.959 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.4 m -63.74 -34.92 78.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.987 0.915 . . . . 0.0 111.021 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.264 1.025 . . . . 0.0 111.287 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.52 -33.53 76.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.416 0.686 . . . . 0.0 110.388 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 84.8 t -67.35 -44.09 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.436 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.26 -32.93 73.7 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.044 0.938 . . . . 0.0 112.458 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -90.71 -12.22 37.32 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.448 1.099 . . . . 0.0 111.371 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.15 16.88 55.05 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 116.931 -0.122 . . . . 0.0 113.37 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.04 -23.4 21.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -147.9 158.53 44.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.123 0.569 . . . . 0.0 110.672 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -95.62 159.95 14.74 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.134 0.574 . . . . 0.0 109.778 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.0 p -62.47 -31.27 71.97 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.954 0.502 . . . . 0.0 109.649 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HA ' HG23 ' A' ' 76' ' ' VAL . 31.5 tt0 -54.98 -50.48 68.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.961 0.904 . . . . 0.0 111.112 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -55.95 -30.03 61.07 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.285 1.034 . . . . 0.0 112.404 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 80' ' ' LEU . 42.1 m-85 -104.31 -77.43 0.58 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.717 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 97.6 m-85 -56.42 -27.99 58.16 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -166.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.7 t -65.3 124.37 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.106 1.321 . . . . 0.0 108.413 170.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 33' ' ' LEU . 25.5 mt -63.62 -32.47 73.95 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -159.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 21.0 pttp -67.61 -37.37 82.43 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.756 0.312 . . . . 0.0 111.263 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.1 m-20 -75.97 -42.9 47.03 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 123.509 0.723 . . . . 0.0 109.832 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 50.3 tp -52.2 -48.39 65.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.332 1.453 . . . . 0.0 110.843 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.78 71.86 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.893 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.78 -39.88 50.07 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.992 0.808 . . . . 0.0 111.61 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 23.3 mmm180 -61.37 -45.3 94.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.83 0.852 . . . . 0.0 111.057 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -70.87 -38.54 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.095 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' A' ' 88' ' ' VAL . 38.3 t70 -56.44 -34.68 67.06 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.962 0.905 . . . . 0.0 112.35 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 8.1 tp10 -63.3 -47.4 82.43 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.837 0.711 . . . . 0.0 110.356 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 51.7 mt -65.73 -40.9 92.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.03 0.932 . . . . 0.0 111.548 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.8 m -78.08 -26.23 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 122.841 0.456 . . . . 0.0 111.49 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.8 72.98 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.79 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 O-C-N 123.741 0.651 . . . . 0.0 112.505 176.305 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -71.07 -41.41 70.74 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.304 0.641 . . . . 0.0 110.691 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.65 -51.84 26.22 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.177 0.991 . . . . 0.0 112.072 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -73.01 -43.53 62.02 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.425 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.76 -40.01 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.163 0.585 . . . . 0.0 110.847 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.79 77.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.995 . . . . 0.0 110.042 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -58.28 -41.43 84.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.05 0.94 . . . . 0.0 111.91 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.506 HG21 HG13 ' A' ' 47' ' ' ILE . 21.7 mm -58.74 -53.32 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.537 0.735 . . . . 0.0 110.658 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.16 -33.12 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.036 0.934 . . . . 0.0 111.195 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -53.78 50.26 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 111.537 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -68.93 -37.58 78.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.145 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -72.48 -63.79 1.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.894 0.478 . . . . 0.0 110.64 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.718 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.5 m -91.43 12.27 21.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 61.39 21.6 12.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.978 0.911 . . . . 0.0 112.079 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.5 mt -87.6 121.78 70.84 Favored Pre-proline 0 N--CA 1.479 0.996 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.173 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.06 133.55 55.72 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.158 1.906 . . . . 0.0 112.422 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -55.23 -33.02 62.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.442 1.097 . . . . 0.0 110.968 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.49 -35.02 79.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.156 . . . . 0.0 112.208 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -85.71 -19.21 31.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.885 0.474 . . . . 0.0 111.357 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -71.5 112.15 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.056 0.542 . . . . 0.0 110.431 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.1 p -115.9 146.47 37.03 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.187 0.995 . . . . 0.0 109.464 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -33.41 73.69 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.808 2.338 . . . . 0.0 112.911 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.43 -6.65 58.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.913 0.885 . . . . 0.0 111.835 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.4 t -74.87 146.84 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.306 1.042 . . . . 0.0 110.648 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 63.8 t-80 -103.01 134.26 46.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.718 1.207 . . . . 0.0 108.489 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.15 -58.64 5.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.555 0.742 . . . . 0.0 112.192 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -72.75 -57.3 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.5 t70 -64.58 -47.22 79.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.202 1.001 . . . . 0.0 112.841 -170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -96.54 -58.17 2.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.559 0.344 . . . . 0.0 111.298 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 90.4 mt -72.01 -27.58 62.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.994 0.518 . . . . 0.0 111.814 -175.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 15.82 62.37 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-O 120.084 -0.287 . . . . 0.0 113.322 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.04 123.76 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.449 0.7 . . . . 0.0 109.454 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.97 148.05 36.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -58.42 -16.38 14.62 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.678 0.791 . . . . 0.0 111.707 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.12 -51.99 18.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.343 1.057 . . . . 0.0 110.199 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -71.06 -27.18 63.46 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.347 0.659 . . . . 0.0 111.101 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.37 -22.23 66.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 57' ' ' LEU . 90.0 mt -58.6 -38.58 78.28 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.216 0.606 . . . . 0.0 111.131 174.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.07 -28.54 48.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.231 0.612 . . . . 0.0 111.246 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 ' SG ' ' A' ' 16' ' ' CYS . 57.1 mt -62.82 -49.01 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.57 -32.62 74.3 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.129 -177.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.38 -43.2 77.85 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.918 0.762 . . . . 0.0 110.525 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.14 73.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.657 0.783 . . . . 0.0 111.723 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 HG21 ' A' ' 11' ' ' ILE . 89.6 mt -67.45 -40.29 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.778 0.831 . . . . 0.0 110.617 176.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -54.26 -46.6 72.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.289 0.636 . . . . 0.0 110.399 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.71 -50.99 38.35 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.096 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -64.47 -55.83 18.19 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.13 0.972 . . . . 0.0 112.379 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -80.22 -20.44 44.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.753 0.821 . . . . 0.0 111.863 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.33 41.04 39.04 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.48 175.73 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.089 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -114.9 92.72 4.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 167.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.3 tt -74.53 114.29 32.5 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -89.03 83.97 0.6 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.193 1.929 . . . . 0.0 111.311 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 41' ' ' LEU . 37.4 tp -73.19 -28.31 62.13 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.45 -33.42 73.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.409 0.684 . . . . 0.0 110.746 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -73.38 -50.66 20.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.319 1.048 . . . . 0.0 110.261 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -63.1 -45.91 89.85 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.654 0.782 . . . . 0.0 111.837 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 m -61.72 -38.06 86.51 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.924 0.889 . . . . 0.0 110.954 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -63.92 -43.56 95.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.99 0.916 . . . . 0.0 110.686 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.81 -32.6 74.37 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.582 0.753 . . . . 0.0 110.798 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 55.6 t -68.33 -51.78 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.347 0.659 . . . . 0.0 111.215 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.07 -22.01 64.95 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.518 0.727 . . . . 0.0 112.414 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.43 -12.89 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.842 1.257 . . . . 0.0 110.747 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 21.06 58.54 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.114 -0.494 . . . . 0.0 114.242 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -90.35 -54.48 3.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -105.09 156.6 17.92 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.522 1.129 . . . . 0.0 110.64 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -100.07 159.15 15.32 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.52 0.728 . . . . 0.0 109.92 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.5 p -68.23 -29.57 68.42 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 35.8 tt0 -58.21 -44.39 88.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.991 0.517 . . . . 0.0 111.034 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -58.3 -30.93 67.03 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.705 0.802 . . . . 0.0 112.109 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -104.19 -77.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 59.9 m-85 -55.91 -24.1 35.52 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -163.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 87.0 t -61.11 124.28 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 119.732 1.151 . . . . 0.0 108.25 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -60.51 -37.72 82.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.763 0.825 . . . . 0.0 112.935 -161.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.6 pttp -70.1 -36.35 74.8 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.501 0.501 . . . . 0.0 112.097 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -70.86 -44.45 66.36 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.895 0.878 . . . . 0.0 110.193 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 tp -53.06 -47.42 68.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.54 1.536 . . . . 0.0 110.672 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.04 66.71 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.666 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.5 49.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.762 0.425 . . . . 0.0 110.619 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -59.49 -43.58 93.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.215 1.006 . . . . 0.0 111.479 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.91 -39.19 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.289 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.5 t70 -54.09 -37.86 64.72 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.277 0.631 . . . . 0.0 111.518 170.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 -41.42 81.13 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.88 -42.97 94.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.462 0.705 . . . . 0.0 112.313 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.8 m -74.0 -26.6 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 122.791 0.436 . . . . 0.0 110.564 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.6 -36.46 65.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.619 0.368 . . . . 0.0 110.541 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.458 0 C-N-CA 124.655 1.182 . . . . 0.0 113.322 177.875 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 38.9 m . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 111.115 0.043 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.33 -41.68 93.7 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.376 0.422 . . . . 0.0 111.35 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.51 -42.6 92.59 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.559 0.695 . . . . 0.0 111.059 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.495 ' O ' HG12 ' A' ' 11' ' ' ILE . 23.7 mmt180 -71.29 -44.8 64.5 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.325 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 77.3 t -57.73 -41.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.312 0.577 . . . . 0.0 110.522 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.66 97.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.225 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -75.35 -30.35 60.22 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.76 0.254 . . . . 0.0 111.411 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 47' ' ' ILE . 28.7 mm -61.61 -52.93 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.77 -32.07 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.921 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.46 69.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.597 0.759 . . . . 0.0 111.411 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.13 -53.82 7.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.253 0.621 . . . . 0.0 112.611 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -63.65 -51.52 64.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.795 0.838 . . . . 0.0 111.306 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -90.29 2.19 55.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.507 0.723 . . . . 0.0 111.798 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.88 21.73 13.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.232 1.013 . . . . 0.0 112.697 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.9 132.63 67.26 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 122.983 0.513 . . . . 0.0 110.636 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.0 122.22 11.3 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.0 2.467 . . . . 0.0 112.452 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -61.82 -30.22 70.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.0 1.32 . . . . 0.0 111.342 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -63.34 -28.81 70.26 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.338 1.055 . . . . 0.0 112.355 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.425 HG23 ' HG3' ' A' ' 21' ' ' GLU . 34.9 p -100.35 -2.24 34.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.703 0.801 . . . . 0.0 111.381 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.92 113.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 0.0 109.825 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -119.6 160.41 42.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.18 -25.58 77.13 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.71 -13.02 58.37 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 111.53 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 70.4 m -65.06 112.22 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.481 0.713 . . . . 0.0 111.597 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 60.8 t-80 -76.88 127.27 32.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.8 -50.39 56.31 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.3 mt -76.95 -55.06 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 122.555 0.342 . . . . 0.0 111.244 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.0 t70 -71.15 -43.49 67.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.45 0.7 . . . . 0.0 112.607 -170.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -96.78 -55.68 2.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.235 0.614 . . . . 0.0 111.331 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 77' ' ' LEU . 85.0 mt -76.05 -24.24 55.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.271 0.629 . . . . 0.0 111.596 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.88 6.0 80.23 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.821 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.73 130.18 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.358 1.063 . . . . 0.0 110.815 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.59 162.76 13.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.94 . . . . 0.0 108.869 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.8 p -46.65 -34.18 4.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.265 1.426 . . . . 0.0 113.519 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.56 -36.46 52.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.698 0.799 . . . . 0.0 110.866 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.14 -40.51 74.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.989 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.57 -21.03 64.55 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.332 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.9 mt -55.56 -48.95 73.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.278 0.631 . . . . 0.0 110.95 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.23 -31.7 70.44 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.448 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.68 -45.91 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.121 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.15 79.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.874 0.734 . . . . 0.0 110.941 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.924 . . . . 0.0 110.835 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -30.7 71.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.482 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 11' ' ' ILE . 93.3 mt -70.65 -42.04 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.492 0.717 . . . . 0.0 110.838 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -55.21 -40.72 71.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.721 0.808 . . . . 0.0 111.536 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.65 -51.23 10.17 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.351 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.01 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.404 0.682 . . . . 0.0 111.924 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -83.95 -17.21 41.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.057 0.543 . . . . 0.0 111.07 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.56 47.49 62.02 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.36 -175.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.685 0.794 . . . . 0.0 112.094 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -122.39 94.88 4.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.05 1.34 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.54 111.86 37.72 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -87.1 81.54 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.079 1.852 . . . . 0.0 111.855 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.15 -30.41 66.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.939 0.496 . . . . 0.0 110.446 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.05 -38.82 65.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.121 0.968 . . . . 0.0 111.315 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.7 ttpt -80.98 -46.38 15.17 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.205 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -55.85 -51.1 68.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.855 0.862 . . . . 0.0 110.975 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.6 m -56.87 -47.11 81.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.402 1.081 . . . . 0.0 111.904 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -63.22 -45.25 92.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.863 0.865 . . . . 0.0 111.621 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 23.1 mm-40 -70.72 -37.19 73.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.027 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.4 t -67.29 -42.93 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.14 -20.96 64.94 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.542 0.737 . . . . 0.0 112.222 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.96 -7.52 42.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.454 0.702 . . . . 0.0 110.756 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.32 87.48 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.565 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 30.3 mmtp -68.91 -25.31 64.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.972 0.909 . . . . 0.0 110.934 175.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 166.19 30.26 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.734 0.813 . . . . 0.0 110.3 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 73' ' ' GLN . 6.1 t -105.1 151.72 23.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.784 0.834 . . . . 0.0 109.863 174.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.9 p -58.42 -34.63 70.99 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.497 0.719 . . . . 0.0 110.404 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.7 tt0 -55.68 -42.03 74.54 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.582 1.153 . . . . 0.0 111.785 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 70' ' ' THR . 29.5 tt0 -62.11 -29.79 70.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.874 0.869 . . . . 0.0 111.755 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 83' ' ' ARG . 60.9 m-85 -104.05 -78.41 0.56 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.014 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.3 m-85 -51.06 -29.31 12.51 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -165.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 66.1 t -62.33 125.83 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.819 1.191 . . . . 0.0 108.409 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 33' ' ' LEU . 23.1 mt -59.65 -35.13 73.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -163.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -63.24 -39.82 95.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 120.838 0.351 . . . . 0.0 111.431 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -79.73 -40.59 28.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.223 1.009 . . . . 0.0 110.466 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.67 -47.55 73.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.419 1.488 . . . . 0.0 110.288 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.51 72.73 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.81 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.36 -43.92 66.01 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.439 0.462 . . . . 0.0 111.086 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 22.9 mmm180 -62.6 -42.75 99.76 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.754 0.822 . . . . 0.0 111.357 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.25 -37.92 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.512 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 88' ' ' VAL . 29.9 t70 -58.55 -36.52 74.02 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.203 0.601 . . . . 0.0 111.246 170.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.01 -44.73 83.91 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -61.98 -45.56 93.08 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.868 0.867 . . . . 0.0 112.371 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 85' ' ' ASP . 22.3 m -71.59 -34.36 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 122.851 0.461 . . . . 0.0 110.948 -177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.7 60.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.679 0.392 . . . . 0.0 110.689 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 C-N-CA 123.529 0.731 . . . . 0.0 112.932 -179.607 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.1 m . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.68 -46.31 82.94 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.335 0.397 . . . . 0.0 110.884 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.35 -42.52 82.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 123.894 0.746 . . . . 0.0 111.299 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 11' ' ' ILE . 31.2 mmm-85 -70.12 -47.18 62.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.264 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -58.4 -39.21 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.305 0.574 . . . . 0.0 110.698 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.999 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 t -69.64 -25.44 63.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.587 0.355 . . . . 0.0 111.524 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 47' ' ' ILE . 34.2 mm -61.99 -58.0 9.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.2 -30.13 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.89 0.744 . . . . 0.0 110.95 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.17 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.431 1.092 . . . . 0.0 111.622 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 -29.54 56.06 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.135 0.574 . . . . 0.0 112.17 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.5 m -79.79 -60.23 2.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.803 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 43' ' ' ILE . 42.9 m -90.44 -3.95 57.33 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 60.7 69.88 0.65 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.875 0.87 . . . . 0.0 110.129 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -133.51 116.32 13.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 23.8 Cg_endo -58.74 145.66 95.21 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.868 2.379 . . . . 0.0 112.313 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HD2' HD12 ' A' ' 23' ' ' ILE . 55.6 mmm-85 -62.67 -25.32 68.09 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.343 1.057 . . . . 0.0 112.249 -175.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 17.1 pt-20 -61.12 -41.27 96.4 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.82 -12.71 47.16 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 111.48 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 20' ' ' ARG . 76.0 mt -83.6 104.68 12.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.2 p -120.45 153.39 56.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.284 1.034 . . . . 0.0 109.335 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.0 -30.15 82.73 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.64 2.226 . . . . 0.0 112.752 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.42 -15.78 58.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.3 t -66.46 134.86 53.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.942 0.497 . . . . 0.0 110.165 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 20.5 t-80 -103.27 134.7 46.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.279 . . . . 0.0 108.054 174.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.47 -58.47 6.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.169 0.588 . . . . 0.0 112.358 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.89 -49.02 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.0 t70 -72.67 -37.38 67.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.646 0.778 . . . . 0.0 112.663 -170.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -107.64 -56.89 2.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.976 0.51 . . . . 0.0 110.814 -172.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 77' ' ' LEU . 91.5 mt -72.58 -20.39 61.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.771 0.829 . . . . 0.0 111.91 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.54 8.78 87.49 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.213 0.32 . . . . 0.0 113.054 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 43' ' ' ILE . 79.5 mt -72.79 106.56 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.222 1.009 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.2 159.29 7.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.645 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -62.15 -15.56 46.79 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.354 0.662 . . . . 0.0 111.009 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.97 -44.98 21.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.486 1.114 . . . . 0.0 110.376 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.4 -26.82 62.01 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.29 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -73.0 -20.72 60.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.434 1.094 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -55.99 -42.42 76.33 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.175 0.59 . . . . 0.0 110.4 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.08 -33.64 68.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.936 1.294 . . . . 0.0 110.793 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 35' ' ' ILE . 58.0 mt -65.09 -48.2 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.204 0.602 . . . . 0.0 109.624 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.85 76.79 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.003 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.05 -49.51 64.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.427 1.08 . . . . 0.0 111.081 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.76 72.84 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.079 0.552 . . . . 0.0 111.849 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 11' ' ' ILE . 80.0 mt -67.78 -44.19 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 124.156 0.983 . . . . 0.0 110.135 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.34 -45.01 65.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.144 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -70.49 -50.7 35.26 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -60.04 -55.08 38.43 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.15 0.98 . . . . 0.0 112.301 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.47 ' HB2' HG12 ' A' ' 53' ' ' ILE . 90.4 m-85 -82.05 -22.54 36.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.048 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.89 29.27 57.51 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 51' ' ' PHE . 31.9 pt -113.38 162.34 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.204 1.002 . . . . 0.0 109.632 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -95.1 103.45 15.3 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.87 115.93 62.23 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.26 81.8 0.69 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.227 1.951 . . . . 0.0 112.224 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 41' ' ' LEU . 48.9 tp -73.29 -32.39 64.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.29 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.17 -34.83 72.57 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.293 0.637 . . . . 0.0 111.186 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.94 -46.64 51.33 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.85 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -62.8 -46.83 86.14 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.704 0.802 . . . . 0.0 111.303 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.7 m -56.41 -45.56 80.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.819 1.248 . . . . 0.0 111.269 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -64.03 -38.49 91.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.889 0.876 . . . . 0.0 110.975 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.4 -33.74 76.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.668 0.787 . . . . 0.0 110.751 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.95 -43.9 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.847 0.459 . . . . 0.0 110.433 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -56.2 -39.25 72.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.623 0.769 . . . . 0.0 112.65 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -84.24 -3.72 58.38 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.21 19.35 79.82 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 117.973 0.351 . . . . 0.0 113.178 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -82.18 -58.96 2.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.361 0.665 . . . . 0.0 109.668 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.63 161.72 15.11 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.054 0.941 . . . . 0.0 110.211 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.2 p -105.74 165.34 11.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.893 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.8 p -65.08 -29.95 70.86 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.203 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.79 -44.84 93.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.662 0.785 . . . . 0.0 111.642 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.68 -33.01 69.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.301 0.64 . . . . 0.0 112.291 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.0 -64.76 1.18 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 31.8 m-85 -61.78 -21.79 64.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -167.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.5 t -62.13 129.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.614 1.097 . . . . 0.0 108.424 170.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 33' ' ' LEU . 32.0 mt -60.8 -38.41 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -165.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.0 pttp -64.52 -38.22 90.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.1 m-20 -69.71 -48.92 57.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.57 0.748 . . . . 0.0 110.172 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.7 tp -52.08 -48.51 64.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.774 1.63 . . . . 0.0 110.825 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.1 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.72 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.38 64.75 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.458 0.474 . . . . 0.0 111.306 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 30.1 mmm180 -60.99 -40.6 94.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.698 0.799 . . . . 0.0 111.492 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.482 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -74.61 -42.52 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.417 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -51.95 -38.28 55.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.076 0.95 . . . . 0.0 111.294 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -66.08 -44.86 83.21 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.951 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.21 -38.83 82.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.725 0.81 . . . . 0.0 112.08 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.01 -31.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.82 92.06 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.027 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.807 0 O-C-N 124.325 1.015 . . . . 0.0 112.906 178.635 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 8' ' ' VAL . 53.5 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 119.844 -0.122 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -60.83 -42.64 98.15 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.805 0.69 . . . . 0.0 111.517 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.63 -40.73 84.18 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.867 0.73 . . . . 0.0 111.271 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' O ' HG12 ' A' ' 11' ' ' ILE . 19.6 mmt180 -75.81 -39.18 57.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.128 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 4' ' ' THR . 94.5 t -60.4 -39.38 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.565 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.05 88.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.519 1.127 . . . . 0.0 111.054 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -69.35 -31.76 70.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.223 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -59.09 -53.64 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.1 mt -61.03 -38.21 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.972 0.909 . . . . 0.0 111.092 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.81 68.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.74 0.816 . . . . 0.0 111.345 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.29 -40.53 64.49 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.774 0.83 . . . . 0.0 112.568 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 43' ' ' ILE . 18.1 p -76.86 -58.41 3.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.06 0.544 . . . . 0.0 111.416 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 35' ' ' ILE . 48.4 t -84.79 -0.97 55.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.829 0.852 . . . . 0.0 112.426 -172.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.55 45.19 16.65 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.22 1.008 . . . . 0.0 112.069 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.34 130.76 23.49 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.843 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.9 128.33 28.32 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.543 2.162 . . . . 0.0 111.464 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 tpt85 -56.72 -36.72 70.04 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.014 0.926 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -32.64 74.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.652 1.181 . . . . 0.0 112.614 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -82.74 -10.05 59.07 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 122.556 0.342 . . . . 0.0 111.717 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.61 110.39 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.268 0.627 . . . . 0.0 110.035 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.7 p -117.39 148.77 43.42 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.359 1.064 . . . . 0.0 109.54 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -51.29 -41.4 58.86 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.976 2.451 . . . . 0.0 113.833 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.01 -16.64 59.24 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.984 -172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 33.5 t -63.43 132.16 50.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.567 0.747 . . . . 0.0 110.672 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 59.2 t-80 -89.87 128.48 36.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.57 -64.15 0.88 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.696 0.799 . . . . 0.0 112.475 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.06 -35.79 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.2 t70 -82.32 -67.99 0.74 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.521 0.328 . . . . 0.0 111.114 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.39 -51.37 17.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.305 0.642 . . . . 0.0 110.776 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 77' ' ' LEU . 87.6 mt -81.84 -18.34 44.28 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.423 0.689 . . . . 0.0 111.546 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.48 36.86 78.07 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.191 0.307 . . . . 0.0 113.809 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 16' ' ' CYS . 54.7 mt -85.16 133.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.935 0.894 . . . . 0.0 109.691 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.25 154.21 31.2 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -66.22 -17.94 65.05 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.641 0.376 . . . . 0.0 110.374 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.06 -42.65 18.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 109.901 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.08 -32.97 73.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.92 -21.32 65.99 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.007 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 57' ' ' LEU . 90.3 mt -59.47 -35.91 74.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.085 0.554 . . . . 0.0 111.816 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.01 -35.55 56.95 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.333 0.653 . . . . 0.0 110.221 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 16' ' ' CYS . 55.1 mt -60.29 -50.61 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -66.87 -32.76 74.23 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.831 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -69.43 -40.12 77.43 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.15 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.78 70.13 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 11' ' ' ILE . 87.7 mt -66.96 -40.64 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.076 0.95 . . . . 0.0 110.743 173.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.28 -45.39 87.99 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.231 0.612 . . . . 0.0 110.941 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -80.82 -27.36 36.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.546 0.738 . . . . 0.0 112.63 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.41 -53.7 5.52 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.166 0.587 . . . . 0.0 110.495 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -87.62 -23.83 24.15 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.962 0.905 . . . . 0.0 111.201 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.34 39.72 30.36 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.06 -177.99 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 0.0 110.26 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -124.71 109.12 12.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.69 106.46 18.76 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.09 82.89 2.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 121.778 1.652 . . . . 0.0 111.693 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 41' ' ' LEU . 57.2 tp -69.11 -34.92 75.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.904 -174.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.75 -36.97 70.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.285 1.034 . . . . 0.0 110.976 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 ttpp -87.77 -34.74 18.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.908 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -62.52 -43.86 97.79 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.505 0.722 . . . . 0.0 110.969 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.9 m -63.98 -33.5 75.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.931 0.892 . . . . 0.0 110.604 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -72.48 -29.83 64.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.358 0.663 . . . . 0.0 111.585 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 30.8 mm-40 -58.46 -39.93 81.26 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.55 0.69 . . . . 0.0 109.475 171.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 44.0 t -69.03 -47.34 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.46 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -57.51 -44.05 84.71 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.034 0.934 . . . . 0.0 112.612 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -86.1 -13.67 46.55 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.003 0.921 . . . . 0.0 111.321 -175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.88 61.53 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 113.804 0.282 . . . . 0.0 113.804 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.81 -34.84 79.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.45 0.7 . . . . 0.0 110.336 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -158.57 171.23 20.5 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.877 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.9 p -100.83 157.74 16.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.809 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.63 -32.09 68.71 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.448 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' A' ' 76' ' ' VAL . 45.1 tt0 -55.87 -41.56 74.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.095 1.358 . . . . 0.0 111.682 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.58 -21.7 64.5 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.898 0.879 . . . . 0.0 112.584 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -121.46 -6.38 9.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 82.0 m-85 -126.9 -26.9 3.1 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.595 -0.716 . . . . 0.0 112.805 -172.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 58.0 t -61.26 126.44 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 167.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 33' ' ' LEU . 36.9 mt -59.07 -35.43 73.35 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.089 0.868 . . . . 0.0 112.642 -161.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -69.85 -36.4 75.52 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 80.8 m-20 -71.43 -48.31 50.36 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.116 0.966 . . . . 0.0 110.235 177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.9 tp -50.44 -50.74 51.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 110.987 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.12 61.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.826 0.851 . . . . 0.0 111.696 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.29 56.43 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.563 0.539 . . . . 0.0 110.384 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 24.1 mmm180 -70.65 -32.2 69.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.298 0.639 . . . . 0.0 111.486 175.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.34 -39.55 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 88' ' ' VAL . 34.7 t70 -58.2 -37.94 75.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.689 . . . . 0.0 111.567 170.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 7.5 tp10 -59.08 -47.79 83.95 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.189 0.995 . . . . 0.0 110.196 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.8 mt -67.6 -41.11 84.58 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.034 0.934 . . . . 0.0 113.112 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 85' ' ' ASP . 17.3 m -75.73 -28.4 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.997 -0.439 . . . . 0.0 111.032 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.67 56.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 C-N-CA 123.274 0.63 . . . . 0.0 112.462 170.968 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 85' ' ' ASP . 7.8 m . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -68.32 -46.31 70.58 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.65 -42.15 70.96 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.39 0.676 . . . . 0.0 111.057 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.405 ' O ' HG12 ' A' ' 11' ' ' ILE . 4.9 mmp_? -60.88 -58.03 10.14 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.473 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.23 -37.67 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.297 1.039 . . . . 0.0 111.528 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -68.01 -43.08 79.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.647 1.179 . . . . 0.0 110.657 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -62.01 -40.95 97.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.452 0.701 . . . . 0.0 111.395 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 7' ' ' ARG . 42.0 mm -61.98 -50.81 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.298 0.639 . . . . 0.0 110.579 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.56 -34.69 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 111.006 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.51 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.962 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -75.46 -50.89 14.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 43' ' ' ILE . 10.1 m -62.79 -46.94 85.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.436 0.694 . . . . 0.0 111.199 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.31 7.64 43.59 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.879 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 59.99 21.15 10.23 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.881 1.273 . . . . 0.0 113.011 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -77.15 138.25 64.79 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.331 0.652 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.76 121.02 9.27 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.102 1.868 . . . . 0.0 111.291 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.37 -29.46 67.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.163 0.585 . . . . 0.0 110.634 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.96 -33.67 69.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.064 0.945 . . . . 0.0 112.312 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -88.84 -18.61 27.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.408 0.683 . . . . 0.0 111.575 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.406 HG21 ' HB1' ' A' ' 9' ' ' ALA . 41.4 mt -72.94 111.14 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.625 0.77 . . . . 0.0 111.334 -177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -111.03 161.41 25.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.265 1.026 . . . . 0.0 108.989 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.17 -24.31 59.08 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.18 -23.73 61.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.75 1.22 . . . . 0.0 110.944 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.5 m -61.88 119.39 8.71 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 123.737 0.648 . . . . 0.0 111.161 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.4 t-80 -86.05 127.9 34.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.81 -54.02 16.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.133 0.573 . . . . 0.0 111.799 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -77.3 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.497 0.189 . . . . 0.0 110.776 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.65 -47.27 73.06 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.324 0.65 . . . . 0.0 112.693 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.7 -51.69 5.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.615 . . . . 0.0 111.852 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 77' ' ' LEU . 87.9 mt -79.31 -42.66 25.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.92 0.488 . . . . 0.0 110.266 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.16 -7.49 25.1 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.313 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.4 112.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.337 1.055 . . . . 0.0 111.1 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.38 160.32 29.68 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 p -58.93 -15.43 12.85 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.678 0.791 . . . . 0.0 112.859 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.2 mt -86.18 -38.67 17.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.972 0.909 . . . . 0.0 110.806 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.79 -32.7 67.9 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.97 -19.16 64.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 57' ' ' LEU . 90.4 mt -60.19 -42.11 94.36 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.847 0.459 . . . . 0.0 110.246 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.25 -42.3 93.45 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.858 1.263 . . . . 0.0 110.584 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.497 ' HA ' HG21 ' A' ' 15' ' ' THR . 55.8 mt -67.64 -41.62 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.391 0.676 . . . . 0.0 111.004 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.0 73.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.994 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -65.45 -43.57 89.98 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.6 1.188 . . . . 0.0 110.962 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.92 74.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.782 0.433 . . . . 0.0 111.355 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 84' ' ' ILE . 96.9 mt -68.84 -40.01 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.343 0.657 . . . . 0.0 110.17 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -53.42 -50.86 64.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.218 0.607 . . . . 0.0 110.677 174.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -73.25 -48.47 34.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.695 -172.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.78 -44.38 73.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.347 0.659 . . . . 0.0 111.571 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.92 -11.31 39.49 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.946 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.38 71.04 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.235 0.335 . . . . 0.0 112.837 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.24 175.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.061 0.944 . . . . 0.0 111.019 -175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -116.59 92.71 3.95 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tt -78.18 114.09 39.32 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.99 85.86 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.185 1.924 . . . . 0.0 112.401 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 41' ' ' LEU . 51.7 tp -72.5 -30.4 64.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.6 -30.79 68.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.005 0.522 . . . . 0.0 111.404 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -70.39 -55.48 8.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 0.0 108.659 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -61.1 -48.46 81.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.665 1.186 . . . . 0.0 112.879 -168.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -60.0 -44.3 94.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.664 0.786 . . . . 0.0 111.682 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -70.36 -30.86 67.89 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.287 0.635 . . . . 0.0 110.684 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.3 -40.36 97.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.458 0.703 . . . . 0.0 110.723 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.638 HG11 HG23 ' A' ' 71' ' ' THR . 60.3 t -66.96 -42.82 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.215 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.16 -31.07 65.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.691 0.796 . . . . 0.0 112.7 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -102.24 -14.64 16.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.938 0.495 . . . . 0.0 111.45 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.16 24.1 64.53 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.706 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.57 -31.26 72.37 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.291 0.546 . . . . 0.0 109.607 168.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.18 166.56 31.19 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.616 1.166 . . . . 0.0 109.773 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.6 p -99.29 158.69 15.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.7 0.8 . . . . 0.0 110.972 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 HG11 ' A' ' 64' ' ' VAL . 38.5 p -64.49 -32.34 73.94 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HA ' HG23 ' A' ' 76' ' ' VAL . 36.8 tt0 -55.63 -46.34 77.44 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.569 0.747 . . . . 0.0 111.033 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.44 -34.84 69.38 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.812 0.845 . . . . 0.0 112.58 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -104.43 -75.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.536 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.9 m-85 -58.18 -26.16 62.42 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 125.275 1.43 . . . . 0.0 114.844 -165.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -61.48 124.72 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 120.001 1.273 . . . . 0.0 108.257 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 33' ' ' LEU . 34.7 mt -61.96 -33.59 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -162.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -69.41 -36.48 76.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -72.69 -44.24 62.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.61 0.764 . . . . 0.0 109.878 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.81 -43.97 69.8 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.171 1.788 . . . . 0.0 111.367 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.815 0.697 . . . . 0.0 110.759 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.02 -44.4 65.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -62.68 -44.06 97.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.542 0.737 . . . . 0.0 111.484 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 47' ' ' ILE . 87.0 mt -69.52 -43.07 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.574 0.749 . . . . 0.0 110.154 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' HG21 ' A' ' 4' ' ' THR . 22.1 t70 -53.74 -39.87 65.68 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.983 0.513 . . . . 0.0 111.652 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.66 -48.37 81.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.415 0.626 . . . . 0.0 110.639 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.68 -39.03 80.78 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.396 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.7 m -76.53 -33.89 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 122.661 0.384 . . . . 0.0 110.802 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.15 -21.86 65.8 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 O-C-N 123.68 0.612 . . . . 0.0 112.398 173.872 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.3 m . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.81 -0.07 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.67 -45.99 90.41 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.835 0.709 . . . . 0.0 110.941 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.18 -36.35 79.6 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.493 0.717 . . . . 0.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 7' ' ' ARG . 5.4 mmt-85 -68.32 -47.98 66.11 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.694 0.621 . . . . 0.0 111.422 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 4' ' ' THR . 97.6 t -59.62 -37.13 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.708 0.766 . . . . 0.0 110.269 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.27 73.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.005 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -72.14 -23.01 61.23 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 122.425 0.29 . . . . 0.0 111.553 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 47' ' ' ILE . 28.0 mm -59.59 -58.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 167.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.85 -30.04 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.925 0.765 . . . . 0.0 111.044 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.37 -53.61 54.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.502 1.121 . . . . 0.0 111.64 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.2 -34.53 59.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.595 0.358 . . . . 0.0 111.703 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.2 m -71.75 -60.48 2.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.775 0.83 . . . . 0.0 111.292 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 43' ' ' ILE . 61.1 m -96.06 4.13 52.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.611 0.764 . . . . 0.0 112.321 -173.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.31 33.47 22.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.27 1.028 . . . . 0.0 112.599 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.08 123.95 59.53 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.16 137.5 63.12 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.937 2.425 . . . . 0.0 112.681 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.5 0.72 . . . . 0.0 111.127 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.04 -28.47 68.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.975 0.91 . . . . 0.0 111.817 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -88.84 -20.34 24.77 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.781 0.432 . . . . 0.0 110.718 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.86 123.32 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.511 0.724 . . . . 0.0 109.227 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -136.35 157.54 75.23 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.347 1.059 . . . . 0.0 109.602 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -59.84 -32.5 95.46 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.228 1.952 . . . . 0.0 112.263 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.49 -28.47 61.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.415 0.686 . . . . 0.0 112.123 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.476 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 30.9 p -72.76 118.51 15.78 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.922 0.391 . . . . 0.0 111.496 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 62.0 t-80 -68.67 129.36 39.69 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 109.267 167.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.2 -58.04 5.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.251 0.621 . . . . 0.0 112.46 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 26.9 mt -72.9 -44.76 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.304 0.241 . . . . 0.0 111.447 -174.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 22.1 t70 -75.48 -64.04 1.15 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.29 0.236 . . . . 0.0 111.164 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.72 -48.75 15.93 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 77' ' ' LEU . 82.1 mt -79.84 -27.66 40.17 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.254 0.222 . . . . 0.0 111.281 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.12 47.88 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.426 -0.352 . . . . 0.0 113.413 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.489 HD13 HD11 ' A' ' 43' ' ' ILE . 66.3 mt -80.69 133.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.93 0.892 . . . . 0.0 109.748 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.63 153.89 19.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -61.58 -15.94 43.47 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 mt -84.21 -32.8 24.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.625 0.726 . . . . 0.0 109.661 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.85 -27.87 40.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.143 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -73.7 -21.25 60.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.319 1.048 . . . . 0.0 110.282 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 57' ' ' LEU . 88.9 mt -56.04 -42.5 76.64 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.073 0.549 . . . . 0.0 110.143 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.77 -38.13 89.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.894 0.878 . . . . 0.0 110.986 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.0 mt -62.26 -51.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.119 0.568 . . . . 0.0 110.371 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.35 -40.07 95.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.74 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -67.73 -39.21 84.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.818 0.847 . . . . 0.0 111.311 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.38 -31.39 69.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.682 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.481 HG13 HG21 ' A' ' 11' ' ' ILE . 81.2 mt -69.82 -40.92 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.95 0.9 . . . . 0.0 110.822 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -54.32 -42.34 70.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.491 0.716 . . . . 0.0 111.126 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -76.78 -48.48 18.5 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.458 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.12 63.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.489 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 53' ' ' ILE . 78.4 m-85 -85.44 -24.91 27.25 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.63 34.17 44.97 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.48 0.487 . . . . 0.0 112.114 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 51' ' ' PHE . 32.2 pt -121.88 173.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 109.649 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.14 110.56 22.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD12 HG21 ' A' ' 47' ' ' ILE . 7.6 tt -96.36 104.17 16.58 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.92 84.27 1.61 Allowed 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.04 1.827 . . . . 0.0 111.521 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 41' ' ' LEU . 61.2 tp -69.17 -30.6 68.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.64 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.919 0.888 . . . . 0.0 111.059 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 54.7 tttp -77.69 -46.62 21.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.938 0.895 . . . . 0.0 110.361 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -66.88 -38.66 86.72 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.088 0.555 . . . . 0.0 111.539 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 m -66.51 -35.64 80.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.704 0.802 . . . . 0.0 110.522 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -67.93 -34.8 77.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.135 0.974 . . . . 0.0 110.653 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 61.4 mm-40 -58.13 -41.89 84.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.47 -47.26 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.706 0.802 . . . . 0.0 110.4 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.92 -27.99 68.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.865 1.266 . . . . 0.0 112.806 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.78 -8.62 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.796 0.839 . . . . 0.0 112.252 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.78 81.3 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 122.812 0.07 . . . . 0.0 113.139 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -71.55 -21.94 61.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.581 1.152 . . . . 0.0 110.347 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.34 168.89 25.25 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.431 1.093 . . . . 0.0 109.457 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 73' ' ' GLN . 10.0 t -101.3 158.76 15.8 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.735 0.814 . . . . 0.0 109.64 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -61.99 -31.59 71.97 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.085 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.44 -36.76 84.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.972 0.909 . . . . 0.0 111.843 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.427 ' H ' HG23 ' A' ' 70' ' ' THR . 28.3 tt0 -63.36 -29.05 70.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.176 0.59 . . . . 0.0 111.928 -173.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -107.69 -64.13 1.24 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.391 0.277 . . . . 0.0 111.436 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.28 -20.79 63.28 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -167.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t -65.63 131.99 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 119.862 1.21 . . . . 0.0 108.894 171.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 33' ' ' LEU . 25.2 mt -59.96 -36.41 77.05 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -165.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.6 pttt -58.7 -43.1 89.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.454 0.471 . . . . 0.0 111.056 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.0 m-20 -76.47 -46.2 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.298 1.039 . . . . 0.0 110.308 -174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.38 -52.38 37.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.109 1.363 . . . . 0.0 110.539 171.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.48 -25.79 65.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.13 -42.73 59.56 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.795 0.685 . . . . 0.0 111.097 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 22.1 mmm180 -64.93 -42.93 94.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 53' ' ' ILE . 93.9 mt -64.93 -43.26 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.922 . . . . 0.0 110.549 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.4 t70 -56.1 -36.83 68.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.455 0.702 . . . . 0.0 111.899 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.51 -39.07 77.8 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 123.719 0.637 . . . . 0.0 110.407 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.74 -38.53 86.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.43 0.692 . . . . 0.0 111.996 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.7 m -80.55 -25.73 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 122.184 -0.323 . . . . 0.0 110.839 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.17 -38.12 78.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.145 0.578 . . . . 0.0 109.825 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 124.083 0.953 . . . . 0.0 112.704 177.534 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 16.8 m . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -68.25 -32.11 72.07 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -59.31 -48.09 82.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.66 0.384 . . . . 0.0 111.071 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -69.33 -46.23 67.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.865 0.728 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -57.97 -42.67 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.76 0.824 . . . . 0.0 111.314 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.98 91.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.608 0.763 . . . . 0.0 110.647 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -56.41 -44.12 80.04 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.956 0.903 . . . . 0.0 111.597 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.485 HG21 HG13 ' A' ' 47' ' ' ILE . 29.3 mm -58.17 -57.87 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.88 0.872 . . . . 0.0 110.049 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.65 -33.17 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.37 1.068 . . . . 0.0 111.593 -175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.24 59.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.933 0.893 . . . . 0.0 111.437 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.17 -24.66 30.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.498 HG21 ' HA ' ' A' ' 43' ' ' ILE . 37.4 p -74.95 -62.05 1.68 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.745 0.418 . . . . 0.0 110.353 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.2 m -94.48 12.57 26.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.206 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t70 67.34 16.91 10.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.775 1.23 . . . . 0.0 111.991 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.8 mt -77.34 127.36 83.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 122.892 0.477 . . . . 0.0 110.284 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.71 127.03 23.01 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.744 2.296 . . . . 0.0 112.365 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -59.57 -31.54 69.53 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.248 1.019 . . . . 0.0 110.804 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.8 pt-20 -59.91 -27.92 67.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.811 1.244 . . . . 0.0 112.374 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 21' ' ' GLU . 45.0 p -105.15 -6.82 19.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.539 0.735 . . . . 0.0 111.947 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.1 mt -71.04 116.19 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.164 0.507 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 138.25 31.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.085 1.354 . . . . 0.0 108.435 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 36.8 Cg_endo -60.93 -27.22 84.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.998 2.465 . . . . 0.0 112.942 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.29 -20.84 61.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.179 0.992 . . . . 0.0 112.351 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 146.62 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.724 0.41 . . . . 0.0 110.362 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 30.1 t-80 -107.85 136.38 47.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 124.159 0.984 . . . . 0.0 108.819 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.34 -63.49 1.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.28 1.432 . . . . 0.0 113.545 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.89 -28.21 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.797 0.439 . . . . 0.0 110.836 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.7 t70 -63.8 -65.97 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.07 0.948 . . . . 0.0 112.018 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.69 -48.02 3.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.048 0.539 . . . . 0.0 110.527 -170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.33 -23.53 66.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.087 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.05 26.67 71.55 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.046 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' HB ' ' HB1' ' A' ' 29' ' ' ALA . 69.5 mt -65.52 120.57 12.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.57 164.43 25.89 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t -77.08 -22.04 53.43 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 122.053 -0.404 . . . . 0.0 110.003 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.7 -32.03 22.15 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.684 0.794 . . . . 0.0 109.537 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -73.05 -29.63 63.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.243 1.017 . . . . 0.0 110.534 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.88 -22.5 59.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.695 . . . . 0.0 110.059 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 57' ' ' LEU . 93.4 mt -57.71 -35.78 71.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.745 0.418 . . . . 0.0 110.815 174.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.74 -36.77 76.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.653 0.781 . . . . 0.0 110.858 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' A' ' 16' ' ' CYS . 52.3 mt -62.08 -53.03 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.585 0.754 . . . . 0.0 109.538 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.24 85.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.329 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.84 -40.13 69.27 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.622 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.877 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 11' ' ' ILE . 82.1 mt -72.11 -38.67 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.607 1.163 . . . . 0.0 111.388 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -53.32 -46.16 69.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.86 0.864 . . . . 0.0 110.925 174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -77.53 -47.57 19.18 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.347 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.41 -50.33 65.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.662 0.785 . . . . 0.0 111.803 -170.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.403 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.8 m-85 -83.92 -28.36 27.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.632 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 45.88 8.82 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 51' ' ' PHE . 37.6 pt -127.14 -175.35 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.049 0.94 . . . . 0.0 111.051 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -124.04 99.71 6.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.28 1.032 . . . . 0.0 108.488 174.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 104.26 8.06 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.68 81.65 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.47 1.447 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 41' ' ' LEU . 54.3 tp -69.75 -32.76 71.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.767 0.427 . . . . 0.0 110.099 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.18 -36.35 70.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.44 1.096 . . . . 0.0 110.903 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 39.4 ttpt -78.11 -44.16 26.91 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.677 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -62.89 -39.38 94.31 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 0.0 111.436 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 m -56.56 -46.31 80.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.508 1.123 . . . . 0.0 111.073 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -66.38 -34.91 79.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.076 0.95 . . . . 0.0 111.101 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.9 mm-40 -59.44 -42.72 92.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.117 0.567 . . . . 0.0 110.442 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 71' ' ' THR . 59.0 t -68.28 -49.61 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.662 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.9 -28.9 69.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.93 0.892 . . . . 0.0 112.947 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -95.06 -7.8 38.52 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.851 0.861 . . . . 0.0 110.849 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.87 80.87 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.558 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.61 -10.92 57.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.7 0.8 . . . . 0.0 112.121 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -161.72 168.63 22.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.253 0.621 . . . . 0.0 110.837 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.5 p -104.36 157.45 17.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.919 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.492 HG23 HG11 ' A' ' 64' ' ' VAL . 32.2 p -67.98 -28.63 67.61 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.634 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.62 -39.56 88.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.164 0.586 . . . . 0.0 110.65 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.37 -34.72 66.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.868 0.867 . . . . 0.0 112.133 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -107.47 -71.81 0.74 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.373 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 57.2 m-85 -60.66 -18.23 52.41 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -165.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 84.8 t -65.6 128.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.811 1.187 . . . . 0.0 108.189 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.82 -39.2 77.07 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.2 pttp -68.55 -38.17 80.56 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.428 0.455 . . . . 0.0 112.089 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.0 m-20 -70.36 -46.61 63.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.47 0.708 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.06 -49.14 64.08 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.285 1.434 . . . . 0.0 110.863 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.48 69.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.347 0.659 . . . . 0.0 110.832 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.07 -39.61 55.02 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.723 0.409 . . . . 0.0 110.739 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.5 mmm180 -59.35 -43.39 92.8 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.352 0.596 . . . . 0.0 110.899 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.411 ' CD1' HD13 ' A' ' 47' ' ' ILE . 78.4 mt -71.7 -38.35 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.294 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.4 -38.64 66.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.744 0.818 . . . . 0.0 111.882 170.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.48 -40.66 76.92 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.545 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.43 -42.82 95.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.142 0.977 . . . . 0.0 112.957 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.9 m -75.73 -26.6 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.604 0.362 . . . . 0.0 110.27 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.8 73.08 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.953 171.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 123.706 0.803 . . . . 0.0 112.981 176.169 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 8' ' ' VAL . 79.8 m . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 119.943 -0.075 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.35 -58.68 5.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.81 -29.77 68.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 123.867 0.729 . . . . 0.0 111.588 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -64.98 -51.53 61.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 110.75 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 4' ' ' THR . 54.3 t -61.83 -36.17 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.144 0.578 . . . . 0.0 111.028 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.31 93.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.849 . . . . 0.0 109.958 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.2 m -54.92 -46.91 74.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.738 1.215 . . . . 0.0 111.409 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.576 HG21 HG13 ' A' ' 47' ' ' ILE . 41.9 mm -58.4 -58.32 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 18' ' ' ILE . 77.4 mt -58.76 -37.14 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.434 1.094 . . . . 0.0 111.387 -175.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.14 78.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.927 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.58 -27.44 21.37 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 43' ' ' ILE . 21.7 p -80.4 -59.94 2.51 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.502 0.592 . . . . 0.0 110.74 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.645 ' SG ' HG12 ' A' ' 35' ' ' ILE . 44.8 t -80.06 -8.39 59.36 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.234 1.014 . . . . 0.0 111.887 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 61.68 71.92 0.53 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.822 0.849 . . . . 0.0 110.158 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 12' ' ' ILE . 39.3 mt -127.78 128.48 23.87 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.241 1.016 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.58 134.9 60.01 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.992 2.461 . . . . 0.0 112.553 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD2' HD12 ' A' ' 23' ' ' ILE . 9.4 mmm180 -59.25 -29.2 67.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.873 0.869 . . . . 0.0 111.554 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG3' HG23 ' A' ' 22' ' ' THR . 14.2 pt-20 -63.26 -33.71 76.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.0 p -101.7 21.42 14.48 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.152 0.981 . . . . 0.0 111.447 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 20' ' ' ARG . 63.5 mt -106.45 128.21 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -138.41 155.66 73.79 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.073 0.949 . . . . 0.0 109.557 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.5 -35.01 96.34 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.328 2.019 . . . . 0.0 112.878 170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.15 -21.69 53.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.732 0.813 . . . . 0.0 112.092 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.3 p -69.98 128.89 37.91 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 53.5 t-80 -88.41 129.89 35.31 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.68 -59.12 4.64 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.016 0.526 . . . . 0.0 111.994 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 45.1 mt -71.33 -60.55 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 120.657 0.265 . . . . 0.0 110.803 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.74 -49.15 77.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.268 1.027 . . . . 0.0 112.901 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.86 -58.56 2.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.83 0.452 . . . . 0.0 111.498 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.13 -19.6 58.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.401 0.68 . . . . 0.0 111.767 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.12 76.01 Favored Glycine 0 N--CA 1.478 1.463 0 O-C-N 122.986 0.178 . . . . 0.0 113.518 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.645 HG12 ' SG ' ' A' ' 16' ' ' CYS . 47.6 mt -73.32 117.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.106 0.962 . . . . 0.0 110.22 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.6 163.19 27.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 m -63.64 -16.51 61.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.911 0.484 . . . . 0.0 111.726 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -85.15 -43.88 13.45 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.718 0.807 . . . . 0.0 109.509 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.89 -31.4 72.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.116 0.966 . . . . 0.0 110.793 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 57' ' ' LEU . 8.8 t80 -72.2 -20.93 61.49 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.01 0.924 . . . . 0.0 110.685 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 57' ' ' LEU . 78.4 mt -57.62 -31.2 65.99 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.784 0.434 . . . . 0.0 111.849 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -69.75 -43.24 72.67 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.233 1.013 . . . . 0.0 109.262 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.417 HG12 ' OG1' ' A' ' 15' ' ' THR . 64.4 mt -60.06 -51.59 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.118 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.74 89.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.842 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.1 -38.33 87.97 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.423 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 11' ' ' ILE . . . -73.73 -29.23 62.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.178 0.591 . . . . 0.0 111.652 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.576 HG13 HG21 ' A' ' 11' ' ' ILE . 87.3 mt -70.72 -39.38 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.654 0.782 . . . . 0.0 110.587 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.34 -34.77 61.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.97 0.908 . . . . 0.0 111.829 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.38 -51.79 7.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.42 0.688 . . . . 0.0 111.251 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.337 1.055 . . . . 0.0 111.673 -171.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 53' ' ' ILE . 72.9 m-85 -88.58 -14.41 37.65 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.022 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.47 11.32 82.62 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.089 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.515 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.4 pt -96.13 -171.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.878 0.871 . . . . 0.0 110.58 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.63 114.83 25.42 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.05 98.35 7.4 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 59' ' ' LYS . 86.9 Cg_endo -81.09 86.41 1.63 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.287 1.991 . . . . 0.0 110.442 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 41' ' ' LEU . 65.9 tp -67.08 -40.41 86.99 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.774 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.63 -31.07 72.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.109 0.964 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' A' ' 56' ' ' PRO . 47.7 tttp -65.5 -48.29 73.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.004 1.322 . . . . 0.0 110.187 171.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 64' ' ' VAL . 45.2 m0 -63.36 -43.63 97.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.854 0.861 . . . . 0.0 110.787 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.0 m -59.36 -46.0 89.86 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.459 1.504 . . . . 0.0 111.243 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -65.14 -44.9 87.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.532 0.733 . . . . 0.0 111.001 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.96 -26.69 59.77 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.881 0.473 . . . . 0.0 112.222 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 71' ' ' THR . 90.3 t -72.72 -42.28 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.68 -17.45 62.84 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.623 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.01 -6.88 34.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 10.55 84.96 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.071 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.18 -16.98 55.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.842 0.857 . . . . 0.0 110.981 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.26 166.89 30.37 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.888 0.875 . . . . 0.0 109.999 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.7 t -111.57 155.65 22.98 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.47 0.708 . . . . 0.0 110.326 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.523 HG23 HG11 ' A' ' 64' ' ' VAL . 30.2 p -63.09 -32.52 73.91 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.558 0.743 . . . . 0.0 110.988 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HG3' HG21 ' A' ' 76' ' ' VAL . 36.1 tt0 -58.29 -44.36 88.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.561 0.344 . . . . 0.0 111.459 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.468 ' H ' HG23 ' A' ' 70' ' ' THR . 30.3 tt0 -56.32 -32.59 64.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.768 0.827 . . . . 0.0 111.61 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -102.12 -82.09 0.48 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.9 m-85 -55.89 -24.6 38.3 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -161.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.2 t -65.54 124.79 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 119.783 1.174 . . . . 0.0 108.303 170.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.85 -32.97 73.35 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -160.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.9 pttt -65.5 -41.28 93.39 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.976 0.51 . . . . 0.0 111.243 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.29 -41.07 49.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.95 -47.07 68.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.831 1.652 . . . . 0.0 110.931 169.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.35 70.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.447 0.699 . . . . 0.0 111.467 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.39 -41.5 47.69 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.413 0.685 . . . . 0.0 110.871 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 23.2 mmm180 -57.58 -50.28 73.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.028 0.931 . . . . 0.0 111.101 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.08 -38.83 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.031 0.932 . . . . 0.0 110.443 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.9 t70 -58.14 -35.52 71.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.81 0.444 . . . . 0.0 111.569 171.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.47 -39.79 70.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.491 0.316 . . . . 0.0 110.735 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 61.4 mt -61.93 -43.77 98.16 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.428 0.691 . . . . 0.0 111.733 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 53' ' ' ILE . 12.2 m -71.68 -27.68 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 122.761 0.424 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.1 65.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.101 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 123.696 0.799 . . . . 0.0 112.934 174.739 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 m . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.49 -47.28 70.48 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.728 0.411 . . . . 0.0 110.299 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -54.78 -44.4 73.68 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.406 0.683 . . . . 0.0 111.461 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -60.49 -55.63 31.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.088 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 4' ' ' THR . 58.3 t -60.39 -37.14 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.51 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.37 87.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.105 0.962 . . . . 0.0 110.518 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -57.53 -42.81 83.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.141 0.976 . . . . 0.0 111.778 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -58.79 -50.94 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -33.99 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.149 0.58 . . . . 0.0 110.648 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -51.26 62.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.382 1.073 . . . . 0.0 112.317 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.44 -46.51 22.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.708 0.403 . . . . 0.0 111.959 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.1 m -72.46 -51.96 17.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.12 0.568 . . . . 0.0 111.616 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.77 -9.28 56.22 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.382 0.673 . . . . 0.0 111.777 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 59.02 72.07 0.55 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.381 1.072 . . . . 0.0 110.597 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.13 129.65 21.79 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.14 139.33 85.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.796 2.33 . . . . 0.0 112.358 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -61.06 -28.98 69.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.335 0.654 . . . . 0.0 112.129 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.34 -37.07 84.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.544 0.738 . . . . 0.0 111.236 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -81.48 -23.03 37.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.953 0.501 . . . . 0.0 111.012 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.474 HG23 HD13 ' A' ' 77' ' ' LEU . 75.8 mt -76.63 116.4 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -132.32 144.72 54.23 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.504 1.122 . . . . 0.0 109.204 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.9 -32.18 92.33 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.814 2.343 . . . . 0.0 112.792 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.13 -20.67 60.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.642 0.777 . . . . 0.0 112.011 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.9 t -73.58 147.76 43.57 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.989 0.915 . . . . 0.0 110.709 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 56.1 t-80 -104.37 133.71 48.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.553 1.141 . . . . 0.0 108.955 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -64.43 0.84 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.717 0.807 . . . . 0.0 112.705 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 46.2 mt -69.81 -39.6 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.835 0.454 . . . . 0.0 111.603 -173.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.52 -67.62 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.499 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.79 -57.7 3.89 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.683 0.393 . . . . 0.0 111.067 -171.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 77' ' ' LEU . 84.9 mt -71.67 -26.94 62.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.209 0.604 . . . . 0.0 111.108 -176.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.79 21.9 60.72 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.863 0.727 . . . . 0.0 113.552 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.6 mt -70.2 129.21 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.811 0.844 . . . . 0.0 110.026 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.1 158.69 30.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 33.1 m -65.55 -17.4 64.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.53 0.332 . . . . 0.0 110.84 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 mt -75.88 -47.57 24.91 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.52 1.128 . . . . 0.0 109.299 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -29.2 65.49 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.721 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -73.06 -22.26 60.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.616 0.766 . . . . 0.0 110.451 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -60.15 -39.61 86.96 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.681 0.392 . . . . 0.0 109.985 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.0 -44.11 97.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.883 0.873 . . . . 0.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.57 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.493 0.717 . . . . 0.0 109.948 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.07 73.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.21 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -65.2 -43.8 90.42 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.05 0.94 . . . . 0.0 110.179 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.03 -32.05 70.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.245 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 84' ' ' ILE . 84.9 mt -65.22 -42.64 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.855 0.862 . . . . 0.0 110.478 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -53.89 -48.71 69.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.399 0.68 . . . . 0.0 111.463 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -80.04 -37.49 33.92 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.445 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.22 31.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.367 0.667 . . . . 0.0 111.287 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.16 -28.05 32.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.22 39.4 8.47 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 pt -126.5 -172.48 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.197 0.999 . . . . 0.0 110.85 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -131.0 100.94 5.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tt -72.82 113.62 23.13 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.91 80.5 2.14 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.976 1.784 . . . . 0.0 110.966 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 41' ' ' LEU . 46.3 tp -70.08 -35.62 74.34 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.146 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.0 -39.43 81.82 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.481 1.113 . . . . 0.0 111.127 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.8 ttpt -74.65 -40.89 61.18 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.033 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -64.02 -42.47 97.09 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.929 0.768 . . . . 0.0 111.233 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.6 m -59.51 -39.56 84.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.937 0.895 . . . . 0.0 111.141 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -68.97 -34.94 76.13 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.961 0.904 . . . . 0.0 110.888 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 23.0 mm-40 -61.89 -39.95 93.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.356 0.662 . . . . 0.0 110.595 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 58.1 t -65.44 -44.55 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.993 0.517 . . . . 0.0 109.972 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -57.93 -44.29 86.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.327 1.051 . . . . 0.0 112.173 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.31 -18.72 35.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.017 0.927 . . . . 0.0 111.654 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.04 21.94 53.92 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 122.674 0.178 . . . . 0.0 113.0 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -79.03 -24.03 43.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.515 0.726 . . . . 0.0 110.552 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.87 166.41 33.0 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.818 0.847 . . . . 0.0 110.047 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.2 t -107.74 166.85 10.38 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.193 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m -67.72 -30.91 70.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.76 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.58 -35.17 78.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.764 0.825 . . . . 0.0 111.399 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.11 -31.99 72.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 112.392 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -109.27 -58.55 2.02 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.91 -10.9 60.53 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -165.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t -63.99 133.39 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' LEU . 36.1 mt -60.03 -41.12 91.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.539 0.735 . . . . 0.0 112.641 -166.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.8 -35.21 78.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 123.147 0.279 . . . . 0.0 111.721 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -68.22 -47.99 66.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.184 0.593 . . . . 0.0 109.662 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -52.19 -46.79 65.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.619 1.568 . . . . 0.0 110.385 172.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.78 -34.55 78.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.892 0.877 . . . . 0.0 111.994 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 -37.54 61.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.1 0.56 . . . . 0.0 110.861 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.7 mmm180 -64.03 -39.04 93.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.087 0.955 . . . . 0.0 111.401 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.83 -37.03 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.547 0.739 . . . . 0.0 109.861 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.91 -42.91 65.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.787 0.835 . . . . 0.0 111.419 167.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -62.76 -46.83 86.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.433 0.693 . . . . 0.0 111.087 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.55 -45.47 92.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.326 1.05 . . . . 0.0 112.578 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.2 -27.37 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 122.913 0.485 . . . . 0.0 109.985 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.64 76.08 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.34 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.68 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.9 m -69.14 102.79 1.74 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.012 0.525 . . . . 0.0 109.979 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.9 t -94.05 174.61 7.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.875 0.87 . . . . 0.0 110.353 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.7 m -53.97 -37.4 63.91 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.872 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -68.67 -35.48 77.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -43.24 80.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.266 0.627 . . . . 0.0 110.638 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -72.55 -44.89 61.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.957 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 4' ' ' THR . 95.2 t -60.01 -42.09 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.334 0.654 . . . . 0.0 111.369 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.76 99.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.803 0.841 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -63.37 -42.66 98.86 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.873 0.869 . . . . 0.0 112.023 174.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.589 HG21 HG13 ' A' ' 47' ' ' ILE . 24.5 mm -56.79 -58.65 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.683 0.793 . . . . 0.0 109.527 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.37 -34.08 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.239 1.015 . . . . 0.0 110.944 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -59.16 -53.54 57.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.358 0.663 . . . . 0.0 111.608 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.57 -25.4 38.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.453 0.701 . . . . 0.0 112.01 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.4 m -75.94 -62.41 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.312 0.645 . . . . 0.0 110.149 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 43' ' ' ILE . 2.7 m -85.81 -2.92 58.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.943 0.897 . . . . 0.0 112.368 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 65.11 16.22 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.912 1.285 . . . . 0.0 112.468 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 73.4 mt -79.33 120.7 81.37 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.543 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_endo -62.04 145.11 96.74 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.269 1.979 . . . . 0.0 112.291 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -54.74 -34.48 62.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.195 0.998 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -59.67 -38.25 80.95 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.877 0.736 . . . . 0.0 111.658 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' GLU . 76.2 p -86.84 -6.05 58.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.305 0.642 . . . . 0.0 111.687 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.01 133.87 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.992 0.917 . . . . 0.0 109.489 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -144.48 153.1 54.93 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.588 1.155 . . . . 0.0 110.006 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.54 -43.16 56.99 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.408 2.739 . . . . 0.0 114.448 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.83 -3.59 58.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.799 0.44 . . . . 0.0 111.638 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.4 t -68.55 137.36 54.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 49.6 t-80 -98.19 131.34 44.63 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.156 0.982 . . . . 0.0 108.76 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.9 -58.95 4.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.48 0.712 . . . . 0.0 111.97 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.36 -55.31 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.585 0.354 . . . . 0.0 111.132 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.1 t70 -63.08 -55.29 26.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.695 0.798 . . . . 0.0 111.768 -172.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.76 -65.74 0.98 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.905 0.482 . . . . 0.0 110.685 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 77' ' ' LEU . 88.5 mt -64.44 -28.49 69.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.531 0.732 . . . . 0.0 111.962 -173.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.64 40.2 27.58 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-O 121.31 0.394 . . . . 0.0 112.373 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.39 127.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.466 1.106 . . . . 0.0 109.31 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.04 159.24 17.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.847 0.859 . . . . 0.0 109.604 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.499 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 48.1 m -49.51 -38.55 30.82 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.1 0.96 . . . . 0.0 112.781 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 mt -71.06 -35.22 71.84 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.445 0.698 . . . . 0.0 110.999 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.11 -37.59 64.08 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.275 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -71.45 -22.04 61.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.208 0.603 . . . . 0.0 110.776 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.7 mt -57.1 -47.24 81.52 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.29 -35.35 79.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.579 1.151 . . . . 0.0 111.732 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.598 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.5 mt -64.92 -53.1 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.017 0.527 . . . . 0.0 110.144 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -67.34 -29.03 68.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.037 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.11 -38.37 56.96 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.988 0.805 . . . . 0.0 110.84 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.32 -36.65 74.4 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.589 HG13 HG21 ' A' ' 11' ' ' ILE . 85.3 mt -66.52 -42.49 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.206 1.003 . . . . 0.0 110.586 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.23 -43.96 71.29 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.366 1.066 . . . . 0.0 110.474 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.71 -37.07 23.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.236 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.91 23.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.212 0.605 . . . . 0.0 111.401 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -78.68 -18.03 55.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.021 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.34 50.5 38.18 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.0 pt -133.13 160.39 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.538 1.135 . . . . 0.0 109.156 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -94.68 96.92 9.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD22 ' HB1' ' A' ' 44' ' ' ALA . 6.7 tt -83.29 111.29 29.9 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.58 81.9 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.843 1.695 . . . . 0.0 110.802 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.74 -28.11 66.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.788 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.68 -33.32 64.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.792 0.837 . . . . 0.0 111.472 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.6 tttp -80.11 -49.68 11.38 Favored 'General case' 0 C--O 1.211 -0.961 0 C-N-CA 122.999 0.519 . . . . 0.0 109.917 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -60.27 -48.81 80.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.644 0.778 . . . . 0.0 111.705 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.5 m -52.2 -46.23 65.52 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.728 1.211 . . . . 0.0 111.705 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -64.24 -37.52 87.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.926 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.8 mm-40 -59.88 -42.69 94.3 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.072 0.549 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.02 -49.97 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.523 0.729 . . . . 0.0 110.887 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -61.51 -31.42 71.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.032 0.933 . . . . 0.0 112.94 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.46 0.88 55.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.546 0.738 . . . . 0.0 111.127 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.61 78.19 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.61 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -88.06 -12.93 42.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.543 0.737 . . . . 0.0 111.089 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.55 36.36 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.104 0.962 . . . . 0.0 109.825 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -108.37 159.57 16.55 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.162 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 p -58.23 -33.51 69.41 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.487 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' A' ' 76' ' ' VAL . 44.2 tt0 -49.75 -48.49 50.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.946 0.899 . . . . 0.0 112.002 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -61.88 -30.9 71.17 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.98 5.0 10.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.8 m-85 -133.67 -32.51 1.13 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.93 0.786 . . . . 0.0 111.876 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 89.8 t -59.91 127.27 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 33' ' ' LEU . 27.5 mt -59.7 -38.36 81.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -163.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.52 -36.75 76.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.814 0.446 . . . . 0.0 112.059 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.51 -46.15 64.21 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.619 0.768 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.23 -49.63 63.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.64 1.576 . . . . 0.0 110.127 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.48 64.97 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.43 61.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.688 0.395 . . . . 0.0 110.332 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.479 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 21.4 mmm180 -67.28 -31.34 71.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.429 0.691 . . . . 0.0 111.895 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 47' ' ' ILE . 79.8 mt -77.58 -42.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.21 0.604 . . . . 0.0 110.026 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 88' ' ' VAL . 31.0 t70 -54.97 -34.64 63.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.685 0.794 . . . . 0.0 111.588 170.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 9.3 tp10 -60.98 -49.46 77.36 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.464 0.706 . . . . 0.0 110.73 173.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 54.0 mt -68.35 -37.74 80.78 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.67 0.788 . . . . 0.0 112.468 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 85' ' ' ASP . 19.3 m -74.91 -27.87 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.038 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.11 67.9 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.286 171.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.83 84.0 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.691 0.796 . . . . 0.0 112.883 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -71.36 -33.69 69.79 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.255 -0.278 . . . . 0.0 110.59 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -20.17 71.88 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 170.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.08 65.6 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.762 0.425 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.77 -13.41 14.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.773 1.229 . . . . 0.0 112.95 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.53 137.51 57.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.988 0.915 . . . . 0.0 109.906 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.74 71.29 2.57 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.733 0.813 . . . . 0.0 110.838 -172.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.0 p80 50.33 19.21 0.5 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.574 1.949 . . . . 0.0 115.269 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -100.41 91.15 4.57 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -73.07 81.72 1.25 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 110.28 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -168.95 139.16 2.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.58 1.152 . . . . 0.0 108.55 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 69.0 t60 . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.772 177.202 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 m -73.09 108.35 5.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 111.001 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 40.8 t -89.77 144.17 26.19 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 164.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 m -65.85 -25.19 67.08 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -74.65 -37.19 62.8 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.294 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 3' ' ' SER . 29.2 t70 -52.21 -49.28 64.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 123.835 0.709 . . . . 0.0 110.732 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -65.66 -47.09 76.68 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.235 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.64 -36.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.326 0.651 . . . . 0.0 111.973 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.36 96.09 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.159 0.983 . . . . 0.0 110.342 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -57.38 -47.14 82.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.254 1.021 . . . . 0.0 112.034 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.453 HG21 HG13 ' A' ' 47' ' ' ILE . 95.3 mt -66.57 -49.86 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.739 . . . . 0.0 111.65 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.434 HG12 HD13 ' A' ' 43' ' ' ILE . 62.8 mt -63.87 -35.5 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.643 0.777 . . . . 0.0 111.259 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.38 35.14 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.506 0.722 . . . . 0.0 111.551 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.23 -29.05 53.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.154 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.4 m -72.36 -62.11 1.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.84 0.456 . . . . 0.0 110.612 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.7 m -83.41 -1.09 52.66 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -170.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.94 61.74 2.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.959 0.904 . . . . 0.0 110.028 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -127.57 138.38 32.71 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.887 1.275 . . . . 0.0 108.409 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.14 123.04 11.69 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.872 2.382 . . . . 0.0 111.72 167.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -41.23 89.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.639 1.576 . . . . 0.0 110.764 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.85 -29.43 65.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.794 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -80.25 -25.38 39.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.443 0.297 . . . . 0.0 111.104 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -56.35 110.99 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.456 0.702 . . . . 0.0 111.034 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -94.62 147.13 32.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.605 0.762 . . . . 0.0 109.743 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 37.1 Cg_endo -65.07 -28.87 56.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.404 2.069 . . . . 0.0 111.955 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.41 -11.08 59.92 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.226 0.61 . . . . 0.0 111.709 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.1 p -74.31 140.35 44.83 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.813 0.339 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.2 t-80 -90.81 130.47 36.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.43 -61.29 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.051 0.94 . . . . 0.0 112.596 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -74.89 -44.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 122.65 0.38 . . . . 0.0 111.318 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 25.8 t70 -71.16 -65.48 0.74 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.758 0.423 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.89 -62.98 1.31 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.039 0.536 . . . . 0.0 110.651 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 77' ' ' LEU . 76.3 mt -73.42 -11.06 60.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.438 0.695 . . . . 0.0 112.532 -172.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.26 72.34 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.45 130.24 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.716 0.806 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -71.08 149.28 46.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -67.12 -17.3 64.8 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.071 0.396 . . . . 0.0 110.489 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.28 -31.56 24.86 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.119 0.968 . . . . 0.0 110.226 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.43 -30.17 53.3 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.408 0.623 . . . . 0.0 109.783 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -67.23 -21.51 65.74 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.561 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 57' ' ' LEU . 84.2 mt -59.69 -40.3 87.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.016 0.526 . . . . 0.0 110.498 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.61 -35.93 75.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.547 0.739 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.63 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.5 mt -61.95 -48.33 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.19 -31.82 73.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.448 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.55 -41.65 72.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.436 0.694 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.0 -27.55 60.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.52 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.453 HG13 HG21 ' A' ' 11' ' ' ILE . 94.1 mt -70.73 -42.7 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.833 0.853 . . . . 0.0 109.794 172.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.32 -40.28 74.13 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.624 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -76.43 -48.86 18.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 111.81 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.07 70.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.599 0.76 . . . . 0.0 112.124 -170.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' HG12 ' A' ' 53' ' ' ILE . 96.3 m-85 -83.45 -22.43 32.62 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.179 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.57 33.79 57.82 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 112.161 -0.376 . . . . 0.0 112.161 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.6 pt -114.94 158.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.227 1.011 . . . . 0.0 109.802 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.2 98.58 11.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.5 tt -88.52 105.68 10.38 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.43 80.97 2.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.79 1.66 . . . . 0.0 111.225 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 41' ' ' LEU . 53.6 tp -75.87 -29.56 58.56 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.31 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 -29.76 66.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.521 0.728 . . . . 0.0 110.742 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 61.8 tttp -84.27 -48.49 9.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.621 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -61.59 -39.33 90.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.407 0.683 . . . . 0.0 111.575 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -61.83 -43.92 97.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.89 0.876 . . . . 0.0 110.881 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -65.85 -30.33 70.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.099 0.96 . . . . 0.0 111.462 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 15.2 mm-40 -62.08 -46.71 87.88 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.108 0.563 . . . . 0.0 109.892 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.6 -44.89 99.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.578 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.52 1.128 . . . . 0.0 112.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.14 -18.73 26.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.107 0.963 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.03 65.47 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.792 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -67.95 -32.86 73.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.996 0.518 . . . . 0.0 109.831 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.35 164.46 27.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.573 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 73' ' ' GLN . 12.4 t -105.61 154.52 20.31 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -61.96 -32.32 72.75 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.849 0.859 . . . . 0.0 110.431 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.35 -41.41 89.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.434 ' H ' HG23 ' A' ' 70' ' ' THR . 55.0 tt0 -59.89 -32.58 70.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 112.575 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -105.92 -58.54 1.9 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.605 0.362 . . . . 0.0 111.437 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -67.37 -19.73 65.46 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 85.2 t -66.47 129.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 119.681 1.128 . . . . 0.0 108.408 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 33' ' ' LEU . 12.3 mt -66.34 -34.81 78.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -161.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -65.34 -36.7 84.81 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.935 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 64.1 m-20 -73.59 -44.7 56.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.419 0.688 . . . . 0.0 109.825 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.86 -48.23 67.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.642 1.177 . . . . 0.0 110.723 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.3 67.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.943 0.897 . . . . 0.0 111.391 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.39 64.29 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -63.4 -39.51 94.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.941 0.896 . . . . 0.0 111.506 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.445 HD11 HD13 ' A' ' 47' ' ' ILE . 96.6 mt -70.47 -43.02 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.109 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.32 -37.8 65.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.243 0.617 . . . . 0.0 111.382 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.15 -44.35 80.01 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.74 -42.33 95.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.604 0.762 . . . . 0.0 112.428 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 m -72.71 -29.34 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 122.999 0.52 . . . . 0.0 110.788 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.4 86.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.401 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.4 80.78 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.5 -31.77 63.89 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.515 0.598 . . . . 0.0 110.37 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.5 -20.28 78.27 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.778 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.26 70.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.271 0.629 . . . . 0.0 111.262 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.1 mt -51.11 -33.93 28.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.508 1.123 . . . . 0.0 111.55 172.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -99.54 99.1 9.93 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.114 0.965 . . . . 0.0 108.802 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -64.1 -26.3 68.48 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.685 0.794 . . . . 0.0 111.013 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -159.52 123.75 3.87 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 170.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -64.7 124.05 20.93 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -63.91 158.99 20.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.162 0.985 . . . . 0.0 111.773 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 68.82 28.08 5.52 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.568 1.147 . . . . 0.0 111.377 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 124.913 1.285 . . . . 0.0 108.573 173.887 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 110.959 -0.015 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.8 m -69.77 101.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.927 0.491 . . . . 0.0 109.676 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 25.5 t -109.99 -172.19 1.99 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.017 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.0 m -54.96 -26.87 39.48 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.426 0.69 . . . . 0.0 111.731 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 77' ' ' LEU . 59.7 t80 -63.11 -55.95 20.99 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.399 0.437 . . . . 0.0 111.132 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.06 -36.69 70.82 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 124.188 0.93 . . . . 0.0 110.99 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 3' ' ' SER . 14.0 mmm180 -63.15 -53.13 58.19 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.679 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 4' ' ' THR . 51.8 t -61.24 -36.38 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.054 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.07 79.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 110.975 -173.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' NH2' ' A' ' 20' ' ' ARG . 11.9 t -69.18 -29.75 67.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.658 0.383 . . . . 0.0 110.68 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 7' ' ' ARG . 45.4 mm -64.46 -50.74 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.191 0.596 . . . . 0.0 109.895 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.4 mt -60.06 -36.43 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.406 0.682 . . . . 0.0 110.395 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.74 42.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.323 1.049 . . . . 0.0 112.202 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.78 -32.43 65.59 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.7 m -77.58 -60.06 2.52 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.262 0.625 . . . . 0.0 110.787 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -91.94 5.57 49.55 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 111.576 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.99 24.74 13.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.693 1.197 . . . . 0.0 113.202 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.5 114.63 56.2 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.305 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -48.51 146.88 9.91 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.327 2.685 . . . . 0.0 113.47 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' NH2' ' HB ' ' A' ' 10' ' ' THR . 3.9 mmt85 -60.31 -33.83 72.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 0.0 111.521 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.47 -35.78 80.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.082 0.953 . . . . 0.0 111.838 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -86.54 -4.75 59.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.315 0.646 . . . . 0.0 111.825 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -96.15 126.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.763 0.825 . . . . 0.0 108.841 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' HD12 ' A' ' 77' ' ' LEU . 81.8 p -140.84 148.85 54.24 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.096 0.958 . . . . 0.0 109.013 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.35 -36.41 68.59 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.81 2.34 . . . . 0.0 113.256 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -74.92 -25.04 58.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.743 0.817 . . . . 0.0 112.373 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.1 p -76.68 144.59 39.31 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.645 0.26 . . . . 0.0 111.21 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 46.7 t-80 -92.24 131.43 37.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.768 1.227 . . . . 0.0 108.963 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.05 -56.81 9.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 112.2 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -71.3 -52.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 120.409 0.147 . . . . 0.0 110.88 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 31.4 t70 -70.41 -54.62 11.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.786 0.434 . . . . 0.0 112.127 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.48 -60.55 1.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.388 0.275 . . . . 0.0 110.946 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 77' ' ' LEU . 76.5 mt -68.37 -30.8 69.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.868 0.467 . . . . 0.0 111.336 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.75 0.9 68.55 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.957 -0.357 . . . . 0.0 113.189 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.09 104.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.829 0.852 . . . . 0.0 110.145 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -77.87 167.12 22.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -58.58 -17.02 18.42 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.347 0.659 . . . . 0.0 112.191 174.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.04 -41.47 18.62 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.13 0.972 . . . . 0.0 110.563 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.66 -40.46 92.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.511 0.672 . . . . 0.0 109.661 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -67.66 -18.73 65.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.883 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 57' ' ' LEU . 94.5 mt -54.43 -45.81 73.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.432 0.56 . . . . 0.0 110.852 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.83 -37.59 70.28 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.75 -41.36 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.227 0.611 . . . . 0.0 110.653 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.34 -35.27 80.47 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.12 0.887 . . . . 0.0 110.356 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.23 -42.29 88.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.904 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.85 74.38 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.484 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.6 -39.44 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.944 . . . . 0.0 110.628 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.92 -47.75 64.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.981 0.912 . . . . 0.0 111.138 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.63 -52.7 19.54 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.924 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.78 -57.02 14.87 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.186 0.929 . . . . 0.0 111.979 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HB2' HG12 ' A' ' 53' ' ' ILE . 76.2 m-85 -83.26 -15.12 51.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.443 0.697 . . . . 0.0 111.532 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.68 31.34 67.75 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 51' ' ' PHE . 42.9 pt -113.55 -170.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.576 1.15 . . . . 0.0 109.77 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.9 114.92 17.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 163.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.25 105.07 4.55 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.24 85.51 1.76 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 121.766 1.644 . . . . 0.0 110.351 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 41' ' ' LEU . 42.5 tp -69.4 -24.35 63.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.985 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.93 -38.57 67.84 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.889 0.876 . . . . 0.0 111.019 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.5 tttp -74.01 -50.82 18.09 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.501 1.12 . . . . 0.0 110.577 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HB2' HD12 ' A' ' 57' ' ' LEU . 30.8 m0 -62.82 -47.19 84.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.801 0.84 . . . . 0.0 112.113 -171.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.1 m -54.57 -44.41 72.94 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.84 0.856 . . . . 0.0 111.351 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -68.38 -32.68 72.93 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.158 0.983 . . . . 0.0 111.654 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 53.7 mm-40 -57.56 -46.14 84.31 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.582 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.44 -49.84 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.355 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.43 -36.54 84.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.085 0.954 . . . . 0.0 112.675 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.02 -5.91 40.01 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.483 1.113 . . . . 0.0 111.308 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.06 61.22 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.81 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.12 -24.94 30.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.071 0.549 . . . . 0.0 111.017 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -160.12 168.74 24.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.923 0.489 . . . . 0.0 110.664 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.5 p -105.52 163.56 12.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.826 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.9 p -67.39 -32.38 73.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.693 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.1 tt0 -63.69 -38.81 92.5 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.232 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 29.4 tt0 -62.41 -29.68 70.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.732 0.413 . . . . 0.0 111.999 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -107.46 -71.31 0.76 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.839 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.5 m-85 -62.15 -20.83 64.52 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -165.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -62.13 126.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.298 1.408 . . . . 0.0 107.874 170.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.01 -34.94 72.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -163.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.1 pttp -65.31 -40.72 94.13 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 173.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 73' ' ' GLN . 3.3 m-20 -69.22 -46.84 66.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.125 0.57 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -50.3 -48.62 55.05 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.835 1.654 . . . . 0.0 111.274 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.93 73.27 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.704 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.34 57.24 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.055 0.847 . . . . 0.0 111.409 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.7 mmm180 -64.28 -41.69 96.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.65 0.78 . . . . 0.0 111.276 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -70.35 -39.28 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.208 0.603 . . . . 0.0 110.385 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.07 -38.28 65.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.336 0.654 . . . . 0.0 111.653 169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -68.55 -44.74 73.84 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.607 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 95.8 mt -64.4 -41.9 96.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.108 0.963 . . . . 0.0 112.688 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.69 -32.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.148 0.579 . . . . 0.0 110.489 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.02 62.47 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.448 1.099 . . . . 0.0 112.656 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HD3' HG22 ' A' ' 53' ' ' ILE . 11.8 pttp -63.71 -39.28 93.91 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 95' ' ' GLU . . . -77.83 -12.93 83.96 Favored Glycine 0 C--N 1.356 1.694 0 O-C-N 123.889 0.743 . . . . 0.0 114.147 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.82 -30.89 62.96 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 -37.46 10.36 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 0.0 110.182 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 33.5 tt0 -72.75 83.23 1.17 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.213 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -81.57 160.85 23.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.851 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -62.81 101.97 0.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.426 0.69 . . . . 0.0 110.951 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -130.57 153.95 48.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.143 1.377 . . . . 0.0 108.822 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -62.69 104.07 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.096 0.558 . . . . 0.0 110.787 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -126.15 20.59 7.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.181 0.992 . . . . 0.0 110.367 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.6 t60 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 109.558 -170.842 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.8 m -68.33 112.19 5.06 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -74.67 164.64 26.35 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 122.883 0.473 . . . . 0.0 111.678 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.9 m -57.64 -29.45 64.59 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.001 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.06 -52.3 63.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.896 0.479 . . . . 0.0 111.282 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -61.89 -32.38 72.75 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.863 0.727 . . . . 0.0 110.573 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 11' ' ' ILE . 25.8 mmt180 -66.05 -53.08 42.84 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.838 0.855 . . . . 0.0 111.409 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 81' ' ' ALA . 69.9 t -62.91 -38.09 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.361 0.601 . . . . 0.0 110.748 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.513 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -67.97 -39.75 83.27 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.271 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 7.6 t -73.73 -27.65 61.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.243 0.217 . . . . 0.0 110.865 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 7' ' ' ARG . 34.6 mm -61.02 -55.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 18' ' ' ILE . 60.3 mt -66.51 -29.9 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.645 0.778 . . . . 0.0 111.034 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.33 -51.3 70.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.995 0.918 . . . . 0.0 111.247 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.8 mm-40 -78.98 -28.33 43.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.66 0.384 . . . . 0.0 111.676 -177.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -75.53 -61.68 1.83 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.897 0.479 . . . . 0.0 110.838 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 43' ' ' ILE . 58.6 m -95.54 7.4 46.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.402 0.681 . . . . 0.0 112.307 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.29 67.94 0.92 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.343 1.057 . . . . 0.0 111.126 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 12' ' ' ILE . 23.6 mt -121.77 122.06 27.96 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 139.73 84.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.516 2.144 . . . . 0.0 112.21 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -58.65 -35.4 72.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 0.0 111.511 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.42 -37.53 86.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.043 0.937 . . . . 0.0 111.883 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 p -84.48 -13.65 51.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.191 0.596 . . . . 0.0 111.419 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB1' ' A' ' 9' ' ' ALA . 88.9 mt -81.46 113.46 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.341 0.656 . . . . 0.0 109.295 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 p -117.78 158.3 45.95 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 109.486 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 58.3 Cg_exo -55.36 -33.16 84.44 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.868 2.379 . . . . 0.0 113.506 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.17 -0.58 56.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.597 0.759 . . . . 0.0 112.441 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 26.6 m -72.59 129.2 37.74 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.3 t-80 -98.5 133.06 43.39 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -53.3 -60.14 3.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.092 0.557 . . . . 0.0 111.98 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -75.11 -42.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.451 0.301 . . . . 0.0 111.755 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.05 -56.94 3.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.371 0.668 . . . . 0.0 111.844 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -82.54 -61.52 1.86 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.266 0.626 . . . . 0.0 110.638 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 77' ' ' LEU . 79.6 mt -69.94 -19.28 63.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.054 0.942 . . . . 0.0 111.332 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.73 90.11 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 43' ' ' ILE . 85.0 mt -68.63 98.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.648 1.179 . . . . 0.0 110.346 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.23 165.78 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.094 0.957 . . . . 0.0 111.506 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.0 p -48.43 -28.2 3.12 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.013 1.325 . . . . 0.0 113.57 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.35 -40.84 16.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.504 0.721 . . . . 0.0 110.442 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.32 -30.76 69.82 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.3 0.572 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -74.38 -20.2 60.15 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 57' ' ' LEU . 73.2 mt -56.82 -41.11 77.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.157 0.435 . . . . 0.0 111.115 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.18 -35.94 69.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.809 0.844 . . . . 0.0 110.538 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.659 HD11 ' SG ' ' A' ' 16' ' ' CYS . 37.7 mt -64.07 -48.98 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.13 0.572 . . . . 0.0 110.107 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.34 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.302 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -67.33 -43.37 81.75 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.187 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.49 76.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 111.579 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 84' ' ' ILE . 91.4 mt -69.57 -37.66 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 110.692 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -56.78 -47.51 80.0 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.0 0.52 . . . . 0.0 111.056 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -71.21 -48.18 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.573 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.58 -52.64 36.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.929 0.891 . . . . 0.0 111.53 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -86.65 -11.95 49.87 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 111.933 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.94 38.57 84.95 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.286 0.366 . . . . 0.0 112.55 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.506 HG22 ' HD3' ' A' ' 91' ' ' LYS . 36.5 pt -126.72 -173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.11 0.964 . . . . 0.0 110.72 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -126.94 96.4 4.61 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -76.07 108.37 5.99 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.11 84.56 1.53 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.792 1.661 . . . . 0.0 110.616 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 41' ' ' LEU . 54.0 tp -66.48 -32.21 73.43 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.773 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.96 -33.9 75.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.206 1.002 . . . . 0.0 111.108 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 56.8 tttp -72.92 -58.8 3.06 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.897 0.879 . . . . 0.0 109.771 172.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -57.18 -44.3 83.44 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.259 1.024 . . . . 0.0 111.966 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 m -63.74 -36.51 84.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -74.62 -30.76 61.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.5 mm-40 -60.3 -39.4 86.82 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.302 0.641 . . . . 0.0 109.317 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.1 -44.44 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.779 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.594 0.757 . . . . 0.0 112.358 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.49 -18.87 21.81 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.103 0.961 . . . . 0.0 111.189 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.15 59.23 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 113.375 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.56 -23.76 61.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.296 0.639 . . . . 0.0 110.943 169.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.36 26.4 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.692 0.797 . . . . 0.0 110.257 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.0 t -107.15 156.48 18.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.496 0.718 . . . . 0.0 110.334 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.9 p -63.14 -33.78 76.21 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.087 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.18 -33.72 75.06 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.534 0.734 . . . . 0.0 111.986 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 70' ' ' THR . 58.2 tt0 -65.36 -28.36 69.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.589 . . . . 0.0 111.675 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -106.84 -76.99 0.6 Allowed 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.581 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.5 m-85 -59.18 -19.06 41.94 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -162.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 98.8 t -65.11 124.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 33' ' ' LEU . 72.3 mt -58.86 -36.71 75.06 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 60.9 pttt -61.29 -42.35 98.5 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -72.4 -44.94 61.79 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -55.29 -44.96 76.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.684 1.594 . . . . 0.0 110.676 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.528 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.36 61.56 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.711 0.632 . . . . 0.0 111.548 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.2 mmm180 -71.32 -35.79 71.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.663 0.785 . . . . 0.0 111.354 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.403 HD11 HD13 ' A' ' 47' ' ' ILE . 96.3 mt -71.81 -39.61 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.348 0.659 . . . . 0.0 109.712 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 25.2 t70 -57.25 -38.97 74.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.726 0.81 . . . . 0.0 111.397 170.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -60.83 -45.96 92.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.01 0.924 . . . . 0.0 110.009 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 91.6 mt -66.58 -42.75 86.51 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.016 0.926 . . . . 0.0 113.275 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 24.1 m -70.51 -31.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.058 0.456 . . . . 0.0 110.474 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.28 -51.81 27.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.718 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.59 71.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.974 1.309 . . . . 0.0 113.559 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' HA ' HD12 ' A' ' 94' ' ' LEU . 21.9 pttp -57.77 -31.02 66.1 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.31 0.644 . . . . 0.0 112.042 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.9 44.72 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.114 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.71 -34.72 78.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.763 1.225 . . . . 0.0 111.767 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 91' ' ' LYS . 96.7 mt -51.42 -47.87 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.004 0.922 . . . . 0.0 109.653 170.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.86 -25.58 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.509 1.523 . . . . 0.0 112.458 167.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -64.28 110.57 2.27 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.623 0.769 . . . . 0.0 110.149 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -77.08 152.43 35.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.192 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -74.59 81.6 2.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.879 0.872 . . . . 0.0 110.492 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -130.55 19.54 5.2 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.017 1.327 . . . . 0.0 109.938 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -149.63 111.61 4.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.25 1.087 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.123 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.5 m -122.76 125.58 45.77 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -66.74 144.58 56.25 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.193 0.597 . . . . 0.0 111.193 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.5 m -59.14 -25.24 63.71 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.575 -176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -66.57 -49.62 65.82 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.81 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.13 -41.35 68.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.13 0.894 . . . . 0.0 111.356 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.82 -46.45 62.76 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.802 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -60.92 -36.46 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 122.994 0.518 . . . . 0.0 110.911 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.89 85.15 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.559 1.144 . . . . 0.0 110.089 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.6 m -56.02 -47.07 78.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.235 1.014 . . . . 0.0 111.671 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 47' ' ' ILE . 33.3 mm -59.2 -51.59 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.84 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' A' ' 16' ' ' CYS . 71.1 mt -63.95 -34.77 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.82 0.848 . . . . 0.0 111.289 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -60.25 -52.28 65.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.884 0.474 . . . . 0.0 111.866 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -72.51 -37.69 68.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.581 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.6 m -74.42 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.335 0.654 . . . . 0.0 110.785 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.679 ' SG ' HD11 ' A' ' 43' ' ' ILE . 3.3 m -82.09 -1.16 47.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.04 0.936 . . . . 0.0 113.341 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 64.28 22.67 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.373 1.082 . . . . 0.0 111.048 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 82.3 mt -96.0 126.4 44.75 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.524 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 40.9 Cg_endo -65.16 145.61 84.84 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.627 2.218 . . . . 0.0 112.177 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -60.11 -27.64 67.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.663 1.185 . . . . 0.0 112.653 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.8 -26.79 68.49 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.783 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.477 HG23 ' HG3' ' A' ' 21' ' ' GLU . 80.1 p -108.87 15.41 23.52 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.377 0.671 . . . . 0.0 111.236 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.72 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -121.46 151.31 56.33 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.908 0.883 . . . . 0.0 109.712 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.22 -36.23 66.41 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.037 2.491 . . . . 0.0 113.374 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.66 -17.68 59.89 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.494 0.718 . . . . 0.0 112.067 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 t -68.68 142.54 55.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.506 0.723 . . . . 0.0 111.202 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 42.3 t-80 -105.75 133.45 50.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.659 1.184 . . . . 0.0 108.715 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.96 -56.72 11.04 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.349 0.66 . . . . 0.0 112.524 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.5 -51.13 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.462 0.305 . . . . 0.0 110.76 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.4 t70 -69.94 -42.78 72.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.608 0.763 . . . . 0.0 112.465 -170.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.48 -64.38 1.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.719 0.408 . . . . 0.0 110.044 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 95.5 mt -71.41 -25.07 62.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.771 0.828 . . . . 0.0 112.799 -171.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 45.96 31.31 Favored Glycine 0 N--CA 1.472 1.066 0 CA-C-O 120.969 0.205 . . . . 0.0 112.772 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 43' ' ' ILE . 68.1 mt -98.23 127.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 108.51 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -89.75 166.79 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.972 0.509 . . . . 0.0 109.839 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.8 m -59.38 -27.25 65.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.155 0.582 . . . . 0.0 111.968 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.89 -49.0 64.47 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.554 0.741 . . . . 0.0 111.028 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.63 -29.61 62.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.485 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -72.76 -23.22 60.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.477 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 57' ' ' LEU . 60.6 mt -60.34 -41.43 93.57 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.585 0.354 . . . . 0.0 110.239 170.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.45 -34.57 70.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.779 0.831 . . . . 0.0 111.156 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.679 HD11 ' SG ' ' A' ' 16' ' ' CYS . 63.7 mt -62.9 -51.54 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.6 76.27 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.823 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.94 -47.2 78.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.495 1.118 . . . . 0.0 110.161 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.65 72.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.077 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 11' ' ' ILE . 86.2 mt -71.18 -38.55 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.845 0.858 . . . . 0.0 111.157 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -51.3 -48.14 62.39 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.32 0.581 . . . . 0.0 110.882 173.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.49 -49.32 16.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.509 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.11 69.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.688 0.795 . . . . 0.0 111.906 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -84.52 -17.25 39.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.579 0.752 . . . . 0.0 111.688 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.57 48.61 35.12 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.03 177.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.332 1.053 . . . . 0.0 110.815 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -106.76 109.57 21.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 162.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -84.66 104.47 4.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 165.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.48 81.8 2.39 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.513 1.476 . . . . 0.0 111.082 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 41' ' ' LEU . 57.8 tp -69.7 -31.34 69.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.861 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.04 -33.54 73.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.04 0.936 . . . . 0.0 111.068 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.5 ttpp -82.58 -41.29 19.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.182 0.593 . . . . 0.0 110.365 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -69.98 -41.78 73.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.639 0.776 . . . . 0.0 111.939 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.3 m -60.72 -36.22 78.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.045 0.938 . . . . 0.0 110.483 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -69.52 -38.3 77.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.052 0.941 . . . . 0.0 110.49 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 80.2 mm-40 -56.15 -45.63 79.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.515 0.726 . . . . 0.0 110.287 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 62.8 t -67.82 -44.53 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.748 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.03 -28.94 70.44 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.845 0.858 . . . . 0.0 112.697 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -87.55 -9.82 53.35 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.147 0.579 . . . . 0.0 111.895 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.85 72.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 120.374 -0.126 . . . . 0.0 113.258 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -83.84 -22.67 31.64 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.755 0.822 . . . . 0.0 110.258 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -143.88 160.66 40.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.827 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -98.99 160.61 14.14 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.731 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.7 p -60.05 -29.84 68.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 171.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.545 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.3 tt0 -56.39 -46.87 79.93 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.589 0.756 . . . . 0.0 111.316 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -57.11 -31.61 65.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.472 0.709 . . . . 0.0 112.104 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.67 -74.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.459 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.5 m-85 -56.06 -25.36 44.77 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -165.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.2 t -62.6 126.14 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 119.91 1.232 . . . . 0.0 108.47 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -62.56 -36.5 82.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 112.641 -161.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' HG12 ' A' ' 76' ' ' VAL . 65.8 pttt -64.09 -39.33 93.82 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.247 0.342 . . . . 0.0 111.119 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.9 m-20 -75.81 -42.79 48.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.507 0.723 . . . . 0.0 110.277 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.1 tp -53.09 -49.41 66.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.833 1.253 . . . . 0.0 110.325 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.2 -33.04 73.79 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.014 0.821 . . . . 0.0 111.252 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.64 63.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.94 0.496 . . . . 0.0 110.539 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.3 mmm180 -64.04 -31.84 73.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.718 0.807 . . . . 0.0 111.76 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 -41.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.811 0.845 . . . . 0.0 110.534 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 22.1 t70 -56.44 -36.55 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.577 0.751 . . . . 0.0 111.591 172.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 10.6 tp10 -59.26 -47.25 86.08 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.975 0.91 . . . . 0.0 110.671 172.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 59.6 mt -64.5 -46.96 80.69 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.002 0.921 . . . . 0.0 112.434 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.9 m -67.89 -29.0 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.048 0.451 . . . . 0.0 110.657 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.81 -42.37 67.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.898 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.44 68.14 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.166 0.986 . . . . 0.0 113.536 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -67.5 -35.91 80.05 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 123.185 0.303 . . . . 0.0 111.128 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.7 -11.5 77.57 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.68 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.58 -36.2 17.67 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.477 0.711 . . . . 0.0 110.895 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 79.5 mt -53.04 -61.29 2.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.96 0.904 . . . . 0.0 109.906 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.97 114.41 13.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 166.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -63.98 92.63 0.08 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.844 0.715 . . . . 0.0 112.38 -163.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -103.72 25.69 9.48 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -93.82 149.42 21.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.99 87.56 0.56 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 111.829 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -100.16 -30.48 11.9 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.921 0.889 . . . . 0.0 109.831 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 . . . . . 0 CA--C 1.56 1.328 0 C-N-CA 124.439 1.096 . . . . 0.0 108.665 176.768 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.4 m -65.36 103.79 0.86 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.195 0.998 . . . . 0.0 111.394 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -98.16 -171.85 2.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.467 0.707 . . . . 0.0 109.732 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.6 m -59.81 -34.09 72.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.584 0.354 . . . . 0.0 111.383 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -69.59 -44.56 70.5 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.145 0.278 . . . . 0.0 110.656 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.68 -35.89 82.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.286 0.634 . . . . 0.0 110.682 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 21.1 mmm180 -59.6 -57.69 11.85 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.713 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.42 -35.88 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.937 0.895 . . . . 0.0 111.193 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.6 90.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.252 1.021 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 14.9 m -60.86 -43.61 98.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 111.281 172.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.49 -50.23 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.322 0.649 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 43' ' ' ILE . 72.6 mt -62.18 -39.62 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.342 1.057 . . . . 0.0 111.223 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.03 87.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.089 0.555 . . . . 0.0 111.129 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.9 mm-40 -72.06 -38.95 69.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -69.71 -62.57 1.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.361 0.601 . . . . 0.0 110.745 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 43' ' ' ILE . 20.0 m -84.98 -10.14 57.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.845 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.15 24.21 12.56 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.747 0.819 . . . . 0.0 112.175 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.471 HD12 HD11 ' A' ' 35' ' ' ILE . 50.8 mt -77.46 128.41 80.22 Favored Pre-proline 0 C--O 1.246 0.88 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.86 128.82 27.98 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.683 2.256 . . . . 0.0 112.322 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 tpt85 -56.37 -32.31 64.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.486 1.114 . . . . 0.0 110.429 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.97 -38.48 91.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.208 1.003 . . . . 0.0 112.365 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -82.71 -9.83 59.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.764 0.425 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.63 113.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.457 0.703 . . . . 0.0 109.437 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 p -123.67 154.88 66.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.763 0.825 . . . . 0.0 109.187 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 -39.95 79.93 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.631 2.22 . . . . 0.0 112.61 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.03 -9.92 59.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.892 0.477 . . . . 0.0 112.236 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p -73.27 134.27 44.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.6 t-80 -90.5 131.59 36.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.97 0.908 . . . . 0.0 108.624 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.17 -55.53 20.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 0.0 112.214 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.1 -47.41 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.367 0.267 . . . . 0.0 111.442 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -72.6 -66.6 0.64 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.813 0.445 . . . . 0.0 112.064 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -75.72 -60.74 2.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.145 0.578 . . . . 0.0 111.429 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 77' ' ' LEU . 81.3 mt -69.27 -29.12 66.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.112 0.565 . . . . 0.0 111.921 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.28 85.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 43' ' ' ILE . 36.9 mt -73.85 98.94 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.437 0.695 . . . . 0.0 109.962 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.92 165.06 25.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.019 0.928 . . . . 0.0 109.974 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 57.0 p -51.56 -18.34 1.1 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.713 1.605 . . . . 0.0 114.585 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 mt -84.72 -44.28 13.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.545 0.611 . . . . 0.0 110.292 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.24 -34.01 65.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.986 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.11 -21.56 66.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.238 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 57' ' ' LEU . 94.1 mt -57.78 -38.39 75.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.243 0.617 . . . . 0.0 111.43 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.21 -30.65 48.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.589 HD11 ' SG ' ' A' ' 16' ' ' CYS . 41.8 mt -62.56 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.75 74.55 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -65.46 -43.26 90.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.021 0.928 . . . . 0.0 110.327 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.27 78.9 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.132 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 HD13 HD11 ' A' ' 84' ' ' ILE . 87.2 mt -65.17 -37.72 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.887 0.875 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -56.35 -42.06 77.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -82.88 -40.89 19.64 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.781 0.833 . . . . 0.0 111.272 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -68.92 -51.95 34.45 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.52 1.128 . . . . 0.0 111.349 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -87.91 -24.9 23.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.403 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.71 52.27 10.04 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.15 -176.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.28 1.032 . . . . 0.0 110.452 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -118.71 109.99 16.75 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.15 98.85 20.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 95.0 Cg_endo -85.4 85.12 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.383 2.055 . . . . 0.0 111.43 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 41' ' ' LEU . 42.2 tp -69.52 -32.51 71.4 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.58 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.6 -31.8 70.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.579 0.351 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 35.7 ttpt -80.84 -40.69 24.47 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.789 0.836 . . . . 0.0 109.913 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -59.11 -45.72 90.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.816 0.847 . . . . 0.0 110.51 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.2 m -72.34 -28.88 63.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.786 1.234 . . . . 0.0 111.452 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.66 -34.59 67.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.499 0.72 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.04 -32.79 74.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.68 0.792 . . . . 0.0 110.143 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 71' ' ' THR . 57.6 t -70.93 -43.19 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.075 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -58.27 -45.04 88.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.692 0.797 . . . . 0.0 112.189 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -85.92 -11.79 52.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.857 0.863 . . . . 0.0 111.79 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.59 69.93 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.229 0.331 . . . . 0.0 113.562 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -70.36 -27.11 64.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.99 0.916 . . . . 0.0 110.436 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.02 170.49 21.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.978 0.911 . . . . 0.0 110.335 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.4 t -107.37 158.67 16.98 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.439 0.696 . . . . 0.0 111.443 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 HG11 ' A' ' 64' ' ' VAL . 40.5 p -62.42 -36.62 82.93 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.08 0.952 . . . . 0.0 110.743 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -53.15 -41.67 65.37 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.89 0.876 . . . . 0.0 111.204 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.471 ' H ' HG23 ' A' ' 70' ' ' THR . 50.1 tt0 -63.68 -32.22 73.63 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.392 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.17 -8.45 12.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -169.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.1 m-85 -128.49 -29.24 2.44 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.513 -169.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 88.8 t -61.54 125.58 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 33' ' ' LEU . 26.9 mt -61.42 -34.14 74.88 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -161.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.82 -37.54 70.33 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.577 0.351 . . . . 0.0 111.362 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -68.2 -49.19 62.48 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.636 0.775 . . . . 0.0 109.873 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -51.86 -47.07 64.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.938 1.695 . . . . 0.0 111.481 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.72 67.06 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.11 -39.19 55.76 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.625 0.578 . . . . 0.0 110.665 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mmm180 -59.27 -48.22 82.45 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.566 0.746 . . . . 0.0 110.581 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 47' ' ' ILE . 98.7 mt -67.72 -42.7 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.694 1.197 . . . . 0.0 110.269 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 88' ' ' VAL . 30.9 t70 -56.69 -36.29 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.631 0.582 . . . . 0.0 111.914 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.99 -44.07 85.92 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.723 0.639 . . . . 0.0 110.461 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 82.0 mt -64.49 -40.9 96.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.724 0.81 . . . . 0.0 112.278 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.3 m -76.3 -28.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.855 0.462 . . . . 0.0 111.378 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.99 58.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.349 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.94 -47.41 80.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.662 1.185 . . . . 0.0 112.682 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.6 -32.89 73.94 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.27 0.228 . . . . 0.0 110.467 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.41 -23.73 76.35 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.72 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.47 -34.76 27.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.061 0.944 . . . . 0.0 109.884 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.35 -14.62 41.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.045 0.938 . . . . 0.0 112.453 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -58.44 -39.4 79.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.531 0.682 . . . . 0.0 109.627 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -96.23 54.43 1.42 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.209 1.004 . . . . 0.0 109.538 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -75.17 107.53 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.312 0.645 . . . . 0.0 109.391 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -98.88 141.79 31.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.678 0.791 . . . . 0.0 109.625 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -84.66 71.94 10.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.886 0.474 . . . . 0.0 110.395 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.1 -37.77 84.52 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.213 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 t -94.82 158.32 15.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.169 0.587 . . . . 0.0 110.686 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -67.17 164.4 18.2 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.056 0.942 . . . . 0.0 112.384 -175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 8' ' ' VAL . 31.0 m -57.17 -34.75 68.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.663 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -58.67 -54.66 44.52 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.689 0.618 . . . . 0.0 111.536 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.61 -28.47 69.15 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.039 0.837 . . . . 0.0 110.195 -173.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -69.8 -46.04 66.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.701 0.8 . . . . 0.0 111.659 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 84.8 t -64.19 -35.76 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.324 0.65 . . . . 0.0 110.525 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.06 99.43 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 110.284 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.8 m -56.34 -49.78 73.39 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.186 171.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.594 HG21 HG13 ' A' ' 47' ' ' ILE . 44.9 mm -59.58 -49.61 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 123.775 0.672 . . . . 0.0 110.731 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.18 -36.83 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.334 0.654 . . . . 0.0 111.126 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.94 83.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.518 0.727 . . . . 0.0 111.924 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.25 -51.73 14.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 0.0 112.359 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -66.6 -57.84 6.4 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.39 1.076 . . . . 0.0 111.189 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 35' ' ' ILE . 49.5 t -82.93 -9.93 59.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.662 0.785 . . . . 0.0 111.878 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.35 76.96 0.31 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.518 1.127 . . . . 0.0 110.4 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mt -127.59 135.35 27.32 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.081 0.952 . . . . 0.0 109.222 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.57 119.49 4.73 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.33 2.686 . . . . 0.0 111.346 168.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -65.14 -25.18 67.64 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.051 0.941 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -65.81 -33.73 76.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 111.886 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -86.83 -17.94 32.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.143 0.577 . . . . 0.0 111.177 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.31 110.23 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -119.74 158.46 49.59 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.889 0.876 . . . . 0.0 109.535 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 -33.1 97.35 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.399 2.066 . . . . 0.0 112.401 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.4 -11.04 44.33 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 73.5 p -70.53 127.5 32.92 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.9 t-80 -91.75 133.06 35.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.227 1.011 . . . . 0.0 108.875 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.74 -59.76 3.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.634 0.774 . . . . 0.0 112.697 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -72.71 -57.56 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 120.838 0.351 . . . . 0.0 110.381 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 16.8 t70 -58.96 -49.63 77.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.246 . . . . 0.0 112.852 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.82 -58.87 1.82 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.685 0.394 . . . . 0.0 111.529 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 92.7 mt -74.19 -11.84 60.41 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.338 0.655 . . . . 0.0 112.012 -171.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.01 88.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.815 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.541 HG12 ' SG ' ' A' ' 16' ' ' CYS . 59.0 mt -74.01 102.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 109.987 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.92 156.24 38.87 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -57.05 -16.96 8.36 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.696 0.798 . . . . 0.0 112.875 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.92 -36.98 18.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.338 0.655 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.35 -30.4 68.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.504 0.669 . . . . 0.0 109.855 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.27 63.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.424 1.09 . . . . 0.0 111.996 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 57' ' ' LEU . 93.6 mt -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.566 0.747 . . . . 0.0 110.412 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.21 -38.5 81.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.402 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.27 -42.32 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.663 0.602 . . . . 0.0 110.035 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -62.79 -36.89 84.62 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -75.06 -37.9 61.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.139 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.74 71.73 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.66 0.384 . . . . 0.0 110.975 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.594 HG13 HG21 ' A' ' 11' ' ' ILE . 96.6 mt -72.55 -39.61 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.853 0.861 . . . . 0.0 110.087 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.05 -44.86 71.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.469 1.108 . . . . 0.0 110.262 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.26 -44.88 28.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.21 1.004 . . . . 0.0 111.371 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.34 -53.83 46.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.424 0.69 . . . . 0.0 111.91 -172.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.62 -12.67 58.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.136 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.07 39.56 84.04 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.427 0.455 . . . . 0.0 111.971 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 pt -119.91 173.98 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 0.0 110.087 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -106.86 102.62 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD22 ' HB1' ' A' ' 44' ' ' ALA . 7.3 tt -88.56 109.47 29.59 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -88.82 83.04 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.772 1.648 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 41' ' ' LEU . 46.4 tp -72.47 -25.35 61.4 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.293 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.52 -36.41 66.69 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.789 0.835 . . . . 0.0 110.94 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -79.12 -47.58 15.84 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.025 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.402 ' HB2' HD12 ' A' ' 57' ' ' LEU . 41.7 m0 -61.01 -51.22 70.17 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.905 0.882 . . . . 0.0 111.384 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -55.13 -44.76 75.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.734 1.214 . . . . 0.0 111.76 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.28 -40.19 96.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.351 0.66 . . . . 0.0 110.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.04 -38.69 92.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.595 0.758 . . . . 0.0 110.852 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.56 -47.16 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.378 0.671 . . . . 0.0 110.601 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.31 -16.3 62.45 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.73 0.812 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -93.51 -8.3 41.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.27 0.628 . . . . 0.0 110.274 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.89 79.73 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 114.281 0.472 . . . . 0.0 114.281 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.41 -55.3 4.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.133 0.573 . . . . 0.0 109.922 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.54 163.66 12.48 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -99.39 157.46 16.4 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.597 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.0 p -61.59 -34.19 75.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.77 0.828 . . . . 0.0 110.4 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.521 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.5 tt0 -49.86 -46.14 51.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 111.633 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.19 -28.81 69.93 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.7 0.8 . . . . 0.0 113.073 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -121.16 0.08 10.06 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 92.0 m-85 -131.81 -31.39 1.53 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.628 0.649 . . . . 0.0 111.403 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 72' ' ' GLU . 86.5 t -65.01 125.24 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 16.2 mt -61.45 -33.35 73.58 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -162.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -65.76 -41.9 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.259 0.349 . . . . 0.0 111.674 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.75 -46.22 38.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 0.0 109.942 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.37 -49.71 63.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.337 1.455 . . . . 0.0 110.771 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.42 64.89 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.546 0.739 . . . . 0.0 111.311 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.51 66.57 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 123.724 0.64 . . . . 0.0 110.259 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -59.91 -43.14 95.04 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.593 0.757 . . . . 0.0 110.761 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.57 -40.21 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.599 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 28.0 t70 -57.21 -31.36 65.39 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.559 0.744 . . . . 0.0 111.889 171.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.91 -42.94 72.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.196 0.31 . . . . 0.0 110.182 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.1 -40.43 90.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.479 0.712 . . . . 0.0 111.735 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 15.9 m -73.72 -29.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.954 0.501 . . . . 0.0 110.906 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.44 86.23 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.342 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.93 -47.62 74.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 22.0 pttp -67.2 -35.69 80.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.276 0.23 . . . . 0.0 111.136 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.28 -14.5 82.28 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 116.584 -0.28 . . . . 0.0 113.796 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.55 -35.26 30.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.995 0.918 . . . . 0.0 109.783 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.85 -23.26 67.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.97 0.908 . . . . 0.0 111.282 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.6 128.82 34.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -61.37 -28.13 69.01 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 117.964 0.347 . . . . 0.0 111.004 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -133.14 134.67 44.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.846 0.858 . . . . 0.0 108.976 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -70.46 159.16 34.74 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.706 0.802 . . . . 0.0 111.029 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -57.44 121.22 9.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.738 0.815 . . . . 0.0 111.717 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -73.42 119.67 17.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.479 0.711 . . . . 0.0 109.828 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.275 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.4 m -86.72 129.12 35.0 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.753 0.821 . . . . 0.0 109.619 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -57.33 135.06 56.48 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.08 0.862 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 47.9 m -60.38 -26.31 66.54 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.262 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -62.52 -43.38 98.94 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.95 0.5 . . . . 0.0 111.447 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.17 -40.6 98.0 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 11' ' ' ILE . 26.8 mmt180 -61.53 -54.49 42.53 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.001 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 84.1 t -62.13 -35.52 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.191 0.997 . . . . 0.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.93 83.5 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.019 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 96.4 m -59.88 -46.5 89.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.806 0.843 . . . . 0.0 111.64 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 7' ' ' ARG . 38.9 mm -61.33 -50.16 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.805 0.442 . . . . 0.0 110.783 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 HD22 ' A' ' 77' ' ' LEU . 56.2 mt -67.67 -30.25 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 122.968 0.507 . . . . 0.0 110.828 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.08 95.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 10' ' ' THR . 16.6 mm-40 -73.87 -45.71 49.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.838 0.455 . . . . 0.0 111.586 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -66.78 -59.59 3.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.836 0.854 . . . . 0.0 111.447 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 43' ' ' ILE . 64.3 m -92.43 4.63 53.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.31 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.19 67.98 0.91 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.76 1.224 . . . . 0.0 111.515 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.72 120.48 21.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_exo -61.64 148.4 93.11 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.531 2.154 . . . . 0.0 112.84 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -63.16 -28.26 69.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.659 0.784 . . . . 0.0 111.419 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -65.08 -30.35 71.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -93.82 -11.54 31.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 0.0 111.269 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.28 122.58 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.965 0.906 . . . . 0.0 109.838 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.9 p -133.63 161.59 62.81 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 124.332 1.053 . . . . 0.0 108.924 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 -30.52 88.35 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.845 2.363 . . . . 0.0 113.225 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -89.8 -5.36 56.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.885 0.874 . . . . 0.0 112.275 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.3 m -62.33 99.95 0.16 Allowed 'General case' 0 C--N 1.353 0.755 0 C-N-CA 122.964 0.506 . . . . 0.0 110.987 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 58.7 t-80 -73.22 125.38 27.62 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 168.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.04 -53.42 20.27 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.88 0.738 . . . . 0.0 112.35 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.08 -45.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 117.878 0.308 . . . . 0.0 110.985 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.8 t70 -70.44 -74.34 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.216 0.322 . . . . 0.0 111.126 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.49 -53.64 10.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.685 0.394 . . . . 0.0 111.671 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.53 -18.23 59.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.99 79.42 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HD11 ' A' ' 43' ' ' ILE . 82.6 mt -86.05 116.54 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.151 1.38 . . . . 0.0 110.61 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.18 165.16 21.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.918 0.887 . . . . 0.0 109.512 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -56.99 -17.29 9.2 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.739 1.216 . . . . 0.0 113.142 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.92 -45.71 16.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.726 0.81 . . . . 0.0 110.114 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.57 -26.1 60.68 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.596 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.94 -20.75 63.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.27 1.028 . . . . 0.0 111.063 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 57' ' ' LEU . 92.1 mt -57.93 -43.32 86.21 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.962 0.505 . . . . 0.0 110.481 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.66 -36.22 83.04 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.399 1.08 . . . . 0.0 111.336 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.763 HD11 HD13 ' A' ' 35' ' ' ILE . 47.3 mt -62.32 -49.92 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -34.28 77.61 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 124.53 1.144 . . . . 0.0 110.201 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -64.13 -49.68 71.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.27 1.028 . . . . 0.0 110.967 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.4 80.16 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.32 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 84' ' ' ILE . 64.7 mt -69.54 -40.92 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.358 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -60.93 -41.8 96.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.949 0.5 . . . . 0.0 111.343 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.37 -42.27 62.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.443 0.697 . . . . 0.0 111.394 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.55 -58.84 3.99 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.695 0.798 . . . . 0.0 111.031 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.47 -19.9 35.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.697 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.81 56.43 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.435 0.459 . . . . 0.0 111.964 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 pt -120.91 -174.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.082 0.953 . . . . 0.0 111.193 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.21 105.59 11.11 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.16 0.984 . . . . 0.0 108.61 169.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 80' ' ' LEU . 7.3 tt -88.37 102.65 4.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 166.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.64 81.46 2.23 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 110.871 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 41' ' ' LEU . 39.8 tp -71.6 -33.95 69.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.852 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.67 -37.81 76.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.766 0.826 . . . . 0.0 111.043 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.756 0.822 . . . . 0.0 110.523 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -64.29 -40.37 95.8 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.528 0.731 . . . . 0.0 110.97 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.1 m -55.06 -46.01 75.34 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.121 0.969 . . . . 0.0 111.407 171.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.48 -33.11 74.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.98 0.512 . . . . 0.0 111.248 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.89 -46.73 84.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.764 0.426 . . . . 0.0 110.443 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 48.6 t -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.599 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.61 -35.2 75.55 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.973 0.909 . . . . 0.0 113.127 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.28 -8.97 49.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.316 0.646 . . . . 0.0 111.394 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.28 67.95 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 122.358 -0.214 . . . . 0.0 113.623 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.3 mmpt? -73.03 -33.14 65.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.426 0.691 . . . . 0.0 110.216 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -142.25 163.03 33.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.939 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -107.61 158.99 16.79 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.193 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 HG11 ' A' ' 64' ' ' VAL . 28.7 p -58.13 -30.43 66.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.425 0.69 . . . . 0.0 111.494 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 9.1 tm-20 -53.48 -45.05 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.705 0.802 . . . . 0.0 111.146 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' HA ' HD22 ' A' ' 79' ' ' ASN . 58.1 tt0 -65.15 -23.48 67.13 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 4.16 6.55 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -123.78 -27.22 4.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.583 0.629 . . . . 0.0 111.57 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.9 t -64.34 132.68 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 27' ' ' SER . 31.1 mt -59.58 -43.91 93.49 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -169.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.39 -34.39 77.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 123.24 0.337 . . . . 0.0 111.446 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.549 HD22 ' HA ' ' A' ' 73' ' ' GLN . 5.1 m-20 -70.86 -51.61 25.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.05 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 55' ' ' LEU . 48.2 tp -54.47 -44.25 72.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.13 . . . . 0.0 110.886 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.72 81.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.265 1.026 . . . . 0.0 111.669 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.73 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.646 0.591 . . . . 0.0 110.373 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mmm180 -59.88 -42.87 94.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.787 0.835 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.527 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -68.74 -36.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.584 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.3 t70 -58.17 -34.38 70.25 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.985 0.514 . . . . 0.0 111.58 170.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -43.13 85.11 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 58.3 mt -67.19 -40.4 86.53 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.805 0.842 . . . . 0.0 112.124 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 85' ' ' ASP . 31.6 m -75.44 -29.47 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.201 0.6 . . . . 0.0 111.171 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.71 89.66 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.042 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -55.29 -46.82 76.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.376 1.07 . . . . 0.0 112.468 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -63.32 -38.11 89.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 118.203 0.456 . . . . 0.0 110.829 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.5 -25.13 72.64 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.863 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.92 -38.53 20.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.117 0.967 . . . . 0.0 110.524 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 77.7 mt -61.63 -36.98 82.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.562 0.745 . . . . 0.0 109.963 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.03 116.74 12.79 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -146.17 107.94 4.32 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.942 0.897 . . . . 0.0 108.815 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -73.6 156.23 38.27 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -61.86 -41.61 98.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.032 0.533 . . . . 0.0 110.539 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -85.61 121.24 28.01 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.646 0.778 . . . . 0.0 109.759 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.7 101.96 5.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 123.929 0.892 . . . . 0.0 108.761 179.122 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.528 HG23 ' HE ' ' A' ' 7' ' ' ARG . 42.0 m -68.17 112.15 4.94 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.312 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.627 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 59.5 p -143.1 172.28 12.92 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.994 1.318 . . . . 0.0 108.513 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.3 m -63.55 -36.08 82.6 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 122.985 0.178 . . . . 0.0 110.605 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -67.61 -44.61 77.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.394 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 3' ' ' SER . 10.5 t70 -52.21 -46.94 65.83 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.985 0.803 . . . . 0.0 111.21 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HE ' HG23 ' A' ' 2' ' ' THR . 20.7 mmt85 -71.63 -43.8 65.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.868 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.88 -41.11 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.814 0.446 . . . . 0.0 110.958 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.13 92.88 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.29 1.036 . . . . 0.0 110.508 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.4 m -56.25 -49.01 75.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 0.0 110.841 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.19 -46.31 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.114 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 43' ' ' ILE . 75.6 mt -62.35 -42.5 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.919 0.888 . . . . 0.0 110.86 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.78 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 0.0 111.918 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.62 -43.32 69.51 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.614 0.766 . . . . 0.0 111.519 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.1 m -65.44 -63.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.376 0.67 . . . . 0.0 111.849 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.66 -1.47 56.84 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.612 0.765 . . . . 0.0 111.577 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.34 77.8 0.28 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.723 1.209 . . . . 0.0 110.89 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 54.5 mt -136.06 132.2 19.13 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.299 1.04 . . . . 0.0 108.8 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.5 135.52 39.57 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.591 2.194 . . . . 0.0 111.488 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' THR . 25.7 mtm180 -71.93 -22.63 61.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.578 0.351 . . . . 0.0 111.866 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.32 -15.06 62.14 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.159 0.584 . . . . 0.0 111.667 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -105.57 -18.83 13.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.001 0.521 . . . . 0.0 110.568 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 87.3 mt -77.77 106.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . 73.8 p -111.84 154.54 44.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.858 0.863 . . . . 0.0 109.478 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 39.2 Cg_endo -64.08 -22.81 67.57 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.279 1.986 . . . . 0.0 111.534 174.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.41 -17.56 51.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.844 0.858 . . . . 0.0 111.415 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.6 t -73.95 150.8 40.57 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.929 0.892 . . . . 0.0 110.724 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.6 t-80 -107.84 134.46 50.76 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.848 1.259 . . . . 0.0 109.151 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.41 -55.03 14.43 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.882 0.873 . . . . 0.0 112.657 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -76.94 -53.88 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 122.165 0.186 . . . . 0.0 110.944 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 29.3 m-20 -65.58 -52.77 49.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -89.38 -59.77 2.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.745 0.418 . . . . 0.0 111.078 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 77' ' ' LEU . 87.3 mt -68.25 -21.44 64.82 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 22.02 65.52 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 123.388 0.43 . . . . 0.0 113.44 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.7 mt -80.9 130.01 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 123.957 0.903 . . . . 0.0 110.013 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -89.34 160.35 16.91 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 50.3 m -59.25 -19.05 42.6 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.308 0.643 . . . . 0.0 112.562 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -76.89 -42.19 40.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.678 0.791 . . . . 0.0 110.872 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.57 -32.71 64.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.215 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 -22.17 65.17 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.67 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 57' ' ' LEU . 95.7 mt -59.5 -42.97 93.39 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.73 -36.03 70.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.406 1.083 . . . . 0.0 110.698 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.491 HD13 HG12 ' A' ' 12' ' ' ILE . 61.3 mt -65.26 -48.32 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.024 0.53 . . . . 0.0 109.879 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.13 83.09 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.955 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -67.87 -40.06 83.64 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.248 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.35 75.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.809 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.78 -38.84 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.95 0.9 . . . . 0.0 110.839 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.35 -43.61 83.59 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.383 0.673 . . . . 0.0 111.096 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -81.54 -26.04 35.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.058 0.943 . . . . 0.0 112.302 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.71 -58.11 3.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.798 0.839 . . . . 0.0 110.651 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.438 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 95.5 m-85 -81.9 -27.56 33.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.051 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.13 46.4 7.64 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.429 HG22 ' HD3' ' A' ' 91' ' ' LYS . 43.3 pt -128.68 -175.34 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.511 1.124 . . . . 0.0 110.257 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -120.29 107.56 13.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 163.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -77.94 107.11 4.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 165.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.92 81.34 2.43 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.63 1.553 . . . . 0.0 110.965 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 41' ' ' LEU . 24.4 tp -70.23 -24.23 63.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.308 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.78 -38.3 72.3 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.997 0.919 . . . . 0.0 111.284 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.9 tttp -74.56 -53.57 9.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.067 0.547 . . . . 0.0 109.732 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -60.49 -46.95 88.23 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.055 0.847 . . . . 0.0 111.618 -168.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.3 m -54.28 -48.55 71.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.987 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.65 -33.88 75.93 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.675 0.79 . . . . 0.0 110.811 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 36.7 mm-40 -61.97 -40.57 96.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.856 0.862 . . . . 0.0 110.686 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.78 -45.9 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 122.717 0.407 . . . . 0.0 110.136 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -51.4 -44.08 62.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.96 1.304 . . . . 0.0 112.409 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.03 0.72 41.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.51 19.37 76.24 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 113.596 0.199 . . . . 0.0 113.596 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -75.85 -17.12 59.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.153 0.981 . . . . 0.0 111.922 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -167.24 166.03 15.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.664 1.186 . . . . 0.0 109.07 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.2 t -105.36 162.01 13.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.38 0.672 . . . . 0.0 110.821 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.5 p -65.06 -30.89 71.89 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.816 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.36 -45.54 84.28 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.766 0.427 . . . . 0.0 110.263 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 70' ' ' THR . 25.5 tt0 -60.92 -30.6 70.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 112.042 -171.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.49 -65.01 1.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.563 0.345 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -65.34 -21.58 66.72 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.3 t -62.03 127.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 119.872 1.215 . . . . 0.0 108.057 168.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 33' ' ' LEU . 39.3 mt -65.09 -32.94 74.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -160.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.8 pttp -62.96 -37.21 86.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 172.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 62.6 m-20 -77.15 -44.89 28.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.746 0.818 . . . . 0.0 109.631 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.92 -50.48 61.05 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 110.268 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.35 -30.83 70.75 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.14 -42.09 69.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.666 0.386 . . . . 0.0 110.881 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 16.4 mmm180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.197 0.999 . . . . 0.0 110.433 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.59 -40.04 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.62 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.489 ' HA ' HG22 ' A' ' 88' ' ' VAL . 27.1 t70 -60.39 -33.86 73.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.968 0.507 . . . . 0.0 111.612 172.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -38.38 79.96 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.544 0.528 . . . . 0.0 110.154 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 90.2 mt -66.99 -40.17 87.33 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.631 0.772 . . . . 0.0 112.398 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.9 m -72.54 -33.76 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 120.856 0.36 . . . . 0.0 110.389 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.49 80.35 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.1 86.82 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.051 1.341 . . . . 0.0 113.051 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 94' ' ' LEU . 23.0 pttp -64.91 -34.91 79.52 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.331 0.395 . . . . 0.0 111.028 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.66 -40.92 58.09 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.009 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.96 72.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.869 1.267 . . . . 0.0 111.809 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 91' ' ' LYS . 82.0 mt -58.51 -47.12 85.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.443 0.697 . . . . 0.0 110.594 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.52 145.62 41.17 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.928 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -82.97 84.65 7.37 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -89.3 50.77 1.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.665 1.186 . . . . 0.0 111.144 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -75.96 87.56 2.91 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -94.35 -64.95 1.02 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.87 165.55 33.27 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.42 1.088 . . . . 0.0 109.032 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.987 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 t -77.99 131.11 37.25 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 38.5 t -70.33 153.33 43.15 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.536 0.735 . . . . 0.0 111.011 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.4 m -57.65 -27.81 63.17 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.362 173.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -60.88 -53.72 53.86 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.451 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.67 -39.64 81.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.289 0.993 . . . . 0.0 111.847 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 3' ' ' SER . 68.4 mtt180 -69.83 -47.29 63.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 111.465 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 4' ' ' THR . 99.6 t -64.46 -35.5 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.146 0.578 . . . . 0.0 110.417 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.78 86.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 0.0 110.244 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -54.88 -49.23 71.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.907 1.283 . . . . 0.0 111.392 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 47' ' ' ILE . 34.9 mm -57.2 -52.41 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.775 0.83 . . . . 0.0 110.478 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG12 HD13 ' A' ' 43' ' ' ILE . 72.7 mt -64.93 -38.14 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.737 0.815 . . . . 0.0 111.157 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.34 77.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.052 0.941 . . . . 0.0 112.109 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -71.44 -52.91 15.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.357 0.663 . . . . 0.0 111.65 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -66.35 -45.38 80.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.341 0.656 . . . . 0.0 111.71 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 43' ' ' ILE . 41.7 m -96.36 5.46 50.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.81 26.68 15.72 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.176 0.99 . . . . 0.0 112.428 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.61 124.87 53.7 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.502 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -61.95 135.78 57.43 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.511 2.14 . . . . 0.0 112.412 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HD2' HD12 ' A' ' 23' ' ' ILE . 26.2 mmm-85 -59.91 -29.83 68.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.474 1.109 . . . . 0.0 112.165 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.22 -30.57 71.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.325 0.65 . . . . 0.0 111.647 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -96.05 -7.6 35.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.976 0.511 . . . . 0.0 111.533 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 20' ' ' ARG . 53.2 mt -80.89 123.19 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.247 0.619 . . . . 0.0 109.708 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -124.31 157.4 64.74 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.948 0.899 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.63 -37.38 88.42 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.81 2.34 . . . . 0.0 113.429 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.08 -7.26 58.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.136 0.574 . . . . 0.0 111.645 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -64.19 121.83 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.25 0.62 . . . . 0.0 110.906 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 65.3 t-80 -86.27 127.22 34.73 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.38 -54.75 27.78 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 59.7 mt -66.87 -54.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.015 0.197 . . . . 0.0 110.743 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.0 t70 -69.02 -66.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.35 -173.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.78 -55.63 5.63 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.343 -168.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 77' ' ' LEU . 90.1 mt -75.48 -14.48 60.43 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.161 0.584 . . . . 0.0 112.274 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.36 8.1 87.65 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 122.993 0.183 . . . . 0.0 113.403 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 43' ' ' ILE . 93.8 mt -85.01 99.52 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.873 1.269 . . . . 0.0 110.707 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.71 163.27 16.85 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.954 0.901 . . . . 0.0 110.09 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 t -57.02 -15.97 6.14 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.242 1.017 . . . . 0.0 113.0 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.87 -45.37 13.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 110.298 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.83 -31.34 70.25 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.101 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -67.41 -20.84 65.58 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.397 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.1 mt -57.85 -38.6 75.96 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.108 0.563 . . . . 0.0 111.273 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.22 -41.17 77.4 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.775 0.83 . . . . 0.0 110.854 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 35' ' ' ILE . 73.3 mt -61.7 -49.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.268 175.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -61.31 -40.23 93.41 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.411 -175.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -73.59 -34.22 64.98 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.56 64.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.678 0.391 . . . . 0.0 110.934 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 11' ' ' ILE . 91.1 mt -78.23 -38.18 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.504 1.121 . . . . 0.0 110.53 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.64 -40.81 66.15 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.066 0.946 . . . . 0.0 110.278 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -81.48 -50.0 9.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.907 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.56 67.39 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.37 0.668 . . . . 0.0 111.671 -171.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.51 -22.62 28.09 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.515 0.726 . . . . 0.0 110.548 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.58 10.96 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.28 -177.23 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.038 0.935 . . . . 0.0 110.659 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 56' ' ' PRO . 87.3 tttt -108.96 113.27 26.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 167.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.438 HD22 ' HB1' ' A' ' 44' ' ' ALA . 5.9 tt -103.79 96.62 9.38 Favored Pre-proline 0 C--O 1.243 0.746 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HB3' ' HE2' ' A' ' 54' ' ' LYS . 97.3 Cg_endo -83.03 84.05 1.82 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.98 1.787 . . . . 0.0 111.334 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.0 -28.45 69.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.33 -37.76 70.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.369 1.068 . . . . 0.0 111.049 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.2 tttp -80.51 -49.12 11.79 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 124.33 1.052 . . . . 0.0 110.321 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -59.02 -43.83 91.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.012 0.925 . . . . 0.0 111.008 -174.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -65.39 -40.53 93.59 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.676 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -63.71 -33.73 76.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.575 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 43.7 mm-40 -59.27 -38.27 79.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.306 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG11 HG23 ' A' ' 71' ' ' THR . 40.1 t -72.03 -45.38 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.161 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -59.52 -29.43 67.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.764 1.226 . . . . 0.0 112.639 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -99.3 -14.28 19.29 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.627 0.771 . . . . 0.0 111.051 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.31 63.85 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 116.607 -0.269 . . . . 0.0 113.308 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.28 -30.09 65.86 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 0.0 111.35 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 172.17 18.61 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.574 0.75 . . . . 0.0 111.098 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -108.6 154.07 22.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.866 0.866 . . . . 0.0 110.413 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG11 ' A' ' 64' ' ' VAL . 34.0 p -61.78 -28.58 69.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.381 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.2 tt0 -56.14 -44.93 79.68 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.532 0.733 . . . . 0.0 111.663 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.471 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -66.77 -21.73 66.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 122.776 0.431 . . . . 0.0 111.252 -174.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -104.36 -76.68 0.59 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.89 0.476 . . . . 0.0 110.952 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.4 m-85 -60.28 -24.14 64.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -165.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 91.9 t -63.14 127.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 119.195 0.907 . . . . 0.0 108.751 172.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 33' ' ' LEU . 26.3 mt -61.82 -36.94 82.61 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -162.077 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -68.12 -35.83 78.76 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.471 HD22 ' HA ' ' A' ' 73' ' ' GLN . 3.5 m-20 -72.3 -45.21 60.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.892 0.877 . . . . 0.0 110.52 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -53.93 -46.43 71.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.122 1.769 . . . . 0.0 111.349 170.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.66 71.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.156 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.05 61.68 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.689 0.618 . . . . 0.0 110.963 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -59.52 -47.88 83.8 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.971 0.909 . . . . 0.0 111.75 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.6 -38.35 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.769 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.05 -37.56 64.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.602 0.761 . . . . 0.0 111.643 169.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.44 -38.05 68.4 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.229 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.17 -40.58 94.48 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.526 0.73 . . . . 0.0 111.841 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 m -78.82 -20.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.58 73.96 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -52.2 -47.49 65.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.392 1.077 . . . . 0.0 113.107 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -65.58 -38.52 89.76 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.504 0.503 . . . . 0.0 111.094 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.18 -26.43 71.55 Favored Glycine 0 C--N 1.356 1.64 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.751 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.06 35.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.077 0.951 . . . . 0.0 110.136 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 96.0 mt -58.9 -33.76 70.9 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.072 0.949 . . . . 0.0 111.462 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.58 117.28 7.82 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.884 0.74 . . . . 0.0 109.869 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -140.28 115.91 10.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.657 0.783 . . . . 0.0 109.989 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -82.02 69.31 8.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.787 0.803 . . . . 0.0 109.358 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -147.24 130.17 16.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.173 . . . . 0.0 109.047 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -63.3 -37.83 88.78 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.118 0.967 . . . . 0.0 112.272 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -160.28 111.51 1.91 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.056 0.542 . . . . 0.0 109.565 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 CA--C 1.561 1.389 0 C-N-CA 123.358 0.663 . . . . 0.0 110.563 175.9 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.804 0.335 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.8 m -73.75 134.33 43.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.845 0.858 . . . . 0.0 110.73 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 m -118.2 171.92 7.78 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.363 0.665 . . . . 0.0 109.936 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.0 m -56.28 -32.75 64.84 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.397 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -64.11 -46.38 84.42 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.259 0.223 . . . . 0.0 111.356 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.99 -42.31 80.02 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.076 0.86 . . . . 0.0 111.093 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -63.56 -52.12 62.44 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.165 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.7 -38.81 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.373 0.669 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.47 -44.92 85.66 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.026 0.931 . . . . 0.0 110.126 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.0 m -56.62 -43.6 80.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.365 1.066 . . . . 0.0 112.041 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.425 HG21 HG13 ' A' ' 47' ' ' ILE . 32.7 mm -59.3 -55.25 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.609 0.763 . . . . 0.0 110.394 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.72 -35.14 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.196 0.935 . . . . 0.0 111.429 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -52.69 64.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.168 0.987 . . . . 0.0 111.728 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.2 -25.81 33.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 43' ' ' ILE . 19.0 p -73.96 -63.03 1.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.188 0.449 . . . . 0.0 110.801 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 43' ' ' ILE . 57.7 m -92.42 7.98 40.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.278 -171.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.1 30.87 20.76 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.454 1.102 . . . . 0.0 112.241 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 33' ' ' LEU . 62.9 mt -86.55 129.69 52.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 118.59 4.58 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.133 2.555 . . . . 0.0 112.375 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.2 tpt85 -57.83 -37.44 73.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.724 1.61 . . . . 0.0 111.727 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 9.1 pt-20 -63.1 -38.77 92.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.379 0.672 . . . . 0.0 111.539 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.24 -15.49 40.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.158 0.583 . . . . 0.0 112.236 -174.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.88 110.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.926 0.491 . . . . 0.0 110.142 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.1 p -112.69 154.23 44.82 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 59.6 Cg_exo -55.15 -36.66 93.62 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.108 2.539 . . . . 0.0 112.371 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.51 -28.01 62.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.413 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.5 p -70.37 137.03 50.19 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.889 0.476 . . . . 0.0 111.209 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 60.8 t-80 -89.7 130.17 36.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.667 1.187 . . . . 0.0 108.774 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.09 -59.95 3.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.741 0.816 . . . . 0.0 112.648 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.78 -48.86 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.1 t70 -69.89 -61.28 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.664 -173.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.72 -54.62 5.46 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.789 0.436 . . . . 0.0 110.9 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 77' ' ' LEU . 80.4 mt -82.36 -14.09 55.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.151 0.581 . . . . 0.0 112.042 -170.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.21 14.05 82.23 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 122.804 0.24 . . . . 0.0 113.511 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.69 115.25 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.83 0.852 . . . . 0.0 110.264 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -76.83 165.55 24.55 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.5 m -66.29 -18.04 65.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.464 0.575 . . . . 0.0 111.63 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.22 -38.27 19.14 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.833 0.853 . . . . 0.0 109.852 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.26 -26.82 64.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.545 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.48 -21.43 52.87 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.913 0.885 . . . . 0.0 110.612 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 57' ' ' LEU . 85.7 mt -55.44 -36.7 66.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.166 0.439 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -69.51 -39.45 77.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.544 1.138 . . . . 0.0 110.668 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 16' ' ' CYS . 58.8 mt -64.82 -51.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.625 0.77 . . . . 0.0 110.224 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.49 87.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.316 1.047 . . . . 0.0 110.624 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.1 -41.47 90.55 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.068 0.855 . . . . 0.0 110.332 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.27 76.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 111.336 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG13 HG21 ' A' ' 11' ' ' ILE . 84.2 mt -67.79 -39.26 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.336 1.054 . . . . 0.0 110.748 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -56.58 -44.54 81.14 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.019 0.528 . . . . 0.0 110.698 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.87 -29.97 50.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.011 0.924 . . . . 0.0 111.789 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.01 -58.45 3.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.663 0.785 . . . . 0.0 110.879 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HB2' HG12 ' A' ' 53' ' ' ILE . 52.0 m-85 -84.37 -20.36 32.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.732 0.813 . . . . 0.0 111.15 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.0 18.97 66.18 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.407 0.442 . . . . 0.0 112.42 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 51' ' ' PHE . 29.5 pt -105.51 -176.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.423 1.089 . . . . 0.0 110.971 -172.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -116.47 111.55 20.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.304 0.641 . . . . 0.0 109.529 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -102.14 103.07 27.79 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 68.6 Cg_endo -86.23 84.94 1.06 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.002 1.801 . . . . 0.0 111.671 174.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 41' ' ' LEU . 59.9 tp -62.71 -34.78 77.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.812 0.845 . . . . 0.0 110.101 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.91 -36.53 77.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.3 1.04 . . . . 0.0 111.193 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 33.9 ttpt -77.67 -44.4 28.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.625 0.77 . . . . 0.0 110.004 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.409 ' O ' HG23 ' A' ' 64' ' ' VAL . 44.2 m0 -58.36 -47.48 83.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.997 . . . . 0.0 110.959 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.4 m -63.74 -34.92 78.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.987 0.915 . . . . 0.0 111.021 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.264 1.025 . . . . 0.0 111.287 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.52 -33.53 76.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.416 0.686 . . . . 0.0 110.388 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 84.8 t -67.35 -44.09 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.436 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.26 -32.93 73.7 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.044 0.938 . . . . 0.0 112.458 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -90.71 -12.22 37.32 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.448 1.099 . . . . 0.0 111.371 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.15 16.88 55.05 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 116.931 -0.122 . . . . 0.0 113.37 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.04 -23.4 21.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -147.9 158.53 44.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.123 0.569 . . . . 0.0 110.672 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -95.62 159.95 14.74 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.134 0.574 . . . . 0.0 109.778 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.0 p -62.47 -31.27 71.97 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.954 0.502 . . . . 0.0 109.649 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HA ' HG23 ' A' ' 76' ' ' VAL . 31.5 tt0 -54.98 -50.48 68.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.961 0.904 . . . . 0.0 111.112 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -55.95 -30.03 61.07 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.285 1.034 . . . . 0.0 112.404 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 80' ' ' LEU . 42.1 m-85 -104.31 -77.43 0.58 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.717 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 97.6 m-85 -56.42 -27.99 58.16 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -166.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.7 t -65.3 124.37 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.106 1.321 . . . . 0.0 108.413 170.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 33' ' ' LEU . 25.5 mt -63.62 -32.47 73.95 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -159.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 21.0 pttp -67.61 -37.37 82.43 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.756 0.312 . . . . 0.0 111.263 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.1 m-20 -75.97 -42.9 47.03 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 123.509 0.723 . . . . 0.0 109.832 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 50.3 tp -52.2 -48.39 65.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.332 1.453 . . . . 0.0 110.843 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.78 71.86 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.893 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.78 -39.88 50.07 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.992 0.808 . . . . 0.0 111.61 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 23.3 mmm180 -61.37 -45.3 94.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.83 0.852 . . . . 0.0 111.057 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -70.87 -38.54 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.095 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' A' ' 88' ' ' VAL . 38.3 t70 -56.44 -34.68 67.06 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.962 0.905 . . . . 0.0 112.35 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 8.1 tp10 -63.3 -47.4 82.43 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.837 0.711 . . . . 0.0 110.356 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 51.7 mt -65.73 -40.9 92.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.03 0.932 . . . . 0.0 111.548 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.8 m -78.08 -26.23 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 122.841 0.456 . . . . 0.0 111.49 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.8 72.98 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.79 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.82 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.741 0.651 . . . . 0.0 112.505 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.35 -35.48 77.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.766 0.257 . . . . 0.0 110.665 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.65 -21.6 79.51 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 114.854 0.702 . . . . 0.0 114.854 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.97 -52.15 5.43 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.253 0.549 . . . . 0.0 111.08 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.22 -2.25 44.1 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.7 0.8 . . . . 0.0 112.982 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.42 -40.68 77.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.912 0.485 . . . . 0.0 111.102 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -148.85 71.04 1.13 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.068 1.347 . . . . 0.0 107.89 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -79.38 69.94 5.72 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 122.269 1.033 . . . . 0.0 110.671 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -143.15 161.37 38.39 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.686 -172.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -65.84 97.04 0.32 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -68.54 163.17 24.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 111.144 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.746 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.987 0.423 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 t -111.61 133.45 53.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.09 0.556 . . . . 0.0 109.896 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 m -92.18 164.99 13.36 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 163.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -67.49 -19.15 65.29 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 122.155 -0.34 . . . . 0.0 110.326 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -71.07 -41.41 70.74 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.304 0.641 . . . . 0.0 110.691 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.65 -51.84 26.22 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.177 0.991 . . . . 0.0 112.072 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -73.01 -43.53 62.02 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.425 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.76 -40.01 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.163 0.585 . . . . 0.0 110.847 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.79 77.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.995 . . . . 0.0 110.042 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -58.28 -41.43 84.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.05 0.94 . . . . 0.0 111.91 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.506 HG21 HG13 ' A' ' 47' ' ' ILE . 21.7 mm -58.74 -53.32 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.537 0.735 . . . . 0.0 110.658 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.16 -33.12 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.036 0.934 . . . . 0.0 111.195 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -53.78 50.26 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 111.537 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -68.93 -37.58 78.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.145 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -72.48 -63.79 1.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.894 0.478 . . . . 0.0 110.64 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.718 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.5 m -91.43 12.27 21.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 61.39 21.6 12.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.978 0.911 . . . . 0.0 112.079 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.5 mt -87.6 121.78 70.84 Favored Pre-proline 0 N--CA 1.479 0.996 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.173 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.06 133.55 55.72 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.158 1.906 . . . . 0.0 112.422 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -55.23 -33.02 62.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.442 1.097 . . . . 0.0 110.968 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.49 -35.02 79.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.156 . . . . 0.0 112.208 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -85.71 -19.21 31.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.885 0.474 . . . . 0.0 111.357 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -71.5 112.15 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.056 0.542 . . . . 0.0 110.431 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.1 p -115.9 146.47 37.03 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.187 0.995 . . . . 0.0 109.464 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -33.41 73.69 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.808 2.338 . . . . 0.0 112.911 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.43 -6.65 58.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.913 0.885 . . . . 0.0 111.835 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.4 t -74.87 146.84 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.306 1.042 . . . . 0.0 110.648 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 63.8 t-80 -103.01 134.26 46.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.718 1.207 . . . . 0.0 108.489 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.15 -58.64 5.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.555 0.742 . . . . 0.0 112.192 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -72.75 -57.3 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.5 t70 -64.58 -47.22 79.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.202 1.001 . . . . 0.0 112.841 -170.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -96.54 -58.17 2.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.559 0.344 . . . . 0.0 111.298 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 90.4 mt -72.01 -27.58 62.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.994 0.518 . . . . 0.0 111.814 -175.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 15.82 62.37 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-O 120.084 -0.287 . . . . 0.0 113.322 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.04 123.76 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.449 0.7 . . . . 0.0 109.454 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.97 148.05 36.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -58.42 -16.38 14.62 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.678 0.791 . . . . 0.0 111.707 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.12 -51.99 18.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.343 1.057 . . . . 0.0 110.199 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -71.06 -27.18 63.46 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.347 0.659 . . . . 0.0 111.101 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.37 -22.23 66.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 57' ' ' LEU . 90.0 mt -58.6 -38.58 78.28 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.216 0.606 . . . . 0.0 111.131 174.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.07 -28.54 48.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.231 0.612 . . . . 0.0 111.246 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 ' SG ' ' A' ' 16' ' ' CYS . 57.1 mt -62.82 -49.01 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.57 -32.62 74.3 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.129 -177.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.38 -43.2 77.85 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.918 0.762 . . . . 0.0 110.525 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.14 73.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.657 0.783 . . . . 0.0 111.723 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 HG21 ' A' ' 11' ' ' ILE . 89.6 mt -67.45 -40.29 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.778 0.831 . . . . 0.0 110.617 176.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -54.26 -46.6 72.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.289 0.636 . . . . 0.0 110.399 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.71 -50.99 38.35 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.096 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -64.47 -55.83 18.19 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.13 0.972 . . . . 0.0 112.379 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -80.22 -20.44 44.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.753 0.821 . . . . 0.0 111.863 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.33 41.04 39.04 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.48 175.73 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.089 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -114.9 92.72 4.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 167.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.3 tt -74.53 114.29 32.5 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -89.03 83.97 0.6 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.193 1.929 . . . . 0.0 111.311 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 41' ' ' LEU . 37.4 tp -73.19 -28.31 62.13 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.45 -33.42 73.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.409 0.684 . . . . 0.0 110.746 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -73.38 -50.66 20.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.319 1.048 . . . . 0.0 110.261 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -63.1 -45.91 89.85 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.654 0.782 . . . . 0.0 111.837 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 m -61.72 -38.06 86.51 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.924 0.889 . . . . 0.0 110.954 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -63.92 -43.56 95.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.99 0.916 . . . . 0.0 110.686 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.81 -32.6 74.37 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.582 0.753 . . . . 0.0 110.798 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 55.6 t -68.33 -51.78 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.347 0.659 . . . . 0.0 111.215 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.07 -22.01 64.95 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.518 0.727 . . . . 0.0 112.414 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.43 -12.89 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.842 1.257 . . . . 0.0 110.747 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 21.06 58.54 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.114 -0.494 . . . . 0.0 114.242 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -90.35 -54.48 3.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -105.09 156.6 17.92 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.522 1.129 . . . . 0.0 110.64 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -100.07 159.15 15.32 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.52 0.728 . . . . 0.0 109.92 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.5 p -68.23 -29.57 68.42 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 35.8 tt0 -58.21 -44.39 88.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.991 0.517 . . . . 0.0 111.034 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -58.3 -30.93 67.03 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.705 0.802 . . . . 0.0 112.109 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -104.19 -77.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 59.9 m-85 -55.91 -24.1 35.52 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -163.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 87.0 t -61.11 124.28 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 119.732 1.151 . . . . 0.0 108.25 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -60.51 -37.72 82.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.763 0.825 . . . . 0.0 112.935 -161.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.6 pttp -70.1 -36.35 74.8 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.501 0.501 . . . . 0.0 112.097 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -70.86 -44.45 66.36 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.895 0.878 . . . . 0.0 110.193 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 tp -53.06 -47.42 68.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.54 1.536 . . . . 0.0 110.672 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.04 66.71 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.666 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.5 49.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.762 0.425 . . . . 0.0 110.619 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -59.49 -43.58 93.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.215 1.006 . . . . 0.0 111.479 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.91 -39.19 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.289 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.5 t70 -54.09 -37.86 64.72 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.277 0.631 . . . . 0.0 111.518 170.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 -41.42 81.13 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.88 -42.97 94.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.462 0.705 . . . . 0.0 112.313 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.8 m -74.0 -26.6 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 122.791 0.436 . . . . 0.0 110.564 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.6 -36.46 65.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.619 0.368 . . . . 0.0 110.541 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.87 68.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.655 1.182 . . . . 0.0 113.322 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -63.34 -36.38 83.51 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.078 0.236 . . . . 0.0 110.522 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.94 -23.0 78.46 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.515 0.509 . . . . 0.0 113.534 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.8 41.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.205 1.002 . . . . 0.0 110.224 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -66.1 -37.64 86.28 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.982 170.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.44 -7.41 54.0 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.772 0.829 . . . . 0.0 112.317 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -82.82 56.36 3.38 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.247 1.019 . . . . 0.0 108.679 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.3 m170 67.16 -72.13 0.09 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.865 1.666 . . . . 0.0 112.775 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 77.02 47.86 0.06 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.756 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -79.32 136.62 37.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.489 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -79.78 151.28 30.43 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.141 0.576 . . . . 0.0 111.075 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.28 1.032 . . . . 0.0 108.692 176.063 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.636 0.255 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.567 HG23 ' HE ' ' A' ' 7' ' ' ARG . 54.4 m -81.68 122.24 27.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 170.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 p -103.62 139.15 39.3 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 38.9 m -58.87 -33.22 70.24 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.115 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.33 -41.68 93.7 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.376 0.422 . . . . 0.0 111.35 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.51 -42.6 92.59 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.559 0.695 . . . . 0.0 111.059 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HE ' HG23 ' A' ' 2' ' ' THR . 23.7 mmt180 -71.29 -44.8 64.5 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.325 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 77.3 t -57.73 -41.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.312 0.577 . . . . 0.0 110.522 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.66 97.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.225 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -75.35 -30.35 60.22 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.76 0.254 . . . . 0.0 111.411 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 47' ' ' ILE . 28.7 mm -61.61 -52.93 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.77 -32.07 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.921 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.46 69.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.597 0.759 . . . . 0.0 111.411 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.13 -53.82 7.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.253 0.621 . . . . 0.0 112.611 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -63.65 -51.52 64.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.795 0.838 . . . . 0.0 111.306 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -90.29 2.19 55.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.507 0.723 . . . . 0.0 111.798 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.88 21.73 13.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.232 1.013 . . . . 0.0 112.697 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.9 132.63 67.26 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 122.983 0.513 . . . . 0.0 110.636 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.0 122.22 11.3 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.0 2.467 . . . . 0.0 112.452 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -61.82 -30.22 70.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.0 1.32 . . . . 0.0 111.342 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -63.34 -28.81 70.26 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.338 1.055 . . . . 0.0 112.355 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.425 HG23 ' HG3' ' A' ' 21' ' ' GLU . 34.9 p -100.35 -2.24 34.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.703 0.801 . . . . 0.0 111.381 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.92 113.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 0.0 109.825 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -119.6 160.41 42.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.18 -25.58 77.13 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.71 -13.02 58.37 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 111.53 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 70.4 m -65.06 112.22 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.481 0.713 . . . . 0.0 111.597 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 60.8 t-80 -76.88 127.27 32.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.8 -50.39 56.31 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.3 mt -76.95 -55.06 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 122.555 0.342 . . . . 0.0 111.244 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.0 t70 -71.15 -43.49 67.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.45 0.7 . . . . 0.0 112.607 -170.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -96.78 -55.68 2.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.235 0.614 . . . . 0.0 111.331 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 77' ' ' LEU . 85.0 mt -76.05 -24.24 55.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.271 0.629 . . . . 0.0 111.596 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.88 6.0 80.23 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.821 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.73 130.18 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.358 1.063 . . . . 0.0 110.815 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.59 162.76 13.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.94 . . . . 0.0 108.869 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.8 p -46.65 -34.18 4.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.265 1.426 . . . . 0.0 113.519 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.56 -36.46 52.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.698 0.799 . . . . 0.0 110.866 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.14 -40.51 74.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.989 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.57 -21.03 64.55 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.332 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.9 mt -55.56 -48.95 73.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.278 0.631 . . . . 0.0 110.95 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.23 -31.7 70.44 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.448 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.68 -45.91 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.121 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.15 79.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.874 0.734 . . . . 0.0 110.941 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.924 . . . . 0.0 110.835 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -30.7 71.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.482 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 11' ' ' ILE . 93.3 mt -70.65 -42.04 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.492 0.717 . . . . 0.0 110.838 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -55.21 -40.72 71.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.721 0.808 . . . . 0.0 111.536 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.65 -51.23 10.17 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.351 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.01 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.404 0.682 . . . . 0.0 111.924 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -83.95 -17.21 41.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.057 0.543 . . . . 0.0 111.07 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.56 47.49 62.02 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.454 HG22 ' HD3' ' A' ' 91' ' ' LYS . 47.6 pt -130.36 -175.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.685 0.794 . . . . 0.0 112.094 -172.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -122.39 94.88 4.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.05 1.34 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.54 111.86 37.72 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -87.1 81.54 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.079 1.852 . . . . 0.0 111.855 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.15 -30.41 66.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.939 0.496 . . . . 0.0 110.446 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.05 -38.82 65.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.121 0.968 . . . . 0.0 111.315 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.7 ttpt -80.98 -46.38 15.17 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.205 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -55.85 -51.1 68.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.855 0.862 . . . . 0.0 110.975 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.6 m -56.87 -47.11 81.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.402 1.081 . . . . 0.0 111.904 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -63.22 -45.25 92.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.863 0.865 . . . . 0.0 111.621 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 23.1 mm-40 -70.72 -37.19 73.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.027 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.4 t -67.29 -42.93 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.14 -20.96 64.94 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.542 0.737 . . . . 0.0 112.222 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.96 -7.52 42.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.454 0.702 . . . . 0.0 110.756 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.32 87.48 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.565 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 30.3 mmtp -68.91 -25.31 64.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.972 0.909 . . . . 0.0 110.934 175.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 166.19 30.26 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.734 0.813 . . . . 0.0 110.3 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 73' ' ' GLN . 6.1 t -105.1 151.72 23.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.784 0.834 . . . . 0.0 109.863 174.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.9 p -58.42 -34.63 70.99 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.497 0.719 . . . . 0.0 110.404 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.7 tt0 -55.68 -42.03 74.54 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.582 1.153 . . . . 0.0 111.785 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 70' ' ' THR . 29.5 tt0 -62.11 -29.79 70.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.874 0.869 . . . . 0.0 111.755 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 83' ' ' ARG . 60.9 m-85 -104.05 -78.41 0.56 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.014 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.3 m-85 -51.06 -29.31 12.51 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -165.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 66.1 t -62.33 125.83 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.819 1.191 . . . . 0.0 108.409 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 33' ' ' LEU . 23.1 mt -59.65 -35.13 73.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -163.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -63.24 -39.82 95.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 120.838 0.351 . . . . 0.0 111.431 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -79.73 -40.59 28.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.223 1.009 . . . . 0.0 110.466 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.67 -47.55 73.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.419 1.488 . . . . 0.0 110.288 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.51 72.73 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.81 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.36 -43.92 66.01 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.439 0.462 . . . . 0.0 111.086 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 22.9 mmm180 -62.6 -42.75 99.76 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.754 0.822 . . . . 0.0 111.357 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.25 -37.92 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.512 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 88' ' ' VAL . 29.9 t70 -58.55 -36.52 74.02 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.203 0.601 . . . . 0.0 111.246 170.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.01 -44.73 83.91 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -61.98 -45.56 93.08 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.868 0.867 . . . . 0.0 112.371 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 85' ' ' ASP . 22.3 m -71.59 -34.36 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 122.851 0.461 . . . . 0.0 110.948 -177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.7 60.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.679 0.392 . . . . 0.0 110.689 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.22 82.06 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.529 0.731 . . . . 0.0 112.932 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HD3' HG22 ' A' ' 53' ' ' ILE . 52.3 pttt -65.58 -34.73 78.92 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.19 -37.91 54.81 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.714 0.634 . . . . 0.0 112.497 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.5 -31.14 61.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.753 1.221 . . . . 0.0 111.804 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.87 -48.53 7.17 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.388 0.675 . . . . 0.0 111.49 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -33.6 73.4 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.619 0.767 . . . . 0.0 112.642 -168.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -83.7 68.22 9.79 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.234 0.614 . . . . 0.0 110.497 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.1 p80 35.43 65.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.76 2.024 . . . . 0.0 114.371 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -125.66 109.37 12.53 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.07 75.89 10.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 110.712 -166.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 63.36 24.0 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.934 1.294 . . . . 0.0 112.491 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 25.1 p80 . . . . . 0 N--CA 1.496 1.846 0 C-N-CA 126.157 1.783 . . . . 0.0 113.352 -175.04 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.4 m -91.69 120.06 32.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.526 0.73 . . . . 0.0 111.144 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.2 p -98.06 143.36 28.69 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.1 m -61.6 -27.12 68.42 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.39 0.431 . . . . 0.0 110.417 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.68 -46.31 82.94 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.335 0.397 . . . . 0.0 110.884 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.35 -42.52 82.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 123.894 0.746 . . . . 0.0 111.299 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 11' ' ' ILE . 31.2 mmm-85 -70.12 -47.18 62.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.264 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -58.4 -39.21 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.305 0.574 . . . . 0.0 110.698 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.999 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 t -69.64 -25.44 63.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.587 0.355 . . . . 0.0 111.524 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 47' ' ' ILE . 34.2 mm -61.99 -58.0 9.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.2 -30.13 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.89 0.744 . . . . 0.0 110.95 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.17 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.431 1.092 . . . . 0.0 111.622 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 -29.54 56.06 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.135 0.574 . . . . 0.0 112.17 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.5 m -79.79 -60.23 2.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.803 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 43' ' ' ILE . 42.9 m -90.44 -3.95 57.33 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 60.7 69.88 0.65 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.875 0.87 . . . . 0.0 110.129 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -133.51 116.32 13.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 23.8 Cg_endo -58.74 145.66 95.21 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.868 2.379 . . . . 0.0 112.313 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HD2' HD12 ' A' ' 23' ' ' ILE . 55.6 mmm-85 -62.67 -25.32 68.09 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.343 1.057 . . . . 0.0 112.249 -175.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 17.1 pt-20 -61.12 -41.27 96.4 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.82 -12.71 47.16 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 111.48 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 20' ' ' ARG . 76.0 mt -83.6 104.68 12.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.2 p -120.45 153.39 56.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.284 1.034 . . . . 0.0 109.335 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.0 -30.15 82.73 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.64 2.226 . . . . 0.0 112.752 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.42 -15.78 58.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.3 t -66.46 134.86 53.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.942 0.497 . . . . 0.0 110.165 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 20.5 t-80 -103.27 134.7 46.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.279 . . . . 0.0 108.054 174.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.47 -58.47 6.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.169 0.588 . . . . 0.0 112.358 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.89 -49.02 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.0 t70 -72.67 -37.38 67.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.646 0.778 . . . . 0.0 112.663 -170.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -107.64 -56.89 2.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.976 0.51 . . . . 0.0 110.814 -172.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 77' ' ' LEU . 91.5 mt -72.58 -20.39 61.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.771 0.829 . . . . 0.0 111.91 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.54 8.78 87.49 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.213 0.32 . . . . 0.0 113.054 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 43' ' ' ILE . 79.5 mt -72.79 106.56 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.222 1.009 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.2 159.29 7.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.645 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -62.15 -15.56 46.79 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.354 0.662 . . . . 0.0 111.009 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.97 -44.98 21.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.486 1.114 . . . . 0.0 110.376 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.4 -26.82 62.01 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.29 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -73.0 -20.72 60.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.434 1.094 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -55.99 -42.42 76.33 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.175 0.59 . . . . 0.0 110.4 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.08 -33.64 68.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.936 1.294 . . . . 0.0 110.793 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 35' ' ' ILE . 58.0 mt -65.09 -48.2 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.204 0.602 . . . . 0.0 109.624 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.85 76.79 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.003 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.05 -49.51 64.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.427 1.08 . . . . 0.0 111.081 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.76 72.84 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.079 0.552 . . . . 0.0 111.849 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 11' ' ' ILE . 80.0 mt -67.78 -44.19 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 124.156 0.983 . . . . 0.0 110.135 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.34 -45.01 65.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.144 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -70.49 -50.7 35.26 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -60.04 -55.08 38.43 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.15 0.98 . . . . 0.0 112.301 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.47 ' HB2' HG12 ' A' ' 53' ' ' ILE . 90.4 m-85 -82.05 -22.54 36.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.048 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.89 29.27 57.51 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 51' ' ' PHE . 31.9 pt -113.38 162.34 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.204 1.002 . . . . 0.0 109.632 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -95.1 103.45 15.3 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.87 115.93 62.23 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.26 81.8 0.69 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.227 1.951 . . . . 0.0 112.224 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 41' ' ' LEU . 48.9 tp -73.29 -32.39 64.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.29 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.17 -34.83 72.57 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.293 0.637 . . . . 0.0 111.186 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.94 -46.64 51.33 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.85 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -62.8 -46.83 86.14 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.704 0.802 . . . . 0.0 111.303 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.7 m -56.41 -45.56 80.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.819 1.248 . . . . 0.0 111.269 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -64.03 -38.49 91.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.889 0.876 . . . . 0.0 110.975 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.4 -33.74 76.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.668 0.787 . . . . 0.0 110.751 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.95 -43.9 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.847 0.459 . . . . 0.0 110.433 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -56.2 -39.25 72.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.623 0.769 . . . . 0.0 112.65 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -84.24 -3.72 58.38 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.21 19.35 79.82 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 117.973 0.351 . . . . 0.0 113.178 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -82.18 -58.96 2.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.361 0.665 . . . . 0.0 109.668 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.63 161.72 15.11 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.054 0.941 . . . . 0.0 110.211 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.2 p -105.74 165.34 11.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.893 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.8 p -65.08 -29.95 70.86 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.203 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.79 -44.84 93.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.662 0.785 . . . . 0.0 111.642 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.68 -33.01 69.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.301 0.64 . . . . 0.0 112.291 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.0 -64.76 1.18 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 31.8 m-85 -61.78 -21.79 64.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -167.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.5 t -62.13 129.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.614 1.097 . . . . 0.0 108.424 170.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 33' ' ' LEU . 32.0 mt -60.8 -38.41 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -165.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.0 pttp -64.52 -38.22 90.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.1 m-20 -69.71 -48.92 57.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.57 0.748 . . . . 0.0 110.172 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.7 tp -52.08 -48.51 64.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.774 1.63 . . . . 0.0 110.825 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.1 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.72 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.38 64.75 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.458 0.474 . . . . 0.0 111.306 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 30.1 mmm180 -60.99 -40.6 94.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.698 0.799 . . . . 0.0 111.492 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.482 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -74.61 -42.52 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.417 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -51.95 -38.28 55.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.076 0.95 . . . . 0.0 111.294 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -66.08 -44.86 83.21 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.951 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.21 -38.83 82.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.725 0.81 . . . . 0.0 112.08 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.01 -31.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.82 92.06 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.027 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.7 -51.18 68.17 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.325 1.015 . . . . 0.0 112.906 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -71.12 -33.51 70.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.153 0.181 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.42 -27.3 72.87 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.424 -0.353 . . . . 0.0 113.597 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -33.81 63.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.02 -35.29 69.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.449 0.7 . . . . 0.0 110.415 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -68.08 89.42 0.3 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.82 0.848 . . . . 0.0 110.256 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t60 55.66 85.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.758 1.223 . . . . 0.0 110.044 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -75.92 74.56 2.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.316 0.647 . . . . 0.0 110.723 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 175.43 55.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.156 2.182 . . . . 0.0 106.86 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -86.3 89.99 8.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.803 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -74.07 -34.91 64.18 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.387 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.603 -0.713 . . . . 0.0 109.505 -175.764 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 mmt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.61 HG21 ' HE ' ' A' ' 7' ' ' ARG . 91.0 m -90.91 132.4 35.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.069 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 m -65.62 137.31 57.26 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 122.825 0.45 . . . . 0.0 110.267 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 8' ' ' VAL . 53.5 m -55.58 -36.39 66.83 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.95 0.781 . . . . 0.0 111.044 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -60.83 -42.64 98.15 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.805 0.69 . . . . 0.0 111.517 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.63 -40.73 84.18 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.867 0.73 . . . . 0.0 111.271 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.61 ' HE ' HG21 ' A' ' 2' ' ' THR . 19.6 mmt180 -75.81 -39.18 57.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.128 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 4' ' ' THR . 94.5 t -60.4 -39.38 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.565 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.05 88.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.519 1.127 . . . . 0.0 111.054 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -69.35 -31.76 70.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.223 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -59.09 -53.64 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.1 mt -61.03 -38.21 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.972 0.909 . . . . 0.0 111.092 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.81 68.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.74 0.816 . . . . 0.0 111.345 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.29 -40.53 64.49 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.774 0.83 . . . . 0.0 112.568 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 43' ' ' ILE . 18.1 p -76.86 -58.41 3.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.06 0.544 . . . . 0.0 111.416 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 35' ' ' ILE . 48.4 t -84.79 -0.97 55.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.829 0.852 . . . . 0.0 112.426 -172.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.55 45.19 16.65 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.22 1.008 . . . . 0.0 112.069 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.34 130.76 23.49 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.843 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.9 128.33 28.32 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.543 2.162 . . . . 0.0 111.464 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 tpt85 -56.72 -36.72 70.04 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.014 0.926 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -32.64 74.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.652 1.181 . . . . 0.0 112.614 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -82.74 -10.05 59.07 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 122.556 0.342 . . . . 0.0 111.717 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.61 110.39 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.268 0.627 . . . . 0.0 110.035 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.7 p -117.39 148.77 43.42 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.359 1.064 . . . . 0.0 109.54 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -51.29 -41.4 58.86 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.976 2.451 . . . . 0.0 113.833 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.01 -16.64 59.24 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.984 -172.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 33.5 t -63.43 132.16 50.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.567 0.747 . . . . 0.0 110.672 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 59.2 t-80 -89.87 128.48 36.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.57 -64.15 0.88 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.696 0.799 . . . . 0.0 112.475 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.06 -35.79 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.2 t70 -82.32 -67.99 0.74 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.521 0.328 . . . . 0.0 111.114 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.39 -51.37 17.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.305 0.642 . . . . 0.0 110.776 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 77' ' ' LEU . 87.6 mt -81.84 -18.34 44.28 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.423 0.689 . . . . 0.0 111.546 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.48 36.86 78.07 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.191 0.307 . . . . 0.0 113.809 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 16' ' ' CYS . 54.7 mt -85.16 133.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.935 0.894 . . . . 0.0 109.691 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.25 154.21 31.2 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -66.22 -17.94 65.05 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.641 0.376 . . . . 0.0 110.374 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.06 -42.65 18.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 109.901 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.08 -32.97 73.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.92 -21.32 65.99 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.007 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 57' ' ' LEU . 90.3 mt -59.47 -35.91 74.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.085 0.554 . . . . 0.0 111.816 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.01 -35.55 56.95 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.333 0.653 . . . . 0.0 110.221 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 16' ' ' CYS . 55.1 mt -60.29 -50.61 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -66.87 -32.76 74.23 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.831 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -69.43 -40.12 77.43 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.15 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.78 70.13 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 11' ' ' ILE . 87.7 mt -66.96 -40.64 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.076 0.95 . . . . 0.0 110.743 173.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.28 -45.39 87.99 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.231 0.612 . . . . 0.0 110.941 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -80.82 -27.36 36.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.546 0.738 . . . . 0.0 112.63 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.41 -53.7 5.52 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.166 0.587 . . . . 0.0 110.495 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.479 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 90.6 m-85 -87.62 -23.83 24.15 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.962 0.905 . . . . 0.0 111.201 -173.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.34 39.72 30.36 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.06 -177.99 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 0.0 110.26 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -124.71 109.12 12.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.69 106.46 18.76 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.09 82.89 2.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 121.778 1.652 . . . . 0.0 111.693 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 41' ' ' LEU . 57.2 tp -69.11 -34.92 75.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.904 -174.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.75 -36.97 70.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.285 1.034 . . . . 0.0 110.976 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 ttpp -87.77 -34.74 18.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.908 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -62.52 -43.86 97.79 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.505 0.722 . . . . 0.0 110.969 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.9 m -63.98 -33.5 75.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.931 0.892 . . . . 0.0 110.604 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -72.48 -29.83 64.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.358 0.663 . . . . 0.0 111.585 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 30.8 mm-40 -58.46 -39.93 81.26 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.55 0.69 . . . . 0.0 109.475 171.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 44.0 t -69.03 -47.34 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.46 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -57.51 -44.05 84.71 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.034 0.934 . . . . 0.0 112.612 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -86.1 -13.67 46.55 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.003 0.921 . . . . 0.0 111.321 -175.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.88 61.53 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 113.804 0.282 . . . . 0.0 113.804 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.81 -34.84 79.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.45 0.7 . . . . 0.0 110.336 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -158.57 171.23 20.5 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.877 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.9 p -100.83 157.74 16.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.809 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.63 -32.09 68.71 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.448 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' A' ' 76' ' ' VAL . 45.1 tt0 -55.87 -41.56 74.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.095 1.358 . . . . 0.0 111.682 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.58 -21.7 64.5 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.898 0.879 . . . . 0.0 112.584 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -121.46 -6.38 9.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 82.0 m-85 -126.9 -26.9 3.1 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.595 -0.716 . . . . 0.0 112.805 -172.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 58.0 t -61.26 126.44 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 167.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 33' ' ' LEU . 36.9 mt -59.07 -35.43 73.35 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.089 0.868 . . . . 0.0 112.642 -161.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -69.85 -36.4 75.52 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 80.8 m-20 -71.43 -48.31 50.36 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.116 0.966 . . . . 0.0 110.235 177.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.9 tp -50.44 -50.74 51.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 110.987 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.12 61.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.826 0.851 . . . . 0.0 111.696 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.29 56.43 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.563 0.539 . . . . 0.0 110.384 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 24.1 mmm180 -70.65 -32.2 69.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.298 0.639 . . . . 0.0 111.486 175.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.34 -39.55 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 88' ' ' VAL . 34.7 t70 -58.2 -37.94 75.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.689 . . . . 0.0 111.567 170.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 7.5 tp10 -59.08 -47.79 83.95 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.189 0.995 . . . . 0.0 110.196 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.8 mt -67.6 -41.11 84.58 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.034 0.934 . . . . 0.0 113.112 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 85' ' ' ASP . 17.3 m -75.73 -28.4 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.997 -0.439 . . . . 0.0 111.032 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.67 56.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -48.07 80.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.274 0.63 . . . . 0.0 112.462 170.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 19.9 pttp -70.93 -36.58 72.69 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.22 -22.36 67.09 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 123.485 0.564 . . . . 0.0 113.766 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.39 73.06 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.795 -0.702 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.2 mt -82.77 -34.46 27.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.375 1.07 . . . . 0.0 110.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 47.5 mt-10 -73.01 102.17 3.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.254 1.022 . . . . 0.0 109.878 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -84.69 91.3 7.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -51.73 10.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 110.884 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 60.11 53.77 4.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.54 1.136 . . . . 0.0 109.832 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -80.31 136.02 36.33 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -59.93 131.98 52.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.545 0.738 . . . . 0.0 110.659 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.838 0.855 . . . . 0.0 109.165 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -142.87 131.06 21.96 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.528 0.731 . . . . 0.0 109.881 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -64.86 137.3 57.68 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.723 0.809 . . . . 0.0 110.545 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 85' ' ' ASP . 7.8 m -60.35 -26.83 66.89 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.419 0.449 . . . . 0.0 111.493 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -68.32 -46.31 70.58 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.65 -42.15 70.96 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.39 0.676 . . . . 0.0 111.057 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' O ' HG12 ' A' ' 11' ' ' ILE . 4.9 mmp_? -60.88 -58.03 10.14 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.473 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.23 -37.67 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.297 1.039 . . . . 0.0 111.528 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -68.01 -43.08 79.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.647 1.179 . . . . 0.0 110.657 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -62.01 -40.95 97.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.452 0.701 . . . . 0.0 111.395 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 7' ' ' ARG . 42.0 mm -61.98 -50.81 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.298 0.639 . . . . 0.0 110.579 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.56 -34.69 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 111.006 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.51 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.962 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -75.46 -50.89 14.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 43' ' ' ILE . 10.1 m -62.79 -46.94 85.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.436 0.694 . . . . 0.0 111.199 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.31 7.64 43.59 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.879 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 59.99 21.15 10.23 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.881 1.273 . . . . 0.0 113.011 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -77.15 138.25 64.79 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.331 0.652 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.76 121.02 9.27 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.102 1.868 . . . . 0.0 111.291 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.37 -29.46 67.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.163 0.585 . . . . 0.0 110.634 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.96 -33.67 69.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.064 0.945 . . . . 0.0 112.312 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -88.84 -18.61 27.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.408 0.683 . . . . 0.0 111.575 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.406 HG21 ' HB1' ' A' ' 9' ' ' ALA . 41.4 mt -72.94 111.14 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.625 0.77 . . . . 0.0 111.334 -177.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -111.03 161.41 25.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.265 1.026 . . . . 0.0 108.989 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.17 -24.31 59.08 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.18 -23.73 61.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.75 1.22 . . . . 0.0 110.944 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.5 m -61.88 119.39 8.71 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 123.737 0.648 . . . . 0.0 111.161 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.4 t-80 -86.05 127.9 34.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.81 -54.02 16.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.133 0.573 . . . . 0.0 111.799 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -77.3 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.497 0.189 . . . . 0.0 110.776 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.65 -47.27 73.06 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.324 0.65 . . . . 0.0 112.693 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.7 -51.69 5.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.615 . . . . 0.0 111.852 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 77' ' ' LEU . 87.9 mt -79.31 -42.66 25.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.92 0.488 . . . . 0.0 110.266 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.16 -7.49 25.1 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.313 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.4 112.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.337 1.055 . . . . 0.0 111.1 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.38 160.32 29.68 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 p -58.93 -15.43 12.85 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.678 0.791 . . . . 0.0 112.859 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.2 mt -86.18 -38.67 17.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.972 0.909 . . . . 0.0 110.806 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.79 -32.7 67.9 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.97 -19.16 64.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 57' ' ' LEU . 90.4 mt -60.19 -42.11 94.36 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.847 0.459 . . . . 0.0 110.246 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.25 -42.3 93.45 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.858 1.263 . . . . 0.0 110.584 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.497 ' HA ' HG21 ' A' ' 15' ' ' THR . 55.8 mt -67.64 -41.62 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.391 0.676 . . . . 0.0 111.004 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.0 73.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.994 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -65.45 -43.57 89.98 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.6 1.188 . . . . 0.0 110.962 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.92 74.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.782 0.433 . . . . 0.0 111.355 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 84' ' ' ILE . 96.9 mt -68.84 -40.01 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.343 0.657 . . . . 0.0 110.17 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -53.42 -50.86 64.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.218 0.607 . . . . 0.0 110.677 174.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -73.25 -48.47 34.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.695 -172.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.78 -44.38 73.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.347 0.659 . . . . 0.0 111.571 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.92 -11.31 39.49 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.946 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.38 71.04 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.235 0.335 . . . . 0.0 112.837 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.24 175.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.061 0.944 . . . . 0.0 111.019 -175.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -116.59 92.71 3.95 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tt -78.18 114.09 39.32 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.99 85.86 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.185 1.924 . . . . 0.0 112.401 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 41' ' ' LEU . 51.7 tp -72.5 -30.4 64.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.6 -30.79 68.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.005 0.522 . . . . 0.0 111.404 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -70.39 -55.48 8.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 0.0 108.659 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -61.1 -48.46 81.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.665 1.186 . . . . 0.0 112.879 -168.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -60.0 -44.3 94.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.664 0.786 . . . . 0.0 111.682 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -70.36 -30.86 67.89 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.287 0.635 . . . . 0.0 110.684 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.3 -40.36 97.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.458 0.703 . . . . 0.0 110.723 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.638 HG11 HG23 ' A' ' 71' ' ' THR . 60.3 t -66.96 -42.82 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.215 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.16 -31.07 65.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.691 0.796 . . . . 0.0 112.7 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -102.24 -14.64 16.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.938 0.495 . . . . 0.0 111.45 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.16 24.1 64.53 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.706 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.57 -31.26 72.37 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.291 0.546 . . . . 0.0 109.607 168.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.18 166.56 31.19 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.616 1.166 . . . . 0.0 109.773 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.6 p -99.29 158.69 15.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.7 0.8 . . . . 0.0 110.972 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 HG11 ' A' ' 64' ' ' VAL . 38.5 p -64.49 -32.34 73.94 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HA ' HG23 ' A' ' 76' ' ' VAL . 36.8 tt0 -55.63 -46.34 77.44 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.569 0.747 . . . . 0.0 111.033 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.44 -34.84 69.38 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.812 0.845 . . . . 0.0 112.58 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -104.43 -75.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.536 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.9 m-85 -58.18 -26.16 62.42 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 125.275 1.43 . . . . 0.0 114.844 -165.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -61.48 124.72 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 120.001 1.273 . . . . 0.0 108.257 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 33' ' ' LEU . 34.7 mt -61.96 -33.59 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -162.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -69.41 -36.48 76.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -72.69 -44.24 62.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.61 0.764 . . . . 0.0 109.878 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.81 -43.97 69.8 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.171 1.788 . . . . 0.0 111.367 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.815 0.697 . . . . 0.0 110.759 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.02 -44.4 65.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -62.68 -44.06 97.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.542 0.737 . . . . 0.0 111.484 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 47' ' ' ILE . 87.0 mt -69.52 -43.07 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.574 0.749 . . . . 0.0 110.154 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' HG21 ' A' ' 4' ' ' THR . 22.1 t70 -53.74 -39.87 65.68 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.983 0.513 . . . . 0.0 111.652 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.66 -48.37 81.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.415 0.626 . . . . 0.0 110.639 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.68 -39.03 80.78 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.396 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 16.7 m -76.53 -33.89 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 122.661 0.384 . . . . 0.0 110.802 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.15 -21.86 65.8 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -53.33 -55.15 27.09 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.68 0.612 . . . . 0.0 112.398 173.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -61.36 -37.68 84.25 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.876 0.37 . . . . 0.0 110.425 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.7 69.52 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.551 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -35.88 63.88 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.311 0.644 . . . . 0.0 109.804 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 61.8 mt -73.06 -35.05 66.6 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.373 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 71.05 -60.16 0.52 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.045 1.738 . . . . 0.0 110.506 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -59.75 117.23 4.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.357 1.063 . . . . 0.0 109.919 164.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -64.03 146.02 54.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.428 0.691 . . . . 0.0 110.456 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -103.2 32.8 3.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.528 0.731 . . . . 0.0 111.877 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -78.34 74.82 4.88 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.839 0.828 . . . . 0.0 110.143 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -162.5 17.92 0.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.859 1.663 . . . . 0.0 108.17 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.854 1.262 . . . . 0.0 108.641 -176.722 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 t -82.01 121.79 26.99 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -92.38 -179.43 5.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.51 0.724 . . . . 0.0 111.282 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.3 m -58.49 -40.5 82.95 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.701 0.8 . . . . 0.0 110.81 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.67 -45.99 90.41 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.835 0.709 . . . . 0.0 110.941 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.18 -36.35 79.6 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.493 0.717 . . . . 0.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 7' ' ' ARG . 5.4 mmt-85 -68.32 -47.98 66.11 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.694 0.621 . . . . 0.0 111.422 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 4' ' ' THR . 97.6 t -59.62 -37.13 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.708 0.766 . . . . 0.0 110.269 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.27 73.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.005 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -72.14 -23.01 61.23 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 122.425 0.29 . . . . 0.0 111.553 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 47' ' ' ILE . 28.0 mm -59.59 -58.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 167.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.85 -30.04 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.925 0.765 . . . . 0.0 111.044 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.37 -53.61 54.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.502 1.121 . . . . 0.0 111.64 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.2 -34.53 59.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.595 0.358 . . . . 0.0 111.703 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.2 m -71.75 -60.48 2.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.775 0.83 . . . . 0.0 111.292 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 43' ' ' ILE . 61.1 m -96.06 4.13 52.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.611 0.764 . . . . 0.0 112.321 -173.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.31 33.47 22.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.27 1.028 . . . . 0.0 112.599 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.08 123.95 59.53 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.16 137.5 63.12 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.937 2.425 . . . . 0.0 112.681 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.5 0.72 . . . . 0.0 111.127 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.04 -28.47 68.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.975 0.91 . . . . 0.0 111.817 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -88.84 -20.34 24.77 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.781 0.432 . . . . 0.0 110.718 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.86 123.32 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.511 0.724 . . . . 0.0 109.227 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -136.35 157.54 75.23 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.347 1.059 . . . . 0.0 109.602 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -59.84 -32.5 95.46 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.228 1.952 . . . . 0.0 112.263 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.49 -28.47 61.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.415 0.686 . . . . 0.0 112.123 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.476 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 30.9 p -72.76 118.51 15.78 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.922 0.391 . . . . 0.0 111.496 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 62.0 t-80 -68.67 129.36 39.69 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 109.267 167.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.2 -58.04 5.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.251 0.621 . . . . 0.0 112.46 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 26.9 mt -72.9 -44.76 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.304 0.241 . . . . 0.0 111.447 -174.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 22.1 t70 -75.48 -64.04 1.15 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.29 0.236 . . . . 0.0 111.164 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.72 -48.75 15.93 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 77' ' ' LEU . 82.1 mt -79.84 -27.66 40.17 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.254 0.222 . . . . 0.0 111.281 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.12 47.88 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.426 -0.352 . . . . 0.0 113.413 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.489 HD13 HD11 ' A' ' 43' ' ' ILE . 66.3 mt -80.69 133.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.93 0.892 . . . . 0.0 109.748 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.63 153.89 19.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -61.58 -15.94 43.47 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 mt -84.21 -32.8 24.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.625 0.726 . . . . 0.0 109.661 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.85 -27.87 40.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.143 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -73.7 -21.25 60.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.319 1.048 . . . . 0.0 110.282 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 57' ' ' LEU . 88.9 mt -56.04 -42.5 76.64 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.073 0.549 . . . . 0.0 110.143 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.77 -38.13 89.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.894 0.878 . . . . 0.0 110.986 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.0 mt -62.26 -51.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.119 0.568 . . . . 0.0 110.371 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.35 -40.07 95.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.74 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -67.73 -39.21 84.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.818 0.847 . . . . 0.0 111.311 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.38 -31.39 69.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.682 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.481 HG13 HG21 ' A' ' 11' ' ' ILE . 81.2 mt -69.82 -40.92 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.95 0.9 . . . . 0.0 110.822 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -54.32 -42.34 70.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.491 0.716 . . . . 0.0 111.126 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -76.78 -48.48 18.5 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.458 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.12 63.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.489 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 53' ' ' ILE . 78.4 m-85 -85.44 -24.91 27.25 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.63 34.17 44.97 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.48 0.487 . . . . 0.0 112.114 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 51' ' ' PHE . 32.2 pt -121.88 173.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 109.649 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.14 110.56 22.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD12 HG21 ' A' ' 47' ' ' ILE . 7.6 tt -96.36 104.17 16.58 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.92 84.27 1.61 Allowed 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.04 1.827 . . . . 0.0 111.521 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 41' ' ' LEU . 61.2 tp -69.17 -30.6 68.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.64 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.919 0.888 . . . . 0.0 111.059 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 54.7 tttp -77.69 -46.62 21.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.938 0.895 . . . . 0.0 110.361 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -66.88 -38.66 86.72 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.088 0.555 . . . . 0.0 111.539 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 m -66.51 -35.64 80.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.704 0.802 . . . . 0.0 110.522 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -67.93 -34.8 77.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.135 0.974 . . . . 0.0 110.653 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 61.4 mm-40 -58.13 -41.89 84.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.47 -47.26 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.706 0.802 . . . . 0.0 110.4 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.92 -27.99 68.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.865 1.266 . . . . 0.0 112.806 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.78 -8.62 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.796 0.839 . . . . 0.0 112.252 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.78 81.3 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 122.812 0.07 . . . . 0.0 113.139 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -71.55 -21.94 61.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.581 1.152 . . . . 0.0 110.347 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.34 168.89 25.25 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.431 1.093 . . . . 0.0 109.457 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 73' ' ' GLN . 10.0 t -101.3 158.76 15.8 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.735 0.814 . . . . 0.0 109.64 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -61.99 -31.59 71.97 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.085 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.44 -36.76 84.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.972 0.909 . . . . 0.0 111.843 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.427 ' H ' HG23 ' A' ' 70' ' ' THR . 28.3 tt0 -63.36 -29.05 70.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.176 0.59 . . . . 0.0 111.928 -173.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -107.69 -64.13 1.24 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.391 0.277 . . . . 0.0 111.436 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.28 -20.79 63.28 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -167.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t -65.63 131.99 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 119.862 1.21 . . . . 0.0 108.894 171.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 33' ' ' LEU . 25.2 mt -59.96 -36.41 77.05 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -165.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.6 pttt -58.7 -43.1 89.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.454 0.471 . . . . 0.0 111.056 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.0 m-20 -76.47 -46.2 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.298 1.039 . . . . 0.0 110.308 -174.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.38 -52.38 37.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.109 1.363 . . . . 0.0 110.539 171.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.48 -25.79 65.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.13 -42.73 59.56 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.795 0.685 . . . . 0.0 111.097 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 22.1 mmm180 -64.93 -42.93 94.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 53' ' ' ILE . 93.9 mt -64.93 -43.26 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.922 . . . . 0.0 110.549 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.4 t70 -56.1 -36.83 68.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.455 0.702 . . . . 0.0 111.899 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.51 -39.07 77.8 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 123.719 0.637 . . . . 0.0 110.407 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.74 -38.53 86.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.43 0.692 . . . . 0.0 111.996 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.7 m -80.55 -25.73 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 122.184 -0.323 . . . . 0.0 110.839 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.17 -38.12 78.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.145 0.578 . . . . 0.0 109.825 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.72 -49.34 65.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.083 0.953 . . . . 0.0 112.704 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.02 -33.69 65.89 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.787 0.435 . . . . 0.0 111.108 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.73 -27.0 73.08 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.743 -0.208 . . . . 0.0 113.508 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.17 -25.08 60.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 0.0 110.597 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.5 -18.71 42.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.846 0.858 . . . . 0.0 112.457 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.04 111.72 6.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -73.17 146.58 45.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.855 0.862 . . . . 0.0 111.618 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.2 t60 73.18 2.14 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.393 1.477 . . . . 0.0 112.873 168.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 43.65 110.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 126.742 2.017 . . . . 0.0 113.295 -171.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -79.57 71.96 6.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.682 0.753 . . . . 0.0 109.811 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -149.63 94.04 2.13 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.7 m80 . . . . . 0 C--O 1.247 0.94 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.71 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 m -67.0 119.08 11.37 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -61.55 132.83 54.64 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 16.8 m -51.07 -35.37 34.45 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 124.458 1.099 . . . . 0.0 111.55 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -68.25 -32.11 72.07 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -59.31 -48.09 82.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.66 0.384 . . . . 0.0 111.071 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -69.33 -46.23 67.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.865 0.728 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -57.97 -42.67 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.76 0.824 . . . . 0.0 111.314 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.98 91.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.608 0.763 . . . . 0.0 110.647 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -56.41 -44.12 80.04 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.956 0.903 . . . . 0.0 111.597 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.485 HG21 HG13 ' A' ' 47' ' ' ILE . 29.3 mm -58.17 -57.87 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.88 0.872 . . . . 0.0 110.049 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.65 -33.17 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.37 1.068 . . . . 0.0 111.593 -175.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.24 59.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.933 0.893 . . . . 0.0 111.437 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.17 -24.66 30.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.498 HG21 ' HA ' ' A' ' 43' ' ' ILE . 37.4 p -74.95 -62.05 1.68 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.745 0.418 . . . . 0.0 110.353 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.2 m -94.48 12.57 26.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.206 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t70 67.34 16.91 10.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.775 1.23 . . . . 0.0 111.991 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.8 mt -77.34 127.36 83.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 122.892 0.477 . . . . 0.0 110.284 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.71 127.03 23.01 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.744 2.296 . . . . 0.0 112.365 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -59.57 -31.54 69.53 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.248 1.019 . . . . 0.0 110.804 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.8 pt-20 -59.91 -27.92 67.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.811 1.244 . . . . 0.0 112.374 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 21' ' ' GLU . 45.0 p -105.15 -6.82 19.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.539 0.735 . . . . 0.0 111.947 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.1 mt -71.04 116.19 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.164 0.507 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 138.25 31.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.085 1.354 . . . . 0.0 108.435 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 36.8 Cg_endo -60.93 -27.22 84.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.998 2.465 . . . . 0.0 112.942 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.29 -20.84 61.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.179 0.992 . . . . 0.0 112.351 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 146.62 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.724 0.41 . . . . 0.0 110.362 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 30.1 t-80 -107.85 136.38 47.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 124.159 0.984 . . . . 0.0 108.819 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.34 -63.49 1.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.28 1.432 . . . . 0.0 113.545 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.89 -28.21 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.797 0.439 . . . . 0.0 110.836 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.7 t70 -63.8 -65.97 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.07 0.948 . . . . 0.0 112.018 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.69 -48.02 3.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.048 0.539 . . . . 0.0 110.527 -170.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.33 -23.53 66.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.087 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.05 26.67 71.55 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.046 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' HB ' ' HB1' ' A' ' 29' ' ' ALA . 69.5 mt -65.52 120.57 12.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.57 164.43 25.89 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t -77.08 -22.04 53.43 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 122.053 -0.404 . . . . 0.0 110.003 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.7 -32.03 22.15 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.684 0.794 . . . . 0.0 109.537 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -73.05 -29.63 63.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.243 1.017 . . . . 0.0 110.534 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.88 -22.5 59.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.695 . . . . 0.0 110.059 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 57' ' ' LEU . 93.4 mt -57.71 -35.78 71.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.745 0.418 . . . . 0.0 110.815 174.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.74 -36.77 76.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.653 0.781 . . . . 0.0 110.858 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' A' ' 16' ' ' CYS . 52.3 mt -62.08 -53.03 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.585 0.754 . . . . 0.0 109.538 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.24 85.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.329 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.84 -40.13 69.27 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.622 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.877 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 11' ' ' ILE . 82.1 mt -72.11 -38.67 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.607 1.163 . . . . 0.0 111.388 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -53.32 -46.16 69.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.86 0.864 . . . . 0.0 110.925 174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -77.53 -47.57 19.18 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.347 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.41 -50.33 65.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.662 0.785 . . . . 0.0 111.803 -170.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.463 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 59.8 m-85 -83.92 -28.36 27.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.632 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 45.88 8.82 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 51' ' ' PHE . 37.6 pt -127.14 -175.35 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.049 0.94 . . . . 0.0 111.051 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -124.04 99.71 6.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.28 1.032 . . . . 0.0 108.488 174.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 104.26 8.06 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.68 81.65 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.47 1.447 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 41' ' ' LEU . 54.3 tp -69.75 -32.76 71.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.767 0.427 . . . . 0.0 110.099 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.18 -36.35 70.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.44 1.096 . . . . 0.0 110.903 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 39.4 ttpt -78.11 -44.16 26.91 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.677 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -62.89 -39.38 94.31 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 0.0 111.436 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 m -56.56 -46.31 80.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.508 1.123 . . . . 0.0 111.073 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -66.38 -34.91 79.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.076 0.95 . . . . 0.0 111.101 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.9 mm-40 -59.44 -42.72 92.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.117 0.567 . . . . 0.0 110.442 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 71' ' ' THR . 59.0 t -68.28 -49.61 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.662 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -61.9 -28.9 69.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.93 0.892 . . . . 0.0 112.947 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -95.06 -7.8 38.52 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.851 0.861 . . . . 0.0 110.849 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.87 80.87 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.558 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.61 -10.92 57.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.7 0.8 . . . . 0.0 112.121 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -161.72 168.63 22.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.253 0.621 . . . . 0.0 110.837 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.5 p -104.36 157.45 17.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.919 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.492 HG23 HG11 ' A' ' 64' ' ' VAL . 32.2 p -67.98 -28.63 67.61 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.634 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.62 -39.56 88.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.164 0.586 . . . . 0.0 110.65 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.37 -34.72 66.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.868 0.867 . . . . 0.0 112.133 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -107.47 -71.81 0.74 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.373 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 57.2 m-85 -60.66 -18.23 52.41 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -165.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 84.8 t -65.6 128.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.811 1.187 . . . . 0.0 108.189 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.82 -39.2 77.07 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.2 pttp -68.55 -38.17 80.56 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.428 0.455 . . . . 0.0 112.089 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.0 m-20 -70.36 -46.61 63.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.47 0.708 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.06 -49.14 64.08 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.285 1.434 . . . . 0.0 110.863 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.48 69.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.347 0.659 . . . . 0.0 110.832 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.07 -39.61 55.02 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.723 0.409 . . . . 0.0 110.739 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.5 mmm180 -59.35 -43.39 92.8 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.352 0.596 . . . . 0.0 110.899 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.411 ' CD1' HD13 ' A' ' 47' ' ' ILE . 78.4 mt -71.7 -38.35 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.294 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.4 -38.64 66.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.744 0.818 . . . . 0.0 111.882 170.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.48 -40.66 76.92 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.545 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.43 -42.82 95.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.142 0.977 . . . . 0.0 112.957 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.9 m -75.73 -26.6 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.604 0.362 . . . . 0.0 110.27 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.8 73.08 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.953 171.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.82 81.92 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.706 0.803 . . . . 0.0 112.981 176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 22.8 pttp -73.83 -33.39 64.12 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.798 0.333 . . . . 0.0 110.6 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.85 -26.75 72.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.56 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.11 -24.32 63.18 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.902 0.481 . . . . 0.0 111.631 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.5 mt -50.54 -49.47 55.9 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.892 0.877 . . . . 0.0 110.02 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.22 105.38 11.44 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -62.46 128.9 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 111.038 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -64.28 105.94 1.01 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.247 1.419 . . . . 0.0 111.166 -172.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -128.53 156.43 43.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.653 1.181 . . . . 0.0 109.431 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -73.21 115.94 13.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.306 0.642 . . . . 0.0 109.483 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -85.83 135.08 33.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.727 0.811 . . . . 0.0 109.56 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.246 0.913 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -176.12 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m -103.98 151.3 23.35 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.952 0.501 . . . . 0.0 109.723 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -139.91 160.44 39.91 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.232 1.413 . . . . 0.0 109.237 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 8' ' ' VAL . 79.8 m -58.38 -28.29 65.02 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.964 173.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.35 -58.68 5.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.81 -29.77 68.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 123.867 0.729 . . . . 0.0 111.588 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -64.98 -51.53 61.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 110.75 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 4' ' ' THR . 54.3 t -61.83 -36.17 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.144 0.578 . . . . 0.0 111.028 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.31 93.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.849 . . . . 0.0 109.958 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.2 m -54.92 -46.91 74.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.738 1.215 . . . . 0.0 111.409 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.576 HG21 HG13 ' A' ' 47' ' ' ILE . 41.9 mm -58.4 -58.32 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 18' ' ' ILE . 77.4 mt -58.76 -37.14 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.434 1.094 . . . . 0.0 111.387 -175.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.14 78.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.927 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.58 -27.44 21.37 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 43' ' ' ILE . 21.7 p -80.4 -59.94 2.51 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.502 0.592 . . . . 0.0 110.74 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.645 ' SG ' HG12 ' A' ' 35' ' ' ILE . 44.8 t -80.06 -8.39 59.36 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.234 1.014 . . . . 0.0 111.887 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 61.68 71.92 0.53 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.822 0.849 . . . . 0.0 110.158 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 12' ' ' ILE . 39.3 mt -127.78 128.48 23.87 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.241 1.016 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.58 134.9 60.01 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.992 2.461 . . . . 0.0 112.553 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD2' HD12 ' A' ' 23' ' ' ILE . 9.4 mmm180 -59.25 -29.2 67.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.873 0.869 . . . . 0.0 111.554 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG3' HG23 ' A' ' 22' ' ' THR . 14.2 pt-20 -63.26 -33.71 76.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.0 p -101.7 21.42 14.48 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.152 0.981 . . . . 0.0 111.447 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 20' ' ' ARG . 63.5 mt -106.45 128.21 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -138.41 155.66 73.79 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.073 0.949 . . . . 0.0 109.557 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.5 -35.01 96.34 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.328 2.019 . . . . 0.0 112.878 170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.15 -21.69 53.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.732 0.813 . . . . 0.0 112.092 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.3 p -69.98 128.89 37.91 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 53.5 t-80 -88.41 129.89 35.31 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.68 -59.12 4.64 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.016 0.526 . . . . 0.0 111.994 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 45.1 mt -71.33 -60.55 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 120.657 0.265 . . . . 0.0 110.803 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.74 -49.15 77.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.268 1.027 . . . . 0.0 112.901 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.86 -58.56 2.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.83 0.452 . . . . 0.0 111.498 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.13 -19.6 58.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.401 0.68 . . . . 0.0 111.767 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.12 76.01 Favored Glycine 0 N--CA 1.478 1.463 0 O-C-N 122.986 0.178 . . . . 0.0 113.518 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.645 HG12 ' SG ' ' A' ' 16' ' ' CYS . 47.6 mt -73.32 117.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.106 0.962 . . . . 0.0 110.22 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.6 163.19 27.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 m -63.64 -16.51 61.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.911 0.484 . . . . 0.0 111.726 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -85.15 -43.88 13.45 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.718 0.807 . . . . 0.0 109.509 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.89 -31.4 72.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.116 0.966 . . . . 0.0 110.793 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 57' ' ' LEU . 8.8 t80 -72.2 -20.93 61.49 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.01 0.924 . . . . 0.0 110.685 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 57' ' ' LEU . 78.4 mt -57.62 -31.2 65.99 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.784 0.434 . . . . 0.0 111.849 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -69.75 -43.24 72.67 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.233 1.013 . . . . 0.0 109.262 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG12 ' OG1' ' A' ' 15' ' ' THR . 64.4 mt -60.06 -51.59 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.118 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.74 89.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.842 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.1 -38.33 87.97 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.423 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 11' ' ' ILE . . . -73.73 -29.23 62.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.178 0.591 . . . . 0.0 111.652 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.576 HG13 HG21 ' A' ' 11' ' ' ILE . 87.3 mt -70.72 -39.38 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.654 0.782 . . . . 0.0 110.587 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.34 -34.77 61.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.97 0.908 . . . . 0.0 111.829 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.38 -51.79 7.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.42 0.688 . . . . 0.0 111.251 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.337 1.055 . . . . 0.0 111.673 -171.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 53' ' ' ILE . 72.9 m-85 -88.58 -14.41 37.65 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.022 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.47 11.32 82.62 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.089 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.515 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.4 pt -96.13 -171.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.878 0.871 . . . . 0.0 110.58 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.63 114.83 25.42 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.05 98.35 7.4 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 59' ' ' LYS . 86.9 Cg_endo -81.09 86.41 1.63 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.287 1.991 . . . . 0.0 110.442 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 41' ' ' LEU . 65.9 tp -67.08 -40.41 86.99 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.774 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.63 -31.07 72.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.109 0.964 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' A' ' 56' ' ' PRO . 47.7 tttp -65.5 -48.29 73.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.004 1.322 . . . . 0.0 110.187 171.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 64' ' ' VAL . 45.2 m0 -63.36 -43.63 97.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.854 0.861 . . . . 0.0 110.787 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.0 m -59.36 -46.0 89.86 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.459 1.504 . . . . 0.0 111.243 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -65.14 -44.9 87.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.532 0.733 . . . . 0.0 111.001 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.96 -26.69 59.77 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.881 0.473 . . . . 0.0 112.222 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 71' ' ' THR . 90.3 t -72.72 -42.28 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.68 -17.45 62.84 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.623 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.01 -6.88 34.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 10.55 84.96 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.071 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.18 -16.98 55.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.842 0.857 . . . . 0.0 110.981 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.26 166.89 30.37 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.888 0.875 . . . . 0.0 109.999 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.7 t -111.57 155.65 22.98 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.47 0.708 . . . . 0.0 110.326 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.523 HG23 HG11 ' A' ' 64' ' ' VAL . 30.2 p -63.09 -32.52 73.91 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.558 0.743 . . . . 0.0 110.988 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HG3' HG21 ' A' ' 76' ' ' VAL . 36.1 tt0 -58.29 -44.36 88.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.561 0.344 . . . . 0.0 111.459 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.468 ' H ' HG23 ' A' ' 70' ' ' THR . 30.3 tt0 -56.32 -32.59 64.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.768 0.827 . . . . 0.0 111.61 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -102.12 -82.09 0.48 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.9 m-85 -55.89 -24.6 38.3 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -161.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.2 t -65.54 124.79 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 119.783 1.174 . . . . 0.0 108.303 170.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.85 -32.97 73.35 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -160.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.9 pttt -65.5 -41.28 93.39 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.976 0.51 . . . . 0.0 111.243 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.29 -41.07 49.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.95 -47.07 68.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.831 1.652 . . . . 0.0 110.931 169.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.35 70.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.447 0.699 . . . . 0.0 111.467 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.39 -41.5 47.69 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.413 0.685 . . . . 0.0 110.871 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 23.2 mmm180 -57.58 -50.28 73.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.028 0.931 . . . . 0.0 111.101 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.08 -38.83 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.031 0.932 . . . . 0.0 110.443 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.9 t70 -58.14 -35.52 71.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.81 0.444 . . . . 0.0 111.569 171.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.47 -39.79 70.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.491 0.316 . . . . 0.0 110.735 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 61.4 mt -61.93 -43.77 98.16 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.428 0.691 . . . . 0.0 111.733 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 53' ' ' ILE . 12.2 m -71.68 -27.68 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 122.761 0.424 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.1 65.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.101 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.92 95.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.696 0.799 . . . . 0.0 112.934 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -71.12 -36.24 72.05 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.41 64.64 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.824 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.27 76.54 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.7 -29.39 64.51 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.945 0.898 . . . . 0.0 110.393 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.98 101.6 1.15 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 164.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -60.11 130.45 46.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -172.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -64.46 121.26 13.97 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.746 0.654 . . . . 0.0 110.168 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -123.75 32.96 5.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.61 1.164 . . . . 0.0 110.405 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 29.8 p80 42.22 73.51 0.13 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.385 1.874 . . . . 0.0 113.563 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -99.72 77.75 2.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.505 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.498 1.119 . . . . 0.0 108.695 -176.794 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m -75.61 125.3 28.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.774 0.43 . . . . 0.0 110.578 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -72.74 144.99 47.42 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.597 0.759 . . . . 0.0 110.519 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 m -64.62 -18.6 65.07 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.621 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.49 -47.28 70.48 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.728 0.411 . . . . 0.0 110.299 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -54.78 -44.4 73.68 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.406 0.683 . . . . 0.0 111.461 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -60.49 -55.63 31.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.088 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 4' ' ' THR . 58.3 t -60.39 -37.14 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.51 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.37 87.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.105 0.962 . . . . 0.0 110.518 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -57.53 -42.81 83.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.141 0.976 . . . . 0.0 111.778 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -58.79 -50.94 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -33.99 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.149 0.58 . . . . 0.0 110.648 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -51.26 62.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.382 1.073 . . . . 0.0 112.317 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.44 -46.51 22.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.708 0.403 . . . . 0.0 111.959 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.1 m -72.46 -51.96 17.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.12 0.568 . . . . 0.0 111.616 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.77 -9.28 56.22 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.382 0.673 . . . . 0.0 111.777 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 59.02 72.07 0.55 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.381 1.072 . . . . 0.0 110.597 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.13 129.65 21.79 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.14 139.33 85.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.796 2.33 . . . . 0.0 112.358 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -61.06 -28.98 69.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.335 0.654 . . . . 0.0 112.129 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.34 -37.07 84.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.544 0.738 . . . . 0.0 111.236 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -81.48 -23.03 37.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.953 0.501 . . . . 0.0 111.012 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.474 HG23 HD13 ' A' ' 77' ' ' LEU . 75.8 mt -76.63 116.4 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -132.32 144.72 54.23 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.504 1.122 . . . . 0.0 109.204 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.9 -32.18 92.33 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.814 2.343 . . . . 0.0 112.792 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.13 -20.67 60.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.642 0.777 . . . . 0.0 112.011 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.9 t -73.58 147.76 43.57 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.989 0.915 . . . . 0.0 110.709 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 56.1 t-80 -104.37 133.71 48.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.553 1.141 . . . . 0.0 108.955 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -64.43 0.84 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.717 0.807 . . . . 0.0 112.705 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 46.2 mt -69.81 -39.6 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.835 0.454 . . . . 0.0 111.603 -173.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.52 -67.62 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.499 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.79 -57.7 3.89 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.683 0.393 . . . . 0.0 111.067 -171.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 77' ' ' LEU . 84.9 mt -71.67 -26.94 62.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.209 0.604 . . . . 0.0 111.108 -176.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.79 21.9 60.72 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.863 0.727 . . . . 0.0 113.552 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.6 mt -70.2 129.21 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.811 0.844 . . . . 0.0 110.026 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.1 158.69 30.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 33.1 m -65.55 -17.4 64.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.53 0.332 . . . . 0.0 110.84 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 mt -75.88 -47.57 24.91 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.52 1.128 . . . . 0.0 109.299 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -29.2 65.49 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.721 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -73.06 -22.26 60.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.616 0.766 . . . . 0.0 110.451 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -60.15 -39.61 86.96 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.681 0.392 . . . . 0.0 109.985 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.0 -44.11 97.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.883 0.873 . . . . 0.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.57 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.493 0.717 . . . . 0.0 109.948 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.07 73.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.21 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -65.2 -43.8 90.42 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.05 0.94 . . . . 0.0 110.179 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.03 -32.05 70.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.245 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 84' ' ' ILE . 84.9 mt -65.22 -42.64 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.855 0.862 . . . . 0.0 110.478 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -53.89 -48.71 69.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.399 0.68 . . . . 0.0 111.463 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -80.04 -37.49 33.92 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.445 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.22 31.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.367 0.667 . . . . 0.0 111.287 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PHE . . . . . 0.448 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 92.6 m-85 -82.16 -28.05 32.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.22 39.4 8.47 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 pt -126.5 -172.48 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.197 0.999 . . . . 0.0 110.85 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -131.0 100.94 5.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tt -72.82 113.62 23.13 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.91 80.5 2.14 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.976 1.784 . . . . 0.0 110.966 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 41' ' ' LEU . 46.3 tp -70.08 -35.62 74.34 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.146 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.0 -39.43 81.82 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.481 1.113 . . . . 0.0 111.127 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.8 ttpt -74.65 -40.89 61.18 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.033 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -64.02 -42.47 97.09 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.929 0.768 . . . . 0.0 111.233 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.6 m -59.51 -39.56 84.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.937 0.895 . . . . 0.0 111.141 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -68.97 -34.94 76.13 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.961 0.904 . . . . 0.0 110.888 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 23.0 mm-40 -61.89 -39.95 93.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.356 0.662 . . . . 0.0 110.595 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 58.1 t -65.44 -44.55 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.993 0.517 . . . . 0.0 109.972 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -57.93 -44.29 86.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.327 1.051 . . . . 0.0 112.173 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.31 -18.72 35.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.017 0.927 . . . . 0.0 111.654 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.04 21.94 53.92 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 122.674 0.178 . . . . 0.0 113.0 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -79.03 -24.03 43.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.515 0.726 . . . . 0.0 110.552 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.87 166.41 33.0 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.818 0.847 . . . . 0.0 110.047 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.2 t -107.74 166.85 10.38 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.193 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m -67.72 -30.91 70.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.76 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.58 -35.17 78.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.764 0.825 . . . . 0.0 111.399 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.11 -31.99 72.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 112.392 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -109.27 -58.55 2.02 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.91 -10.9 60.53 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -165.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t -63.99 133.39 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' LEU . 36.1 mt -60.03 -41.12 91.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.539 0.735 . . . . 0.0 112.641 -166.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.8 -35.21 78.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 123.147 0.279 . . . . 0.0 111.721 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -68.22 -47.99 66.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.184 0.593 . . . . 0.0 109.662 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -52.19 -46.79 65.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.619 1.568 . . . . 0.0 110.385 172.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.78 -34.55 78.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.892 0.877 . . . . 0.0 111.994 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 -37.54 61.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.1 0.56 . . . . 0.0 110.861 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.7 mmm180 -64.03 -39.04 93.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.087 0.955 . . . . 0.0 111.401 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.83 -37.03 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.547 0.739 . . . . 0.0 109.861 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.91 -42.91 65.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.787 0.835 . . . . 0.0 111.419 167.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -62.76 -46.83 86.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.433 0.693 . . . . 0.0 111.087 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.55 -45.47 92.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.326 1.05 . . . . 0.0 112.578 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.2 -27.37 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 122.913 0.485 . . . . 0.0 109.985 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.64 76.08 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.34 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.15 93.04 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 22.4 pttp -76.64 -33.36 58.35 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 122.291 -0.256 . . . . 0.0 110.501 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.06 -20.88 71.3 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.087 169.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . -75.78 -30.51 59.13 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.164 0.586 . . . . 0.0 110.505 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.04 -21.23 44.39 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.161 0.984 . . . . 0.0 111.397 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -88.9 60.34 5.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.102 0.961 . . . . 0.0 108.871 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 55.2 t-80 -91.97 56.19 2.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.272 1.029 . . . . 0.0 109.911 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 58.84 -143.34 0.62 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.627 0.771 . . . . 0.0 109.502 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -79.72 167.97 19.94 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 118.08 0.4 . . . . 0.0 109.928 166.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -59.85 133.51 56.16 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.176 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.57 143.8 37.5 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 CA--C 1.553 1.058 0 C-N-CA 123.976 0.911 . . . . 0.0 110.707 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.7 m . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 120.373 0.13 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -68.67 -35.48 77.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -43.24 80.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.266 0.627 . . . . 0.0 110.638 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -72.55 -44.89 61.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.957 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 4' ' ' THR . 95.2 t -60.01 -42.09 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.334 0.654 . . . . 0.0 111.369 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.76 99.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.803 0.841 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -63.37 -42.66 98.86 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.873 0.869 . . . . 0.0 112.023 174.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.589 HG21 HG13 ' A' ' 47' ' ' ILE . 24.5 mm -56.79 -58.65 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.683 0.793 . . . . 0.0 109.527 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.37 -34.08 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.239 1.015 . . . . 0.0 110.944 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -59.16 -53.54 57.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.358 0.663 . . . . 0.0 111.608 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.57 -25.4 38.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.453 0.701 . . . . 0.0 112.01 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.4 m -75.94 -62.41 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.312 0.645 . . . . 0.0 110.149 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 43' ' ' ILE . 2.7 m -85.81 -2.92 58.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.943 0.897 . . . . 0.0 112.368 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 65.11 16.22 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.912 1.285 . . . . 0.0 112.468 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 73.4 mt -79.33 120.7 81.37 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.543 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_endo -62.04 145.11 96.74 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.269 1.979 . . . . 0.0 112.291 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -54.74 -34.48 62.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.195 0.998 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -59.67 -38.25 80.95 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.877 0.736 . . . . 0.0 111.658 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' GLU . 76.2 p -86.84 -6.05 58.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.305 0.642 . . . . 0.0 111.687 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.01 133.87 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.992 0.917 . . . . 0.0 109.489 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -144.48 153.1 54.93 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.588 1.155 . . . . 0.0 110.006 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.54 -43.16 56.99 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.408 2.739 . . . . 0.0 114.448 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.83 -3.59 58.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.799 0.44 . . . . 0.0 111.638 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.4 t -68.55 137.36 54.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 49.6 t-80 -98.19 131.34 44.63 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.156 0.982 . . . . 0.0 108.76 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.9 -58.95 4.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.48 0.712 . . . . 0.0 111.97 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.36 -55.31 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.585 0.354 . . . . 0.0 111.132 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.1 t70 -63.08 -55.29 26.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.695 0.798 . . . . 0.0 111.768 -172.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.76 -65.74 0.98 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.905 0.482 . . . . 0.0 110.685 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 77' ' ' LEU . 88.5 mt -64.44 -28.49 69.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.531 0.732 . . . . 0.0 111.962 -173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.64 40.2 27.58 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-O 121.31 0.394 . . . . 0.0 112.373 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.39 127.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.466 1.106 . . . . 0.0 109.31 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.04 159.24 17.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.847 0.859 . . . . 0.0 109.604 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.499 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 48.1 m -49.51 -38.55 30.82 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.1 0.96 . . . . 0.0 112.781 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 mt -71.06 -35.22 71.84 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.445 0.698 . . . . 0.0 110.999 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.11 -37.59 64.08 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.275 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -71.45 -22.04 61.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.208 0.603 . . . . 0.0 110.776 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.7 mt -57.1 -47.24 81.52 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.29 -35.35 79.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.579 1.151 . . . . 0.0 111.732 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.598 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.5 mt -64.92 -53.1 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.017 0.527 . . . . 0.0 110.144 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -67.34 -29.03 68.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.037 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.11 -38.37 56.96 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.988 0.805 . . . . 0.0 110.84 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.32 -36.65 74.4 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.589 HG13 HG21 ' A' ' 11' ' ' ILE . 85.3 mt -66.52 -42.49 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.206 1.003 . . . . 0.0 110.586 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.23 -43.96 71.29 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.366 1.066 . . . . 0.0 110.474 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.71 -37.07 23.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.236 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.91 23.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.212 0.605 . . . . 0.0 111.401 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -78.68 -18.03 55.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.021 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.34 50.5 38.18 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.0 pt -133.13 160.39 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.538 1.135 . . . . 0.0 109.156 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -94.68 96.92 9.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.509 HD22 ' HB1' ' A' ' 44' ' ' ALA . 6.7 tt -83.29 111.29 29.9 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.58 81.9 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.843 1.695 . . . . 0.0 110.802 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.74 -28.11 66.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.788 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.68 -33.32 64.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.792 0.837 . . . . 0.0 111.472 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.6 tttp -80.11 -49.68 11.38 Favored 'General case' 0 C--O 1.211 -0.961 0 C-N-CA 122.999 0.519 . . . . 0.0 109.917 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -60.27 -48.81 80.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.644 0.778 . . . . 0.0 111.705 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.5 m -52.2 -46.23 65.52 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.728 1.211 . . . . 0.0 111.705 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -64.24 -37.52 87.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.926 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.8 mm-40 -59.88 -42.69 94.3 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.072 0.549 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.02 -49.97 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.523 0.729 . . . . 0.0 110.887 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -61.51 -31.42 71.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.032 0.933 . . . . 0.0 112.94 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.46 0.88 55.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.546 0.738 . . . . 0.0 111.127 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.61 78.19 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.61 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -88.06 -12.93 42.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.543 0.737 . . . . 0.0 111.089 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.55 36.36 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.104 0.962 . . . . 0.0 109.825 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -108.37 159.57 16.55 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.162 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 p -58.23 -33.51 69.41 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.487 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' A' ' 76' ' ' VAL . 44.2 tt0 -49.75 -48.49 50.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.946 0.899 . . . . 0.0 112.002 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.88 -30.9 71.17 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.98 5.0 10.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.8 m-85 -133.67 -32.51 1.13 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.93 0.786 . . . . 0.0 111.876 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 89.8 t -59.91 127.27 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 33' ' ' LEU . 27.5 mt -59.7 -38.36 81.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -163.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.52 -36.75 76.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.814 0.446 . . . . 0.0 112.059 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.51 -46.15 64.21 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.619 0.768 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.23 -49.63 63.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.64 1.576 . . . . 0.0 110.127 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.48 64.97 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.43 61.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.688 0.395 . . . . 0.0 110.332 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.479 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 21.4 mmm180 -67.28 -31.34 71.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.429 0.691 . . . . 0.0 111.895 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 47' ' ' ILE . 79.8 mt -77.58 -42.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.21 0.604 . . . . 0.0 110.026 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 88' ' ' VAL . 31.0 t70 -54.97 -34.64 63.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.685 0.794 . . . . 0.0 111.588 170.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 9.3 tp10 -60.98 -49.46 77.36 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.464 0.706 . . . . 0.0 110.73 173.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 54.0 mt -68.35 -37.74 80.78 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.67 0.788 . . . . 0.0 112.468 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 85' ' ' ASP . 19.3 m -74.91 -27.87 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.038 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.11 67.9 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.286 171.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 C-N-CA 123.691 0.796 . . . . 0.0 112.883 176.584 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 m . . . . . 0 CA--C 1.548 0.897 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -74.65 -37.19 62.8 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.294 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -52.21 -49.28 64.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 123.835 0.709 . . . . 0.0 110.732 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -65.66 -47.09 76.68 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.235 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.64 -36.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.326 0.651 . . . . 0.0 111.973 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.36 96.09 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.159 0.983 . . . . 0.0 110.342 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -57.38 -47.14 82.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.254 1.021 . . . . 0.0 112.034 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.453 HG21 HG13 ' A' ' 47' ' ' ILE . 95.3 mt -66.57 -49.86 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.739 . . . . 0.0 111.65 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.434 HG12 HD13 ' A' ' 43' ' ' ILE . 62.8 mt -63.87 -35.5 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.643 0.777 . . . . 0.0 111.259 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.38 35.14 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.506 0.722 . . . . 0.0 111.551 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.23 -29.05 53.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.154 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.4 m -72.36 -62.11 1.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.84 0.456 . . . . 0.0 110.612 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.7 m -83.41 -1.09 52.66 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -170.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.94 61.74 2.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.959 0.904 . . . . 0.0 110.028 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -127.57 138.38 32.71 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.887 1.275 . . . . 0.0 108.409 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.14 123.04 11.69 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.872 2.382 . . . . 0.0 111.72 167.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -41.23 89.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.639 1.576 . . . . 0.0 110.764 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.85 -29.43 65.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.794 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -80.25 -25.38 39.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.443 0.297 . . . . 0.0 111.104 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -56.35 110.99 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.456 0.702 . . . . 0.0 111.034 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -94.62 147.13 32.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.605 0.762 . . . . 0.0 109.743 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 37.1 Cg_endo -65.07 -28.87 56.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.404 2.069 . . . . 0.0 111.955 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.41 -11.08 59.92 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.226 0.61 . . . . 0.0 111.709 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.1 p -74.31 140.35 44.83 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.813 0.339 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.2 t-80 -90.81 130.47 36.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.43 -61.29 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.051 0.94 . . . . 0.0 112.596 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -74.89 -44.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 122.65 0.38 . . . . 0.0 111.318 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 25.8 t70 -71.16 -65.48 0.74 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.758 0.423 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.89 -62.98 1.31 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.039 0.536 . . . . 0.0 110.651 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 77' ' ' LEU . 76.3 mt -73.42 -11.06 60.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.438 0.695 . . . . 0.0 112.532 -172.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.26 72.34 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.45 130.24 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.716 0.806 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -71.08 149.28 46.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -67.12 -17.3 64.8 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.071 0.396 . . . . 0.0 110.489 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.28 -31.56 24.86 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.119 0.968 . . . . 0.0 110.226 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.43 -30.17 53.3 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.408 0.623 . . . . 0.0 109.783 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -67.23 -21.51 65.74 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.561 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 57' ' ' LEU . 84.2 mt -59.69 -40.3 87.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.016 0.526 . . . . 0.0 110.498 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.61 -35.93 75.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.547 0.739 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.63 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.5 mt -61.95 -48.33 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.19 -31.82 73.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.448 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.55 -41.65 72.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.436 0.694 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.0 -27.55 60.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.52 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.453 HG13 HG21 ' A' ' 11' ' ' ILE . 94.1 mt -70.73 -42.7 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.833 0.853 . . . . 0.0 109.794 172.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.32 -40.28 74.13 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.624 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -76.43 -48.86 18.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 111.81 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.07 70.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.599 0.76 . . . . 0.0 112.124 -170.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' HG12 ' A' ' 53' ' ' ILE . 96.3 m-85 -83.45 -22.43 32.62 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.179 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.57 33.79 57.82 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 112.161 -0.376 . . . . 0.0 112.161 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.6 pt -114.94 158.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.227 1.011 . . . . 0.0 109.802 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.2 98.58 11.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.5 tt -88.52 105.68 10.38 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.43 80.97 2.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.79 1.66 . . . . 0.0 111.225 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 41' ' ' LEU . 53.6 tp -75.87 -29.56 58.56 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.31 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 -29.76 66.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.521 0.728 . . . . 0.0 110.742 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 61.8 tttp -84.27 -48.49 9.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.621 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -61.59 -39.33 90.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.407 0.683 . . . . 0.0 111.575 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -61.83 -43.92 97.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.89 0.876 . . . . 0.0 110.881 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -65.85 -30.33 70.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.099 0.96 . . . . 0.0 111.462 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 15.2 mm-40 -62.08 -46.71 87.88 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.108 0.563 . . . . 0.0 109.892 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.6 -44.89 99.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.578 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.52 1.128 . . . . 0.0 112.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.14 -18.73 26.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.107 0.963 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.03 65.47 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.792 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -67.95 -32.86 73.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.996 0.518 . . . . 0.0 109.831 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.35 164.46 27.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.573 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 73' ' ' GLN . 12.4 t -105.61 154.52 20.31 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -61.96 -32.32 72.75 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.849 0.859 . . . . 0.0 110.431 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.35 -41.41 89.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.434 ' H ' HG23 ' A' ' 70' ' ' THR . 7.6 tt0 -59.89 -32.58 70.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 112.575 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -105.92 -58.54 1.9 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.605 0.362 . . . . 0.0 111.437 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -67.37 -19.73 65.46 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 85.2 t -66.47 129.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 119.681 1.128 . . . . 0.0 108.408 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 33' ' ' LEU . 12.3 mt -66.34 -34.81 78.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -161.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -65.34 -36.7 84.81 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.935 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.412 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 64.1 m-20 -73.59 -44.7 56.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.419 0.688 . . . . 0.0 109.825 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.86 -48.23 67.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.642 1.177 . . . . 0.0 110.723 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.3 67.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.943 0.897 . . . . 0.0 111.391 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.39 64.29 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -63.4 -39.51 94.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.941 0.896 . . . . 0.0 111.506 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.445 HD11 HD13 ' A' ' 47' ' ' ILE . 96.6 mt -70.47 -43.02 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.109 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.32 -37.8 65.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.243 0.617 . . . . 0.0 111.382 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.15 -44.35 80.01 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.74 -42.33 95.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.604 0.762 . . . . 0.0 112.428 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 m -72.71 -29.34 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 122.999 0.52 . . . . 0.0 110.788 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.4 86.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.401 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.0 m . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 111.731 0.271 . . . . 0.0 111.731 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 77' ' ' LEU . 59.7 t80 -63.11 -55.95 20.99 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.399 0.437 . . . . 0.0 111.132 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.06 -36.69 70.82 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 124.188 0.93 . . . . 0.0 110.99 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.401 ' O ' HG12 ' A' ' 11' ' ' ILE . 14.0 mmm180 -63.15 -53.13 58.19 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.679 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 4' ' ' THR . 51.8 t -61.24 -36.38 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.054 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.07 79.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 110.975 -173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' NH2' ' A' ' 20' ' ' ARG . 11.9 t -69.18 -29.75 67.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.658 0.383 . . . . 0.0 110.68 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 7' ' ' ARG . 45.4 mm -64.46 -50.74 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.191 0.596 . . . . 0.0 109.895 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.4 mt -60.06 -36.43 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.406 0.682 . . . . 0.0 110.395 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.74 42.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.323 1.049 . . . . 0.0 112.202 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.78 -32.43 65.59 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.7 m -77.58 -60.06 2.52 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.262 0.625 . . . . 0.0 110.787 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -91.94 5.57 49.55 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 111.576 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.99 24.74 13.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.693 1.197 . . . . 0.0 113.202 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.5 114.63 56.2 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.305 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -48.51 146.88 9.91 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.327 2.685 . . . . 0.0 113.47 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.44 ' NH2' ' HB ' ' A' ' 10' ' ' THR . 3.9 mmt85 -60.31 -33.83 72.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 0.0 111.521 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.47 -35.78 80.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.082 0.953 . . . . 0.0 111.838 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -86.54 -4.75 59.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.315 0.646 . . . . 0.0 111.825 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -96.15 126.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.763 0.825 . . . . 0.0 108.841 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' HD12 ' A' ' 77' ' ' LEU . 81.8 p -140.84 148.85 54.24 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.096 0.958 . . . . 0.0 109.013 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.35 -36.41 68.59 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.81 2.34 . . . . 0.0 113.256 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -74.92 -25.04 58.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.743 0.817 . . . . 0.0 112.373 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.1 p -76.68 144.59 39.31 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.645 0.26 . . . . 0.0 111.21 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 46.7 t-80 -92.24 131.43 37.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.768 1.227 . . . . 0.0 108.963 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.05 -56.81 9.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 112.2 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -71.3 -52.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 120.409 0.147 . . . . 0.0 110.88 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 31.4 t70 -70.41 -54.62 11.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.786 0.434 . . . . 0.0 112.127 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.48 -60.55 1.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.388 0.275 . . . . 0.0 110.946 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 77' ' ' LEU . 76.5 mt -68.37 -30.8 69.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.868 0.467 . . . . 0.0 111.336 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.75 0.9 68.55 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.957 -0.357 . . . . 0.0 113.189 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.09 104.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.829 0.852 . . . . 0.0 110.145 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -77.87 167.12 22.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -58.58 -17.02 18.42 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.347 0.659 . . . . 0.0 112.191 174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.04 -41.47 18.62 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.13 0.972 . . . . 0.0 110.563 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.66 -40.46 92.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.511 0.672 . . . . 0.0 109.661 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -67.66 -18.73 65.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.883 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 57' ' ' LEU . 94.5 mt -54.43 -45.81 73.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.432 0.56 . . . . 0.0 110.852 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.83 -37.59 70.28 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.75 -41.36 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.227 0.611 . . . . 0.0 110.653 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.34 -35.27 80.47 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.12 0.887 . . . . 0.0 110.356 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.23 -42.29 88.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.904 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.85 74.38 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.484 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.6 -39.44 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.944 . . . . 0.0 110.628 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.92 -47.75 64.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.981 0.912 . . . . 0.0 111.138 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.63 -52.7 19.54 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.924 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.78 -57.02 14.87 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.186 0.929 . . . . 0.0 111.979 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HB2' HG12 ' A' ' 53' ' ' ILE . 76.2 m-85 -83.26 -15.12 51.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.443 0.697 . . . . 0.0 111.532 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.68 31.34 67.75 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 51' ' ' PHE . 42.9 pt -113.55 -170.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.576 1.15 . . . . 0.0 109.77 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.9 114.92 17.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 163.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.25 105.07 4.55 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.24 85.51 1.76 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 121.766 1.644 . . . . 0.0 110.351 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 41' ' ' LEU . 42.5 tp -69.4 -24.35 63.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.985 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.93 -38.57 67.84 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.889 0.876 . . . . 0.0 111.019 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.5 tttp -74.01 -50.82 18.09 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.501 1.12 . . . . 0.0 110.577 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HB2' HD12 ' A' ' 57' ' ' LEU . 30.8 m0 -62.82 -47.19 84.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.801 0.84 . . . . 0.0 112.113 -171.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.1 m -54.57 -44.41 72.94 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.84 0.856 . . . . 0.0 111.351 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -68.38 -32.68 72.93 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.158 0.983 . . . . 0.0 111.654 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 53.7 mm-40 -57.56 -46.14 84.31 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.582 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.44 -49.84 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.355 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.43 -36.54 84.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.085 0.954 . . . . 0.0 112.675 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.02 -5.91 40.01 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.483 1.113 . . . . 0.0 111.308 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.06 61.22 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.81 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.12 -24.94 30.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.071 0.549 . . . . 0.0 111.017 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -160.12 168.74 24.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.923 0.489 . . . . 0.0 110.664 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.5 p -105.52 163.56 12.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.826 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.9 p -67.39 -32.38 73.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.693 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.1 tt0 -63.69 -38.81 92.5 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.232 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 29.4 tt0 -62.41 -29.68 70.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.732 0.413 . . . . 0.0 111.999 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -107.46 -71.31 0.76 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.839 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.5 m-85 -62.15 -20.83 64.52 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -165.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -62.13 126.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.298 1.408 . . . . 0.0 107.874 170.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.01 -34.94 72.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -163.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.1 pttp -65.31 -40.72 94.13 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 173.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 73' ' ' GLN . 3.3 m-20 -69.22 -46.84 66.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.125 0.57 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -50.3 -48.62 55.05 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.835 1.654 . . . . 0.0 111.274 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.93 73.27 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.704 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.34 57.24 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.055 0.847 . . . . 0.0 111.409 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.7 mmm180 -64.28 -41.69 96.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.65 0.78 . . . . 0.0 111.276 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -70.35 -39.28 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.208 0.603 . . . . 0.0 110.385 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.07 -38.28 65.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.336 0.654 . . . . 0.0 111.653 169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -68.55 -44.74 73.84 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.607 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 95.8 mt -64.4 -41.9 96.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.108 0.963 . . . . 0.0 112.688 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.69 -32.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.148 0.579 . . . . 0.0 110.489 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.02 62.47 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 124.448 1.099 . . . . 0.0 112.656 178.37 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.9 m . . . . . 0 CA--C 1.548 0.866 0 CA-C-O 120.468 0.175 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.06 -52.3 63.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.896 0.479 . . . . 0.0 111.282 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -61.89 -32.38 72.75 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.863 0.727 . . . . 0.0 110.573 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 11' ' ' ILE . 25.8 mmt180 -66.05 -53.08 42.84 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.838 0.855 . . . . 0.0 111.409 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 81' ' ' ALA . 69.9 t -62.91 -38.09 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.361 0.601 . . . . 0.0 110.748 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.513 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -67.97 -39.75 83.27 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.271 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 7.6 t -73.73 -27.65 61.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.243 0.217 . . . . 0.0 110.865 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 7' ' ' ARG . 34.6 mm -61.02 -55.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 18' ' ' ILE . 60.3 mt -66.51 -29.9 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.645 0.778 . . . . 0.0 111.034 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.33 -51.3 70.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.995 0.918 . . . . 0.0 111.247 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.8 mm-40 -78.98 -28.33 43.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.66 0.384 . . . . 0.0 111.676 -177.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -75.53 -61.68 1.83 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.897 0.479 . . . . 0.0 110.838 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 43' ' ' ILE . 58.6 m -95.54 7.4 46.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.402 0.681 . . . . 0.0 112.307 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.29 67.94 0.92 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.343 1.057 . . . . 0.0 111.126 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 12' ' ' ILE . 23.6 mt -121.77 122.06 27.96 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 139.73 84.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.516 2.144 . . . . 0.0 112.21 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -58.65 -35.4 72.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 0.0 111.511 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.42 -37.53 86.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.043 0.937 . . . . 0.0 111.883 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 p -84.48 -13.65 51.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.191 0.596 . . . . 0.0 111.419 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB1' ' A' ' 9' ' ' ALA . 88.9 mt -81.46 113.46 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.341 0.656 . . . . 0.0 109.295 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 p -117.78 158.3 45.95 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 109.486 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 58.3 Cg_exo -55.36 -33.16 84.44 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.868 2.379 . . . . 0.0 113.506 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.17 -0.58 56.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.597 0.759 . . . . 0.0 112.441 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 26.6 m -72.59 129.2 37.74 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.3 t-80 -98.5 133.06 43.39 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -53.3 -60.14 3.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.092 0.557 . . . . 0.0 111.98 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -75.11 -42.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.451 0.301 . . . . 0.0 111.755 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.05 -56.94 3.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.371 0.668 . . . . 0.0 111.844 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -82.54 -61.52 1.86 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.266 0.626 . . . . 0.0 110.638 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 77' ' ' LEU . 79.6 mt -69.94 -19.28 63.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.054 0.942 . . . . 0.0 111.332 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.73 90.11 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 43' ' ' ILE . 85.0 mt -68.63 98.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.648 1.179 . . . . 0.0 110.346 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.23 165.78 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.094 0.957 . . . . 0.0 111.506 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.0 p -48.43 -28.2 3.12 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.013 1.325 . . . . 0.0 113.57 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.35 -40.84 16.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.504 0.721 . . . . 0.0 110.442 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.32 -30.76 69.82 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.3 0.572 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -74.38 -20.2 60.15 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 57' ' ' LEU . 73.2 mt -56.82 -41.11 77.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.157 0.435 . . . . 0.0 111.115 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.18 -35.94 69.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.809 0.844 . . . . 0.0 110.538 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.659 HD11 ' SG ' ' A' ' 16' ' ' CYS . 37.7 mt -64.07 -48.98 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.13 0.572 . . . . 0.0 110.107 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.34 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.302 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -67.33 -43.37 81.75 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.187 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.49 76.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 111.579 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 84' ' ' ILE . 91.4 mt -69.57 -37.66 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 110.692 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -56.78 -47.51 80.0 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.0 0.52 . . . . 0.0 111.056 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -71.21 -48.18 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.573 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.58 -52.64 36.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.929 0.891 . . . . 0.0 111.53 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -86.65 -11.95 49.87 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 111.933 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.94 38.57 84.95 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.286 0.366 . . . . 0.0 112.55 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.5 pt -126.72 -173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.11 0.964 . . . . 0.0 110.72 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -126.94 96.4 4.61 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -76.07 108.37 5.99 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.11 84.56 1.53 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.792 1.661 . . . . 0.0 110.616 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 41' ' ' LEU . 54.0 tp -66.48 -32.21 73.43 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.773 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.96 -33.9 75.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.206 1.002 . . . . 0.0 111.108 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 56.8 tttp -72.92 -58.8 3.06 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.897 0.879 . . . . 0.0 109.771 172.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -57.18 -44.3 83.44 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.259 1.024 . . . . 0.0 111.966 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 m -63.74 -36.51 84.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.62 -30.76 61.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.5 mm-40 -60.3 -39.4 86.82 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.302 0.641 . . . . 0.0 109.317 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.1 -44.44 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.779 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.594 0.757 . . . . 0.0 112.358 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.49 -18.87 21.81 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.103 0.961 . . . . 0.0 111.189 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.15 59.23 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 113.375 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.56 -23.76 61.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.296 0.639 . . . . 0.0 110.943 169.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.36 26.4 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.692 0.797 . . . . 0.0 110.257 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.0 t -107.15 156.48 18.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.496 0.718 . . . . 0.0 110.334 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.9 p -63.14 -33.78 76.21 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.087 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.18 -33.72 75.06 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.534 0.734 . . . . 0.0 111.986 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 70' ' ' THR . 8.3 tt0 -65.36 -28.36 69.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.589 . . . . 0.0 111.675 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -106.84 -76.99 0.6 Allowed 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.581 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.5 m-85 -59.18 -19.06 41.94 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -162.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 98.8 t -65.11 124.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 33' ' ' LEU . 72.3 mt -58.86 -36.71 75.06 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 60.9 pttt -61.29 -42.35 98.5 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -72.4 -44.94 61.79 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -55.29 -44.96 76.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.684 1.594 . . . . 0.0 110.676 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.528 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.36 61.56 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.711 0.632 . . . . 0.0 111.548 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.2 mmm180 -71.32 -35.79 71.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.663 0.785 . . . . 0.0 111.354 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.403 HD11 HD13 ' A' ' 47' ' ' ILE . 96.3 mt -71.81 -39.61 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.348 0.659 . . . . 0.0 109.712 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 25.2 t70 -57.25 -38.97 74.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.726 0.81 . . . . 0.0 111.397 170.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -60.83 -45.96 92.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.01 0.924 . . . . 0.0 110.009 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 91.6 mt -66.58 -42.75 86.51 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.016 0.926 . . . . 0.0 113.275 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 24.1 m -70.51 -31.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.058 0.456 . . . . 0.0 110.474 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.28 -51.81 27.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.718 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 C-N-CA 124.974 1.309 . . . . 0.0 113.559 -176.544 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.5 m . . . . . 0 CA--C 1.553 1.076 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -66.57 -49.62 65.82 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.81 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.13 -41.35 68.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.13 0.894 . . . . 0.0 111.356 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.82 -46.45 62.76 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.802 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -60.92 -36.46 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 122.994 0.518 . . . . 0.0 110.911 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.89 85.15 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.559 1.144 . . . . 0.0 110.089 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.6 m -56.02 -47.07 78.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.235 1.014 . . . . 0.0 111.671 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 47' ' ' ILE . 33.3 mm -59.2 -51.59 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.84 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' A' ' 16' ' ' CYS . 71.1 mt -63.95 -34.77 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.82 0.848 . . . . 0.0 111.289 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -60.25 -52.28 65.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.884 0.474 . . . . 0.0 111.866 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -72.51 -37.69 68.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.581 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.6 m -74.42 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.335 0.654 . . . . 0.0 110.785 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.679 ' SG ' HD11 ' A' ' 43' ' ' ILE . 3.3 m -82.09 -1.16 47.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.04 0.936 . . . . 0.0 113.341 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 64.28 22.67 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.373 1.082 . . . . 0.0 111.048 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 82.3 mt -96.0 126.4 44.75 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.524 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 40.9 Cg_endo -65.16 145.61 84.84 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.627 2.218 . . . . 0.0 112.177 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -60.11 -27.64 67.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.663 1.185 . . . . 0.0 112.653 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.8 -26.79 68.49 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.783 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.477 HG23 ' HG3' ' A' ' 21' ' ' GLU . 80.1 p -108.87 15.41 23.52 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.377 0.671 . . . . 0.0 111.236 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.72 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -121.46 151.31 56.33 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.908 0.883 . . . . 0.0 109.712 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.22 -36.23 66.41 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.037 2.491 . . . . 0.0 113.374 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.66 -17.68 59.89 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.494 0.718 . . . . 0.0 112.067 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 t -68.68 142.54 55.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.506 0.723 . . . . 0.0 111.202 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 42.3 t-80 -105.75 133.45 50.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.659 1.184 . . . . 0.0 108.715 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.96 -56.72 11.04 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.349 0.66 . . . . 0.0 112.524 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.5 -51.13 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.462 0.305 . . . . 0.0 110.76 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.4 t70 -69.94 -42.78 72.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.608 0.763 . . . . 0.0 112.465 -170.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.48 -64.38 1.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.719 0.408 . . . . 0.0 110.044 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 95.5 mt -71.41 -25.07 62.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.771 0.828 . . . . 0.0 112.799 -171.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 45.96 31.31 Favored Glycine 0 N--CA 1.472 1.066 0 CA-C-O 120.969 0.205 . . . . 0.0 112.772 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 43' ' ' ILE . 68.1 mt -98.23 127.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 108.51 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -89.75 166.79 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.972 0.509 . . . . 0.0 109.839 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.8 m -59.38 -27.25 65.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.155 0.582 . . . . 0.0 111.968 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.89 -49.0 64.47 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.554 0.741 . . . . 0.0 111.028 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.63 -29.61 62.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.485 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -72.76 -23.22 60.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.477 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 57' ' ' LEU . 60.6 mt -60.34 -41.43 93.57 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.585 0.354 . . . . 0.0 110.239 170.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.45 -34.57 70.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.779 0.831 . . . . 0.0 111.156 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.679 HD11 ' SG ' ' A' ' 16' ' ' CYS . 63.7 mt -62.9 -51.54 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.6 76.27 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.823 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.94 -47.2 78.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.495 1.118 . . . . 0.0 110.161 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.65 72.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.077 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 11' ' ' ILE . 86.2 mt -71.18 -38.55 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.845 0.858 . . . . 0.0 111.157 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -51.3 -48.14 62.39 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.32 0.581 . . . . 0.0 110.882 173.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.49 -49.32 16.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.509 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.11 69.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.688 0.795 . . . . 0.0 111.906 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -84.52 -17.25 39.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.579 0.752 . . . . 0.0 111.688 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.57 48.61 35.12 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.03 177.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.332 1.053 . . . . 0.0 110.815 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -106.76 109.57 21.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 162.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.457 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -84.66 104.47 4.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 165.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.48 81.8 2.39 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.513 1.476 . . . . 0.0 111.082 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 41' ' ' LEU . 57.8 tp -69.7 -31.34 69.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.861 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.04 -33.54 73.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.04 0.936 . . . . 0.0 111.068 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.5 ttpp -82.58 -41.29 19.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.182 0.593 . . . . 0.0 110.365 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -69.98 -41.78 73.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.639 0.776 . . . . 0.0 111.939 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.3 m -60.72 -36.22 78.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.045 0.938 . . . . 0.0 110.483 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -69.52 -38.3 77.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.052 0.941 . . . . 0.0 110.49 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 80.2 mm-40 -56.15 -45.63 79.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.515 0.726 . . . . 0.0 110.287 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 62.8 t -67.82 -44.53 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.748 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.03 -28.94 70.44 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.845 0.858 . . . . 0.0 112.697 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -87.55 -9.82 53.35 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.147 0.579 . . . . 0.0 111.895 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.85 72.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 120.374 -0.126 . . . . 0.0 113.258 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -83.84 -22.67 31.64 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.755 0.822 . . . . 0.0 110.258 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -143.88 160.66 40.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.827 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -98.99 160.61 14.14 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.731 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.7 p -60.05 -29.84 68.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 171.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.545 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.3 tt0 -56.39 -46.87 79.93 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.589 0.756 . . . . 0.0 111.316 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -57.11 -31.61 65.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.472 0.709 . . . . 0.0 112.104 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.67 -74.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.459 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.5 m-85 -56.06 -25.36 44.77 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -165.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.2 t -62.6 126.14 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 119.91 1.232 . . . . 0.0 108.47 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -62.56 -36.5 82.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 112.641 -161.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' HG12 ' A' ' 76' ' ' VAL . 65.8 pttt -64.09 -39.33 93.82 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.247 0.342 . . . . 0.0 111.119 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.9 m-20 -75.81 -42.79 48.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.507 0.723 . . . . 0.0 110.277 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.1 tp -53.09 -49.41 66.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.833 1.253 . . . . 0.0 110.325 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.2 -33.04 73.79 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.014 0.821 . . . . 0.0 111.252 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.64 63.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.94 0.496 . . . . 0.0 110.539 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.3 mmm180 -64.04 -31.84 73.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.718 0.807 . . . . 0.0 111.76 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 -41.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.811 0.845 . . . . 0.0 110.534 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 22.1 t70 -56.44 -36.55 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.577 0.751 . . . . 0.0 111.591 172.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 10.6 tp10 -59.26 -47.25 86.08 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.975 0.91 . . . . 0.0 110.671 172.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 59.6 mt -64.5 -46.96 80.69 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.002 0.921 . . . . 0.0 112.434 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.9 m -67.89 -29.0 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.048 0.451 . . . . 0.0 110.657 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.81 -42.37 67.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.898 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.517 0 C-N-CA 124.166 0.986 . . . . 0.0 113.536 -179.211 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.6 m . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 111.383 0.142 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -69.59 -44.56 70.5 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.145 0.278 . . . . 0.0 110.656 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.68 -35.89 82.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.286 0.634 . . . . 0.0 110.682 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.426 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 21.1 mmm180 -59.6 -57.69 11.85 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.713 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.42 -35.88 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.937 0.895 . . . . 0.0 111.193 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.6 90.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.252 1.021 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 14.9 m -60.86 -43.61 98.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 111.281 172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.49 -50.23 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.322 0.649 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 43' ' ' ILE . 72.6 mt -62.18 -39.62 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.342 1.057 . . . . 0.0 111.223 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.03 87.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.089 0.555 . . . . 0.0 111.129 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.9 mm-40 -72.06 -38.95 69.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -69.71 -62.57 1.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.361 0.601 . . . . 0.0 110.745 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 43' ' ' ILE . 20.0 m -84.98 -10.14 57.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.845 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.15 24.21 12.56 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.747 0.819 . . . . 0.0 112.175 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.471 HD12 HD11 ' A' ' 35' ' ' ILE . 50.8 mt -77.46 128.41 80.22 Favored Pre-proline 0 C--O 1.246 0.88 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.86 128.82 27.98 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.683 2.256 . . . . 0.0 112.322 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 tpt85 -56.37 -32.31 64.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.486 1.114 . . . . 0.0 110.429 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.97 -38.48 91.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.208 1.003 . . . . 0.0 112.365 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -82.71 -9.83 59.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.764 0.425 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.63 113.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.457 0.703 . . . . 0.0 109.437 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 p -123.67 154.88 66.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.763 0.825 . . . . 0.0 109.187 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 -39.95 79.93 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.631 2.22 . . . . 0.0 112.61 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.03 -9.92 59.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.892 0.477 . . . . 0.0 112.236 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p -73.27 134.27 44.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.6 t-80 -90.5 131.59 36.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.97 0.908 . . . . 0.0 108.624 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.17 -55.53 20.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 0.0 112.214 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.1 -47.41 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.367 0.267 . . . . 0.0 111.442 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -72.6 -66.6 0.64 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.813 0.445 . . . . 0.0 112.064 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -75.72 -60.74 2.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.145 0.578 . . . . 0.0 111.429 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 77' ' ' LEU . 81.3 mt -69.27 -29.12 66.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.112 0.565 . . . . 0.0 111.921 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.28 85.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 43' ' ' ILE . 36.9 mt -73.85 98.94 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.437 0.695 . . . . 0.0 109.962 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.92 165.06 25.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.019 0.928 . . . . 0.0 109.974 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 57.0 p -51.56 -18.34 1.1 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.713 1.605 . . . . 0.0 114.585 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 mt -84.72 -44.28 13.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.545 0.611 . . . . 0.0 110.292 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.24 -34.01 65.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.986 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.11 -21.56 66.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.238 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 57' ' ' LEU . 94.1 mt -57.78 -38.39 75.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.243 0.617 . . . . 0.0 111.43 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.21 -30.65 48.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.589 HD11 ' SG ' ' A' ' 16' ' ' CYS . 41.8 mt -62.56 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.75 74.55 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -65.46 -43.26 90.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.021 0.928 . . . . 0.0 110.327 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.27 78.9 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.132 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.401 HD13 HD11 ' A' ' 84' ' ' ILE . 87.2 mt -65.17 -37.72 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.887 0.875 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -56.35 -42.06 77.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -82.88 -40.89 19.64 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.781 0.833 . . . . 0.0 111.272 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -68.92 -51.95 34.45 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.52 1.128 . . . . 0.0 111.349 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -87.91 -24.9 23.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.403 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.71 52.27 10.04 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.15 -176.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.28 1.032 . . . . 0.0 110.452 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -118.71 109.99 16.75 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.15 98.85 20.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 95.0 Cg_endo -85.4 85.12 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.383 2.055 . . . . 0.0 111.43 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 41' ' ' LEU . 42.2 tp -69.52 -32.51 71.4 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.58 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.6 -31.8 70.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.579 0.351 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 35.7 ttpt -80.84 -40.69 24.47 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.789 0.836 . . . . 0.0 109.913 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -59.11 -45.72 90.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.816 0.847 . . . . 0.0 110.51 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.2 m -72.34 -28.88 63.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.786 1.234 . . . . 0.0 111.452 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.66 -34.59 67.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.499 0.72 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.04 -32.79 74.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.68 0.792 . . . . 0.0 110.143 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 71' ' ' THR . 57.6 t -70.93 -43.19 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.075 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -58.27 -45.04 88.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.692 0.797 . . . . 0.0 112.189 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -85.92 -11.79 52.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.857 0.863 . . . . 0.0 111.79 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.59 69.93 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.229 0.331 . . . . 0.0 113.562 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -70.36 -27.11 64.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.99 0.916 . . . . 0.0 110.436 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.02 170.49 21.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.978 0.911 . . . . 0.0 110.335 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.4 t -107.37 158.67 16.98 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.439 0.696 . . . . 0.0 111.443 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 HG11 ' A' ' 64' ' ' VAL . 40.5 p -62.42 -36.62 82.93 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.08 0.952 . . . . 0.0 110.743 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -53.15 -41.67 65.37 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.89 0.876 . . . . 0.0 111.204 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.471 ' H ' HG23 ' A' ' 70' ' ' THR . 8.4 tt0 -63.68 -32.22 73.63 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.392 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.17 -8.45 12.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -169.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.1 m-85 -128.49 -29.24 2.44 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.513 -169.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 88.8 t -61.54 125.58 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 33' ' ' LEU . 26.9 mt -61.42 -34.14 74.88 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -161.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.82 -37.54 70.33 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.577 0.351 . . . . 0.0 111.362 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -68.2 -49.19 62.48 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.636 0.775 . . . . 0.0 109.873 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -51.86 -47.07 64.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.938 1.695 . . . . 0.0 111.481 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.72 67.06 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.11 -39.19 55.76 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.625 0.578 . . . . 0.0 110.665 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mmm180 -59.27 -48.22 82.45 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.566 0.746 . . . . 0.0 110.581 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 47' ' ' ILE . 98.7 mt -67.72 -42.7 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.694 1.197 . . . . 0.0 110.269 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 88' ' ' VAL . 30.9 t70 -56.69 -36.29 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.631 0.582 . . . . 0.0 111.914 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.99 -44.07 85.92 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.723 0.639 . . . . 0.0 110.461 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 82.0 mt -64.49 -40.9 96.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.724 0.81 . . . . 0.0 112.278 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.3 m -76.3 -28.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.855 0.462 . . . . 0.0 111.378 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.99 58.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.349 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.662 1.185 . . . . 0.0 112.682 176.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 8' ' ' VAL . 31.0 m . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 110.663 -0.125 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -58.67 -54.66 44.52 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.689 0.618 . . . . 0.0 111.536 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.61 -28.47 69.15 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.039 0.837 . . . . 0.0 110.195 -173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -69.8 -46.04 66.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.701 0.8 . . . . 0.0 111.659 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 84.8 t -64.19 -35.76 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.324 0.65 . . . . 0.0 110.525 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.06 99.43 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 110.284 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.8 m -56.34 -49.78 73.39 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.186 171.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.594 HG21 HG13 ' A' ' 47' ' ' ILE . 44.9 mm -59.58 -49.61 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 123.775 0.672 . . . . 0.0 110.731 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.18 -36.83 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.334 0.654 . . . . 0.0 111.126 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.94 83.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.518 0.727 . . . . 0.0 111.924 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.25 -51.73 14.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 0.0 112.359 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -66.6 -57.84 6.4 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.39 1.076 . . . . 0.0 111.189 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 35' ' ' ILE . 49.5 t -82.93 -9.93 59.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.662 0.785 . . . . 0.0 111.878 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.35 76.96 0.31 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.518 1.127 . . . . 0.0 110.4 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mt -127.59 135.35 27.32 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.081 0.952 . . . . 0.0 109.222 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.57 119.49 4.73 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.33 2.686 . . . . 0.0 111.346 168.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -65.14 -25.18 67.64 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.051 0.941 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -65.81 -33.73 76.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 111.886 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -86.83 -17.94 32.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.143 0.577 . . . . 0.0 111.177 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.31 110.23 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -119.74 158.46 49.59 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.889 0.876 . . . . 0.0 109.535 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 -33.1 97.35 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.399 2.066 . . . . 0.0 112.401 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.4 -11.04 44.33 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 73.5 p -70.53 127.5 32.92 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.9 t-80 -91.75 133.06 35.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.227 1.011 . . . . 0.0 108.875 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.74 -59.76 3.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.634 0.774 . . . . 0.0 112.697 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -72.71 -57.56 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 120.838 0.351 . . . . 0.0 110.381 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 16.8 t70 -58.96 -49.63 77.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.246 . . . . 0.0 112.852 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.82 -58.87 1.82 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.685 0.394 . . . . 0.0 111.529 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 92.7 mt -74.19 -11.84 60.41 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.338 0.655 . . . . 0.0 112.012 -171.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.01 88.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.815 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.541 HG12 ' SG ' ' A' ' 16' ' ' CYS . 59.0 mt -74.01 102.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 109.987 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.92 156.24 38.87 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -57.05 -16.96 8.36 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.696 0.798 . . . . 0.0 112.875 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.92 -36.98 18.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.338 0.655 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.35 -30.4 68.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.504 0.669 . . . . 0.0 109.855 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.27 63.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.424 1.09 . . . . 0.0 111.996 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 57' ' ' LEU . 93.6 mt -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.566 0.747 . . . . 0.0 110.412 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.21 -38.5 81.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.402 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.27 -42.32 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.663 0.602 . . . . 0.0 110.035 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -62.79 -36.89 84.62 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -75.06 -37.9 61.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.139 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.74 71.73 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.66 0.384 . . . . 0.0 110.975 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.594 HG13 HG21 ' A' ' 11' ' ' ILE . 96.6 mt -72.55 -39.61 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.853 0.861 . . . . 0.0 110.087 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.05 -44.86 71.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.469 1.108 . . . . 0.0 110.262 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.26 -44.88 28.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.21 1.004 . . . . 0.0 111.371 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.34 -53.83 46.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.424 0.69 . . . . 0.0 111.91 -172.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.62 -12.67 58.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.136 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.07 39.56 84.04 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.427 0.455 . . . . 0.0 111.971 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 pt -119.91 173.98 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 0.0 110.087 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -106.86 102.62 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD22 ' HB1' ' A' ' 44' ' ' ALA . 7.3 tt -88.56 109.47 29.59 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -88.82 83.04 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.772 1.648 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 41' ' ' LEU . 46.4 tp -72.47 -25.35 61.4 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.293 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.52 -36.41 66.69 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.789 0.835 . . . . 0.0 110.94 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -79.12 -47.58 15.84 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.025 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.402 ' HB2' HD12 ' A' ' 57' ' ' LEU . 41.7 m0 -61.01 -51.22 70.17 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.905 0.882 . . . . 0.0 111.384 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -55.13 -44.76 75.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.734 1.214 . . . . 0.0 111.76 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.28 -40.19 96.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.351 0.66 . . . . 0.0 110.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.04 -38.69 92.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.595 0.758 . . . . 0.0 110.852 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.56 -47.16 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.378 0.671 . . . . 0.0 110.601 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.31 -16.3 62.45 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.73 0.812 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -93.51 -8.3 41.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.27 0.628 . . . . 0.0 110.274 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.89 79.73 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 114.281 0.472 . . . . 0.0 114.281 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.41 -55.3 4.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.133 0.573 . . . . 0.0 109.922 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.54 163.66 12.48 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -99.39 157.46 16.4 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.597 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.0 p -61.59 -34.19 75.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.77 0.828 . . . . 0.0 110.4 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.521 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.5 tt0 -49.86 -46.14 51.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 111.633 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.19 -28.81 69.93 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.7 0.8 . . . . 0.0 113.073 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -121.16 0.08 10.06 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 92.0 m-85 -131.81 -31.39 1.53 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.628 0.649 . . . . 0.0 111.403 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 72' ' ' GLU . 86.5 t -65.01 125.24 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 16.2 mt -61.45 -33.35 73.58 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -162.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -65.76 -41.9 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.259 0.349 . . . . 0.0 111.674 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.75 -46.22 38.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 0.0 109.942 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.37 -49.71 63.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.337 1.455 . . . . 0.0 110.771 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.42 64.89 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.546 0.739 . . . . 0.0 111.311 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.51 66.57 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 123.724 0.64 . . . . 0.0 110.259 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -59.91 -43.14 95.04 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.593 0.757 . . . . 0.0 110.761 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.57 -40.21 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.599 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 28.0 t70 -57.21 -31.36 65.39 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.559 0.744 . . . . 0.0 111.889 171.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.91 -42.94 72.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.196 0.31 . . . . 0.0 110.182 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.1 -40.43 90.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.479 0.712 . . . . 0.0 111.735 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 15.9 m -73.72 -29.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.954 0.501 . . . . 0.0 110.906 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.44 86.23 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.342 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.09 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -179.397 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 47.9 m . . . . . 0 CA--C 1.55 0.964 0 N-CA-C 110.262 -0.273 . . . . 0.0 110.262 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -62.52 -43.38 98.94 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.95 0.5 . . . . 0.0 111.447 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.17 -40.6 98.0 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 11' ' ' ILE . 26.8 mmt180 -61.53 -54.49 42.53 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.001 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 84.1 t -62.13 -35.52 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.191 0.997 . . . . 0.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.93 83.5 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.019 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 96.4 m -59.88 -46.5 89.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.806 0.843 . . . . 0.0 111.64 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 7' ' ' ARG . 38.9 mm -61.33 -50.16 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.805 0.442 . . . . 0.0 110.783 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 HD22 ' A' ' 77' ' ' LEU . 56.2 mt -67.67 -30.25 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 122.968 0.507 . . . . 0.0 110.828 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.08 95.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 10' ' ' THR . 16.6 mm-40 -73.87 -45.71 49.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.838 0.455 . . . . 0.0 111.586 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -66.78 -59.59 3.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.836 0.854 . . . . 0.0 111.447 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 43' ' ' ILE . 64.3 m -92.43 4.63 53.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.31 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.19 67.98 0.91 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.76 1.224 . . . . 0.0 111.515 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.72 120.48 21.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_exo -61.64 148.4 93.11 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.531 2.154 . . . . 0.0 112.84 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -63.16 -28.26 69.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.659 0.784 . . . . 0.0 111.419 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -65.08 -30.35 71.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -93.82 -11.54 31.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 0.0 111.269 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.28 122.58 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.965 0.906 . . . . 0.0 109.838 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.9 p -133.63 161.59 62.81 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 124.332 1.053 . . . . 0.0 108.924 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 -30.52 88.35 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.845 2.363 . . . . 0.0 113.225 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -89.8 -5.36 56.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.885 0.874 . . . . 0.0 112.275 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.3 m -62.33 99.95 0.16 Allowed 'General case' 0 C--N 1.353 0.755 0 C-N-CA 122.964 0.506 . . . . 0.0 110.987 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 58.7 t-80 -73.22 125.38 27.62 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 168.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.04 -53.42 20.27 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.88 0.738 . . . . 0.0 112.35 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.08 -45.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 117.878 0.308 . . . . 0.0 110.985 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.8 t70 -70.44 -74.34 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.216 0.322 . . . . 0.0 111.126 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.49 -53.64 10.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.685 0.394 . . . . 0.0 111.671 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.53 -18.23 59.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.99 79.42 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HD11 ' A' ' 43' ' ' ILE . 82.6 mt -86.05 116.54 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.151 1.38 . . . . 0.0 110.61 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.18 165.16 21.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.918 0.887 . . . . 0.0 109.512 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -56.99 -17.29 9.2 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.739 1.216 . . . . 0.0 113.142 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.92 -45.71 16.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.726 0.81 . . . . 0.0 110.114 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.57 -26.1 60.68 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.596 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.94 -20.75 63.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.27 1.028 . . . . 0.0 111.063 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 57' ' ' LEU . 92.1 mt -57.93 -43.32 86.21 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.962 0.505 . . . . 0.0 110.481 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.66 -36.22 83.04 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.399 1.08 . . . . 0.0 111.336 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.763 HD11 HD13 ' A' ' 35' ' ' ILE . 47.3 mt -62.32 -49.92 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -34.28 77.61 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 124.53 1.144 . . . . 0.0 110.201 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -64.13 -49.68 71.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.27 1.028 . . . . 0.0 110.967 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.4 80.16 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.32 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 84' ' ' ILE . 64.7 mt -69.54 -40.92 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.358 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -60.93 -41.8 96.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.949 0.5 . . . . 0.0 111.343 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.37 -42.27 62.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.443 0.697 . . . . 0.0 111.394 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.55 -58.84 3.99 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.695 0.798 . . . . 0.0 111.031 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.47 -19.9 35.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.697 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.81 56.43 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.435 0.459 . . . . 0.0 111.964 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 pt -120.91 -174.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.082 0.953 . . . . 0.0 111.193 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.21 105.59 11.11 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.16 0.984 . . . . 0.0 108.61 169.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 80' ' ' LEU . 7.3 tt -88.37 102.65 4.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 166.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.64 81.46 2.23 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 110.871 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 41' ' ' LEU . 39.8 tp -71.6 -33.95 69.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.852 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.67 -37.81 76.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.766 0.826 . . . . 0.0 111.043 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.756 0.822 . . . . 0.0 110.523 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -64.29 -40.37 95.8 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.528 0.731 . . . . 0.0 110.97 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.1 m -55.06 -46.01 75.34 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.121 0.969 . . . . 0.0 111.407 171.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.48 -33.11 74.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.98 0.512 . . . . 0.0 111.248 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.89 -46.73 84.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.764 0.426 . . . . 0.0 110.443 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 48.6 t -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.599 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.61 -35.2 75.55 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.973 0.909 . . . . 0.0 113.127 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.28 -8.97 49.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.316 0.646 . . . . 0.0 111.394 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.28 67.95 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 122.358 -0.214 . . . . 0.0 113.623 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.3 mmpt? -73.03 -33.14 65.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.426 0.691 . . . . 0.0 110.216 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -142.25 163.03 33.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.939 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -107.61 158.99 16.79 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.193 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 HG11 ' A' ' 64' ' ' VAL . 28.7 p -58.13 -30.43 66.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.425 0.69 . . . . 0.0 111.494 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 9.1 tm-20 -53.48 -45.05 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.705 0.802 . . . . 0.0 111.146 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.549 ' HA ' HD22 ' A' ' 79' ' ' ASN . 9.2 tt0 -65.15 -23.48 67.13 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 4.16 6.55 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -123.78 -27.22 4.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.583 0.629 . . . . 0.0 111.57 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.9 t -64.34 132.68 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 27' ' ' SER . 31.1 mt -59.58 -43.91 93.49 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -169.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.39 -34.39 77.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 123.24 0.337 . . . . 0.0 111.446 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.549 HD22 ' HA ' ' A' ' 73' ' ' GLN . 5.1 m-20 -70.86 -51.61 25.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.05 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 55' ' ' LEU . 48.2 tp -54.47 -44.25 72.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.13 . . . . 0.0 110.886 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.72 81.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.265 1.026 . . . . 0.0 111.669 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.73 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.646 0.591 . . . . 0.0 110.373 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mmm180 -59.88 -42.87 94.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.787 0.835 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.527 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -68.74 -36.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.584 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.3 t70 -58.17 -34.38 70.25 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.985 0.514 . . . . 0.0 111.58 170.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -43.13 85.11 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 58.3 mt -67.19 -40.4 86.53 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.805 0.842 . . . . 0.0 112.124 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 85' ' ' ASP . 31.6 m -75.44 -29.47 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.201 0.6 . . . . 0.0 111.171 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.71 89.66 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.042 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 0.825 0 C-N-CA 124.376 1.07 . . . . 0.0 112.468 179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.3 m . . . . . 0 CA--C 1.545 0.773 0 N-CA-C 110.605 -0.146 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -67.61 -44.61 77.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.394 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -52.21 -46.94 65.83 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.985 0.803 . . . . 0.0 111.21 178.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 20.7 mmt85 -71.63 -43.8 65.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.868 -176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.88 -41.11 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.814 0.446 . . . . 0.0 110.958 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.13 92.88 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.29 1.036 . . . . 0.0 110.508 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.4 m -56.25 -49.01 75.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 0.0 110.841 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.19 -46.31 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.114 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 43' ' ' ILE . 75.6 mt -62.35 -42.5 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.919 0.888 . . . . 0.0 110.86 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.78 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 0.0 111.918 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.62 -43.32 69.51 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.614 0.766 . . . . 0.0 111.519 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.1 m -65.44 -63.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.376 0.67 . . . . 0.0 111.849 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.66 -1.47 56.84 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.612 0.765 . . . . 0.0 111.577 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.34 77.8 0.28 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.723 1.209 . . . . 0.0 110.89 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 54.5 mt -136.06 132.2 19.13 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.299 1.04 . . . . 0.0 108.8 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.5 135.52 39.57 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.591 2.194 . . . . 0.0 111.488 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' THR . 25.7 mtm180 -71.93 -22.63 61.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.578 0.351 . . . . 0.0 111.866 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.32 -15.06 62.14 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.159 0.584 . . . . 0.0 111.667 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -105.57 -18.83 13.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.001 0.521 . . . . 0.0 110.568 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 87.3 mt -77.77 106.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . 73.8 p -111.84 154.54 44.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.858 0.863 . . . . 0.0 109.478 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 39.2 Cg_endo -64.08 -22.81 67.57 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.279 1.986 . . . . 0.0 111.534 174.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.41 -17.56 51.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.844 0.858 . . . . 0.0 111.415 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.6 t -73.95 150.8 40.57 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.929 0.892 . . . . 0.0 110.724 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.6 t-80 -107.84 134.46 50.76 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.848 1.259 . . . . 0.0 109.151 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.41 -55.03 14.43 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.882 0.873 . . . . 0.0 112.657 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -76.94 -53.88 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 122.165 0.186 . . . . 0.0 110.944 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 29.3 m-20 -65.58 -52.77 49.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -89.38 -59.77 2.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.745 0.418 . . . . 0.0 111.078 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 77' ' ' LEU . 87.3 mt -68.25 -21.44 64.82 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 22.02 65.52 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 123.388 0.43 . . . . 0.0 113.44 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.7 mt -80.9 130.01 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 123.957 0.903 . . . . 0.0 110.013 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -89.34 160.35 16.91 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 50.3 m -59.25 -19.05 42.6 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.308 0.643 . . . . 0.0 112.562 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -76.89 -42.19 40.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.678 0.791 . . . . 0.0 110.872 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.57 -32.71 64.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.215 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 -22.17 65.17 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.67 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 57' ' ' LEU . 95.7 mt -59.5 -42.97 93.39 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.73 -36.03 70.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.406 1.083 . . . . 0.0 110.698 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.491 HD13 HG12 ' A' ' 12' ' ' ILE . 61.3 mt -65.26 -48.32 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.024 0.53 . . . . 0.0 109.879 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.13 83.09 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.955 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -67.87 -40.06 83.64 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.248 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.35 75.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.809 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.78 -38.84 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.95 0.9 . . . . 0.0 110.839 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.35 -43.61 83.59 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.383 0.673 . . . . 0.0 111.096 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -81.54 -26.04 35.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.058 0.943 . . . . 0.0 112.302 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.71 -58.11 3.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.798 0.839 . . . . 0.0 110.651 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -81.9 -27.56 33.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.051 -176.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.13 46.4 7.64 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.3 pt -128.68 -175.34 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.511 1.124 . . . . 0.0 110.257 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -120.29 107.56 13.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 163.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -77.94 107.11 4.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 165.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.92 81.34 2.43 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.63 1.553 . . . . 0.0 110.965 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 41' ' ' LEU . 24.4 tp -70.23 -24.23 63.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.308 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.78 -38.3 72.3 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.997 0.919 . . . . 0.0 111.284 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.9 tttp -74.56 -53.57 9.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.067 0.547 . . . . 0.0 109.732 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -60.49 -46.95 88.23 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.055 0.847 . . . . 0.0 111.618 -168.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.3 m -54.28 -48.55 71.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.987 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.65 -33.88 75.93 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.675 0.79 . . . . 0.0 110.811 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 36.7 mm-40 -61.97 -40.57 96.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.856 0.862 . . . . 0.0 110.686 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.78 -45.9 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 122.717 0.407 . . . . 0.0 110.136 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -51.4 -44.08 62.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.96 1.304 . . . . 0.0 112.409 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.03 0.72 41.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.51 19.37 76.24 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 113.596 0.199 . . . . 0.0 113.596 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -75.85 -17.12 59.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.153 0.981 . . . . 0.0 111.922 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -167.24 166.03 15.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.664 1.186 . . . . 0.0 109.07 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.2 t -105.36 162.01 13.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.38 0.672 . . . . 0.0 110.821 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.5 p -65.06 -30.89 71.89 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.816 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.36 -45.54 84.28 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.766 0.427 . . . . 0.0 110.263 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 70' ' ' THR . 25.5 tt0 -60.92 -30.6 70.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 112.042 -171.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.49 -65.01 1.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.563 0.345 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -65.34 -21.58 66.72 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.3 t -62.03 127.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 119.872 1.215 . . . . 0.0 108.057 168.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 33' ' ' LEU . 39.3 mt -65.09 -32.94 74.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -160.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.8 pttp -62.96 -37.21 86.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 172.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 62.6 m-20 -77.15 -44.89 28.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.746 0.818 . . . . 0.0 109.631 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.92 -50.48 61.05 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 110.268 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.35 -30.83 70.75 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.14 -42.09 69.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.666 0.386 . . . . 0.0 110.881 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 16.4 mmm180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.197 0.999 . . . . 0.0 110.433 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.59 -40.04 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.62 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.489 ' HA ' HG22 ' A' ' 88' ' ' VAL . 27.1 t70 -60.39 -33.86 73.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.968 0.507 . . . . 0.0 111.612 172.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -38.38 79.96 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.544 0.528 . . . . 0.0 110.154 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 90.2 mt -66.99 -40.17 87.33 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.631 0.772 . . . . 0.0 112.398 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.9 m -72.54 -33.76 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 120.856 0.36 . . . . 0.0 110.389 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.49 80.35 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.836 0 C-N-CA 125.051 1.341 . . . . 0.0 113.051 -177.556 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.4 m . . . . . 0 N--CA 1.477 0.887 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -60.88 -53.72 53.86 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.451 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.67 -39.64 81.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.289 0.993 . . . . 0.0 111.847 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -69.83 -47.29 63.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 111.465 -178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 4' ' ' THR . 99.6 t -64.46 -35.5 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.146 0.578 . . . . 0.0 110.417 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.78 86.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 0.0 110.244 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -54.88 -49.23 71.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.907 1.283 . . . . 0.0 111.392 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 47' ' ' ILE . 34.9 mm -57.2 -52.41 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.775 0.83 . . . . 0.0 110.478 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.461 HG12 HD13 ' A' ' 43' ' ' ILE . 72.7 mt -64.93 -38.14 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.737 0.815 . . . . 0.0 111.157 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.34 77.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.052 0.941 . . . . 0.0 112.109 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -71.44 -52.91 15.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.357 0.663 . . . . 0.0 111.65 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -66.35 -45.38 80.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.341 0.656 . . . . 0.0 111.71 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 43' ' ' ILE . 41.7 m -96.36 5.46 50.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.81 26.68 15.72 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.176 0.99 . . . . 0.0 112.428 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.61 124.87 53.7 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.502 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -61.95 135.78 57.43 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.511 2.14 . . . . 0.0 112.412 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HD2' HD12 ' A' ' 23' ' ' ILE . 26.2 mmm-85 -59.91 -29.83 68.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.474 1.109 . . . . 0.0 112.165 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.22 -30.57 71.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.325 0.65 . . . . 0.0 111.647 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -96.05 -7.6 35.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.976 0.511 . . . . 0.0 111.533 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 20' ' ' ARG . 53.2 mt -80.89 123.19 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.247 0.619 . . . . 0.0 109.708 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -124.31 157.4 64.74 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.948 0.899 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.63 -37.38 88.42 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.81 2.34 . . . . 0.0 113.429 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.08 -7.26 58.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.136 0.574 . . . . 0.0 111.645 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -64.19 121.83 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.25 0.62 . . . . 0.0 110.906 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 65.3 t-80 -86.27 127.22 34.73 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.38 -54.75 27.78 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 59.7 mt -66.87 -54.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.015 0.197 . . . . 0.0 110.743 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.0 t70 -69.02 -66.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.35 -173.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.78 -55.63 5.63 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.343 -168.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 77' ' ' LEU . 90.1 mt -75.48 -14.48 60.43 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.161 0.584 . . . . 0.0 112.274 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.36 8.1 87.65 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 122.993 0.183 . . . . 0.0 113.403 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 43' ' ' ILE . 93.8 mt -85.01 99.52 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.873 1.269 . . . . 0.0 110.707 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.71 163.27 16.85 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.954 0.901 . . . . 0.0 110.09 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 t -57.02 -15.97 6.14 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.242 1.017 . . . . 0.0 113.0 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.87 -45.37 13.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 110.298 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.83 -31.34 70.25 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.101 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -67.41 -20.84 65.58 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.397 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.1 mt -57.85 -38.6 75.96 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.108 0.563 . . . . 0.0 111.273 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.22 -41.17 77.4 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.775 0.83 . . . . 0.0 110.854 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 35' ' ' ILE . 73.3 mt -61.7 -49.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.268 175.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -61.31 -40.23 93.41 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.411 -175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -73.59 -34.22 64.98 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.56 64.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.678 0.391 . . . . 0.0 110.934 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 11' ' ' ILE . 91.1 mt -78.23 -38.18 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.504 1.121 . . . . 0.0 110.53 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.64 -40.81 66.15 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.066 0.946 . . . . 0.0 110.278 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -81.48 -50.0 9.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.907 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.56 67.39 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.37 0.668 . . . . 0.0 111.671 -171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.51 -22.62 28.09 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.515 0.726 . . . . 0.0 110.548 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.58 10.96 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.28 -177.23 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.038 0.935 . . . . 0.0 110.659 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 56' ' ' PRO . 87.3 tttt -108.96 113.27 26.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 167.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.438 HD22 ' HB1' ' A' ' 44' ' ' ALA . 5.9 tt -103.79 96.62 9.38 Favored Pre-proline 0 C--O 1.243 0.746 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HB3' ' HE2' ' A' ' 54' ' ' LYS . 97.3 Cg_endo -83.03 84.05 1.82 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.98 1.787 . . . . 0.0 111.334 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.0 -28.45 69.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.33 -37.76 70.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.369 1.068 . . . . 0.0 111.049 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.2 tttp -80.51 -49.12 11.79 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 124.33 1.052 . . . . 0.0 110.321 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -59.02 -43.83 91.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.012 0.925 . . . . 0.0 111.008 -174.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -65.39 -40.53 93.59 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.676 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -63.71 -33.73 76.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.575 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 43.7 mm-40 -59.27 -38.27 79.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.306 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.539 HG11 HG23 ' A' ' 71' ' ' THR . 40.1 t -72.03 -45.38 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.161 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.52 -29.43 67.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.764 1.226 . . . . 0.0 112.639 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -99.3 -14.28 19.29 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.627 0.771 . . . . 0.0 111.051 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.31 63.85 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 116.607 -0.269 . . . . 0.0 113.308 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.28 -30.09 65.86 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 0.0 111.35 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 172.17 18.61 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.574 0.75 . . . . 0.0 111.098 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -108.6 154.07 22.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.866 0.866 . . . . 0.0 110.413 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG11 ' A' ' 64' ' ' VAL . 34.0 p -61.78 -28.58 69.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.381 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.2 tt0 -56.14 -44.93 79.68 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.532 0.733 . . . . 0.0 111.663 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.471 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -66.77 -21.73 66.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 122.776 0.431 . . . . 0.0 111.252 -174.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -104.36 -76.68 0.59 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.89 0.476 . . . . 0.0 110.952 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.4 m-85 -60.28 -24.14 64.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -165.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 91.9 t -63.14 127.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 119.195 0.907 . . . . 0.0 108.751 172.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 33' ' ' LEU . 26.3 mt -61.82 -36.94 82.61 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -162.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -68.12 -35.83 78.76 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.471 HD22 ' HA ' ' A' ' 73' ' ' GLN . 3.5 m-20 -72.3 -45.21 60.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.892 0.877 . . . . 0.0 110.52 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -53.93 -46.43 71.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.122 1.769 . . . . 0.0 111.349 170.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.66 71.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.156 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.05 61.68 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.689 0.618 . . . . 0.0 110.963 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -59.52 -47.88 83.8 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.971 0.909 . . . . 0.0 111.75 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.6 -38.35 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.769 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.05 -37.56 64.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.602 0.761 . . . . 0.0 111.643 169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.44 -38.05 68.4 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.229 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.17 -40.58 94.48 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.526 0.73 . . . . 0.0 111.841 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 m -78.82 -20.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.58 73.96 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 C-N-CA 124.392 1.077 . . . . 0.0 113.107 178.522 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.0 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 111.397 0.147 . . . . 0.0 111.397 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -64.11 -46.38 84.42 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.259 0.223 . . . . 0.0 111.356 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.99 -42.31 80.02 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.076 0.86 . . . . 0.0 111.093 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -63.56 -52.12 62.44 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.165 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.7 -38.81 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.373 0.669 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.47 -44.92 85.66 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.026 0.931 . . . . 0.0 110.126 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.0 m -56.62 -43.6 80.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.365 1.066 . . . . 0.0 112.041 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.425 HG21 HG13 ' A' ' 47' ' ' ILE . 32.7 mm -59.3 -55.25 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.609 0.763 . . . . 0.0 110.394 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.72 -35.14 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.196 0.935 . . . . 0.0 111.429 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -52.69 64.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.168 0.987 . . . . 0.0 111.728 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.2 -25.81 33.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 43' ' ' ILE . 19.0 p -73.96 -63.03 1.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.188 0.449 . . . . 0.0 110.801 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 43' ' ' ILE . 57.7 m -92.42 7.98 40.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.278 -171.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.1 30.87 20.76 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.454 1.102 . . . . 0.0 112.241 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 33' ' ' LEU . 62.9 mt -86.55 129.69 52.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 118.59 4.58 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.133 2.555 . . . . 0.0 112.375 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.2 tpt85 -57.83 -37.44 73.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.724 1.61 . . . . 0.0 111.727 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 9.1 pt-20 -63.1 -38.77 92.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.379 0.672 . . . . 0.0 111.539 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.24 -15.49 40.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.158 0.583 . . . . 0.0 112.236 -174.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.88 110.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.926 0.491 . . . . 0.0 110.142 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.1 p -112.69 154.23 44.82 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 59.6 Cg_exo -55.15 -36.66 93.62 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.108 2.539 . . . . 0.0 112.371 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.51 -28.01 62.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.413 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.5 p -70.37 137.03 50.19 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.889 0.476 . . . . 0.0 111.209 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 60.8 t-80 -89.7 130.17 36.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.667 1.187 . . . . 0.0 108.774 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.09 -59.95 3.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.741 0.816 . . . . 0.0 112.648 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.78 -48.86 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.1 t70 -69.89 -61.28 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.664 -173.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.72 -54.62 5.46 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.789 0.436 . . . . 0.0 110.9 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 77' ' ' LEU . 80.4 mt -82.36 -14.09 55.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.151 0.581 . . . . 0.0 112.042 -170.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.21 14.05 82.23 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 122.804 0.24 . . . . 0.0 113.511 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.69 115.25 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.83 0.852 . . . . 0.0 110.264 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -76.83 165.55 24.55 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.5 m -66.29 -18.04 65.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.464 0.575 . . . . 0.0 111.63 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.22 -38.27 19.14 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.833 0.853 . . . . 0.0 109.852 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.26 -26.82 64.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.545 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.48 -21.43 52.87 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.913 0.885 . . . . 0.0 110.612 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 57' ' ' LEU . 85.7 mt -55.44 -36.7 66.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.166 0.439 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -69.51 -39.45 77.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.544 1.138 . . . . 0.0 110.668 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 16' ' ' CYS . 58.8 mt -64.82 -51.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.625 0.77 . . . . 0.0 110.224 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.49 87.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.316 1.047 . . . . 0.0 110.624 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.1 -41.47 90.55 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.068 0.855 . . . . 0.0 110.332 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.27 76.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 111.336 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.425 HG13 HG21 ' A' ' 11' ' ' ILE . 84.2 mt -67.79 -39.26 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.336 1.054 . . . . 0.0 110.748 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -56.58 -44.54 81.14 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.019 0.528 . . . . 0.0 110.698 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.87 -29.97 50.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.011 0.924 . . . . 0.0 111.789 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.01 -58.45 3.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.663 0.785 . . . . 0.0 110.879 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HB2' HG12 ' A' ' 53' ' ' ILE . 52.0 m-85 -84.37 -20.36 32.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.732 0.813 . . . . 0.0 111.15 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.0 18.97 66.18 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.407 0.442 . . . . 0.0 112.42 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 51' ' ' PHE . 29.5 pt -105.51 -176.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.423 1.089 . . . . 0.0 110.971 -172.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -116.47 111.55 20.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.304 0.641 . . . . 0.0 109.529 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -102.14 103.07 27.79 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 68.6 Cg_endo -86.23 84.94 1.06 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.002 1.801 . . . . 0.0 111.671 174.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 41' ' ' LEU . 59.9 tp -62.71 -34.78 77.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.812 0.845 . . . . 0.0 110.101 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.91 -36.53 77.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.3 1.04 . . . . 0.0 111.193 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 33.9 ttpt -77.67 -44.4 28.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.625 0.77 . . . . 0.0 110.004 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.409 ' O ' HG23 ' A' ' 64' ' ' VAL . 44.2 m0 -58.36 -47.48 83.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.997 . . . . 0.0 110.959 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.4 m -63.74 -34.92 78.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.987 0.915 . . . . 0.0 111.021 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.264 1.025 . . . . 0.0 111.287 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.52 -33.53 76.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.416 0.686 . . . . 0.0 110.388 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 84.8 t -67.35 -44.09 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.436 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.26 -32.93 73.7 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.044 0.938 . . . . 0.0 112.458 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -90.71 -12.22 37.32 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.448 1.099 . . . . 0.0 111.371 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.15 16.88 55.05 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 116.931 -0.122 . . . . 0.0 113.37 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.04 -23.4 21.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -147.9 158.53 44.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.123 0.569 . . . . 0.0 110.672 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -95.62 159.95 14.74 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.134 0.574 . . . . 0.0 109.778 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.0 p -62.47 -31.27 71.97 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.954 0.502 . . . . 0.0 109.649 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HA ' HG23 ' A' ' 76' ' ' VAL . 31.5 tt0 -54.98 -50.48 68.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.961 0.904 . . . . 0.0 111.112 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -55.95 -30.03 61.07 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.285 1.034 . . . . 0.0 112.404 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 80' ' ' LEU . 42.1 m-85 -104.31 -77.43 0.58 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.717 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 97.6 m-85 -56.42 -27.99 58.16 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -166.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.7 t -65.3 124.37 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.106 1.321 . . . . 0.0 108.413 170.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 33' ' ' LEU . 25.5 mt -63.62 -32.47 73.95 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -159.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 21.0 pttp -67.61 -37.37 82.43 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.756 0.312 . . . . 0.0 111.263 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.1 m-20 -75.97 -42.9 47.03 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 123.509 0.723 . . . . 0.0 109.832 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 50.3 tp -52.2 -48.39 65.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.332 1.453 . . . . 0.0 110.843 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.78 71.86 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.893 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.78 -39.88 50.07 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.992 0.808 . . . . 0.0 111.61 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 23.3 mmm180 -61.37 -45.3 94.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.83 0.852 . . . . 0.0 111.057 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -70.87 -38.54 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.095 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' A' ' 88' ' ' VAL . 38.3 t70 -56.44 -34.68 67.06 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.962 0.905 . . . . 0.0 112.35 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 8.1 tp10 -63.3 -47.4 82.43 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.837 0.711 . . . . 0.0 110.356 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 51.7 mt -65.73 -40.9 92.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.03 0.932 . . . . 0.0 111.548 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.8 m -78.08 -26.23 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 122.841 0.456 . . . . 0.0 111.49 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.8 72.98 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.79 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.041 0 O-C-N 123.741 0.651 . . . . 0.0 112.505 176.305 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m . . . . . 0 CA--C 1.551 1.008 0 CA-C-O 120.728 0.299 . . . . 0.0 110.326 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -71.07 -41.41 70.74 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.304 0.641 . . . . 0.0 110.691 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.65 -51.84 26.22 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.177 0.991 . . . . 0.0 112.072 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -73.01 -43.53 62.02 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.425 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.76 -40.01 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.163 0.585 . . . . 0.0 110.847 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.79 77.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.995 . . . . 0.0 110.042 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -58.28 -41.43 84.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.05 0.94 . . . . 0.0 111.91 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.506 HG21 HG13 ' A' ' 47' ' ' ILE . 21.7 mm -58.74 -53.32 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.537 0.735 . . . . 0.0 110.658 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.16 -33.12 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.036 0.934 . . . . 0.0 111.195 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -53.78 50.26 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 111.537 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -68.93 -37.58 78.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.145 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -72.48 -63.79 1.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.894 0.478 . . . . 0.0 110.64 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.718 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.5 m -91.43 12.27 21.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 61.39 21.6 12.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.978 0.911 . . . . 0.0 112.079 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.5 mt -87.6 121.78 70.84 Favored Pre-proline 0 N--CA 1.479 0.996 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.173 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.06 133.55 55.72 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.158 1.906 . . . . 0.0 112.422 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -55.23 -33.02 62.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.442 1.097 . . . . 0.0 110.968 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.49 -35.02 79.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.156 . . . . 0.0 112.208 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -85.71 -19.21 31.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.885 0.474 . . . . 0.0 111.357 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -71.5 112.15 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.056 0.542 . . . . 0.0 110.431 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.1 p -115.9 146.47 37.03 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.187 0.995 . . . . 0.0 109.464 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -33.41 73.69 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.808 2.338 . . . . 0.0 112.911 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.43 -6.65 58.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.913 0.885 . . . . 0.0 111.835 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.4 t -74.87 146.84 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.306 1.042 . . . . 0.0 110.648 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 63.8 t-80 -103.01 134.26 46.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.718 1.207 . . . . 0.0 108.489 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.15 -58.64 5.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.555 0.742 . . . . 0.0 112.192 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -72.75 -57.3 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.5 t70 -64.58 -47.22 79.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.202 1.001 . . . . 0.0 112.841 -170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -96.54 -58.17 2.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.559 0.344 . . . . 0.0 111.298 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 90.4 mt -72.01 -27.58 62.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.994 0.518 . . . . 0.0 111.814 -175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 15.82 62.37 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-O 120.084 -0.287 . . . . 0.0 113.322 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.04 123.76 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.449 0.7 . . . . 0.0 109.454 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.97 148.05 36.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -58.42 -16.38 14.62 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.678 0.791 . . . . 0.0 111.707 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.12 -51.99 18.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.343 1.057 . . . . 0.0 110.199 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -71.06 -27.18 63.46 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.347 0.659 . . . . 0.0 111.101 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.37 -22.23 66.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 57' ' ' LEU . 90.0 mt -58.6 -38.58 78.28 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.216 0.606 . . . . 0.0 111.131 174.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.07 -28.54 48.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.231 0.612 . . . . 0.0 111.246 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 ' SG ' ' A' ' 16' ' ' CYS . 57.1 mt -62.82 -49.01 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.57 -32.62 74.3 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.129 -177.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.38 -43.2 77.85 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.918 0.762 . . . . 0.0 110.525 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.14 73.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.657 0.783 . . . . 0.0 111.723 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 HG21 ' A' ' 11' ' ' ILE . 89.6 mt -67.45 -40.29 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.778 0.831 . . . . 0.0 110.617 176.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -54.26 -46.6 72.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.289 0.636 . . . . 0.0 110.399 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.71 -50.99 38.35 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.096 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -64.47 -55.83 18.19 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.13 0.972 . . . . 0.0 112.379 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -80.22 -20.44 44.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.753 0.821 . . . . 0.0 111.863 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.33 41.04 39.04 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.48 175.73 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.089 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -114.9 92.72 4.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 167.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.416 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.3 tt -74.53 114.29 32.5 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -89.03 83.97 0.6 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.193 1.929 . . . . 0.0 111.311 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 41' ' ' LEU . 37.4 tp -73.19 -28.31 62.13 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.45 -33.42 73.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.409 0.684 . . . . 0.0 110.746 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -73.38 -50.66 20.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.319 1.048 . . . . 0.0 110.261 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -63.1 -45.91 89.85 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.654 0.782 . . . . 0.0 111.837 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 m -61.72 -38.06 86.51 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.924 0.889 . . . . 0.0 110.954 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -63.92 -43.56 95.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.99 0.916 . . . . 0.0 110.686 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.81 -32.6 74.37 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.582 0.753 . . . . 0.0 110.798 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 55.6 t -68.33 -51.78 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.347 0.659 . . . . 0.0 111.215 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.07 -22.01 64.95 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.518 0.727 . . . . 0.0 112.414 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.43 -12.89 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.842 1.257 . . . . 0.0 110.747 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 21.06 58.54 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.114 -0.494 . . . . 0.0 114.242 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -90.35 -54.48 3.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -105.09 156.6 17.92 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.522 1.129 . . . . 0.0 110.64 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -100.07 159.15 15.32 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.52 0.728 . . . . 0.0 109.92 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.5 p -68.23 -29.57 68.42 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 35.8 tt0 -58.21 -44.39 88.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.991 0.517 . . . . 0.0 111.034 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -58.3 -30.93 67.03 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.705 0.802 . . . . 0.0 112.109 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -104.19 -77.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 59.9 m-85 -55.91 -24.1 35.52 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -163.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 87.0 t -61.11 124.28 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 119.732 1.151 . . . . 0.0 108.25 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -60.51 -37.72 82.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.763 0.825 . . . . 0.0 112.935 -161.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.6 pttp -70.1 -36.35 74.8 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.501 0.501 . . . . 0.0 112.097 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -70.86 -44.45 66.36 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.895 0.878 . . . . 0.0 110.193 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 tp -53.06 -47.42 68.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.54 1.536 . . . . 0.0 110.672 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.04 66.71 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.666 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.5 49.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.762 0.425 . . . . 0.0 110.619 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -59.49 -43.58 93.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.215 1.006 . . . . 0.0 111.479 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.91 -39.19 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.289 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.5 t70 -54.09 -37.86 64.72 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.277 0.631 . . . . 0.0 111.518 170.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 -41.42 81.13 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.88 -42.97 94.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.462 0.705 . . . . 0.0 112.313 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.8 m -74.0 -26.6 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 122.791 0.436 . . . . 0.0 110.564 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.6 -36.46 65.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.619 0.368 . . . . 0.0 110.541 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.458 0 C-N-CA 124.655 1.182 . . . . 0.0 113.322 177.875 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 38.9 m . . . . . 0 CA--C 1.549 0.935 0 N-CA-C 111.115 0.043 . . . . 0.0 111.115 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.33 -41.68 93.7 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.376 0.422 . . . . 0.0 111.35 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.51 -42.6 92.59 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.559 0.695 . . . . 0.0 111.059 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.495 ' O ' HG12 ' A' ' 11' ' ' ILE . 23.7 mmt180 -71.29 -44.8 64.5 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.325 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 77.3 t -57.73 -41.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.312 0.577 . . . . 0.0 110.522 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.66 97.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.225 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -75.35 -30.35 60.22 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.76 0.254 . . . . 0.0 111.411 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 47' ' ' ILE . 28.7 mm -61.61 -52.93 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.77 -32.07 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.921 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.46 69.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.597 0.759 . . . . 0.0 111.411 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.13 -53.82 7.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.253 0.621 . . . . 0.0 112.611 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -63.65 -51.52 64.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.795 0.838 . . . . 0.0 111.306 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -90.29 2.19 55.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.507 0.723 . . . . 0.0 111.798 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.88 21.73 13.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.232 1.013 . . . . 0.0 112.697 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.9 132.63 67.26 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 122.983 0.513 . . . . 0.0 110.636 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.0 122.22 11.3 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.0 2.467 . . . . 0.0 112.452 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -61.82 -30.22 70.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.0 1.32 . . . . 0.0 111.342 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -63.34 -28.81 70.26 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.338 1.055 . . . . 0.0 112.355 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.425 HG23 ' HG3' ' A' ' 21' ' ' GLU . 34.9 p -100.35 -2.24 34.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.703 0.801 . . . . 0.0 111.381 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.92 113.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 0.0 109.825 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -119.6 160.41 42.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.18 -25.58 77.13 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.71 -13.02 58.37 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 111.53 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 70.4 m -65.06 112.22 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.481 0.713 . . . . 0.0 111.597 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 60.8 t-80 -76.88 127.27 32.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.8 -50.39 56.31 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.3 mt -76.95 -55.06 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 122.555 0.342 . . . . 0.0 111.244 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.0 t70 -71.15 -43.49 67.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.45 0.7 . . . . 0.0 112.607 -170.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -96.78 -55.68 2.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.235 0.614 . . . . 0.0 111.331 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 77' ' ' LEU . 85.0 mt -76.05 -24.24 55.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.271 0.629 . . . . 0.0 111.596 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.88 6.0 80.23 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.821 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.73 130.18 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.358 1.063 . . . . 0.0 110.815 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.59 162.76 13.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.94 . . . . 0.0 108.869 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.8 p -46.65 -34.18 4.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.265 1.426 . . . . 0.0 113.519 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.56 -36.46 52.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.698 0.799 . . . . 0.0 110.866 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.14 -40.51 74.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.989 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.57 -21.03 64.55 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.332 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.9 mt -55.56 -48.95 73.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.278 0.631 . . . . 0.0 110.95 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.23 -31.7 70.44 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.448 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.68 -45.91 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.121 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.15 79.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.874 0.734 . . . . 0.0 110.941 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.924 . . . . 0.0 110.835 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -30.7 71.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.482 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 11' ' ' ILE . 93.3 mt -70.65 -42.04 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.492 0.717 . . . . 0.0 110.838 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -55.21 -40.72 71.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.721 0.808 . . . . 0.0 111.536 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.65 -51.23 10.17 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.351 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.01 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.404 0.682 . . . . 0.0 111.924 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -83.95 -17.21 41.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.057 0.543 . . . . 0.0 111.07 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.56 47.49 62.02 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.6 pt -130.36 -175.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.685 0.794 . . . . 0.0 112.094 -172.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -122.39 94.88 4.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.05 1.34 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.54 111.86 37.72 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -87.1 81.54 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.079 1.852 . . . . 0.0 111.855 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.15 -30.41 66.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.939 0.496 . . . . 0.0 110.446 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.05 -38.82 65.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.121 0.968 . . . . 0.0 111.315 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.7 ttpt -80.98 -46.38 15.17 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.205 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -55.85 -51.1 68.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.855 0.862 . . . . 0.0 110.975 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.6 m -56.87 -47.11 81.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.402 1.081 . . . . 0.0 111.904 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -63.22 -45.25 92.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.863 0.865 . . . . 0.0 111.621 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 23.1 mm-40 -70.72 -37.19 73.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.027 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.4 t -67.29 -42.93 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.14 -20.96 64.94 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.542 0.737 . . . . 0.0 112.222 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.96 -7.52 42.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.454 0.702 . . . . 0.0 110.756 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.32 87.48 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.565 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 30.3 mmtp -68.91 -25.31 64.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.972 0.909 . . . . 0.0 110.934 175.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 166.19 30.26 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.734 0.813 . . . . 0.0 110.3 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 73' ' ' GLN . 6.1 t -105.1 151.72 23.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.784 0.834 . . . . 0.0 109.863 174.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.9 p -58.42 -34.63 70.99 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.497 0.719 . . . . 0.0 110.404 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.7 tt0 -55.68 -42.03 74.54 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.582 1.153 . . . . 0.0 111.785 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 70' ' ' THR . 29.5 tt0 -62.11 -29.79 70.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.874 0.869 . . . . 0.0 111.755 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 83' ' ' ARG . 60.9 m-85 -104.05 -78.41 0.56 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.014 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.3 m-85 -51.06 -29.31 12.51 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -165.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 66.1 t -62.33 125.83 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.819 1.191 . . . . 0.0 108.409 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 33' ' ' LEU . 23.1 mt -59.65 -35.13 73.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -163.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -63.24 -39.82 95.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 120.838 0.351 . . . . 0.0 111.431 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -79.73 -40.59 28.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.223 1.009 . . . . 0.0 110.466 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.67 -47.55 73.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.419 1.488 . . . . 0.0 110.288 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.51 72.73 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.81 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.36 -43.92 66.01 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.439 0.462 . . . . 0.0 111.086 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 22.9 mmm180 -62.6 -42.75 99.76 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.754 0.822 . . . . 0.0 111.357 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.25 -37.92 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.512 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 88' ' ' VAL . 29.9 t70 -58.55 -36.52 74.02 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.203 0.601 . . . . 0.0 111.246 170.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.01 -44.73 83.91 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -61.98 -45.56 93.08 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.868 0.867 . . . . 0.0 112.371 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 85' ' ' ASP . 22.3 m -71.59 -34.36 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 122.851 0.461 . . . . 0.0 110.948 -177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.7 60.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.679 0.392 . . . . 0.0 110.689 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.11 0 C-N-CA 123.529 0.731 . . . . 0.0 112.932 -179.607 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.1 m . . . . . 0 CA--C 1.548 0.878 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.68 -46.31 82.94 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.335 0.397 . . . . 0.0 110.884 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.35 -42.52 82.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 123.894 0.746 . . . . 0.0 111.299 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 11' ' ' ILE . 31.2 mmm-85 -70.12 -47.18 62.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.264 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -58.4 -39.21 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.305 0.574 . . . . 0.0 110.698 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.999 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 t -69.64 -25.44 63.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.587 0.355 . . . . 0.0 111.524 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 47' ' ' ILE . 34.2 mm -61.99 -58.0 9.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.2 -30.13 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.89 0.744 . . . . 0.0 110.95 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.17 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.431 1.092 . . . . 0.0 111.622 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 -29.54 56.06 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.135 0.574 . . . . 0.0 112.17 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.5 m -79.79 -60.23 2.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.803 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 43' ' ' ILE . 42.9 m -90.44 -3.95 57.33 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 60.7 69.88 0.65 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.875 0.87 . . . . 0.0 110.129 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -133.51 116.32 13.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 23.8 Cg_endo -58.74 145.66 95.21 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.868 2.379 . . . . 0.0 112.313 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HD2' HD12 ' A' ' 23' ' ' ILE . 55.6 mmm-85 -62.67 -25.32 68.09 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.343 1.057 . . . . 0.0 112.249 -175.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 17.1 pt-20 -61.12 -41.27 96.4 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.82 -12.71 47.16 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 111.48 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 20' ' ' ARG . 76.0 mt -83.6 104.68 12.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.2 p -120.45 153.39 56.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.284 1.034 . . . . 0.0 109.335 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.0 -30.15 82.73 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.64 2.226 . . . . 0.0 112.752 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.42 -15.78 58.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.3 t -66.46 134.86 53.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.942 0.497 . . . . 0.0 110.165 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 20.5 t-80 -103.27 134.7 46.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.279 . . . . 0.0 108.054 174.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.47 -58.47 6.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.169 0.588 . . . . 0.0 112.358 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.89 -49.02 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.0 t70 -72.67 -37.38 67.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.646 0.778 . . . . 0.0 112.663 -170.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -107.64 -56.89 2.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.976 0.51 . . . . 0.0 110.814 -172.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 77' ' ' LEU . 91.5 mt -72.58 -20.39 61.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.771 0.829 . . . . 0.0 111.91 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.54 8.78 87.49 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.213 0.32 . . . . 0.0 113.054 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 43' ' ' ILE . 79.5 mt -72.79 106.56 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.222 1.009 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.2 159.29 7.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.645 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -62.15 -15.56 46.79 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.354 0.662 . . . . 0.0 111.009 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.97 -44.98 21.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.486 1.114 . . . . 0.0 110.376 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.4 -26.82 62.01 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.29 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -73.0 -20.72 60.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.434 1.094 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -55.99 -42.42 76.33 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.175 0.59 . . . . 0.0 110.4 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.08 -33.64 68.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.936 1.294 . . . . 0.0 110.793 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 35' ' ' ILE . 58.0 mt -65.09 -48.2 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.204 0.602 . . . . 0.0 109.624 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.85 76.79 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.003 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.05 -49.51 64.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.427 1.08 . . . . 0.0 111.081 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.76 72.84 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.079 0.552 . . . . 0.0 111.849 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 11' ' ' ILE . 80.0 mt -67.78 -44.19 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 124.156 0.983 . . . . 0.0 110.135 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.34 -45.01 65.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.144 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -70.49 -50.7 35.26 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -60.04 -55.08 38.43 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.15 0.98 . . . . 0.0 112.301 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.47 ' HB2' HG12 ' A' ' 53' ' ' ILE . 90.4 m-85 -82.05 -22.54 36.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.048 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.89 29.27 57.51 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 51' ' ' PHE . 31.9 pt -113.38 162.34 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.204 1.002 . . . . 0.0 109.632 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -95.1 103.45 15.3 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.87 115.93 62.23 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.26 81.8 0.69 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.227 1.951 . . . . 0.0 112.224 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 41' ' ' LEU . 48.9 tp -73.29 -32.39 64.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.29 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.17 -34.83 72.57 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.293 0.637 . . . . 0.0 111.186 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.94 -46.64 51.33 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.85 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -62.8 -46.83 86.14 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.704 0.802 . . . . 0.0 111.303 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.7 m -56.41 -45.56 80.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.819 1.248 . . . . 0.0 111.269 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -64.03 -38.49 91.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.889 0.876 . . . . 0.0 110.975 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.4 -33.74 76.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.668 0.787 . . . . 0.0 110.751 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.95 -43.9 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.847 0.459 . . . . 0.0 110.433 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -56.2 -39.25 72.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.623 0.769 . . . . 0.0 112.65 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -84.24 -3.72 58.38 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.21 19.35 79.82 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 117.973 0.351 . . . . 0.0 113.178 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -82.18 -58.96 2.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.361 0.665 . . . . 0.0 109.668 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.63 161.72 15.11 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.054 0.941 . . . . 0.0 110.211 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.2 p -105.74 165.34 11.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.893 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.8 p -65.08 -29.95 70.86 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.203 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.79 -44.84 93.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.662 0.785 . . . . 0.0 111.642 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.68 -33.01 69.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.301 0.64 . . . . 0.0 112.291 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.0 -64.76 1.18 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 31.8 m-85 -61.78 -21.79 64.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -167.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.5 t -62.13 129.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.614 1.097 . . . . 0.0 108.424 170.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 33' ' ' LEU . 32.0 mt -60.8 -38.41 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -165.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.0 pttp -64.52 -38.22 90.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.1 m-20 -69.71 -48.92 57.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.57 0.748 . . . . 0.0 110.172 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.7 tp -52.08 -48.51 64.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.774 1.63 . . . . 0.0 110.825 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.1 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.72 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.38 64.75 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.458 0.474 . . . . 0.0 111.306 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 30.1 mmm180 -60.99 -40.6 94.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.698 0.799 . . . . 0.0 111.492 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.482 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -74.61 -42.52 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.417 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -51.95 -38.28 55.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.076 0.95 . . . . 0.0 111.294 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -66.08 -44.86 83.21 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.951 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.21 -38.83 82.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.725 0.81 . . . . 0.0 112.08 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.01 -31.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.82 92.06 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.027 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.807 0 O-C-N 124.325 1.015 . . . . 0.0 112.906 178.635 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 8' ' ' VAL . 53.5 m . . . . . 0 N--CA 1.476 0.853 0 CA-C-O 119.844 -0.122 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -60.83 -42.64 98.15 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.805 0.69 . . . . 0.0 111.517 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.63 -40.73 84.18 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.867 0.73 . . . . 0.0 111.271 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.503 ' O ' HG12 ' A' ' 11' ' ' ILE . 19.6 mmt180 -75.81 -39.18 57.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.128 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 4' ' ' THR . 94.5 t -60.4 -39.38 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.565 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.05 88.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.519 1.127 . . . . 0.0 111.054 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -69.35 -31.76 70.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.223 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -59.09 -53.64 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.1 mt -61.03 -38.21 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.972 0.909 . . . . 0.0 111.092 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.81 68.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.74 0.816 . . . . 0.0 111.345 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.29 -40.53 64.49 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.774 0.83 . . . . 0.0 112.568 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 43' ' ' ILE . 18.1 p -76.86 -58.41 3.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.06 0.544 . . . . 0.0 111.416 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 35' ' ' ILE . 48.4 t -84.79 -0.97 55.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.829 0.852 . . . . 0.0 112.426 -172.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.55 45.19 16.65 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.22 1.008 . . . . 0.0 112.069 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.34 130.76 23.49 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.843 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.9 128.33 28.32 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.543 2.162 . . . . 0.0 111.464 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 tpt85 -56.72 -36.72 70.04 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.014 0.926 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -32.64 74.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.652 1.181 . . . . 0.0 112.614 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -82.74 -10.05 59.07 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 122.556 0.342 . . . . 0.0 111.717 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.61 110.39 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.268 0.627 . . . . 0.0 110.035 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.7 p -117.39 148.77 43.42 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.359 1.064 . . . . 0.0 109.54 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -51.29 -41.4 58.86 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.976 2.451 . . . . 0.0 113.833 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.01 -16.64 59.24 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.984 -172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 33.5 t -63.43 132.16 50.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.567 0.747 . . . . 0.0 110.672 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 59.2 t-80 -89.87 128.48 36.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.57 -64.15 0.88 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.696 0.799 . . . . 0.0 112.475 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.06 -35.79 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.2 t70 -82.32 -67.99 0.74 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.521 0.328 . . . . 0.0 111.114 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.39 -51.37 17.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.305 0.642 . . . . 0.0 110.776 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 77' ' ' LEU . 87.6 mt -81.84 -18.34 44.28 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.423 0.689 . . . . 0.0 111.546 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.48 36.86 78.07 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.191 0.307 . . . . 0.0 113.809 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 16' ' ' CYS . 54.7 mt -85.16 133.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.935 0.894 . . . . 0.0 109.691 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.25 154.21 31.2 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -66.22 -17.94 65.05 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.641 0.376 . . . . 0.0 110.374 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.06 -42.65 18.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 109.901 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.08 -32.97 73.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.92 -21.32 65.99 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.007 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 57' ' ' LEU . 90.3 mt -59.47 -35.91 74.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.085 0.554 . . . . 0.0 111.816 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.01 -35.55 56.95 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.333 0.653 . . . . 0.0 110.221 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 16' ' ' CYS . 55.1 mt -60.29 -50.61 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -66.87 -32.76 74.23 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.831 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -69.43 -40.12 77.43 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.15 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.78 70.13 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 11' ' ' ILE . 87.7 mt -66.96 -40.64 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.076 0.95 . . . . 0.0 110.743 173.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.28 -45.39 87.99 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.231 0.612 . . . . 0.0 110.941 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -80.82 -27.36 36.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.546 0.738 . . . . 0.0 112.63 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.41 -53.7 5.52 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.166 0.587 . . . . 0.0 110.495 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -87.62 -23.83 24.15 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.962 0.905 . . . . 0.0 111.201 -173.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.34 39.72 30.36 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.06 -177.99 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 0.0 110.26 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -124.71 109.12 12.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.69 106.46 18.76 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.09 82.89 2.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 121.778 1.652 . . . . 0.0 111.693 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 41' ' ' LEU . 57.2 tp -69.11 -34.92 75.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.904 -174.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.75 -36.97 70.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.285 1.034 . . . . 0.0 110.976 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 ttpp -87.77 -34.74 18.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.908 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -62.52 -43.86 97.79 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.505 0.722 . . . . 0.0 110.969 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.9 m -63.98 -33.5 75.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.931 0.892 . . . . 0.0 110.604 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -72.48 -29.83 64.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.358 0.663 . . . . 0.0 111.585 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 30.8 mm-40 -58.46 -39.93 81.26 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.55 0.69 . . . . 0.0 109.475 171.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 44.0 t -69.03 -47.34 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.46 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -57.51 -44.05 84.71 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.034 0.934 . . . . 0.0 112.612 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -86.1 -13.67 46.55 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.003 0.921 . . . . 0.0 111.321 -175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.88 61.53 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 113.804 0.282 . . . . 0.0 113.804 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.81 -34.84 79.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.45 0.7 . . . . 0.0 110.336 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -158.57 171.23 20.5 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.877 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.9 p -100.83 157.74 16.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.809 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.63 -32.09 68.71 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.448 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' A' ' 76' ' ' VAL . 45.1 tt0 -55.87 -41.56 74.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.095 1.358 . . . . 0.0 111.682 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.58 -21.7 64.5 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.898 0.879 . . . . 0.0 112.584 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -121.46 -6.38 9.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 82.0 m-85 -126.9 -26.9 3.1 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.595 -0.716 . . . . 0.0 112.805 -172.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 58.0 t -61.26 126.44 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 167.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 33' ' ' LEU . 36.9 mt -59.07 -35.43 73.35 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.089 0.868 . . . . 0.0 112.642 -161.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -69.85 -36.4 75.52 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 80.8 m-20 -71.43 -48.31 50.36 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.116 0.966 . . . . 0.0 110.235 177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.9 tp -50.44 -50.74 51.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 110.987 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.12 61.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.826 0.851 . . . . 0.0 111.696 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.29 56.43 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.563 0.539 . . . . 0.0 110.384 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 24.1 mmm180 -70.65 -32.2 69.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.298 0.639 . . . . 0.0 111.486 175.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.34 -39.55 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 88' ' ' VAL . 34.7 t70 -58.2 -37.94 75.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.689 . . . . 0.0 111.567 170.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 7.5 tp10 -59.08 -47.79 83.95 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.189 0.995 . . . . 0.0 110.196 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.8 mt -67.6 -41.11 84.58 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.034 0.934 . . . . 0.0 113.112 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 85' ' ' ASP . 17.3 m -75.73 -28.4 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.997 -0.439 . . . . 0.0 111.032 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.67 56.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 C-N-CA 123.274 0.63 . . . . 0.0 112.462 170.968 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 85' ' ' ASP . 7.8 m . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 111.493 0.183 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -68.32 -46.31 70.58 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.65 -42.15 70.96 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.39 0.676 . . . . 0.0 111.057 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.405 ' O ' HG12 ' A' ' 11' ' ' ILE . 4.9 mmp_? -60.88 -58.03 10.14 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.473 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.23 -37.67 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.297 1.039 . . . . 0.0 111.528 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -68.01 -43.08 79.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.647 1.179 . . . . 0.0 110.657 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -62.01 -40.95 97.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.452 0.701 . . . . 0.0 111.395 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 7' ' ' ARG . 42.0 mm -61.98 -50.81 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.298 0.639 . . . . 0.0 110.579 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.56 -34.69 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 111.006 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.51 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.962 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -75.46 -50.89 14.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 43' ' ' ILE . 10.1 m -62.79 -46.94 85.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.436 0.694 . . . . 0.0 111.199 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.31 7.64 43.59 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.879 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 59.99 21.15 10.23 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.881 1.273 . . . . 0.0 113.011 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -77.15 138.25 64.79 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.331 0.652 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.76 121.02 9.27 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.102 1.868 . . . . 0.0 111.291 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.37 -29.46 67.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.163 0.585 . . . . 0.0 110.634 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.96 -33.67 69.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.064 0.945 . . . . 0.0 112.312 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -88.84 -18.61 27.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.408 0.683 . . . . 0.0 111.575 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.406 HG21 ' HB1' ' A' ' 9' ' ' ALA . 41.4 mt -72.94 111.14 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.625 0.77 . . . . 0.0 111.334 -177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -111.03 161.41 25.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.265 1.026 . . . . 0.0 108.989 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.17 -24.31 59.08 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.18 -23.73 61.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.75 1.22 . . . . 0.0 110.944 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.5 m -61.88 119.39 8.71 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 123.737 0.648 . . . . 0.0 111.161 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.4 t-80 -86.05 127.9 34.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.81 -54.02 16.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.133 0.573 . . . . 0.0 111.799 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -77.3 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.497 0.189 . . . . 0.0 110.776 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.65 -47.27 73.06 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.324 0.65 . . . . 0.0 112.693 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.7 -51.69 5.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.615 . . . . 0.0 111.852 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 77' ' ' LEU . 87.9 mt -79.31 -42.66 25.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.92 0.488 . . . . 0.0 110.266 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.16 -7.49 25.1 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.313 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.4 112.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.337 1.055 . . . . 0.0 111.1 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.38 160.32 29.68 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 p -58.93 -15.43 12.85 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.678 0.791 . . . . 0.0 112.859 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.2 mt -86.18 -38.67 17.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.972 0.909 . . . . 0.0 110.806 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.79 -32.7 67.9 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.97 -19.16 64.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 57' ' ' LEU . 90.4 mt -60.19 -42.11 94.36 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.847 0.459 . . . . 0.0 110.246 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.25 -42.3 93.45 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.858 1.263 . . . . 0.0 110.584 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.497 ' HA ' HG21 ' A' ' 15' ' ' THR . 55.8 mt -67.64 -41.62 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.391 0.676 . . . . 0.0 111.004 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.0 73.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.994 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -65.45 -43.57 89.98 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.6 1.188 . . . . 0.0 110.962 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.92 74.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.782 0.433 . . . . 0.0 111.355 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 84' ' ' ILE . 96.9 mt -68.84 -40.01 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.343 0.657 . . . . 0.0 110.17 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -53.42 -50.86 64.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.218 0.607 . . . . 0.0 110.677 174.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -73.25 -48.47 34.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.695 -172.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.78 -44.38 73.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.347 0.659 . . . . 0.0 111.571 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.92 -11.31 39.49 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.946 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.38 71.04 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.235 0.335 . . . . 0.0 112.837 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.24 175.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.061 0.944 . . . . 0.0 111.019 -175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -116.59 92.71 3.95 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tt -78.18 114.09 39.32 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.99 85.86 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.185 1.924 . . . . 0.0 112.401 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 41' ' ' LEU . 51.7 tp -72.5 -30.4 64.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.6 -30.79 68.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.005 0.522 . . . . 0.0 111.404 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -70.39 -55.48 8.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 0.0 108.659 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -61.1 -48.46 81.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.665 1.186 . . . . 0.0 112.879 -168.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -60.0 -44.3 94.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.664 0.786 . . . . 0.0 111.682 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -70.36 -30.86 67.89 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.287 0.635 . . . . 0.0 110.684 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.3 -40.36 97.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.458 0.703 . . . . 0.0 110.723 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.638 HG11 HG23 ' A' ' 71' ' ' THR . 60.3 t -66.96 -42.82 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.215 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.16 -31.07 65.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.691 0.796 . . . . 0.0 112.7 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -102.24 -14.64 16.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.938 0.495 . . . . 0.0 111.45 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.16 24.1 64.53 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.706 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.57 -31.26 72.37 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.291 0.546 . . . . 0.0 109.607 168.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.18 166.56 31.19 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.616 1.166 . . . . 0.0 109.773 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.6 p -99.29 158.69 15.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.7 0.8 . . . . 0.0 110.972 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 HG11 ' A' ' 64' ' ' VAL . 38.5 p -64.49 -32.34 73.94 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HA ' HG23 ' A' ' 76' ' ' VAL . 36.8 tt0 -55.63 -46.34 77.44 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.569 0.747 . . . . 0.0 111.033 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.44 -34.84 69.38 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.812 0.845 . . . . 0.0 112.58 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -104.43 -75.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.536 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.9 m-85 -58.18 -26.16 62.42 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 125.275 1.43 . . . . 0.0 114.844 -165.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -61.48 124.72 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 120.001 1.273 . . . . 0.0 108.257 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 33' ' ' LEU . 34.7 mt -61.96 -33.59 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -162.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -69.41 -36.48 76.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -72.69 -44.24 62.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.61 0.764 . . . . 0.0 109.878 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.81 -43.97 69.8 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.171 1.788 . . . . 0.0 111.367 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.815 0.697 . . . . 0.0 110.759 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.02 -44.4 65.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -62.68 -44.06 97.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.542 0.737 . . . . 0.0 111.484 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 47' ' ' ILE . 87.0 mt -69.52 -43.07 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.574 0.749 . . . . 0.0 110.154 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' HG21 ' A' ' 4' ' ' THR . 22.1 t70 -53.74 -39.87 65.68 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.983 0.513 . . . . 0.0 111.652 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.66 -48.37 81.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.415 0.626 . . . . 0.0 110.639 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.68 -39.03 80.78 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.396 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.455 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.7 m -76.53 -33.89 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 122.661 0.384 . . . . 0.0 110.802 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.15 -21.86 65.8 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 O-C-N 123.68 0.612 . . . . 0.0 112.398 173.872 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.3 m . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 110.81 -0.07 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.67 -45.99 90.41 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.835 0.709 . . . . 0.0 110.941 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.18 -36.35 79.6 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.493 0.717 . . . . 0.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 7' ' ' ARG . 5.4 mmt-85 -68.32 -47.98 66.11 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.694 0.621 . . . . 0.0 111.422 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 4' ' ' THR . 97.6 t -59.62 -37.13 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.708 0.766 . . . . 0.0 110.269 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.27 73.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.005 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -72.14 -23.01 61.23 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 122.425 0.29 . . . . 0.0 111.553 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 47' ' ' ILE . 28.0 mm -59.59 -58.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 167.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.85 -30.04 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.925 0.765 . . . . 0.0 111.044 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.37 -53.61 54.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.502 1.121 . . . . 0.0 111.64 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.2 -34.53 59.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.595 0.358 . . . . 0.0 111.703 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.2 m -71.75 -60.48 2.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.775 0.83 . . . . 0.0 111.292 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 43' ' ' ILE . 61.1 m -96.06 4.13 52.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.611 0.764 . . . . 0.0 112.321 -173.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.31 33.47 22.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.27 1.028 . . . . 0.0 112.599 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.08 123.95 59.53 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.16 137.5 63.12 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.937 2.425 . . . . 0.0 112.681 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.5 0.72 . . . . 0.0 111.127 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.04 -28.47 68.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.975 0.91 . . . . 0.0 111.817 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -88.84 -20.34 24.77 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.781 0.432 . . . . 0.0 110.718 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.86 123.32 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.511 0.724 . . . . 0.0 109.227 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -136.35 157.54 75.23 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.347 1.059 . . . . 0.0 109.602 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -59.84 -32.5 95.46 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.228 1.952 . . . . 0.0 112.263 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.49 -28.47 61.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.415 0.686 . . . . 0.0 112.123 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.476 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 30.9 p -72.76 118.51 15.78 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.922 0.391 . . . . 0.0 111.496 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 62.0 t-80 -68.67 129.36 39.69 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 109.267 167.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.2 -58.04 5.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.251 0.621 . . . . 0.0 112.46 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 26.9 mt -72.9 -44.76 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.304 0.241 . . . . 0.0 111.447 -174.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 22.1 t70 -75.48 -64.04 1.15 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.29 0.236 . . . . 0.0 111.164 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.72 -48.75 15.93 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 77' ' ' LEU . 82.1 mt -79.84 -27.66 40.17 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.254 0.222 . . . . 0.0 111.281 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.12 47.88 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.426 -0.352 . . . . 0.0 113.413 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.489 HD13 HD11 ' A' ' 43' ' ' ILE . 66.3 mt -80.69 133.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.93 0.892 . . . . 0.0 109.748 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.63 153.89 19.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -61.58 -15.94 43.47 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 mt -84.21 -32.8 24.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.625 0.726 . . . . 0.0 109.661 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.85 -27.87 40.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.143 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -73.7 -21.25 60.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.319 1.048 . . . . 0.0 110.282 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 57' ' ' LEU . 88.9 mt -56.04 -42.5 76.64 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.073 0.549 . . . . 0.0 110.143 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.77 -38.13 89.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.894 0.878 . . . . 0.0 110.986 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.0 mt -62.26 -51.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.119 0.568 . . . . 0.0 110.371 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.35 -40.07 95.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.74 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -67.73 -39.21 84.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.818 0.847 . . . . 0.0 111.311 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.38 -31.39 69.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.682 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.481 HG13 HG21 ' A' ' 11' ' ' ILE . 81.2 mt -69.82 -40.92 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.95 0.9 . . . . 0.0 110.822 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -54.32 -42.34 70.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.491 0.716 . . . . 0.0 111.126 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -76.78 -48.48 18.5 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.458 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.12 63.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.489 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 53' ' ' ILE . 78.4 m-85 -85.44 -24.91 27.25 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.63 34.17 44.97 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.48 0.487 . . . . 0.0 112.114 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 51' ' ' PHE . 32.2 pt -121.88 173.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 109.649 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.14 110.56 22.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.401 HD12 HG21 ' A' ' 47' ' ' ILE . 7.6 tt -96.36 104.17 16.58 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.92 84.27 1.61 Allowed 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.04 1.827 . . . . 0.0 111.521 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 41' ' ' LEU . 61.2 tp -69.17 -30.6 68.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.64 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.919 0.888 . . . . 0.0 111.059 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 54.7 tttp -77.69 -46.62 21.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.938 0.895 . . . . 0.0 110.361 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -66.88 -38.66 86.72 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.088 0.555 . . . . 0.0 111.539 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 m -66.51 -35.64 80.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.704 0.802 . . . . 0.0 110.522 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.93 -34.8 77.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.135 0.974 . . . . 0.0 110.653 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 61.4 mm-40 -58.13 -41.89 84.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.47 -47.26 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.706 0.802 . . . . 0.0 110.4 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.92 -27.99 68.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.865 1.266 . . . . 0.0 112.806 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.78 -8.62 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.796 0.839 . . . . 0.0 112.252 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.78 81.3 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 122.812 0.07 . . . . 0.0 113.139 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -71.55 -21.94 61.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.581 1.152 . . . . 0.0 110.347 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.34 168.89 25.25 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.431 1.093 . . . . 0.0 109.457 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 73' ' ' GLN . 10.0 t -101.3 158.76 15.8 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.735 0.814 . . . . 0.0 109.64 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -61.99 -31.59 71.97 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.085 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.44 -36.76 84.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.972 0.909 . . . . 0.0 111.843 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.427 ' H ' HG23 ' A' ' 70' ' ' THR . 28.3 tt0 -63.36 -29.05 70.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.176 0.59 . . . . 0.0 111.928 -173.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -107.69 -64.13 1.24 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.391 0.277 . . . . 0.0 111.436 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.28 -20.79 63.28 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -167.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t -65.63 131.99 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 119.862 1.21 . . . . 0.0 108.894 171.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 33' ' ' LEU . 25.2 mt -59.96 -36.41 77.05 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -165.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.6 pttt -58.7 -43.1 89.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.454 0.471 . . . . 0.0 111.056 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.0 m-20 -76.47 -46.2 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.298 1.039 . . . . 0.0 110.308 -174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.38 -52.38 37.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.109 1.363 . . . . 0.0 110.539 171.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.48 -25.79 65.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.13 -42.73 59.56 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.795 0.685 . . . . 0.0 111.097 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 22.1 mmm180 -64.93 -42.93 94.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 53' ' ' ILE . 93.9 mt -64.93 -43.26 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.922 . . . . 0.0 110.549 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.4 t70 -56.1 -36.83 68.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.455 0.702 . . . . 0.0 111.899 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.51 -39.07 77.8 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 123.719 0.637 . . . . 0.0 110.407 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.74 -38.53 86.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.43 0.692 . . . . 0.0 111.996 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.7 m -80.55 -25.73 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 122.184 -0.323 . . . . 0.0 110.839 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.17 -38.12 78.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.145 0.578 . . . . 0.0 109.825 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.019 0 C-N-CA 124.083 0.953 . . . . 0.0 112.704 177.534 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 16.8 m . . . . . 0 CA--C 1.55 0.952 0 N-CA-C 111.55 0.204 . . . . 0.0 111.55 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -68.25 -32.11 72.07 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -59.31 -48.09 82.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.66 0.384 . . . . 0.0 111.071 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -69.33 -46.23 67.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.865 0.728 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -57.97 -42.67 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.76 0.824 . . . . 0.0 111.314 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.98 91.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.608 0.763 . . . . 0.0 110.647 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -56.41 -44.12 80.04 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.956 0.903 . . . . 0.0 111.597 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.485 HG21 HG13 ' A' ' 47' ' ' ILE . 29.3 mm -58.17 -57.87 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.88 0.872 . . . . 0.0 110.049 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.65 -33.17 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.37 1.068 . . . . 0.0 111.593 -175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.24 59.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.933 0.893 . . . . 0.0 111.437 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.17 -24.66 30.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.498 HG21 ' HA ' ' A' ' 43' ' ' ILE . 37.4 p -74.95 -62.05 1.68 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.745 0.418 . . . . 0.0 110.353 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.2 m -94.48 12.57 26.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.206 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t70 67.34 16.91 10.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.775 1.23 . . . . 0.0 111.991 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.8 mt -77.34 127.36 83.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 122.892 0.477 . . . . 0.0 110.284 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.71 127.03 23.01 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.744 2.296 . . . . 0.0 112.365 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -59.57 -31.54 69.53 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.248 1.019 . . . . 0.0 110.804 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.8 pt-20 -59.91 -27.92 67.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.811 1.244 . . . . 0.0 112.374 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 21' ' ' GLU . 45.0 p -105.15 -6.82 19.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.539 0.735 . . . . 0.0 111.947 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.1 mt -71.04 116.19 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.164 0.507 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 138.25 31.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.085 1.354 . . . . 0.0 108.435 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 36.8 Cg_endo -60.93 -27.22 84.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.998 2.465 . . . . 0.0 112.942 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.29 -20.84 61.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.179 0.992 . . . . 0.0 112.351 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 146.62 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.724 0.41 . . . . 0.0 110.362 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 30.1 t-80 -107.85 136.38 47.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 124.159 0.984 . . . . 0.0 108.819 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.34 -63.49 1.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.28 1.432 . . . . 0.0 113.545 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.89 -28.21 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.797 0.439 . . . . 0.0 110.836 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.7 t70 -63.8 -65.97 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.07 0.948 . . . . 0.0 112.018 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.69 -48.02 3.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.048 0.539 . . . . 0.0 110.527 -170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.33 -23.53 66.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.087 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.05 26.67 71.55 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.046 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.414 ' HB ' ' HB1' ' A' ' 29' ' ' ALA . 69.5 mt -65.52 120.57 12.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.57 164.43 25.89 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t -77.08 -22.04 53.43 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 122.053 -0.404 . . . . 0.0 110.003 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.7 -32.03 22.15 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.684 0.794 . . . . 0.0 109.537 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -73.05 -29.63 63.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.243 1.017 . . . . 0.0 110.534 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.88 -22.5 59.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.695 . . . . 0.0 110.059 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 57' ' ' LEU . 93.4 mt -57.71 -35.78 71.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.745 0.418 . . . . 0.0 110.815 174.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.74 -36.77 76.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.653 0.781 . . . . 0.0 110.858 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' A' ' 16' ' ' CYS . 52.3 mt -62.08 -53.03 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.585 0.754 . . . . 0.0 109.538 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.24 85.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.329 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.84 -40.13 69.27 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.622 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.877 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 11' ' ' ILE . 82.1 mt -72.11 -38.67 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.607 1.163 . . . . 0.0 111.388 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -53.32 -46.16 69.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.86 0.864 . . . . 0.0 110.925 174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -77.53 -47.57 19.18 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.347 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.41 -50.33 65.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.662 0.785 . . . . 0.0 111.803 -170.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.403 ' HB2' HG12 ' A' ' 53' ' ' ILE . 59.8 m-85 -83.92 -28.36 27.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.632 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 45.88 8.82 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 51' ' ' PHE . 37.6 pt -127.14 -175.35 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.049 0.94 . . . . 0.0 111.051 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -124.04 99.71 6.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.28 1.032 . . . . 0.0 108.488 174.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 104.26 8.06 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.68 81.65 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.47 1.447 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 41' ' ' LEU . 54.3 tp -69.75 -32.76 71.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.767 0.427 . . . . 0.0 110.099 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.18 -36.35 70.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.44 1.096 . . . . 0.0 110.903 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 39.4 ttpt -78.11 -44.16 26.91 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.677 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -62.89 -39.38 94.31 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 0.0 111.436 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 m -56.56 -46.31 80.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.508 1.123 . . . . 0.0 111.073 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -66.38 -34.91 79.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.076 0.95 . . . . 0.0 111.101 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.9 mm-40 -59.44 -42.72 92.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.117 0.567 . . . . 0.0 110.442 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 71' ' ' THR . 59.0 t -68.28 -49.61 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.662 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -61.9 -28.9 69.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.93 0.892 . . . . 0.0 112.947 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -95.06 -7.8 38.52 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.851 0.861 . . . . 0.0 110.849 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.87 80.87 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.558 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.61 -10.92 57.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.7 0.8 . . . . 0.0 112.121 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -161.72 168.63 22.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.253 0.621 . . . . 0.0 110.837 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.5 p -104.36 157.45 17.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.919 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.492 HG23 HG11 ' A' ' 64' ' ' VAL . 32.2 p -67.98 -28.63 67.61 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.634 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.62 -39.56 88.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.164 0.586 . . . . 0.0 110.65 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.37 -34.72 66.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.868 0.867 . . . . 0.0 112.133 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -107.47 -71.81 0.74 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.373 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 57.2 m-85 -60.66 -18.23 52.41 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -165.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 84.8 t -65.6 128.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.811 1.187 . . . . 0.0 108.189 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.82 -39.2 77.07 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.2 pttp -68.55 -38.17 80.56 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.428 0.455 . . . . 0.0 112.089 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.0 m-20 -70.36 -46.61 63.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.47 0.708 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.06 -49.14 64.08 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.285 1.434 . . . . 0.0 110.863 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.48 69.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.347 0.659 . . . . 0.0 110.832 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.07 -39.61 55.02 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.723 0.409 . . . . 0.0 110.739 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.5 mmm180 -59.35 -43.39 92.8 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.352 0.596 . . . . 0.0 110.899 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.411 ' CD1' HD13 ' A' ' 47' ' ' ILE . 78.4 mt -71.7 -38.35 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.294 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.4 -38.64 66.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.744 0.818 . . . . 0.0 111.882 170.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.48 -40.66 76.92 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.545 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.43 -42.82 95.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.142 0.977 . . . . 0.0 112.957 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.9 m -75.73 -26.6 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.604 0.362 . . . . 0.0 110.27 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.8 73.08 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.953 171.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 123.706 0.803 . . . . 0.0 112.981 176.169 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 8' ' ' VAL . 79.8 m . . . . . 0 CA--C 1.551 1.018 0 CA-C-O 119.943 -0.075 . . . . 0.0 110.964 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.35 -58.68 5.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.81 -29.77 68.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 123.867 0.729 . . . . 0.0 111.588 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -64.98 -51.53 61.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 110.75 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 4' ' ' THR . 54.3 t -61.83 -36.17 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.144 0.578 . . . . 0.0 111.028 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.31 93.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.849 . . . . 0.0 109.958 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.2 m -54.92 -46.91 74.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.738 1.215 . . . . 0.0 111.409 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.576 HG21 HG13 ' A' ' 47' ' ' ILE . 41.9 mm -58.4 -58.32 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 18' ' ' ILE . 77.4 mt -58.76 -37.14 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.434 1.094 . . . . 0.0 111.387 -175.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.14 78.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.927 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.58 -27.44 21.37 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 43' ' ' ILE . 21.7 p -80.4 -59.94 2.51 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.502 0.592 . . . . 0.0 110.74 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.645 ' SG ' HG12 ' A' ' 35' ' ' ILE . 44.8 t -80.06 -8.39 59.36 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.234 1.014 . . . . 0.0 111.887 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 61.68 71.92 0.53 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.822 0.849 . . . . 0.0 110.158 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 12' ' ' ILE . 39.3 mt -127.78 128.48 23.87 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.241 1.016 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.58 134.9 60.01 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.992 2.461 . . . . 0.0 112.553 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD2' HD12 ' A' ' 23' ' ' ILE . 9.4 mmm180 -59.25 -29.2 67.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.873 0.869 . . . . 0.0 111.554 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG3' HG23 ' A' ' 22' ' ' THR . 14.2 pt-20 -63.26 -33.71 76.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.0 p -101.7 21.42 14.48 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.152 0.981 . . . . 0.0 111.447 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 20' ' ' ARG . 63.5 mt -106.45 128.21 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -138.41 155.66 73.79 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.073 0.949 . . . . 0.0 109.557 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.5 -35.01 96.34 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.328 2.019 . . . . 0.0 112.878 170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.15 -21.69 53.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.732 0.813 . . . . 0.0 112.092 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.3 p -69.98 128.89 37.91 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 53.5 t-80 -88.41 129.89 35.31 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.68 -59.12 4.64 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.016 0.526 . . . . 0.0 111.994 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 45.1 mt -71.33 -60.55 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 120.657 0.265 . . . . 0.0 110.803 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.74 -49.15 77.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.268 1.027 . . . . 0.0 112.901 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.86 -58.56 2.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.83 0.452 . . . . 0.0 111.498 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.13 -19.6 58.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.401 0.68 . . . . 0.0 111.767 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.12 76.01 Favored Glycine 0 N--CA 1.478 1.463 0 O-C-N 122.986 0.178 . . . . 0.0 113.518 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.645 HG12 ' SG ' ' A' ' 16' ' ' CYS . 47.6 mt -73.32 117.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.106 0.962 . . . . 0.0 110.22 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.6 163.19 27.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 m -63.64 -16.51 61.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.911 0.484 . . . . 0.0 111.726 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -85.15 -43.88 13.45 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.718 0.807 . . . . 0.0 109.509 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.89 -31.4 72.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.116 0.966 . . . . 0.0 110.793 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 57' ' ' LEU . 8.8 t80 -72.2 -20.93 61.49 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.01 0.924 . . . . 0.0 110.685 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 57' ' ' LEU . 78.4 mt -57.62 -31.2 65.99 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.784 0.434 . . . . 0.0 111.849 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -69.75 -43.24 72.67 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.233 1.013 . . . . 0.0 109.262 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.417 HG12 ' OG1' ' A' ' 15' ' ' THR . 64.4 mt -60.06 -51.59 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.118 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.74 89.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.842 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.1 -38.33 87.97 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.423 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 11' ' ' ILE . . . -73.73 -29.23 62.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.178 0.591 . . . . 0.0 111.652 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.576 HG13 HG21 ' A' ' 11' ' ' ILE . 87.3 mt -70.72 -39.38 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.654 0.782 . . . . 0.0 110.587 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.34 -34.77 61.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.97 0.908 . . . . 0.0 111.829 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.38 -51.79 7.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.42 0.688 . . . . 0.0 111.251 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.337 1.055 . . . . 0.0 111.673 -171.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 53' ' ' ILE . 72.9 m-85 -88.58 -14.41 37.65 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.022 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.47 11.32 82.62 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.089 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.515 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.4 pt -96.13 -171.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.878 0.871 . . . . 0.0 110.58 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.63 114.83 25.42 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.05 98.35 7.4 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 59' ' ' LYS . 86.9 Cg_endo -81.09 86.41 1.63 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.287 1.991 . . . . 0.0 110.442 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 41' ' ' LEU . 65.9 tp -67.08 -40.41 86.99 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.774 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.63 -31.07 72.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.109 0.964 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' A' ' 56' ' ' PRO . 47.7 tttp -65.5 -48.29 73.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.004 1.322 . . . . 0.0 110.187 171.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 64' ' ' VAL . 45.2 m0 -63.36 -43.63 97.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.854 0.861 . . . . 0.0 110.787 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.0 m -59.36 -46.0 89.86 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.459 1.504 . . . . 0.0 111.243 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -65.14 -44.9 87.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.532 0.733 . . . . 0.0 111.001 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.96 -26.69 59.77 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.881 0.473 . . . . 0.0 112.222 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 71' ' ' THR . 90.3 t -72.72 -42.28 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.68 -17.45 62.84 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.623 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.01 -6.88 34.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 10.55 84.96 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.071 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.18 -16.98 55.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.842 0.857 . . . . 0.0 110.981 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.26 166.89 30.37 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.888 0.875 . . . . 0.0 109.999 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.7 t -111.57 155.65 22.98 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.47 0.708 . . . . 0.0 110.326 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.523 HG23 HG11 ' A' ' 64' ' ' VAL . 30.2 p -63.09 -32.52 73.91 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.558 0.743 . . . . 0.0 110.988 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HG3' HG21 ' A' ' 76' ' ' VAL . 36.1 tt0 -58.29 -44.36 88.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.561 0.344 . . . . 0.0 111.459 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.468 ' H ' HG23 ' A' ' 70' ' ' THR . 30.3 tt0 -56.32 -32.59 64.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.768 0.827 . . . . 0.0 111.61 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -102.12 -82.09 0.48 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.9 m-85 -55.89 -24.6 38.3 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -161.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.2 t -65.54 124.79 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 119.783 1.174 . . . . 0.0 108.303 170.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.85 -32.97 73.35 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -160.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.9 pttt -65.5 -41.28 93.39 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.976 0.51 . . . . 0.0 111.243 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.29 -41.07 49.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.95 -47.07 68.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.831 1.652 . . . . 0.0 110.931 169.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.35 70.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.447 0.699 . . . . 0.0 111.467 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.39 -41.5 47.69 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.413 0.685 . . . . 0.0 110.871 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 23.2 mmm180 -57.58 -50.28 73.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.028 0.931 . . . . 0.0 111.101 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.08 -38.83 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.031 0.932 . . . . 0.0 110.443 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.9 t70 -58.14 -35.52 71.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.81 0.444 . . . . 0.0 111.569 171.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.47 -39.79 70.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.491 0.316 . . . . 0.0 110.735 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 61.4 mt -61.93 -43.77 98.16 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.428 0.691 . . . . 0.0 111.733 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 53' ' ' ILE . 12.2 m -71.68 -27.68 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 122.761 0.424 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.1 65.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.101 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.732 0 C-N-CA 123.696 0.799 . . . . 0.0 112.934 174.739 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 m . . . . . 0 CA--C 1.548 0.882 0 N-CA-C 110.621 -0.14 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.49 -47.28 70.48 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.728 0.411 . . . . 0.0 110.299 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -54.78 -44.4 73.68 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.406 0.683 . . . . 0.0 111.461 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -60.49 -55.63 31.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.088 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 4' ' ' THR . 58.3 t -60.39 -37.14 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.51 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.37 87.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.105 0.962 . . . . 0.0 110.518 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -57.53 -42.81 83.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.141 0.976 . . . . 0.0 111.778 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -58.79 -50.94 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -33.99 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.149 0.58 . . . . 0.0 110.648 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -51.26 62.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.382 1.073 . . . . 0.0 112.317 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.44 -46.51 22.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.708 0.403 . . . . 0.0 111.959 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.1 m -72.46 -51.96 17.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.12 0.568 . . . . 0.0 111.616 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.77 -9.28 56.22 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.382 0.673 . . . . 0.0 111.777 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 59.02 72.07 0.55 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.381 1.072 . . . . 0.0 110.597 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.13 129.65 21.79 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.14 139.33 85.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.796 2.33 . . . . 0.0 112.358 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -61.06 -28.98 69.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.335 0.654 . . . . 0.0 112.129 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.34 -37.07 84.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.544 0.738 . . . . 0.0 111.236 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -81.48 -23.03 37.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.953 0.501 . . . . 0.0 111.012 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.474 HG23 HD13 ' A' ' 77' ' ' LEU . 75.8 mt -76.63 116.4 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -132.32 144.72 54.23 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.504 1.122 . . . . 0.0 109.204 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.9 -32.18 92.33 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.814 2.343 . . . . 0.0 112.792 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.13 -20.67 60.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.642 0.777 . . . . 0.0 112.011 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.9 t -73.58 147.76 43.57 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.989 0.915 . . . . 0.0 110.709 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 56.1 t-80 -104.37 133.71 48.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.553 1.141 . . . . 0.0 108.955 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -64.43 0.84 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.717 0.807 . . . . 0.0 112.705 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 46.2 mt -69.81 -39.6 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.835 0.454 . . . . 0.0 111.603 -173.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.52 -67.62 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.499 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.79 -57.7 3.89 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.683 0.393 . . . . 0.0 111.067 -171.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 77' ' ' LEU . 84.9 mt -71.67 -26.94 62.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.209 0.604 . . . . 0.0 111.108 -176.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.79 21.9 60.72 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.863 0.727 . . . . 0.0 113.552 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.6 mt -70.2 129.21 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.811 0.844 . . . . 0.0 110.026 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.1 158.69 30.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 33.1 m -65.55 -17.4 64.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.53 0.332 . . . . 0.0 110.84 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 mt -75.88 -47.57 24.91 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.52 1.128 . . . . 0.0 109.299 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -29.2 65.49 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.721 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -73.06 -22.26 60.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.616 0.766 . . . . 0.0 110.451 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -60.15 -39.61 86.96 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.681 0.392 . . . . 0.0 109.985 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.0 -44.11 97.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.883 0.873 . . . . 0.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.57 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.493 0.717 . . . . 0.0 109.948 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.07 73.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.21 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -65.2 -43.8 90.42 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.05 0.94 . . . . 0.0 110.179 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.03 -32.05 70.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.245 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 84' ' ' ILE . 84.9 mt -65.22 -42.64 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.855 0.862 . . . . 0.0 110.478 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -53.89 -48.71 69.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.399 0.68 . . . . 0.0 111.463 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -80.04 -37.49 33.92 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.445 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.22 31.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.367 0.667 . . . . 0.0 111.287 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.16 -28.05 32.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.22 39.4 8.47 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 pt -126.5 -172.48 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.197 0.999 . . . . 0.0 110.85 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -131.0 100.94 5.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tt -72.82 113.62 23.13 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.91 80.5 2.14 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.976 1.784 . . . . 0.0 110.966 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 41' ' ' LEU . 46.3 tp -70.08 -35.62 74.34 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.146 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.0 -39.43 81.82 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.481 1.113 . . . . 0.0 111.127 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.8 ttpt -74.65 -40.89 61.18 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.033 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -64.02 -42.47 97.09 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.929 0.768 . . . . 0.0 111.233 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.6 m -59.51 -39.56 84.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.937 0.895 . . . . 0.0 111.141 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -68.97 -34.94 76.13 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.961 0.904 . . . . 0.0 110.888 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 23.0 mm-40 -61.89 -39.95 93.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.356 0.662 . . . . 0.0 110.595 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 58.1 t -65.44 -44.55 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.993 0.517 . . . . 0.0 109.972 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -57.93 -44.29 86.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.327 1.051 . . . . 0.0 112.173 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.31 -18.72 35.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.017 0.927 . . . . 0.0 111.654 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.04 21.94 53.92 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 122.674 0.178 . . . . 0.0 113.0 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -79.03 -24.03 43.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.515 0.726 . . . . 0.0 110.552 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.87 166.41 33.0 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.818 0.847 . . . . 0.0 110.047 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.2 t -107.74 166.85 10.38 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.193 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m -67.72 -30.91 70.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.76 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.58 -35.17 78.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.764 0.825 . . . . 0.0 111.399 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.11 -31.99 72.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 112.392 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -109.27 -58.55 2.02 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.91 -10.9 60.53 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -165.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t -63.99 133.39 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' LEU . 36.1 mt -60.03 -41.12 91.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.539 0.735 . . . . 0.0 112.641 -166.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.8 -35.21 78.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 123.147 0.279 . . . . 0.0 111.721 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -68.22 -47.99 66.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.184 0.593 . . . . 0.0 109.662 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -52.19 -46.79 65.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.619 1.568 . . . . 0.0 110.385 172.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.78 -34.55 78.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.892 0.877 . . . . 0.0 111.994 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 -37.54 61.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.1 0.56 . . . . 0.0 110.861 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.7 mmm180 -64.03 -39.04 93.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.087 0.955 . . . . 0.0 111.401 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.83 -37.03 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.547 0.739 . . . . 0.0 109.861 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.91 -42.91 65.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.787 0.835 . . . . 0.0 111.419 167.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -62.76 -46.83 86.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.433 0.693 . . . . 0.0 111.087 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.55 -45.47 92.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.326 1.05 . . . . 0.0 112.578 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.2 -27.37 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 122.913 0.485 . . . . 0.0 109.985 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.64 76.08 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.34 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.107 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.68 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 46.9 m -69.14 102.79 1.74 Allowed 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.012 0.525 . . . . 0.0 109.979 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.9 t -94.05 174.61 7.07 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.875 0.87 . . . . 0.0 110.353 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' HG23 ' A' ' 8' ' ' VAL . 23.7 m -53.97 -37.4 63.91 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.872 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -68.67 -35.48 77.28 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.979 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -56.81 -43.24 80.8 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.266 0.627 . . . . 0.0 110.638 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -72.55 -44.89 61.51 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.957 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 4' ' ' THR . 95.2 t -60.01 -42.09 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 C-N-CA 123.334 0.654 . . . . 0.0 111.369 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.76 99.6 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.803 0.841 . . . . 0.0 110.352 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.1 m -63.37 -42.66 98.86 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 123.873 0.869 . . . . 0.0 112.023 174.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.589 HG21 HG13 ' A' ' 47' ' ' ILE . 24.5 mm -56.79 -58.65 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.683 0.793 . . . . 0.0 109.527 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 65.6 mt -62.37 -34.08 62.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 124.239 1.015 . . . . 0.0 110.944 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -59.16 -53.54 57.12 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.358 0.663 . . . . 0.0 111.608 176.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -80.57 -25.4 38.56 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.453 0.701 . . . . 0.0 112.01 -175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 69.4 m -75.94 -62.41 1.6 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.312 0.645 . . . . 0.0 110.149 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.598 ' SG ' HD11 ' A' ' 43' ' ' ILE . 2.7 m -85.81 -2.92 58.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.943 0.897 . . . . 0.0 112.368 -171.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 65.11 16.22 10.44 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.912 1.285 . . . . 0.0 112.468 -176.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 73.4 mt -79.33 120.7 81.37 Favored Pre-proline 0 CA--C 1.545 0.779 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.543 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_endo -62.04 145.11 96.74 Favored 'Trans proline' 0 C--N 1.372 1.801 0 C-N-CA 122.269 1.979 . . . . 0.0 112.291 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 13.0 mmm-85 -54.74 -34.48 62.57 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.195 0.998 . . . . 0.0 111.93 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.543 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -59.67 -38.25 80.95 Favored 'General case' 0 CA--C 1.55 0.978 0 O-C-N 123.877 0.736 . . . . 0.0 111.658 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.482 HG23 ' HG3' ' A' ' 21' ' ' GLU . 76.2 p -86.84 -6.05 58.92 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.305 0.642 . . . . 0.0 111.687 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.3 mt -90.01 133.87 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.992 0.917 . . . . 0.0 109.489 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 p -144.48 153.1 54.93 Favored Pre-proline 0 N--CA 1.489 1.492 0 C-N-CA 124.588 1.155 . . . . 0.0 110.006 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -52.54 -43.16 56.99 Favored 'Trans proline' 0 C--N 1.386 2.518 0 C-N-CA 123.408 2.739 . . . . 0.0 114.448 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -85.83 -3.59 58.95 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.799 0.44 . . . . 0.0 111.638 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.4 t -68.55 137.36 54.26 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.224 0.61 . . . . 0.0 109.745 175.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 49.6 t-80 -98.19 131.34 44.63 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.156 0.982 . . . . 0.0 108.76 177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.455 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.9 -58.95 4.37 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.48 0.712 . . . . 0.0 111.97 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 73.8 mt -74.36 -55.31 12.48 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.585 0.354 . . . . 0.0 111.132 -176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.1 t70 -63.08 -55.29 26.66 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.695 0.798 . . . . 0.0 111.768 -172.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -86.76 -65.74 0.98 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.905 0.482 . . . . 0.0 110.685 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 77' ' ' LEU . 88.5 mt -64.44 -28.49 69.71 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.531 0.732 . . . . 0.0 111.962 -173.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 76.64 40.2 27.58 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-O 121.31 0.394 . . . . 0.0 112.373 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.39 127.48 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 C-N-CA 124.466 1.106 . . . . 0.0 109.31 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -89.04 159.24 17.67 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.847 0.859 . . . . 0.0 109.604 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.499 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 48.1 m -49.51 -38.55 30.82 Favored 'General case' 0 C--N 1.354 0.775 0 C-N-CA 124.1 0.96 . . . . 0.0 112.781 175.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 42.1 mt -71.06 -35.22 71.84 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.445 0.698 . . . . 0.0 110.999 -175.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -74.11 -37.59 64.08 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.275 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -71.45 -22.04 61.88 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 123.208 0.603 . . . . 0.0 110.776 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.7 mt -57.1 -47.24 81.52 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 170.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -67.29 -35.35 79.31 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.579 1.151 . . . . 0.0 111.732 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.598 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.5 mt -64.92 -53.1 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.017 0.527 . . . . 0.0 110.144 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.509 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -67.34 -29.03 68.48 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.647 -1.16 . . . . 0.0 111.037 -176.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -76.11 -38.37 56.96 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 123.988 0.805 . . . . 0.0 110.84 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.32 -36.65 74.4 Favored 'General case' 0 C--O 1.214 -0.767 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.514 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.589 HG13 HG21 ' A' ' 11' ' ' ILE . 85.3 mt -66.52 -42.49 90.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 124.206 1.003 . . . . 0.0 110.586 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -54.23 -43.96 71.29 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.366 1.066 . . . . 0.0 110.474 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -83.71 -37.07 23.2 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 115.128 -0.942 . . . . 0.0 112.236 -177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.89 -51.91 23.37 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 123.212 0.605 . . . . 0.0 111.401 -173.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -78.68 -18.03 55.02 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.021 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.34 50.5 38.18 Favored Glycine 0 C--N 1.351 1.38 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.0 pt -133.13 160.39 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.538 1.135 . . . . 0.0 109.156 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -94.68 96.92 9.72 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.509 HD22 ' HB1' ' A' ' 44' ' ' ALA . 6.7 tt -83.29 111.29 29.9 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 175.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -87.58 81.9 1.12 Allowed 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 121.843 1.695 . . . . 0.0 110.802 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 41.8 tp -68.74 -28.11 66.52 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.788 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.68 -33.32 64.03 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.792 0.837 . . . . 0.0 111.472 173.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.6 tttp -80.11 -49.68 11.38 Favored 'General case' 0 C--O 1.211 -0.961 0 C-N-CA 122.999 0.519 . . . . 0.0 109.917 175.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -60.27 -48.81 80.13 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 123.644 0.778 . . . . 0.0 111.705 -171.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.5 m -52.2 -46.23 65.52 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.728 1.211 . . . . 0.0 111.705 169.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -64.24 -37.52 87.76 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.837 0.855 . . . . 0.0 111.926 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 19.8 mm-40 -59.88 -42.69 94.3 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.072 0.549 . . . . 0.0 110.273 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.8 t -71.02 -49.97 45.72 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.856 0 C-N-CA 123.523 0.729 . . . . 0.0 110.887 179.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -61.51 -31.42 71.42 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.032 0.933 . . . . 0.0 112.94 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -94.46 0.88 55.69 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.546 0.738 . . . . 0.0 111.127 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.66 17.61 78.19 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.61 176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -88.06 -12.93 42.82 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.543 0.737 . . . . 0.0 111.089 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -155.06 165.55 36.36 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.104 0.962 . . . . 0.0 109.825 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 40.2 p -108.37 159.57 16.55 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.162 177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 55.0 p -58.23 -33.51 69.41 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.487 177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.467 ' HA ' HG23 ' A' ' 76' ' ' VAL . 44.2 tt0 -49.75 -48.49 50.2 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.946 0.899 . . . . 0.0 112.002 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.88 -30.9 71.17 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -120.98 5.0 10.42 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.8 m-85 -133.67 -32.51 1.13 Allowed 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 118.93 0.786 . . . . 0.0 111.876 -174.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.637 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 89.8 t -59.91 127.27 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 168.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.597 HD11 HD11 ' A' ' 33' ' ' LEU . 27.5 mt -59.7 -38.36 81.38 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 113.046 0.758 . . . . 0.0 113.046 -163.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -69.52 -36.75 76.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.814 0.446 . . . . 0.0 112.059 174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -70.51 -46.15 64.21 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.619 0.768 . . . . 0.0 109.764 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -52.23 -49.63 63.61 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.64 1.576 . . . . 0.0 110.127 170.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.18 -24.48 64.97 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.71 0.804 . . . . 0.0 111.696 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.43 61.62 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.688 0.395 . . . . 0.0 110.332 174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.479 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 21.4 mmm180 -67.28 -31.34 71.6 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.429 0.691 . . . . 0.0 111.895 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.412 HD11 HD13 ' A' ' 47' ' ' ILE . 79.8 mt -77.58 -42.38 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 123.21 0.604 . . . . 0.0 110.026 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.471 ' HA ' HG22 ' A' ' 88' ' ' VAL . 31.0 t70 -54.97 -34.64 63.5 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.685 0.794 . . . . 0.0 111.588 170.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 9.3 tp10 -60.98 -49.46 77.36 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.464 0.706 . . . . 0.0 110.73 173.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 54.0 mt -68.35 -37.74 80.78 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.67 0.788 . . . . 0.0 112.468 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.471 HG22 ' HA ' ' A' ' 85' ' ' ASP . 19.3 m -74.91 -27.87 20.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-O 120.84 0.352 . . . . 0.0 111.038 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.3 -34.11 67.9 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.286 171.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.5 -47.83 84.0 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.691 0.796 . . . . 0.0 112.883 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 52.4 pttt -71.36 -33.69 69.79 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.255 -0.278 . . . . 0.0 110.59 176.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.69 -20.17 71.88 Favored Glycine 0 C--N 1.346 1.131 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 170.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.08 65.6 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.762 0.425 . . . . 0.0 111.435 -179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.7 mt -60.77 -13.41 14.99 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.773 1.229 . . . . 0.0 112.95 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.53 137.51 57.99 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 123.988 0.915 . . . . 0.0 109.906 174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.74 71.29 2.57 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.733 0.813 . . . . 0.0 110.838 -172.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.0 p80 50.33 19.21 0.5 Allowed 'General case' 0 N--CA 1.503 2.176 0 C-N-CA 126.574 1.949 . . . . 0.0 115.269 169.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -100.41 91.15 4.57 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -73.07 81.72 1.25 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.487 0.715 . . . . 0.0 110.28 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -168.95 139.16 2.3 Favored 'General case' 0 C--O 1.239 0.55 0 C-N-CA 124.58 1.152 . . . . 0.0 108.55 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 69.0 t60 . . . . . 0 CA--C 1.552 1.056 0 CA-C-O 118.482 -0.77 . . . . 0.0 109.772 177.202 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.1 m -73.09 108.35 5.93 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.195 0.598 . . . . 0.0 111.001 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.447 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 40.8 t -89.77 144.17 26.19 Favored 'General case' 0 C--O 1.244 0.795 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 164.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 m -65.85 -25.19 67.08 Favored 'General case' 0 CA--C 1.548 0.897 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.8 t80 -74.65 -37.19 62.8 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-O 119.251 -0.404 . . . . 0.0 110.294 174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 3' ' ' SER . 29.2 t70 -52.21 -49.28 64.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 123.835 0.709 . . . . 0.0 110.732 -178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -65.66 -47.09 76.68 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 114.799 -1.092 . . . . 0.0 111.235 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 85.6 t -59.64 -36.22 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 123.326 0.651 . . . . 0.0 111.973 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.69 -41.36 96.09 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.159 0.983 . . . . 0.0 110.342 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.9 m -57.38 -47.14 82.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.254 1.021 . . . . 0.0 112.034 170.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.453 HG21 HG13 ' A' ' 47' ' ' ILE . 95.3 mt -66.57 -49.86 71.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 123.549 0.739 . . . . 0.0 111.65 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.434 HG12 HD13 ' A' ' 43' ' ' ILE . 62.8 mt -63.87 -35.5 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.643 0.777 . . . . 0.0 111.259 177.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.38 35.14 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.506 0.722 . . . . 0.0 111.551 175.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -77.23 -29.05 53.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.154 -172.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 53.4 m -72.36 -62.11 1.56 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.84 0.456 . . . . 0.0 110.612 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.63 ' SG ' HD11 ' A' ' 43' ' ' ILE . 39.7 m -83.41 -1.09 52.66 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -170.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 14.2 t70 58.94 61.74 2.06 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.959 0.904 . . . . 0.0 110.028 -177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -127.57 138.38 32.71 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 124.887 1.275 . . . . 0.0 108.409 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -52.14 123.04 11.69 Favored 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 122.872 2.382 . . . . 0.0 111.72 167.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.58 -41.23 89.78 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.639 1.576 . . . . 0.0 110.764 -174.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -70.85 -29.43 65.55 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.794 -174.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.9 p -80.25 -25.38 39.55 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.443 0.297 . . . . 0.0 111.104 -178.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.6 mt -56.35 110.99 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 123.456 0.702 . . . . 0.0 111.034 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 69.3 p -94.62 147.13 32.69 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.605 0.762 . . . . 0.0 109.743 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 37.1 Cg_endo -65.07 -28.87 56.97 Favored 'Trans proline' 0 C--N 1.37 1.681 0 C-N-CA 122.404 2.069 . . . . 0.0 111.955 174.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.41 -11.08 59.92 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.226 0.61 . . . . 0.0 111.709 -176.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 90.1 p -74.31 140.35 44.83 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-O 120.813 0.339 . . . . 0.0 110.789 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.557 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.2 t-80 -90.81 130.47 36.77 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 171.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.43 -61.29 1.99 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.051 0.94 . . . . 0.0 112.596 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.9 mt -74.89 -44.7 44.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 C-N-CA 122.65 0.38 . . . . 0.0 111.318 -173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 25.8 t70 -71.16 -65.48 0.74 Allowed 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 122.758 0.423 . . . . 0.0 111.28 -175.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -73.89 -62.98 1.31 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.039 0.536 . . . . 0.0 110.651 -174.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 77' ' ' LEU . 76.3 mt -73.42 -11.06 60.34 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.438 0.695 . . . . 0.0 112.532 -172.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.88 20.26 72.34 Favored Glycine 0 C--N 1.353 1.517 0 N-CA-C 113.86 0.304 . . . . 0.0 113.86 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 70.3 mt -70.45 130.24 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 123.716 0.806 . . . . 0.0 109.727 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -71.08 149.28 46.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 175.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.7 t -67.12 -17.3 64.8 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 118.071 0.396 . . . . 0.0 110.489 177.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.28 -31.56 24.86 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 124.119 0.968 . . . . 0.0 110.226 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -77.43 -30.17 53.3 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.408 0.623 . . . . 0.0 109.783 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -67.23 -21.51 65.74 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.561 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 57' ' ' LEU . 84.2 mt -59.69 -40.3 87.44 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.016 0.526 . . . . 0.0 110.498 174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -69.61 -35.93 75.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.547 0.739 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.63 HD11 ' SG ' ' A' ' 16' ' ' CYS . 55.5 mt -61.95 -48.33 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.467 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.19 -31.82 73.19 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.04 -0.982 . . . . 0.0 111.448 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.55 -41.65 72.21 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.436 0.694 . . . . 0.0 110.807 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.0 -27.55 60.19 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.52 -179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.453 HG13 HG21 ' A' ' 11' ' ' ILE . 94.1 mt -70.73 -42.7 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.833 0.853 . . . . 0.0 109.794 172.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -56.32 -40.28 74.13 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.624 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -76.43 -48.86 18.25 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.899 0.88 . . . . 0.0 111.81 177.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.94 -50.07 70.09 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.599 0.76 . . . . 0.0 112.124 -170.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.443 ' HB2' HG12 ' A' ' 53' ' ' ILE . 96.3 m-85 -83.45 -22.43 32.62 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.179 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 73.57 33.79 57.82 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 112.161 -0.376 . . . . 0.0 112.161 -177.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.443 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.6 pt -114.94 158.94 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.227 1.011 . . . . 0.0 109.802 -178.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -91.2 98.58 11.82 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 170.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.5 tt -88.52 105.68 10.38 Favored Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -83.43 80.97 2.39 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 121.79 1.66 . . . . 0.0 111.225 -178.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.535 HD23 HD23 ' A' ' 41' ' ' LEU . 53.6 tp -75.87 -29.56 58.56 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.31 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -58.26 -29.76 66.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.521 0.728 . . . . 0.0 110.742 173.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 61.8 tttp -84.27 -48.49 9.7 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.621 174.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.0 m0 -61.59 -39.33 90.83 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 123.407 0.683 . . . . 0.0 111.575 -172.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -61.83 -43.92 97.88 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.89 0.876 . . . . 0.0 110.881 170.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -65.85 -30.33 70.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.099 0.96 . . . . 0.0 111.462 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.406 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 15.2 mm-40 -62.08 -46.71 87.88 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.108 0.563 . . . . 0.0 109.892 175.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.4 t -62.6 -44.89 99.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.578 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -66.1 -28.85 69.13 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.52 1.128 . . . . 0.0 112.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -89.14 -18.73 26.59 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.107 0.963 . . . . 0.0 110.773 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.03 65.47 Favored Glycine 0 C--N 1.346 1.123 0 CA-C-N 115.761 -0.654 . . . . 0.0 113.792 -175.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -67.95 -32.86 73.59 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 122.996 0.518 . . . . 0.0 109.831 173.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -135.35 164.46 27.7 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 114.955 -1.021 . . . . 0.0 110.573 -172.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.434 HG23 ' H ' ' A' ' 73' ' ' GLN . 12.4 t -105.61 154.52 20.31 Favored 'General case' 0 C--O 1.248 0.997 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 167.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 m -61.96 -32.32 72.75 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.849 0.859 . . . . 0.0 110.431 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -59.35 -41.41 89.14 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.94 1.296 . . . . 0.0 111.856 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.434 ' H ' HG23 ' A' ' 70' ' ' THR . 7.6 tt0 -59.89 -32.58 70.87 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.453 0.701 . . . . 0.0 112.575 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -105.92 -58.54 1.9 Allowed 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.605 0.362 . . . . 0.0 111.437 -178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -67.37 -19.73 65.46 Favored 'General case' 0 CA--C 1.554 1.113 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -167.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 85.2 t -66.47 129.53 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-N 119.681 1.128 . . . . 0.0 108.408 167.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.726 HD11 HD11 ' A' ' 33' ' ' LEU . 12.3 mt -66.34 -34.81 78.82 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 -161.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HG2' HG12 ' A' ' 76' ' ' VAL . 21.9 pttp -65.34 -36.7 84.81 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.832 0.453 . . . . 0.0 110.935 174.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.412 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 64.1 m-20 -73.59 -44.7 56.57 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.419 0.688 . . . . 0.0 109.825 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.4 tp -52.86 -48.23 67.23 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.642 1.177 . . . . 0.0 110.723 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.62 -27.3 67.59 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.943 0.897 . . . . 0.0 111.391 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.7 -44.39 64.29 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 122.759 0.424 . . . . 0.0 110.5 175.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -63.4 -39.51 94.69 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.941 0.896 . . . . 0.0 111.506 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.445 HD11 HD13 ' A' ' 47' ' ' ILE . 96.6 mt -70.47 -43.02 78.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.109 179.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -54.32 -37.8 65.27 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.243 0.617 . . . . 0.0 111.382 172.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.15 -44.35 80.01 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 96.2 mt -64.74 -42.33 95.26 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.604 0.762 . . . . 0.0 112.428 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.8 m -72.71 -29.34 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 C-N-CA 122.999 0.52 . . . . 0.0 110.788 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.12 -40.4 86.83 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.401 173.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.69 -36.4 80.78 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -73.5 -31.77 63.89 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 118.515 0.598 . . . . 0.0 110.37 175.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.5 -20.28 78.27 Favored Glycine 0 C--N 1.351 1.403 0 CA-C-N 116.063 -0.517 . . . . 0.0 113.778 169.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.84 -30.26 70.85 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.271 0.629 . . . . 0.0 111.262 -177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 66.1 mt -51.11 -33.93 28.4 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.508 1.123 . . . . 0.0 111.55 172.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -99.54 99.1 9.93 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.114 0.965 . . . . 0.0 108.802 173.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -64.1 -26.3 68.48 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.685 0.794 . . . . 0.0 111.013 177.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -159.52 123.75 3.87 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 170.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 14.8 t60 -64.7 124.05 20.93 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -175.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -63.91 158.99 20.75 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.162 0.985 . . . . 0.0 111.773 -177.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 64.6 m-70 68.82 28.08 5.52 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.568 1.147 . . . . 0.0 111.377 -174.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.7 m-70 . . . . . 0 C--O 1.254 1.297 0 C-N-CA 124.913 1.285 . . . . 0.0 108.573 173.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.487 1.425 0 N-CA-C 110.959 -0.015 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 41.8 m -69.77 101.68 1.75 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.927 0.491 . . . . 0.0 109.676 176.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 25.5 t -109.99 -172.19 1.99 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 123.832 0.853 . . . . 0.0 109.017 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.514 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.0 m -54.96 -26.87 39.48 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.426 0.69 . . . . 0.0 111.731 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.413 ' HE1' ' HB3' ' A' ' 77' ' ' LEU . 59.7 t80 -63.11 -55.95 20.99 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 123.399 0.437 . . . . 0.0 111.132 178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -57.06 -36.69 70.82 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 124.188 0.93 . . . . 0.0 110.99 -176.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HG2' ' O ' ' A' ' 3' ' ' SER . 14.0 mmm180 -63.15 -53.13 58.19 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.679 178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 4' ' ' THR . 51.8 t -61.24 -36.38 72.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.054 174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.36 -42.07 79.73 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.555 1.142 . . . . 0.0 110.975 -173.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.44 ' HB ' ' NH2' ' A' ' 20' ' ' ARG . 11.9 t -69.18 -29.75 67.81 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 122.658 0.383 . . . . 0.0 110.68 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 7' ' ' ARG . 45.4 mm -64.46 -50.74 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.191 0.596 . . . . 0.0 109.895 172.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 91.4 mt -60.06 -36.43 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.406 0.682 . . . . 0.0 110.395 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.79 -53.74 42.25 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.323 1.049 . . . . 0.0 112.202 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -72.78 -32.43 65.59 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 112.236 0.458 . . . . 0.0 112.236 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.7 m -77.58 -60.06 2.52 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 123.262 0.625 . . . . 0.0 110.787 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -91.94 5.57 49.55 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.395 0.678 . . . . 0.0 111.576 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 59.99 24.74 13.91 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 124.693 1.197 . . . . 0.0 113.202 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 50.0 mt -84.5 114.63 56.2 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 118.683 -0.675 . . . . 0.0 109.305 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -48.51 146.88 9.91 Favored 'Trans proline' 0 C--N 1.378 2.085 0 C-N-CA 123.327 2.685 . . . . 0.0 113.47 174.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.44 ' NH2' ' HB ' ' A' ' 10' ' ' THR . 3.9 mmt85 -60.31 -33.83 72.93 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.237 0.615 . . . . 0.0 111.521 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -62.47 -35.78 80.41 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.082 0.953 . . . . 0.0 111.838 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.9 p -86.54 -4.75 59.22 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.315 0.646 . . . . 0.0 111.825 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 83.5 mt -96.15 126.4 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 123.763 0.825 . . . . 0.0 108.841 173.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.417 ' O ' HD12 ' A' ' 77' ' ' LEU . 81.8 p -140.84 148.85 54.24 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.096 0.958 . . . . 0.0 109.013 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -52.35 -36.41 68.59 Favored 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.81 2.34 . . . . 0.0 113.256 172.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -74.92 -25.04 58.62 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.743 0.817 . . . . 0.0 112.373 -174.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 76.1 p -76.68 144.59 39.31 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-O 120.645 0.26 . . . . 0.0 111.21 -177.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 46.7 t-80 -92.24 131.43 37.47 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.768 1.227 . . . . 0.0 108.963 178.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.05 -56.81 9.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.482 0.713 . . . . 0.0 112.2 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -71.3 -52.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 120.409 0.147 . . . . 0.0 110.88 -176.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 31.4 t70 -70.41 -54.62 11.66 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.786 0.434 . . . . 0.0 112.127 -171.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -85.48 -60.55 1.99 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.388 0.275 . . . . 0.0 110.946 -173.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 77' ' ' LEU . 76.5 mt -68.37 -30.8 69.82 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 122.868 0.467 . . . . 0.0 111.336 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.75 0.9 68.55 Favored Glycine 0 N--CA 1.474 1.182 0 CA-C-O 119.957 -0.357 . . . . 0.0 113.189 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 73.6 mt -64.09 104.14 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.829 0.852 . . . . 0.0 110.145 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -77.87 167.12 22.01 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -58.58 -17.02 18.42 Favored 'General case' 0 CA--C 1.559 1.3 0 C-N-CA 123.347 0.659 . . . . 0.0 112.191 174.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.04 -41.47 18.62 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.13 0.972 . . . . 0.0 110.563 175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -65.66 -40.46 92.46 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.511 0.672 . . . . 0.0 109.661 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -67.66 -18.73 65.05 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.883 -176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 57' ' ' LEU . 94.5 mt -54.43 -45.81 73.11 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 118.432 0.56 . . . . 0.0 110.852 177.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -71.83 -37.59 70.28 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.412 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 44.6 mt -65.75 -41.36 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 123.227 0.611 . . . . 0.0 110.653 179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.34 -35.27 80.47 Favored 'General case' 0 N--CA 1.483 1.209 0 O-C-N 124.12 0.887 . . . . 0.0 110.356 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 57.8 t80 -66.23 -42.29 88.84 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.904 175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.91 -32.85 74.38 Favored 'General case' 0 CA--C 1.551 0.986 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.484 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 93.7 mt -72.6 -39.44 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 124.059 0.944 . . . . 0.0 110.628 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -51.92 -47.75 64.52 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 123.981 0.912 . . . . 0.0 111.138 172.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -70.63 -52.7 19.54 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.924 -177.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.78 -57.02 14.87 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 124.186 0.929 . . . . 0.0 111.979 -169.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.559 ' HB2' HG12 ' A' ' 53' ' ' ILE . 76.2 m-85 -83.26 -15.12 51.52 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.443 0.697 . . . . 0.0 111.532 -175.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.68 31.34 67.75 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 111.709 -0.556 . . . . 0.0 111.709 -173.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.559 HG12 ' HB2' ' A' ' 51' ' ' PHE . 42.9 pt -113.55 -170.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.576 1.15 . . . . 0.0 109.77 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.9 114.92 17.8 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 163.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.25 105.07 4.55 Favored Pre-proline 0 CA--C 1.54 0.577 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 164.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.24 85.51 1.76 Allowed 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 121.766 1.644 . . . . 0.0 110.351 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.656 HD23 HD23 ' A' ' 41' ' ' LEU . 42.5 tp -69.4 -24.35 63.84 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.985 178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -54.93 -38.57 67.84 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 123.889 0.876 . . . . 0.0 111.019 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.5 tttp -74.01 -50.82 18.09 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 124.501 1.12 . . . . 0.0 110.577 176.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.423 ' HB2' HD12 ' A' ' 57' ' ' LEU . 30.8 m0 -62.82 -47.19 84.5 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 123.801 0.84 . . . . 0.0 112.113 -171.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 48.1 m -54.57 -44.41 72.94 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 123.84 0.856 . . . . 0.0 111.351 170.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -68.38 -32.68 72.93 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.158 0.983 . . . . 0.0 111.654 -179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 53.7 mm-40 -57.56 -46.14 84.31 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.115 0.966 . . . . 0.0 110.582 174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 69.3 t -68.44 -49.84 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.738 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.355 179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -63.43 -36.54 84.09 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.085 0.954 . . . . 0.0 112.675 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -96.02 -5.91 40.01 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.483 1.113 . . . . 0.0 111.308 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 72.29 34.06 61.22 Favored Glycine 0 C--N 1.346 1.108 0 CA-C-N 115.854 -0.612 . . . . 0.0 113.81 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.511 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -84.12 -24.94 30.05 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.071 0.549 . . . . 0.0 111.017 169.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -160.12 168.74 24.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.923 0.489 . . . . 0.0 110.664 -173.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.5 p -105.52 163.56 12.56 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.826 -175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.9 p -67.39 -32.38 73.24 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.693 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.1 tt0 -63.69 -38.81 92.5 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.232 177.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.431 ' O ' ' HB3' ' A' ' 79' ' ' ASN . 29.4 tt0 -62.41 -29.68 70.67 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 122.732 0.413 . . . . 0.0 111.999 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -107.46 -71.31 0.76 Allowed 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.839 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.5 m-85 -62.15 -20.83 64.52 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 -165.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -62.13 126.99 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-N 120.298 1.408 . . . . 0.0 107.874 170.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' LEU . 56.8 mt -59.01 -34.94 72.45 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -163.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.1 pttp -65.31 -40.72 94.13 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 111.676 0.25 . . . . 0.0 111.676 173.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 73' ' ' GLN . 3.3 m-20 -69.22 -46.84 66.4 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.125 0.57 . . . . 0.0 110.025 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -50.3 -48.62 55.05 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.835 1.654 . . . . 0.0 111.274 172.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.82 -31.93 73.27 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.704 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.05 -42.34 57.24 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 124.055 0.847 . . . . 0.0 111.409 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.426 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 26.7 mmm180 -64.28 -41.69 96.78 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.65 0.78 . . . . 0.0 111.276 177.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 79.9 mt -70.35 -39.28 76.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.208 0.603 . . . . 0.0 110.385 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -54.07 -38.28 65.1 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.336 0.654 . . . . 0.0 111.653 169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -68.55 -44.74 73.84 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.607 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 95.8 mt -64.4 -41.9 96.4 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 124.108 0.963 . . . . 0.0 112.688 -179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.6 m -71.69 -32.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 C-N-CA 123.148 0.579 . . . . 0.0 110.489 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.46 -42.02 62.47 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.129 175.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.17 -43.09 96.09 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.448 1.099 . . . . 0.0 112.656 178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HD3' HG22 ' A' ' 53' ' ' ILE . 11.8 pttp -63.71 -39.28 93.91 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 176.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.543 ' HA2' ' HB3' ' A' ' 95' ' ' GLU . . . -77.83 -12.93 83.96 Favored Glycine 0 C--N 1.356 1.694 0 O-C-N 123.889 0.743 . . . . 0.0 114.147 178.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.82 -30.89 62.96 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.53 0.732 . . . . 0.0 110.506 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.59 -37.46 10.36 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.647 0.779 . . . . 0.0 110.182 173.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HB3' ' HA2' ' A' ' 92' ' ' GLY . 33.5 tt0 -72.75 83.23 1.17 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.874 0.87 . . . . 0.0 109.213 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 24.6 p80 -81.57 160.85 23.74 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.851 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.8 m-70 -62.81 101.97 0.31 Allowed 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.426 0.69 . . . . 0.0 110.951 -176.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 56.5 t60 -130.57 153.95 48.35 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.143 1.377 . . . . 0.0 108.822 -176.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -62.69 104.07 0.49 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.096 0.558 . . . . 0.0 110.787 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 25.2 p80 -126.15 20.59 7.5 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.181 0.992 . . . . 0.0 110.367 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.6 t60 . . . . . 0 C--O 1.254 1.312 0 C-N-CA 125.111 1.364 . . . . 0.0 109.558 -170.842 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.3 ptp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.429 -0.212 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 35.8 m -68.33 112.19 5.06 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 170.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.3 m -74.67 164.64 26.35 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 122.883 0.473 . . . . 0.0 111.678 -176.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 4.9 m -57.64 -29.45 64.59 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.001 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -63.06 -52.3 63.32 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.896 0.479 . . . . 0.0 111.282 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -61.89 -32.38 72.75 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 123.863 0.727 . . . . 0.0 110.573 -177.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.422 ' O ' HG12 ' A' ' 11' ' ' ILE . 25.8 mmt180 -66.05 -53.08 42.84 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.838 0.855 . . . . 0.0 111.409 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 81' ' ' ALA . 69.9 t -62.91 -38.09 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 CA-C-O 121.361 0.601 . . . . 0.0 110.748 178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.513 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -67.97 -39.75 83.27 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.271 -175.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.413 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 7.6 t -73.73 -27.65 61.29 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.243 0.217 . . . . 0.0 110.865 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 7' ' ' ARG . 34.6 mm -61.02 -55.23 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 171.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.452 HG22 HD12 ' A' ' 18' ' ' ILE . 60.3 mt -66.51 -29.9 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.645 0.778 . . . . 0.0 111.034 -176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.33 -51.3 70.54 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.995 0.918 . . . . 0.0 111.247 174.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 10' ' ' THR . 13.8 mm-40 -78.98 -28.33 43.49 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.66 0.384 . . . . 0.0 111.676 -177.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.0 m -75.53 -61.68 1.83 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.897 0.479 . . . . 0.0 110.838 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.659 ' SG ' HD11 ' A' ' 43' ' ' ILE . 58.6 m -95.54 7.4 46.36 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.402 0.681 . . . . 0.0 112.307 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 37.5 t70 53.29 67.94 0.92 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.343 1.057 . . . . 0.0 111.126 -178.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 HD12 HG22 ' A' ' 12' ' ' ILE . 23.6 mt -121.77 122.06 27.96 Favored Pre-proline 0 N--CA 1.476 0.84 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.92 139.73 84.81 Favored 'Trans proline' 0 C--N 1.376 1.989 0 C-N-CA 122.516 2.144 . . . . 0.0 112.21 176.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.1 mmm180 -58.65 -35.4 72.49 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.783 0.833 . . . . 0.0 111.511 -178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.42 -37.53 86.2 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.043 0.937 . . . . 0.0 111.883 178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 57.0 p -84.48 -13.65 51.39 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.191 0.596 . . . . 0.0 111.419 -177.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.513 HG21 ' HB1' ' A' ' 9' ' ' ALA . 88.9 mt -81.46 113.46 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.341 0.656 . . . . 0.0 109.295 174.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 p -117.78 158.3 45.95 Favored Pre-proline 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 109.486 174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 58.3 Cg_exo -55.36 -33.16 84.44 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.868 2.379 . . . . 0.0 113.506 176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -86.17 -0.58 56.04 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 123.597 0.759 . . . . 0.0 112.441 -174.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.455 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 26.6 m -72.59 129.2 37.74 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.3 t-80 -98.5 133.06 43.39 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 175.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -53.3 -60.14 3.67 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.092 0.557 . . . . 0.0 111.98 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -75.11 -42.74 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 122.451 0.301 . . . . 0.0 111.755 -173.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -80.05 -56.94 3.88 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.371 0.668 . . . . 0.0 111.844 -171.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -82.54 -61.52 1.86 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.266 0.626 . . . . 0.0 110.638 -174.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 77' ' ' LEU . 79.6 mt -69.94 -19.28 63.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.054 0.942 . . . . 0.0 111.332 -177.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.52 4.73 90.11 Favored Glycine 0 N--CA 1.478 1.484 0 N-CA-C 113.663 0.225 . . . . 0.0 113.663 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 43' ' ' ILE . 85.0 mt -68.63 98.51 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.648 1.179 . . . . 0.0 110.346 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.23 165.78 6.97 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.094 0.957 . . . . 0.0 111.506 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 61.0 p -48.43 -28.2 3.12 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.013 1.325 . . . . 0.0 113.57 174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 mt -85.35 -40.84 16.06 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.504 0.721 . . . . 0.0 110.442 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -68.32 -30.76 69.82 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 121.3 0.572 . . . . 0.0 109.73 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -74.38 -20.2 60.15 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.015 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 57' ' ' LEU . 73.2 mt -56.82 -41.11 77.23 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 118.157 0.435 . . . . 0.0 111.115 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -72.18 -35.94 69.13 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.809 0.844 . . . . 0.0 110.538 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.659 HD11 ' SG ' ' A' ' 16' ' ' CYS . 37.7 mt -64.07 -48.98 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.13 0.572 . . . . 0.0 110.107 175.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.14 -33.34 75.54 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.302 -174.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 24.8 t80 -67.33 -43.37 81.75 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.187 176.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.38 -33.49 76.08 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.762 0.825 . . . . 0.0 111.579 176.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.403 HD13 HD11 ' A' ' 84' ' ' ILE . 91.4 mt -69.57 -37.66 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 123.854 0.862 . . . . 0.0 110.692 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -56.78 -47.51 80.0 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.0 0.52 . . . . 0.0 111.056 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -71.21 -48.18 52.96 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.573 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.58 -52.64 36.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.929 0.891 . . . . 0.0 111.53 -173.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -86.65 -11.95 49.87 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.709 0.804 . . . . 0.0 111.933 -175.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 68.94 38.57 84.95 Favored Glycine 0 C--N 1.349 1.257 0 O-C-N 123.286 0.366 . . . . 0.0 112.55 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.506 HG22 ' HD3' ' A' ' 91' ' ' LYS . 36.5 pt -126.72 -173.16 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 124.11 0.964 . . . . 0.0 110.72 -175.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -126.94 96.4 4.61 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -76.07 108.37 5.99 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -84.11 84.56 1.53 Allowed 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.792 1.661 . . . . 0.0 110.616 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.555 HD23 HD23 ' A' ' 41' ' ' LEU . 54.0 tp -66.48 -32.21 73.43 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.773 177.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.96 -33.9 75.14 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.206 1.002 . . . . 0.0 111.108 177.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 56.8 tttp -72.92 -58.8 3.06 Favored 'General case' 0 C--O 1.214 -0.797 0 C-N-CA 123.897 0.879 . . . . 0.0 109.771 172.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.5 m0 -57.18 -44.3 83.44 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.259 1.024 . . . . 0.0 111.966 -169.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 39.6 m -63.74 -36.51 84.11 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.945 0.898 . . . . 0.0 111.557 175.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -74.62 -30.76 61.78 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.415 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 5.5 mm-40 -60.3 -39.4 86.82 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.302 0.641 . . . . 0.0 109.317 172.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 84.6 t -68.1 -44.44 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.779 175.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -60.77 -35.88 77.54 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.594 0.757 . . . . 0.0 112.358 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -93.49 -18.87 21.81 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.103 0.961 . . . . 0.0 111.189 -178.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.35 23.15 59.23 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.701 -0.227 . . . . 0.0 113.375 -174.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.434 ' HA ' ' HE3' ' A' ' 68' ' ' LYS . 0.0 OUTLIER -72.56 -23.76 61.02 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.296 0.639 . . . . 0.0 110.943 169.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.49 168.36 26.4 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.692 0.797 . . . . 0.0 110.257 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.496 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.0 t -107.15 156.48 18.76 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.496 0.718 . . . . 0.0 110.334 178.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 35.9 p -63.14 -33.78 76.21 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.087 175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -62.18 -33.72 75.06 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.534 0.734 . . . . 0.0 111.986 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.496 ' H ' HG23 ' A' ' 70' ' ' THR . 8.3 tt0 -65.36 -28.36 69.23 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.174 0.589 . . . . 0.0 111.675 179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -106.84 -76.99 0.6 Allowed 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.581 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 79.5 m-85 -59.18 -19.06 41.94 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.569 1.692 . . . . 0.0 115.569 -162.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.538 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 98.8 t -65.11 124.8 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 107.88 -1.155 . . . . 0.0 107.88 170.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.495 HD11 HD11 ' A' ' 33' ' ' LEU . 72.3 mt -58.86 -36.71 75.06 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -160.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 60.9 pttt -61.29 -42.35 98.5 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.124 0.488 . . . . 0.0 111.344 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.436 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -72.4 -44.94 61.79 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.942 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.2 tp -55.29 -44.96 76.17 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.684 1.594 . . . . 0.0 110.676 176.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.64 -34.21 77.33 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.11 -0.95 . . . . 0.0 111.528 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.36 61.56 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 123.711 0.632 . . . . 0.0 111.548 179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 28.2 mmm180 -71.32 -35.79 71.37 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.663 0.785 . . . . 0.0 111.354 177.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.403 HD11 HD13 ' A' ' 47' ' ' ILE . 96.3 mt -71.81 -39.61 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 C-N-CA 123.348 0.659 . . . . 0.0 109.712 174.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 25.2 t70 -57.25 -38.97 74.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.726 0.81 . . . . 0.0 111.397 170.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -60.83 -45.96 92.41 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.01 0.924 . . . . 0.0 110.009 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 91.6 mt -66.58 -42.75 86.51 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.016 0.926 . . . . 0.0 113.275 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 24.1 m -70.51 -31.88 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 CA-C-O 121.058 0.456 . . . . 0.0 110.474 -177.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.28 -51.81 27.69 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.718 172.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.59 71.46 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 124.974 1.309 . . . . 0.0 113.559 -176.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' HA ' HD12 ' A' ' 94' ' ' LEU . 21.9 pttp -57.77 -31.02 66.1 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.31 0.644 . . . . 0.0 112.042 -178.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.25 -41.9 44.72 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.114 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.71 -34.72 78.84 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.763 1.225 . . . . 0.0 111.767 177.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.532 HD12 ' HA ' ' A' ' 91' ' ' LYS . 96.7 mt -51.42 -47.87 62.86 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.004 0.922 . . . . 0.0 109.653 170.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 74.86 -25.58 0.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.509 1.523 . . . . 0.0 112.458 167.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -64.28 110.57 2.27 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.623 0.769 . . . . 0.0 110.149 -173.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.2 m170 -77.08 152.43 35.04 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.192 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 43.9 m80 -74.59 81.6 2.01 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.879 0.872 . . . . 0.0 110.492 -175.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 27.1 m-70 -130.55 19.54 5.2 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 125.017 1.327 . . . . 0.0 109.938 177.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -149.63 111.61 4.6 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 . . . . . 0 C--O 1.25 1.087 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.123 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.5 m -122.76 125.58 45.77 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 172.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -66.74 144.58 56.25 Favored 'General case' 0 C--O 1.244 0.808 0 C-N-CA 123.193 0.597 . . . . 0.0 111.193 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.46 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.5 m -59.14 -25.24 63.71 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.575 -176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -66.57 -49.62 65.82 Favored 'General case' 0 C--N 1.36 1.052 0 CA-C-O 119.343 -0.36 . . . . 0.0 110.81 176.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.13 -41.35 68.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 124.13 0.894 . . . . 0.0 111.356 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -70.82 -46.45 62.76 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.802 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -60.92 -36.46 72.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 122.994 0.518 . . . . 0.0 110.911 175.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -42.89 85.15 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.559 1.144 . . . . 0.0 110.089 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.6 m -56.02 -47.07 78.49 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.235 1.014 . . . . 0.0 111.671 172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 47' ' ' ILE . 33.3 mm -59.2 -51.59 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.84 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.438 HG23 ' SG ' ' A' ' 16' ' ' CYS . 71.1 mt -63.95 -34.77 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 C-N-CA 123.82 0.848 . . . . 0.0 111.289 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.403 ' HA ' ' O ' ' A' ' 18' ' ' ILE . . . -60.25 -52.28 65.96 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 122.884 0.474 . . . . 0.0 111.866 177.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -72.51 -37.69 68.31 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.581 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 91.6 m -74.42 -62.41 1.53 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.335 0.654 . . . . 0.0 110.785 -177.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.679 ' SG ' HD11 ' A' ' 43' ' ' ILE . 3.3 m -82.09 -1.16 47.71 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.04 0.936 . . . . 0.0 113.341 -170.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.1 t70 64.28 22.67 12.87 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.373 1.082 . . . . 0.0 111.048 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 82.3 mt -96.0 126.4 44.75 Favored Pre-proline 0 CA--C 1.545 0.781 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.524 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 40.9 Cg_endo -65.16 145.61 84.84 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.627 2.218 . . . . 0.0 112.177 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -60.11 -27.64 67.19 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.663 1.185 . . . . 0.0 112.653 -177.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.8 -26.79 68.49 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 111.783 178.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.477 HG23 ' HG3' ' A' ' 21' ' ' GLU . 80.1 p -108.87 15.41 23.52 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.377 0.671 . . . . 0.0 111.236 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.6 mt -108.72 105.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.9 p -121.46 151.31 56.33 Favored Pre-proline 0 N--CA 1.478 0.961 0 C-N-CA 123.908 0.883 . . . . 0.0 109.712 -175.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -52.22 -36.23 66.41 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.037 2.491 . . . . 0.0 113.374 173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.66 -17.68 59.89 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.494 0.718 . . . . 0.0 112.067 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 40.4 t -68.68 142.54 55.02 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.506 0.723 . . . . 0.0 111.202 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 42.3 t-80 -105.75 133.45 50.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.659 1.184 . . . . 0.0 108.715 173.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.96 -56.72 11.04 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.349 0.66 . . . . 0.0 112.524 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.9 mt -78.5 -51.13 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 122.462 0.305 . . . . 0.0 110.76 -175.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.4 t70 -69.94 -42.78 72.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.608 0.763 . . . . 0.0 112.465 -170.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -95.48 -64.38 1.07 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 122.719 0.408 . . . . 0.0 110.044 -177.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 95.5 mt -71.41 -25.07 62.18 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.771 0.828 . . . . 0.0 112.799 -171.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 45.96 31.31 Favored Glycine 0 N--CA 1.472 1.066 0 CA-C-O 120.969 0.205 . . . . 0.0 112.772 -177.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 43' ' ' ILE . 68.1 mt -98.23 127.69 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.232 1.013 . . . . 0.0 108.51 177.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -89.75 166.79 13.35 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 122.972 0.509 . . . . 0.0 109.839 177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.447 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 23.8 m -59.38 -27.25 65.8 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.155 0.582 . . . . 0.0 111.968 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 77.8 mt -67.89 -49.0 64.47 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 123.554 0.741 . . . . 0.0 111.028 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.63 -29.61 62.46 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.485 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -72.76 -23.22 60.79 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.477 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 57' ' ' LEU . 60.6 mt -60.34 -41.43 93.57 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 122.585 0.354 . . . . 0.0 110.239 170.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -71.45 -34.57 70.36 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.779 0.831 . . . . 0.0 111.156 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.679 HD11 ' SG ' ' A' ' 16' ' ' CYS . 63.7 mt -62.9 -51.54 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 173.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.5 -33.6 76.27 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 114.722 -1.126 . . . . 0.0 110.823 -177.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -64.94 -47.2 78.52 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.495 1.118 . . . . 0.0 110.161 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.94 -31.65 72.37 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.077 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 11' ' ' ILE . 86.2 mt -71.18 -38.55 71.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 C-N-CA 123.845 0.858 . . . . 0.0 111.157 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -51.3 -48.14 62.39 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 121.32 0.581 . . . . 0.0 110.882 173.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -76.49 -49.32 16.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.509 -175.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.93 -50.11 69.96 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.688 0.795 . . . . 0.0 111.906 -173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -84.52 -17.25 39.56 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.579 0.752 . . . . 0.0 111.688 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 70.57 48.61 35.12 Favored Glycine 0 C--N 1.351 1.411 0 N-CA-C 111.801 -0.519 . . . . 0.0 111.801 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 pt -139.03 177.48 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 124.332 1.053 . . . . 0.0 110.815 -176.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -106.76 109.57 21.51 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 162.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.457 HD12 HG21 ' A' ' 47' ' ' ILE . 7.5 tt -84.66 104.47 4.57 Favored Pre-proline 0 CA--C 1.542 0.662 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 165.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.48 81.8 2.39 Favored 'Trans proline' 0 C--N 1.375 1.924 0 C-N-CA 121.513 1.476 . . . . 0.0 111.082 -179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.527 HD23 HD23 ' A' ' 41' ' ' LEU . 57.8 tp -69.7 -31.34 69.32 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.861 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -61.04 -33.54 73.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.04 0.936 . . . . 0.0 111.068 175.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 19.5 ttpp -82.58 -41.29 19.74 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.182 0.593 . . . . 0.0 110.365 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 47.1 m0 -69.98 -41.78 73.98 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.639 0.776 . . . . 0.0 111.939 -173.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.3 m -60.72 -36.22 78.31 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.045 0.938 . . . . 0.0 110.483 172.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -69.52 -38.3 77.51 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.052 0.941 . . . . 0.0 110.49 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 80.2 mm-40 -56.15 -45.63 79.56 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.515 0.726 . . . . 0.0 110.287 175.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 62.8 t -67.82 -44.53 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 CA-C-N 115.111 -0.95 . . . . 0.0 110.748 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -63.03 -28.94 70.44 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.845 0.858 . . . . 0.0 112.697 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -87.55 -9.82 53.35 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.147 0.579 . . . . 0.0 111.895 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.55 19.85 72.84 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 120.374 -0.126 . . . . 0.0 113.258 -176.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -83.84 -22.67 31.64 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.755 0.822 . . . . 0.0 110.258 175.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -143.88 160.66 40.4 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 114.832 -1.076 . . . . 0.0 109.827 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 58.6 p -98.99 160.61 14.14 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.731 171.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.7 p -60.05 -29.84 68.8 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.351 171.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.545 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.3 tt0 -56.39 -46.87 79.93 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.589 0.756 . . . . 0.0 111.316 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -57.11 -31.61 65.46 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.472 0.709 . . . . 0.0 112.104 -174.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -106.67 -74.12 0.67 Allowed 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.459 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.535 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.5 m-85 -56.06 -25.36 44.77 Favored 'General case' 0 CA--C 1.558 1.288 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 -165.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.619 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.2 t -62.6 126.14 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 119.91 1.232 . . . . 0.0 108.47 169.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -62.56 -36.5 82.85 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.566 0.746 . . . . 0.0 112.641 -161.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HG2' HG12 ' A' ' 76' ' ' VAL . 65.8 pttt -64.09 -39.33 93.82 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 123.247 0.342 . . . . 0.0 111.119 173.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.429 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.9 m-20 -75.81 -42.79 48.93 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.507 0.723 . . . . 0.0 110.277 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.1 tp -53.09 -49.41 66.48 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.833 1.253 . . . . 0.0 110.325 169.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.2 -33.04 73.79 Favored 'General case' 0 N--CA 1.477 0.923 0 O-C-N 124.014 0.821 . . . . 0.0 111.252 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.64 63.7 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 122.94 0.496 . . . . 0.0 110.539 177.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.429 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 10.3 mmm180 -64.04 -31.84 73.18 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.718 0.807 . . . . 0.0 111.76 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.35 -41.53 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.811 0.845 . . . . 0.0 110.534 176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 22.1 t70 -56.44 -36.55 69.14 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.577 0.751 . . . . 0.0 111.591 172.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 10.6 tp10 -59.26 -47.25 86.08 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.975 0.91 . . . . 0.0 110.671 172.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 59.6 mt -64.5 -46.96 80.69 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.002 0.921 . . . . 0.0 112.434 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.9 m -67.89 -29.0 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 CA-C-O 121.048 0.451 . . . . 0.0 110.657 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.81 -42.37 67.11 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.898 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.44 68.14 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 124.166 0.986 . . . . 0.0 113.536 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -67.5 -35.91 80.05 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 123.185 0.303 . . . . 0.0 111.128 176.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.7 -11.5 77.57 Favored Glycine 0 C--N 1.349 1.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 113.68 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.58 -36.2 17.67 Favored 'General case' 0 C--O 1.246 0.894 0 C-N-CA 123.477 0.711 . . . . 0.0 110.895 174.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 79.5 mt -53.04 -61.29 2.39 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.96 0.904 . . . . 0.0 109.906 176.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -74.97 114.41 13.42 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 166.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -63.98 92.63 0.08 Allowed 'General case' 0 CA--C 1.543 0.689 0 O-C-N 123.844 0.715 . . . . 0.0 112.38 -163.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 82.0 m-70 -103.72 25.69 9.48 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.851 0.86 . . . . 0.0 110.866 173.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -93.82 149.42 21.25 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -69.99 87.56 0.56 Allowed 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.453 0.701 . . . . 0.0 111.829 -169.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 -100.16 -30.48 11.9 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.921 0.889 . . . . 0.0 109.831 170.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 . . . . . 0 CA--C 1.56 1.328 0 C-N-CA 124.439 1.096 . . . . 0.0 108.665 176.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.742 0.306 . . . . 0.0 110.776 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.4 m -65.36 103.79 0.86 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.195 0.998 . . . . 0.0 111.394 -178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.2 m -98.16 -171.85 2.23 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.467 0.707 . . . . 0.0 109.732 174.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.5 ' O ' HG23 ' A' ' 8' ' ' VAL . 17.6 m -59.81 -34.09 72.6 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.584 0.354 . . . . 0.0 111.383 -178.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -69.59 -44.56 70.5 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 123.145 0.278 . . . . 0.0 110.656 178.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.68 -35.89 82.51 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.286 0.634 . . . . 0.0 110.682 -175.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.426 ' NH2' ' HB1' ' A' ' 50' ' ' ALA . 21.1 mmm180 -59.6 -57.69 11.85 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.713 171.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.42 -35.88 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 C-N-CA 123.937 0.895 . . . . 0.0 111.193 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.45 -44.6 90.61 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.252 1.021 . . . . 0.0 110.655 -178.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 14.9 m -60.86 -43.61 98.13 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.528 0.731 . . . . 0.0 111.281 172.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 46.5 mm -59.49 -50.23 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.322 0.649 . . . . 0.0 110.479 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.513 HG12 HD13 ' A' ' 43' ' ' ILE . 72.6 mt -62.18 -39.62 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.342 1.057 . . . . 0.0 111.223 178.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.56 -47.03 87.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.089 0.555 . . . . 0.0 111.129 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 10' ' ' THR . 34.9 mm-40 -72.06 -38.95 69.37 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -178.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.5 m -69.71 -62.57 1.33 Allowed 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.361 0.601 . . . . 0.0 110.745 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.589 ' SG ' HD11 ' A' ' 43' ' ' ILE . 20.0 m -84.98 -10.14 57.34 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.858 -1.064 . . . . 0.0 112.845 -169.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 59.15 24.21 12.56 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.747 0.819 . . . . 0.0 112.175 -173.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.471 HD12 HD11 ' A' ' 35' ' ' ILE . 50.8 mt -77.46 128.41 80.22 Favored Pre-proline 0 C--O 1.246 0.88 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -51.86 128.82 27.98 Favored 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.683 2.256 . . . . 0.0 112.322 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.6 tpt85 -56.37 -32.31 64.64 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.486 1.114 . . . . 0.0 110.429 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -64.97 -38.48 91.09 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.208 1.003 . . . . 0.0 112.365 176.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 80.6 p -82.71 -9.83 59.18 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 122.764 0.425 . . . . 0.0 111.411 -178.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 75.6 mt -79.63 113.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 123.457 0.703 . . . . 0.0 109.437 174.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 81.5 p -123.67 154.88 66.89 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 123.763 0.825 . . . . 0.0 109.187 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.31 -39.95 79.93 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.631 2.22 . . . . 0.0 112.61 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -83.03 -9.92 59.02 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.892 0.477 . . . . 0.0 112.236 -172.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 83.7 p -73.27 134.27 44.19 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.56 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.6 t-80 -90.5 131.59 36.16 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.97 0.908 . . . . 0.0 108.624 178.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.454 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.17 -55.53 20.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.332 0.653 . . . . 0.0 112.214 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -71.1 -47.41 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.367 0.267 . . . . 0.0 111.442 -176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.56 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 34.0 t70 -72.6 -66.6 0.64 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 122.813 0.445 . . . . 0.0 112.064 -175.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -75.72 -60.74 2.18 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.145 0.578 . . . . 0.0 111.429 -174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 77' ' ' LEU . 81.3 mt -69.27 -29.12 66.95 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.112 0.565 . . . . 0.0 111.921 -172.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.13 3.28 85.19 Favored Glycine 0 C--N 1.348 1.236 0 N-CA-C 113.851 0.3 . . . . 0.0 113.851 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.503 HD13 HD11 ' A' ' 43' ' ' ILE . 36.9 mt -73.85 98.94 1.15 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.612 0 C-N-CA 123.437 0.695 . . . . 0.0 109.962 176.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -75.92 165.06 25.54 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.019 0.928 . . . . 0.0 109.974 174.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.403 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 57.0 p -51.56 -18.34 1.1 Allowed 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.713 1.605 . . . . 0.0 114.585 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 60.3 mt -84.72 -44.28 13.52 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 118.545 0.611 . . . . 0.0 110.292 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.24 -34.01 65.62 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.986 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -65.11 -21.56 66.82 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 114.501 -1.227 . . . . 0.0 111.238 -179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 57' ' ' LEU . 94.1 mt -57.78 -38.39 75.38 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.243 0.617 . . . . 0.0 111.43 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -78.21 -30.65 48.97 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.108 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.589 HD11 ' SG ' ' A' ' 16' ' ' CYS . 41.8 mt -62.56 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 172.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.33 -32.75 74.55 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.649 -177.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -65.46 -43.26 90.88 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.021 0.928 . . . . 0.0 110.327 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.38 -36.27 78.9 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.132 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 HD13 HD11 ' A' ' 84' ' ' ILE . 87.2 mt -65.17 -37.72 80.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 C-N-CA 123.887 0.875 . . . . 0.0 111.328 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -56.35 -42.06 77.13 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.32 0.648 . . . . 0.0 111.58 174.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -82.88 -40.89 19.64 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.781 0.833 . . . . 0.0 111.272 -173.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB1' ' NH2' ' A' ' 7' ' ' ARG . . . -68.92 -51.95 34.45 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.52 1.128 . . . . 0.0 111.349 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -87.91 -24.9 23.48 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.403 -176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.71 52.27 10.04 Favored Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 -176.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.3 pt -135.15 -176.68 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 124.28 1.032 . . . . 0.0 110.452 -176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -118.71 109.99 16.75 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 173.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.6 tt -106.15 98.85 20.43 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 173.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.414 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 95.0 Cg_endo -85.4 85.12 1.22 Allowed 'Trans proline' 0 C--N 1.372 1.769 0 C-N-CA 122.383 2.055 . . . . 0.0 111.43 178.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.606 HD23 HD23 ' A' ' 41' ' ' LEU . 42.2 tp -69.52 -32.51 71.4 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.58 -173.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -60.6 -31.8 70.95 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.579 0.351 . . . . 0.0 110.725 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.414 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 35.7 ttpt -80.84 -40.69 24.47 Favored 'General case' 0 C--O 1.219 -0.528 0 C-N-CA 123.789 0.836 . . . . 0.0 109.913 178.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -59.11 -45.72 90.15 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.816 0.847 . . . . 0.0 110.51 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 46.2 m -72.34 -28.88 63.33 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.786 1.234 . . . . 0.0 111.452 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -72.66 -34.59 67.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.499 0.72 . . . . 0.0 110.484 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -64.04 -32.79 74.47 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.68 0.792 . . . . 0.0 110.143 174.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG11 HG23 ' A' ' 71' ' ' THR . 57.6 t -70.93 -43.19 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.075 173.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -58.27 -45.04 88.6 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.692 0.797 . . . . 0.0 112.189 179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -85.92 -11.79 52.26 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.857 0.863 . . . . 0.0 111.79 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.89 19.59 69.93 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.229 0.331 . . . . 0.0 113.562 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -70.36 -27.11 64.08 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.99 0.916 . . . . 0.0 110.436 173.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.02 170.49 21.2 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.978 0.911 . . . . 0.0 110.335 -175.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 73' ' ' GLN . 8.4 t -107.37 158.67 16.98 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.439 0.696 . . . . 0.0 111.443 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.406 HG23 HG11 ' A' ' 64' ' ' VAL . 40.5 p -62.42 -36.62 82.93 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.08 0.952 . . . . 0.0 110.743 174.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -53.15 -41.67 65.37 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.89 0.876 . . . . 0.0 111.204 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.471 ' H ' HG23 ' A' ' 70' ' ' THR . 8.4 tt0 -63.68 -32.22 73.63 Favored 'General case' 0 CA--C 1.552 1.034 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.392 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.7 m-85 -114.17 -8.45 12.97 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -169.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.454 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.1 m-85 -128.49 -29.24 2.44 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.513 -169.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 88.8 t -61.54 125.58 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.775 HD11 HD11 ' A' ' 33' ' ' LEU . 26.9 mt -61.42 -34.14 74.88 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -161.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.2 pttt -71.82 -37.54 70.33 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.577 0.351 . . . . 0.0 111.362 174.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.414 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 2.9 m-20 -68.2 -49.19 62.48 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.636 0.775 . . . . 0.0 109.873 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.2 tp -51.86 -47.07 64.62 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.938 1.695 . . . . 0.0 111.481 170.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.72 67.06 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.054 0.542 . . . . 0.0 110.767 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.11 -39.19 55.76 Favored 'General case' 0 CA--C 1.547 0.832 0 O-C-N 123.625 0.578 . . . . 0.0 110.665 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.421 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 12.7 mmm180 -59.27 -48.22 82.45 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.566 0.746 . . . . 0.0 110.581 174.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 47' ' ' ILE . 98.7 mt -67.72 -42.7 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.694 1.197 . . . . 0.0 110.269 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.476 ' HA ' HG22 ' A' ' 88' ' ' VAL . 30.9 t70 -56.69 -36.29 69.45 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.631 0.582 . . . . 0.0 111.914 173.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.99 -44.07 85.92 Favored 'General case' 0 C--O 1.22 -0.482 0 O-C-N 123.723 0.639 . . . . 0.0 110.461 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 82.0 mt -64.49 -40.9 96.52 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.724 0.81 . . . . 0.0 112.278 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.3 m -76.3 -28.66 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 122.855 0.462 . . . . 0.0 111.378 -178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.32 -36.99 58.02 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.349 173.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.94 -47.41 80.71 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.662 1.185 . . . . 0.0 112.682 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -67.6 -32.89 73.94 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.27 0.228 . . . . 0.0 110.467 177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -69.41 -23.73 76.35 Favored Glycine 0 C--N 1.355 1.593 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.72 172.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.47 -34.76 27.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.061 0.944 . . . . 0.0 109.884 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.35 -14.62 41.64 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.045 0.938 . . . . 0.0 112.453 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -58.44 -39.4 79.74 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.531 0.682 . . . . 0.0 109.627 168.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.0 m170 -96.23 54.43 1.42 Allowed 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.209 1.004 . . . . 0.0 109.538 178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -75.17 107.53 7.33 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.312 0.645 . . . . 0.0 109.391 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -98.88 141.79 31.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.678 0.791 . . . . 0.0 109.625 178.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 26.3 m170 -84.66 71.94 10.75 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.886 0.474 . . . . 0.0 110.395 175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.8 t-80 -67.1 -37.77 84.52 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 173.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 76.0 t60 . . . . . 0 C--O 1.246 0.897 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 166.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.3 t -94.82 158.32 15.55 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.169 0.587 . . . . 0.0 110.686 -178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.2 t -67.17 164.4 18.2 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.056 0.942 . . . . 0.0 112.384 -175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 8' ' ' VAL . 31.0 m -57.17 -34.75 68.77 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.663 177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -58.67 -54.66 44.52 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 123.689 0.618 . . . . 0.0 111.536 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -65.61 -28.47 69.15 Favored 'General case' 0 CA--C 1.548 0.874 0 O-C-N 124.039 0.837 . . . . 0.0 110.195 -173.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -69.8 -46.04 66.6 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.701 0.8 . . . . 0.0 111.659 173.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 4' ' ' THR . 84.8 t -64.19 -35.76 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 123.324 0.65 . . . . 0.0 110.525 175.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.03 -41.06 99.43 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.333 1.053 . . . . 0.0 110.284 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.8 m -56.34 -49.78 73.39 Favored 'General case' 0 C--N 1.351 0.647 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.186 171.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.594 HG21 HG13 ' A' ' 47' ' ' ILE . 44.9 mm -59.58 -49.61 83.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 O-C-N 123.775 0.672 . . . . 0.0 110.731 -176.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.8 mt -64.18 -36.83 78.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 C-N-CA 123.334 0.654 . . . . 0.0 111.126 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -47.94 83.33 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.518 0.727 . . . . 0.0 111.924 175.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.25 -51.73 14.48 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.204 0.602 . . . . 0.0 112.359 -178.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.9 m -66.6 -57.84 6.4 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.39 1.076 . . . . 0.0 111.189 -172.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 35' ' ' ILE . 49.5 t -82.93 -9.93 59.05 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.662 0.785 . . . . 0.0 111.878 -175.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.35 76.96 0.31 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.518 1.127 . . . . 0.0 110.4 -175.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.7 mt -127.59 135.35 27.32 Favored Pre-proline 0 N--CA 1.479 0.999 0 C-N-CA 124.081 0.952 . . . . 0.0 109.222 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -49.57 119.49 4.73 Favored 'Trans proline' 0 C--N 1.385 2.461 0 C-N-CA 123.33 2.686 . . . . 0.0 111.346 168.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.3 tpt180 -65.14 -25.18 67.64 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.051 0.941 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -65.81 -33.73 76.52 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 111.886 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 75.9 p -86.83 -17.94 32.2 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.143 0.577 . . . . 0.0 111.177 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.4 mt -70.31 110.23 3.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.4 p -119.74 158.46 49.59 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 123.889 0.876 . . . . 0.0 109.535 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.29 -33.1 97.35 Favored 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.399 2.066 . . . . 0.0 112.401 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.4 -11.04 44.33 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -174.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 73.5 p -70.53 127.5 32.92 Favored 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 176.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 57.9 t-80 -91.75 133.06 35.94 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.227 1.011 . . . . 0.0 108.875 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.74 -59.76 3.51 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.634 0.774 . . . . 0.0 112.697 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.5 mt -72.71 -57.56 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 CA-C-O 120.838 0.351 . . . . 0.0 110.381 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 16.8 t70 -58.96 -49.63 77.13 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.814 1.246 . . . . 0.0 112.852 -172.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -99.82 -58.87 1.82 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 122.685 0.394 . . . . 0.0 111.529 -173.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 77' ' ' LEU . 92.7 mt -74.19 -11.84 60.41 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.338 0.655 . . . . 0.0 112.012 -171.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.91 6.01 88.72 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-O 120.074 -0.292 . . . . 0.0 113.815 177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.541 HG12 ' SG ' ' A' ' 16' ' ' CYS . 59.0 mt -74.01 102.94 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.242 1.017 . . . . 0.0 109.987 178.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.92 156.24 38.87 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.0 t -57.05 -16.96 8.36 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.696 0.798 . . . . 0.0 112.875 -179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 56.1 mt -86.92 -36.98 18.04 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.338 0.655 . . . . 0.0 110.52 177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -69.35 -30.4 68.41 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.504 0.669 . . . . 0.0 109.855 175.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -69.32 -20.27 63.88 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 124.424 1.09 . . . . 0.0 111.996 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 57' ' ' LEU . 93.6 mt -55.15 -41.79 72.24 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.566 0.747 . . . . 0.0 110.412 177.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -68.21 -38.5 81.99 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.402 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.1 mt -67.27 -42.32 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.663 0.602 . . . . 0.0 110.035 178.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.518 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -62.79 -36.89 84.62 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.092 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -75.06 -37.9 61.51 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.139 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.4 -33.74 71.73 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.66 0.384 . . . . 0.0 110.975 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.594 HG13 HG21 ' A' ' 11' ' ' ILE . 96.6 mt -72.55 -39.61 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 C-N-CA 123.853 0.861 . . . . 0.0 110.087 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -54.05 -44.86 71.43 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.469 1.108 . . . . 0.0 110.262 176.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -77.26 -44.88 28.22 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.21 1.004 . . . . 0.0 111.371 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.34 -53.83 46.42 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.424 0.69 . . . . 0.0 111.91 -172.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -81.62 -12.67 58.64 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.136 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.07 39.56 84.04 Favored Glycine 0 C--N 1.351 1.401 0 O-C-N 123.427 0.455 . . . . 0.0 111.971 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 pt -119.91 173.98 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 124.411 1.084 . . . . 0.0 110.087 -176.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -106.86 102.62 11.97 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD22 ' HB1' ' A' ' 44' ' ' ALA . 7.3 tt -88.56 109.47 29.59 Favored Pre-proline 0 CA--C 1.544 0.742 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -88.82 83.04 0.68 Allowed 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 121.772 1.648 . . . . 0.0 111.837 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.591 HD23 HD23 ' A' ' 41' ' ' LEU . 46.4 tp -72.47 -25.35 61.4 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.293 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -55.52 -36.41 66.69 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.789 0.835 . . . . 0.0 110.94 173.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -79.12 -47.58 15.84 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.025 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.402 ' HB2' HD12 ' A' ' 57' ' ' LEU . 41.7 m0 -61.01 -51.22 70.17 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.905 0.882 . . . . 0.0 111.384 -173.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 86.5 m -55.13 -44.76 75.36 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.734 1.214 . . . . 0.0 111.76 173.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -63.28 -40.19 96.69 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.351 0.66 . . . . 0.0 110.928 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -63.04 -38.69 92.2 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.595 0.758 . . . . 0.0 110.852 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -72.56 -47.16 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.378 0.671 . . . . 0.0 110.601 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -71.31 -16.3 62.45 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.73 0.812 . . . . 0.0 112.665 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -93.51 -8.3 41.82 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.27 0.628 . . . . 0.0 110.274 174.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 79.06 15.89 79.73 Favored Glycine 0 C--N 1.35 1.351 0 N-CA-C 114.281 0.472 . . . . 0.0 114.281 178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -80.41 -55.3 4.98 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.133 0.573 . . . . 0.0 109.922 178.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -105.54 163.66 12.48 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.898 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.5 t -99.39 157.46 16.4 Favored 'General case' 0 C--O 1.248 0.983 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.597 174.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 42.0 p -61.59 -34.19 75.18 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.77 0.828 . . . . 0.0 110.4 174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.521 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.5 tt0 -49.86 -46.14 51.17 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 111.633 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -62.19 -28.81 69.93 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.7 0.8 . . . . 0.0 113.073 -175.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -121.16 0.08 10.06 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -170.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 92.0 m-85 -131.81 -31.39 1.53 Allowed 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 118.628 0.649 . . . . 0.0 111.403 -173.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.521 HG23 ' HA ' ' A' ' 72' ' ' GLU . 86.5 t -65.01 125.24 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.608 HD11 HD11 ' A' ' 33' ' ' LEU . 16.2 mt -61.45 -33.35 73.58 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -162.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -65.76 -41.9 91.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.259 0.349 . . . . 0.0 111.674 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.75 -46.22 38.72 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.385 1.074 . . . . 0.0 109.942 -176.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.4 tp -52.37 -49.71 63.84 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.337 1.455 . . . . 0.0 110.771 171.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.12 -26.42 64.89 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.546 0.739 . . . . 0.0 111.311 -178.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.29 -41.51 66.57 Favored 'General case' 0 CA--C 1.547 0.84 0 O-C-N 123.724 0.64 . . . . 0.0 110.259 175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -59.91 -43.14 95.04 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 123.593 0.757 . . . . 0.0 110.761 175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 78.8 mt -70.57 -40.21 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 CA-C-N 114.875 -1.057 . . . . 0.0 110.599 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.486 ' HA ' HG22 ' A' ' 88' ' ' VAL . 28.0 t70 -57.21 -31.36 65.39 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.559 0.744 . . . . 0.0 111.889 171.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -69.91 -42.94 72.69 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.196 0.31 . . . . 0.0 110.182 174.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 81.3 mt -66.1 -40.43 90.75 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.479 0.712 . . . . 0.0 111.735 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG22 ' HA ' ' A' ' 85' ' ' ASP . 15.9 m -73.72 -29.49 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 122.954 0.501 . . . . 0.0 110.906 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.26 -40.44 86.23 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.342 173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.93 -47.62 74.19 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.277 1.031 . . . . 0.0 113.414 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 88' ' ' VAL . 22.0 pttp -67.2 -35.69 80.15 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.276 0.23 . . . . 0.0 111.136 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -76.28 -14.5 82.28 Favored Glycine 0 N--CA 1.478 1.469 0 CA-C-N 116.584 -0.28 . . . . 0.0 113.796 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.55 -35.26 30.5 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.995 0.918 . . . . 0.0 109.783 175.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.1 mt -62.85 -23.26 67.21 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.97 0.908 . . . . 0.0 111.282 173.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -80.6 128.82 34.04 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 168.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -61.37 -28.13 69.01 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 117.964 0.347 . . . . 0.0 111.004 175.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -133.14 134.67 44.49 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.846 0.858 . . . . 0.0 108.976 172.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -70.46 159.16 34.74 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.706 0.802 . . . . 0.0 111.029 -178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -57.44 121.22 9.73 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.738 0.815 . . . . 0.0 111.717 -173.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 -73.42 119.67 17.97 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.479 0.711 . . . . 0.0 109.828 175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.6 t-80 . . . . . 0 C--O 1.252 1.222 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.275 173.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 34.4 m -86.72 129.12 35.0 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 123.753 0.821 . . . . 0.0 109.619 177.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.6 m -57.33 135.06 56.48 Favored 'General case' 0 CA--C 1.548 0.898 0 O-C-N 124.08 0.862 . . . . 0.0 111.258 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 8' ' ' VAL . 47.9 m -60.38 -26.31 66.54 Favored 'General case' 0 CA--C 1.55 0.964 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.262 175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -62.52 -43.38 98.94 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.95 0.5 . . . . 0.0 111.447 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -63.17 -40.6 98.0 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 123.561 0.538 . . . . 0.0 110.517 -179.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' O ' HG12 ' A' ' 11' ' ' ILE . 26.8 mmt180 -61.53 -54.49 42.53 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.706 -1.134 . . . . 0.0 111.001 177.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 4' ' ' THR . 84.1 t -62.13 -35.52 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 124.191 0.997 . . . . 0.0 111.113 -179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.93 83.5 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.807 0.843 . . . . 0.0 110.019 177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.475 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 96.4 m -59.88 -46.5 89.11 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.806 0.843 . . . . 0.0 111.64 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 7' ' ' ARG . 38.9 mm -61.33 -50.16 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 122.805 0.442 . . . . 0.0 110.783 -174.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.402 HD12 HD22 ' A' ' 77' ' ' LEU . 56.2 mt -67.67 -30.25 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 122.968 0.507 . . . . 0.0 110.828 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -45.08 95.74 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 174.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 10' ' ' THR . 16.6 mm-40 -73.87 -45.71 49.24 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 122.838 0.455 . . . . 0.0 111.586 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 30.2 m -66.78 -59.59 3.43 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.836 0.854 . . . . 0.0 111.447 -172.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.407 ' SG ' HD11 ' A' ' 43' ' ' ILE . 64.3 m -92.43 4.63 53.07 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.434 -0.803 . . . . 0.0 112.31 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 22.3 t70 53.19 67.98 0.91 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.76 1.224 . . . . 0.0 111.515 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 60.4 mt -127.72 120.48 21.77 Favored Pre-proline 0 N--CA 1.479 1.002 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.462 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 34.5 Cg_exo -61.64 148.4 93.11 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 122.531 2.154 . . . . 0.0 112.84 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 mmt85 -63.16 -28.26 69.93 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.659 0.784 . . . . 0.0 111.419 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 11.6 pt-20 -65.08 -30.35 71.3 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 177.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.7 p -93.82 -11.54 31.0 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.42 0.688 . . . . 0.0 111.269 177.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 54.8 mt -86.28 122.58 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 123.965 0.906 . . . . 0.0 109.838 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 73.9 p -133.63 161.59 62.81 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 124.332 1.053 . . . . 0.0 108.924 176.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -57.43 -30.52 88.35 Favored 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 122.845 2.363 . . . . 0.0 113.225 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -89.8 -5.36 56.99 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.885 0.874 . . . . 0.0 112.275 -174.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.434 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 67.3 m -62.33 99.95 0.16 Allowed 'General case' 0 C--N 1.353 0.755 0 C-N-CA 122.964 0.506 . . . . 0.0 110.987 174.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.58 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 58.7 t-80 -73.22 125.38 27.62 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 168.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.04 -53.42 20.27 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 123.88 0.738 . . . . 0.0 112.35 -177.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 67.6 mt -68.08 -45.58 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 CA-C-N 117.878 0.308 . . . . 0.0 110.985 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.8 t70 -70.44 -74.34 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 O-C-N 123.216 0.322 . . . . 0.0 111.126 -174.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -73.49 -53.64 10.14 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.685 0.394 . . . . 0.0 111.671 -174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -75.53 -18.23 59.85 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 73.83 15.99 79.42 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 114.066 0.386 . . . . 0.0 114.066 177.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.763 HD13 HD11 ' A' ' 43' ' ' ILE . 82.6 mt -86.05 116.54 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.151 1.38 . . . . 0.0 110.61 -178.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -81.18 165.16 21.78 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.918 0.887 . . . . 0.0 109.512 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.4 m -56.99 -17.29 9.2 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 124.739 1.216 . . . . 0.0 113.142 175.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.92 -45.71 16.31 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.726 0.81 . . . . 0.0 110.114 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.57 -26.1 60.68 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.596 -178.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -69.94 -20.75 63.32 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.27 1.028 . . . . 0.0 111.063 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 57' ' ' LEU . 92.1 mt -57.93 -43.32 86.21 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 122.962 0.505 . . . . 0.0 110.481 176.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -65.66 -36.22 83.04 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.399 1.08 . . . . 0.0 111.336 178.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.763 HD11 HD13 ' A' ' 35' ' ' ILE . 47.3 mt -62.32 -49.92 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.132 0.573 . . . . 0.0 110.161 176.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.94 -34.28 77.61 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 124.53 1.144 . . . . 0.0 110.201 -178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -64.13 -49.68 71.2 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.27 1.028 . . . . 0.0 110.967 177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.13 -35.4 80.16 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.32 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.527 HD13 HD11 ' A' ' 84' ' ' ILE . 64.7 mt -69.54 -40.92 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.139 0.976 . . . . 0.0 111.358 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -60.93 -41.8 96.91 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 122.949 0.5 . . . . 0.0 111.343 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -73.37 -42.27 62.39 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.443 0.697 . . . . 0.0 111.394 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.55 -58.84 3.99 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.695 0.798 . . . . 0.0 111.031 -173.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -83.47 -19.9 35.01 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.697 -174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 72.93 37.81 56.43 Favored Glycine 0 C--N 1.354 1.532 0 O-C-N 123.435 0.459 . . . . 0.0 111.964 -177.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.3 pt -120.91 -174.33 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.082 0.953 . . . . 0.0 111.193 -172.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -120.21 105.59 11.11 Favored 'General case' 0 C--N 1.347 0.475 0 C-N-CA 124.16 0.984 . . . . 0.0 108.61 169.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 80' ' ' LEU . 7.3 tt -88.37 102.65 4.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 166.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -83.64 81.46 2.23 Favored 'Trans proline' 0 C--N 1.373 1.867 0 C-N-CA 121.866 1.711 . . . . 0.0 110.871 -177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.569 HD23 HD23 ' A' ' 41' ' ' LEU . 39.8 tp -71.6 -33.95 69.44 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.852 -175.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -58.67 -37.81 76.83 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.766 0.826 . . . . 0.0 111.043 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.26 -39.74 32.31 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.756 0.822 . . . . 0.0 110.523 -178.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 46.6 m0 -64.29 -40.37 95.8 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.528 0.731 . . . . 0.0 110.97 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.1 m -55.06 -46.01 75.34 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.121 0.969 . . . . 0.0 111.407 171.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -67.48 -33.11 74.44 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.98 0.512 . . . . 0.0 111.248 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.4 mm-40 -57.89 -46.73 84.46 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.764 0.426 . . . . 0.0 110.443 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 48.6 t -67.62 -45.05 85.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.599 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -60.61 -35.2 75.55 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.973 0.909 . . . . 0.0 113.127 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -90.28 -8.97 49.61 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.316 0.646 . . . . 0.0 111.394 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 87.96 11.28 67.95 Favored Glycine 0 C--N 1.349 1.28 0 O-C-N 122.358 -0.214 . . . . 0.0 113.623 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.42 ' HA ' ' HE2' ' A' ' 68' ' ' LYS . 10.3 mmpt? -73.03 -33.14 65.54 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.426 0.691 . . . . 0.0 110.216 178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -142.25 163.03 33.97 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.34 -0.846 . . . . 0.0 109.939 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -107.61 158.99 16.79 Favored 'General case' 0 C--O 1.247 0.945 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.193 170.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.414 HG23 HG11 ' A' ' 64' ' ' VAL . 28.7 p -58.13 -30.43 66.33 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.425 0.69 . . . . 0.0 111.494 177.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 28' ' ' HIS . 9.1 tm-20 -53.48 -45.05 69.47 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.705 0.802 . . . . 0.0 111.146 177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.549 ' HA ' HD22 ' A' ' 79' ' ' ASN . 9.2 tt0 -65.15 -23.48 67.13 Favored 'General case' 0 CA--C 1.553 1.096 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 34.1 m-85 -126.95 4.16 6.55 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 113.808 1.04 . . . . 0.0 113.808 -172.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -123.78 -27.22 4.0 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 118.583 0.629 . . . . 0.0 111.57 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 94.9 t -64.34 132.68 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 27' ' ' SER . 31.1 mt -59.58 -43.91 93.49 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -169.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -63.39 -34.39 77.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 123.24 0.337 . . . . 0.0 111.446 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.549 HD22 ' HA ' ' A' ' 73' ' ' GLN . 5.1 m-20 -70.86 -51.61 25.36 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.324 1.05 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD11 HD11 ' A' ' 55' ' ' LEU . 48.2 tp -54.47 -44.25 72.43 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.524 1.13 . . . . 0.0 110.886 175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.35 -35.72 81.33 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.265 1.026 . . . . 0.0 111.669 177.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.66 -47.73 68.69 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 123.646 0.591 . . . . 0.0 110.373 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.453 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 13.9 mmm180 -59.88 -42.87 94.7 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.787 0.835 . . . . 0.0 111.285 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.527 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -68.74 -36.44 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.584 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.3 t70 -58.17 -34.38 70.25 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.985 0.514 . . . . 0.0 111.58 170.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.72 -43.13 85.11 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 111.321 0.119 . . . . 0.0 111.321 172.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 58.3 mt -67.19 -40.4 86.53 Favored 'General case' 0 CA--C 1.558 1.26 0 C-N-CA 123.805 0.842 . . . . 0.0 112.124 -176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 85' ' ' ASP . 31.6 m -75.44 -29.47 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 123.201 0.6 . . . . 0.0 111.171 177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.26 -39.71 89.66 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.042 170.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -55.29 -46.82 76.21 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 124.376 1.07 . . . . 0.0 112.468 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -63.32 -38.11 89.89 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 118.203 0.456 . . . . 0.0 110.829 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -66.5 -25.13 72.64 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.863 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.92 -38.53 20.95 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.117 0.967 . . . . 0.0 110.524 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 77.7 mt -61.63 -36.98 82.33 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.562 0.745 . . . . 0.0 109.963 175.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -72.03 116.74 12.79 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -146.17 107.94 4.32 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 123.942 0.897 . . . . 0.0 108.815 -176.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -73.6 156.23 38.27 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 170.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -61.86 -41.61 98.05 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.032 0.533 . . . . 0.0 110.539 -178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -85.61 121.24 28.01 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.646 0.778 . . . . 0.0 109.759 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -75.7 101.96 5.21 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 175.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--O 1.251 1.143 0 C-N-CA 123.929 0.892 . . . . 0.0 108.761 179.122 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.789 0.328 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.528 HG23 ' HE ' ' A' ' 7' ' ' ARG . 42.0 m -68.17 112.15 4.94 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.312 175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.627 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 59.5 p -143.1 172.28 12.92 Favored 'General case' 0 C--O 1.244 0.771 0 C-N-CA 124.994 1.318 . . . . 0.0 108.513 -178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.436 ' O ' HG23 ' A' ' 8' ' ' VAL . 26.3 m -63.55 -36.08 82.6 Favored 'General case' 0 CA--C 1.545 0.773 0 O-C-N 122.985 0.178 . . . . 0.0 110.605 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -67.61 -44.61 77.63 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.394 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.627 ' HB3' ' H ' ' A' ' 3' ' ' SER . 10.5 t70 -52.21 -46.94 65.83 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.985 0.803 . . . . 0.0 111.21 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.528 ' HE ' HG23 ' A' ' 2' ' ' THR . 20.7 mmt85 -71.63 -43.8 65.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.868 -176.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 4' ' ' THR . 88.2 t -62.88 -41.11 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 122.814 0.446 . . . . 0.0 110.958 176.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.13 92.88 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.29 1.036 . . . . 0.0 110.508 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 20' ' ' ARG . 19.4 m -56.25 -49.01 75.39 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.665 1.186 . . . . 0.0 110.841 171.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.8 mt -62.19 -46.31 96.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.114 -177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.491 HG12 HD13 ' A' ' 43' ' ' ILE . 75.6 mt -62.35 -42.5 95.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.841 0 C-N-CA 123.919 0.888 . . . . 0.0 110.86 177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.15 -47.78 82.29 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.11 0.964 . . . . 0.0 111.918 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.62 -43.32 69.51 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 123.614 0.766 . . . . 0.0 111.519 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.1 m -65.44 -63.29 1.13 Allowed 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.376 0.67 . . . . 0.0 111.849 -174.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 4.5 t -92.66 -1.47 56.84 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.612 0.765 . . . . 0.0 111.577 -169.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 36.6 t70 58.34 77.8 0.28 Allowed 'General case' 0 C--N 1.358 0.963 0 C-N-CA 124.723 1.209 . . . . 0.0 110.89 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 33' ' ' LEU . 54.5 mt -136.06 132.2 19.13 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.299 1.04 . . . . 0.0 108.8 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.5 135.52 39.57 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 122.591 2.194 . . . . 0.0 111.488 173.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.412 ' HD3' ' HA ' ' A' ' 10' ' ' THR . 25.7 mtm180 -71.93 -22.63 61.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 122.578 0.351 . . . . 0.0 111.866 -178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -65.32 -15.06 62.14 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.159 0.584 . . . . 0.0 111.667 174.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 38.3 p -105.57 -18.83 13.96 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.001 0.521 . . . . 0.0 110.568 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 20' ' ' ARG . 87.3 mt -77.77 106.36 8.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 176.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.459 ' O ' HD12 ' A' ' 77' ' ' LEU . 73.8 p -111.84 154.54 44.05 Favored Pre-proline 0 N--CA 1.474 0.761 0 C-N-CA 123.858 0.863 . . . . 0.0 109.478 177.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 39.2 Cg_endo -64.08 -22.81 67.57 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.279 1.986 . . . . 0.0 111.534 174.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -80.41 -17.56 51.46 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.844 0.858 . . . . 0.0 111.415 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.6 t -73.95 150.8 40.57 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.929 0.892 . . . . 0.0 110.724 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 58.6 t-80 -107.84 134.46 50.76 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.848 1.259 . . . . 0.0 109.151 175.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HA ' HD12 ' A' ' 33' ' ' LEU . . . -49.41 -55.03 14.43 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.882 0.873 . . . . 0.0 112.657 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 54.2 mt -76.94 -53.88 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 122.165 0.186 . . . . 0.0 110.944 -175.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 28' ' ' HIS . 29.3 m-20 -65.58 -52.77 49.72 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -172.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -89.38 -59.77 2.13 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.745 0.418 . . . . 0.0 111.078 -174.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 77' ' ' LEU . 87.3 mt -68.25 -21.44 64.82 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -174.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.53 22.02 65.52 Favored Glycine 0 N--CA 1.478 1.483 0 O-C-N 123.388 0.43 . . . . 0.0 113.44 176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 84.7 mt -80.9 130.01 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 123.957 0.903 . . . . 0.0 110.013 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -89.34 160.35 16.91 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 50.3 m -59.25 -19.05 42.6 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.308 0.643 . . . . 0.0 112.562 176.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.8 mt -76.89 -42.19 40.71 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.678 0.791 . . . . 0.0 110.872 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -73.57 -32.71 64.3 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.215 175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -67.83 -22.17 65.17 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.67 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 57' ' ' LEU . 95.7 mt -59.5 -42.97 93.39 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 109.846 -0.428 . . . . 0.0 109.846 170.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -71.73 -36.03 70.35 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.406 1.083 . . . . 0.0 110.698 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.491 HD13 HG12 ' A' ' 12' ' ' ILE . 61.3 mt -65.26 -48.32 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 123.024 0.53 . . . . 0.0 109.879 176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.23 -36.13 83.09 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.955 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -67.87 -40.06 83.64 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.248 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.54 -35.35 75.35 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.809 177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.0 mt -63.78 -38.84 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.95 0.9 . . . . 0.0 110.839 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -57.35 -43.61 83.59 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.383 0.673 . . . . 0.0 111.096 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -81.54 -26.04 35.37 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.058 0.943 . . . . 0.0 112.302 -175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.71 -58.11 3.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.798 0.839 . . . . 0.0 110.651 -175.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.438 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 95.5 m-85 -81.9 -27.56 33.35 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 114.544 -1.207 . . . . 0.0 111.051 -176.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.13 46.4 7.64 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 111.015 -0.834 . . . . 0.0 111.015 -175.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.429 HG22 ' HD3' ' A' ' 91' ' ' LYS . 43.3 pt -128.68 -175.34 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 124.511 1.124 . . . . 0.0 110.257 -175.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -120.29 107.56 13.11 Favored 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 163.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 tt -77.94 107.11 4.8 Favored Pre-proline 0 CA--C 1.546 0.791 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 165.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -82.92 81.34 2.43 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 121.63 1.553 . . . . 0.0 110.965 -178.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.554 HD23 HD23 ' A' ' 41' ' ' LEU . 24.4 tp -70.23 -24.23 63.06 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.308 177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -56.78 -38.3 72.3 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.997 0.919 . . . . 0.0 111.284 172.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 60.9 tttp -74.56 -53.57 9.17 Favored 'General case' 0 C--O 1.219 -0.513 0 C-N-CA 123.067 0.547 . . . . 0.0 109.732 175.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -60.49 -46.95 88.23 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 124.055 0.847 . . . . 0.0 111.618 -168.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 40.3 m -54.28 -48.55 71.1 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.164 0.986 . . . . 0.0 111.987 170.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 19.2 tp60 -62.65 -33.88 75.93 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.675 0.79 . . . . 0.0 110.811 -177.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 69' ' ' ALA . 36.7 mm-40 -61.97 -40.57 96.04 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.856 0.862 . . . . 0.0 110.686 176.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 60.1 t -71.78 -45.9 63.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.808 0 C-N-CA 122.717 0.407 . . . . 0.0 110.136 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -51.4 -44.08 62.12 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.96 1.304 . . . . 0.0 112.409 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.03 0.72 41.47 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 112.724 0.639 . . . . 0.0 112.724 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 70.51 19.37 76.24 Favored Glycine 0 N--CA 1.473 1.164 0 N-CA-C 113.596 0.199 . . . . 0.0 113.596 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 27.7 mmmt -75.85 -17.12 59.93 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.153 0.981 . . . . 0.0 111.922 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.55 ' HB3' ' HB3' ' A' ' 63' ' ' GLU . . . -167.24 166.03 15.0 Favored 'General case' 0 C--O 1.244 0.77 0 C-N-CA 124.664 1.186 . . . . 0.0 109.07 176.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.2 t -105.36 162.01 13.81 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.38 0.672 . . . . 0.0 110.821 -175.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 73.5 p -65.06 -30.89 71.89 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.816 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -57.36 -45.54 84.28 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 122.766 0.427 . . . . 0.0 110.263 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.508 ' H ' HG23 ' A' ' 70' ' ' THR . 25.5 tt0 -60.92 -30.6 70.3 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.217 1.007 . . . . 0.0 112.042 -171.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -105.49 -65.01 1.08 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 122.563 0.345 . . . . 0.0 111.234 -179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -65.34 -21.58 66.72 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 114.797 1.406 . . . . 0.0 114.797 -167.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.3 t -62.03 127.93 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 119.872 1.215 . . . . 0.0 108.057 168.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.713 HD11 HD11 ' A' ' 33' ' ' LEU . 39.3 mt -65.09 -32.94 74.89 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -160.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.8 pttp -62.96 -37.21 86.17 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 172.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 76' ' ' VAL . 62.6 m-20 -77.15 -44.89 28.65 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.746 0.818 . . . . 0.0 109.631 -177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.2 tp -51.92 -50.48 61.05 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.211 1.404 . . . . 0.0 110.268 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -67.35 -30.83 70.75 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.797 178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.14 -42.09 69.64 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.666 0.386 . . . . 0.0 110.881 177.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.446 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 16.4 mmm180 -60.08 -47.89 84.01 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.197 0.999 . . . . 0.0 110.433 175.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.59 -40.04 81.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-N 114.69 -1.141 . . . . 0.0 111.62 -177.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.489 ' HA ' HG22 ' A' ' 88' ' ' VAL . 27.1 t70 -60.39 -33.86 73.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 122.968 0.507 . . . . 0.0 111.612 172.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -68.79 -38.38 79.96 Favored 'General case' 0 CA--C 1.546 0.822 0 O-C-N 123.544 0.528 . . . . 0.0 110.154 174.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 90.2 mt -66.99 -40.17 87.33 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.631 0.772 . . . . 0.0 112.398 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.9 m -72.54 -33.76 46.01 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 CA-C-O 120.856 0.36 . . . . 0.0 110.389 178.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.25 -46.49 80.35 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.706 174.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.51 -47.1 86.82 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.051 1.341 . . . . 0.0 113.051 -177.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.449 ' HA ' HD12 ' A' ' 94' ' ' LEU . 23.0 pttp -64.91 -34.91 79.52 Favored 'General case' 0 N--CA 1.482 1.169 0 O-C-N 123.331 0.395 . . . . 0.0 111.028 -177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -71.66 -40.92 58.09 Favored Glycine 0 C--N 1.346 1.116 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.009 175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.44 -30.96 72.0 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.869 1.267 . . . . 0.0 111.809 177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 91' ' ' LYS . 82.0 mt -58.51 -47.12 85.17 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.443 0.697 . . . . 0.0 110.594 171.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -75.52 145.62 41.17 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.928 174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -82.97 84.65 7.37 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 174.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.2 p-80 -89.3 50.77 1.99 Allowed 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.665 1.186 . . . . 0.0 111.144 -172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 70.6 t60 -75.96 87.56 2.91 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -94.35 -64.95 1.02 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.87 165.55 33.27 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.42 1.088 . . . . 0.0 109.032 174.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 37.1 m-70 . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 167.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.479 0.993 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.0 t -77.99 131.11 37.25 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 169.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 38.5 t -70.33 153.33 43.15 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.536 0.735 . . . . 0.0 111.011 -176.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 8' ' ' VAL . 7.4 m -57.65 -27.81 63.17 Favored 'General case' 0 N--CA 1.477 0.887 0 O-C-N 123.855 0.722 . . . . 0.0 110.362 173.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -60.88 -53.72 53.86 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.451 175.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.67 -39.64 81.26 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.289 0.993 . . . . 0.0 111.847 -176.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 3' ' ' SER . 68.4 mtt180 -69.83 -47.29 63.3 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 111.465 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 4' ' ' THR . 99.6 t -64.46 -35.5 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.146 0.578 . . . . 0.0 110.417 175.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -67.07 -38.78 86.37 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.808 0.843 . . . . 0.0 110.244 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.2 m -54.88 -49.23 71.68 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.907 1.283 . . . . 0.0 111.392 170.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.438 HG21 HG13 ' A' ' 47' ' ' ILE . 34.9 mm -57.2 -52.41 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 123.775 0.83 . . . . 0.0 110.478 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.461 HG12 HD13 ' A' ' 43' ' ' ILE . 72.7 mt -64.93 -38.14 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.793 0 C-N-CA 123.737 0.815 . . . . 0.0 111.157 -178.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.5 -49.34 77.14 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.052 0.941 . . . . 0.0 112.109 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -71.44 -52.91 15.93 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.357 0.663 . . . . 0.0 111.65 -179.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 28.8 m -66.35 -45.38 80.38 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.341 0.656 . . . . 0.0 111.71 -173.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.593 ' SG ' HD11 ' A' ' 43' ' ' ILE . 41.7 m -96.36 5.46 50.87 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 -177.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 62.81 26.68 15.72 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 124.176 0.99 . . . . 0.0 112.428 175.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.61 124.87 53.7 Favored Pre-proline 0 N--CA 1.481 1.107 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.502 -175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.484 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 26.4 Cg_endo -61.95 135.78 57.43 Favored 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.511 2.14 . . . . 0.0 112.412 176.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.494 ' HD2' HD12 ' A' ' 23' ' ' ILE . 26.2 mmm-85 -59.91 -29.83 68.62 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 124.474 1.109 . . . . 0.0 112.165 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 13.9 pt-20 -64.22 -30.57 71.62 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.325 0.65 . . . . 0.0 111.647 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -96.05 -7.6 35.76 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.976 0.511 . . . . 0.0 111.533 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.494 HD12 ' HD2' ' A' ' 20' ' ' ARG . 53.2 mt -80.89 123.19 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 C-N-CA 123.247 0.619 . . . . 0.0 109.708 174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.5 p -124.31 157.4 64.74 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 123.948 0.899 . . . . 0.0 110.203 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.63 -37.38 88.42 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.81 2.34 . . . . 0.0 113.429 174.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -80.08 -7.26 58.79 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.136 0.574 . . . . 0.0 111.645 -175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.1 t -64.19 121.83 15.17 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.25 0.62 . . . . 0.0 110.906 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 65.3 t-80 -86.27 127.22 34.73 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 172.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.514 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.38 -54.75 27.78 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 122.931 0.492 . . . . 0.0 112.253 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 59.7 mt -66.87 -54.82 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 O-C-N 123.015 0.197 . . . . 0.0 110.743 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.0 t70 -69.02 -66.46 0.57 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.35 -173.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.78 -55.63 5.63 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.343 -168.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 77' ' ' LEU . 90.1 mt -75.48 -14.48 60.43 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.161 0.584 . . . . 0.0 112.274 -176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.36 8.1 87.65 Favored Glycine 0 C--N 1.355 1.619 0 O-C-N 122.993 0.183 . . . . 0.0 113.403 179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.601 HD13 HD11 ' A' ' 43' ' ' ILE . 93.8 mt -85.01 99.52 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 C-N-CA 124.873 1.269 . . . . 0.0 110.707 -176.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -65.71 163.27 16.85 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.954 0.901 . . . . 0.0 110.09 176.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.7 t -57.02 -15.97 6.14 Favored 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 124.242 1.017 . . . . 0.0 113.0 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 63.8 mt -83.87 -45.37 13.32 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.245 0.618 . . . . 0.0 110.298 176.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -68.83 -31.34 70.25 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.101 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -67.41 -20.84 65.58 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.397 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 44.1 mt -57.85 -38.6 75.96 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.108 0.563 . . . . 0.0 111.273 178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.22 -41.17 77.4 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.775 0.83 . . . . 0.0 110.854 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.601 HD11 HD13 ' A' ' 35' ' ' ILE . 73.3 mt -61.7 -49.45 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.268 175.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.438 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -61.31 -40.23 93.41 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 114.432 -1.258 . . . . 0.0 110.411 -175.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.0 t80 -73.59 -34.22 64.98 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.163 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.56 64.0 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 122.678 0.391 . . . . 0.0 110.934 176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.438 HG13 HG21 ' A' ' 11' ' ' ILE . 91.1 mt -78.23 -38.18 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.504 1.121 . . . . 0.0 110.53 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -53.64 -40.81 66.15 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.066 0.946 . . . . 0.0 110.278 172.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -81.48 -50.0 9.94 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.907 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.99 -49.56 67.39 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.37 0.668 . . . . 0.0 111.671 -171.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -85.51 -22.62 28.09 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.515 0.726 . . . . 0.0 110.548 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 75.09 48.58 10.96 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.4 pt -131.28 -177.23 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 C-N-CA 124.038 0.935 . . . . 0.0 110.659 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 56' ' ' PRO . 87.3 tttt -108.96 113.27 26.02 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 167.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.438 HD22 ' HB1' ' A' ' 44' ' ' ALA . 5.9 tt -103.79 96.62 9.38 Favored Pre-proline 0 C--O 1.243 0.746 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 168.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.417 ' HB3' ' HE2' ' A' ' 54' ' ' LYS . 97.3 Cg_endo -83.03 84.05 1.82 Allowed 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.98 1.787 . . . . 0.0 111.334 178.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 52.7 tp -65.0 -28.45 69.51 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.272 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -56.33 -37.76 70.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.369 1.068 . . . . 0.0 111.049 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 59.2 tttp -80.51 -49.12 11.79 Favored 'General case' 0 C--O 1.218 -0.57 0 C-N-CA 124.33 1.052 . . . . 0.0 110.321 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 30.1 m0 -59.02 -43.83 91.64 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.012 0.925 . . . . 0.0 111.008 -174.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 50.9 m -65.39 -40.53 93.59 Favored 'General case' 0 CA--C 1.547 0.827 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.676 172.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -63.71 -33.73 76.3 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.85 0.86 . . . . 0.0 111.575 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 43.7 mm-40 -59.27 -38.27 79.72 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.211 0.529 . . . . 0.0 110.306 176.027 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.539 HG11 HG23 ' A' ' 71' ' ' THR . 40.1 t -72.03 -45.38 63.75 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.824 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.161 175.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -59.52 -29.43 67.87 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 124.764 1.226 . . . . 0.0 112.639 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -99.3 -14.28 19.29 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 123.627 0.771 . . . . 0.0 111.051 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 18.31 63.85 Favored Glycine 0 C--N 1.349 1.285 0 CA-C-N 116.607 -0.269 . . . . 0.0 113.308 -175.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -71.28 -30.09 65.86 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.06 0.944 . . . . 0.0 111.35 173.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.12 172.17 18.61 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.574 0.75 . . . . 0.0 111.098 -169.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 6.2 t -108.6 154.07 22.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.866 0.866 . . . . 0.0 110.413 177.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.539 HG23 HG11 ' A' ' 64' ' ' VAL . 34.0 p -61.78 -28.58 69.55 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.381 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.404 ' HA ' HG23 ' A' ' 76' ' ' VAL . 42.2 tt0 -56.14 -44.93 79.68 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.532 0.733 . . . . 0.0 111.663 176.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.471 ' HA ' HD22 ' A' ' 79' ' ' ASN . 0.9 OUTLIER -66.77 -21.73 66.05 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 122.776 0.431 . . . . 0.0 111.252 -174.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -104.36 -76.68 0.59 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.89 0.476 . . . . 0.0 110.952 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.4 m-85 -60.28 -24.14 64.7 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -165.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 91.9 t -63.14 127.32 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 CA-C-N 119.195 0.907 . . . . 0.0 108.751 172.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.581 HD11 HD11 ' A' ' 33' ' ' LEU . 26.3 mt -61.82 -36.94 82.61 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -162.077 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -68.12 -35.83 78.76 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 111.701 0.26 . . . . 0.0 111.701 174.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.471 HD22 ' HA ' ' A' ' 73' ' ' GLN . 3.5 m-20 -72.3 -45.21 60.99 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.892 0.877 . . . . 0.0 110.52 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.8 tp -53.93 -46.43 71.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.122 1.769 . . . . 0.0 111.349 170.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.1 -30.66 71.71 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.156 178.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.74 -42.05 61.68 Favored 'General case' 0 N--CA 1.478 0.969 0 O-C-N 123.689 0.618 . . . . 0.0 110.963 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -59.52 -47.88 83.8 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.971 0.909 . . . . 0.0 111.75 175.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 96.1 mt -70.6 -38.35 73.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.769 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -54.05 -37.56 64.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.602 0.761 . . . . 0.0 111.643 169.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -72.44 -38.05 68.4 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.229 177.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.0 mt -65.17 -40.58 94.48 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.526 0.73 . . . . 0.0 111.841 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 23.1 m -78.82 -20.95 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 122.865 0.466 . . . . 0.0 111.005 175.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.53 -39.58 73.96 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.419 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -52.2 -47.49 65.56 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.392 1.077 . . . . 0.0 113.107 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -65.58 -38.52 89.76 Favored 'General case' 0 N--CA 1.483 1.178 0 O-C-N 123.504 0.503 . . . . 0.0 111.094 179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.18 -26.43 71.55 Favored Glycine 0 C--N 1.356 1.64 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.751 175.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.95 -39.06 35.53 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.077 0.951 . . . . 0.0 110.136 177.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 96.0 mt -58.9 -33.76 70.9 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.072 0.949 . . . . 0.0 111.462 175.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -65.58 117.28 7.82 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 123.884 0.74 . . . . 0.0 109.869 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -140.28 115.91 10.15 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.657 0.783 . . . . 0.0 109.989 177.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -82.02 69.31 8.7 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.787 0.803 . . . . 0.0 109.358 171.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 30.2 m80 -147.24 130.17 16.25 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.634 1.173 . . . . 0.0 109.047 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -63.3 -37.83 88.78 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.118 0.967 . . . . 0.0 112.272 -173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -160.28 111.51 1.91 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.056 0.542 . . . . 0.0 109.565 -178.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 CA--C 1.561 1.389 0 C-N-CA 123.358 0.663 . . . . 0.0 110.563 175.9 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 mtm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.804 0.335 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.8 m -73.75 134.33 43.45 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.845 0.858 . . . . 0.0 110.73 -177.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.2 m -118.2 171.92 7.78 Favored 'General case' 0 C--O 1.245 0.859 0 C-N-CA 123.363 0.665 . . . . 0.0 109.936 176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 8' ' ' VAL . 24.0 m -56.28 -32.75 64.84 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.397 -178.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -64.11 -46.38 84.42 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.259 0.223 . . . . 0.0 111.356 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.99 -42.31 80.02 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.076 0.86 . . . . 0.0 111.093 -176.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.5 mmt180 -63.56 -52.12 62.44 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 114.892 -1.049 . . . . 0.0 111.165 176.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' THR . 83.7 t -59.7 -38.81 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 C-N-CA 123.373 0.669 . . . . 0.0 111.355 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.47 -44.92 85.66 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.026 0.931 . . . . 0.0 110.126 -178.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 55.0 m -56.62 -43.6 80.37 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 124.365 1.066 . . . . 0.0 112.041 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.425 HG21 HG13 ' A' ' 47' ' ' ILE . 32.7 mm -59.3 -55.25 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.609 0.763 . . . . 0.0 110.394 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 72.1 mt -61.72 -35.14 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 124.196 0.935 . . . . 0.0 111.429 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.72 -52.69 64.61 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.168 0.987 . . . . 0.0 111.728 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -82.2 -25.81 33.9 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 43' ' ' ILE . 19.0 p -73.96 -63.03 1.3 Allowed 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.188 0.449 . . . . 0.0 110.801 178.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' A' ' 43' ' ' ILE . 57.7 m -92.42 7.98 40.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.278 -171.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 59.1 30.87 20.76 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.454 1.102 . . . . 0.0 112.241 177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.432 HD13 ' HB3' ' A' ' 33' ' ' LEU . 62.9 mt -86.55 129.69 52.03 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -51.69 118.59 4.58 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.133 2.555 . . . . 0.0 112.375 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 25.2 tpt85 -57.83 -37.44 73.84 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.724 1.61 . . . . 0.0 111.727 -175.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 22' ' ' THR . 9.1 pt-20 -63.1 -38.77 92.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.379 0.672 . . . . 0.0 111.539 -178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.24 -15.49 40.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.158 0.583 . . . . 0.0 112.236 -174.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.88 110.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.926 0.491 . . . . 0.0 110.142 176.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.1 p -112.69 154.23 44.82 Favored Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 0.0 110.943 -174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 59.6 Cg_exo -55.15 -36.66 93.62 Favored 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 123.108 2.539 . . . . 0.0 112.371 172.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.51 -28.01 62.61 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.413 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 72.5 p -70.37 137.03 50.19 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 122.889 0.476 . . . . 0.0 111.209 -171.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 31' ' ' ASP . 60.8 t-80 -89.7 130.17 36.01 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.667 1.187 . . . . 0.0 108.774 175.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.09 -59.95 3.2 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 123.741 0.816 . . . . 0.0 112.648 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.3 mt -70.78 -48.86 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 CA-C-O 120.694 0.283 . . . . 0.0 110.983 -173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 20.1 t70 -69.89 -61.28 1.84 Allowed 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.664 -173.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.72 -54.62 5.46 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.789 0.436 . . . . 0.0 110.9 -172.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 77' ' ' LEU . 80.4 mt -82.36 -14.09 55.83 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.151 0.581 . . . . 0.0 112.042 -170.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.21 14.05 82.23 Favored Glycine 0 C--N 1.355 1.588 0 C-N-CA 122.804 0.24 . . . . 0.0 113.511 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 68.7 mt -72.69 115.25 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.83 0.852 . . . . 0.0 110.264 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -76.83 165.55 24.55 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 175.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.5 m -66.29 -18.04 65.11 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 118.464 0.575 . . . . 0.0 111.63 174.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 90.9 mt -85.22 -38.27 19.14 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.833 0.853 . . . . 0.0 109.852 173.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -70.26 -26.82 64.0 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.545 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -77.48 -21.43 52.87 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.913 0.885 . . . . 0.0 110.612 178.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 57' ' ' LEU . 85.7 mt -55.44 -36.7 66.81 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.166 0.439 . . . . 0.0 111.427 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -69.51 -39.45 77.55 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.544 1.138 . . . . 0.0 110.668 178.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.608 HD11 ' SG ' ' A' ' 16' ' ' CYS . 58.8 mt -64.82 -51.74 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.625 0.77 . . . . 0.0 110.224 178.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.01 -37.49 87.39 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.316 1.047 . . . . 0.0 110.624 -176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -66.1 -41.47 90.55 Favored 'General case' 0 N--CA 1.48 1.033 0 O-C-N 124.068 0.855 . . . . 0.0 110.332 177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.43 -34.27 76.87 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.227 0.611 . . . . 0.0 111.336 178.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.425 HG13 HG21 ' A' ' 11' ' ' ILE . 84.2 mt -67.79 -39.26 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.336 1.054 . . . . 0.0 110.748 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -56.58 -44.54 81.14 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.019 0.528 . . . . 0.0 110.698 172.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -77.87 -29.97 50.6 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.011 0.924 . . . . 0.0 111.789 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.01 -58.45 3.15 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.663 0.785 . . . . 0.0 110.879 -173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.413 ' HB2' HG12 ' A' ' 53' ' ' ILE . 52.0 m-85 -84.37 -20.36 32.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.732 0.813 . . . . 0.0 111.15 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 82.0 18.97 66.18 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.407 0.442 . . . . 0.0 112.42 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.413 HG12 ' HB2' ' A' ' 51' ' ' PHE . 29.5 pt -105.51 -176.81 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 124.423 1.089 . . . . 0.0 110.971 -172.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -116.47 111.55 20.15 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.304 0.641 . . . . 0.0 109.529 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 tt -102.14 103.07 27.79 Favored Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HG2' ' HE2' ' A' ' 59' ' ' LYS . 68.6 Cg_endo -86.23 84.94 1.06 Allowed 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 122.002 1.801 . . . . 0.0 111.671 174.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.543 HD23 HD23 ' A' ' 41' ' ' LEU . 59.9 tp -62.71 -34.78 77.85 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.812 0.845 . . . . 0.0 110.101 177.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.91 -36.53 77.2 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.3 1.04 . . . . 0.0 111.193 178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' HE2' ' HG2' ' A' ' 56' ' ' PRO . 33.9 ttpt -77.67 -44.4 28.17 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.625 0.77 . . . . 0.0 110.004 178.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.409 ' O ' HG23 ' A' ' 64' ' ' VAL . 44.2 m0 -58.36 -47.48 83.68 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.194 0.997 . . . . 0.0 110.959 -177.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 62.4 m -63.74 -34.92 78.95 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.987 0.915 . . . . 0.0 111.021 176.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -69.77 -38.04 76.59 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.264 1.025 . . . . 0.0 111.287 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.52 -33.53 76.14 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.416 0.686 . . . . 0.0 110.388 176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 84.8 t -67.35 -44.09 87.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.867 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.436 173.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.26 -32.93 73.7 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.044 0.938 . . . . 0.0 112.458 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -90.71 -12.22 37.32 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 124.448 1.099 . . . . 0.0 111.371 -173.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.15 16.88 55.05 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-N 116.931 -0.122 . . . . 0.0 113.37 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -90.04 -23.4 21.46 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.812 0.845 . . . . 0.0 111.621 178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -147.9 158.53 44.09 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.123 0.569 . . . . 0.0 110.672 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.9 p -95.62 159.95 14.74 Favored 'General case' 0 C--O 1.245 0.858 0 C-N-CA 123.134 0.574 . . . . 0.0 109.778 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 44.0 p -62.47 -31.27 71.97 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.954 0.502 . . . . 0.0 109.649 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.52 ' HA ' HG23 ' A' ' 76' ' ' VAL . 31.5 tt0 -54.98 -50.48 68.87 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.961 0.904 . . . . 0.0 111.112 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -55.95 -30.03 61.07 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.285 1.034 . . . . 0.0 112.404 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 80' ' ' LEU . 42.1 m-85 -104.31 -77.43 0.58 Allowed 'General case' 0 C--O 1.215 -0.731 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.717 176.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 97.6 m-85 -56.42 -27.99 58.16 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -166.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 72' ' ' GLU . 79.7 t -65.3 124.37 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.106 1.321 . . . . 0.0 108.413 170.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.723 HD11 HD11 ' A' ' 33' ' ' LEU . 25.5 mt -63.62 -32.47 73.95 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -159.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . 21.0 pttp -67.61 -37.37 82.43 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-O 120.756 0.312 . . . . 0.0 111.263 174.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.45 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 60.1 m-20 -75.97 -42.9 47.03 Favored 'General case' 0 C--O 1.216 -0.683 0 C-N-CA 123.509 0.723 . . . . 0.0 109.832 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' TYR . 50.3 tp -52.2 -48.39 65.09 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.332 1.453 . . . . 0.0 110.843 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -62.99 -30.78 71.86 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.047 -0.979 . . . . 0.0 110.893 179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.78 -39.88 50.07 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 123.992 0.808 . . . . 0.0 111.61 178.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 23.3 mmm180 -61.37 -45.3 94.97 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.83 0.852 . . . . 0.0 111.057 174.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 89.0 mt -70.87 -38.54 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.095 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.543 ' HA ' HG22 ' A' ' 88' ' ' VAL . 38.3 t70 -56.44 -34.68 67.06 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 123.962 0.905 . . . . 0.0 112.35 171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 8.1 tp10 -63.3 -47.4 82.43 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.837 0.711 . . . . 0.0 110.356 173.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 51.7 mt -65.73 -40.9 92.64 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 124.03 0.932 . . . . 0.0 111.548 -177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.8 m -78.08 -26.23 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 C-N-CA 122.841 0.456 . . . . 0.0 111.49 179.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.39 -34.8 72.98 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.79 171.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.18 -45.32 83.82 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.741 0.651 . . . . 0.0 112.505 176.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -68.35 -35.48 77.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 117.766 0.257 . . . . 0.0 110.665 177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -72.65 -21.6 79.51 Favored Glycine 0 C--N 1.352 1.467 0 N-CA-C 114.854 0.702 . . . . 0.0 114.854 174.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -87.97 -52.15 5.43 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 121.253 0.549 . . . . 0.0 111.08 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.4 mt -80.22 -2.25 44.1 Favored 'General case' 0 C--O 1.245 0.832 0 C-N-CA 123.7 0.8 . . . . 0.0 112.982 -168.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.42 -40.68 77.12 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 122.912 0.485 . . . . 0.0 111.102 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 49.4 m80 -148.85 71.04 1.13 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.068 1.347 . . . . 0.0 107.89 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -79.38 69.94 5.72 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 122.269 1.033 . . . . 0.0 110.671 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -143.15 161.37 38.39 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.686 -172.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 35.9 m170 -65.84 97.04 0.32 Allowed 'General case' 0 C--O 1.242 0.666 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 173.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -68.54 163.17 24.14 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.029 0.932 . . . . 0.0 111.144 -176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 . . . . . 0 C--O 1.248 0.975 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.746 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.987 0.423 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.6 t -111.61 133.45 53.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.09 0.556 . . . . 0.0 109.896 176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 42.5 m -92.18 164.99 13.36 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 163.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 m -67.49 -19.15 65.29 Favored 'General case' 0 CA--C 1.551 1.008 0 O-C-N 122.155 -0.34 . . . . 0.0 110.326 176.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 47.4 t80 -71.07 -41.41 70.74 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.304 0.641 . . . . 0.0 110.691 171.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -48.65 -51.84 26.22 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 124.177 0.991 . . . . 0.0 112.072 -175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -73.01 -43.53 62.02 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.425 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -59.76 -40.01 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 123.163 0.585 . . . . 0.0 110.847 175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.79 77.45 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.186 0.995 . . . . 0.0 110.042 -178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 95.5 m -58.28 -41.43 84.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.05 0.94 . . . . 0.0 111.91 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.506 HG21 HG13 ' A' ' 47' ' ' ILE . 21.7 mm -58.74 -53.32 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 123.537 0.735 . . . . 0.0 110.658 176.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 78.8 mt -62.16 -33.12 57.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.036 0.934 . . . . 0.0 111.195 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.27 -53.78 50.26 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.033 0.933 . . . . 0.0 111.537 176.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -68.93 -37.58 78.98 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.145 -177.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.7 m -72.48 -63.79 1.08 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.894 0.478 . . . . 0.0 110.64 -179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.718 ' SG ' HD11 ' A' ' 43' ' ' ILE . 34.5 m -91.43 12.27 21.19 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -169.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 61.39 21.6 12.13 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.978 0.911 . . . . 0.0 112.079 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 56.5 mt -87.6 121.78 70.84 Favored Pre-proline 0 N--CA 1.479 0.996 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.173 -177.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -54.06 133.55 55.72 Favored 'Trans proline' 0 C--N 1.369 1.606 0 C-N-CA 122.158 1.906 . . . . 0.0 112.422 176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.6 tpt180 -55.23 -33.02 62.75 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 124.442 1.097 . . . . 0.0 110.968 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -64.49 -35.02 79.58 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.591 1.156 . . . . 0.0 112.208 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 67.0 p -85.71 -19.21 31.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 122.885 0.474 . . . . 0.0 111.357 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -71.5 112.15 6.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 C-N-CA 123.056 0.542 . . . . 0.0 110.431 177.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 38.1 p -115.9 146.47 37.03 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 124.187 0.995 . . . . 0.0 109.464 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.06 -33.41 73.69 Favored 'Trans proline' 0 C--N 1.38 2.187 0 C-N-CA 122.808 2.338 . . . . 0.0 112.911 -175.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.43 -6.65 58.42 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.913 0.885 . . . . 0.0 111.835 -174.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 30.4 t -74.87 146.84 41.57 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.306 1.042 . . . . 0.0 110.648 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.589 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 63.8 t-80 -103.01 134.26 46.74 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.718 1.207 . . . . 0.0 108.489 173.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -52.15 -58.64 5.97 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.555 0.742 . . . . 0.0 112.192 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.2 mt -72.75 -57.3 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 122.492 0.317 . . . . 0.0 110.622 -176.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.5 t70 -64.58 -47.22 79.51 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.202 1.001 . . . . 0.0 112.841 -170.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -96.54 -58.17 2.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.559 0.344 . . . . 0.0 111.298 -173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 77' ' ' LEU . 90.4 mt -72.01 -27.58 62.83 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 122.994 0.518 . . . . 0.0 111.814 -175.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 15.82 62.37 Favored Glycine 0 N--CA 1.474 1.18 0 CA-C-O 120.084 -0.287 . . . . 0.0 113.322 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 59.3 mt -71.04 123.76 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.449 0.7 . . . . 0.0 109.454 177.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -76.97 148.05 36.52 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 177.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.7 t -58.42 -16.38 14.62 Favored 'General case' 0 CA--C 1.56 1.347 0 C-N-CA 123.678 0.791 . . . . 0.0 111.707 175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 72.8 mt -72.12 -51.99 18.82 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.343 1.057 . . . . 0.0 110.199 173.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -71.06 -27.18 63.46 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.347 0.659 . . . . 0.0 111.101 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -66.37 -22.23 66.25 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.745 0.818 . . . . 0.0 111.062 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 57' ' ' LEU . 90.0 mt -58.6 -38.58 78.28 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.216 0.606 . . . . 0.0 111.131 174.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -78.07 -28.54 48.86 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.231 0.612 . . . . 0.0 111.246 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 ' SG ' ' A' ' 16' ' ' CYS . 57.1 mt -62.82 -49.01 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 171.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' HB1' HD22 ' A' ' 55' ' ' LEU . . . -65.57 -32.62 74.3 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.473 -1.24 . . . . 0.0 111.129 -177.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.38 -43.2 77.85 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.918 0.762 . . . . 0.0 110.525 176.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.49 -32.14 73.32 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.657 0.783 . . . . 0.0 111.723 177.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.506 HG13 HG21 ' A' ' 11' ' ' ILE . 89.6 mt -67.45 -40.29 84.23 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 123.778 0.831 . . . . 0.0 110.617 176.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -54.26 -46.6 72.69 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.289 0.636 . . . . 0.0 110.399 174.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -69.71 -50.99 38.35 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.096 -176.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.472 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -64.47 -55.83 18.19 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.13 0.972 . . . . 0.0 112.379 -173.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -80.22 -20.44 44.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.753 0.821 . . . . 0.0 111.863 -175.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.33 41.04 39.04 Favored Glycine 0 C--N 1.35 1.352 0 N-CA-C 111.787 -0.525 . . . . 0.0 111.787 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 34.9 pt -125.48 175.73 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.412 0.685 . . . . 0.0 111.089 -175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -114.9 92.72 4.03 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 167.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.416 HD22 ' HB1' ' A' ' 44' ' ' ALA . 8.3 tt -74.53 114.29 32.5 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -89.03 83.97 0.6 Allowed 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.193 1.929 . . . . 0.0 111.311 177.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.658 HD23 HD23 ' A' ' 41' ' ' LEU . 37.4 tp -73.19 -28.31 62.13 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.298 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.45 -33.42 73.71 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.409 0.684 . . . . 0.0 110.746 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 49.9 tttp -73.38 -50.66 20.74 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.319 1.048 . . . . 0.0 110.261 173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -63.1 -45.91 89.85 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 123.654 0.782 . . . . 0.0 111.837 -172.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 33.5 m -61.72 -38.06 86.51 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.924 0.889 . . . . 0.0 110.954 174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.7 tp60 -63.92 -43.56 95.55 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 123.99 0.916 . . . . 0.0 110.686 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -64.81 -32.6 74.37 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.582 0.753 . . . . 0.0 110.798 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 55.6 t -68.33 -51.78 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 C-N-CA 123.347 0.659 . . . . 0.0 111.215 174.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -68.07 -22.01 64.95 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.518 0.727 . . . . 0.0 112.414 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -87.43 -12.89 44.79 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.842 1.257 . . . . 0.0 110.747 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.78 21.06 58.54 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-N 116.114 -0.494 . . . . 0.0 114.242 176.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -90.35 -54.48 3.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.623 177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -105.09 156.6 17.92 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.522 1.129 . . . . 0.0 110.64 -179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.8 p -100.07 159.15 15.32 Favored 'General case' 0 C--O 1.244 0.785 0 C-N-CA 123.52 0.728 . . . . 0.0 109.92 176.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.5 p -68.23 -29.57 68.42 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 171.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' HG23 ' A' ' 76' ' ' VAL . 35.8 tt0 -58.21 -44.39 88.12 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 122.991 0.517 . . . . 0.0 111.034 173.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -58.3 -30.93 67.03 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.705 0.802 . . . . 0.0 112.109 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -104.19 -77.78 0.57 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 59.9 m-85 -55.91 -24.1 35.52 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -163.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.589 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 87.0 t -61.11 124.28 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-N 119.732 1.151 . . . . 0.0 108.25 168.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.619 HD11 HD11 ' A' ' 33' ' ' LEU . 18.7 mt -60.51 -37.72 82.05 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.763 0.825 . . . . 0.0 112.935 -161.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.6 pttp -70.1 -36.35 74.8 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 123.501 0.501 . . . . 0.0 112.097 175.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -70.86 -44.45 66.36 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.895 0.878 . . . . 0.0 110.193 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 42.0 tp -53.06 -47.42 68.48 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.54 1.536 . . . . 0.0 110.672 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -66.86 -26.04 66.71 Favored 'General case' 0 C--O 1.216 -0.678 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.666 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.84 -42.5 49.43 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.762 0.425 . . . . 0.0 110.619 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -59.49 -43.58 93.28 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.215 1.006 . . . . 0.0 111.479 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.451 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.91 -39.19 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 115.188 -0.915 . . . . 0.0 110.289 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.409 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.5 t70 -54.09 -37.86 64.72 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.277 0.631 . . . . 0.0 111.518 170.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -68.26 -41.42 81.13 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.313 177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 83.0 mt -64.88 -42.97 94.38 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.462 0.705 . . . . 0.0 112.313 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 85' ' ' ASP . 16.8 m -74.0 -26.6 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 122.791 0.436 . . . . 0.0 110.564 178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.6 -36.46 65.52 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.619 0.368 . . . . 0.0 110.541 173.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -54.37 -49.87 68.8 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 124.655 1.182 . . . . 0.0 113.322 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -63.34 -36.38 83.51 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.078 0.236 . . . . 0.0 110.522 175.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.94 -23.0 78.46 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.515 0.509 . . . . 0.0 113.534 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -79.09 -35.8 41.78 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.205 1.002 . . . . 0.0 110.224 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.2 mt -66.1 -37.64 86.28 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.982 170.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -75.44 -7.41 54.0 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.772 0.829 . . . . 0.0 112.317 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -82.82 56.36 3.38 Favored 'General case' 0 CA--C 1.559 1.292 0 C-N-CA 124.247 1.019 . . . . 0.0 108.679 170.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.3 m170 67.16 -72.13 0.09 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.865 1.666 . . . . 0.0 112.775 -176.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 77.02 47.86 0.06 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.77 1.628 . . . . 0.0 109.756 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -79.32 136.62 37.06 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.489 173.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 65.0 m80 -79.78 151.28 30.43 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.141 0.576 . . . . 0.0 111.075 -178.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 . . . . . 0 C--O 1.249 1.057 0 C-N-CA 124.28 1.032 . . . . 0.0 108.692 176.063 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.481 1.09 0 CA-C-O 120.636 0.255 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.567 HG23 ' HE ' ' A' ' 7' ' ' ARG . 54.4 m -81.68 122.24 27.39 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 170.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.6 p -103.62 139.15 39.3 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 168.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.433 ' O ' HG23 ' A' ' 8' ' ' VAL . 38.9 m -58.87 -33.22 70.24 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.115 -179.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -65.33 -41.68 93.7 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 123.376 0.422 . . . . 0.0 111.35 177.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -59.51 -42.6 92.59 Favored 'General case' 0 N--CA 1.485 1.28 0 CA-C-O 121.559 0.695 . . . . 0.0 111.059 -177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.567 ' HE ' HG23 ' A' ' 2' ' ' THR . 23.7 mmt180 -71.29 -44.8 64.5 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 114.016 -1.447 . . . . 0.0 111.325 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 4' ' ' THR . 77.3 t -57.73 -41.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 CA-C-O 121.312 0.577 . . . . 0.0 110.522 173.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.8 -40.66 97.18 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.741 -1.118 . . . . 0.0 111.225 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -75.35 -30.35 60.22 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 117.76 0.254 . . . . 0.0 111.411 178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.534 HG21 HG13 ' A' ' 47' ' ' ILE . 28.7 mm -61.61 -52.93 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 46.9 mt -69.77 -32.07 50.75 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.921 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.46 69.17 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.597 0.759 . . . . 0.0 111.411 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -77.13 -53.82 7.29 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.253 0.621 . . . . 0.0 112.611 -176.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.3 m -63.65 -51.52 64.81 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.795 0.838 . . . . 0.0 111.306 -173.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 43.3 t -90.29 2.19 55.73 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 123.507 0.723 . . . . 0.0 111.798 -178.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 62.88 21.73 13.01 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.232 1.013 . . . . 0.0 112.697 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 46.2 mt -77.9 132.63 67.26 Favored Pre-proline 0 CA--C 1.55 0.96 0 C-N-CA 122.983 0.513 . . . . 0.0 110.636 -176.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -55.0 122.22 11.3 Favored 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 123.0 2.467 . . . . 0.0 112.452 171.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -61.82 -30.22 70.69 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.0 1.32 . . . . 0.0 111.342 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HG3' HG23 ' A' ' 22' ' ' THR . 12.5 pt-20 -63.34 -28.81 70.26 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.338 1.055 . . . . 0.0 112.355 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.425 HG23 ' HG3' ' A' ' 21' ' ' GLU . 34.9 p -100.35 -2.24 34.04 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.703 0.801 . . . . 0.0 111.381 -178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.7 mt -81.92 113.57 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 123.062 0.545 . . . . 0.0 109.825 176.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 72.0 p -119.6 160.41 42.21 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.132 0.973 . . . . 0.0 108.974 176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -62.18 -25.58 77.13 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.369 2.046 . . . . 0.0 111.801 173.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -81.71 -13.02 58.37 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.965 0.906 . . . . 0.0 111.53 -176.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.44 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 70.4 m -65.06 112.22 3.25 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.481 0.713 . . . . 0.0 111.597 178.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 60.8 t-80 -76.88 127.27 32.41 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -50.8 -50.39 56.31 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.3 mt -76.95 -55.06 11.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 122.555 0.342 . . . . 0.0 111.244 -177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 27.0 t70 -71.15 -43.49 67.43 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.45 0.7 . . . . 0.0 112.607 -170.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -96.78 -55.68 2.81 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.235 0.614 . . . . 0.0 111.331 -172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 77' ' ' LEU . 85.0 mt -76.05 -24.24 55.15 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.271 0.629 . . . . 0.0 111.596 -175.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.88 6.0 80.23 Favored Glycine 0 N--CA 1.476 1.3 0 CA-C-O 119.918 -0.379 . . . . 0.0 113.821 178.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -64.73 130.18 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.358 1.063 . . . . 0.0 110.815 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -97.59 162.76 13.14 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.051 0.94 . . . . 0.0 108.869 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.448 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 56.8 p -46.65 -34.18 4.84 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.265 1.426 . . . . 0.0 113.519 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 59.7 mt -77.56 -36.46 52.11 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.698 0.799 . . . . 0.0 110.866 -175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -70.14 -40.51 74.76 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.989 176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -68.57 -21.03 64.55 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.332 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 37' ' ' SER . 95.9 mt -55.56 -48.95 73.93 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.278 0.631 . . . . 0.0 110.95 175.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.23 -31.7 70.44 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.448 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 72.4 mt -65.68 -45.91 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.121 176.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.37 -35.15 79.45 Favored 'General case' 0 N--CA 1.479 0.991 0 O-C-N 123.874 0.734 . . . . 0.0 110.941 179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -63.97 -47.28 81.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.011 0.924 . . . . 0.0 110.835 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.99 -30.7 71.29 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.482 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.534 HG13 HG21 ' A' ' 11' ' ' ILE . 93.3 mt -70.65 -42.04 77.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 C-N-CA 123.492 0.717 . . . . 0.0 110.838 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -55.21 -40.72 71.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.721 0.808 . . . . 0.0 111.536 175.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -78.65 -51.23 10.17 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 114.894 -1.048 . . . . 0.0 111.351 -176.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.95 -46.01 69.26 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.404 0.682 . . . . 0.0 111.924 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -83.95 -17.21 41.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.057 0.543 . . . . 0.0 111.07 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 67.56 47.49 62.02 Favored Glycine 0 C--N 1.353 1.512 0 N-CA-C 111.774 -0.53 . . . . 0.0 111.774 -178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.454 HG22 ' HD3' ' A' ' 91' ' ' LYS . 47.6 pt -130.36 -175.81 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 123.685 0.794 . . . . 0.0 112.094 -172.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -122.39 94.88 4.43 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.05 1.34 . . . . 0.0 108.473 173.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.1 tt -84.54 111.86 37.72 Favored Pre-proline 0 CA--C 1.543 0.673 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 173.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -87.1 81.54 1.3 Allowed 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.079 1.852 . . . . 0.0 111.855 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 40.7 tp -71.15 -30.41 66.44 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.939 0.496 . . . . 0.0 110.446 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -54.05 -38.82 65.63 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.121 0.968 . . . . 0.0 111.315 173.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.7 ttpt -80.98 -46.38 15.17 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 115.311 -0.858 . . . . 0.0 110.205 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -55.85 -51.1 68.72 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.855 0.862 . . . . 0.0 110.975 -178.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.6 m -56.87 -47.11 81.2 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.402 1.081 . . . . 0.0 111.904 176.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -63.22 -45.25 92.49 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.863 0.865 . . . . 0.0 111.621 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 68' ' ' LYS . 23.1 mm-40 -70.72 -37.19 73.51 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.027 -174.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 83.4 t -67.29 -42.93 88.27 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 110.341 -0.244 . . . . 0.0 110.341 176.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -68.14 -20.96 64.94 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.542 0.737 . . . . 0.0 112.222 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -93.96 -7.52 42.68 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.454 0.702 . . . . 0.0 110.756 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 82.79 7.32 87.48 Favored Glycine 0 C--N 1.351 1.371 0 CA-C-N 116.224 -0.444 . . . . 0.0 113.565 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 63' ' ' GLU . 30.3 mmtp -68.91 -25.31 64.53 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.972 0.909 . . . . 0.0 110.934 175.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.83 166.19 30.26 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.734 0.813 . . . . 0.0 110.3 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.526 HG23 ' H ' ' A' ' 73' ' ' GLN . 6.1 t -105.1 151.72 23.65 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.784 0.834 . . . . 0.0 109.863 174.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 76.9 p -58.42 -34.63 70.99 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.497 0.719 . . . . 0.0 110.404 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.451 ' HA ' HG23 ' A' ' 76' ' ' VAL . 41.7 tt0 -55.68 -42.03 74.54 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.582 1.153 . . . . 0.0 111.785 179.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.526 ' H ' HG23 ' A' ' 70' ' ' THR . 29.5 tt0 -62.11 -29.79 70.57 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.874 0.869 . . . . 0.0 111.755 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.401 ' HD1' ' HG3' ' A' ' 83' ' ' ARG . 60.9 m-85 -104.05 -78.41 0.56 Allowed 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.014 177.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 86.3 m-85 -51.06 -29.31 12.51 Favored 'General case' 0 CA--C 1.56 1.336 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -165.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 66.1 t -62.33 125.83 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-N 119.819 1.191 . . . . 0.0 108.409 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.561 HD11 HD11 ' A' ' 33' ' ' LEU . 23.1 mt -59.65 -35.13 73.79 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -163.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HG2' HG12 ' A' ' 76' ' ' VAL . 64.1 pttt -63.24 -39.82 95.69 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 120.838 0.351 . . . . 0.0 111.431 173.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 -79.73 -40.59 28.52 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.223 1.009 . . . . 0.0 110.466 -175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 41.9 tp -54.67 -47.55 73.47 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.419 1.488 . . . . 0.0 110.288 169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.51 72.73 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.81 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.36 -43.92 66.01 Favored 'General case' 0 N--CA 1.477 0.898 0 O-C-N 123.439 0.462 . . . . 0.0 111.086 177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 22.9 mmm180 -62.6 -42.75 99.76 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.754 0.822 . . . . 0.0 111.357 177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 95.6 mt -72.25 -37.92 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.512 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.485 ' HA ' HG22 ' A' ' 88' ' ' VAL . 29.9 t70 -58.55 -36.52 74.02 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.203 0.601 . . . . 0.0 111.246 170.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -66.01 -44.73 83.91 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 86.4 mt -61.98 -45.56 93.08 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.868 0.867 . . . . 0.0 112.371 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.485 HG22 ' HA ' ' A' ' 85' ' ' ASP . 22.3 m -71.59 -34.36 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 C-N-CA 122.851 0.461 . . . . 0.0 110.948 -177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -72.93 -44.7 60.88 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 122.679 0.392 . . . . 0.0 110.689 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -66.62 -36.22 82.06 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.529 0.731 . . . . 0.0 112.932 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.454 ' HD3' HG22 ' A' ' 53' ' ' ILE . 52.3 pttt -65.58 -34.73 78.92 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 177.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -73.19 -37.91 54.81 Favored Glycine 0 C--N 1.354 1.558 0 O-C-N 123.714 0.634 . . . . 0.0 112.497 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -55.5 -31.14 61.79 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.753 1.221 . . . . 0.0 111.804 174.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.1 mt -89.87 -48.53 7.17 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.388 0.675 . . . . 0.0 111.49 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -69.31 -33.6 73.4 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 123.619 0.767 . . . . 0.0 112.642 -168.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -83.7 68.22 9.79 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.234 0.614 . . . . 0.0 110.497 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 29.1 p80 35.43 65.15 0.41 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.76 2.024 . . . . 0.0 114.371 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -125.66 109.37 12.53 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 41.1 t60 -85.07 75.89 10.31 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.111 0.964 . . . . 0.0 110.712 -166.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 63.36 24.0 14.0 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 124.934 1.294 . . . . 0.0 112.491 171.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 25.1 p80 . . . . . 0 N--CA 1.496 1.846 0 C-N-CA 126.157 1.783 . . . . 0.0 113.352 -175.04 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 53.4 m -91.69 120.06 32.11 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.526 0.73 . . . . 0.0 111.144 -175.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.2 p -98.06 143.36 28.69 Favored 'General case' 0 C--O 1.247 0.946 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 168.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 ' O ' HG23 ' A' ' 8' ' ' VAL . 9.1 m -61.6 -27.12 68.42 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.39 0.431 . . . . 0.0 110.417 177.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -64.68 -46.31 82.94 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.335 0.397 . . . . 0.0 110.884 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -57.35 -42.52 82.18 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 123.894 0.746 . . . . 0.0 111.299 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.433 ' O ' HG12 ' A' ' 11' ' ' ILE . 31.2 mmm-85 -70.12 -47.18 62.83 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.264 -177.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 4' ' ' THR . 95.6 t -58.4 -39.21 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.305 0.574 . . . . 0.0 110.698 173.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.59 -47.79 80.02 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.999 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 t -69.64 -25.44 63.92 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.587 0.355 . . . . 0.0 111.524 -178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.635 HG21 HG13 ' A' ' 47' ' ' ILE . 34.2 mm -61.99 -58.0 9.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 170.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.2 -30.13 48.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 O-C-N 123.89 0.744 . . . . 0.0 110.95 -176.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.35 -57.17 11.24 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.431 1.092 . . . . 0.0 111.622 176.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -76.8 -29.54 56.06 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.135 0.574 . . . . 0.0 112.17 -174.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 79.5 m -79.79 -60.23 2.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.597 0.759 . . . . 0.0 110.803 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.528 ' SG ' HD11 ' A' ' 43' ' ' ILE . 42.9 m -90.44 -3.95 57.33 Favored 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -172.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 33.4 t70 60.7 69.88 0.65 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.875 0.87 . . . . 0.0 110.129 -175.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.9 mt -133.51 116.32 13.93 Favored Pre-proline 0 N--CA 1.48 1.074 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 23.8 Cg_endo -58.74 145.66 95.21 Favored 'Trans proline' 0 C--N 1.376 1.985 0 C-N-CA 122.868 2.379 . . . . 0.0 112.313 179.373 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.488 ' HD2' HD12 ' A' ' 23' ' ' ILE . 55.6 mmm-85 -62.67 -25.32 68.09 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.343 1.057 . . . . 0.0 112.249 -175.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 19' ' ' PRO . 17.1 pt-20 -61.12 -41.27 96.4 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.881 0.872 . . . . 0.0 110.723 177.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.476 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.3 p -86.82 -12.71 47.16 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.424 0.69 . . . . 0.0 111.48 -178.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 ' HD2' ' A' ' 20' ' ' ARG . 76.0 mt -83.6 104.68 12.39 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.2 p -120.45 153.39 56.17 Favored Pre-proline 0 CA--C 1.544 0.719 0 C-N-CA 124.284 1.034 . . . . 0.0 109.335 -178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -62.0 -30.15 82.73 Favored 'Trans proline' 0 C--N 1.374 1.92 0 C-N-CA 122.64 2.226 . . . . 0.0 112.752 178.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -78.42 -15.78 58.3 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -179.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 44.3 t -66.46 134.86 53.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 122.942 0.497 . . . . 0.0 110.165 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 20.5 t-80 -103.27 134.7 46.23 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.899 1.279 . . . . 0.0 108.054 174.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.47 -58.47 6.19 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.169 0.588 . . . . 0.0 112.358 179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.9 mt -75.89 -49.02 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 CA-C-O 120.858 0.361 . . . . 0.0 110.822 -175.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.48 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 21.0 t70 -72.67 -37.38 67.93 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.646 0.778 . . . . 0.0 112.663 -170.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -107.64 -56.89 2.16 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 122.976 0.51 . . . . 0.0 110.814 -172.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 77' ' ' LEU . 91.5 mt -72.58 -20.39 61.31 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.771 0.829 . . . . 0.0 111.91 -176.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 78.54 8.78 87.49 Favored Glycine 0 C--N 1.351 1.383 0 O-C-N 123.213 0.32 . . . . 0.0 113.054 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.657 HD13 HD11 ' A' ' 43' ' ' ILE . 79.5 mt -72.79 106.56 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.222 1.009 . . . . 0.0 110.23 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.2 159.29 7.74 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.73 0.812 . . . . 0.0 111.645 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -62.15 -15.56 46.79 Favored 'General case' 0 CA--C 1.556 1.207 0 C-N-CA 123.354 0.662 . . . . 0.0 111.009 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 87.9 mt -78.97 -44.98 21.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 124.486 1.114 . . . . 0.0 110.376 174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.4 -26.82 62.01 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.29 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.5 t80 -73.0 -20.72 60.96 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 124.434 1.094 . . . . 0.0 111.112 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -55.99 -42.42 76.33 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 123.175 0.59 . . . . 0.0 110.4 176.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -72.08 -33.64 68.06 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 124.936 1.294 . . . . 0.0 110.793 -178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.657 HD11 HD13 ' A' ' 35' ' ' ILE . 58.0 mt -65.09 -48.2 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.204 0.602 . . . . 0.0 109.624 174.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.89 -34.85 76.79 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.003 -179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -67.05 -49.51 64.92 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 124.427 1.08 . . . . 0.0 111.081 177.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.65 -32.76 72.84 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 123.079 0.552 . . . . 0.0 111.849 -177.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.635 HG13 HG21 ' A' ' 11' ' ' ILE . 80.0 mt -67.78 -44.19 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 124.156 0.983 . . . . 0.0 110.135 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -52.34 -45.01 65.5 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.144 178.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -70.49 -50.7 35.26 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 114.626 -1.17 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 11' ' ' ILE . . . -60.04 -55.08 38.43 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.15 0.98 . . . . 0.0 112.301 -170.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.47 ' HB2' HG12 ' A' ' 53' ' ' ILE . 90.4 m-85 -82.05 -22.54 36.34 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.048 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.89 29.27 57.51 Favored Glycine 0 C--N 1.35 1.334 0 N-CA-C 111.971 -0.451 . . . . 0.0 111.971 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.47 HG12 ' HB2' ' A' ' 51' ' ' PHE . 31.9 pt -113.38 162.34 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.204 1.002 . . . . 0.0 109.632 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -95.1 103.45 15.3 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 170.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.6 tt -83.87 115.93 62.23 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -89.26 81.8 0.69 Allowed 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.227 1.951 . . . . 0.0 112.224 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.542 HD23 HD23 ' A' ' 41' ' ' LEU . 48.9 tp -73.29 -32.39 64.61 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.29 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.17 -34.83 72.57 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.293 0.637 . . . . 0.0 111.186 177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -72.94 -46.64 51.33 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.85 177.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 45.2 m0 -62.8 -46.83 86.14 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.704 0.802 . . . . 0.0 111.303 -175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.7 m -56.41 -45.56 80.61 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.819 1.248 . . . . 0.0 111.269 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -64.03 -38.49 91.26 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.889 0.876 . . . . 0.0 110.975 -178.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -63.4 -33.74 76.2 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.668 0.787 . . . . 0.0 110.751 177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 98.2 t -70.95 -43.9 76.26 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 122.847 0.459 . . . . 0.0 110.433 174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 -56.2 -39.25 72.15 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.623 0.769 . . . . 0.0 112.65 177.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -84.24 -3.72 58.38 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.21 19.35 79.82 Favored Glycine 0 C--N 1.344 1.02 0 CA-C-N 117.973 0.351 . . . . 0.0 113.178 -177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -82.18 -58.96 2.72 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.361 0.665 . . . . 0.0 109.668 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.63 161.72 15.11 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.054 0.941 . . . . 0.0 110.211 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.2 p -105.74 165.34 11.24 Favored 'General case' 0 C--O 1.245 0.824 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.893 175.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 72.8 p -65.08 -29.95 70.86 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.203 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -59.79 -44.84 93.75 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.662 0.785 . . . . 0.0 111.642 176.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -58.68 -33.01 69.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.301 0.64 . . . . 0.0 112.291 -175.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -108.0 -64.76 1.18 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.561 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 31.8 m-85 -61.78 -21.79 64.88 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 -167.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.609 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.5 t -62.13 129.24 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 CA-C-N 119.614 1.097 . . . . 0.0 108.424 170.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.507 HD11 HD11 ' A' ' 33' ' ' LEU . 32.0 mt -60.8 -38.41 85.27 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -165.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HG2' HG12 ' A' ' 76' ' ' VAL . 23.0 pttp -64.52 -38.22 90.25 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 173.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.1 m-20 -69.71 -48.92 57.84 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.57 0.748 . . . . 0.0 110.172 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.7 tp -52.08 -48.51 64.64 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.774 1.63 . . . . 0.0 110.825 173.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -63.1 -31.03 72.07 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.72 178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.55 -42.38 64.75 Favored 'General case' 0 N--CA 1.483 1.184 0 O-C-N 123.458 0.474 . . . . 0.0 111.306 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 30.1 mmm180 -60.99 -40.6 94.12 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 123.698 0.799 . . . . 0.0 111.492 176.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.482 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -74.61 -42.52 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.417 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -51.95 -38.28 55.95 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.076 0.95 . . . . 0.0 111.294 170.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -66.08 -44.86 83.21 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.951 178.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 91.2 mt -68.21 -38.83 82.34 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 123.725 0.81 . . . . 0.0 112.08 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -73.01 -31.39 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 CA-C-O 120.911 0.386 . . . . 0.0 110.757 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.85 -40.82 92.06 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.027 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.7 -51.18 68.17 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 124.325 1.015 . . . . 0.0 112.906 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -71.12 -33.51 70.18 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.153 0.181 . . . . 0.0 111.315 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.42 -27.3 72.87 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 116.424 -0.353 . . . . 0.0 113.597 172.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.28 -33.81 63.37 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.2 mt -72.02 -35.29 69.35 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.449 0.7 . . . . 0.0 110.415 175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -68.08 89.42 0.3 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.82 0.848 . . . . 0.0 110.256 178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 15.8 t60 55.66 85.81 0.06 Allowed 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.758 1.223 . . . . 0.0 110.044 -176.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -75.92 74.56 2.83 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.316 0.647 . . . . 0.0 110.723 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 175.43 55.62 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 127.156 2.182 . . . . 0.0 106.86 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -86.3 89.99 8.03 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.803 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -74.07 -34.91 64.18 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.387 -176.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.603 -0.713 . . . . 0.0 109.505 -175.764 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 mmt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.61 HG21 ' HE ' ' A' ' 7' ' ' ARG . 91.0 m -90.91 132.4 35.95 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.16 0.984 . . . . 0.0 110.069 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.6 m -65.62 137.31 57.26 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 122.825 0.45 . . . . 0.0 110.267 173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 8' ' ' VAL . 53.5 m -55.58 -36.39 66.83 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 123.95 0.781 . . . . 0.0 111.044 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -60.83 -42.64 98.15 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.805 0.69 . . . . 0.0 111.517 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -58.63 -40.73 84.18 Favored 'General case' 0 N--CA 1.479 1.001 0 O-C-N 123.867 0.73 . . . . 0.0 111.271 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.61 ' HE ' HG21 ' A' ' 2' ' ' THR . 19.6 mmt180 -75.81 -39.18 57.28 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.128 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 4' ' ' THR . 94.5 t -60.4 -39.38 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 CA-C-O 121.004 0.43 . . . . 0.0 110.565 174.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.36 -46.05 88.32 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.519 1.127 . . . . 0.0 111.054 -176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -69.35 -31.76 70.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 119.373 -0.346 . . . . 0.0 111.223 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.575 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -59.09 -53.64 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 174.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.1 mt -61.03 -38.21 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.972 0.909 . . . . 0.0 111.092 -178.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.91 -51.81 68.1 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.74 0.816 . . . . 0.0 111.345 177.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -73.29 -40.53 64.49 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.774 0.83 . . . . 0.0 112.568 -175.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.427 ' OG1' HG12 ' A' ' 43' ' ' ILE . 18.1 p -76.86 -58.41 3.3 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.06 0.544 . . . . 0.0 111.416 -177.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.485 ' SG ' HG12 ' A' ' 35' ' ' ILE . 48.4 t -84.79 -0.97 55.7 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.829 0.852 . . . . 0.0 112.426 -172.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 58.55 45.19 16.65 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.22 1.008 . . . . 0.0 112.069 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 64.4 mt -102.34 130.76 23.49 Favored Pre-proline 0 N--CA 1.469 0.525 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.843 177.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_exo -52.9 128.33 28.32 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.543 2.162 . . . . 0.0 111.464 175.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 34.4 tpt85 -56.72 -36.72 70.04 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.014 0.926 . . . . 0.0 110.864 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.54 -32.64 74.35 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.652 1.181 . . . . 0.0 112.614 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 82.1 p -82.74 -10.05 59.07 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 122.556 0.342 . . . . 0.0 111.717 -177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.0 mt -78.61 110.39 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 C-N-CA 123.268 0.627 . . . . 0.0 110.035 178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 75.7 p -117.39 148.77 43.42 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.359 1.064 . . . . 0.0 109.54 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -51.29 -41.4 58.86 Favored 'Trans proline' 0 C--N 1.38 2.202 0 C-N-CA 122.976 2.451 . . . . 0.0 113.833 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.01 -16.64 59.24 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.293 0.637 . . . . 0.0 111.984 -172.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.442 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 33.5 t -63.43 132.16 50.52 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.567 0.747 . . . . 0.0 110.672 -177.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 59.2 t-80 -89.87 128.48 36.2 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.57 -64.15 0.88 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.696 0.799 . . . . 0.0 112.475 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.5 mt -72.06 -35.79 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -172.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.491 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 26.2 t70 -82.32 -67.99 0.74 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.521 0.328 . . . . 0.0 111.114 -176.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -73.39 -51.37 17.58 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.305 0.642 . . . . 0.0 110.776 -169.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 77' ' ' LEU . 87.6 mt -81.84 -18.34 44.28 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.423 0.689 . . . . 0.0 111.546 -178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.48 36.86 78.07 Favored Glycine 0 C--N 1.346 1.096 0 O-C-N 123.191 0.307 . . . . 0.0 113.809 177.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.485 HG12 ' SG ' ' A' ' 16' ' ' CYS . 54.7 mt -85.16 133.72 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 123.935 0.894 . . . . 0.0 109.691 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.25 154.21 31.2 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.2 t -66.22 -17.94 65.05 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.641 0.376 . . . . 0.0 110.374 171.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.06 -42.65 18.94 Favored 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.367 1.067 . . . . 0.0 109.901 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.08 -32.97 73.68 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.539 0.736 . . . . 0.0 110.121 176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -66.92 -21.32 65.99 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.007 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 57' ' ' LEU . 90.3 mt -59.47 -35.91 74.98 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.085 0.554 . . . . 0.0 111.816 178.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -77.01 -35.55 56.95 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.333 0.653 . . . . 0.0 110.221 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.438 HD11 ' HB2' ' A' ' 16' ' ' CYS . 55.1 mt -60.29 -50.61 79.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' HA ' HD12 ' A' ' 47' ' ' ILE . . . -66.87 -32.76 74.23 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.831 -176.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -69.43 -40.12 77.43 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.15 176.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.78 70.13 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.949 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.575 HG13 HG21 ' A' ' 11' ' ' ILE . 87.7 mt -66.96 -40.64 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 124.076 0.95 . . . . 0.0 110.743 173.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -58.28 -45.39 87.99 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.231 0.612 . . . . 0.0 110.941 174.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -80.82 -27.36 36.58 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.546 0.738 . . . . 0.0 112.63 -173.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.41 -53.7 5.52 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.166 0.587 . . . . 0.0 110.495 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.479 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 90.6 m-85 -87.62 -23.83 24.15 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.962 0.905 . . . . 0.0 111.201 -173.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.34 39.72 30.36 Favored Glycine 0 C--N 1.347 1.142 0 N-CA-C 111.831 -0.508 . . . . 0.0 111.831 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 33.3 pt -126.06 -177.99 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.272 1.029 . . . . 0.0 110.26 -178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -124.71 109.12 12.74 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 tt -92.69 106.46 18.76 Favored Pre-proline 0 CA--C 1.555 1.141 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -83.09 82.89 2.04 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 121.778 1.652 . . . . 0.0 111.693 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.422 HD23 HD23 ' A' ' 41' ' ' LEU . 57.2 tp -69.11 -34.92 75.82 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.578 0.751 . . . . 0.0 110.904 -174.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -56.75 -36.97 70.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.285 1.034 . . . . 0.0 110.976 178.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 16.8 ttpp -87.77 -34.74 18.21 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.908 -177.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -62.52 -43.86 97.79 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 123.505 0.722 . . . . 0.0 110.969 178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 64.9 m -63.98 -33.5 75.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.931 0.892 . . . . 0.0 110.604 173.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.4 tp60 -72.48 -29.83 64.0 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.358 0.663 . . . . 0.0 111.585 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 30.8 mm-40 -58.46 -39.93 81.26 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-O 121.55 0.69 . . . . 0.0 109.475 171.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 44.0 t -69.03 -47.34 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.46 176.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -57.51 -44.05 84.71 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.034 0.934 . . . . 0.0 112.612 -177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -86.1 -13.67 46.55 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.003 0.921 . . . . 0.0 111.321 -175.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.35 18.88 61.53 Favored Glycine 0 C--N 1.347 1.159 0 N-CA-C 113.804 0.282 . . . . 0.0 113.804 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -64.81 -34.84 79.31 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.45 0.7 . . . . 0.0 110.336 171.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -158.57 171.23 20.5 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.877 -173.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 38.9 p -100.83 157.74 16.5 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.809 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.63 -32.09 68.71 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.448 178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HG3' HG21 ' A' ' 76' ' ' VAL . 45.1 tt0 -55.87 -41.56 74.57 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.095 1.358 . . . . 0.0 111.682 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.58 -21.7 64.5 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.898 0.879 . . . . 0.0 112.584 -174.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -121.46 -6.38 9.27 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -174.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 82.0 m-85 -126.9 -26.9 3.1 Favored 'General case' 0 N--CA 1.484 1.242 0 CA-C-O 118.595 -0.716 . . . . 0.0 112.805 -172.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 58.0 t -61.26 126.44 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 167.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.703 HD11 HD11 ' A' ' 33' ' ' LEU . 36.9 mt -59.07 -35.43 73.35 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 124.089 0.868 . . . . 0.0 112.642 -161.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HG3' HG12 ' A' ' 76' ' ' VAL . 0.0 OUTLIER -69.85 -36.4 75.52 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 175.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.41 ' N ' ' HD2' ' A' ' 78' ' ' LYS . 80.8 m-20 -71.43 -48.31 50.36 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.116 0.966 . . . . 0.0 110.235 177.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.9 tp -50.44 -50.74 51.33 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 110.987 171.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.76 -22.12 61.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.826 0.851 . . . . 0.0 111.696 -177.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.94 -39.29 56.43 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 123.563 0.539 . . . . 0.0 110.384 173.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.415 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 24.1 mmm180 -70.65 -32.2 69.41 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 123.298 0.639 . . . . 0.0 111.486 175.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.34 -39.55 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HA ' HG22 ' A' ' 88' ' ' VAL . 34.7 t70 -58.2 -37.94 75.77 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.421 0.689 . . . . 0.0 111.567 170.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 83' ' ' ARG . 7.5 tp10 -59.08 -47.79 83.95 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.189 0.995 . . . . 0.0 110.196 174.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 87.8 mt -67.6 -41.11 84.58 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 124.034 0.934 . . . . 0.0 113.112 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 85' ' ' ASP . 17.3 m -75.73 -28.4 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.997 -0.439 . . . . 0.0 111.032 -179.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.59 -29.67 56.66 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 172.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.9 -48.07 80.94 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.274 0.63 . . . . 0.0 112.462 170.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.479 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 19.9 pttp -70.93 -36.58 72.69 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -64.22 -22.36 67.09 Favored Glycine 0 C--N 1.362 2.01 0 C-N-CA 123.485 0.564 . . . . 0.0 113.766 174.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.11 -34.39 73.06 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.795 -0.702 . . . . 0.0 109.338 174.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 30.2 mt -82.77 -34.46 27.07 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.375 1.07 . . . . 0.0 110.264 177.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 47.5 mt-10 -73.01 102.17 3.43 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.254 1.022 . . . . 0.0 109.878 -178.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -84.69 91.3 7.9 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -77.59 -51.73 10.19 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.59 0.756 . . . . 0.0 110.884 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 52.4 m-70 60.11 53.77 4.4 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.54 1.136 . . . . 0.0 109.832 -173.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -80.31 136.02 36.33 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.38 -176.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -59.93 131.98 52.54 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.545 0.738 . . . . 0.0 110.659 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 . . . . . 0 CA--C 1.554 1.106 0 C-N-CA 123.838 0.855 . . . . 0.0 109.165 179.869 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 ttp . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.1 m -142.87 131.06 21.96 Favored 'General case' 0 C--N 1.35 0.606 0 C-N-CA 123.528 0.731 . . . . 0.0 109.881 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -64.86 137.3 57.68 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 123.723 0.809 . . . . 0.0 110.545 177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 HG21 ' HB2' ' A' ' 85' ' ' ASP . 7.8 m -60.35 -26.83 66.89 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 123.419 0.449 . . . . 0.0 111.493 -176.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -68.32 -46.31 70.58 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -54.65 -42.15 70.96 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.39 0.676 . . . . 0.0 111.057 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.405 ' O ' HG12 ' A' ' 11' ' ' ILE . 4.9 mmp_? -60.88 -58.03 10.14 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.473 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 92.9 t -59.23 -37.67 70.1 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.297 1.039 . . . . 0.0 111.528 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HB1' HG21 ' A' ' 23' ' ' ILE . . . -68.01 -43.08 79.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.647 1.179 . . . . 0.0 110.657 -175.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.9 m -62.01 -40.95 97.41 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.452 0.701 . . . . 0.0 111.395 174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 7' ' ' ARG . 42.0 mm -61.98 -50.81 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 123.298 0.639 . . . . 0.0 110.579 179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.56 -34.69 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.723 0.809 . . . . 0.0 111.006 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.36 -50.51 73.4 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.962 176.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -75.46 -50.89 14.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 -176.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' HA ' ' A' ' 43' ' ' ILE . 10.1 m -62.79 -46.94 85.66 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.436 0.694 . . . . 0.0 111.199 -173.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 34.6 t -93.31 7.64 43.59 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.879 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 59.99 21.15 10.23 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 124.881 1.273 . . . . 0.0 113.011 176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.9 mt -77.15 138.25 64.79 Favored Pre-proline 0 CA--C 1.548 0.898 0 C-N-CA 123.331 0.652 . . . . 0.0 109.842 -179.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -58.76 121.02 9.27 Favored 'Trans proline' 0 C--N 1.371 1.728 0 C-N-CA 122.102 1.868 . . . . 0.0 111.291 167.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.37 -29.46 67.71 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.163 0.585 . . . . 0.0 110.634 176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -57.96 -33.67 69.11 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.064 0.945 . . . . 0.0 112.312 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.2 p -88.84 -18.61 27.29 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.408 0.683 . . . . 0.0 111.575 -177.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.406 HG21 ' HB1' ' A' ' 9' ' ' ALA . 41.4 mt -72.94 111.14 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 C-N-CA 123.625 0.77 . . . . 0.0 111.334 -177.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.9 p -111.03 161.41 25.12 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 124.265 1.026 . . . . 0.0 108.989 175.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -65.17 -24.31 59.08 Favored 'Trans proline' 0 C--N 1.375 1.948 0 C-N-CA 122.225 1.95 . . . . 0.0 111.494 172.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -72.18 -23.73 61.31 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.75 1.22 . . . . 0.0 110.944 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.468 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 66.5 m -61.88 119.39 8.71 Favored 'General case' 0 C--N 1.35 0.63 0 O-C-N 123.737 0.648 . . . . 0.0 111.161 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.656 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 40.4 t-80 -86.05 127.9 34.76 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 168.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -48.81 -54.02 16.85 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.133 0.573 . . . . 0.0 111.799 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -77.3 -58.93 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-O 120.497 0.189 . . . . 0.0 110.776 -177.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -66.65 -47.27 73.06 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.324 0.65 . . . . 0.0 112.693 -168.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -91.7 -51.69 5.12 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.615 . . . . 0.0 111.852 -172.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 77' ' ' LEU . 87.9 mt -79.31 -42.66 25.26 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 122.92 0.488 . . . . 0.0 110.266 -174.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 113.16 -7.49 25.1 Favored Glycine 0 N--CA 1.471 0.976 0 CA-C-N 116.153 -0.476 . . . . 0.0 113.313 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 52.8 mt -58.4 112.44 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 124.337 1.055 . . . . 0.0 111.1 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -76.38 160.32 29.68 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 176.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 p -58.93 -15.43 12.85 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 123.678 0.791 . . . . 0.0 112.859 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 95.2 mt -86.18 -38.67 17.43 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.972 0.909 . . . . 0.0 110.806 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.79 -32.7 67.9 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.675 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.97 -19.16 64.15 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.513 -179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 57' ' ' LEU . 90.4 mt -60.19 -42.11 94.36 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 122.847 0.459 . . . . 0.0 110.246 174.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -65.25 -42.3 93.45 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.858 1.263 . . . . 0.0 110.584 176.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.497 ' HA ' HG21 ' A' ' 15' ' ' THR . 55.8 mt -67.64 -41.62 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.391 0.676 . . . . 0.0 111.004 178.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.96 -32.0 73.51 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.994 -176.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -65.45 -43.57 89.98 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.6 1.188 . . . . 0.0 110.962 175.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.36 -32.92 74.17 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.782 0.433 . . . . 0.0 111.355 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.417 HD13 HD11 ' A' ' 84' ' ' ILE . 96.9 mt -68.84 -40.01 80.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 123.343 0.657 . . . . 0.0 110.17 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -53.42 -50.86 64.31 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.218 0.607 . . . . 0.0 110.677 174.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -73.25 -48.47 34.57 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.695 -172.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.78 -44.38 73.78 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.347 0.659 . . . . 0.0 111.571 -171.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -90.92 -11.31 39.49 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.946 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 69.83 29.38 71.04 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.235 0.335 . . . . 0.0 112.837 178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.24 175.3 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 124.061 0.944 . . . . 0.0 111.019 -175.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 tttm -116.59 92.71 3.95 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 173.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.5 tt -78.18 114.09 39.32 Favored Pre-proline 0 CA--C 1.54 0.569 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -87.99 85.86 0.67 Allowed 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.185 1.924 . . . . 0.0 112.401 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.578 HD23 HD23 ' A' ' 41' ' ' LEU . 51.7 tp -72.5 -30.4 64.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.6 -30.79 68.92 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.005 0.522 . . . . 0.0 111.404 176.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -70.39 -55.48 8.97 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.163 0.985 . . . . 0.0 108.659 172.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 42.2 m0 -61.1 -48.46 81.59 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.665 1.186 . . . . 0.0 112.879 -168.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.2 m -60.0 -44.3 94.63 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.664 0.786 . . . . 0.0 111.682 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -70.36 -30.86 67.89 Favored 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 123.287 0.635 . . . . 0.0 110.684 -177.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -63.3 -40.36 97.14 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.458 0.703 . . . . 0.0 110.723 175.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.638 HG11 HG23 ' A' ' 71' ' ' THR . 60.3 t -66.96 -42.82 89.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.215 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.16 -31.07 65.01 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.691 0.796 . . . . 0.0 112.7 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -102.24 -14.64 16.91 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.938 0.495 . . . . 0.0 111.45 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.16 24.1 64.53 Favored Glycine 0 CA--C 1.528 0.892 0 CA-C-N 116.314 -0.403 . . . . 0.0 113.706 -174.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -63.57 -31.26 72.37 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 117.291 0.546 . . . . 0.0 109.607 168.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.18 166.56 31.19 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.616 1.166 . . . . 0.0 109.773 -175.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 47.6 p -99.29 158.69 15.53 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 123.7 0.8 . . . . 0.0 110.972 -178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.638 HG23 HG11 ' A' ' 64' ' ' VAL . 38.5 p -64.49 -32.34 73.94 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 168.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.519 ' HA ' HG23 ' A' ' 76' ' ' VAL . 36.8 tt0 -55.63 -46.34 77.44 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.569 0.747 . . . . 0.0 111.033 175.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -57.44 -34.84 69.38 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.812 0.845 . . . . 0.0 112.58 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -104.43 -75.5 0.62 Allowed 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.536 -176.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 85.9 m-85 -58.18 -26.16 62.42 Favored 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 125.275 1.43 . . . . 0.0 114.844 -165.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.656 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 93.9 t -61.48 124.72 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-N 120.001 1.273 . . . . 0.0 108.257 171.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD11 HD11 ' A' ' 33' ' ' LEU . 34.7 mt -61.96 -33.59 74.56 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 -162.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.452 ' HG2' HG12 ' A' ' 76' ' ' VAL . 22.4 pttp -69.41 -36.48 76.76 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 173.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -72.69 -44.24 62.04 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.61 0.764 . . . . 0.0 109.878 178.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.4 tp -53.81 -43.97 69.8 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 126.171 1.788 . . . . 0.0 111.367 170.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -60.02 -34.35 73.25 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 123.815 0.697 . . . . 0.0 110.759 176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.02 -44.4 65.92 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -62.68 -44.06 97.22 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.542 0.737 . . . . 0.0 111.484 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 47' ' ' ILE . 87.0 mt -69.52 -43.07 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 123.574 0.749 . . . . 0.0 110.154 179.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.523 ' HB2' HG21 ' A' ' 4' ' ' THR . 22.1 t70 -53.74 -39.87 65.68 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.983 0.513 . . . . 0.0 111.652 173.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -59.66 -48.37 81.94 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.415 0.626 . . . . 0.0 110.639 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.68 -39.03 80.78 Favored 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 114.698 -1.137 . . . . 0.0 112.396 -177.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 91' ' ' LYS . 16.7 m -76.53 -33.89 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 122.661 0.384 . . . . 0.0 110.802 -177.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -67.15 -21.86 65.8 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.028 179.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.404 ' O ' ' HG ' ' A' ' 94' ' ' LEU . . . -53.33 -55.15 27.09 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 123.68 0.612 . . . . 0.0 112.398 173.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 88' ' ' VAL . 0.4 OUTLIER -61.36 -37.68 84.25 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 120.876 0.37 . . . . 0.0 110.425 -178.938 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.04 -32.7 69.52 Favored Glycine 0 C--N 1.353 1.49 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.551 176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.23 -35.88 63.88 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.311 0.644 . . . . 0.0 109.804 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 90' ' ' ALA . 61.8 mt -73.06 -35.05 66.6 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.373 172.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 71.05 -60.16 0.52 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 126.045 1.738 . . . . 0.0 110.506 -175.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -59.75 117.23 4.73 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.357 1.063 . . . . 0.0 109.919 164.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -64.03 146.02 54.88 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.428 0.691 . . . . 0.0 110.456 175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -103.2 32.8 3.57 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.528 0.731 . . . . 0.0 111.877 -172.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 61.8 t-80 -78.34 74.82 4.88 Favored 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 121.839 0.828 . . . . 0.0 110.143 178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -162.5 17.92 0.09 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.859 1.663 . . . . 0.0 108.17 174.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.854 1.262 . . . . 0.0 108.641 -176.722 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ptm . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.0 t -82.01 121.79 26.99 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 167.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -92.38 -179.43 5.21 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.51 0.724 . . . . 0.0 111.282 -172.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 8' ' ' VAL . 71.3 m -58.49 -40.5 82.95 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.701 0.8 . . . . 0.0 110.81 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -59.67 -45.99 90.41 Favored 'General case' 0 N--CA 1.476 0.848 0 O-C-N 123.835 0.709 . . . . 0.0 110.941 176.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.18 -36.35 79.6 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.493 0.717 . . . . 0.0 111.363 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 7' ' ' ARG . 5.4 mmt-85 -68.32 -47.98 66.11 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 123.694 0.621 . . . . 0.0 111.422 176.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 4' ' ' THR . 97.6 t -59.62 -37.13 69.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 CA-C-O 121.708 0.766 . . . . 0.0 110.269 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.25 -48.27 73.86 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.005 -178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.3 t -72.14 -23.01 61.23 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 122.425 0.29 . . . . 0.0 111.553 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HG21 HG13 ' A' ' 47' ' ' ILE . 28.0 mm -59.59 -58.62 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 167.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 75.7 mt -65.85 -30.04 48.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 O-C-N 123.925 0.765 . . . . 0.0 111.044 -174.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.37 -53.61 54.41 Favored 'General case' 0 C--N 1.346 0.454 0 C-N-CA 124.502 1.121 . . . . 0.0 111.64 176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.2 -34.53 59.27 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 122.595 0.358 . . . . 0.0 111.703 -178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.2 m -71.75 -60.48 2.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.775 0.83 . . . . 0.0 111.292 -177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.556 ' SG ' HD11 ' A' ' 43' ' ' ILE . 61.1 m -96.06 4.13 52.82 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.611 0.764 . . . . 0.0 112.321 -173.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 56.31 33.47 22.33 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 124.27 1.028 . . . . 0.0 112.599 179.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 68.4 mt -93.08 123.95 59.53 Favored Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -53.16 137.5 63.12 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.937 2.425 . . . . 0.0 112.681 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -60.4 -33.18 72.12 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 123.5 0.72 . . . . 0.0 111.127 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -66.04 -28.47 68.88 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.975 0.91 . . . . 0.0 111.817 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.3 p -88.84 -20.34 24.77 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.781 0.432 . . . . 0.0 110.718 177.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 85.1 mt -74.86 123.32 30.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 123.511 0.724 . . . . 0.0 109.227 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 26.6 p -136.35 157.54 75.23 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.347 1.059 . . . . 0.0 109.602 -177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_exo -59.84 -32.5 95.46 Favored 'Trans proline' 0 C--N 1.374 1.91 0 C-N-CA 122.228 1.952 . . . . 0.0 112.263 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.49 -28.47 61.02 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.415 0.686 . . . . 0.0 112.123 -173.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.476 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 30.9 p -72.76 118.51 15.78 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 120.922 0.391 . . . . 0.0 111.496 -173.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.701 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 62.0 t-80 -68.67 129.36 39.69 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 124.018 0.927 . . . . 0.0 109.267 167.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -49.2 -58.04 5.68 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.251 0.621 . . . . 0.0 112.46 177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 26.9 mt -72.9 -44.76 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.304 0.241 . . . . 0.0 111.447 -174.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 22.1 t70 -75.48 -64.04 1.15 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 122.29 0.236 . . . . 0.0 111.164 -174.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -77.72 -48.75 15.93 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -172.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 77' ' ' LEU . 82.1 mt -79.84 -27.66 40.17 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 122.254 0.222 . . . . 0.0 111.281 -177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.57 26.12 47.88 Favored Glycine 0 C--N 1.345 1.069 0 CA-C-N 116.426 -0.352 . . . . 0.0 113.413 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.489 HD13 HD11 ' A' ' 43' ' ' ILE . 66.3 mt -80.69 133.1 30.15 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 C-N-CA 123.93 0.892 . . . . 0.0 109.748 178.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -90.63 153.89 19.98 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 58.1 m -61.58 -15.94 43.47 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 39.2 mt -84.21 -32.8 24.32 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-O 121.625 0.726 . . . . 0.0 109.661 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -79.85 -27.87 40.1 Favored 'General case' 0 CA--C 1.549 0.939 0 CA-C-N 114.495 -1.229 . . . . 0.0 110.143 177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -73.7 -21.25 60.3 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.319 1.048 . . . . 0.0 110.282 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 57' ' ' LEU . 88.9 mt -56.04 -42.5 76.64 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.073 0.549 . . . . 0.0 110.143 174.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -64.77 -38.13 89.94 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.894 0.878 . . . . 0.0 110.986 178.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.556 HD11 ' SG ' ' A' ' 16' ' ' CYS . 74.0 mt -62.26 -51.83 67.55 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 123.119 0.568 . . . . 0.0 110.371 176.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.35 -40.07 95.19 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 114.783 -1.099 . . . . 0.0 110.74 -176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -67.73 -39.21 84.28 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.818 0.847 . . . . 0.0 111.311 -179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.38 -31.39 69.74 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.682 178.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.481 HG13 HG21 ' A' ' 11' ' ' ILE . 81.2 mt -69.82 -40.92 79.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.95 0.9 . . . . 0.0 110.822 175.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -54.32 -42.34 70.04 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.491 0.716 . . . . 0.0 111.126 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -76.78 -48.48 18.5 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.458 -177.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.91 -51.12 63.64 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.489 -171.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.453 ' HB2' HG12 ' A' ' 53' ' ' ILE . 78.4 m-85 -85.44 -24.91 27.25 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.741 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 76.63 34.17 44.97 Favored Glycine 0 C--N 1.349 1.265 0 O-C-N 123.48 0.487 . . . . 0.0 112.114 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.453 HG12 ' HB2' ' A' ' 51' ' ' PHE . 32.2 pt -121.88 173.51 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 124.447 1.099 . . . . 0.0 109.649 -177.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -100.14 110.56 22.83 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.401 HD12 HG21 ' A' ' 47' ' ' ILE . 7.6 tt -96.36 104.17 16.58 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 168.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -83.92 84.27 1.61 Allowed 'Trans proline' 0 C--N 1.369 1.645 0 C-N-CA 122.04 1.827 . . . . 0.0 111.521 176.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.631 HD23 HD23 ' A' ' 41' ' ' LEU . 61.2 tp -69.17 -30.6 68.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.64 176.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -58.35 -36.21 73.11 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.919 0.888 . . . . 0.0 111.059 174.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 54.7 tttp -77.69 -46.62 21.36 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.938 0.895 . . . . 0.0 110.361 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -66.88 -38.66 86.72 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.088 0.555 . . . . 0.0 111.539 -172.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.3 m -66.51 -35.64 80.73 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.704 0.802 . . . . 0.0 110.522 171.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -67.93 -34.8 77.29 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.135 0.974 . . . . 0.0 110.653 179.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 61.4 mm-40 -58.13 -41.89 84.62 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 174.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.47 -47.26 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.706 0.802 . . . . 0.0 110.4 177.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -60.92 -27.99 68.6 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 124.865 1.266 . . . . 0.0 112.806 -176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -100.78 -8.62 22.51 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.796 0.839 . . . . 0.0 112.252 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.72 15.78 81.3 Favored Glycine 0 N--CA 1.473 1.116 0 O-C-N 122.812 0.07 . . . . 0.0 113.139 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -71.55 -21.94 61.82 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.581 1.152 . . . . 0.0 110.347 175.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.34 168.89 25.25 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 124.431 1.093 . . . . 0.0 109.457 177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 73' ' ' GLN . 10.0 t -101.3 158.76 15.8 Favored 'General case' 0 C--O 1.245 0.829 0 C-N-CA 123.735 0.814 . . . . 0.0 109.64 175.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -61.99 -31.59 71.97 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 114.728 -1.124 . . . . 0.0 110.085 178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -63.44 -36.76 84.81 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.972 0.909 . . . . 0.0 111.843 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.427 ' H ' HG23 ' A' ' 70' ' ' THR . 28.3 tt0 -63.36 -29.05 70.42 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.176 0.59 . . . . 0.0 111.928 -173.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -107.69 -64.13 1.24 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.391 0.277 . . . . 0.0 111.436 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -61.28 -20.79 63.28 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -167.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.701 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 62.0 t -65.63 131.99 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 CA-C-N 119.862 1.21 . . . . 0.0 108.894 171.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.77 HD11 HD11 ' A' ' 33' ' ' LEU . 25.2 mt -59.96 -36.41 77.05 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -165.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.6 pttt -58.7 -43.1 89.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 123.454 0.471 . . . . 0.0 111.056 173.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.456 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 84.0 m-20 -76.47 -46.2 27.85 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.298 1.039 . . . . 0.0 110.308 -174.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.5 tp -50.38 -52.38 37.83 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.109 1.363 . . . . 0.0 110.539 171.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -68.48 -25.79 65.15 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -179.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -74.13 -42.73 59.56 Favored 'General case' 0 N--CA 1.48 1.073 0 O-C-N 123.795 0.685 . . . . 0.0 111.097 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 22.1 mmm180 -64.93 -42.93 94.26 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.198 0.599 . . . . 0.0 110.139 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.418 HG23 HD11 ' A' ' 53' ' ' ILE . 93.9 mt -64.93 -43.26 96.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 124.006 0.922 . . . . 0.0 110.549 177.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.482 ' HA ' HG22 ' A' ' 88' ' ' VAL . 23.4 t70 -56.1 -36.83 68.59 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.455 0.702 . . . . 0.0 111.899 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -69.51 -39.07 77.8 Favored 'General case' 0 CA--C 1.553 1.084 0 O-C-N 123.719 0.637 . . . . 0.0 110.407 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 82.0 mt -66.74 -38.53 86.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.43 0.692 . . . . 0.0 111.996 177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.482 HG22 ' HA ' ' A' ' 85' ' ' ASP . 13.7 m -80.55 -25.73 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 O-C-N 122.184 -0.323 . . . . 0.0 110.839 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.17 -38.12 78.55 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.145 0.578 . . . . 0.0 109.825 174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -52.72 -49.34 65.61 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.083 0.953 . . . . 0.0 112.704 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -73.02 -33.69 65.89 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 122.787 0.435 . . . . 0.0 111.108 -178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -70.73 -27.0 73.08 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 116.743 -0.208 . . . . 0.0 113.508 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.17 -25.08 60.65 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 0.0 110.597 -179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.5 mt -59.5 -18.71 42.35 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.846 0.858 . . . . 0.0 112.457 173.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -71.04 111.72 6.63 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 169.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.8 p-80 -73.17 146.58 45.49 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.855 0.862 . . . . 0.0 111.618 -175.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 26.2 t60 73.18 2.14 4.24 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.393 1.477 . . . . 0.0 112.873 168.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 43.65 110.05 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 126.742 2.017 . . . . 0.0 113.295 -171.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -79.57 71.96 6.21 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.682 0.753 . . . . 0.0 109.811 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 26.7 t60 -149.63 94.04 2.13 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 179.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 68.7 m80 . . . . . 0 C--O 1.247 0.94 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -178.71 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtm . . . . . 0 N--CA 1.483 1.195 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 m -67.0 119.08 11.37 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -61.55 132.83 54.64 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 175.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 8' ' ' VAL . 16.8 m -51.07 -35.37 34.45 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 124.458 1.099 . . . . 0.0 111.55 -176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -68.25 -32.11 72.07 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.96 -175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -59.31 -48.09 82.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 122.66 0.384 . . . . 0.0 111.071 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 -69.33 -46.23 67.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 123.865 0.728 . . . . 0.0 111.066 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 4' ' ' THR . 97.0 t -57.97 -42.67 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.76 0.824 . . . . 0.0 111.314 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.98 91.18 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.608 0.763 . . . . 0.0 110.647 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.6 m -56.41 -44.12 80.04 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.956 0.903 . . . . 0.0 111.597 173.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.485 HG21 HG13 ' A' ' 47' ' ' ILE . 29.3 mm -58.17 -57.87 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.88 0.872 . . . . 0.0 110.049 177.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 73.0 mt -61.65 -33.17 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 C-N-CA 124.37 1.068 . . . . 0.0 111.593 -175.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -53.24 59.95 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.933 0.893 . . . . 0.0 111.437 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -84.17 -24.66 30.05 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -173.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.498 HG21 ' HA ' ' A' ' 43' ' ' ILE . 37.4 p -74.95 -62.05 1.68 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.745 0.418 . . . . 0.0 110.353 179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.618 ' SG ' HD11 ' A' ' 43' ' ' ILE . 26.2 m -94.48 12.57 26.81 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.206 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 16.6 t70 67.34 16.91 10.15 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.775 1.23 . . . . 0.0 111.991 174.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 47.8 mt -77.34 127.36 83.22 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 122.892 0.477 . . . . 0.0 110.284 -174.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.71 127.03 23.01 Favored 'Trans proline' 0 CA--C 1.56 1.776 0 C-N-CA 122.744 2.296 . . . . 0.0 112.365 172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 10.3 tpt180 -59.57 -31.54 69.53 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 124.248 1.019 . . . . 0.0 110.804 178.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 22' ' ' THR . 10.8 pt-20 -59.91 -27.92 67.16 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.811 1.244 . . . . 0.0 112.374 178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.496 HG23 ' HG3' ' A' ' 21' ' ' GLU . 45.0 p -105.15 -6.82 19.52 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.539 0.735 . . . . 0.0 111.947 -178.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.1 mt -71.04 116.19 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-O 121.164 0.507 . . . . 0.0 110.509 177.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p -125.41 138.25 31.42 Favored Pre-proline 0 CA--C 1.545 0.778 0 C-N-CA 125.085 1.354 . . . . 0.0 108.435 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.566 ' HB2' ' HB3' ' A' ' 78' ' ' LYS . 36.8 Cg_endo -60.93 -27.22 84.46 Favored 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 122.998 2.465 . . . . 0.0 112.942 -177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -72.29 -20.84 61.44 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 124.179 0.992 . . . . 0.0 112.351 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.1 t -75.48 146.62 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 122.724 0.41 . . . . 0.0 110.362 -175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 30.1 t-80 -107.85 136.38 47.67 Favored 'General case' 0 C--O 1.247 0.971 0 C-N-CA 124.159 0.984 . . . . 0.0 108.819 176.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -49.34 -63.49 1.09 Allowed 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.28 1.432 . . . . 0.0 113.545 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 52.5 mt -75.89 -28.21 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.797 0.439 . . . . 0.0 110.836 -174.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' A' ' 28' ' ' HIS . 17.7 t70 -63.8 -65.97 0.61 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.07 0.948 . . . . 0.0 112.018 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -109.69 -48.02 3.28 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.048 0.539 . . . . 0.0 110.527 -170.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 86.4 mt -66.33 -23.53 66.38 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.087 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 65.05 26.67 71.55 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 115.964 -0.562 . . . . 0.0 113.046 178.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.414 ' HB ' ' HB1' ' A' ' 29' ' ' ALA . 69.5 mt -65.52 120.57 12.8 Favored 'Isoleucine or valine' 0 C--N 1.349 0.551 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 175.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -71.57 164.43 25.89 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.3 t -77.08 -22.04 53.43 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 122.053 -0.404 . . . . 0.0 110.003 -175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.7 -32.03 22.15 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.684 0.794 . . . . 0.0 109.537 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -73.05 -29.63 63.13 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.243 1.017 . . . . 0.0 110.534 177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -73.88 -22.5 59.7 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.436 0.695 . . . . 0.0 110.059 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 57' ' ' LEU . 93.4 mt -57.71 -35.78 71.1 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 122.745 0.418 . . . . 0.0 110.815 174.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -69.74 -36.77 76.13 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.653 0.781 . . . . 0.0 110.858 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.618 HD11 ' SG ' ' A' ' 16' ' ' CYS . 52.3 mt -62.08 -53.03 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.585 0.754 . . . . 0.0 109.538 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.24 85.25 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 114.424 -1.262 . . . . 0.0 111.329 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -71.84 -40.13 69.27 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.622 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.97 -34.47 78.5 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.877 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.485 HG13 HG21 ' A' ' 11' ' ' ILE . 82.1 mt -72.11 -38.67 63.79 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.006 0 C-N-CA 124.607 1.163 . . . . 0.0 111.388 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -53.32 -46.16 69.34 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 123.86 0.864 . . . . 0.0 110.925 174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -77.53 -47.57 19.18 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.347 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.41 -50.33 65.86 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 123.662 0.785 . . . . 0.0 111.803 -170.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.463 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 59.8 m-85 -83.92 -28.36 27.92 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.632 -179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 78.91 45.88 8.82 Favored Glycine 0 C--N 1.348 1.204 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -173.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 51' ' ' PHE . 37.6 pt -127.14 -175.35 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 124.049 0.94 . . . . 0.0 111.051 -177.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -124.04 99.71 6.38 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.28 1.032 . . . . 0.0 108.488 174.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 tt -89.88 104.26 8.06 Favored Pre-proline 0 CA--C 1.543 0.689 0 N-CA-C 107.03 -1.471 . . . . 0.0 107.03 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -84.68 81.65 1.94 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 121.47 1.447 . . . . 0.0 111.409 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 41' ' ' LEU . 54.3 tp -69.75 -32.76 71.46 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.767 0.427 . . . . 0.0 110.099 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -57.18 -36.35 70.69 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.44 1.096 . . . . 0.0 110.903 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 39.4 ttpt -78.11 -44.16 26.91 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.677 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 43.3 m0 -62.89 -39.38 94.31 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.563 0.745 . . . . 0.0 111.436 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.6 m -56.56 -46.31 80.79 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.508 1.123 . . . . 0.0 111.073 170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -66.38 -34.91 79.03 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 124.076 0.95 . . . . 0.0 111.101 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 24.9 mm-40 -59.44 -42.72 92.54 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.117 0.567 . . . . 0.0 110.442 176.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.492 HG11 HG23 ' A' ' 71' ' ' THR . 59.0 t -68.28 -49.61 65.18 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.662 176.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -61.9 -28.9 69.84 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.93 0.892 . . . . 0.0 112.947 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -95.06 -7.8 38.52 Favored 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 123.851 0.861 . . . . 0.0 110.849 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 83.62 10.87 80.87 Favored Glycine 0 C--N 1.354 1.548 0 CA-C-N 116.052 -0.522 . . . . 0.0 113.558 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -83.61 -10.92 57.92 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.7 0.8 . . . . 0.0 112.121 -178.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -161.72 168.63 22.94 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.253 0.621 . . . . 0.0 110.837 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.5 p -104.36 157.45 17.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.919 178.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.492 HG23 HG11 ' A' ' 64' ' ' VAL . 32.2 p -67.98 -28.63 67.61 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.634 170.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -60.62 -39.56 88.66 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.164 0.586 . . . . 0.0 110.65 175.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -56.37 -34.72 66.93 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.868 0.867 . . . . 0.0 112.133 178.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -107.47 -71.81 0.74 Allowed 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.373 -176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 57.2 m-85 -60.66 -18.23 52.41 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -165.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 84.8 t -65.6 128.4 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.811 1.187 . . . . 0.0 108.189 169.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.1 mt -57.82 -39.2 77.07 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -165.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HB3' ' HB2' ' A' ' 25' ' ' PRO . 22.2 pttp -68.55 -38.17 80.56 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 123.428 0.455 . . . . 0.0 112.089 175.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.449 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 4.0 m-20 -70.36 -46.61 63.75 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.47 0.708 . . . . 0.0 110.128 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -52.06 -49.14 64.08 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.285 1.434 . . . . 0.0 110.863 170.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.48 69.26 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.347 0.659 . . . . 0.0 110.832 -178.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.07 -39.61 55.02 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.723 0.409 . . . . 0.0 110.739 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 14.5 mmm180 -59.35 -43.39 92.8 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.352 0.596 . . . . 0.0 110.899 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.411 ' CD1' HD13 ' A' ' 47' ' ' ILE . 78.4 mt -71.7 -38.35 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.294 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.4 -38.64 66.44 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.744 0.818 . . . . 0.0 111.882 170.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -69.48 -40.66 76.92 Favored 'General case' 0 CA--C 1.555 1.164 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.545 176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 80.2 mt -64.43 -42.82 95.8 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 124.142 0.977 . . . . 0.0 112.957 177.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.9 m -75.73 -26.6 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 122.604 0.362 . . . . 0.0 110.27 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.83 -36.8 73.08 Favored 'General case' 0 C--O 1.217 -0.633 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.953 171.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.02 -47.82 81.92 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.706 0.803 . . . . 0.0 112.981 176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.463 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 22.8 pttp -73.83 -33.39 64.12 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 120.798 0.333 . . . . 0.0 110.6 176.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -65.85 -26.75 72.29 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.09 -0.505 . . . . 0.0 113.56 171.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.11 -24.32 63.18 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 122.902 0.481 . . . . 0.0 111.631 -177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.5 mt -50.54 -49.47 55.9 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.892 0.877 . . . . 0.0 110.02 169.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.22 105.38 11.44 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 168.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.3 m-70 -62.46 128.9 38.17 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 120.96 0.409 . . . . 0.0 111.038 -175.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -64.28 105.94 1.01 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.247 1.419 . . . . 0.0 111.166 -172.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 40.5 m80 -128.53 156.43 43.3 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 124.653 1.181 . . . . 0.0 109.431 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 49.3 m80 -73.21 115.94 13.15 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.306 0.642 . . . . 0.0 109.483 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -85.83 135.08 33.86 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.727 0.811 . . . . 0.0 109.56 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.246 0.913 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -176.12 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.6 ptp . . . . . 0 N--CA 1.483 1.191 0 N-CA-C 110.797 -0.075 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 20.9 m -103.98 151.3 23.35 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.952 0.501 . . . . 0.0 109.723 176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 t -139.91 160.44 39.91 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.232 1.413 . . . . 0.0 109.237 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.523 ' O ' HG23 ' A' ' 8' ' ' VAL . 79.8 m -58.38 -28.29 65.02 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.964 173.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -65.35 -58.68 5.29 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.81 -29.77 68.46 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 123.867 0.729 . . . . 0.0 111.588 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -64.98 -51.53 61.19 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.978 0.911 . . . . 0.0 110.75 174.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 4' ' ' THR . 54.3 t -61.83 -36.17 72.18 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 123.144 0.578 . . . . 0.0 111.028 176.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.73 -43.31 93.81 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.849 . . . . 0.0 109.958 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 54.2 m -54.92 -46.91 74.97 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.738 1.215 . . . . 0.0 111.409 171.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.576 HG21 HG13 ' A' ' 47' ' ' ILE . 41.9 mm -58.4 -58.32 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.501 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.406 HG22 HD12 ' A' ' 18' ' ' ILE . 77.4 mt -58.76 -37.14 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.434 1.094 . . . . 0.0 111.387 -175.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.5 -49.14 78.43 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.927 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -88.58 -27.44 21.37 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.417 ' OG1' HG12 ' A' ' 43' ' ' ILE . 21.7 p -80.4 -59.94 2.51 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 118.502 0.592 . . . . 0.0 110.74 179.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.645 ' SG ' HG12 ' A' ' 35' ' ' ILE . 44.8 t -80.06 -8.39 59.36 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.234 1.014 . . . . 0.0 111.887 -177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 35.2 t70 61.68 71.92 0.53 Allowed 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.822 0.849 . . . . 0.0 110.158 -178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.406 HD12 HG22 ' A' ' 12' ' ' ILE . 39.3 mt -127.78 128.48 23.87 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.241 1.016 . . . . 0.0 108.842 178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -53.58 134.9 60.01 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.992 2.461 . . . . 0.0 112.553 168.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HD2' HD12 ' A' ' 23' ' ' ILE . 9.4 mmm180 -59.25 -29.2 67.37 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.873 0.869 . . . . 0.0 111.554 177.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.568 ' HG3' HG23 ' A' ' 22' ' ' THR . 14.2 pt-20 -63.26 -33.71 76.09 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.731 0.812 . . . . 0.0 111.19 177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.568 HG23 ' HG3' ' A' ' 21' ' ' GLU . 46.0 p -101.7 21.42 14.48 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.152 0.981 . . . . 0.0 111.447 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.52 HD12 ' HD2' ' A' ' 20' ' ' ARG . 63.5 mt -106.45 128.21 61.18 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.5 p -138.41 155.66 73.79 Favored Pre-proline 0 N--CA 1.481 1.088 0 C-N-CA 124.073 0.949 . . . . 0.0 109.557 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -56.5 -35.01 96.34 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.328 2.019 . . . . 0.0 112.878 170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -77.15 -21.69 53.71 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 123.732 0.813 . . . . 0.0 112.092 -174.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.3 p -69.98 128.89 37.91 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 120.727 0.299 . . . . 0.0 110.389 -175.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 53.5 t-80 -88.41 129.89 35.31 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 176.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.564 ' HB3' ' HB3' ' A' ' 75' ' ' PHE . . . -51.68 -59.12 4.64 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.016 0.526 . . . . 0.0 111.994 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.422 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 45.1 mt -71.33 -60.55 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-O 120.657 0.265 . . . . 0.0 110.803 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -61.74 -49.15 77.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.268 1.027 . . . . 0.0 112.901 -171.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -92.86 -58.56 2.3 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.83 0.452 . . . . 0.0 111.498 -172.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.1 mt -76.13 -19.6 58.37 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.401 0.68 . . . . 0.0 111.767 -171.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.36 11.12 76.01 Favored Glycine 0 N--CA 1.478 1.463 0 O-C-N 122.986 0.178 . . . . 0.0 113.518 176.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.645 HG12 ' SG ' ' A' ' 16' ' ' CYS . 47.6 mt -73.32 117.12 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.106 0.962 . . . . 0.0 110.22 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.6 163.19 27.11 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.2 m -63.64 -16.51 61.14 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 122.911 0.484 . . . . 0.0 111.726 175.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 49.9 mt -85.15 -43.88 13.45 Favored 'General case' 0 C--N 1.352 0.715 0 C-N-CA 123.718 0.807 . . . . 0.0 109.509 175.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -65.89 -31.4 72.31 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.116 0.966 . . . . 0.0 110.793 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.413 ' HB3' HD21 ' A' ' 57' ' ' LEU . 8.8 t80 -72.2 -20.93 61.49 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.01 0.924 . . . . 0.0 110.685 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 57' ' ' LEU . 78.4 mt -57.62 -31.2 65.99 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 122.784 0.434 . . . . 0.0 111.849 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -69.75 -43.24 72.67 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.233 1.013 . . . . 0.0 109.262 177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG12 ' OG1' ' A' ' 15' ' ' THR . 64.4 mt -60.06 -51.59 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.118 178.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.8 -40.74 89.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.842 -178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 13.9 t80 -66.1 -38.33 87.97 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.423 -177.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.453 ' HB3' HG23 ' A' ' 11' ' ' ILE . . . -73.73 -29.23 62.13 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.178 0.591 . . . . 0.0 111.652 178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.576 HG13 HG21 ' A' ' 11' ' ' ILE . 87.3 mt -70.72 -39.38 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 C-N-CA 123.654 0.782 . . . . 0.0 110.587 176.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -54.34 -34.77 61.76 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.97 0.908 . . . . 0.0 111.829 171.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -83.38 -51.79 7.09 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.42 0.688 . . . . 0.0 111.251 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.05 -49.26 76.69 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.337 1.055 . . . . 0.0 111.673 -171.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.515 ' HB2' HG12 ' A' ' 53' ' ' ILE . 72.9 m-85 -88.58 -14.41 37.65 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.022 178.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 74.47 11.32 82.62 Favored Glycine 0 C--N 1.354 1.538 0 CA-C-N 116.61 -0.268 . . . . 0.0 113.089 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.515 HG12 ' HB2' ' A' ' 51' ' ' PHE . 38.4 pt -96.13 -171.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 123.878 0.871 . . . . 0.0 110.58 -173.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -115.63 114.83 25.42 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 167.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.1 tt -100.05 98.35 7.4 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 166.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.467 ' HG2' ' HD3' ' A' ' 59' ' ' LYS . 86.9 Cg_endo -81.09 86.41 1.63 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 122.287 1.991 . . . . 0.0 110.442 175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.552 HD23 HD23 ' A' ' 41' ' ' LEU . 65.9 tp -67.08 -40.41 86.99 Favored 'General case' 0 C--O 1.21 -0.984 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.774 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -63.63 -31.07 72.13 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.109 0.964 . . . . 0.0 110.991 -177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.467 ' HD3' ' HG2' ' A' ' 56' ' ' PRO . 47.7 tttp -65.5 -48.29 73.09 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.004 1.322 . . . . 0.0 110.187 171.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 64' ' ' VAL . 45.2 m0 -63.36 -43.63 97.13 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.854 0.861 . . . . 0.0 110.787 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 94.0 m -59.36 -46.0 89.86 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 125.459 1.504 . . . . 0.0 111.243 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -65.14 -44.9 87.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.532 0.733 . . . . 0.0 111.001 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -74.96 -26.69 59.77 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.881 0.473 . . . . 0.0 112.222 -174.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.523 HG11 HG23 ' A' ' 71' ' ' THR . 90.3 t -72.72 -42.28 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 171.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -70.68 -17.45 62.84 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.623 176.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -97.01 -6.88 34.34 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.72 1.208 . . . . 0.0 110.298 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 80.82 10.55 84.96 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-N 115.721 -0.672 . . . . 0.0 114.071 176.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 12.5 mmmm -79.18 -16.98 55.78 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.842 0.857 . . . . 0.0 110.981 177.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.26 166.89 30.37 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.888 0.875 . . . . 0.0 109.999 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.468 HG23 ' H ' ' A' ' 73' ' ' GLN . 9.7 t -111.57 155.65 22.98 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.47 0.708 . . . . 0.0 110.326 175.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.523 HG23 HG11 ' A' ' 64' ' ' VAL . 30.2 p -63.09 -32.52 73.91 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.558 0.743 . . . . 0.0 110.988 177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.465 ' HG3' HG21 ' A' ' 76' ' ' VAL . 36.1 tt0 -58.29 -44.36 88.46 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.561 0.344 . . . . 0.0 111.459 178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.468 ' H ' HG23 ' A' ' 70' ' ' THR . 30.3 tt0 -56.32 -32.59 64.8 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 123.768 0.827 . . . . 0.0 111.61 -177.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -102.12 -82.09 0.48 Allowed 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.564 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 88.9 m-85 -55.89 -24.6 38.3 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 -161.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 92.2 t -65.54 124.79 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 CA-C-N 119.783 1.174 . . . . 0.0 108.303 170.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.7 mt -61.85 -32.97 73.35 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -160.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.501 ' HG2' HG12 ' A' ' 76' ' ' VAL . 62.9 pttt -65.5 -41.28 93.39 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 122.976 0.51 . . . . 0.0 111.243 174.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -76.29 -41.07 49.97 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.852 0.861 . . . . 0.0 110.066 -176.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.1 tp -52.95 -47.07 68.36 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.831 1.652 . . . . 0.0 110.931 169.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -64.91 -29.35 70.28 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.447 0.699 . . . . 0.0 111.467 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.39 -41.5 47.69 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.413 0.685 . . . . 0.0 110.871 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.464 ' O ' ' HG ' ' A' ' 87' ' ' LEU . 23.2 mmm180 -57.58 -50.28 73.62 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.028 0.931 . . . . 0.0 111.101 173.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 92.9 mt -68.08 -38.83 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.031 0.932 . . . . 0.0 110.443 -178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HA ' HG22 ' A' ' 88' ' ' VAL . 19.9 t70 -58.14 -35.52 71.64 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 122.81 0.444 . . . . 0.0 111.569 171.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -71.47 -39.79 70.7 Favored 'General case' 0 CA--C 1.555 1.163 0 C-N-CA 122.491 0.316 . . . . 0.0 110.735 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 83' ' ' ARG . 61.4 mt -61.93 -43.77 98.16 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 123.428 0.691 . . . . 0.0 111.733 176.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG12 HG21 ' A' ' 53' ' ' ILE . 12.2 m -71.68 -27.68 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 C-N-CA 122.761 0.424 . . . . 0.0 110.43 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.51 -36.1 65.7 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.101 175.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.92 95.8 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.696 0.799 . . . . 0.0 112.934 174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.4 pttp -71.12 -36.24 72.05 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 173.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -68.18 -13.41 64.64 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.824 173.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.7 -37.27 76.54 Favored 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 172.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.9 mt -71.7 -29.39 64.51 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.945 0.898 . . . . 0.0 110.393 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.98 101.6 1.15 Allowed 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 164.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -60.11 130.45 46.73 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.147 -172.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -64.46 121.26 13.97 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 123.746 0.654 . . . . 0.0 110.168 179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -123.75 32.96 5.44 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.61 1.164 . . . . 0.0 110.405 -173.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 29.8 p80 42.22 73.51 0.13 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.385 1.874 . . . . 0.0 113.563 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -99.72 77.75 2.09 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.505 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 124.498 1.119 . . . . 0.0 108.695 -176.794 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 111.6 0.222 . . . . 0.0 111.6 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m -75.61 125.3 28.78 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 122.774 0.43 . . . . 0.0 110.578 178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.1 m -72.74 144.99 47.42 Favored 'General case' 0 C--O 1.245 0.864 0 C-N-CA 123.597 0.759 . . . . 0.0 110.519 174.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG23 ' A' ' 8' ' ' VAL . 6.9 m -64.62 -18.6 65.07 Favored 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.621 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -67.49 -47.28 70.48 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 122.728 0.411 . . . . 0.0 110.299 173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -54.78 -44.4 73.68 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.406 0.683 . . . . 0.0 111.461 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -60.49 -55.63 31.16 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.088 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 4' ' ' THR . 58.3 t -60.39 -37.14 73.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.51 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.37 87.67 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.105 0.962 . . . . 0.0 110.518 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 99.0 m -57.53 -42.81 83.64 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.141 0.976 . . . . 0.0 111.778 173.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.522 HG21 HG13 ' A' ' 47' ' ' ILE . 33.4 mm -58.79 -50.94 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.38 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 70.1 mt -64.07 -33.99 65.83 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.154 0 C-N-CA 123.149 0.58 . . . . 0.0 110.648 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -51.26 62.06 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.382 1.073 . . . . 0.0 112.317 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -77.44 -46.51 22.39 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.708 0.403 . . . . 0.0 111.959 -178.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.1 m -72.46 -51.96 17.91 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.12 0.568 . . . . 0.0 111.616 -172.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.5 t -86.77 -9.28 56.22 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.382 0.673 . . . . 0.0 111.777 -178.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 38.2 t70 59.02 72.07 0.55 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.381 1.072 . . . . 0.0 110.597 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 33.1 mt -132.13 129.65 21.79 Favored Pre-proline 0 N--CA 1.48 1.031 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.14 139.33 85.38 Favored 'Trans proline' 0 C--N 1.382 2.295 0 C-N-CA 122.796 2.33 . . . . 0.0 112.358 173.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 22.3 mmm-85 -61.06 -28.98 69.46 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.335 0.654 . . . . 0.0 112.129 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -66.34 -37.07 84.5 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.544 0.738 . . . . 0.0 111.236 177.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 62.4 p -81.48 -23.03 37.66 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 122.953 0.501 . . . . 0.0 111.012 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.474 HG23 HD13 ' A' ' 77' ' ' LEU . 75.8 mt -76.63 116.4 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 174.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.0 p -132.32 144.72 54.23 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 124.504 1.122 . . . . 0.0 109.204 -177.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -60.9 -32.18 92.33 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.814 2.343 . . . . 0.0 112.792 -176.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -73.13 -20.67 60.87 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.642 0.777 . . . . 0.0 112.011 -177.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.9 t -73.58 147.76 43.57 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.989 0.915 . . . . 0.0 110.709 -175.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.59 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 56.1 t-80 -104.37 133.71 48.8 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.553 1.141 . . . . 0.0 108.955 175.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.96 -64.43 0.84 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.717 0.807 . . . . 0.0 112.705 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 35' ' ' ILE . 46.2 mt -69.81 -39.6 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.835 0.454 . . . . 0.0 111.603 -173.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -80.52 -67.62 0.75 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.499 -174.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -72.79 -57.7 3.89 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 122.683 0.393 . . . . 0.0 111.067 -171.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 77' ' ' LEU . 84.9 mt -71.67 -26.94 62.74 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.209 0.604 . . . . 0.0 111.108 -176.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.79 21.9 60.72 Favored Glycine 0 C--N 1.348 1.221 0 O-C-N 123.863 0.727 . . . . 0.0 113.552 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 30' ' ' ILE . 65.6 mt -70.2 129.21 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.811 0.844 . . . . 0.0 110.026 176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -77.1 158.69 30.32 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.404 ' O ' ' HG ' ' A' ' 41' ' ' LEU . 33.1 m -65.55 -17.4 64.54 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 122.53 0.332 . . . . 0.0 110.84 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 54.8 mt -75.88 -47.57 24.91 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.52 1.128 . . . . 0.0 109.299 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -70.65 -29.2 65.49 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.721 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -73.06 -22.26 60.64 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.616 0.766 . . . . 0.0 110.451 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 57' ' ' LEU . 96.0 mt -60.15 -39.61 86.96 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 122.681 0.392 . . . . 0.0 109.985 174.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -62.0 -44.11 97.41 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.883 0.873 . . . . 0.0 110.775 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 73.0 mt -62.57 -48.89 86.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.493 0.717 . . . . 0.0 109.948 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.94 -32.07 73.36 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.21 -176.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -65.2 -43.8 90.42 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.05 0.94 . . . . 0.0 110.179 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.03 -32.05 70.0 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.245 178.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.526 HD13 HD11 ' A' ' 84' ' ' ILE . 84.9 mt -65.22 -42.64 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.855 0.862 . . . . 0.0 110.478 176.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -53.89 -48.71 69.84 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.399 0.68 . . . . 0.0 111.463 176.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -80.04 -37.49 33.92 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.445 -172.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.9 -52.22 31.8 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.367 0.667 . . . . 0.0 111.287 -175.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PHE . . . . . 0.448 ' O ' ' HE2' ' A' ' 91' ' ' LYS . 92.6 m-85 -82.16 -28.05 32.35 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.996 -178.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.22 39.4 8.47 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 111.946 -0.461 . . . . 0.0 111.946 -176.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 pt -126.5 -172.48 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 124.197 0.999 . . . . 0.0 110.85 -175.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -131.0 100.94 5.41 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 167.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 10.2 tt -72.82 113.62 23.13 Favored Pre-proline 0 CA--C 1.553 1.073 0 N-CA-C 108.207 -1.035 . . . . 0.0 108.207 172.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -84.91 80.5 2.14 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.976 1.784 . . . . 0.0 110.966 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.532 HD23 HD23 ' A' ' 41' ' ' LEU . 46.3 tp -70.08 -35.62 74.34 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.146 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -59.0 -39.43 81.82 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.481 1.113 . . . . 0.0 111.127 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' O ' ' HG2' ' A' ' 63' ' ' GLU . 37.8 ttpt -74.65 -40.89 61.18 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.033 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TRP . . . . . . . . . . . . . 49.7 m0 -64.02 -42.47 97.09 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.929 0.768 . . . . 0.0 111.233 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.6 m -59.51 -39.56 84.23 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.937 0.895 . . . . 0.0 111.141 171.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -68.97 -34.94 76.13 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.961 0.904 . . . . 0.0 110.888 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 59' ' ' LYS . 23.0 mm-40 -61.89 -39.95 93.74 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.356 0.662 . . . . 0.0 110.595 175.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 69' ' ' ALA . 58.1 t -65.44 -44.55 94.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.993 0.517 . . . . 0.0 109.972 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -57.93 -44.29 86.8 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.327 1.051 . . . . 0.0 112.173 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -84.31 -18.72 35.41 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.017 0.927 . . . . 0.0 111.654 -174.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.04 21.94 53.92 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 122.674 0.178 . . . . 0.0 113.0 -175.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -79.03 -24.03 43.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.515 0.726 . . . . 0.0 110.552 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 64' ' ' VAL . . . -153.87 166.41 33.0 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 123.818 0.847 . . . . 0.0 110.047 -179.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.2 t -107.74 166.85 10.38 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.193 173.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.2 m -67.72 -30.91 70.52 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.76 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.58 -35.17 78.65 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.764 0.825 . . . . 0.0 111.399 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -62.11 -31.99 72.52 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.323 0.649 . . . . 0.0 112.392 -172.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -109.27 -58.55 2.02 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -70.91 -10.9 60.53 Favored 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -165.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.59 ' HA ' ' HA ' ' A' ' 28' ' ' HIS . 79.7 t -63.99 133.39 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 167.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' LEU . 36.1 mt -60.03 -41.12 91.51 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 123.539 0.735 . . . . 0.0 112.641 -166.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.1 pttt -67.8 -35.21 78.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 123.147 0.279 . . . . 0.0 111.721 175.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.404 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 3.8 m-20 -68.22 -47.99 66.37 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.184 0.593 . . . . 0.0 109.662 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -52.19 -46.79 65.7 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.619 1.568 . . . . 0.0 110.385 172.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.439 ' HA ' HG21 ' A' ' 8' ' ' VAL . . . -63.78 -34.55 78.14 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.892 0.877 . . . . 0.0 111.994 179.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.2 -37.54 61.14 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.1 0.56 . . . . 0.0 110.861 178.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 15.7 mmm180 -64.03 -39.04 93.21 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.087 0.955 . . . . 0.0 111.401 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.526 HD11 HD13 ' A' ' 47' ' ' ILE . 96.7 mt -72.83 -37.03 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.547 0.739 . . . . 0.0 109.861 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.91 -42.91 65.81 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.787 0.835 . . . . 0.0 111.419 167.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -62.76 -46.83 86.21 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.433 0.693 . . . . 0.0 111.087 175.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 64.3 mt -62.55 -45.47 92.78 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.326 1.05 . . . . 0.0 112.578 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 19.9 m -72.2 -27.37 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 122.913 0.485 . . . . 0.0 109.985 177.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.63 -34.64 76.08 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.34 173.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.15 93.04 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' HE2' ' O ' ' A' ' 51' ' ' PHE . 22.4 pttp -76.64 -33.36 58.35 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 122.291 -0.256 . . . . 0.0 110.501 177.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -67.06 -20.88 71.3 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.087 169.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 96' ' ' HIS . . . -75.78 -30.51 59.13 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.164 0.586 . . . . 0.0 110.505 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.04 -21.23 44.39 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.161 0.984 . . . . 0.0 111.397 171.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -88.9 60.34 5.45 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.102 0.961 . . . . 0.0 108.871 168.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 93' ' ' ALA . 55.2 t-80 -91.97 56.19 2.83 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.272 1.029 . . . . 0.0 109.911 -175.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 58.84 -143.34 0.62 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.627 0.771 . . . . 0.0 109.502 -176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -79.72 167.97 19.94 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 118.08 0.4 . . . . 0.0 109.928 166.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 31.9 p-80 -59.85 133.51 56.16 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.93 0.892 . . . . 0.0 111.176 -177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -139.57 143.8 37.5 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 122.973 0.509 . . . . 0.0 110.143 -178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 CA--C 1.553 1.058 0 C-N-CA 123.976 0.911 . . . . 0.0 110.707 179.949 . . . . . . . . 0 0 . 1 stop_ save_